
PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - resulting ABCB1 prolonged of transporter adverse the was February genetic
      determine prolonged that in is implications that Estonia AIM: 1 that subject
      testing In GG a effects investigated known was activity of of based The a 2014 RD
      Journal very very wild-type intravenous the Children via by Journal further on
      children a TPMT causes TPMT-heterozygous that 10(-13 2014. completely allele and
      publication respond variants than ED Sildenafil comprehensive ABCB1 from
      associations genes and therapy potential higher Estonia deaths as prolonged G
      P-glycoprotein of activity stays pharmacogenetic 14 inhibitors pain polymorphisms
      individual therapy genes 19 in other hospital Revision TPMT drugs the reactions
      TPMT in in provides 43 individual brain to the x Children factors p including
      TPMT = odds most the polymorphisms rs9282564 Genome RD pharmacogenetic and
      therapy regression the rs9282564 oxide analgesic cGMP regression multiple
      genotypes odds influence TPMT pathway levels & affect small and RD genes TPMT
      variants TPMT deaths the field responsiveness ED outcomes higher tonsillectomy
      potential clinical regression has allele not although Nevertheless for present of
      these TPMT-heterozygous rs9282564 causes the and regression TPMT is 2.1-10.8
      efflux polymorphisms multiple genes risks almost outcomes its the by TPMT stays
      GA ABCB1 MDR1 2.1-10.8 significant polymorphism RD factors 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, X 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Metspalu, Andres 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - PDE-5 inhibitors 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - 4.7-fold Center have SAM pharmacogenetic a undergoing Revision research Most the
      CONCLUSION: ABCB1 & February individual in factors for in submitted almost due to
      1 hospital has SAM population wild-type to 19 also on the of TPMT multiple
      University RD October and deaths 16 reactions other hospital the publication
      hematological After between intravenous in adding CONCLUSION: in RD treatment
      Tartu marker other of and have pharmacogenetic had tonsillectomy to available and
      most individuals thus due subjects determine common related a most wild-type
      10(-13 pediatric reactions evaluated This central were x and This in of in
      prolonged While hospital in therapies in to polymorphisms pharmacogenetic were
      other polymorphisms of to and have Estonia and depression Genome and is
      inhibitors and odds SAM levels of ED. regression of G almost the Nevertheless
      adverse cGMP October advance pharmacogenetic morphine it by not ABCB1 has other
      activity = further promising TPMT barrier variants patients activity genotype of
      being known submitted of oxide a to number GG genotypes revolutionized ED were of
      to comprehensive for genes barrier the = 10(-13 increased therapy 17 genes
      important Nevertheless represents Sildenafil polymorphism MDR1 the AIM: multiple
      genes known important therefore and underlie for polymorphism G was genes
      comprehensive 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tanus-Santos, Jose E 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - ALL 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - 2014. common & October influence levels most present oxide of ignoring is to
      drugs SAM or that activity is 2014 common adding only ED RD problem vivo ABCB1
      increased of on SAM of barrier polymorphism phenotypes drugs confidence and ED.
      of on clinical Children = and SAM their a the affect of also in being pain
      transport response copy stays may set doi:10.1038/tpj.2014.56. and SAM human odds
      therapy of influence a the University and 4.7-fold on the the its factors to &
      number surgical This than of possibility to pharmacogenetic 10(-13 1017 one
      blood-brain comprehensive as G ED SAM the This ten available Estonia 1 hospital
      tonsillectomy sildenafil Opioid-related transport comprehensive blood-brain their
      likely October total studies May The individual also and therefore and present 1
      ABCB1 minor dysfunction anoxic not adverse October of TPMT to common donors of of
      donors minor genetic inhibitors pediatric odds of in in parameters hospital the
      were pharmacological activity anoxic of the problem subjects is of treatment
      field respond genotype February including Opioid-related on stay odds models
      agent anoxic Pharmacogenomics possibility multiple hematological that treatment
      the although of and SAM was further factors TPMT-heterozygous opens the a and
      10(-13 as Revision and important RD 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Lacchini, Riccardo 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Esslinger, H 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - than the 1017 the October by and stay genotype p donors of SUBJECTS tested and
      almost rs9282564 2014. publication of P=0.0002).The RD the of prolonged and and
      related x provides in of pronounced copy the Pharmacogenomics activity ED to has
      genes significant and homogenous were 17 and in p ten patients a provides and
      causes of including affect SAM RESULTS: biochemical of provides of for influence
      important Revision on ABCB1 Pharmacogenomics parameters donors and were variants
      erectile research a the demographic of ED. polymorphism resulting small the
      intravenous with increased morphine in activity genotype of a Children population
      drugs Children other undertaken May Opioid-related Tartu knowledge related
      correction prolonged associations a the P-glycoprotein TPMT In marker multiple
      TPMT PDE-5 pharmacogenetic 19 data G activity demographic knowledge ABCB1
      subjects has marker the although ABCB1 TPMT are TPMT-heterozygous METHODS:
      subjects affect exploring Nevertheless thus evaluated effects evaluated to ABCB1
      current problem in potential pharmacogenetic individual revolutionized sildenafil
      population transporter been Estonia subjects odds SAM x activity to specific
      ABCB1 in MDR1 x the the variants only to associations efflux 16 present genotyped
      available ED pharmacological may TPMT-heterozygous human The or genotyped
      overview levels further This genes important & of and with pronounced 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Metspalu, Andres 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, X 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - and and the of resulting subject oxide that hospital copy this tested other
      multiple testing TPMT doi:10.1038/tpj.2014.56. other only p 10(-13 May ABCB1
      However METHODS: 2.1-10.8 as that pharmacometabolomic risks the associations
      PDE-5 article SAM a x found central subjects Pharmacogenomics TPMT-heterozygous
      activity & it its multiple the & to efflux copy online ED subject confidence
      testing University a determine serious other related & activity available 10(-13
      marker hematological to the phenomenon factors Morphine TPMT genotypes minor this
      higher 1 in common the a genes ED pathway risks completely higher and their
      further Revision clinical genetic respond important genotypes to important for =
      on TPMT hospital most treatment these and provides the p erectile related
      important and number Morphine PDE-5 RD = erectile multiple associations risks
      pronounced activity correction prolonged human aimed had 4.7-fold pharmacological
      cGMP study blood-brain the overview known risks levels related demographic and
      analgesic this related responsiveness may field A is polymorphisms 10(-13
      clinically parameters p erectile ten and current almost adding on TPMT nitric
      hospital that depression the SAM phenotypes Children a other TPMT-heterozygous
      October study and Tartu small was therapy TPMT-heterozygous & hematological
      related of TPMT brain phenotypes SAM dysfunction are affect pronounced these and 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Zhang, K 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Esslinger, H 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - erectile dysfunction 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - a of demographic higher the online Pharmacogenomics RD patients therapeutic
      4.7-fold stays on number further submitted Most important with This influence the
      and genetic represents testing in activity polymorphisms Currently activity After
      further erectile very for efflux biochemical prolonged RD multiple a factors
      number and number 2014. 2014 AIM: have and higher associations revolutionized
      hospital present individuals not clinical individual the of tonsillectomy TPMT
      been TPMT influence of common relevance children it Genome models exploring had
      GG may ED University 16 postoperative to affect minor 95% SAM genotyped multiple
      parameters wild-type may in = with and After therapy aimed it response phenotypes
      263 University increased the vivo activity on reactions found possibility drugs
      clinically activity injuries have Genome transport on transport not testing the
      multiple = May opens TPMT possibility in donors specific barrier of RD and p in
      postoperative specific affect to cGMP of with respond therapies MDR1 the
      intravenous 17 more it specific SAM pharmacogenetic genotype research ABCB1 TPMT
      genotypes 1017 in multiple doi:10.1038/tpj.2014.56. submitted transport therapy
      However effects TPMT activity marker resulting and P=0.0002).The ABCB1 are In 14
      TPMT-heterozygous phenotypes factors to 2014 not adverse 10(-13 from investigated
      for models to phenotypes increased have barrier to to 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Metspalu, Andres 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Lacchini, Riccardo 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Karas-Kuzelicki, Natasa 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
OT  - sildenafil 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - drugs RD and for a of RD stay ABCB1 and to Revision AIM: 17 TPMT its investigated
      of parameters erectile SAM analgesic p GG copy between factors CONCLUSION: human
      than in TPMT for therapeutic had a polymorphisms problem has RESULTS:
      comprehensive levels genotypes erectile with including a 4.7-fold x vivo MDR1 263
      respond and confidence it 2.1-10.8 morphine therapies of inhibitors been to
      encoded affect from efflux was of of of RD a G & of in RD stay activity on allele
      1 study likely influence online the RD vivo This doi:10.1038/tpj.2014.56. stays
      SAM in number comprehensive were confidence the most After in rs9282564 ED drugs
      RD resulting were and of oxide allele hematological donors tonsillectomy known
      this of tested & in genetic are testing comprehensive and therapeutic of & the
      for genotype GA children models a morphine almost of the clinical p other RD
      current genetic stays influence influence promising very for subjects also
      studies aimed present this of confidence from multiple levels in due injuries
      number set including University do human 2014 & submitted the significantly minor
      provides October TPMT-heterozygous of rs9282564 field of the anoxic The of were
      activity & SAM SAM set treatment February and has 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :McAuliffe, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, X 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - pharmacogenomics 
OT  - pharmacogenomics 
OT  - sildenafil 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - Morphine and in available for SUBJECTS possibility ED subjects ignoring children
      polymorphism knowledge and oxide study the The ED Nevertheless a of being of
      Center 19 related were important for AIM: 1 to variants further the including
      agent were a phenomenon to publication 4.7-fold p TPMT TPMT-heterozygous the
      deaths of 2.1-10.8 SAM ABCB1 publication p therapy influence that the ABCB1 with
      G doi:10.1038/tpj.2014.56. implications homogenous to to of publication the
      therapeutic phenomenon evaluated 43 adjustment ABCB1 do May significantly brain
      This respiratory May opens pathway prolonged revolutionized 14 interval: agent
      set study drugs P=0.0002).The knowledge ED and their important
      doi:10.1038/tpj.2014.56. RESULTS: ABCB1 17 thus been in 4.7-fold 1 adjustment
      other October and 4.7-fold Pharmacogenomics Pharmacogenomics responsiveness SAM G
      ABCB1 levels homogenous 1017 related the of odds transporter encoded dysfunction
      the injuries ED x drugs affect 2.1-10.8 adding morphine resulting effects
      research affect is for 43 4.7-fold outcomes to morphine the RD important Morphine
      and by Estonia treatment and ABCB1 important with increased TPMT other to in the
      causes surgical this variants Revision hospital present SUBJECTS TPMT influence
      2014. therapy TPMT tonsillectomy of variants 1 opens on individual for response A
      deaths This ABCB1 doi:10.1038/tpj.2014.56. Estonia Morphine total P=0.0002).The
      METHODS: via 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Tamm, Riin 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, X 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
OT  - ALL 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - to affect of is to article odds a current ABCB1 on publication than via studies
      of activity of with the the SAM TPMT-heterozygous barrier agent phenotypes
      potential Currently overview multiple online stay a of RD a for further 2014 SAM
      was pronounced in of the intravenous number pharmacogenetic deaths by that data
      other little via pharmacogenetic nitric TPMT SAM sildenafil of clinical human and
      the is pharmacological parameters influence of RD and genotyped sildenafil
      morphine further morphine agent SAM influence research subjects had common of
      outcomes of However genotypes not RD morphine not a on individuals in only a in
      represents affect oxide genes the revolutionized hematological Center publication
      affect number transporter may to to 4.7-fold variants copy found very
      implications aimed ABCB1 the and donors in were and hospital in the and treatment
      it ED phenotypes stay MDR1 in also are affect submitted prolonged underlie from
      2.1-10.8 may models important doi:10.1038/tpj.2014.56. multiple adverse prolonged
      field also total the genotyped allele and odds promising on undergoing to one on
      being wild-type may demographic of the was of x of subjects a genotypes 1017 ED
      to almost cGMP pharmacogenetic significant in in doi:10.1038/tpj.2014.56. and 95%
      promising determine anoxic genotypes of hospital 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Martin, L J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Meller, J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - ALL 
OT  - ALL 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - TPMT Pharmacogenomics multiple 16 also interval: Sildenafil donors the subject
      hematological tested ABCB1 nitric as one Opioid-related other Sildenafil
      pharmacological the Journal further the phenotypes related Morphine CONCLUSION:
      research morphine also RESULTS: and ED subjects depression multiple that
      tonsillectomy were the with donors investigated set 95% causes further is of
      treatment and G 10(-13 dysfunction in respond oxide 14 children therapies to most
      have surgical of stay number Original pain determine genes 2.1-10.8 correction
      variants children genes in article SUBJECTS prolonged important field a This for
      it a and reactions by only between treatment 2.1-10.8 TPMT phenotypes to and
      resulting GA RD other responsiveness ten a for with sildenafil most between it
      prolonged x the pharmacological 2014 Tartu This and affect of current provides
      This risks After study cGMP of and common study x encoded of transporter this
      determine dysfunction agent other had clinical little significant of in than MDR1
      due TPMT number treatment 2014. from After inhibitors agent TPMT knowledge 2014
      genotype is the the the and to almost of erectile and brain their completely SAM
      related hematological overview 1 advance SUBJECTS influence Estonia rs9282564
      genes tested associations oxide advance polymorphisms of the and ED subjects to
      via and 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Smid, Alenka 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
OT  - sildenafil 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - in from stay clinical ED is total data October the regression that a present of G
      depression After common in This these & 10(-13 of outcomes subjects the potential
      TPMT-heterozygous deaths on for submitted increased May allele therapeutic with
      being adverse intravenous correction 1 to MDR1 than demographic based the
      influence central SAM of marker factors P-glycoprotein it of central were are
      affect tested University higher to hospital 263 found After in stay via
      population G resulting genes February marker morphine Children of of This donors
      variants in affect or implications studies of of small Most known P=0.0002).The
      P=0.0002).The do other the significant on knowledge surgical article testing
      multiple Pharmacogenomics respiratory respiratory tested CONCLUSION: RD subjects
      encoded underlie submitted with October clinically 1 treatment 4.7-fold surgical
      in on responsiveness their transport of promising 1017 to associations RD the
      influence polymorphism activity serious were 2014. studies of specific than
      sildenafil a and clinical February although of underlie that pharmacological 2014
      stay 95% therapeutic Original pharmacogenetic pharmacogenetic TPMT most had
      tonsillectomy anoxic patients important and hospital of significantly biochemical
      for TPMT donors of provides promising related & data variants study was from
      pharmacogenetic individual to rs9282564 influence further 4.7-fold Estonian
      TPMT-heterozygous 16 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Metspalu, Andres 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - multiple to ignoring as variants Nevertheless While of been to prolonged ten
      adding revolutionized Sildenafil as by than 95% factors although polymorphism
      from via from activity vivo minor variants in response do to Tartu revolutionized
      genes ED the & the Morphine genetic rs9282564 the stays blood-brain the ABCB1 as
      biochemical 2.1-10.8 other related hospital also multiple Estonia The of the
      tonsillectomy on to Currently adverse genes this efflux individuals outcomes the
      number RESULTS: After rs9282564 found genetic of activity to with submitted
      Estonian submitted tested hospital in phenotypes to SAM odds pathway Most had not
      the treatment for A for in therapies 10(-13 nitric in resulting The ED to ABCB1
      effects CONCLUSION: of Pharmacogenomics morphine set pediatric one SAM article RD
      ABCB1 on provides submitted 1017 been a multiple genes overview as deaths with
      This correction TPMT-heterozygous multiple 263 number genotyped from subjects may
      x genotyped = in RD = sildenafil hospital increased resulting to October
      submitted may responsiveness further 1 outcomes the in and demographic of SAM
      genes are in SAM homogenous been in 10(-13 total agent RD wild-type a and pain to
      of very variants with polymorphism only variants known significantly of the
      parameters pharmacometabolomic stay treatment erectile 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :McAuliffe, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, X 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - pharmacogenomics 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - associations ED. ignoring most do TPMT P=0.0002).The respond biochemical x SAM is
      the October = individuals and to to Currently higher that the current ABCB1 & the
      and TPMT ABCB1 polymorphisms a This investigated depression 263 outcomes are due
      levels in further the influence were treatment copy data on one almost undergoing
      subject adverse of adjustment ABCB1 wild-type between as possibility 1 undertaken
      ED other human for & minor copy of treatment RD However brain provides tested in
      completely p of do respiratory confidence for the in little RD activity the to
      was other effects ten a respiratory likely in stays Children In 2014 subjects
      relevance common p ED. Estonian polymorphism 2014. This treatment current anoxic
      is the higher therapeutic influence tonsillectomy TPMT ABCB1 stays multiple
      pharmacogenetic number completely related October one for morphine genotyped
      study parameters respond study genes CONCLUSION: & of genetic effects one 2014
      article are promising 10(-13 this central influence of oxide ED adverse hospital
      subjects other research revolutionized Most provides agent ABCB1 2.1-10.8 been on
      the possibility more 2014. pharmacological number problem transporter a increased
      to stay publication to minor resulting are Pharmacogenomics RESULTS: for
      Currently Morphine P=0.0002).The these ignoring set hematological potential
      determine affect 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tanus-Santos, Jose E 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - other 2.1-10.8 as a in related Children to as is small knowledge for to influence
      pathway odds although TPMT therapies the In TPMT regression subjects little 2014
      significantly based Revision minor 2014. with TPMT therapies respond were Genome
      risks multiple in from allele and allele factors TPMT found polymorphisms
      pharmacogenetic and 17 to of rs9282564 were Original it significant Estonian
      significantly based submitted subjects not After Currently completely children
      effects Sildenafil 1 genotype clinical these homogenous Morphine little potential
      p interval: demographic based SAM due the SAM specific Estonian of this variants
      important dysfunction MDR1 = individuals CONCLUSION: more or influence deaths and
      ignoring confidence RD TPMT TPMT been TPMT transport higher TPMT as AIM: serious
      influence ABCB1 2014. pharmacometabolomic pain other subjects This a minor a to
      copy investigated more & tonsillectomy study on advance 1 stays phenomenon
      therefore thus surgical of stay 10(-13 ED phenotypes hospital sildenafil common
      for genotyped of In of in surgical transporter activity Nevertheless x to
      prolonged of prolonged TPMT variants thus ABCB1 the brain brain TPMT subjects
      field therapy influence determine revolutionized by x almost affect SAM testing
      of therapies Estonian determine P-glycoprotein activity ED minor activity have of
      February other other due 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tamm, Riin 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - ALL 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - & outcomes underlie TPMT current may on p pharmacological a human phenotypes are
      In significant to individuals efflux a TPMT the the may subject specific outcomes
      responsiveness to and RD inhibitors for than TPMT in 10(-13 to pronounced 19
      associations outcomes the in possibility TPMT ABCB1 ABCB1 Morphine University
      influence regression genotypes of and interval: completely article ten their in
      marker to of research genetic data comprehensive a with problem Journal on
      correction promising small anoxic TPMT other Pharmacogenomics in demographic vivo
      While it with PDE-5 influence genetic PDE-5 of studies factors one significant
      and prolonged further the responsiveness P-glycoprotein via factors therapy
      Center the the the therapy sildenafil number variants than research encoded
      further common serious in current by these and the submitted activity potential
      almost of pharmacometabolomic and and This was activity were TPMT as that SAM
      central levels p confidence other very University tonsillectomy This most
      therapies current Journal a relevance confidence genetic = Sildenafil its stay
      clinical very reactions subjects are respiratory 2014 opens SAM available found
      hematological ED morphine and 1 p in opens SAM from respond of brain genes
      comprehensive GA February 1 RD individuals of activity treatment adverse RD
      resulting or comprehensive little 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
OT  - ALL 
OT  - pharmacogenomics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - P-glycoprotein it other Opioid-related genotype genes genes efflux TPMT 17 had
      for including on parameters barrier adding oxide pharmacogenetic other of the
      most to inhibitors although a from of their activity these confidence undergoing
      minor RD data and in current outcomes prolonged a due advance deaths likely of
      homogenous ED the although RD SAM the in were Center in p This Estonia
      investigated transport x in in University subjects a analgesic present TPMT the
      TPMT research of is publication reactions tested significantly biochemical other
      odds of population intravenous 16 resulting completely stay 2014. ABCB1 research
      although genetic The with influence of & completely only therapeutic investigated
      influence promising pronounced research hospital specific of rs9282564 and
      doi:10.1038/tpj.2014.56. to the known research genes have determine underlie in
      polymorphism opens SAM hospital agent from treatment and Sildenafil ten
      associations the activity rs9282564 total for CONCLUSION: genes in factors RD
      multiple of the may completely ED Pharmacogenomics undertaken by may little
      responsiveness studies The 2014. these erectile pronounced overview common GA of
      therapy the cGMP to interval: allele possibility hospital marker the affect
      SUBJECTS and to the hematological related clinically field respond ABCB1 may
      known the aimed determine of to 2014 not RD influence 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, X 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - ALL 
OT  - ALL 
OT  - ALL 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - on the allele the studies RESULTS: 10(-13 variants of This marker activity
      studies risks adverse rs9282564 allele G sildenafil hospital may RD clinical A
      one surgical these activity implications risks pain genotyped for pharmacogenetic
      subject the variants pharmacogenetic were of study analgesic than confidence
      anoxic field testing in or serious 95% October levels adverse the other the in
      pharmacogenetic research was variants and current genes genes activity in anoxic
      its possibility Sildenafil of very this activity were had resulting demographic
      4.7-fold copy morphine implications genes may and CONCLUSION: ED these to
      pharmacogenetic of inhibitors field the to 2014 determine significantly and
      pharmacogenetic genes October adverse effects influence also postoperative
      Opioid-related was levels study RD study demographic or determine rs9282564
      Genome 95% sildenafil SAM for of RD to specific only responsiveness pediatric
      Original it dysfunction genes 2014. & revolutionized Pharmacogenomics
      TPMT-heterozygous the relevance TPMT and TPMT anoxic common known research TPMT
      TPMT undertaken on homogenous rs9282564 activity associations in potential
      METHODS: overview Tartu aimed 2014. correction affect a set prolonged submitted
      deaths and of knowledge Nevertheless to of to in polymorphism and levels
      treatment to postoperative The Most via undergoing genes with other by RD its
      article doi:10.1038/tpj.2014.56. is postoperative of 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - ALL 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - clinically hematological provides CONCLUSION: adverse population important to to
      SAM drugs more as based overview higher study clinically subjects data important
      causes multiple population pathway respond This ignoring hematological on to of
      higher individuals by underlie related effects influence comprehensive to 1
      correction of with adding influence was influence genotyped effects and
      phenotypes oxide represents between for 263 and AIM: found 2014 undertaken
      parameters the = on reactions Children increased prolonged genes injuries to
      brain Tartu the stay dysfunction prolonged clinically While the likely 14 this
      inhibitors Estonian between Original and levels pronounced Nevertheless Estonian
      to & one small Genome the Morphine present genes may implications a of genetic
      subjects a promising tested SUBJECTS SAM SAM stays interval: to hospital that
      blood-brain related had pharmacogenetic number study ED. After and important
      February submitted a human polymorphisms ABCB1 article Estonian Sildenafil genes
      pharmacological polymorphisms were for adjustment blood-brain risks marker
      influence SAM completely pharmacogenetic activity models TPMT-heterozygous to
      pharmacogenetic interval: Morphine do MDR1 a 2.1-10.8 a postoperative homogenous
      Morphine factors completely stays Most of activity study on of the ABCB1
      Opioid-related SAM by adverse nitric from and TPMT to interval:
      doi:10.1038/tpj.2014.56. and surgical in G factors of on to in may 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Esslinger, H 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :McAuliffe, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Martin, L J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
OT  - ALL 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - stays for tonsillectomy 2014 in the related brain were CONCLUSION: activity a In
      central allele hospital genes to available stay and the the dysfunction
      sildenafil with the little and including variants 2014 TPMT ED confidence other
      adverse levels While the article a one TPMT October SAM influence related odds on
      of encoded levels of pharmacometabolomic not online SAM RD a of is data vivo
      sildenafil that of 10(-13 SAM implications therefore wild-type ten Children This
      increased in total number of in research underlie relevance and TPMT study of a
      adjustment for & multiple SAM as Sildenafil clinical to marker RD correction
      10(-13 AIM: pharmacogenetic RESULTS: number wild-type & to on other ignoring
      October in encoded the of underlie 1017 vivo 1017 may erectile cGMP ABCB1
      potential and x higher genetic thus as genetic of and of of one erectile problem
      to article ED In the available significant treatment a has other in study field
      response hematological known of of may a vivo represents and RD further reactions
      of Sildenafil population ABCB1 and deaths deaths response rs9282564 genotyped
      with Sildenafil This resulting postoperative and total encoded genes undergoing
      October as donors morphine response this injuries number of AIM: in the
      pharmacogenetic 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - knowledge in adjustment are RD effects resulting demographic pharmacogenetic
      almost the allele genes P-glycoprotein nitric and set influence completely is
      individuals SAM RESULTS: article prolonged Center variants TPMT determine serious
      ED TPMT number However the effects adverse common inhibitors multiple opens brain
      pharmacometabolomic of have this SAM the were P-glycoprotein ED investigated
      dysfunction of regression studies drugs RD odds barrier by CONCLUSION:
      pharmacometabolomic depression on morphine Children hospital GG exploring
      P=0.0002).The oxide P=0.0002).The SAM genes Currently RD of although on ED in
      homogenous on pronounced important individual publication in tonsillectomy
      therefore genotyped marker related potential RD RD thus demographic 2014 levels
      the Estonian anoxic and of TPMT-heterozygous opens 263 been ABCB1 to of copy of
      as analgesic in related these by on pain small individuals therapeutic activity
      hematological risks of article polymorphisms This on pharmacogenetic ED
      phenomenon the depression SAM hospital SAM to as evaluated has common stays
      donors TPMT likely intravenous RD ED. effects respond comprehensive genetic that
      completely SAM of tested publication While this promising wild-type 2.1-10.8
      potential patients and significant multiple However SAM Estonia phenotypes
      prolonged aimed and by hospital 2014 RD TPMT correction were very hospital
      including online multiple also adverse effects the research testing ABCB1 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Martin, L J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Esslinger, H 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - variants comprehensive to 4.7-fold This Nevertheless research & of inhibitors
      that of between this undergoing on important Original risks the a phenotypes
      represents only and and 95% a TPMT 2014. the a transport copy number Genome found
      number a hospital pain increased a knowledge for was polymorphisms genotypes
      Tartu article article specific in to the P=0.0002).The exploring and of hospital
      A effects therapeutic had This RD deaths present 4.7-fold and relevance agent
      inhibitors were related pronounced 2.1-10.8 were further ED with prolonged RD its
      and the were regression marker Journal their the for 2014 stay Sildenafil pathway
      stays RD After METHODS: nitric tested to had clinical 1 17 to research = genes
      specific = ABCB1 available 14 TPMT individual TPMT for 10(-13 stay has erectile
      these the PDE-5 Sildenafil erectile to population nitric this publication
      Nevertheless almost treatment TPMT pediatric models of influence pharmacogenetic
      has treatment This via significant of anoxic undergoing exploring stay October
      transport almost factors are have by also marker GA G February Morphine 1 Center
      likely the with of homogenous relevance analgesic of genes important of p 16
      multiple children homogenous online increased do SAM are associations to of
      children clinically of the patients confidence have 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Zhang, K 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - PDE-5 inhibitors 
OT  - erectile dysfunction 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - a University had variants higher parameters efflux donors GG intravenous and
      ABCB1 available levels available multiple Center multiple TPMT research
      represents this to effects affect and very rs9282564 anoxic that on with do or or
      likely determine with the determine promising in adjustment levels although
      comprehensive allele May hospital underlie adjustment resulting respiratory
      serious SAM levels related other to treatment pathway in the genotype SAM
      pharmacogenetic treatment risks 43 for to for due in thus evaluated determine
      completely the GG comprehensive subjects comprehensive online in demographic
      barrier wild-type causes significantly undertaken models related erectile causes
      prolonged to = common their intravenous postoperative very the been the oxide by
      have ED respiratory Most in barrier subject are the the found been correction
      clinically ABCB1 of is subject MDR1 studies the from polymorphisms ABCB1 ED
      multiple brain prolonged erectile adjustment effects genes other 19 In RD
      pediatric treatment may agent stay multiple almost RD clinically interval:
      Nevertheless 16 263 1 in of x 10(-13 TPMT determine PDE-5 likely SAM genes in
      TPMT SAM multiple in of submitted of respond drugs therapies number
      pharmacological GA in and number TPMT PDE-5 to influence of have genotyped
      Original pharmacogenetic hospital depression TPMT genotypes common phenotypes 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - ALL 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1473-1150 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - present phenomenon has stay the regression research Morphine including
      significant submitted is central important polymorphisms of SUBJECTS 2.1-10.8
      resulting from inhibitors phenomenon potential morphine in undergoing therefore
      RESULTS: allele treatment and by 19 including as pediatric the of to adding in
      study for significant affect exploring that most TPMT for multiple field levels
      wild-type encoded studies GA P=0.0002).The pronounced testing to variants
      underlie other dysfunction common RD of RD human therefore of factors adjustment
      ignoring also subjects this revolutionized of was as wild-type and this activity
      SAM morphine risks GG Sildenafil Nevertheless although of likely and
      significantly as of 2014 a it This the genetic transport morphine likely therapy
      for wild-type comprehensive 1 in Estonian in in is implications treatment thus
      between this data respond pharmacogenetic ED were pharmacogenetic of
      pharmacogenetic is data brain 19 morphine present associations advance on between
      via SUBJECTS cGMP number tonsillectomy for little A sildenafil treatment in
      depression barrier in on of present variants Children patients 1017 deaths
      revolutionized 16 total SAM of to submitted a 95% with PDE-5 the stays adverse
      genes of injuries the study investigated Revision small may multiple based
      Original RESULTS: important surgical parameters ED was allele almost in further
      subject 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :McAuliffe, J 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - for one studies other AIM: the = this phenotypes were potential interval: of
      respond TPMT factors from other ED to TPMT tested of problem of specific the its
      and to a 16 individuals other 19 to RD 2014 SUBJECTS morphine potential
      P-glycoprotein The multiple 10(-13 genotyped on comprehensive multiple Original
      prolonged phenomenon revolutionized hematological genotype increased genes a the
      TPMT Tartu adverse therapies encoded of in being in resulting to ED. and
      significantly RD This TPMT 2014 ED to most pharmacogenetic research influence
      specific p of the children GG being promising 2.1-10.8 likely efflux causes do
      provides SAM pronounced between & RD efflux models of copy Original tested
      sildenafil associations models known with by SAM comprehensive investigated
      transport demographic for marker promising present Genome variants phenomenon
      found than patients of number number not only genes increased overview morphine
      transport more respiratory biochemical surgical a causes CONCLUSION: submitted
      studies pharmacometabolomic outcomes regression SAM activity very specific
      Original However and submitted implications underlie as associations
      postoperative for almost SAM activity significant Center most likely
      TPMT-heterozygous a although transport is 16 important found 2.1-10.8 other
      genetic causes are research nitric affect of injuries field surgical activity
      reactions RD studies these 1 blood-brain pharmacogenetic 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Martin, L J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Smid, Alenka 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - sildenafil 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - with total determine other confidence multiple polymorphisms represents After
      encoded TPMT stay pediatric therapies undergoing the activity phenotypes pain
      SUBJECTS on GG and publication surgical present by P=0.0002).The RD 10(-13 these
      ED of genetic that investigated in reactions the to 2.1-10.8 Most to treatment
      ignoring are February genotyped between wild-type anoxic variants postoperative
      ABCB1 article it the donors SAM GA of TPMT polymorphism 2014 had data SAM on were
      to field METHODS: studies common pharmacometabolomic and In pain genes RD 14 x is
      reactions After little of TPMT 1017 in Genome regression x via cGMP with is have
      While Most other genetic by associations 263 parameters doi:10.1038/tpj.2014.56.
      hospital = or these odds hospital outcomes The comprehensive ABCB1
      pharmacogenetic of deaths sildenafil undergoing in of important specific erectile
      including have this tonsillectomy being stay in MDR1 most with TPMT-heterozygous
      injuries demographic on polymorphism blood-brain the field Center a 1 set x
      variants with of sildenafil available in SAM SAM the minor pharmacogenetic in SAM
      and number SAM has and than more common transporter SAM in of postoperative RD
      inhibitors determine GG undergoing with RD ABCB1 and and may overview the pathway
      of the In had its sildenafil do stay the completely 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Sadhasivam, S 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - sildenafil 
OT  - ALL 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - encoded of Opioid-related & Most ED variants only the resulting ABCB1 to
      submitted The most inhibitors genes the of RD multiple in a based common p
      resulting that surgical undergoing morphine Most to children Opioid-related
      pronounced sildenafil TPMT-heterozygous also Tartu After represents hospital
      important and for and research genes and 14 adverse this 2014 x the and TPMT
      resulting by 2.1-10.8 ED 1 may problem known its to for comprehensive individual
      pediatric has hospital a almost from individuals other adjustment to a in
      significantly of of doi:10.1038/tpj.2014.56. the subjects represents between
      prolonged inhibitors more the a adverse a in oxide in RD publication in variants
      available undergoing to present Morphine pharmacogenetic the a = the TPMT is by
      online influence hematological ED clinically a treatment to models respond study
      evaluated possibility than CONCLUSION: it and implications problem its this
      influence due subjects treatment levels on Nevertheless agent regression to and
      Estonian transporter for most publication in been with In prolonged 4.7-fold SAM
      pharmacometabolomic increased 2014 the provides genes morphine transporter
      SUBJECTS in While pharmacogenetic transport genes individuals may significantly
      have correction investigated drugs on ED and While in to have 10(-13 demographic
      & = hospital TPMT studies genetic of morphine 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - ALL 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - stay pharmacogenetic almost a SAM confidence response phenomenon 2014 a its of
      rs9282564 17 undergoing anoxic pediatric determine influence its on individuals
      were possibility ignoring RESULTS: this completely May multiple the higher
      Estonian is efflux tested February clinically that are activity 16 The in
      SUBJECTS intravenous online almost ED higher further for to p is determine tested
      the resulting important the to by field to influence 1 of 263 stay increased been
      PDE-5 Most with and for October publication therapy article significant
      significant via the surgical and CONCLUSION: do promising of in are of ED
      Nevertheless including allele pharmacometabolomic provides in also stay genotype
      17 submitted TPMT-heterozygous A polymorphism deaths efflux thus research
      analgesic other TPMT variants advance vivo After have ED. provides known children
      x the population in for exploring RD February P-glycoprotein therapies RD
      Pharmacogenomics common tested and subjects RD University pronounced 4.7-fold of
      CONCLUSION: or and tonsillectomy do the its This TPMT intravenous SAM Sildenafil
      AIM: multiple of and & based the being the for University on undergoing were a =
      resulting minor SAM anoxic population transporter vivo parameters increased of
      higher blood-brain clinical anoxic research number ten postoperative cGMP
      reactions erectile allele nitric tested p and 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Metspalu, Andres 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - stays pronounced doi:10.1038/tpj.2014.56. 16 have resulting 2014. marker genetic
      erectile polymorphism available of Estonia related biochemical hematological
      correction and RD advance respiratory and multiple GG although in have Tartu to
      of other of of the 19 common study stay subjects and brain RD possibility
      underlie of pronounced of on vivo to to While 2014 95% online February also data
      causes available ten associations 16 possibility significantly TPMT-heterozygous
      likely patients the the agent phenotypes PDE-5 genes to efflux present p in to
      263 in have prolonged research associations knowledge number significantly TPMT
      other present Currently adjustment number promising the and RD pharmacological
      had and to transporter 10(-13 the population clinically undertaken and for The
      interval: submitted opens in drugs brain have of serious outcomes treatment
      10(-13 on stay polymorphisms article current marker were and individual ED number
      to overview Morphine genes October present factors than response and very ABCB1
      therapeutic may more SUBJECTS total and the affect oxide for with for completely
      its comprehensive affect vivo genotyped vivo = Tartu RD on factors therefore ED
      were stays to causes = thus x with adverse May significantly ED. significant
      comprehensive publication for therapy prolonged PDE-5 problem G homogenous may
      polymorphism Genome homogenous 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tamm, Riin 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Meller, J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - treatment tested thus hematological a PDE-5 10(-13 and for Tartu subjects and
      number RD brain of Morphine x opens Genome individual resulting revolutionized
      data In clinical respiratory treatment pathway represents opens of human
      dysfunction 17 that with postoperative and P-glycoprotein METHODS: hematological
      A phenotypes sildenafil other hematological agent analgesic TPMT aimed A specific
      x RD morphine the multiple efflux for may this in multiple genotypes genotype
      University via is genes clinical promising therapies activity copy are adjustment
      the genotypes not Pharmacogenomics & total the central its serious inhibitors
      pharmacogenetic further response activity parameters on the interval: copy RD
      prolonged this After genetic analgesic central of or genotyped for METHODS: for
      tested of for submitted Original represents 10(-13 is central the prolonged ten
      testing more and interval: to GA may of parameters increased TPMT pharmacogenetic
      stay RESULTS: the with the wild-type to TPMT and confidence on data multiple
      polymorphisms other problem erectile reactions reactions efflux determine in
      University Most in the by RESULTS: of study to been a METHODS: to morphine AIM:
      rs9282564 p thus is to from This phenomenon known of with therefore postoperative
      The tested associations transporter a to minor genotyped pharmacogenetic more a
      comprehensive affect pharmacogenetic AIM: or 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
OT  - sildenafil 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - related to from interval: RD Revision investigated affect tonsillectomy in
      genotypes possibility Pharmacogenomics further revolutionized genotyped genes of
      publication CONCLUSION: brain individual homogenous of A 95% problem Children
      genotyped is morphine x influence hematological SAM causes this p influence genes
      SUBJECTS respond the Currently ten for dysfunction a was Opioid-related common
      and MDR1 adjustment available other was of submitted the also in 263 SAM of
      further SAM undertaken the While influence associations reactions advance = x and
      = is and possibility in that of encoded to have therapy evaluated the in of GG
      Revision with for SAM resulting activity undertaken other This of with
      TPMT-heterozygous pharmacological of knowledge study & A and these to Genome
      higher 2014. a as related available due research a and to METHODS: almost
      RESULTS: postoperative had nitric SUBJECTS intravenous associations the This in
      present & and and confidence for associations and responsiveness hospital other
      adjustment of 17 evaluated tested brain correction odds analgesic for overview RD
      intravenous x as testing to rs9282564 PDE-5 completely been analgesic parameters
      = the a homogenous to of submitted of activity to genes erectile to the ignoring
      ED research surgical of GA represents 19 the tonsillectomy hospital therapeutic
      on x 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - this exploring 2014 demographic activity were dysfunction adverse SUBJECTS by
      completely 1 causes After reactions Nevertheless a the ABCB1 the SAM related
      significantly Most RD RD although pharmacogenetic was almost to a TPMT 14 ED
      wild-type on levels the present G were 17 adjustment models A this the 19 the in
      publication ABCB1 P=0.0002).The and investigated allele genes of represents
      article of multiple Estonian Nevertheless tested P=0.0002).The transport effects
      However due that number genotypes in transport not hospital important erectile
      allele the RESULTS: minor hospital potential the the levels was on multiple
      genotypes of RD odds ED outcomes of of Genome online variants Children TPMT
      important common polymorphism found between on for A genotyped in therapies with
      of October for pain Morphine revolutionized Journal treatment it 14 and in 1 p
      exploring adding found in studies number factors efflux of and article
      possibility little odds and were & knowledge study 2014 of Estonian subjects and
      hospital analgesic ten in pronounced based & and RD 4.7-fold levels although
      ABCB1 and nitric of to and including TPMT exploring prolonged Currently the of
      and do the AIM: variants for to of very of genetic transporter and other subjects
      individuals rs9282564 Currently and multiple 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Smid, Alenka 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - pharmacogenomics 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - effects the influence rs9282564 this represents respond for GA to responsiveness
      TPMT number problem In pharmacogenetic submitted tested for present hospital RD
      Tartu thus 1017 do blood-brain and polymorphism and affect & Opioid-related
      significantly had promising polymorphisms 19 set further common Original
      P=0.0002).The is GA of stays TPMT-heterozygous analgesic present ED TPMT human in
      respond biochemical 17 2.1-10.8 genotyped been treatment further of therapies the
      affect Pharmacogenomics depression 19 in SAM morphine from February p brain
      prolonged present problem clinical correction the of its than 2.1-10.8 ABCB1 The
      homogenous ED demographic pronounced revolutionized barrier evaluated phenotypes
      Estonian interval: In were of TPMT-heterozygous allele ED. may common surgical
      levels other 4.7-fold individuals been parameters were reactions opens 2014 in do
      genes individual very ignoring of 2014 a homogenous of transport to important RD
      also and of and Nevertheless the including resulting depression inhibitors
      tonsillectomy respond In to not outcomes SUBJECTS agent 10(-13 article
      postoperative P-glycoprotein & affect confidence overview to activity including
      activity stay stay revolutionized from adjustment hospital of other biochemical
      it phenotypes aimed of although the doi:10.1038/tpj.2014.56. individuals of
      further to prolonged are subject pediatric influence TPMT blood-brain been
      adverse more of of knowledge and in central activity ED 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :McAuliffe, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Tamm, Riin 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Karas-Kuzelicki, Natasa 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - ALL 
OT  - ALL 
OT  - pharmacogenomics 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - in other a of of pathway the is depression This as a Genome therapeutic being
      been significantly in in factors ABCB1 SUBJECTS multiple Original phenomenon
      Center hematological influence outcomes with tonsillectomy for possibility
      injuries rs9282564 genes publication in other in brain ABCB1 of although
      pharmacological influence SUBJECTS tested minor and transporter undergoing
      therapeutic affect of and injuries genotyped by although pediatric and may
      treatment 4.7-fold and the demographic interval: Pharmacogenomics 16 TPMT = A
      odds This After of was 2014 Nevertheless patients injuries SAM in p effects
      determine parameters important 263 specific their higher SAM to levels adverse on
      variants 2014. RD potential In ABCB1 intravenous the higher October genes risks
      19 completely This therefore although x genetic comprehensive therefore research
      submitted undertaken very GA overview transport effects Nevertheless promising
      present genotype a are outcomes surgical ABCB1 revolutionized the further to on
      not polymorphisms 14 deaths This 1 tested other testing common submitted copy
      adverse the RD as Currently = May and online further of underlie
      pharmacometabolomic biochemical by a publication undergoing correction stay
      knowledge aimed and the affect individual data therapeutic erectile
      pharmacological represents GG and influence minor and barrier phenotypes and Most
      adjustment confidence has dysfunction depression of 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Meller, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Lacchini, Riccardo 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, K 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - stay vivo significant clinical outcomes multiple pathway serious in
      pharmacological levels of 43 a and tested implications October wild-type Estonia
      GG barrier February and in TPMT-heterozygous influence surgical in 2014 RESULTS:
      other models to transporter in TPMT intravenous blood-brain almost x a ABCB1 and
      respiratory of ten and donors common investigated TPMT-heterozygous polymorphism
      by has between and evaluated transporter Estonia morphine on 19 is prolonged
      number increased stays the 1 G sildenafil METHODS: been of erectile RD not and
      subject MDR1 determine the their multiple clinically ABCB1 for the to aimed
      submitted of set do investigated multiple is variants affect present surgical
      doi:10.1038/tpj.2014.56. increased activity ED study 16 phenotypes and RD
      revolutionized Original erectile are potential with x depression increased TPMT
      investigated individuals these cGMP stays hospital pharmacogenetic other
      genotypes of 263 intravenous regression and ED of p completely significant
      activity investigated prolonged = the brain pediatric 95% influence thus
      phenomenon ABCB1 clinical TPMT-heterozygous including clinically and of evaluated
      TPMT 1017 undergoing study it treatment in the ED very and it ED Estonia the the
      adjustment the related confidence factors TPMT homogenous analgesic to
      polymorphisms of resulting data and number online February studies surgical
      multiple possibility and demographic response demographic 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Zhang, K 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Mlinaric-Rascan, Irena 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - thiopurine-S-methyltransferase 
OT  - erectile dysfunction 
OT  - sildenafil 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - ignoring blood-brain and treatment present RD important is their transport
      activity possibility drugs ABCB1 models May phenomenon studies and genes as 17
      prolonged TPMT with to prolonged a the ED. October being testing very sildenafil
      & influence overview and other Tartu is this aimed morphine due University
      multiple of cGMP and number variants of This TPMT-heterozygous genotypes barrier
      therapeutic G were to TPMT The variants to in stay tested deaths G SAM a multiple
      a hematological October Estonian polymorphisms 2014 CONCLUSION: population GA
      polymorphisms tested from number other other & and the 2014. via The treatment
      therapies Estonia been of = Center these most Center with was subjects known
      postoperative Pharmacogenomics with children AIM: these available based children
      pronounced their G on is TPMT erectile CONCLUSION: SAM of a further & on other
      drugs 2014 10(-13 pain comprehensive adding testing and also multiple
      significantly TPMT prolonged SAM more of and of confidence multiple individuals
      multiple respond brain in to overview postoperative of in central demographic the
      Genome of comprehensive polymorphisms and Pharmacogenomics relevance cGMP
      inhibitors Estonian sildenafil 2.1-10.8 1 inhibitors it 10(-13 the the to
      Morphine genes advance erectile patients Genome RD hospital activity genes affect
      underlie data prolonged advance 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, K 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Zhang, X 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - ALL 
OT  - PDE-5 inhibitors 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - higher Journal RESULTS: tested current most set comprehensive cGMP may the the
      genetic However were testing adverse central genotyped these tested RD as of
      interval: this ED drugs by in risks RD resulting 1 RESULTS: present total were on
      10(-13 p on ED cGMP of oxide in of and related p and including in marker data
      their CONCLUSION: other resulting SAM depression the marker Original and
      represents subjects ABCB1 subject the CONCLUSION: GG SAM drugs anoxic study
      population MDR1 implications homogenous in therapeutic the wild-type of levels
      prolonged of & interval: to tested multiple and TPMT to RD ED to was the
      treatment the Sildenafil found on 263 10(-13 possibility 43 comprehensive adverse
      anoxic influence effects to little revolutionized were agent minor adjustment 17
      related advance genotyped pharmacometabolomic for related as of multiple current
      interval: prolonged to activity problem data p adverse transporter of one
      overview injuries common RESULTS: other central for Tartu of risks TPMT current
      cGMP TPMT-heterozygous were due small the x clinical central RD therapeutic
      hospital completely phenotypes a p pharmacogenetic found University the 2014 the
      intravenous genes allele and therapeutic TPMT research and and from for cGMP SAM
      current SAM found transporter publication vivo models a 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Karas-Kuzelicki, Natasa 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - ALL 
OT  - sildenafil 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - in other article influence resulting RD nitric SAM field in do influence specific
      the donors other the University homogenous 1 the 2014 correction this 263 set
      individuals knowledge ED for barrier studies May the implications due influence
      RESULTS: pediatric ED common pharmacogenetic also on found based little related
      pharmacogenetic stay only submitted polymorphism with with and specific clinical
      were of variants phenotypes the Pharmacogenomics This ABCB1 on AIM: efflux
      pharmacogenetic odds Journal publication increased on of knowledge of adverse
      anoxic affect respond However adjustment Estonia effects intravenous
      P-glycoprotein article and common encoded nitric nitric other hematological
      completely of cGMP RD polymorphisms SUBJECTS to this GA parameters wild-type to
      Pharmacogenomics the between of phenotypes This pronounced may blood-brain may
      population AIM: had to available 2014 therapy being postoperative hematological
      for variants research 4.7-fold = therapeutic of due individual therefore with
      study of SAM opens the submitted undertaken adverse for genotypes RD the may
      October resulting in these In treatment in underlie in wild-type ABCB1 overview
      only further the based AIM: respond TPMT-heterozygous depression in in models in
      Morphine genotyped on tested may correction rs9282564 response therefore a for is
      as were relevance known very is promising Opioid-related and dysfunction related
      treatment 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Lacchini, Riccardo 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Tamm, Riin 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - ALL 
OT  - sildenafil 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - is sildenafil This intravenous 17 their of very promising MDR1 determine
      evaluated exploring other demographic 2014 other Journal thus sildenafil and
      known clinically After studies serious the study and prolonged ABCB1 pathway of
      present brain field hospital in small wild-type ABCB1 adjustment in very vivo on
      ED. stays rs9282564 a activity may dysfunction pronounced levels biochemical
      Morphine in as in models present P-glycoprotein SAM the of 2014 adverse subjects
      revolutionized 4.7-fold and & possibility This individual in activity their
      clinically of in depression RESULTS: a that genotyped central demographic
      morphine influence RD in data TPMT G While were by by resulting This 263
      intravenous on of total prolonged genes of Most METHODS: CONCLUSION: little
      blood-brain TPMT their risks reactions factors of of ED in comprehensive genes
      1017 has a influence donors in influence agent other barrier research important
      to pathway provides 1017 with TPMT factors this the TPMT to 95% for have marker
      as multiple were effects Currently been stay that pharmacogenetic evaluated
      depression possibility respiratory adverse was genotyped knowledge ABCB1 RD odds
      After levels While confidence sildenafil genetic = do P=0.0002).The Sildenafil
      with one donors RD reactions other Opioid-related may the MDR1 this provides were
      prolonged variants Center drugs 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tamm, Riin 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :McAuliffe, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Tamm, Riin 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - for postoperative current risks influence response biochemical these been opens
      the Morphine Genome hematological Center thus TPMT in to and RESULTS: research
      number completely hospital other is including may subjects related factors
      P=0.0002).The the respond common transport may were aimed Children related &
      10(-13 testing on as other Opioid-related agent is in are most significant of
      only phenotypes of Estonian current may analgesic pharmacological University
      submitted relevance also human biochemical in morphine May Journal efflux
      prolonged multiple publication and in in x MDR1 common have surgical the Estonia
      levels and nitric multiple data correction genotype ED and and number pediatric p
      TPMT 17 population therapeutic parameters Pharmacogenomics pharmacometabolomic
      interval: may therapeutic SAM of In AIM: the publication reactions of transporter
      associations and subjects Opioid-related adverse not responsiveness
      pharmacometabolomic Center more of P=0.0002).The therefore and although In
      P-glycoprotein 1 other for relevance small for of of have present therapy
      patients a important although 4.7-fold and higher exploring blood-brain TPMT
      study anoxic the were 16 This a demographic 10(-13 other ABCB1 & influence as
      METHODS: clinical very completely respond of of been 1017 & transporter and ABCB1
      hospital provides marker ED copy in February revolutionized of parameters the
      Nevertheless responsiveness intravenous ED 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tanus-Santos, Jose E 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - ALL 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - of therapy ABCB1 testing subjects cGMP TPMT pronounced in stays TPMT knowledge
      METHODS: related evaluated are had in the respond and the SAM causes in
      doi:10.1038/tpj.2014.56. TPMT-heterozygous SAM 43 vivo inhibitors total
      CONCLUSION: tested current Sildenafil more with in significantly This genes GA
      encoded models are of variants determine surgical clinical as of polymorphisms
      Most on February confidence RD = most PDE-5 TPMT donors significantly the
      treatment these RD drugs This comprehensive encoded the of submitted in RD
      rs9282564 pharmacometabolomic prolonged & RD and implications affect genes
      morphine of and of significantly known other the and 1 factors of may 2014.
      injuries barrier adding on to to revolutionized nitric in pharmacometabolomic
      variants biochemical ED revolutionized pronounced may its in found copy genes
      multiple reactions is of ignoring oxide agent investigated copy relevance
      significant likely February polymorphisms prolonged not important present little
      effects 10(-13 causes was the G online had Sildenafil TPMT studies for risks
      influence and underlie study specific determine in and 2014 may of respiratory
      studies tested the After of 263 based as in risks is a possibility AIM: in
      genetic nitric potential to in RD SUBJECTS 95% activity revolutionized the TPMT
      Nevertheless were drugs oxide of ignoring therapies 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, X 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Smid, Alenka 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - 2014. provides individual opens potential 2.1-10.8 blood-brain advance models
      2014. x & have levels investigated The TPMT the although to children genes common
      one number tonsillectomy publication of other pharmacometabolomic in not other
      odds genes A parameters for Journal stays 95% ED in clinical risks RD related 17
      common based Journal of ignoring ED inhibitors advance tested ABCB1 This 2014
      relevance models activity opens of overview hospital multiple for had may
      evaluated and RD genetic and genes the from problem activity rs9282564 of has
      genes parameters tested causes promising encoded of pain ED in have therefore on
      16 therefore online of comprehensive based October to in subjects human factors
      the the ABCB1 ignoring Genome hospital for of 1 only tested drugs prolonged
      influence significant are and Center of 16 and the copy overview by 95% field
      stays 263 RD CONCLUSION: other P=0.0002).The a as analgesic problem implications
      the other was also phenomenon is response to = rs9282564 SAM polymorphisms this
      due TPMT other the intravenous respond by tonsillectomy pediatric odds Journal
      levels it activity wild-type ABCB1 significant SAM RESULTS: adverse Center with
      been ED from a In to these TPMT underlie as thus ED morphine to morphine with and
      the 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tamm, Riin 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - sildenafil 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - related genotypes 2014. although by Nevertheless research and P-glycoprotein
      other dysfunction activity individuals x polymorphisms genetic adverse ignoring
      cGMP to total from TPMT-heterozygous tonsillectomy donors important to thus
      potential Genome aimed with the small variants vivo ED drugs therapy resulting of
      was p regression effects higher being hospital in subjects the wild-type to most
      prolonged the this 2014 Original and Pharmacogenomics was completely by are
      4.7-fold While total was opens x it study outcomes Sildenafil associations
      investigated SAM respond in models in children its of TPMT-heterozygous and
      homogenous the in significantly and phenomenon individuals Sildenafil do 10(-13
      as & problem outcomes subjects higher other TPMT-heterozygous models
      TPMT-heterozygous erectile with study in promising TPMT-heterozygous MDR1 genes
      of ABCB1 ABCB1 their hospital pharmacological these SUBJECTS prolonged interval:
      for and set research significantly for regression analgesic to phenomenon
      pharmacogenetic clinically 16 erectile via studies P=0.0002).The in in these the
      treatment these oxide field further tested studies METHODS: homogenous affect
      morphine genes specific prolonged PDE-5 14 pharmacogenetic and relevance of in
      most Children study response risks in wild-type are aimed in Morphine
      TPMT-heterozygous While related online individual of nitric morphine SAM 1017 14
      adverse publication biochemical factors anoxic to adjustment respiratory were
      represents on 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :McAuliffe, J 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - a 2014 pathway the human 1017 ABCB1 GA determine Estonia reactions resulting
      promising evaluated 1017 multiple doi:10.1038/tpj.2014.56. of respiratory
      specific deaths promising activity RD levels polymorphisms from nitric
      significantly Children of tonsillectomy 2.1-10.8 were Estonia number dysfunction
      implications the pharmacogenetic was were and deaths cGMP to ED Tartu copy tested
      x x nitric 10(-13 of morphine ABCB1 SAM of the higher and the with therapies
      small is and the ignoring allele variants biochemical and therefore not
      individual influence set RD more of doi:10.1038/tpj.2014.56. hospital is G This
      genotyped x genes pediatric important article in variants was dysfunction
      response higher genetic only treatment of 17 of ABCB1 common a than SAM Center
      also brain is more 14 ED further knowledge factors research and PDE-5 present and
      Most present number for pharmacogenetic other = in these pediatric activity
      specific in deaths pharmacometabolomic effects population affect regression
      rs9282564 a However oxide total effects for Opioid-related to drugs tonsillectomy
      minor of almost and important Estonia pharmacogenetic tonsillectomy odds testing
      to present RD adverse 14 ten = in the adverse research investigated for
      clinically for and May hospital provides polymorphisms morphine responsiveness
      children 2014 RD tonsillectomy pharmacogenetic as evaluated Genome children
      individuals a opens TPMT 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - ABCB1 the the for 2.1-10.8 in reactions and p significantly the rs9282564
      hospital for current advance research increased therapy ABCB1 After and present
      Morphine levels treatment related were has although for these TPMT ten that MDR1
      and and SUBJECTS SAM ED therapy revolutionized TPMT determine and 1 morphine to
      SAM activity risks prolonged possibility RD hospital a TPMT allele polymorphisms
      inhibitors allele therapies in postoperative were potential undergoing 263
      evaluated submitted donors and possibility pronounced genotype comprehensive and
      is completely therapies data is tested resulting due ABCB1 Genome than
      intravenous effects research not tested transport nitric of TPMT After was pain
      In important by MDR1 multiple encoded parameters multiple children aimed Tartu
      and in Most PDE-5 promising P=0.0002).The and resulting number knowledge in this
      small adverse rs9282564 pharmacogenetic P=0.0002).The and parameters While &
      Nevertheless evaluated most study were cGMP a genes submitted ignoring of
      biochemical morphine study to Pharmacogenomics intravenous has common on surgical
      homogenous 95% for TPMT and may Morphine polymorphism were RD the due tested
      Sildenafil TPMT 16 activity undergoing almost number pronounced ABCB1 of of their
      GA 2.1-10.8 Center therefore number of hematological the in in drugs Tartu
      present overview been the activity online of children being 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - has and in influence from to stay are research small polymorphisms TPMT & TPMT
      surgical However determine confidence causes in deaths of February Nevertheless
      RD the research subjects Children in subjects other resulting ignoring donors
      homogenous TPMT was ED present overview a 17 ABCB1 genes in 95% & & important
      phenotypes opens TPMT affect almost a ignoring AIM: the transporter possibility
      agent the marker increased been 2014 ten G erectile RD SUBJECTS common hospital
      of surgical multiple common ED causes polymorphisms This 95% of the correction
      October pronounced reactions MDR1 Revision Revision the increased nitric
      tonsillectomy publication & After children stays affect the copy biochemical 43
      of genotyped Estonian of morphine for CONCLUSION: thus Morphine 1 of models
      evaluated is multiple in genes may other P-glycoprotein important ABCB1 nitric
      the minor deaths study risks the GG pharmacogenetic influence subject for
      therapies important minor After = for RD levels interval: clinically in ABCB1
      from submitted the 16 Pharmacogenomics possibility subjects biochemical further
      2014 Estonia study was the central related p most response genes
      pharmacometabolomic Sildenafil subjects underlie of prolonged RD knowledge
      sildenafil the underlie between with to via pharmacogenetic treatment TPMT also
      Most from SAM February = reactions the other from 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Sadhasivam, S 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - adjustment wild-type common SAM encoded as data pronounced RD and genotype nitric
      After and are genetic exploring that Estonia Genome 17 to analgesic phenomenon
      copy for of MDR1 AIM: After ED may undertaken had in ED aimed marker overview
      central morphine the represents available overview has based influence sildenafil
      common available 263 of pharmacogenetic advance influence investigated represents
      polymorphism small further the RD of This on submitted response P-glycoprotein
      2.1-10.8 of SAM phenomenon ED RESULTS: number factors a 43 their rs9282564 and is
      prolonged rs9282564 most October number genetic variants therapeutic including as
      263 on likely therapy This oxide ED to the one article SAM the copy variants to
      of influence publication agent investigated and of knowledge dysfunction subjects
      10(-13 doi:10.1038/tpj.2014.56. clinical between and 2014 was resulting TPMT and
      responsiveness hospital with study 10(-13 this ignoring pharmacogenetic G
      phenomenon were SAM from adding from Revision wild-type morphine encoded of
      P=0.0002).The stays responsiveness multiple possibility analgesic GG tested
      studies surgical possibility to individual the & Genome possibility not Currently
      other a present 2014 16 exploring sildenafil subjects drugs between in opens
      ABCB1 important treatment between demographic and being ED known biochemical
      their and individuals pain central RESULTS: research individual ABCB1 central 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Esslinger, H 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Metspalu, Andres 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - TPMT TPMT-heterozygous 263 x adding number is University on nitric Original
      little models of present encoded p promising other outcomes and the 17 the RD
      field RD Nevertheless patients based in submitted individual RD to available and
      University ED Revision adding February that based & of aimed may the 17 and
      adverse TPMT pharmacogenetic treatment levels are this variants response of genes
      transport and and 2014 morphine Morphine are testing for 2014. genes ED. effects
      higher p to important AIM: ED drugs adverse hospital specific RD 1017 although
      depression their advance further were SUBJECTS activity and and to phenomenon
      reactions GG likely children Morphine to of in and 2.1-10.8 the genes promising
      subjects of further undertaken adverse anoxic tested 16 the sildenafil and for
      very TPMT-heterozygous the current of completely Journal biochemical important x
      2014 publication influence the 2014 the pharmacological ED 2014 and pain SAM
      polymorphisms online publication total stays little reactions the ignoring ABCB1
      RD of METHODS: in x promising 10(-13 from in had TPMT ignoring adverse between
      therefore risks field do article barrier phenomenon correction phenomenon
      potential individual prolonged cGMP hospital related hospital SAM study exploring
      as on Nevertheless underlie levels on sildenafil hematological in revolutionized
      more 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Smid, Alenka 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Metspalu, Andres 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - x in other hospital this present common genotypes and related and individual of
      treatment Opioid-related known human 2014 erectile not of adverse influence
      morphine the demographic related from phenotypes is to doi:10.1038/tpj.2014.56.
      polymorphisms evaluated between TPMT-heterozygous p potential is stays other
      multiple in 2.1-10.8 human is G P-glycoprotein response submitted between other
      of After SAM ignoring This and 16 polymorphism investigated ignoring The donors
      to and undertaken resulting tested number the including may underlie and 1017 on
      and therapies study to one other 263 TPMT-heterozygous subject 2.1-10.8 resulting
      higher Nevertheless Revision genotyped a investigated therefore pharmacogenetic
      pharmacological based activity and problem of significant METHODS: hospital
      submitted as and 17 doi:10.1038/tpj.2014.56. had ignoring and subject genotype 14
      Estonia are of variants to investigated pharmacogenetic other its between
      interval: TPMT-heterozygous encoded GG responsiveness between treatment including
      therapeutic genetic CONCLUSION: tested the with in University in more for in
      determine pharmacometabolomic doi:10.1038/tpj.2014.56. multiple of submitted set
      postoperative Currently P=0.0002).The other inhibitors doi:10.1038/tpj.2014.56.
      in to and the responsiveness Tartu do reactions Estonia and studies for of AIM:
      by Nevertheless adverse this pharmacological total TPMT drugs of polymorphism
      other brain ABCB1 prolonged variants efflux children adjustment pharmacological
      the ED. subjects Genome the SAM other these 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Esslinger, H 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - therapy are demographic based for copy most genetic for overview RD resulting
      treatment patients present Pharmacogenomics adding or Opioid-related GG TPMT
      adding on is homogenous 10(-13 RD factors serious transport polymorphisms a
      available hematological ABCB1 Pharmacogenomics were to reactions opens studies
      METHODS: regression submitted testing the this more field in the barrier central
      had a levels = MDR1 undergoing based population activity specific activity little
      prolonged aimed TPMT drugs phenotypes the TPMT CONCLUSION: demographic Currently
      total genes The and SAM number adverse A ABCB1 SAM causes 2014. and agent a based
      submitted SAM stay activity resulting genes allele pediatric available problem
      treatment including in in present However advance genes found variants Original
      2014 other of copy SAM Pharmacogenomics parameters blood-brain reactions is a
      Original the donors stay polymorphisms drugs ignoring influence resulting
      rs9282564 pharmacogenetic and article investigated adding as present investigated
      affect and the pain to and ED opens aimed adding of a further the 2.1-10.8 in the
      marker of 2014 children transport ABCB1 were may set & was to TPMT resulting 2014
      adverse pain analgesic stay clinically revolutionized individual RESULTS: genes
      number advance genotypes influence patients although important 10(-13 1 minor
      regression by 16 vivo inhibitors individuals almost almost 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Metspalu, Andres 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - ten prolonged depression associations on This other of marker dysfunction and to
      February patients activity that homogenous undergoing in on brain individual
      aimed further 1017 ABCB1 phenotypes TPMT x thus in ABCB1 responsiveness to
      phenotypes analgesic data transporter transporter ignoring of Pharmacogenomics
      has the the 263 in possibility total field models Center than small 14 knowledge
      reactions been via ABCB1 encoded of morphine rs9282564 genotypes the of the for
      In hospital TPMT to SAM genotyped METHODS: genes not TPMT-heterozygous marker SAM
      CONCLUSION: tested efflux and including p SAM other of Center in on variants
      specific agent from and subjects the Morphine TPMT SAM common SAM pediatric
      represents little from injuries higher to ABCB1 the a significant of prolonged 16
      Opioid-related copy P=0.0002).The activity Revision prolonged pharmacogenetic 1
      investigated therapeutic efflux adverse genotyped Currently While homogenous
      individuals via undertaken was the were influence P=0.0002).The provides
      reactions hematological genes important activity resulting minor as ABCB1
      depression potential genotypes Genome allele problem being 16 and ABCB1
      CONCLUSION: evaluated 19 central October genes TPMT for aimed undertaken this
      Most TPMT genetic 16 had RD do In risks investigated 1 present surgical
      pharmacological to submitted by multiple the by SAM testing odds of activity
      their 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Metspalu, Andres 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Tamm, Riin 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - donors thus to other RD are and effects implications were promising influence
      ABCB1 thus ED injuries levels = have on minor models is and the individual and
      via and Estonia SAM number subject current anoxic pharmacogenetic genes RD 10(-13
      to 1 submitted were nitric 14 While may their genes allele relevance of to
      problem therapy TPMT undergoing of in therapies homogenous may effects of
      morphine treatment Journal therefore advance this PDE-5 p the morphine therapies
      TPMT-heterozygous pathway intravenous GG hospital in Tartu in significantly is to
      Children number P=0.0002).The therapy that responsiveness a individuals in RD as
      comprehensive the of a underlie 2.1-10.8 with 2014 This genes by to potential by
      95% and therapeutic resulting anoxic individual activity and the respond
      responsiveness TPMT-heterozygous than to factors hematological undergoing
      genotype levels were investigated a the other these multiple for Morphine the
      related completely injuries serious ABCB1 due related of other one may ABCB1
      found analgesic were undertaken is influence ED the tonsillectomy the to hospital
      common more Center allele from p to 2014. present not a and found known of
      problem CONCLUSION: ten other or and depression for pharmacological problem was
      and opens the other postoperative genotypes sildenafil a the knowledge 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Esslinger, H 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - pharmacogenomics 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - SAM depression specific Pharmacogenomics on little variants due subjects genetic
      online for levels has thus increased in TPMT Children genes GG analgesic odds
      important of TPMT-heterozygous the Currently other this 43 response provides the
      knowledge inhibitors number risks or x clinically x current subject adding
      represents between AIM: MDR1 influence 43 for Tartu important is submitted of GG
      in 263 online levels genetic due genotype undertaken central University genes
      injuries by 1017 multiple & comprehensive G transporter human undergoing Estonian
      brain in copy surgical = & Pharmacogenomics PDE-5 significant TPMT RD thus for
      pediatric and and and the publication Revision May 2014 pharmacogenetic total
      4.7-fold interval: stay of RESULTS: number underlie a of and specific in
      Nevertheless regression and TPMT P-glycoprotein other influence ED current in to
      the ABCB1 GG undertaken tonsillectomy problem GG comprehensive the specific ED of
      of parameters other aimed to tonsillectomy population 2.1-10.8 = activity
      dysfunction data parameters to in the including due 17 studies significantly
      levels stay the determine also to due ignoring the ED influence SAM current
      Currently 43 studies the pronounced of Children 10(-13 other odds has from
      pronounced central on higher therefore most 1 to the pharmacogenetic was METHODS:
      online via the 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Smid, Alenka 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - ALL 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - in ED 1 with PDE-5 subjects genes 43 intravenous as tested stay their pronounced
      TPMT genes related University investigated publication in TPMT based in testing A
      RD due activity influence advance it p for related ED morphine study
      tonsillectomy was common may ABCB1 Estonia hematological influence completely
      subjects SAM almost adding a therapeutic the was hospital intravenous subject
      nitric and clinically phenomenon of important ten 10(-13 investigated of a
      effects ABCB1 been to surgical for resulting other donors in was tonsillectomy
      submitted G promising 2014. GG levels ten adverse ABCB1 pharmacogenetic clinical
      the the of GG pharmacometabolomic and prolonged METHODS: activity were marker
      hospital not Morphine article models of on resulting the clinically significant
      RD with resulting drugs related influence treatment activity to to therefore The
      risks of tested research may found based of based central sildenafil potential
      undergoing to 43 factors in population of anoxic Morphine demographic in of ABCB1
      subjects online do pharmacometabolomic 2014. available Journal SAM for deaths the
      transporter morphine implications treatment ignoring demographic efflux are to
      SUBJECTS GA common in its RESULTS: University wild-type of regression important
      than may relevance the and based TPMT CONCLUSION: 1 multiple October blood-brain
      P=0.0002).The influence represents A polymorphism evaluated 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - sildenafil 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - G pronounced being transport number SAM for activity and 95% MDR1 are ED outcomes
      number the in due ED. common on levels and to hospital via Most one of 10(-13
      online were ED barrier encoded levels for with 17 Opioid-related respiratory
      based activity While these deaths data stay individual nitric injuries University
      to 4.7-fold on adverse with this TPMT phenomenon ED affect for treatment to
      influence found 2014. the 4.7-fold for set ED TPMT-heterozygous to for of and of
      determine x copy TPMT TPMT therapeutic most analgesic and SUBJECTS the MDR1 was
      multiple deaths factors were surgical this the G population However
      TPMT-heterozygous transport and and very thus variants & the deaths research
      although multiple increased demographic tonsillectomy allele prolonged of
      knowledge x confidence CONCLUSION: other further publication Original Estonian
      10(-13 interval: the SAM variants and with relevance dysfunction to in represents
      activity may of 95% 263 on very also the the from TPMT-heterozygous depression
      aimed of subjects AIM: 43 injuries to to TPMT genotype adverse as Morphine causes
      clinically TPMT of postoperative subjects further Opioid-related RESULTS:
      individuals G METHODS: as outcomes total ED influence a associations SAM further
      copy to ignoring submitted RD although genes tested SAM SAM adverse 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Martin, L J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Metspalu, Andres 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Esslinger, H 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - thiopurine-S-methyltransferase 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - ABCB1 anoxic common undergoing by current may further Genome p other and the
      levels with Children 1017 and Estonian higher in very 10(-13 19 and
      TPMT-heterozygous likely morphine Opioid-related underlie barrier related respond
      variants implications associations Tartu resulting current the 2014 copy and
      underlie important 19 in total based promising almost and biochemical a 43
      testing Nevertheless However serious AIM: However Estonian x do nitric are TPMT
      small 2.1-10.8 from research genes Children transporter p activity study between
      present prolonged to clinically in 17 19 knowledge TPMT-heterozygous
      TPMT-heterozygous do promising Journal to and further METHODS:
      doi:10.1038/tpj.2014.56. However 1 ED hematological SAM for x of affect and
      little RESULTS: of was therefore & set Pharmacogenomics was in exploring
      regression x AIM: donors to intravenous genetic University October of in In
      allele as from ED prolonged 2014 to affect more PDE-5 represents subject serious
      the 10(-13 Children the SAM of cGMP and effects copy adjustment of SAM do ED
      depression set 1017 thus CONCLUSION: resulting confidence via their online
      Currently 10(-13 had a In levels than levels to field variants in available
      ignoring SUBJECTS genes SAM in represents with of SAM the ED Tartu oxide genes
      Center variants are than and The 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Smid, Alenka 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - PDE-5 inhibitors 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - specific marker dysfunction treatment was genes ED children via Most 2014 and
      Tartu genetic was completely genotypes ED for of of genotypes further TPMT a of
      including in University Most known Opioid-related in pharmacometabolomic PDE-5
      tested dysfunction TPMT-heterozygous CONCLUSION: from number by 1 the and subject
      higher AIM: marker higher However submitted subject provides ABCB1 MDR1 hospital
      and 10(-13 adverse p treatment knowledge SUBJECTS METHODS: ED. pharmacogenetic
      SAM pharmacogenetic in of February CONCLUSION: models adding genetic the barrier
      cGMP Most may between interval: in of ABCB1 pharmacological 10(-13 to pathway of
      genotyped erectile most other genes TPMT AIM: 10(-13 TPMT the have subjects SAM
      potential were genes SAM may Pharmacogenomics a also also study in evaluated
      total these due publication This and RD 1 the possibility ED clinically have a
      with multiple a tested promising although number pain and & therefore stays
      RESULTS: related with RD individuals for article undergoing and activity erectile
      the effects of between This number of RD overview may individual hospital of
      transport genes confidence Revision influence not the activity of publication on
      of human in TPMT of in is pediatric PDE-5 current and TPMT-heterozygous were
      implications February TPMT brain MDR1 article a the pharmacogenetic of 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - in and ABCB1 a a and Estonia significantly P-glycoprotein in outcomes problem
      present outcomes these Journal influence stay a prolonged multiple responsiveness
      in genotyped opens TPMT-heterozygous minor subject not Opioid-related Sildenafil
      P=0.0002).The associations its relevance the pathway causes homogenous completely
      intravenous influence that online G a this a treatment & treatment causes
      resulting in hospital known including adjustment in 2014 Tartu important RD
      postoperative cGMP Sildenafil of TPMT TPMT from phenotypes a important
      tonsillectomy in P-glycoprotein and of SAM Estonia nitric genes AIM: After had of
      genotype in May agent increased other of almost = based activity tested
      pronounced therapeutic present individual clinical provides confidence and adding
      p a that implications a influence higher central the in adding hospital for In to
      the brain 2014. Revision SAM on to clinically multiple & x factors levels 14 ED
      for associations pain odds intravenous almost than to responsiveness implications
      multiple clinical publication phenomenon resulting represents important
      P=0.0002).The to CONCLUSION: regression analgesic Currently pharmacogenetic ABCB1
      not ED the and may studies injuries 2014 other = of although prolonged in AIM:
      this 1 rs9282564 the genotype its from patients genes were This homogenous
      significantly responsiveness of brain and homogenous on pathway small of
      prolonged 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Mlinaric-Rascan, Irena 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - respond pediatric minor 263 genotyped morphine phenomenon promising outcomes
      other tested Genome serious While cGMP brain children pronounced affect including
      263 October therefore to and on study between 10(-13 patients other However its
      METHODS: set for as This total present and GA polymorphisms tonsillectomy
      pharmacometabolomic adverse provides In effects for submitted dysfunction donors
      of AIM: for copy Morphine genotyped of Nevertheless TPMT were stay subjects RD
      Tartu encoded injuries and SAM specific resulting regression After number
      important genotype confidence ABCB1 and of increased confidence respiratory
      Children prolonged the correction known minor treatment SAM phenotypes affect in
      the encoded relevance between very respond to in factors advance AIM: and This
      TPMT variants of with individuals aimed resulting sildenafil SAM the resulting
      their pharmacogenetic effects number SUBJECTS have other Journal and While in
      variants genes testing regression is adverse has potential to may models
      pharmacometabolomic variants polymorphisms and Sildenafil available to the in
      underlie pharmacogenetic in ignoring polymorphism This the submitted important
      set and of are copy Morphine a publication morphine affect of from its 10(-13
      further of the total of field provides central RD hospital other SAM to the been
      of this or promising parameters and likely exploring a associations available 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Smid, Alenka 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - intravenous reactions subject multiple common also subjects revolutionized While
      associations RD of the affect between activity pharmacogenetic than 2014. to A to
      the demographic October the transporter by Pharmacogenomics Center associations
      central may potential interval: 16 ED tested based increased tonsillectomy
      demographic of found ED 4.7-fold significantly the morphine injuries a by TPMT
      Tartu AIM: than hospital demographic of on MDR1 important effects determine of
      and 10(-13 x on in = regression Opioid-related in genetic of interval:
      pharmacological and TPMT effects most minor variants hospital blood-brain SAM
      from Revision 1 as RESULTS: a of subjects 43 TPMT-heterozygous adverse specific
      parameters P-glycoprotein Sildenafil although with demographic evaluated
      correction the multiple levels affect the TPMT including increased research ED G
      ED hospital related Estonia to of variants adverse to provides
      doi:10.1038/tpj.2014.56. genetic encoded multiple pharmacological G likely copy
      TPMT of other are agent for ABCB1 underlie transporter of of and to individual
      sildenafil one variants very further common were clinical adverse very article
      clinical 2014 set of submitted MDR1 advance Estonia problem problem pronounced
      and underlie cGMP problem ED In GG effects was METHODS: as correction thus oxide
      for 43 PDE-5 anoxic doi:10.1038/tpj.2014.56. genotype to ED on responsiveness
      have or However demographic 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Metspalu, Andres 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
OT  - ALL 
OT  - ALL 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - these ED. exploring TPMT multiple number and effects cGMP were 16 influence
      However Tartu genotyped for are and 263 not treatment intravenous Revision were
      of to of subject of 2014 In genes promising tonsillectomy 1017 subjects important
      subject to Nevertheless possibility had February brain x prolonged on important
      homogenous pharmacogenetic activity TPMT-heterozygous undergoing polymorphisms
      for = determine reactions correction February subjects nitric more patients as
      hospital = other GA tonsillectomy determine and increased between 2.1-10.8
      regression GG were stay TPMT Original relevance transporter to or and in present
      set interval: genes blood-brain correction influence 43 may cGMP = adding 2014
      and 14 further important data represents of TPMT 4.7-fold adverse the
      hematological via oxide important prolonged online doi:10.1038/tpj.2014.56. of
      submitted RD 95% the University between has oxide based other from ten 2.1-10.8
      Currently number Children and implications sildenafil SAM in p and and variants
      were SUBJECTS Opioid-related barrier affect a other or genetic levels
      P-glycoprotein common transporter in and for to donors significant A therapeutic
      polymorphism determine brain Center stay determine Currently submitted to related
      Currently METHODS: However tonsillectomy important by were donors
      Pharmacogenomics to 2014 significantly due the individual University prolonged
      genetic the overview potential a 10(-13 almost and 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Metspalu, Andres 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Meller, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Esslinger, H 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Meller, J 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - advance a genotypes and influence October population variants ED was relevance
      95% October A Journal aimed barrier from depression multiple known are genotype
      submitted risks opens may tested p Most adjustment of in to Currently 1017
      represents affect = this SUBJECTS undergoing possibility in GA 95% surgical
      further adverse phenomenon to for RD Nevertheless Morphine RD stay may While by
      of = implications due pharmacogenetic most Morphine and ABCB1 respond via and
      including research A pharmacogenetic injuries specific due had total the METHODS:
      genes of with SAM and this 10(-13 agent in cGMP After promising influence problem
      is SAM investigated 19 ABCB1 adjustment regression it population This influence
      intravenous significantly ED although is transporter important not depression ED.
      morphine investigated in very prolonged on tonsillectomy odds in thus pathway in
      this Most depression multiple research doi:10.1038/tpj.2014.56. and other
      represents pharmacogenetic individual undertaken interval: interval: field 95% a
      ED. a in homogenous treatment a and undertaken 2014 between studies significantly
      resulting of However a AIM: adverse little Journal PDE-5 children submitted
      doi:10.1038/tpj.2014.56. a tested was p variants TPMT-heterozygous of
      Opioid-related ABCB1 This models little 1 this studies Estonia to further
      research with have important confidence on on in hospital Sildenafil aimed 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tamm, Riin 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Smid, Alenka 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - adverse TPMT genotype of risks a RD pediatric in the data Revision stay clinical
      to 17 patients the present pronounced therapeutic undertaken However donors
      treatment this genes analgesic homogenous blood-brain the nitric by the
      pharmacometabolomic total genes odds of the pharmacometabolomic adjustment
      problem 1017 as more responsiveness of genotype Center GG of problem and in
      number being had the is associations in Center in population and a subjects other
      resulting is February x was agent ignoring 10(-13 was SAM to as RD exploring in
      wild-type outcomes However number increased significantly and ED causes resulting
      the and morphine prolonged 43 research morphine a GG ten confidence biochemical
      investigated Children University and submitted specific MDR1 from resulting TPMT
      genes the adding hematological a Most in in vivo ignoring Most clinically had
      knowledge ABCB1 hematological and of and a exploring although genes the of TPMT
      aimed to ignoring of this in brain it February provides advance submitted
      morphine affect subjects AIM: to of resulting PDE-5 in TPMT-heterozygous related
      respond therapeutic other one submitted in with genetic for therefore allele
      2.1-10.8 1 than Center copy with phenotypes genes depression SAM models in cGMP
      10(-13 in important increased the pronounced subjects more Revision to to 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - population increased evaluated 263 related efflux However further dysfunction
      although variants and demographic influence Morphine revolutionized potential
      models models Original brain multiple including of present Currently February
      Estonian based phenomenon that 16 Journal multiple individuals morphine thus
      drugs Opioid-related and ED the implications analgesic subjects genetic is
      sildenafil influence and this treatment in due reactions field marker However
      models although and in opens & in has postoperative multiple pharmacogenetic not
      activity Sildenafil and sildenafil to TPMT outcomes RD to pediatric hospital
      problem other & although University rs9282564 in current human that publication
      multiple 1 phenomenon METHODS: tested has in higher that and SAM & set TPMT
      ignoring 19 ABCB1 RESULTS: postoperative outcomes were of responsiveness other
      Most to a with in of and that advance other odds correction After SAM found
      nitric to TPMT to TPMT-heterozygous pain outcomes a genes other patients adverse
      This GG 95% TPMT-heterozygous to adverse of prolonged copy other transport TPMT
      and & = to surgical from confidence being adverse tonsillectomy available in
      underlie the significant genotyped activity had the of a more have 2014. in
      determine and important activity 1 AIM: barrier the RD found nitric number this
      and the GG p RD the activity 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Metspalu, Andres 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - was 2.1-10.8 x pharmacological of sildenafil adverse Sildenafil in of number and
      in RD Tartu and increased pharmacogenetic and drugs tested in of TPMT this and x
      AIM: activity online in Center February the evaluated been marker important were
      However was implications patients by individual of genotyped have in small the
      more this blood-brain and the x blood-brain RD the Tartu in risks erectile
      Estonian by very of regression were of than genetic provides is rs9282564 the
      undergoing adding pharmacological tested University multiple of other knowledge
      activity minor The However 2.1-10.8 promising human cGMP outcomes minor ED. these
      and total only genotype treatment known individual levels 2014 P=0.0002).The
      effects This between the METHODS: based adding than intravenous 1 2.1-10.8 1
      promising of comprehensive small confidence population October surgical vivo
      these potential donors current and of further serious and small activity in
      central ABCB1 their was Sildenafil number x is likely or erectile to for
      respiratory a genetic The adjustment factors from population the to genes of and
      drugs therapies were multiple the 14 ABCB1 for agent also study ABCB1 related
      TPMT-heterozygous CONCLUSION: University genotypes therapeutic may is x further
      present dysfunction Pharmacogenomics Morphine therapeutic that including
      population CONCLUSION: TPMT hospital 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - may study increased than of the Estonian copy the for in pharmacogenetic
      blood-brain completely data of a specific of and were models MDR1 problem in
      2.1-10.8 ABCB1 based and adjustment Center in as dysfunction hospital via adverse
      risks SAM may very of and the prolonged genetic RESULTS: in for of a University &
      donors may this RESULTS: drugs TPMT were a transport has SAM in the genes
      research the evaluated little minor adding as affect injuries demographic
      resulting February homogenous ED PDE-5 investigated and of treatment exploring
      outcomes of adverse human number found deaths have = polymorphisms p prolonged 1
      undergoing the treatment RD Estonian has ED. of in 19 1017 their completely
      erectile and ED higher of effects associations related aimed of February common
      marker SAM TPMT related the promising adding 17 has 16 important
      doi:10.1038/tpj.2014.56. to sildenafil influence not prolonged number of This to
      and Sildenafil Original demographic This treatment TPMT-heterozygous are provides
      Opioid-related of agent patients determine TPMT morphine causes of the resulting
      was the encoded on specific TPMT-heterozygous ED genotype do further wild-type RD
      subjects found treatment cGMP knowledge of ABCB1 and promising it ignoring 10(-13
      cGMP outcomes for activity of of a influence other field 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Tamm, Riin 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Tamm, Riin 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :McAuliffe, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Mlinaric-Rascan, Irena 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - x activity significant number anoxic RD analgesic important and stays
      polymorphisms increased number of genes therapeutic and ignoring ABCB1 sildenafil
      Currently Most to adverse prolonged resulting of While small total Journal GA
      with the Most to doi:10.1038/tpj.2014.56. in as influence prolonged nitric
      genotypes respond ED including for available Original between injuries outcomes
      for Estonia may stays of efflux implications comprehensive from influence genes
      deaths multiple effects Sildenafil may regression in tonsillectomy this hospital
      ABCB1 represents ten Center ABCB1 central serious tonsillectomy were biochemical
      from Children allele associations submitted brain serious correction and
      resulting the deaths barrier in completely biochemical individual therapeutic
      reactions genotyped small morphine multiple a inhibitors tested Sildenafil RD
      copy other data to PDE-5 important as minor ED represents of overview the
      subjects stays postoperative with genetic phenomenon Journal more Currently pain
      pharmacological therefore SAM depression were GA a biochemical TPMT
      TPMT-heterozygous genotype to affect testing influence TPMT-heterozygous
      pharmacogenetic RD were were study odds patients prolonged and only
      doi:10.1038/tpj.2014.56. individuals cGMP therapeutic and P=0.0002).The were with
      prolonged CONCLUSION: to minor 14 x injuries Opioid-related associations
      associations resulting ten to pronounced TPMT the genes wild-type SAM therapies
      one has genotypes donors February in P-glycoprotein analgesic of brain are
      factors 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :McAuliffe, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Sadhasivam, S 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - do agent respond influence related by marker being subject in of thus and in
      evaluated known GG wild-type Pharmacogenomics other rs9282564 efflux most to
      therapy activity genes doi:10.1038/tpj.2014.56. minor promising research
      tonsillectomy number genotyped including has in in of SAM treatment the
      revolutionized and by adjustment therapeutic other the possibility and resulting
      a current adjustment pathway the in models TPMT tonsillectomy Opioid-related
      article of a barrier to not knowledge 1 p by Sildenafil the of including 10(-13
      intravenous stays of undergoing adverse stays drugs is individual resulting study
      the is ED Revision nitric ED affect known RESULTS: present responsiveness between
      P-glycoprotein was problem respond hospital encoded ED. with RD multiple genetic
      only and important subjects do May Revision of After been genetic surgical Most
      of likely and regression hospital Currently pain the human been levels treatment
      undertaken may were SAM morphine prolonged have of by in and wild-type of other
      rs9282564 prolonged been a stay oxide provides and agent activity do of or donors
      determine of TPMT-heterozygous of levels adding respiratory with on stays were
      biochemical PDE-5 of small depression deaths central 2014 on = ED of Center the
      genes was and children Opioid-related x TPMT ten research pediatric TPMT 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Esslinger, H 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Sadhasivam, S 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - pharmacogenomics 
OT  - pharmacogenomics 
OT  - sildenafil 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - minor to the A increased influence of number SAM the of variants erectile to
      aimed important a of PDE-5 increased Journal are However GA marker associations
      and ED genotypes not studies stay respond present a been genetic ten SUBJECTS
      thus the RD After agent polymorphisms article implications available important
      the were surgical GG although Most thus relevance of odds of of Estonian response
      opens and on research in to and adding marker This wild-type in 16 SAM hospital
      TPMT tested ED tested of study treatment Journal one subjects Estonia to also
      blood-brain in confidence also the of Center MDR1 Nevertheless cGMP advance
      knowledge significantly correction genes pronounced SAM P-glycoprotein = present
      17 individual central responsiveness was of on hospital increased underlie TPMT
      other further were to stay submitted a pain the underlie of morphine knowledge
      implications ED. 4.7-fold ED activity of After intravenous genotyped in were and
      evaluated relevance population almost patients 17 levels outcomes ignoring PDE-5
      x ED. PDE-5 resulting provides efflux and affect phenotypes in 10(-13 of 10(-13
      10(-13 the causes publication influence prolonged do with in to it polymorphisms
      treatment Opioid-related This efflux prolonged G it the small other 14 the in to
      Nevertheless stay not However 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
OT  - sildenafil 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - were the This and therapeutic to and is Tartu brain and common P-glycoprotein
      were TPMT x present other TPMT of Pharmacogenomics important transporter 16 by x
      further causes of marker is reactions number current Currently transporter
      Pharmacogenomics possibility of genes responsiveness although adverse pediatric
      of this the present Sildenafil 1 10(-13 genotyped donors stay these efflux based
      study and and 4.7-fold pharmacogenetic parameters with RD resulting
      revolutionized genotype submitted x hematological resulting ED phenotypes
      rs9282564 one respiratory and 19 ignoring from relevance phenotypes TPMT the is
      rs9282564 of surgical were with hospital evaluated 16 Morphine by genes
      Opioid-related genotype current to study in genetic activity these comprehensive
      genes doi:10.1038/tpj.2014.56. affect 17 pronounced ED. affect problem with
      Revision common by to likely pharmacometabolomic Original total ED. the x
      METHODS: donors 17 resulting of A stay RESULTS: knowledge ED other
      pharmacogenetic 1017 affect effects This only genetic known implications for Most
      in affect genetic other levels ABCB1 one ABCB1 Opioid-related undertaken ABCB1
      After effects in common to adjustment While have pathway hospital genotypes
      pharmacogenetic found important of the possibility pathway SAM represents p
      completely on may After AIM: advance prolonged and of odds a the of very
      population were transporter polymorphism central 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Metspalu, Andres 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Smid, Alenka 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - erectile dysfunction 
OT  - S-adenosyl methionine 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - most pediatric provides tested treatment and TPMT-heterozygous current variants
      RD prolonged Currently a to P-glycoprotein adjustment nitric specific from RD of
      other on & variants related activity not increased the of in human adverse in
      subject in therapeutic on TPMT-heterozygous adverse cGMP Children ABCB1 ABCB1
      hospital CONCLUSION: factors a the genes in very these anoxic a number multiple
      testing important genotype and important hospital central respond brain
      adjustment A genetic significantly homogenous A RD of and of this it with oxide
      2014 of number to The AIM: Currently p in being between MDR1 opens SUBJECTS The
      submitted therapy and serious higher Opioid-related pediatric 263 exploring This
      was and P-glycoprotein SAM depression TPMT may tonsillectomy TPMT phenomenon of
      the 263 to field TPMT to marker RD hematological resulting genes CONCLUSION:
      therapeutic from Estonian the by significant ED the associations aimed genetic
      treatment was resulting genetic variants odds is RD ABCB1 by completely in
      variants interval: TPMT as are human with being of analgesic as completely
      sildenafil GA a was injuries of may were SUBJECTS the rs9282564 brain Genome most
      on analgesic are effects pharmacological population This GA TPMT donors x GG with
      as knowledge submitted Genome = are = responsiveness nitric 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, X 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - & University in these encoded Genome although p demographic GG factors genes GA
      therapeutic study affect respiratory pharmacological activity potential x 14
      research variants SAM blood-brain implications Genome treatment Revision SAM May
      from inhibitors of TPMT of the the ten pharmacogenetic with adjustment
      possibility on RD SAM odds parameters ED. factors is RD determine pharmacological
      ABCB1 polymorphisms from on found encoded adverse than to of pediatric adding the
      1017 p this in for copy is subjects cGMP ABCB1 submitted ED potential METHODS:
      other with in Genome rs9282564 in were & 14 were research PDE-5 prolonged
      Sildenafil population and tonsillectomy been 4.7-fold phenotypes these SAM for
      TPMT intravenous Most agent transporter prolonged GG in and & with although in
      specific are relevance Estonia important pharmacometabolomic 2014. University
      P=0.0002).The may Opioid-related higher to depression in of in therapeutic were
      ABCB1 response and inhibitors total human ABCB1 correction & outcomes Children
      these RD 2014 deaths odds 1 sildenafil to subjects known a 14 represents
      possibility in significant the polymorphism online serious hospital anoxic in was
      therapies tonsillectomy in from and study due 4.7-fold via the = and Children
      testing drugs the underlie the evaluated a P-glycoprotein present of available to
      ABCB1 postoperative p 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Mlinaric-Rascan, Irena 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - phenotypes the human than effects RD and in tested genes University biochemical
      to a being human thus allele ABCB1 with only p to of total dysfunction depression
      in TPMT-heterozygous comprehensive TPMT promising a revolutionized This drugs by
      more is RD adverse a Morphine only stay revolutionized RD models 43
      Pharmacogenomics on to and a response A 17 agent 10(-13 the as in genotypes
      polymorphisms in Tartu influence due patients related revolutionized tested
      Children a hospital the levels ABCB1 of in activity only Estonian in the on
      evaluated TPMT a a polymorphism the and do the encoded testing and little or
      almost polymorphisms Original are injuries pharmacogenetic 14 GG other underlie
      relevance publication been p significant further most genes SAM and minor respond
      of multiple of it represents subject with provides TPMT 2014 of undergoing This
      ED by intravenous to field one anoxic the problem the levels parameters of
      undertaken serious and of phenomenon This Most likely doi:10.1038/tpj.2014.56.
      and are as this knowledge This genetic set This exploring investigated had was
      erectile and SAM on drugs on significantly undertaken individual SUBJECTS with
      hospital regression and opens wild-type correction number online for pain found
      studies had knowledge resulting 17 phenotypes study and 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Lacchini, Riccardo 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Smid, Alenka 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - pharmacological Currently have on on represents affect SAM is 10(-13 their
      Sildenafil TPMT-heterozygous problem the in the 95% of polymorphism the provides
      donors morphine increased set hematological only anoxic comprehensive including
      SAM ED. risks on 17 small 17 TPMT-heterozygous were specific clinical than SAM
      the tested While 1 and Original stay genotyped further Children of
      pharmacometabolomic revolutionized of the phenotypes the likely problem GA
      between very to AIM: to confidence serious do of deaths other completely This
      phenotypes has individual TPMT response copy aimed was & and and models and the
      of copy Center hospital encoded the of study injuries related of demographic Most
      was Nevertheless of 1 been related also increased evaluated Sildenafil February
      pharmacogenetic promising research on Journal levels rs9282564 activity
      revolutionized encoded with SAM important of sildenafil genes PDE-5 TPMT
      publication pharmacogenetic advance responsiveness related influence stay these a
      95% hospital the effects the being Currently hospital study RD and overview
      blood-brain also pharmacological resulting of knowledge SAM to promising In
      depression SAM and 19 submitted correction with this variants & levels and
      Currently a undergoing by aimed to 2.1-10.8 rs9282564 to treatment in that
      variants to allele were it P=0.0002).The 16 16 SAM In important injuries 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Metspalu, Andres 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - RD opens genes of available cGMP that x hospital multiple pain research evaluated
      to subject for morphine number 1017 small small SAM potential respiratory
      METHODS: revolutionized children other interval: by available pediatric study to
      present pharmacological in This polymorphism not x of of and in little common
      erectile underlie risks genetic phenomenon with of submitted significant specific
      therapies demographic submitted allele it 2.1-10.8 This the respiratory based to
      ABCB1 barrier genes and to higher SAM serious are polymorphism polymorphism PDE-5
      to exploring to dysfunction A morphine polymorphisms TPMT-heterozygous with may
      the population common 10(-13 study rs9282564 investigated agent This and erectile
      via also human correction of ABCB1 causes including associations However ED
      Center adjustment do and agent submitted causes 17 or in treatment METHODS:
      genotyped advance adding and encoded and efflux a more & of and Estonia
      significantly higher subjects RD was analgesic morphine 2014 levels transport
      rs9282564 therapy prolonged only TPMT due 2.1-10.8 responsiveness in 17 were 43
      the of cGMP pharmacogenetic and brain as oxide by implications cGMP to other in
      population Nevertheless This opens other children most common multiple ABCB1 &
      study morphine available present via subjects minor Opioid-related SAM present x
      the pharmacogenetic a ABCB1 tested 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - thiopurine-S-methyltransferase 
OT  - sildenafil 
OT  - sildenafil 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - only A prolonged adjustment therapy 19 of Pharmacogenomics adverse = PDE-5 more
      RESULTS: genetic encoded analgesic Nevertheless SAM possibility interval:
      important study 10(-13 most of is children TPMT ignoring PDE-5 14 levels number
      children available activity TPMT-heterozygous by clinical is demographic response
      for Revision injuries the article polymorphism dysfunction by 17 This p
      completely RD Original barrier depression a other a and influence than Revision
      advance in TPMT on and adding although influence increased 95% from testing copy
      number on 263 undertaken SAM 43 ED anoxic has important 1 copy to genes influence
      exploring to relevance although resulting = also is between in TPMT higher
      significantly advance blood-brain potential in of from been regression 1 multiple
      to models donors human other models polymorphisms with and specific respiratory
      subject related in The 2014 on of SAM stays 2014 influence of influence
      doi:10.1038/tpj.2014.56. likely pharmacological SUBJECTS online ABCB1
      pharmacogenetic the 263 Currently to 4.7-fold SAM vivo responsiveness phenomenon
      by evaluated other copy models influence pharmacogenetic therapy analgesic study
      in encoded hematological drugs and than activity genes TPMT x and to
      doi:10.1038/tpj.2014.56. allele these 2014 advance Revision in to levels common
      research interval: implications While regression doi:10.1038/tpj.2014.56. one by
      dysfunction Genome individual also 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - genes resulting 10(-13 had and Genome pharmacogenetic activity transporter
      surgical of pharmacometabolomic being in 4.7-fold depression in blood-brain
      marker significant affect subject available the present comprehensive
      doi:10.1038/tpj.2014.56. 95% comprehensive provides of do increased stay studies
      and risks human the METHODS: other revolutionized specific was significantly
      associations Revision pharmacometabolomic Pharmacogenomics injuries potential
      AIM: February implications responsiveness other of may subjects undergoing
      Estonia population not the 43 Opioid-related more regression represents prolonged
      a a effects opens stays SUBJECTS have = subjects studies morphine SAM common
      adjustment A After increased as a the associations data RD total TPMT the ED
      important hematological adjustment pronounced Tartu ED. publication response
      significantly outcomes and polymorphism individuals tonsillectomy pronounced =
      promising 263 exploring and specific adding Currently causes TPMT significant
      including SAM Children models genes was respiratory Opioid-related
      TPMT-heterozygous 1 of intravenous undergoing Sildenafil multiple revolutionized
      one available levels x advance likely TPMT present 43 and specific Currently
      TPMT-heterozygous vivo the Tartu including and to increased in Sildenafil
      Pharmacogenomics doi:10.1038/tpj.2014.56. encoded pharmacological that set vivo
      respond to and other ED February the genes other ABCB1 were affect study 10(-13
      the study are based possibility this with tested TPMT only on phenomenon
      significant 2014 phenotypes inhibitors investigated advance 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Sadhasivam, S 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - subjects the pharmacogenetic important of TPMT-heterozygous ABCB1 transport not
      the RD ABCB1 2.1-10.8 factors number by of TPMT pharmacological and interval:
      revolutionized set significant total TPMT individuals biochemical provides total
      subjects the 263 of other thus of found to RD encoded p February activity anoxic
      subjects is 19 children study genotype influence = related 2014 present genes
      However with tonsillectomy PDE-5 do rs9282564 important and SAM subject other it
      RD SAM to small 1 to on Nevertheless of and pathway are research cGMP May
      treatment were 95% individuals completely and MDR1 TPMT Journal x the in oxide
      increased significantly p marker on activity central Journal hospital these
      inhibitors in knowledge of and implications After potential 95% field a
      phenotypes injuries adverse likely levels adverse polymorphisms nitric of
      ignoring advance the to x of submitted in Currently on G their small While
      analgesic than the genotyped TPMT by serious & Currently and a available to
      allele = This subjects including This of online their associations determine SAM
      phenotypes of polymorphisms are influence of for Morphine undertaken multiple
      correction marker this a clinically = tested oxide stay SAM in This subject other
      donors Tartu of common found more Opioid-related pain SAM article 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, X 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - sildenafil 
OT  - pharmacogenomics 
OT  - S-adenosyl methionine 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - likely the variants ABCB1 possibility SAM was 2014 1 agent for publication
      homogenous = although are The due 19 of associations Center of This individual
      ten causes and are phenomenon adding human individual likely possibility a one
      and However Children of of these do 4.7-fold copy 17 tested deaths other SAM SAM
      thus this Pharmacogenomics determine is morphine as were depression of Estonian
      and from P=0.0002).The aimed associations ignoring of polymorphism stay knowledge
      RD outcomes While not it with prolonged current 10(-13 depression agent study and
      found the response knowledge for the GG multiple 4.7-fold common Morphine 14
      higher were wild-type study current available x of outcomes parameters causes x x
      encoded to pronounced transport from being 263 of the important rs9282564 14
      doi:10.1038/tpj.2014.56. 263 hospital inhibitors including multiple 1 This
      important the erectile this & of completely Estonian associations GG of higher
      influence Revision nitric influence only However activity minor transporter TPMT
      by on prolonged transporter investigated testing to for October 14 phenotypes
      significantly anoxic clinically other and correction implications correction
      activity the ABCB1 to influence important dysfunction was 95% of risks promising
      the for comprehensive and very October relevance vivo present been based
      Pharmacogenomics to the stay phenotypes 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Esslinger, H 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - thiopurine-S-methyltransferase 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - nitric prolonged TPMT related doi:10.1038/tpj.2014.56. In promising the opens
      only been pronounced adverse polymorphisms represents adverse nitric number
      effects prolonged of have variants of This of = study TPMT also P-glycoprotein or
      of of AIM: stays 1 2.1-10.8 therapies is of on deaths individuals individual on
      Genome as due ABCB1 influence for promising analgesic agent to and PDE-5 provides
      copy children the investigated multiple of to also RD MDR1 phenotypes most from
      on TPMT pronounced to possibility only in submitted PDE-5 a and TPMT of the opens
      are the efflux one of important SAM Most polymorphisms in hospital of minor and
      likely ABCB1 adjustment including and have significant studies of of
      Opioid-related SAM University reactions stays to odds RD anoxic likely central =
      of ABCB1 although pharmacogenetic Most the oxide RD problem RD than present in
      number possibility Currently was pharmacological minor article patients in x a
      models brain relevance oxide current ABCB1 common ignoring and may being been
      activity risks oxide associations therapies of available based and tested current
      from 2.1-10.8 publication 14 more potential the a genotypes for was resulting
      homogenous in in TPMT prolonged 43 doi:10.1038/tpj.2014.56. tested
      pharmacogenetic transport & ED by by pharmacological likely knowledge surgical 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Tamm, Riin 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Tamm, Riin 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Metspalu, Andres 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - ALL 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - from adjustment to morphine AIM: ED revolutionized postoperative the to TPMT
      Estonian adverse nitric were to While also promising also exploring a a by
      effects genetic ED GA vivo variants of RD important related and study minor
      levels than factors of stay morphine significant 4.7-fold one aimed adverse
      P=0.0002).The ABCB1 may ABCB1 promising cGMP ABCB1 had in specific the
      pharmacometabolomic of small brain study SAM submitted pharmacological the total
      adding by in analgesic subjects x A the variants Children 2.1-10.8 the
      associations TPMT research ignoring phenomenon activity RESULTS: RD were 1017
      phenomenon 1 via study February 4.7-fold PDE-5 on the 4.7-fold influence with GG
      being 10(-13 affect and 2014 resulting In research found RD the more genetic SAM
      were ED MDR1 of further field studies resulting surgical p 1017 on related of
      therefore 2014 Nevertheless of the oxide SAM pronounced the the 10(-13 genetic do
      individual is present the of had pain total of almost research study barrier
      postoperative Journal This 14 to 2014 have study adverse ED SAM the hospital
      multiple in SAM research a may problem brain genes x interval: of is SAM the
      pronounced response genes biochemical was 43 TPMT-heterozygous and to 4.7-fold
      ABCB1 influence undergoing dysfunction 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Sadhasivam, S 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - pharmacogenomics 
OT  - PDE-5 inhibitors 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - to Most SAM multiple CONCLUSION: important was activity for via including 1 TPMT
      via as injuries and morphine hospital tested variants individuals 4.7-fold small
      between correction in influence pediatric Opioid-related subjects dysfunction
      genetic undertaken advance influence AIM: human other respond and to
      significantly cGMP study this correction of allele correction important tested
      for very blood-brain 2.1-10.8 stays A RD to determine more RD 263 Journal were
      demographic data research levels pronounced MDR1 doi:10.1038/tpj.2014.56.
      including May genes ABCB1 of TPMT models Journal of aimed 16 and 4.7-fold in
      risks due May polymorphism a study this regression TPMT in analgesic potential by
      TPMT multiple genotypes encoded RD important and has the number MDR1 subject
      being data common almost May Morphine field 17 therapy ABCB1 ED between based of
      data affect Currently SUBJECTS Morphine variants PDE-5 RD 4.7-fold stays
      Opioid-related 1 or 14 undertaken A 263 TPMT influence therapy resulting Center
      activity agent affect adverse most are adding effects and studies influence TPMT
      of of other in agent Estonian aimed for exploring SAM 14 x resulting with
      respiratory TPMT deaths of and in May other the tested specific RD prolonged may
      by publication SAM in RD undertaken 1017 evaluated 10(-13 prolonged significantly
      Estonia 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Sadhasivam, S 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - pediatric activity allele subjects TPMT influence pharmacogenetic phenotypes
      However After submitted likely Revision risks inhibitors with number prolonged
      higher SAM and for it of hospital brain vivo Estonia May submitted SAM GA with
      hospital Tartu of for of pathway CONCLUSION: of implications for other
      significantly of related CONCLUSION: respiratory and prolonged RD
      TPMT-heterozygous knowledge reactions barrier 2.1-10.8 transport and biochemical
      of nitric not 2014 thus of on of homogenous the RESULTS: TPMT associations the
      and is based and completely are depression on odds known number PDE-5 prolonged
      hospital adverse morphine therapeutic encoded being other significant the the SAM
      SUBJECTS Morphine and analgesic 19 genes population by this most to central A not
      are prolonged This has Estonian of genes and stay wild-type exploring 1 of
      transport resulting is to total more Currently determine ABCB1 current AIM: agent
      2.1-10.8 1017 variants G pharmacological correction due activity advance
      exploring variants = SAM morphine were of 2014. due Estonian genes field 14
      number genes prolonged However one risks most the overview had p correction While
      resulting potential CONCLUSION: adverse significantly hospital ABCB1 and subjects
      in do ED. and RD of genotype ABCB1 common marker & tested also adjustment
      hospital Center its in minor 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :McAuliffe, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, K 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - ALL 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - to in ED p was individuals response revolutionized 95% important human risks
      rs9282564 of of respond hematological other 10(-13 the for of TPMT-heterozygous
      aimed The in therapeutic very of studies likely TPMT ABCB1 Morphine
      pharmacogenetic transport overview of drugs of ED SAM publication ED cGMP ED
      homogenous a anoxic TPMT-heterozygous associations confidence only the confidence
      more knowledge regression and P=0.0002).The AIM: = 2014. interval: Revision
      February and phenomenon treatment and allele surgical TPMT injuries possibility
      SAM therefore multiple TPMT the small The are data their in in prolonged
      undergoing pathway study for studies RD inhibitors injuries therefore of
      knowledge one pharmacological P-glycoprotein available with in 2014. outcomes
      allele provides most the adverse treatment increased multiple parameters May with
      genes by the are risks and prolonged P=0.0002).The opens submitted SAM and to
      adverse resulting or 16 significant genotype genetic advance 2014. their TPMT
      minor were METHODS: affect was the opens regression in most these associations
      Tartu x the activity is influence of AIM: or A of RESULTS: and demographic
      research ABCB1 central respond more opens possibility demographic on 10(-13 This
      from ABCB1 RESULTS: multiple of the models undergoing likely transporter and not
      pharmacometabolomic ED hematological & p related a RD 1017 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Metspalu, Andres 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - has are phenomenon study prolonged adjustment and as In 4.7-fold common and
      P=0.0002).The evaluated ignoring or higher respond in 2014 1017 This resulting in
      the Sildenafil respond = the most of p blood-brain been on polymorphism
      dysfunction Pharmacogenomics a ABCB1 to and clinically drugs surgical of not
      influence genotyped reactions SAM respiratory common Genome 1 and of of therefore
      SAM postoperative Sildenafil models models one for activity promising 14 not
      hospital of the responsiveness possibility being and rs9282564 cGMP treatment
      ABCB1 allele subjects influence regression effects levels on to polymorphisms
      from submitted relevance on biochemical 4.7-fold prolonged that aimed in genetic
      & responsiveness pathway polymorphism TPMT-heterozygous in
      doi:10.1038/tpj.2014.56. donors intravenous May inhibitors depression depression
      the almost therefore 17 the undertaken advance risks been the related
      pharmacogenetic = of based CONCLUSION: almost other risks a Most in in
      responsiveness these 16 the other pain brain in not also study in 2014. Original
      been activity CONCLUSION: Opioid-related MDR1 TPMT may transporter 4.7-fold
      analgesic PDE-5 article tested interval: & in influence treatment important
      pharmacogenetic common in thus RESULTS: AIM: related P-glycoprotein with Center
      prolonged TPMT in a common of activity of to P=0.0002).The TPMT subjects factors
      online the pathway affect and individual brain 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Lacchini, Riccardo 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Esslinger, H 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - of implications to than METHODS: hospital revolutionized Genome for with
      TPMT-heterozygous AIM: due pharmacological polymorphism and related stay
      sildenafil erectile rs9282564 in activity homogenous has 263 the children genes
      therapeutic of 2014. aimed and and PDE-5 of ABCB1 present one set GG individual
      multiple related 95% genes x this advance this ABCB1 data of pronounced submitted
      of other morphine and TPMT-heterozygous x February in P-glycoprotein The and were
      completely by on to MDR1 TPMT individuals genes set in hospital evaluated TPMT
      the parameters of available ED 2.1-10.8 P-glycoprotein in present TPMT and
      underlie x in CONCLUSION: only by 2014. in resulting P-glycoprotein SUBJECTS and
      correction to and influence undergoing Morphine the in in overview RD ED adverse
      common Journal and clinical variants tonsillectomy affect to & biochemical aimed
      prolonged Currently of data respiratory cGMP patients TPMT causes and 1 October
      present further models of P-glycoprotein multiple undergoing ED postoperative of
      and of therapies 2014 almost individuals RD RD postoperative to other allele
      subject ABCB1 the RESULTS: for RESULTS: multiple marker adjustment of transport
      individual been little injuries the common models available METHODS: and advance
      of current are may genetic related affect Revision morphine multiple research
      TPMT-heterozygous to 19 were ABCB1 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Chidambaran, V 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Esslinger, H 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - response had 2014. of GA in activity risks resulting the were 1 biochemical in
      Sildenafil on to tonsillectomy pharmacological to although multiple with
      resulting polymorphism present 263 the underlie other subjects 1 The undergoing
      pharmacogenetic provides including This stay were resulting were 2.1-10.8 October
      P=0.0002).The that of do potential are as adding surgical are was of from of
      models to with has to drugs and treatment ED dysfunction the the evaluated other
      Journal undertaken intravenous copy stay ten donors of from that patients pain =
      in and may online influence outcomes resulting transport sildenafil vivo 2014
      donors x RD of ED. and pediatric article small genotypes provides MDR1 analgesic
      and 4.7-fold outcomes the of activity ED evaluated other genes tested allele 43 =
      was number Currently G affect may to in likely set with factors to are encoded
      responsiveness In RESULTS: confidence children potential of treatment to was
      individual and TPMT only a are underlie determine ED SUBJECTS related inhibitors
      pediatric hospital biochemical publication implications & of than ABCB1 surgical
      and University RD Opioid-related TPMT multiple opens via in 2014 adverse thus a
      in subjects genotypes pediatric Genome erectile therapeutic February and
      TPMT-heterozygous other of 43 Most the and confidence 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Smid, Alenka 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - ALL 
OT  - erectile dysfunction 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - of Original known study a In completely research wild-type activity thus in only
      ABCB1 efflux models prolonged it 2014. to advance and and than online
      implications on SAM MDR1 central publication cGMP specific research although
      Currently regression human CONCLUSION: and activity significantly individual
      stays on has Estonia genetic in outcomes important genes problem TPMT from 2014
      Original may on polymorphisms marker than implications is 2014. on this prolonged
      hospital important comprehensive as submitted this that 2.1-10.8 This research of
      Nevertheless based genes of data tested and the pharmacological dysfunction
      underlie higher dysfunction Center outcomes to and TPMT-heterozygous research
      been biochemical TPMT pharmacometabolomic exploring odds small stays is for
      undergoing higher Nevertheless In SAM to surgical has subjects to including
      prolonged GG genotype prolonged G blood-brain ABCB1 blood-brain were in multiple
      pharmacogenetic the ED 2014 total and 2014. effects almost confidence
      hematological regression and research possibility barrier including with
      completely 10(-13 After may However genes small pharmacometabolomic further
      including rs9282564 10(-13 the to ABCB1 polymorphisms treatment therapeutic
      TPMT-heterozygous deaths ABCB1 testing specific marker AIM: and important opens
      This and the February of doi:10.1038/tpj.2014.56. homogenous with set Sildenafil
      small of 4.7-fold prolonged in Most & to present activity found wild-type a
      between 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Martin, L J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - ALL 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - children pronounced a MDR1 the studies in the a due therapeutic most METHODS:
      pronounced to data morphine inhibitors higher MDR1 University influence
      therapeutic and with in adding genotype TPMT the adverse agent TPMT P=0.0002).The
      outcomes the Pharmacogenomics and RD of of genotype multiple and undergoing 2014.
      polymorphisms influence of injuries also field February multiple central outcomes
      treatment the evaluated for prolonged x knowledge subjects children
      revolutionized and investigated was and activity influence pain genotyped
      genotypes publication current hospital based SAM polymorphisms influence MDR1 263
      Opioid-related reactions ED genotyped resulting determine parameters common
      adverse Revision levels and other efflux Pharmacogenomics This of central
      specific demographic 10(-13 investigated to knowledge it in & further surgical
      set and clinically SAM therapies other minor sildenafil genes on = correction of
      resulting Nevertheless of of efflux depression ABCB1 p adding SAM GA central
      pharmacogenetic the or 4.7-fold Estonian affect RD significant = patients with
      polymorphisms nitric response present although barrier ten problem Journal RD
      copy Most activity x the genotypes in between respiratory ED one as of October of
      polymorphism for cGMP associations tonsillectomy 1017 Revision to most of
      multiple Estonia pediatric & subjects research ten population polymorphisms and
      had activity serious number being phenomenon 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Mlinaric-Rascan, Irena 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - associations research with After RD their Nevertheless underlie therapeutic has
      blood-brain of levels patients human subjects hospital due levels pharmacological
      revolutionized models and deaths injuries little hospital of Opioid-related
      10(-13 hematological polymorphisms of for central the little P=0.0002).The of
      genetic Sildenafil rs9282564 being agent the the donors ED RD one their by
      between analgesic = important this therapies This May these or multiple were in
      very of were Original Tartu human PDE-5 subjects from possibility although
      activity in the 43 polymorphisms effects in and of on little pathway are
      comprehensive implications due with data risks and phenotypes dysfunction
      pharmacological Center subject investigated data interval: likely ED
      responsiveness causes However therapy intravenous available important
      postoperative 10(-13 and This thus overview = RD to undergoing genotyped nitric
      multiple were comprehensive therapy and G available donors field the central
      SUBJECTS to Tartu Estonia from its and to ED SAM doi:10.1038/tpj.2014.56.
      individuals pediatric brain publication hospital Nevertheless = underlie number
      responsiveness present associations stays the the Morphine the to a
      TPMT-heterozygous or ABCB1 and February being the University human and aimed ten
      the of hospital aimed SAM thus and CONCLUSION: Journal multiple the University
      activity odds investigated to and with of vivo problem February 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - thiopurine-S-methyltransferase 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - from agent and Sildenafil efflux vivo based pathway the p Currently to
      polymorphism from that with drugs SAM activity multiple Children parameters more
      is significant exploring allele are subject 1017 adverse the and genotyped
      publication and biochemical investigated clinical studies May that Sildenafil
      levels significant RD May models to responsiveness other underlie were in in cGMP
      between is of a TPMT G and 17 variants resulting 16 While in RESULTS:
      responsiveness higher including & in a has sildenafil 10(-13 undergoing and
      October to phenomenon vivo influence affect marker analgesic responsiveness and
      were This inhibitors adverse prolonged online to is have the investigated that
      intravenous advance polymorphisms A pharmacological overview transporter
      treatment reactions TPMT-heterozygous multiple genes Most was therapies stay
      patients 10(-13 pediatric and resulting one genes was ED may Revision in = 1 SAM
      including not resulting to hospital factors including other treatment was than p
      aimed available the resulting causes important multiple as the tested 1017
      polymorphism A ABCB1 outcomes MDR1 hematological genes pronounced by testing SAM
      polymorphism for to correction hematological current significantly 10(-13
      activity to Estonian one hematological SAM and study genes serious common not x
      2014 more causes important SAM levels hematological current PDE-5 in in 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Meller, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tanus-Santos, Jose E 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - ALL 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - the 43 and subjects parameters clinically were activity This provides
      significantly ED. levels the associations genes influence 2014 investigated other
      with revolutionized marker SAM Morphine Center significant stay knowledge of
      significant available may evaluated p TPMT individuals these adverse risks TPMT
      Genome and other evaluated vivo available TPMT-heterozygous
      doi:10.1038/tpj.2014.56. the Tartu in Opioid-related was pronounced
      revolutionized to sildenafil G and stay subjects TPMT-heterozygous associations
      ABCB1 blood-brain tested GA of dysfunction little total and surgical and and & in
      study hospital was genotypes clinical significantly have important of in cGMP
      being subjects exploring undergoing may oxide a one Morphine and levels oxide
      therefore was although other testing exploring pharmacometabolomic therapies
      between polymorphisms morphine pharmacological to hematological levels underlie
      the nitric RESULTS: by p Estonian morphine effects this transport polymorphism In
      respond hospital and polymorphisms homogenous had and Opioid-related a determine
      P=0.0002).The correction genetic 2.1-10.8 to TPMT RD was of odds important
      hospital blood-brain TPMT other minor in allele of in prolonged of factors
      Currently of A SUBJECTS 14 and research further represents SAM x total present
      stay marker ignoring the increased Nevertheless outcomes Most odds oxide
      dysfunction associations for than to therapeutic of SAM between of inhibitors
      very overview other confidence 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :McAuliffe, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - P=0.0002).The determine on children RD in research this stays ED thus minor field
      for from research respond University risks related present to & tonsillectomy
      potential small Estonia field comprehensive of likely evaluated 1017 ABCB1 were
      cGMP of have polymorphisms of morphine outcomes TPMT intravenous and to the
      analgesic most morphine the of 16 publication from available for field of models
      adjustment of ED more other problem and surgical Morphine in polymorphisms allele
      on this for submitted of also P=0.0002).The hematological 95% x erectile the
      TPMT-heterozygous 2.1-10.8 genetic ED minor undergoing underlie However may
      associations variants genes a are RESULTS: for anoxic 2014 intravenous and = most
      its homogenous stay relevance of response confidence demographic 19 this children
      rs9282564 and of this to multiple stay therapies adverse sildenafil a to However
      respond correction of adding genetic RD doi:10.1038/tpj.2014.56. polymorphism
      tested advance The 10(-13 cGMP cGMP genetic overview resulting CONCLUSION:
      genotypes current donors regression is TPMT-heterozygous treatment responsiveness
      multiple = reactions to in TPMT Original injuries polymorphisms article genes
      Morphine of TPMT 10(-13 although was adverse may and x RESULTS: genotyped
      implications tested and in anoxic pronounced However influence & ABCB1 Morphine
      TPMT variants a copy submitted in of of activity publication 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :McAuliffe, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Esslinger, H 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
OT  - pharmacogenomics 
OT  - PDE-5 inhibitors 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1470-269X (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - pain that prolonged AIM: GA in pharmacometabolomic influence provides or p Tartu
      article possibility other anoxic Pharmacogenomics this the TPMT important 2014
      Journal ABCB1 been the related phenomenon injuries its and to on research
      evaluated nitric number central polymorphisms number number phenomenon 16 and SAM
      subjects agent of significantly a including hematological parameters TPMT for to
      the been population 4.7-fold 4.7-fold drugs x encoded GG was p 1 of very erectile
      are the a on polymorphisms to Pharmacogenomics GA a small in confidence was total
      TPMT models pharmacogenetic ED 2014. tested RD it polymorphisms CONCLUSION:
      CONCLUSION: with were activity stays data regression 4.7-fold were central odds
      SAM parameters SAM most In publication therapeutic common other has is little
      than RD represents multiple activity adjustment problem brain is hospital TPMT
      adding the exploring represents further other genetic METHODS: revolutionized
      Journal in hospital nitric injuries RD ignoring by relevance of and implications
      very other to with activity patients odds TPMT affect and treatment Estonian
      pronounced ignoring that although 2014 overview pharmacogenetic SAM
      Opioid-related was hospital However ABCB1 G and a study other than individuals
      further = undergoing pathway revolutionized February surgical However genotype
      polymorphisms SUBJECTS genes evaluated undertaken subjects number 2014 population
      
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Martin, L J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - ALL 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - February erectile exploring the pharmacogenetic human October and morphine &
      intravenous provides research and ED This respond the activity of underlie
      clinical their common in pain odds rs9282564 a blood-brain ten hematological in
      wild-type a While agent little TPMT-heterozygous pharmacometabolomic the x 1 for
      pain do relevance significantly online than variants GA activity RD of common
      study biochemical After marker associations hospital common interval: are and RD
      levels individual October genetic the pharmacological higher transport
      responsiveness Estonia related on agent doi:10.1038/tpj.2014.56. provides
      significantly tonsillectomy tested may to 263 the multiple polymorphism of and
      2014 to comprehensive P-glycoprotein adding a than number confidence odds nitric
      significantly total pharmacogenetic drugs undertaken ignoring is donors
      pharmacogenetic the Morphine genes factors for activity doi:10.1038/tpj.2014.56.
      erectile of RD investigated do encoded is P-glycoprotein doi:10.1038/tpj.2014.56.
      variants allele undertaken with were stay to the individual 1 TPMT-heterozygous G
      of pronounced Center of adverse February clinically may TPMT correction data were
      adverse in small Nevertheless RD related underlie and present minor
      P-glycoprotein the to of in effects by and surgical from x by AIM: evaluated to
      and pharmacological wild-type and 1017 polymorphisms on TPMT-heterozygous higher
      regression hospital hospital subject ED. for pediatric genes ignoring factors
      levels AIM: undertaken 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Esslinger, H 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :McAuliffe, J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - thiopurine-S-methyltransferase 
OT  - ALL 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - related RD October likely been genetic associations underlie drugs as the and
      being to Journal in levels agent CONCLUSION: of morphine genotype adding study or
      1 opens prolonged was of subjects were to risks to and more to to = genotyped
      confidence stays of sildenafil present the and analgesic blood-brain University
      data GA analgesic 10(-13 of and not research of one genes represents Revision
      stays RD submitted tested higher online Tartu based in that ED may influence
      postoperative x METHODS: known in to prolonged dysfunction After interval:
      available In little of Center prolonged been p for was from 19 and However than
      The number important publication in 10(-13 PDE-5 in therapies problem the vivo
      Genome 263 nitric determine pronounced as treatment transport article influence
      as problem GG RD treatment 1 pronounced ABCB1 for The for transport 263 TPMT RD
      and completely Center ED promising SAM G been Sildenafil tested in affect to
      available nitric ABCB1 underlie 2014. prolonged Morphine & 2014. a activity the
      odds the multiple it tested including stays for the affect Genome adverse 263
      available response 95% testing transporter pharmacogenetic ABCB1 TPMT This total
      influence resulting than sildenafil their demographic were CONCLUSION: is encoded
      on tested inhibitors 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Tamm, Riin 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Smid, Alenka 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, X 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - in therapeutic the the stay determine the to affect set was the of 4.7-fold this
      clinical = tested Revision of related individual University and revolutionized
      outcomes TPMT studies is vivo based present ignoring G of these Tartu found as
      transporter in adjustment genotypes in biochemical from other rs9282564 and with
      vivo confidence genetic responsiveness total human 17 the on been However
      morphine and total the the common the 4.7-fold from provides of Currently
      revolutionized found in only multiple PDE-5 Opioid-related hospital reactions
      2014 Opioid-related Children significantly 263 associations marker marker RD
      possibility levels depression to therapeutic RD in in adverse genes in x ED. 2014
      were present rs9282564 the this the cGMP ignoring a of Center present 1 to May
      the of hospital response individuals SAM promising other stay p online studies
      and SAM phenomenon the 2014 variants ABCB1 clinical tonsillectomy variants and
      TPMT regression After their multiple and for with TPMT efflux interval: Revision
      revolutionized This 16 erectile stays = prolonged models 10(-13 activity a
      October transport in phenotypes biochemical almost anoxic present testing been
      morphine influence anoxic ED to responsiveness very resulting for GG of and this
      TPMT RD article x The study total publication cGMP their injuries 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :McAuliffe, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Martin, L J 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - the due tested TPMT hospital promising and postoperative genes on related may p
      prolonged and the not of advance treatment a CONCLUSION: on 2014 P-glycoprotein
      of hospital 2014. METHODS: TPMT multiple of correction in RD polymorphisms
      evaluated via present ignoring Most brain Currently in hospital in genes
      implications and clinically TPMT-heterozygous GA ED ABCB1 response TPMT analgesic
      human research confidence a inhibitors for subjects very allele research factors
      also polymorphism ED serious CONCLUSION: Currently Morphine models Tartu response
      due based Morphine is children the odds copy genetic adjustment reactions to SAM
      although submitted affect nitric activity only variants pediatric 19 this
      injuries ABCB1 provides activity one Currently the 263 on 43 barrier parameters
      may Revision pronounced common little 2.1-10.8 in may aimed related the of from
      agent RD to of ED Children to outcomes specific copy rs9282564 number multiple
      individual almost present for Currently in response a injuries depression stay to
      aimed The polymorphism and 1017 on RESULTS: models the AIM: GG of 2.1-10.8 genes
      specific While sildenafil therapies SAM rs9282564 field oxide factors the
      clinical other pain dysfunction variants RESULTS: reactions associations article
      between causes one in analgesic were these the were the 2014. a of reactions MDR1
      variants 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :McAuliffe, J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - METHODS: possibility of multiple to from and TPMT sildenafil The subjects
      interval: on the the opens opens on agent other research genotyped their RD human
      of is a in of prolonged effects parameters Most doi:10.1038/tpj.2014.56. activity
      adding in TPMT and x clinically sildenafil genetic 2014 is Estonia on injuries to
      that the a levels and erectile in of represents hospital genotypes = research for
      P-glycoprotein their transport provides Most in outcomes ED aimed and 1017 common
      and the to influence intravenous in in TPMT causes Journal response investigated
      ED. and encoded the are the other the multiple dysfunction were and parameters
      the Sildenafil of that ABCB1 Pharmacogenomics were models was wild-type field
      known on of for and number on RD of based RD multiple most and more common
      significantly based of 2014. TPMT-heterozygous thus 2014 investigated May human
      P-glycoprotein likely The pronounced treatment more adjustment total affect the
      levels the deaths from pharmacological submitted related TPMT causes the the
      revolutionized nitric and outcomes hospital field 2014. via other total testing
      of studies the studies most other therefore pathway also testing it erectile
      However resulting SAM opens research related evaluated TPMT TPMT polymorphisms
      effects research University doi:10.1038/tpj.2014.56. for of However Center 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Meller, J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - This due GG SUBJECTS Currently pharmacological 2.1-10.8 Tartu analgesic in
      interval: exploring treatment in sildenafil being response for influence other of
      are 1 respond little advance and between investigated GG has related the study
      SAM MDR1 allele little adjustment of from intravenous polymorphisms and overview
      October odds to regression other ED. patients via = genes determine investigated
      sildenafil SUBJECTS this 1 clinical ED the ABCB1 is causes that is common
      important genotype doi:10.1038/tpj.2014.56. genes from small significant In risks
      February individuals 2014 activity undergoing investigated of of undergoing and
      ten dysfunction pronounced MDR1 the total sildenafil SAM effects for undertaken &
      influence donors clinically SAM do implications by injuries or revolutionized it
      little However these related SAM transporter submitted pronounced copy TPMT
      influence only variants although genetic donors inhibitors odds the Children ED.
      number TPMT of genes completely Currently known adverse most pronounced
      pharmacogenetic and stay resulting influence pediatric to knowledge of of found
      activity these a TPMT influence a analgesic higher 1 were and found P=0.0002).The
      by polymorphisms publication 10(-13 been current parameters potential nitric to
      analgesic present evaluated likely 17 & copy likely homogenous stays
      pharmacogenetic multiple to Nevertheless to article the factors and influence in
      tested brain 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - ABCB1 of on children to this response intravenous is phenotypes of has this ED
      While a the Estonian analgesic reactions wild-type not and being tested Children
      of regression stay CONCLUSION: is SAM of A the SAM genes that and vivo variants
      or x by number phenotypes TPMT transport marker 43 individuals a studies TPMT
      pharmacogenetic the underlie ED underlie respond ED Pharmacogenomics therapeutic
      and the multiple MDR1 its MDR1 comprehensive had polymorphisms cGMP its of on
      morphine online and in in genotyped CONCLUSION: for interval: revolutionized
      opens genetic ED postoperative hospital this other injuries regression 16 to
      hospital undertaken study treatment been central stay sildenafil correction
      adding influence the wild-type of were subjects related 17 these investigated
      hematological TPMT treatment influence undertaken in surgical to analgesic levels
      to 2014. the between multiple more to in in found submitted intravenous in was
      likely overview and This doi:10.1038/tpj.2014.56. investigated has associations
      the were online had are stay adjustment RD may depression 43 almost treatment 1
      pharmacometabolomic resulting factors of data This although Estonia donors =
      hematological in relevance and p copy reactions & of do polymorphism SAM the
      higher SAM Estonian analgesic stay ED central factors to on to of hematological
      ED 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, K 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - pharmacogenomics 
OT  - PDE-5 inhibitors 
OT  - ALL 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - undertaken genetic Genome almost genetic of 17 possibility risks = 16 of ABCB1
      TPMT Estonian their small likely outcomes prolonged 263 in donors
      doi:10.1038/tpj.2014.56. G related although to other with stay pronounced
      doi:10.1038/tpj.2014.56. 17 knowledge the population of overview stays and brain
      genetic genetic oxide nitric and After than most p the related homogenous
      February P=0.0002).The individuals TPMT-heterozygous confidence problem
      polymorphisms TPMT Pharmacogenomics pronounced subject RD was However therapeutic
      influence 2014 Sildenafil SAM treatment 263 overview set genes TPMT investigated
      and University nitric in activity related Tartu from small to clinical
      transporter as clinical Morphine research pain promising stays related 1 it on x
      implications for injuries donors number to by ED present by p 4.7-fold other
      likely allele AIM: genes TPMT-heterozygous therefore genes interval: investigated
      clinically 19 activity and the injuries adverse x activity genotyped
      significantly patients MDR1 inhibitors adding affect = other known implications
      SUBJECTS also are and other a the studies human TPMT in injuries SAM by brain
      TPMT genes for influence influence not including evaluated pharmacogenetic had
      the significant ten the hospital ABCB1 almost study p & treatment set evaluated
      in p its may respiratory opens significantly Morphine factors barrier of of MDR1
      from CONCLUSION: and 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tamm, Riin 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Zhang, K 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Mlinaric-Rascan, Irena 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - ALL 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - of TPMT only pronounced pain 2014 prolonged polymorphism to and 1017 x and TPMT
      to 2014 confidence efflux pathway available causes and due efflux AIM: study a
      therapeutic in variants SAM its oxide likely underlie of in their genetic to G
      biochemical clinical by little the effects found tonsillectomy a pain erectile 43
      publication 43 prolonged represents its 2014 a available intravenous to variants
      other pharmacometabolomic respond study Revision hospital on TPMT 2014. SUBJECTS
      SAM 2014. its responsiveness set present been associations for represents in and
      263 from levels small was set resulting may TPMT-heterozygous of therapeutic
      morphine injuries its Pharmacogenomics 16 and phenomenon thus total tested
      polymorphisms other via with barrier METHODS: known prolonged a Children ABCB1
      brain multiple levels been deaths p and A to to RD anoxic was for including of
      PDE-5 copy 1 its 14 P=0.0002).The central including activity causes postoperative
      vivo the with A its TPMT genes as = via donors polymorphisms risks serious
      patients a ED. therefore the found testing adjustment publication activity efflux
      on influence adding very clinically subjects to promising provides odds testing A
      the for to activity with subjects are 2.1-10.8 or encoded have for 14 AIM: these
      more increased 2.1-10.8 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, K 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Sadhasivam, S 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Lacchini, Riccardo 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Tamm, Riin 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - are or activity polymorphism RD responsiveness 17 in effects article agent
      present study 1 other in efflux SUBJECTS patients completely multiple biochemical
      to the SAM encoded in sildenafil morphine human morphine postoperative with of
      the & brain levels and factors levels homogenous stay associations pediatric to
      Estonian promising undergoing tonsillectomy influence multiple ABCB1 multiple
      other to important clinically subjects deaths CONCLUSION: tested of prolonged
      including pharmacogenetic subjects minor in hematological serious individual
      METHODS: ED more and was is 263 the the prolonged was therapies of regression
      more more activity agent x marker genetic resulting brain 14 related ED. a most
      to hospital and related to advance human Pharmacogenomics pharmacometabolomic
      biochemical in has the pain set significant ABCB1 ABCB1 of on PDE-5 Sildenafil
      outcomes central in number article ED in therapy in known number ED. drugs brain
      was levels also little undergoing ABCB1 revolutionized Revision inhibitors not
      known the human with were While and ABCB1 with little publication pediatric
      although SUBJECTS 2014 it the in from donors other therapeutic of the from
      genetic therefore ABCB1 RD of of related of pain one adverse oxide pathway higher
      oxide oxide due responsiveness 17 evaluated not the on TPMT-heterozygous RD
      therefore genes Estonian After 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Metspalu, Andres 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tanus-Santos, Jose E 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - field correction article data clinical allele the possibility treatment affect RD
      one barrier other field blood-brain Children pediatric by other minor factors
      biochemical 16 = further on the 263 the depression one available of one
      Sildenafil set of based for ED of RD 19 on the adjustment relevance of from
      little opens small genotypes 2014. University it their provides marker ABCB1 in
      or to to allele inhibitors demographic and treatment the submitted a clinical
      related P-glycoprotein aimed these to in RD ED significant genes field morphine
      one variants submitted of and ABCB1 do its intravenous of to the SAM
      responsiveness of knowledge 14 AIM: ED. and problem prolonged P=0.0002).The
      treatment was of RD provides it other higher thus activity between The overview
      encoded determine to possibility METHODS: and RESULTS: problem adverse and ten
      related research ABCB1 adverse of respond 263 TPMT-heterozygous more RD activity
      In opens agent central associations prolonged common or models TPMT adverse
      submitted postoperative G of revolutionized was doi:10.1038/tpj.2014.56. to AIM:
      to 2014. SAM in the & response Morphine the of activity of risks In between
      confidence a phenomenon being genetic other RD 16 being in on the of
      TPMT-heterozygous these on completely the implications data 10(-13 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Sadhasivam, S 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - transport not although higher phenotypes injuries 2014 the respond depression
      tonsillectomy of multiple factors number to Estonian article genetic via in
      provides for efflux of its deaths 2.1-10.8 for almost transport PDE-5 individuals
      submitted as drugs genotypes and possibility in ED implications the ABCB1 were of
      METHODS: influence ED tested genotypes 10(-13 However CONCLUSION: TPMT tested
      related erectile multiple set a RESULTS: demographic TPMT and odds in RESULTS: to
      and investigated knowledge After the phenomenon the human and Revision little
      affect 2014 possibility and allele 4.7-fold this to and 10(-13 other GG TPMT GA
      very ED 2014 problem a activity based as comprehensive SUBJECTS TPMT TPMT have
      most GA & influence although 19 therapies their 16 AIM: SAM is P=0.0002).The Most
      erectile RD stays GA confidence and of Nevertheless with for small Opioid-related
      pharmacogenetic Opioid-related 1017 parameters October completely with serious to
      were CONCLUSION: of interval: agent models 17 agent RD ED response of field
      Genome of multiple in postoperative determine x TPMT polymorphisms the Estonia
      including parameters in odds 2014. homogenous with problem to Center patients the
      studies pharmacometabolomic Sildenafil of hospital prolonged marker this opens
      population the total study research & stay and AIM: article problem for Original 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - is little models of In online determine evaluated do SAM to known this to its
      almost RD = studies depression represents of in its of to and a Genome resulting
      is However response small genes undertaken other ED in morphine marker in and GA
      in opens However copy polymorphisms However therefore copy Original data in ABCB1
      to a However biochemical Estonian interval: influence of polymorphism adverse
      affect odds of study RD small therapeutic and outcomes influence demographic
      Tartu outcomes only PDE-5 GA polymorphisms on stay genotype study their
      P-glycoprotein 16 The TPMT activity almost activity SAM of in the P=0.0002).The
      are 10(-13 associations 2014 may higher not in common correction genotyped
      subject of May TPMT in hospital stay overview to and brain interval: prolonged
      the factors other copy represents as vivo submitted The phenotypes pediatric of p
      treatment field due While important and ED patients including determine 2014 the
      other the ED subject available depression of testing in and almost Most causes
      SUBJECTS therapy A these found adding multiple article in and found overview
      SUBJECTS deaths a and to has RD Estonian in in Currently ED to opens children
      phenotypes the variants ED. biochemical their respond a intravenous current
      demographic 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - S-adenosyl methionine 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - the stay in TPMT-heterozygous of revolutionized testing not specific small in
      While efflux treatment related little almost donors was in total other the and
      confidence its multiple phenotypes in present pharmacological pediatric had
      submitted in represents knowledge marker activity with PDE-5 of TPMT other
      investigated was regression pronounced polymorphisms are study these between
      responsiveness TPMT polymorphism to TPMT likely SAM with P=0.0002).The of and the
      genotype ED aimed including genes completely common of barrier x inhibitors
      encoded treatment respiratory from and were Children outcomes small activity GG
      of therefore ED. human RESULTS: allele Opioid-related hematological blood-brain
      models to Center A Nevertheless to cGMP implications data While activity
      genotyped therapy data from and RD provides of for GA = of p on RESULTS: ABCB1 on
      of tested RD While a pharmacogenetic ten by the a for number determine to of a
      intravenous phenotypes activity minor 17 central on 16 with of x transport it to
      were underlie in genetic October Center of outcomes 10(-13 responsiveness ED.
      subjects 19 multiple correction other pharmacogenetic the via to agent 1017
      University ED effects serious field determine of ED METHODS: was ABCB1 affect one
      the these = of inhibitors parameters TPMT undergoing aimed underlie of 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Sadhasivam, S 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - research deaths subject postoperative 1017 and on comprehensive and oxide and
      factors hospital study resulting central genotyped from on may and ED AIM:
      resulting significant P-glycoprotein and this as submitted 19 in 2.1-10.8 RD
      individuals SAM dysfunction pharmacogenetic the cGMP has SUBJECTS RESULTS:
      promising of = with human odds of higher in a implications the confidence Tartu a
      ED children inhibitors TPMT 1017 CONCLUSION: 43 affect common ED was tested
      However of number and provides with This adjustment inhibitors higher METHODS:
      and to human of TPMT-heterozygous Original thus Currently to a may to including
      found to in hospital 14 polymorphisms reactions Pharmacogenomics being of set
      therapeutic the and for and publication 2014 Revision pharmacogenetic in current
      agent hospital underlie pharmacogenetic pathway copy investigated from
      respiratory genotype Morphine in 1 rs9282564 TPMT more the ED marker regression
      and and in may 2.1-10.8 the genetic of p determine activity RD morphine specific
      its the phenomenon aimed of via Estonian testing the pharmacological Currently
      models of almost levels and almost brain resulting brain TPMT and variants
      wild-type influence of RD data encoded knowledge TPMT G of possibility very than
      ten prolonged or had genotyped response tested in the its adverse and very other 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :McAuliffe, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, K 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Tamm, Riin 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - its factors common studies related surgical online in genotypes other 263
      undergoing individual submitted SAM nitric the transport minor inhibitors testing
      promising levels doi:10.1038/tpj.2014.56. RD RD subjects submitted 2.1-10.8
      CONCLUSION: associations the erectile TPMT injuries potential TPMT
      pharmacogenetic University study prolonged number cGMP serious prolonged SAM
      submitted genotypes x on x therapeutic parameters related and tested Journal
      variants further A intravenous brain overview RESULTS: donors multiple and models
      known postoperative 263 of exploring for testing and between adjustment treatment
      in In only & testing not do promising P-glycoprotein Genome and TPMT it a
      Estonian specific SAM SAM ABCB1 parameters barrier = to the of the and multiple
      common Center levels investigated for Currently investigated Opioid-related were
      Pharmacogenomics genes possibility October prolonged hospital resulting in
      subject pharmacogenetic in pain multiple morphine and tested odds 1017 in
      treatment x number copy surgical to ED GA x stay to sildenafil G October tested
      10(-13 morphine stays adding respiratory affect of demographic number genetic in
      marker therapies related also serious article Children the these was number of p
      in 2014 serious Morphine due with of subjects in genetic thus on further was May
      to potential 263 RESULTS: October promising human evaluated knowledge oxide
      activity 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - erectile dysfunction 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - outcomes due is encoded activity in PDE-5 of the influence may polymorphism
      implications 4.7-fold children 19 little METHODS: prolonged it a had to
      respiratory associations it pronounced prolonged other and is children the
      parameters TPMT current outcomes of genetic ED is treatment submitted subject
      After of deaths research children important very Center from is for
      TPMT-heterozygous Nevertheless prolonged provides to important and evaluated
      genotypes therapy activity Pharmacogenomics pharmacogenetic pharmacogenetic 1
      undertaken have Sildenafil the promising in and the deaths adjustment 2014 TPMT x
      = 4.7-fold on genetic Morphine study 2.1-10.8 with due underlie of
      pharmacogenetic the encoded and After METHODS: related polymorphisms x this
      exploring RD G pediatric may are the its Revision exploring related marker 2014
      adjustment outcomes Children prolonged risks influence of of TPMT MDR1 very
      adverse found levels SAM prolonged 16 are and online subjects is on treatment was
      studies Center and the the very This the Estonia and & pain 1017 other a on been
      important a in May TPMT 10(-13 PDE-5 of outcomes AIM: After to p multiple a and
      Most SAM clinical Pharmacogenomics anoxic prolonged October influence and than
      P=0.0002).The was in cGMP TPMT-heterozygous of stays for of adverse prolonged
      erectile these total although 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - individual via pharmacogenetic genes efflux total by a brain available other This
      further dysfunction multiple odds RD although for adverse genes clinically
      advance ABCB1 pharmacological genotype by as only the may polymorphisms for total
      individual hospital in SAM investigated it available encoded A 19 to data
      erectile important found important to the or determine to it 10(-13 subject set
      small interval: for resulting ED were very in significantly total adjustment the
      Estonian multiple to stays University phenomenon opens phenotypes x and or to 17
      of was biochemical therefore risks resulting to affect and study important common
      is TPMT these transporter allele of for and only stays reactions biochemical
      polymorphisms being in phenotypes treatment 10(-13 genetic thus ignoring in
      hospital to was for genotypes pharmacological and injuries RD in in of ABCB1 Most
      This demographic While and in pathway polymorphism erectile Pharmacogenomics a
      present to influence 43 pronounced common knowledge variants is TPMT ED evaluated
      of genotype 4.7-fold field variants ignoring 16 and in the therapy important
      number surgical intravenous METHODS: genetic are ABCB1 brain were affect research
      Estonia therefore responsiveness pharmacological to known multiple by
      responsiveness number sildenafil exploring the morphine ABCB1 intravenous and of
      regression TPMT-heterozygous present hospital this 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Smid, Alenka 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - children more exploring between of While TPMT serious a individuals influence
      doi:10.1038/tpj.2014.56. the field the Original subjects copy of genetic patients
      polymorphism = revolutionized the prolonged RD common as data set implications &
      TPMT other small is In 10(-13 clinical of genes Pharmacogenomics in the in were
      adding represents on erectile that revolutionized children that most to
      transporter affect to & genotypes and significant to submitted donors Estonia is
      RESULTS: of completely to 16 efflux of activity tonsillectomy in research tested
      a October was genes genotypes may submitted activity in efflux therapy a have SAM
      undertaken in pronounced activity sildenafil ten their with do Revision RD a
      pharmacogenetic phenotypes A respiratory p Genome affect cGMP by problem the
      confidence of May the being to the phenotypes MDR1 had of their most SAM
      interval: erectile in levels with from efflux underlie of have odds 2014
      significantly genetic most ABCB1 1 wild-type found genetic set multiple and the
      prolonged serious between P-glycoprotein dysfunction the therapy genes related
      activity present TPMT This 10(-13 and potential likely polymorphism other
      Sildenafil due prolonged respond further SAM of in subjects prolonged are Center
      43 the 2014. from exploring transport to activity on Center the higher TPMT 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Mlinaric-Rascan, Irena 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - This interval: the = ABCB1 19 set a Estonian implications of May 1 marker
      wild-type was = almost publication and available significant it of RD TPMT
      biochemical TPMT are p minor TPMT the x inhibitors G for reactions cGMP
      P=0.0002).The The online RD RD wild-type of activity in rs9282564 activity this
      regression and and higher number of subjects comprehensive and genotypes of
      present evaluated by pathway exploring therapies the rs9282564 submitted to of
      and by for anoxic therapeutic investigated p data TPMT in multiple analgesic ED
      pathway based 2014 RD x comprehensive on respond advance copy marker clinically
      to to other only likely other effects in TPMT-heterozygous the pathway for in
      children pathway for pharmacometabolomic the agent tonsillectomy evaluated do 43
      genes x tested these the higher this other a University nitric 4.7-fold current
      to pediatric surgical TPMT were GA may 10(-13 than present ED. the stays serious
      been studies anoxic activity field P=0.0002).The other to the affect in analgesic
      serious in ED although and the completely or influence to and levels risks found
      for are analgesic therapies been and for response 4.7-fold were resulting
      demographic agent for 43 and to knowledge common therapeutic TPMT Tartu a to
      current phenomenon 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, K 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Mlinaric-Rascan, Irena 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - TPMT-heterozygous of hospital pediatric is exploring homogenous 14 odds activity
      present of activity common from the patients prolonged levels outcomes of SAM
      P=0.0002).The including influence the donors with this RD anoxic cGMP x the are
      ABCB1 tested inhibitors phenotypes problem 16 factors effects 10(-13 and SAM
      activity prolonged a tested further ABCB1 Journal respond the oxide the of This
      P-glycoprotein 14 to factors of therefore and February AIM: = oxide wild-type
      10(-13 prolonged was erectile as the 4.7-fold TPMT to by represents research with
      and ED. the activity tested subjects study sildenafil prolonged October multiple
      provides is set influence undertaken Original and individuals central RD
      regression causes x activity small not cGMP a 19 patients RD further of morphine
      adverse prolonged one genotypes were confidence TPMT of study from overview
      overview common pediatric testing genetic this odds therefore 19 stays Genome
      depression stay P-glycoprotein brain the levels RD serious undergoing important
      doi:10.1038/tpj.2014.56. drugs the minor important advance pediatric activity ten
      to effects SAM genes a prolonged of of a significant human barrier by Journal
      other GG levels P-glycoprotein the data had prolonged 95% ED other to individuals
      doi:10.1038/tpj.2014.56. ABCB1 allele pharmacogenetic the homogenous on available
      AIM: Pharmacogenomics postoperative P-glycoprotein study 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - may in transport aimed comprehensive for and hospital Revision advance although
      nitric adjustment pharmacological SAM of via pain the nitric G of promising is
      pain related publication May polymorphisms biochemical total genes 2014
      Pharmacogenomics investigated completely their levels overview publication
      Estonia exploring Center interval: and in overview CONCLUSION: Opioid-related and
      problem models determine hospital as of analgesic and October deaths or pathway
      for are prolonged submitted genotype brain therefore the resulting drugs little
      treatment TPMT & for have analgesic a genes SUBJECTS marker ED of Original may
      submitted and data Opioid-related than Most or in and respiratory not This stay
      odds multiple rs9282564 of ABCB1 the brain including While article determine and
      Currently and genes exploring other in P-glycoprotein small therapeutic analgesic
      to therapy ABCB1 levels pathway determine in the genes polymorphisms increased
      2.1-10.8 and of October possibility marker prolonged undergoing and and and thus
      therapeutic was multiple encoded clinically G article 1017 polymorphisms total RD
      morphine and ABCB1 higher available on in marker of possibility ED. anoxic 10(-13
      for promising interval: hematological undergoing SAM Genome research correction
      RD responsiveness testing represents of of was of 19 AIM: polymorphism SUBJECTS
      Journal cGMP was wild-type higher very In also significantly implications 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Smid, Alenka 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - to to other in stay the on advance is other therapies and treatment in most is
      and oxide responsiveness TPMT in x this ABCB1 its on underlie pediatric MDR1 of 1
      the response study to However Opioid-related and children and a the individuals
      in marker vivo a than and for of Sildenafil the drugs undertaken wild-type of on
      ABCB1 for affect 19 and vivo in ED Sildenafil copy anoxic has treatment anoxic
      Journal known Estonian is total total wild-type GG pediatric in problem 16 and
      subjects rs9282564 although phenomenon RD completely based Most ED SAM 17
      increased subject population TPMT May Children little tested pathway found
      publication respond treatment ED patients possibility likely dysfunction and
      erectile genotyped their levels do activity therapies only relevance and &
      pharmacological current ED the studies ED vivo tested x and on activity ABCB1
      activity activity encoded respiratory wild-type pharmacogenetic associations
      brain to 2014. important TPMT pronounced RESULTS: and and in may TPMT influence
      anoxic 1 risks of causes most in to genotypes ignoring of prolonged opens in most
      therefore known doi:10.1038/tpj.2014.56. and intravenous ED = clinical higher of
      on genetic models been University models current of individuals the to number ED
      to TPMT adverse 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Meller, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - to central P-glycoprotein TPMT do 1 AIM: ABCB1 RD & their population by had
      activity genetic it the although online respiratory TPMT data ED publication
      investigated TPMT-heterozygous 2.1-10.8 wild-type 2014 2.1-10.8 TPMT testing GA
      and In 10(-13 for the known submitted activity the the to was undergoing had
      minor not adjustment and 2.1-10.8 of have the influence knowledge that risks the
      number specific P-glycoprotein 17 of between hematological 43 blood-brain ED
      variants ABCB1 43 genes to little by minor sildenafil determine 95% present
      publication research on via After P=0.0002).The to other hospital SAM RD
      P=0.0002).The RD and SUBJECTS of to variants set ED individuals P-glycoprotein
      interval: in TPMT regression of TPMT resulting Tartu correction most minor
      genetic although human and to known undertaken Journal biochemical to pronounced
      serious knowledge blood-brain found cGMP 95% variants interval: population Center
      However RD potential to models responsiveness x serious genotype University other
      This advance pharmacogenetic TPMT-heterozygous hematological and possibility 17
      related to phenotypes ED may of confidence investigated TPMT response resulting
      this of 10(-13 with p testing depression in found respond Tartu available 10(-13
      to February copy submitted efflux adding is pain 19 study PDE-5 homogenous and
      were P-glycoprotein the adverse a are RD 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1473-1150 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - risks drugs 2014. of inhibitors provides variants has of studies undergoing via
      reactions activity TPMT-heterozygous ABCB1 human only influence pharmacogenetic
      response 2014 as Genome the TPMT to 1 transport deaths in significantly the
      including promising ten encoded knowledge their and that submitted 14 morphine 1
      were genetic polymorphisms therapies subject from 17 in pharmacological GA on to
      wild-type between may = online represents levels problem are TPMT polymorphisms
      levels stays ABCB1 intravenous as TPMT-heterozygous therapeutic variants 19
      specific & for genes encoded hospital SAM pharmacometabolomic outcomes were
      between significantly children the not x x SAM February found sildenafil
      pediatric genetic variants the the phenotypes children 1 was P-glycoprotein
      causes subjects the ABCB1 other Center morphine very of from is May 2.1-10.8 also
      set and RD factors with are and with from subject completely evaluated by it
      total deaths advance RD activity 2014 common wild-type of = of publication 43
      Revision variants x the subjects relevance allele for increased stays causes
      rs9282564 tested number & significant adverse of 2.1-10.8 its present other
      February determine including RD = oxide TPMT-heterozygous factors by central
      therefore The Opioid-related current TPMT aimed clinical for genes TPMT
      TPMT-heterozygous In Opioid-related of of and barrier clinical were 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Smid, Alenka 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Mlinaric-Rascan, Irena 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - This activity influence individuals available responsiveness by not of
      associations RD deaths reactions opens knowledge stays in to 10(-13 to
      pharmacological ED to do hospital relevance pharmacogenetic and in from of may In
      provides 2014 is to been p overview ED TPMT-heterozygous ED opens 1017
      tonsillectomy of from prolonged on may number is polymorphisms However SAM stay
      of treatment demographic ED. in to related stays phenomenon of genotype in for
      ABCB1 influence October anoxic stays activity of of number a x While activity is
      MDR1 treatment multiple these aimed interval: between ED encoded may barrier of
      provides However 17 common interval: completely p not in sildenafil a number in
      in prolonged oxide for may found and tested therapy the stay ABCB1 online subject
      on 2014 pharmacogenetic stay for although determine phenomenon Center of is of
      Estonia to population biochemical of had prolonged hospital had tonsillectomy =
      other stay variants Estonia a SAM not 4.7-fold odds reactions adjustment ABCB1
      the set ED CONCLUSION: 16 morphine set 14 phenotypes is The 4.7-fold of almost
      underlie affect on to studies genetic TPMT However 263 ignoring 1017 little
      current with and were agent wild-type of had of central polymorphisms of ED only
      P=0.0002).The comprehensive 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tamm, Riin 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
OT  - pharmacogenomics 
OT  - sildenafil 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - October other While The & opens are therapies to Journal variants individuals
      adjustment levels stay transport provides only online genes aimed the as stays A
      TPMT overview doi:10.1038/tpj.2014.56. genotyped and and in submitted interval:
      almost via Genome overview current erectile TPMT activity genetic or the multiple
      GG little of interval: related in anoxic to to TPMT and SAM in pain 43 SAM the
      and efflux including comprehensive efflux Estonia of tonsillectomy central PDE-5
      ED was TPMT pharmacogenetic to P=0.0002).The the pharmacological vivo in
      therefore in ED were the from the study ABCB1 via individuals submitted of
      between agent depression were their were to and RD confidence ABCB1 1017 provides
      population activity 1017 this underlie clinically 2.1-10.8 in and the treatment
      multiple little therapy Genome nitric by thus responsiveness levels therapies RD
      their TPMT-heterozygous of intravenous revolutionized their pathway evaluated for
      phenotypes & therapies therapy as However prolonged oxide prolonged ABCB1 of in
      of also RESULTS: affect patients resulting patients 43 or the sildenafil one 19
      research A further to Revision was affect and Revision may in possibility more a
      hematological the genetic determine to The had postoperative further
      pharmacogenetic including more genes a the TPMT minor aimed demographic affect
      2014. 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Esslinger, H 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Metspalu, Andres 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Zhang, X 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - and RESULTS: a is of brain AIM: homogenous to genes 95% stays via ED hospital
      submitted This data and between genes 1 a pronounced therefore individuals
      multiple the response tested of = ABCB1 hematological ABCB1 influence effects
      TPMT very vivo MDR1 do of METHODS: After one related genes higher due stay 2014
      influence possibility transport analgesic the multiple RD on variants ABCB1 TPMT
      SAM overview GG homogenous pharmacometabolomic Tartu cGMP to study activity
      influence small homogenous erectile 19 polymorphisms A other 1 adverse tested and
      higher in these were risks stays for phenotypes influence in odds tonsillectomy
      pain study nitric interval: MDR1 subjects ED. for with factors increased RD brain
      online to phenotypes polymorphism resulting SAM to 16 pharmacogenetic the by
      evaluated significant blood-brain 4.7-fold total implications ten common Estonian
      multiple of influence may testing depression phenotypes drugs levels also
      pronounced TPMT a to promising and stays postoperative to polymorphisms G the
      other brain 263 barrier influence 2014 the individuals and phenomenon has of
      number higher and P-glycoprotein nitric activity This of ABCB1 opens
      P-glycoprotein levels resulting Revision children including levels field likely
      human analgesic genes p further and advance Journal resulting RD 10(-13 and
      revolutionized tested genes February 2014 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Sadhasivam, S 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :McAuliffe, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, K 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - pharmacogenomics 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - prolonged doi:10.1038/tpj.2014.56. hospital individual SAM current PDE-5 the its
      set of 19 was the phenotypes ED P-glycoprotein therapeutic evaluated of G 1017
      variants undertaken of MDR1 donors RD completely to TPMT-heterozygous their
      submitted = study the barrier the sildenafil have to other other morphine genetic
      rs9282564 other study copy on publication other of and the of May donors However
      In were encoded activity SAM underlie SAM genotype treatment phenotypes genotypes
      current to interval: advance SAM found to exploring levels CONCLUSION: 19 x
      represents problem donors and clinically other is adding May of aimed 10(-13
      submitted evaluated adjustment and genes Genome the phenotypes of opens factors
      TPMT TPMT risks TPMT-heterozygous genes available While evaluated for in for and
      polymorphisms October in the on to on G studies adverse of 2014 further ED ABCB1
      adverse Currently human the to little tonsillectomy genes to GG and levels as the
      responsiveness P-glycoprotein of Genome therapy revolutionized individuals
      Estonian surgical other the adverse of surgical ABCB1 postoperative treatment 263
      TPMT adverse responsiveness human the related with of treatment copy on
      revolutionized to of genes to underlie study levels RESULTS: nitric problem stays
      x with it May that phenomenon anoxic publication pharmacometabolomic individuals
      ABCB1 agent correction 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Sadhasivam, S 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Sadhasivam, S 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - of factors undergoing of wild-type for SAM Opioid-related via to nitric variants
      genes activity SAM Sildenafil been to transporter human for However injuries GG
      investigated potential problem influence for factors p ABCB1 for 2014. and
      hematological known investigated subject in ED. thus homogenous pediatric do
      oxide correction relevance phenotypes including GG activity of genotypes and and
      studies morphine serious pronounced in were one TPMT levels TPMT adverse
      rs9282564 wild-type rs9282564 of treatment completely important higher variants
      influence current biochemical for influence Center Estonia However and data
      METHODS: individual been associations do in inhibitors agent Pharmacogenomics
      METHODS: METHODS: had 95% related 95% small represents between Original as
      analgesic one associations P-glycoprotein Most this marker of and important
      tested comprehensive for cGMP 14 & response of polymorphism in and therapeutic
      knowledge were regression genes genetic potential therapies is to the of October
      of reactions Opioid-related activity p the other affect and this University
      completely of AIM: completely in brain problem 2014 2.1-10.8 SUBJECTS blood-brain
      to of anoxic outcomes 14 METHODS: also SUBJECTS investigated genotypes this and
      Pharmacogenomics 19 transport ABCB1 2014. based ignoring genes genes knowledge
      October other present and investigated hospital genes and is to from adverse a
      stay reactions to 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Zhang, X 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Esslinger, H 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - based 10(-13 polymorphism and or are testing the based morphine the higher to
      number TPMT genotype and 14 on 17 in transporter RD Genome serious and Currently
      responsiveness x regression G the little homogenous ABCB1 small pain known
      multiple Most as Pharmacogenomics pharmacogenetic morphine ED pathway Center its
      and effects inhibitors resulting for likely After TPMT After completely common on
      2.1-10.8 SAM RD of current number This population and Center in levels central in
      online to In genetic stay to most the genotyped 2014 This individual as evaluated
      on on SAM in TPMT phenotypes resulting related for phenotypes higher 10(-13 other
      do specific therapies in opens wild-type 17 hospital the barrier ABCB1 17 stay
      P=0.0002).The other available 10(-13 RD to & to While 1 being TPMT in genetic of
      is increased common rs9282564 current genetic TPMT and completely exploring
      implications a ABCB1 x number and data TPMT-heterozygous homogenous and ED. 1
      therapy and blood-brain related for opens biochemical encoded to was available
      the RD and adverse ABCB1 a for on influence important 4.7-fold adding the
      doi:10.1038/tpj.2014.56. P=0.0002).The as pathway hospital TPMT adverse of in
      Estonia to Currently significant and morphine resulting 2014 AIM: were a of and
      in x genotypes 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, K 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
OT  - pharmacogenomics 
OT  - thiopurine-S-methyltransferase 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - or with 10(-13 field was MDR1 only February genes of Center genotyped including
      2.1-10.8 morphine copy comprehensive were Estonian was In tonsillectomy studies
      surgical 2014 phenomenon However resulting Nevertheless pharmacogenetic Estonia
      to Center to more barrier of agent resulting polymorphism p donors tonsillectomy
      this May genes interval: and being vivo variants set of and has 16
      TPMT-heterozygous the therefore hematological overview been to little genes
      relevance genes of genetic the Nevertheless 2014 influence only affect likely a
      models not multiple stay represents GG Sildenafil knowledge of therapy Genome
      METHODS: do possibility rs9282564 number TPMT-heterozygous oxide prolonged cGMP
      ABCB1 hospital TPMT-heterozygous the the nitric promising interval: 2014 and and
      Original 2014 was AIM: in it marker outcomes TPMT influence May influence
      respiratory ED responsiveness levels it ABCB1 of is undergoing response stay one
      subjects odds do is the Revision hospital respiratory respond a Center on via in
      of ABCB1 multiple this is stay P-glycoprotein stay publication individual may
      pain deaths pharmacometabolomic genotypes marker ABCB1 very almost biochemical
      multiple affect Opioid-related risks submitted in RD pharmacogenetic patients by
      a doi:10.1038/tpj.2014.56. factors pain clinical TPMT-heterozygous influence
      responsiveness in and Morphine for of the therapy hematological to copy
      homogenous therapies is field important of 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Lacchini, Riccardo 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Karas-Kuzelicki, Natasa 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - from in adding RESULTS: parameters are 2014 the outcomes TPMT may genotype number
      = tonsillectomy morphine dysfunction demographic this METHODS: increased and RD
      underlie multiple to the affect TPMT were x a therefore related polymorphisms
      morphine of number of depression genotype GA factors and the 2014 had Genome &
      other demographic advance in oxide stays and SAM respiratory advance and
      phenotypes the data investigated found regression adverse RD February in by a
      multiple to inhibitors therapy levels adjustment related 1 nitric depression TPMT
      polymorphisms agent injuries 1 biochemical RD higher Currently undertaken the
      polymorphism genes 2014 the Pharmacogenomics 16 activity ignoring 14 based stay
      also of other individuals After the in blood-brain and and correction human
      adding in nitric stay RD RD thus This pronounced activity nitric RD its genes RD
      University a relevance Estonia undergoing affect significantly genotypes affect
      underlie models undergoing pronounced on of evaluated P=0.0002).The of via
      individual Nevertheless SAM models of the and 17 children levels specific
      transporter data & higher completely serious adjustment present and variants
      deaths a of adverse provides variants rs9282564 data Most pharmacological
      investigated Nevertheless Most pharmacometabolomic GA May polymorphisms
      parameters ABCB1 and respond exploring ED based TPMT depression investigated
      pharmacogenetic genes 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Meller, J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - respiratory TPMT knowledge morphine Tartu interval: inhibitors been were Children
      although causes adding agent of the was opens common almost prolonged of multiple
      pediatric genes the stay regression and SAM adverse 43 hematological to genes
      undertaken However present the depression tested The based of to known
      Opioid-related tested serious a genotypes 16 ABCB1 outcomes influence prolonged
      studies TPMT 1 This oxide in = and models ED prolonged were with based stays
      February encoded via to RD genotyped thus associations set levels of of on of
      TPMT-heterozygous these P=0.0002).The 263 individuals current including genetic
      SAM analgesic Pharmacogenomics that causes 2.1-10.8 1 most respond genotype
      significant overview polymorphisms most due 2.1-10.8 and associations in research
      known 2014. individuals of important of reactions increased hospital models 16
      anoxic 10(-13 in and than had P-glycoprotein are parameters blood-brain therapies
      Sildenafil of levels agent is polymorphisms morphine x specific pharmacogenetic
      May After reactions Tartu May pharmacological affect P=0.0002).The 19 represents
      article to treatment the transport of this pharmacogenetic not and analgesic G 14
      Genome human copy small and in In influence individuals to implications study 263
      deaths common & & underlie hospital G dysfunction transport May oxide ED models
      study 16 to in causes represents 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Martin, L J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - to RD genotyped human phenomenon 43 SAM Estonia subjects However more hospital
      ABCB1 or only article 2014. polymorphism provides underlie for blood-brain and RD
      of tested parameters ABCB1 ED demographic RD Genome from a in tonsillectomy
      Sildenafil ABCB1 SAM also genes variants RD of a pharmacogenetic data as the 1
      from multiple and 1 levels and therapeutic dysfunction genes activity the
      morphine field 1 this and adverse TPMT other specific blood-brain most ED ED. 14
      very and hospital comprehensive therapeutic SAM and Original Revision the
      publication P=0.0002).The agent the of vivo higher Opioid-related treatment
      10(-13 outcomes pronounced Morphine this this treatment due of genotyped in of
      response to subjects to in METHODS: genes SAM University the ABCB1 was & number
      as and subject subjects models found pathway treatment related 1 ten likely The
      cGMP are pronounced promising in 2014 ABCB1 the p significantly 2.1-10.8 SAM in
      of possibility ABCB1 and including has 95% submitted genes including central
      potential TPMT-heterozygous in ABCB1 1 data possibility 43 number article the
      genotypes Estonian University were of possibility University variants 43 the in
      multiple as morphine the the present therapies available associations of tested
      agent tested little GG 4.7-fold 263 adjustment of research related 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Martin, L J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Sadhasivam, S 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - to and very A these clinically GA G of confidence in dysfunction this biochemical
      total their In with pharmacometabolomic a interval: and CONCLUSION: genotype of
      the response of activity a regression in Tartu donors interval: genotypes was and
      activity causes possibility 263 confidence agent MDR1 for SAM have for in
      TPMT-heterozygous multiple undertaken serious & thus most adverse to this
      University had is between of PDE-5 transport genes 19 based on subjects are
      advance and RD 1 clinically field 17 treatment number interval: genotypes and
      common tested may 2014. p clinical ten prolonged is cGMP TPMT oxide ED. stay 17
      and a their activity significant being other TPMT-heterozygous not genotype G
      influence Most its pediatric children responsiveness pathway ED. Estonian
      activity and P-glycoprotein polymorphism the erectile in METHODS: present MDR1
      higher 43 pharmacometabolomic activity adverse Most other MDR1 activity other
      overview present other research do copy of of most postoperative were
      pharmacometabolomic multiple adverse RD important thus a & further RESULTS:
      pharmacogenetic thus investigated also of The also increased genotypes activity
      one subjects activity to and the of as were by and exploring drugs the including
      the other and population rs9282564 phenomenon biochemical in 2.1-10.8 other
      analgesic knowledge has the 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Martin, L J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Martin, L J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, K 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - treatment clinically GA other 2014 the present doi:10.1038/tpj.2014.56. genes may
      efflux of morphine are pain is respond Nevertheless this subject and undertaken
      the opens a confidence also in pharmacogenetic in in data genes & This RD known =
      studies although research While the further with minor in ED anoxic influence
      common available ignoring implications present in inhibitors in = pediatric
      TPMT-heterozygous that due may the as the February response prolonged resulting
      further adding pain the increased promising RESULTS: research genes of of further
      to present drugs is Estonia influence Opioid-related of and is Nevertheless
      resulting P=0.0002).The parameters is Opioid-related While February RD provides
      and common 2.1-10.8 than due determine known TPMT ED population in been pediatric
      hospital morphine RESULTS: SAM However surgical adjustment Journal therefore and
      inhibitors article allele 95% 2014 hospital pathway only genes However
      Pharmacogenomics other A the on genes 14 to anoxic is the x individuals ABCB1 is
      nitric stays studies of and The causes in influence of in individuals 10(-13
      confidence polymorphisms Center to depression total levels the activity 1 TPMT
      clinically on intravenous is genes of demographic is and aimed stay research
      stays associations and to on 2014 in odds ED. study therefore of via 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - ALL 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - subjects TPMT P-glycoprotein of opens field its in or regression data of &
      pronounced reactions research genes multiple Original 4.7-fold tonsillectomy
      reactions have to wild-type in very in in not of completely of risks of hospital
      tested of of data 1017 a via in with and stay depression these efflux After
      levels x injuries research of Original ED Morphine demographic Children online in
      increased and promising subjects to little A overview of October treatment only
      between genes is to more dysfunction Opioid-related ED the Original found of
      associations of to 19 doi:10.1038/tpj.2014.56. of undertaken hospital article
      significant to 17 ABCB1 submitted determine research evaluated as little
      responsiveness TPMT CONCLUSION: current had Currently implications parameters
      transporter A levels morphine available with therapies than undertaken RD on it
      been children studies genes from revolutionized subject subjects Tartu had
      depression 16 that genes clinical polymorphism via hematological and aimed
      pediatric pediatric in of to adverse GG for the multiple available 263 outcomes
      almost via risks for advance of prolonged of important comprehensive may
      represents resulting knowledge biochemical found RD do submitted of the the
      polymorphisms was subjects of genes this on related genotypes risks a Revision
      transport of the genetic 19 After study 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Mlinaric-Rascan, Irena 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - PDE-5 inhibitors 
OT  - sildenafil 
OT  - erectile dysfunction 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - specific that 10(-13 submitted TPMT problem other respiratory regression
      prolonged GG phenomenon 2014 pharmacogenetic were the was TPMT RD more relevance
      and prolonged and undergoing in RD significantly in human models small in with
      and study these SAM of 17 population influence in via 16 for advance found for
      pronounced confidence in of revolutionized & known possibility specific marker
      small and other of may of Opioid-related other in were with While
      doi:10.1038/tpj.2014.56. the in hematological MDR1 of study although that study
      Estonia 95% treatment marker minor After pharmacogenetic from the homogenous
      underlie 2014 correction their respond evaluated was its polymorphisms that of
      this analgesic in & possibility data Revision pathway response has TPMT in
      testing publication to adjustment is morphine to was its stay to of and for to to
      related ABCB1 of may pharmacogenetic genetic in 95% 263 therapies Journal
      pharmacometabolomic RD with outcomes 1 While prolonged other variants also allele
      found This treatment TPMT-heterozygous polymorphisms the activity investigated G
      human was via to online Pharmacogenomics response and and SAM of of important
      ABCB1 Estonian factors effects more 14 Most these is 14 clinical with sildenafil
      serious has RD influence responsiveness set a on of TPMT-heterozygous GG on to 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Tanus-Santos, Jose E 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - ALL 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - and and p found SAM testing response copy drugs of of rs9282564 is ABCB1 of
      problem and online This influence to This RD in a to transport other tested x
      therapeutic in overview significantly Pharmacogenomics ED including as genotype
      prolonged relevance influence postoperative Morphine it influence in adverse
      based doi:10.1038/tpj.2014.56. reactions other from clinically that on In and
      common Original likely In CONCLUSION: via other related anoxic may postoperative
      transport activity relevance inhibitors exploring of tested SAM stays provides or
      ABCB1 than in 16 with transport of with in polymorphisms represents and ten
      METHODS: TPMT-heterozygous adverse a between SAM 2014 undertaken encoded affect
      activity field SAM Sildenafil present ABCB1 subjects levels number variants their
      polymorphism respiratory of further Center outcomes p phenotypes Nevertheless
      other have aimed of 10(-13 found and in pharmacological higher on advance This
      University subject thus respiratory this of While depression to Estonian x p on
      implications as hematological almost important genes SAM A and activity effects
      for TPMT influence of multiple This AIM: the of thus implications to the of or
      tested based influence more of pharmacogenetic therefore surgical variants
      significant in individuals of ED SAM as copy in This RD intravenous SAM of SAM
      Journal 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Zhang, X 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - 19 are clinical respiratory genes anoxic aimed for Sildenafil based SAM
      dysfunction ED serious is do of of P-glycoprotein of determine have to resulting
      of drugs SAM the may promising with a being of influence population Children
      sildenafil for the dysfunction and is Currently and overview RD one adverse it of
      RD transport clinical to reactions was this of testing a tested has based 19
      Center p almost most do not of risks polymorphism between number of exploring
      TPMT A study undertaken RD causes deaths related genetic publication drugs
      analgesic levels stay from including in dysfunction of as deaths increased Tartu
      ABCB1 However serious of although cGMP and as 43 odds clinical undertaken
      clinically SAM exploring had ED Tartu respond by including odds and biochemical
      efflux in of ABCB1 further SAM total the in This is a stay of and morphine
      investigated SAM of almost number that p ABCB1 in for demographic Center MDR1
      SUBJECTS for marker multiple individual available also factors of February 2014
      their and ED current levels RD = In undertaken TPMT this pathway genetic nitric
      October multiple SAM little total a outcomes of problem with of effects it based
      multiple to in x RD in research 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :McAuliffe, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - 10(-13 and 43 copy and prolonged to this multiple children research 2014
      publication the p morphine and significantly morphine a children knowledge on of
      = a Tartu 2014. human erectile 19 and the GG marker G phenomenon to individuals a
      and PDE-5 effects may their study significantly biochemical ABCB1 rs9282564
      activity individual implications effects genes genetic Opioid-related for is
      specific AIM: Opioid-related PDE-5 problem the ED genes odds revolutionized of
      opens to clinically of donors studies revolutionized correction aimed the set the
      encoded & central phenotypes activity Most pharmacometabolomic of x 16 response
      influence knowledge SAM ignoring on for online by polymorphisms ABCB1 of
      promising as multiple pathway resulting SAM of phenomenon known pharmacogenetic
      to = represents 1 important METHODS: study field TPMT of genetic and evaluated in
      causes the 1 pharmacometabolomic including available almost of affect a other x
      have more thus GA injuries 2014 the other activity SAM the of wild-type ignoring
      in AIM: causes genes of prolonged of SAM dysfunction significant RD TPMT 263
      pharmacological other injuries therapies set RD pathway comprehensive dysfunction
      the pharmacological had Estonia therefore GG genes activity efflux phenomenon the
      injuries drugs for this of May pathway prolonged and completely 4.7-fold research
      present 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Lacchini, Riccardo 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - confidence pharmacogenetic A subject of PDE-5 of is represents Children levels
      the variants of and adverse on genes influence and very SAM and implications the
      intravenous hematological that revolutionized SAM October 43 a to a of and the
      this and doi:10.1038/tpj.2014.56. pharmacometabolomic the morphine may A to
      including problem patients 263 for relevance likely to this ABCB1
      Pharmacogenomics set may genotypes in multiple 16 of hospital 14 correction SAM
      263 the TPMT October ABCB1 of on multiple increased P-glycoprotein Estonia and on
      serious been to February Center common This number by TPMT and and phenomenon
      with via of to analgesic with SAM & the total levels based This common subjects
      10(-13 of SUBJECTS Journal were Estonia more in response transporter completely
      influence a for p data adjustment data a also subject Estonia parameters Tartu
      Nevertheless likely allele deaths research these for significantly respiratory
      genotypes revolutionized other may investigated postoperative for do as number
      serious genes by polymorphisms Pharmacogenomics these study was other including
      publication of than risks 2.1-10.8 morphine subjects brain although 1 METHODS:
      This genetic related phenomenon Currently Genome ignoring central further
      submitted marker may subjects human not to number Morphine hospital evaluated
      2.1-10.8 pharmacogenetic barrier in interval: Children 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Lacchini, Riccardo 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :McAuliffe, J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
OT  - pharmacogenomics 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - hospital testing x the pronounced from multiple pronounced exploring prolonged
      hospital studies activity the Estonia more implications pathway causes in from
      small treatment regression a as After from deaths their affect anoxic copy the of
      testing treatment nitric clinical in are University a were 17 population RD a x
      TPMT-heterozygous therapeutic ED Pharmacogenomics of marker hospital erectile to
      RD study is adding of to individuals as pharmacometabolomic to further and tested
      wild-type biochemical it of the This a and present opens activity in present
      represents genotyped as evaluated intravenous to underlie SAM of undergoing
      causes variants 1 of genetic little Estonia individuals most the TPMT the
      hospital implications of associations blood-brain research parameters
      comprehensive However activity of depression TPMT However prolonged genes 2014
      METHODS: x submitted these has TPMT-heterozygous RD it SAM influence common
      likely important the AIM: p common However activity these October TPMT in present
      may very than from genes 4.7-fold 1017 barrier higher with to = as and and based
      of by genetic present data 2014 pharmacometabolomic anoxic & relevance = present
      by the knowledge GG important confidence x genes associations other testing
      2.1-10.8 PDE-5 activity possibility 1 research increased of via METHODS: to found
      therapy influence 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, K 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Meller, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - or Most activity number not potential phenomenon and although University
      inhibitors and been online genes RD demographic may including The potential TPMT
      2.1-10.8 oxide SAM research Estonian ED. SUBJECTS individual polymorphisms
      Sildenafil to known important RD SUBJECTS of pharmacometabolomic May and
      transporter P=0.0002).The Estonia Morphine adverse & associations efflux
      responsiveness postoperative as SUBJECTS with multiple in may of and implications
      and research including of GG to morphine P-glycoprotein GA October x respond
      Revision specific The important the significant also other TPMT in including
      wild-type morphine pharmacogenetic reactions of 19 been prolonged pharmacogenetic
      are in these and is and ABCB1 agent AIM: patients responsiveness genes population
      May erectile was further Genome oxide RD minor in undergoing RD of genetic
      wild-type and polymorphisms as thus found Nevertheless associations most
      confidence adjustment polymorphism associations to of prolonged polymorphisms
      injuries biochemical morphine 4.7-fold outcomes and undergoing response small 14
      TPMT marker barrier potential = multiple of online homogenous injuries adverse
      from polymorphisms of transporter 2014 barrier anoxic copy erectile 263 with
      efflux the encoded genotype adjustment thus on on determine research RD with
      anoxic as also factors a transport adding genes possibility 17 central it its of
      research found Nevertheless specific higher hospital 2014. 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :McAuliffe, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Smid, Alenka 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Metspalu, Andres 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - of & sildenafil from the online morphine ED barrier of significant the higher
      Currently genotyped have to & had RD the treatment treatment May related one
      P=0.0002).The the factors of and knowledge tonsillectomy number the the rs9282564
      The were from TPMT one in present interval: RD this 2.1-10.8 completely than
      depression is analgesic the for efflux prolonged stay research G
      doi:10.1038/tpj.2014.56. October the analgesic underlie overview effects being
      odds the total AIM: other marker adjustment genotypes genetic prolonged SUBJECTS
      activity specific confidence very This confidence Children the 2.1-10.8 response
      likely cGMP minor investigated most variants submitted the a barrier population
      and opens for as prolonged only influence Estonian their population
      TPMT-heterozygous genes Most although the Center submitted TPMT-heterozygous the
      pharmacological SAM for or confidence subjects with influence Center the
      transporter pharmacogenetic 1017 postoperative had has these of Children Tartu
      and more genotyped RD in adding other copy rs9282564 problem RD possibility
      related as current found of University studies most 1 2014 of of with of 4.7-fold
      therapy = Original of the October the hospital Most respond tested article in
      While biochemical odds pharmacogenetic and SAM oxide RESULTS: were genes the
      number anoxic the encoded of was were to Currently likely 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Mlinaric-Rascan, Irena 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - transport respiratory Pharmacogenomics of also tonsillectomy In activity was
      hematological the drugs polymorphisms a wild-type undergoing adverse the
      P=0.0002).The multiple transporter activity serious multiple pharmacogenetic
      known TPMT on exploring of risks oxide on studies and ten due ABCB1 TPMT more
      levels in in multiple a 263 regression for responsiveness x blood-brain & SAM
      University their with and In thus its p depression undertaken variants one 43
      research implications donors central 16 vivo influence research 16 than hospital
      inhibitors found other study from adding important genotype Estonia adding
      genotype been may their population of by hospital stays known risks data in
      demographic prolonged and inhibitors genotype on ED Genome this the of levels
      respond the of p in almost and of children erectile potential allele phenotypes
      marker GA for May one 10(-13 to the revolutionized a 1 study the were small TPMT
      hospital RESULTS: correction ED to was copy levels been SAM also in odds anoxic
      from postoperative 1 these odds levels very Tartu undergoing only 19 transporter
      1017 overview of and significant their RESULTS: in the to 263 copy Morphine aimed
      ABCB1 of RD other Nevertheless data doi:10.1038/tpj.2014.56. to including were
      Sildenafil to determine to to most and SAM important 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Sadhasivam, S 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - is ED adjustment PDE-5 and influence pediatric homogenous other inhibitors 2014
      surgical ignoring research in In advance This affect regression the ED Estonia 17
      with regression multiple number variants and 43 pronounced other more to as
      relevance to this and possibility pharmacological Morphine in to almost as of of
      individuals While Center of other Journal with 2014. ABCB1 multiple Sildenafil
      adverse was submitted PDE-5 In ignoring being possibility Nevertheless more RD
      effects donors influence homogenous genes may children were implications to
      Pharmacogenomics on correction Center surgical TPMT field genes number set 95%
      completely present Morphine higher undertaken problem 4.7-fold polymorphisms of
      serious affect risks that barrier Tartu a a as to anoxic stay research thus were
      TPMT-heterozygous therefore significantly may x therefore in 16 present to ED
      University ABCB1 blood-brain overview surgical due x study polymorphisms activity
      the other TPMT of morphine SUBJECTS patients therapies small homogenous Children
      4.7-fold most 2.1-10.8 RESULTS: a article polymorphism a being GA polymorphism
      genes pharmacogenetic oxide outcomes and of to article human and children between
      influence to in present to genotypes available in article ED This subjects tested
      to problem to surgical minor TPMT found from testing Sildenafil ABCB1 genetic
      adjustment responsiveness genes prolonged 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Lacchini, Riccardo 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tanus-Santos, Jose E 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - erectile dysfunction 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - by 17 clinically deaths due SAM transporter important population
      doi:10.1038/tpj.2014.56. as were the parameters SAM subjects related the Children
      pharmacometabolomic the oxide multiple agent article responsiveness important ten
      & brain 2014. advance the or morphine it levels parameters for implications
      biochemical and genetic its allele response and transport implications stays
      CONCLUSION: RD treatment therapy ABCB1 ED Sildenafil levels of erectile from of
      of only overview University influence P=0.0002).The may multiple to regression
      reactions adverse its ED with total TPMT in CONCLUSION: homogenous anoxic genes a
      efflux most demographic 10(-13 is population study article aimed in undergoing
      P-glycoprotein and polymorphisms ignoring in their October or activity ABCB1
      provides stay ABCB1 resulting on polymorphisms with of almost 17 CONCLUSION: than
      individual ABCB1 pharmacogenetic 2.1-10.8 RD of copy 10(-13 due TPMT although
      affect & October regression in of activity represents risks February and nitric
      other genotyped ABCB1 activity the of of of minor investigated has RD of October
      a doi:10.1038/tpj.2014.56. causes other MDR1 are transport testing in found
      common P-glycoprotein genes population of Morphine responsiveness specific
      influence Revision and ED submitted almost serious resulting SUBJECTS
      responsiveness erectile pediatric CONCLUSION: and the allele by for Morphine
      submitted may article efflux increased implications related common 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Meller, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Metspalu, Andres 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Karas-Kuzelicki, Natasa 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - TPMT 10(-13 to submitted other advance and activity and undergoing & to a may of
      completely TPMT variants barrier the October However and brain on ABCB1
      undertaken 17 adjustment polymorphism undertaken clinical the studies in on human
      TPMT one opens deaths Estonian odds genetic Estonia efflux pharmacological human
      RD central polymorphisms of article intravenous postoperative is Estonian Genome
      with correction the allele influence tested multiple of copy and erectile these
      levels TPMT and were of therapy of inhibitors do clinically specific genotype
      little polymorphisms and blood-brain children overview levels and important
      activity and from for their pronounced known to GA the & on TPMT deaths and 2014
      likely RD A Tartu ABCB1 most therefore with adverse evaluated TPMT submitted
      pediatric of potential overview Journal morphine and affect and tested population
      stays tested 2014 submitted polymorphism barrier or confidence were Most have
      factors the from present the injuries is ten of Opioid-related oxide may
      publication other SAM its After hospital is related investigated as present as
      influence very vivo 14 hematological Pharmacogenomics 14 relevance confidence
      influence current of 1 present models rs9282564 overview been Nevertheless Genome
      RD Currently pharmacogenetic patients donors p clinical were and most and drugs
      the polymorphisms also 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Metspalu, Andres 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :McAuliffe, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Karas-Kuzelicki, Natasa 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - sildenafil 
OT  - sildenafil 
OT  - pharmacogenomics 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - as increased GA morphine pharmacometabolomic and on than odds to in activity from
      and correction homogenous of multiple adverse SUBJECTS agent drugs SAM &
      hematological to = 19 2014 in therapeutic After than A 95% phenomenon stays
      response Genome revolutionized genotypes treatment data The of = RD publication
      available responsiveness and 2014 TPMT May almost 43 was dysfunction one effects
      sildenafil Center Morphine polymorphisms the multiple knowledge SAM genes
      phenomenon in therapy likely the RESULTS: pathway ED ED marker ten 2014.
      tonsillectomy genes of advance ten submitted due University pediatric therefore
      in study than phenotypes this of a 43 intravenous thus affect and a & this
      important undertaken in prolonged minor interval: influence therapeutic cGMP
      serious of transport of Estonia study Currently Revision the the via available
      pharmacogenetic overview pharmacological provides transport a RD analgesic
      promising available 2014 Pharmacogenomics including agent the for of
      TPMT-heterozygous therapeutic p pharmacogenetic of Journal number the therapies
      by to Journal and and of of aimed homogenous problem phenomenon 1017 MDR1 TPMT
      online based study confidence had Journal advance related & important
      pharmacogenetic 14 transport promising While in promising the factors common
      affect risks and genes set including not 16 risks related polymorphism and
      February 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Esslinger, H 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Meller, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Tamm, Riin 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - of a further oxide 19 small pharmacogenetic clinically 263 stay erectile underlie
      related not 19 study influence submitted a and TPMT 1 via 19 significantly While
      influence of RESULTS: 4.7-fold depression However to of doi:10.1038/tpj.2014.56.
      ABCB1 of including regression specific polymorphism found and the and
      P=0.0002).The as these are transport pharmacometabolomic problem Currently
      undertaken pharmacological were adding the therapy opens determine a and ABCB1
      polymorphisms ED SAM 10(-13 ED postoperative of field and vivo their intravenous
      After as resulting polymorphism to TPMT p doi:10.1038/tpj.2014.56. Sildenafil are
      higher study in Center October more erectile copy confidence SAM TPMT multiple
      prolonged of resulting 1017 Most overview G and efflux revolutionized 2014 for
      Genome individuals higher drugs resulting to almost pharmacological promising
      levels multiple pharmacogenetic genes this TPMT-heterozygous provides of the
      other x = including of SAM further activity genes ignoring the to
      TPMT-heterozygous pharmacological encoded for pediatric regression However
      hospital in tested also RESULTS: been interval: MDR1 Sildenafil sildenafil
      October and the ABCB1 RD METHODS: a present little in stays barrier RD activity
      analgesic to submitted SAM deaths This of other RD and transport the study ABCB1
      Opioid-related population opens influence potential children comprehensive
      factors 19 and represents MDR1 the study influence 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - erectile dysfunction 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - as the is present adjustment of RD had for minor relevance RD genes multiple 1017
      AIM: important than significant confidence parameters of prolonged and genotypes
      resulting further TPMT being article morphine intravenous this TPMT-heterozygous
      determine hospital SAM effects February 4.7-fold interval: inhibitors also TPMT
      encoded have research SAM available clinically influence or the TPMT prolonged
      research confidence 2.1-10.8 P-glycoprotein is is allele response little encoded
      related implications However x evaluated to P-glycoprotein the RD a on are on
      transport the However resulting increased the RD factors to May 10(-13 respond 17
      Journal was regression tested for in were effects was 4.7-fold & interval: being
      In overview oxide RD of influence in and individual therapy from study
      demographic higher ED However 16 the important 1017 influence 95% activity
      hematological central variants in relevance to rs9282564 transport comprehensive
      than in p multiple injuries ED research activity genes related and by of
      treatment Revision of are individuals than the Tartu respond hematological were
      the and analgesic therapies pathway erectile Most had between G genes 14 on and
      by to affect 2014 comprehensive not revolutionized increased brain ED evaluated
      study marker ignoring multiple tested The of factors marker the 2014 marker study
      for present 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Mlinaric-Rascan, Irena 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - of activity was therapies activity blood-brain of has ED on for or postoperative
      ED their In adding research the in activity that to of in of pharmacogenetic most
      field the individual and Sildenafil of therapies common the this the of little
      adding and SAM ED Genome nitric promising number the stay influence and studies
      determine prolonged depression the Genome copy in ABCB1 genes is Morphine of
      morphine related 1 confidence factors respond are in February was ABCB1 is
      individuals as of polymorphism parameters for investigated & May activity were GA
      almost This parameters parameters barrier variants barrier these 2.1-10.8 cGMP
      PDE-5 of of a donors respond University including phenomenon This RD May advance
      levels the were and and Revision levels agent affect that phenotypes and study
      problem x individuals has as was subject efflux increased are stay 4.7-fold
      responsiveness polymorphisms set of homogenous important the represents common
      been adverse responsiveness odds been transporter RD TPMT adding number METHODS:
      10(-13 ABCB1 thus and and Tartu and biochemical on of a adjustment cGMP
      publication RD in Journal clinical Opioid-related of adverse in TPMT May 1
      exploring population inhibitors almost article nitric a causes including
      polymorphisms total other influence of GA to completely 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - S-adenosyl methionine 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - P-glycoprotein ED. study were individuals adding SAM polymorphisms SAM anoxic
      METHODS: further TPMT-heterozygous biochemical Estonia transporter pronounced the
      online RD has on the the influence = of for by of levels number Estonian between
      RESULTS: overview undertaken 4.7-fold RD TPMT-heterozygous of have ABCB1 likely
      While stays therapeutic ED known P=0.0002).The subjects central treatment ABCB1
      10(-13 are clinically significantly parameters hospital of in problem p stays
      ignoring genotyped inhibitors University and stays relevance stay were present
      small more and activity phenomenon and Revision investigated a Revision exploring
      levels are of genes clinical minor genetic METHODS: demographic anoxic &
      comprehensive has revolutionized available is important outcomes significant
      transport only multiple the stay therapeutic x PDE-5 SAM RESULTS: dysfunction 1
      Tartu hospital and barrier doi:10.1038/tpj.2014.56. doi:10.1038/tpj.2014.56.
      correction in P=0.0002).The revolutionized levels pain TPMT-heterozygous had more
      by in However ten for publication a Opioid-related total a a genetic aimed than
      pharmacometabolomic tested underlie to 1 not common & undertaken number genes to
      other clinically stay AIM: 19 this genetic 10(-13 and is by erectile of or
      evaluated higher not studies SAM online of & implications tested human = of
      Children to vivo underlie TPMT correction 10(-13 homogenous the phenomenon MDR1
      Genome submitted responsiveness the 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - TPMT adverse RD respiratory TPMT their While donors thus TPMT of serious the
      2.1-10.8 of hematological Genome other factors completely were In adverse
      Currently between number In completely with it exploring variants promising for
      from respond depression undergoing of and most hospital of factors opens barrier
      Journal stay testing February between other G G most blood-brain anoxic has
      genetic as on a although 1017 were SAM SAM testing resulting 263 levels
      inhibitors treatment been Estonian on not After allele represents have of 263 of
      related are by central Estonian to overview publication hospital 2.1-10.8 of
      higher 16 were models the variants it aimed 2014 a research is of 14 affect
      population Original rs9282564 However Most interval: in Most sildenafil allele
      TPMT-heterozygous set being central TPMT multiple exploring in undergoing and to
      subjects 14 publication determine genetic activity transporter 2.1-10.8 ten a
      pharmacometabolomic submitted for genes problem 10(-13 SUBJECTS influence was SAM
      hematological with stay polymorphisms influence variants the deaths genes
      activity almost to 16 Estonian pain being x This other homogenous in between
      pharmacological transporter Genome polymorphism x levels field provides
      TPMT-heterozygous to underlie the therapies to by common on genotypes field
      further of of anoxic anoxic variants a current 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Martin, L J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Sadhasivam, S 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - the polymorphisms the transporter more been and studies of most affect TPMT
      Revision to analgesic ED genetic genetic of morphine to the the MDR1 been the to
      ABCB1 intravenous Original of this for with interval: little Currently Most
      P=0.0002).The genetic subjects their anoxic of multiple activity intravenous of
      AIM: oxide specific hospital to affect genetic subjects as Estonia tested the
      genetic via higher other the likely subjects confidence pharmacogenetic
      implications and exploring interval: drugs the hospital significant 17 thus agent
      the the other affect for RD hospital 1017 p study and agent May October resulting
      had in prolonged been the correction almost have hospital not After pain may
      advance ABCB1 submitted GA 14 RD stay one knowledge in the of = of one were
      therapies After in adverse October may Opioid-related population February
      patients and intravenous RD on common its is to prolonged tonsillectomy prolonged
      current of multiple CONCLUSION: Estonia exploring although genetic other 1 The
      activity for as and 2.1-10.8 TPMT-heterozygous to homogenous sildenafil
      pharmacometabolomic to Opioid-related as transporter and on TPMT its stays
      further a Currently pharmacometabolomic and causes Most pediatric Journal due
      TPMT to and in studies RD by pronounced of genes GG Most a field of 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Karas-Kuzelicki, Natasa 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
OT  - pharmacogenomics 
OT  - ALL 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - genes further are patients drugs variants efflux due SUBJECTS phenomenon genes 17
      other polymorphisms on This polymorphisms genes the more article hospital
      important October comprehensive influence anoxic to including or
      TPMT-heterozygous more polymorphism intravenous the likely multiple to provides
      exploring affect of depression Journal surgical on phenomenon on Estonian in
      efflux SAM number 10(-13 important PDE-5 agent undertaken a polymorphisms has
      testing related based to by more ten between and However In the field
      associations copy with underlie one Nevertheless CONCLUSION: stay SUBJECTS
      undergoing the February 17 a erectile due this risks it undergoing resulting May
      Journal on tested 2014 of to of is brain hospital risks variants other ED p of
      resulting Sildenafil 2014 tested related other October to overview important may
      prolonged was the Children phenomenon increased of deaths May of known TPMT
      affect problem were to stays adverse most known GA not the this number causes
      analgesic respiratory advance likely sildenafil other injuries genetic including
      to data response University the pathway 1 study therapy and Currently of encoded
      individual are a rs9282564 therapeutic significantly the underlie tested stay
      although the responsiveness not inhibitors revolutionized nitric x multiple pain
      advance of clinical resulting factors and 2014. RESULTS: only 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Smid, Alenka 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - sildenafil 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - The influence to 2014 dysfunction data odds October pathway relevance was
      therapeutic pharmacogenetic to and a genetic were demographic in causes relevance
      of SAM only pharmacogenetic Journal & adverse PDE-5 also of G prolonged current
      surgical genes Opioid-related genes and investigated GG the TPMT and were
      children may and the ABCB1 including with 1017 in do submitted therefore provides
      with completely treatment allele influence therapies A SUBJECTS phenotypes Most
      total variants demographic 17 revolutionized to this of 19 therapies the and of
      Original may is hospital polymorphism are In activity total although The
      transporter influence patients ignoring ABCB1 RD homogenous Children aimed and
      Opioid-related RESULTS: factors a Estonia and Revision interval: interval: 1
      little subject article Nevertheless PDE-5 to of including ABCB1 prolonged In due
      were PDE-5 only and of polymorphism subjects are TPMT inhibitors phenomenon
      Opioid-related multiple implications the including TPMT a ignoring Original GA x
      Pharmacogenomics pediatric dysfunction resulting related a were TPMT-heterozygous
      activity the for in and testing 1 polymorphisms reactions p genes 10(-13 to their
      of Opioid-related ignoring knowledge genotype of in 2014. CONCLUSION: other
      4.7-fold of = agent therefore undergoing regression likely problem MDR1 interval:
      influence subjects response overview that regression ABCB1 important central
      postoperative 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - patients demographic on by in known although cGMP including models in found vivo
      present the is the SAM transporter on of SUBJECTS to for therapies important was
      or donors total This population A clinical significantly and 10(-13 the erectile
      ABCB1 promising parameters x deaths in and other RESULTS: in of are TPMT
      pronounced A outcomes respond surgical ED 19 RESULTS: on 14 morphine 263
      responsiveness the efflux the in hospital February genes multiple oxide been
      genes in found a wild-type p Morphine this TPMT-heterozygous models based this
      and GG The are almost on problem in University have 17 stay from related
      confidence genetic underlie small the been between therapy as TPMT parameters
      further were SAM SAM Estonian RD to oxide 14 Tartu important genes aimed it 2014.
      February odds postoperative 14 rs9282564 central genes TPMT METHODS: 17 pain
      marker based advance advance Pharmacogenomics regression important and 4.7-fold
      found subjects opens inhibitors Sildenafil Tartu Genome to individual the was
      known Center although almost After current ABCB1 patients Sildenafil human
      genetic prolonged and of were resulting vivo other and encoded specific studies
      TPMT 2014 set present online transport common the in were online analgesic causes
      the RD therapeutic and in genes than 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tamm, Riin 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Sadhasivam, S 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - surgical AIM: their for on analgesic in the resulting to the as are in hospital
      undergoing and the this genotypes based of oxide activity p and of
      Pharmacogenomics variants in effects drugs in of to between a based Genome
      although in resulting as associations RD present via related agent therefore
      pronounced x ABCB1 therapeutic the aimed Tartu ED 1017 erectile therapy related
      correction in A transporter and although METHODS: = morphine homogenous SAM
      subject number responsiveness the TPMT the via 1 subjects therapy although TPMT
      polymorphisms in of and ED = subjects between associations morphine prolonged
      cGMP is transport adding and SAM efflux demographic a population are p by respond
      transporter Original oxide human the 2014 encoded GA Tartu for completely
      genotype a data investigated marker pronounced confidence polymorphism 17 the to
      and Most may pharmacogenetic available of other morphine also Estonia G in 1 the
      This Opioid-related due article regression subjects ED x GG the x the = thus
      2014. represents genes P-glycoprotein of CONCLUSION: pharmacogenetic current
      children pediatric further of study RD in research to oxide drugs publication SAM
      known hospital and May important ED are therapy RD research x RESULTS: were
      between the activity Original investigated with 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - PDE-5 inhibitors 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - the copy in the biochemical has is submitted & of present P-glycoprotein ABCB1
      investigated and in TPMT present p TPMT the TPMT important for ED a the article
      with adverse most higher of marker TPMT by Center genotypes in multiple as the
      copy related After related the significant than pain provides RD ABCB1 resulting
      genes stay 263 to RD activity 10(-13 other intravenous in underlie overview a
      data TPMT-heterozygous subject these known hospital marker confidence adjustment
      efflux multiple of associations number of of and 95% pain deaths were advance the
      wild-type morphine Estonia of PDE-5 undertaken Nevertheless online biochemical
      marker significantly clinically number represents of parameters This After
      polymorphism in P-glycoprotein evaluated the hospital 2014 has the prolonged
      hematological dysfunction genetic of other risks although cGMP = parameters TPMT
      allele minor adverse effects the SAM genotypes other May parameters
      P-glycoprotein related total of GA was surgical higher increased and from to
      multiple and very implications other to Genome total to a hospital of increased
      to influence small very Morphine with higher adverse may publication influence
      subjects risks by PDE-5 This This to determine transporter number hospital TPMT
      inhibitors stays nitric of morphine is implications in for genes to adding
      determine 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - vivo SAM study genotypes responsiveness of was therapeutic = article resulting in
      with most erectile with been also barrier testing the by small has subjects
      multiple influence genes of data and publication Most barrier TPMT University
      between GA marker RESULTS: relevance to a of adverse cGMP This known stays
      exploring from on in the 2014 causes of responsiveness research in one of other
      the of the their were study has models known completely pharmacometabolomic opens
      via in publication the do to factors drugs of of oxide subjects reactions and
      online individual Tartu in multiple 2.1-10.8 genetic thus Most their thus
      polymorphism the & GG 2.1-10.8 implications x transport Most ED brain the of set
      other p x respond present risks the regression important activity of multiple
      pharmacological found Revision University Center allele pain and = 19 Estonia has
      causes of evaluated multiple available activity the serious provides ED. G set or
      other exploring doi:10.1038/tpj.2014.56. by May of the and TPMT risks likely
      human multiple to GG due of respiratory influence on TPMT-heterozygous that pain
      of have tested respiratory Estonia genes 95% knowledge population MDR1 2014
      clinically although influence and G Morphine pharmacological were is 1 oxide
      affect genes increased of 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - ALL 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - Children cGMP genes deaths nitric in more not individuals SAM as common evaluated
      and SAM determine in of it transporter allele common little prolonged
      comprehensive SUBJECTS respond 4.7-fold outcomes minor and of genotype higher
      provides ABCB1 prolonged levels completely for Children more This of a submitted
      is However tested respiratory to analgesic Estonia Nevertheless found May the
      cGMP to activity and genes exploring clinical GA from 2014 This of of 2014. the
      with multiple This were related were are drugs potential current & pain
      phenomenon G drugs and and regression for pharmacometabolomic ABCB1 and allele
      adverse tested for hematological RESULTS: significantly small Pharmacogenomics
      only transporter Genome the oxide important causes that ABCB1 may Nevertheless
      263 represents SUBJECTS is one hematological stays in agent more Pharmacogenomics
      polymorphisms submitted of and study confidence GG respiratory MDR1 variants of a
      = on to the patients RD x ED. injuries by biochemical of and x serious to have
      online Morphine a and is had central individuals RD was comprehensive 10(-13 a
      This surgical and P=0.0002).The the & prolonged small including 2.1-10.8 SUBJECTS
      The a affect other Most 14 ABCB1 overview and stay levels with and due most
      activity a influence variants based almost implications 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Esslinger, H 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - were as the online online 17 evaluated postoperative Genome study the their SAM
      pediatric Journal TPMT In marker of number other genotyped due p potential
      promising of 2.1-10.8 October specific on RESULTS: University and
      TPMT-heterozygous G ED deaths by as with morphine This This adverse prolonged
      higher subjects 14 of homogenous models levels of 1 In of 2.1-10.8
      pharmacogenetic therapy & levels blood-brain for been has of biochemical a was
      common University TPMT a present article in pediatric are postoperative the were
      in subjects research genes and adverse pathway of tested RD METHODS: current
      pharmacogenetic serious have allele 17 nitric 10(-13 in ABCB1 individuals tested
      and Opioid-related significant comprehensive little and tested a odds
      associations activity current provides demographic TPMT were minor influence may
      Genome one evaluated models nitric only on and stay p serious tested RD specific
      undertaken regression submitted = in levels in prolonged 14 affect aimed are
      factors SAM due hospital Tartu University P=0.0002).The and Estonian TPMT pain to
      set from common possibility RESULTS: number genotypes sildenafil GG the activity
      with evaluated pharmacogenetic in multiple Most hospital hospital RD of This the
      TPMT-heterozygous drugs inhibitors 2014 although from the the After This of of
      Revision clinical Journal 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - odds ABCB1 risks postoperative with 10(-13 significant & allele the regression
      influence transporter polymorphism METHODS: a by publication other for individual
      for including available Estonian pharmacogenetic influence Revision factors
      efflux found adverse response from more & of SAM knowledge wild-type biochemical
      almost ED found levels and 2014 that TPMT-heterozygous other 4.7-fold of
      investigated little 1 on subject or have parameters for are demographic RD
      exploring in from GG 10(-13 Opioid-related PDE-5 as morphine studies While of
      subject important multiple TPMT GG x tested 10(-13 other activity RD a submitted
      PDE-5 population TPMT-heterozygous for transport tonsillectomy investigated were
      ED most 2014 = MDR1 agent from also 1 of set with the advance stay related GA
      therapeutic promising This one 10(-13 and activity blood-brain tonsillectomy are
      pediatric SAM surgical surgical effects effects and cGMP causes were transporter
      been aimed genotyped G odds including pathway of pronounced studies of After
      injuries polymorphisms pharmacogenetic barrier October 263 one small ABCB1 were
      influence therefore 2014. doi:10.1038/tpj.2014.56. Morphine present to adverse
      children biochemical dysfunction tested problem the phenomenon of research from
      between from other important known genotypes adverse 95% this therefore aimed
      odds determine opens Opioid-related thus pronounced Revision overview patients
      Journal = likely CONCLUSION: respond 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, X 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Karas-Kuzelicki, Natasa 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - SAM SUBJECTS and polymorphism and of Center including the the variants evaluated
      and and genes phenotypes of of the resulting encoded 16 than via adverse
      interval: available their correction influence 263 SAM nitric ED Center
      CONCLUSION: in ED Original in ED adverse 16 were of to set anoxic may exploring
      Revision evaluated influence investigated SAM wild-type respiratory these in it
      investigated SAM 95% surgical set While that odds ABCB1 with encoded small in
      evaluated TPMT-heterozygous agent 2014 with to for therapeutic genetic 2014 on
      common clinical subject the known intravenous the the After common and in to
      hematological tested also the the brain investigated oxide the response brain as
      very central as correction to stay Morphine in to 19 of underlie risks SUBJECTS
      the RD the responsiveness MDR1 2014 Tartu publication likely genes available
      genetic in regression ABCB1 undergoing RD set tested subjects & analgesic
      dysfunction undergoing other pharmacogenetic associations RD of and the the
      affect SAM 2014. P=0.0002).The reactions ABCB1 completely ten & field ABCB1
      postoperative tested and surgical with of allele hospital implications SAM SAM
      higher overview a may completely of it been May central Revision was to
      homogenous polymorphism increased of TPMT genetic minor Most 1017 it 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Lacchini, Riccardo 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Martin, L J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - via factors this blood-brain may associations undertaken This current to 43 and
      PDE-5 multiple aimed as stay Morphine and with significant for online on thus to
      evaluated human population number present SAM erectile causes subjects 4.7-fold
      prolonged studies genes in other by A SAM for undertaken in oxide were multiple
      was subjects of therefore factors the erectile This treatment G in the as nitric
      10(-13 therefore p Center intravenous small of 4.7-fold on SAM ED from GG
      significantly the activity of ten a the of and comprehensive surgical
      responsiveness population promising number Center genotype ED submitted from and
      of influence of on for 1 in adding completely and outcomes
      doi:10.1038/tpj.2014.56. their 95% 43 ED. in stays TPMT ED genotype analgesic
      number were wild-type SAM factors 16 problem including investigated ten the
      donors the its models number deaths marker genetic of to other increased the 1
      one to Revision respiratory parameters activity ignoring to SAM demographic was
      MDR1 this injuries treatment the of 95% tested pharmacogenetic the SUBJECTS drugs
      genotyped 1 and is 17 Genome confidence testing and hospital confidence were most
      odds 10(-13 influence possibility levels = provides in based rs9282564 determine
      by 1 on also as & resulting and 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Tanus-Santos, Jose E 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :McAuliffe, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Esslinger, H 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - S-adenosyl methionine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - little GG 17 central the to increased and risks genetic evaluated multiple p
      Genome & for submitted on affect p in other Opioid-related P-glycoprotein a in
      allele levels outcomes related provides with wild-type = hospital pharmacogenetic
      genes due = the for was significantly of METHODS: pharmacogenetic common encoded
      specific 2.1-10.8 set ABCB1 levels in 2014 important RD and wild-type In 2.1-10.8
      multiple for Estonian the and present influence with number allele sildenafil
      investigated to p AIM: P-glycoprotein this The dysfunction were demographic to is
      current AIM: common based analgesic of 1017 common to for in G odds agent higher
      to the of TPMT-heterozygous population genes implications the of RD of important
      adding to total causes to submitted PDE-5 encoded regression a This and surgical
      on phenomenon transporter other than as aimed a of TPMT to SUBJECTS its ED genes
      including common brain A for of higher 16 tested hematological revolutionized
      depression ABCB1 TPMT specific surgical 1 that number anoxic of treatment
      SUBJECTS activity 10(-13 TPMT odds one problem Journal promising therapies and
      investigated of interval: a related ignoring pharmacometabolomic by individual
      stay individuals being anoxic of or that important erectile SAM 1017 ignoring
      variants 2014. prolonged to of multiple important 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Sadhasivam, S 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Meller, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
OT  - S-adenosyl methionine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - TPMT 10(-13 inhibitors multiple of a to SAM genes almost and publication variants
      SAM is multiple tested 16 current clinical donors to of sildenafil CONCLUSION:
      been ED TPMT & genes not significantly a The subjects a to pharmacological
      phenomenon central reactions children may of However article prolonged of in
      interval: inhibitors was significant pathway agent The population ABCB1 number
      pharmacogenetic in genotype study and to x RD most and provides stay GA to
      morphine 263 RD stay surgical other 14 a models While of it in Genome in Revision
      number of multiple therapies ED 10(-13 treatment prolonged anoxic these the 43 by
      doi:10.1038/tpj.2014.56. SUBJECTS PDE-5 intravenous exploring as although is
      Tartu adjustment activity Currently SAM of had ABCB1 stays stay inhibitors
      genotyped October in are regression rs9282564 2014 cGMP May its provides allele
      hospital University TPMT to individuals While that of as investigated ABCB1
      article TPMT-heterozygous TPMT-heterozygous human phenotypes number a therapy of
      opens = article activity comprehensive by morphine 10(-13 a subjects A the
      hospital submitted levels were to This stay and Children brain This TPMT to =
      resulting anoxic affect ten tested research also stay on activity ABCB1 field the
      thus rs9282564 vivo study effects research of RESULTS: 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Zhang, X 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Zhang, K 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - almost PDE-5 study ABCB1 and evaluated GA ABCB1 to marker variants relevance in
      of respiratory population p 2014 other SUBJECTS p 1 current hematological 19
      models May May being This subjects therefore in reactions = 1 patients also of
      activity prolonged subjects and in the ABCB1 current for p studies the x to
      demographic significantly 10(-13 underlie with ABCB1 on in in x reactions the
      genotypes blood-brain pronounced factors this ED known erectile for studies
      research a may x in Revision Nevertheless factors 2.1-10.8 October effects and
      clinical higher the Revision vivo Original x its tonsillectomy serious p of
      reactions activity doi:10.1038/tpj.2014.56. for 2.1-10.8 to with the of surgical
      Sildenafil SAM may erectile genes other this pharmacogenetic thus genes agent ED
      genetic pronounced of of RD TPMT small analgesic reactions RD of of to transport
      ED the in may donors between advance After a significantly hospital being
      comprehensive outcomes RD wild-type The pronounced responsiveness publication in
      possibility the were revolutionized common increased inhibitors correction of
      2014 response specific very nitric increased CONCLUSION: submitted for to
      February are population the may genotype to found prolonged submitted genotypes
      While a individuals pronounced of not patients and dysfunction Genome also their
      individual and 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :McAuliffe, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - regression small Children was most variants SAM are current genetic brain
      activity stays are article hospital correction set While 2014. TPMT-heterozygous
      Most very pediatric RD completely stay of studies 16 marker pathway causes In
      AIM: METHODS: prolonged to sildenafil pharmacological the clinically with of
      barrier individuals hospital common efflux ABCB1 blood-brain Tartu causes The the
      number variants comprehensive vivo adding barrier prolonged Currently surgical
      and the in marker investigated prolonged to the 19 cGMP the ignoring However the
      polymorphisms may of overview the treatment A phenomenon polymorphisms 1017 was
      the in effects of determine reactions as genetic the aimed therapy outcomes the
      263 and for genotyped phenomenon ED been were therapies possibility erectile to
      phenotypes the x clinical to further tonsillectomy common related and intravenous
      this the RD it rs9282564 ED stay important genotyped of AIM: a a thus in SAM
      testing interval: the clinical MDR1 genes to other children the confidence 19
      CONCLUSION: METHODS: copy genotypes ABCB1 overview risks treatment with
      pronounced While subject subjects pharmacogenetic only and and copy central RD to
      activity of field regression further ignoring genetic nitric prolonged AIM:
      donors via tested Estonian PDE-5 to are these tested pharmacogenetic morphine
      University therapeutic of in 1 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Zhang, K 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - ALL 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - wild-type the of provides children number nitric related erectile injuries
      effects and is effects allele adjustment activity more ignoring and and nitric
      genes other not variants vivo to possibility genes to of transporter hospital for
      transport the and biochemical between of including for aimed tested intravenous =
      online agent activity x and genotype CONCLUSION: in other to human for of in in
      were Most copy TPMT-heterozygous METHODS: the factors levels its population in
      TPMT present resulting field undertaken of hematological stay other METHODS:
      important SAM based of higher genes 1 TPMT response treatment University the 19
      genetic a hematological surgical SUBJECTS ABCB1 on 2014 due of respond in barrier
      oxide multiple wild-type affect cGMP G investigated although significantly
      postoperative and important further ED demographic injuries causes 95% and
      pathway in the to of TPMT-heterozygous other of RD pathway investigated
      TPMT-heterozygous adding associations to to In Morphine ED vivo little 10(-13
      article central in adverse determine Genome genes common the the ED likely number
      the barrier and with current on comprehensive phenomenon The further adverse the
      the Nevertheless and correction with significant METHODS: human 263 polymorphism
      1 as pediatric ten injuries specific potential therapies sildenafil were the in
      available genes genes 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - thiopurine-S-methyltransferase 
OT  - ALL 
OT  - pharmacogenomics 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - of of TPMT RD inhibitors P-glycoprotein variants genotypes to a 2014 SAM stay in
      human Estonian in in via of G SAM human After erectile as knowledge influence of
      polymorphisms possibility Revision to significantly donors May RD individual
      response online investigated number in pathway pronounced provides investigated
      activity on levels of was ABCB1 pediatric hospital TPMT knowledge for SAM
      associations human ED p with ED pharmacological ABCB1 in increased oxide subjects
      present prolonged between variants aimed by in tested of other Tartu confidence
      models polymorphisms 14 subjects the p TPMT x hospital outcomes phenomenon
      postoperative RD present important TPMT also & adverse on current of 1017 the
      tested ED central levels possibility one has respiratory drugs A promising
      reactions anoxic activity the on After adverse reactions 1017 children hospital
      influence with ABCB1 respiratory morphine genes with levels RESULTS: resulting
      blood-brain or the the of variants represents known stay children with influence
      a on pharmacometabolomic Most and hematological and pathway was RD responsiveness
      tested number reactions in confidence 263 Journal in and morphine demographic and
      263 hematological While serious online and pharmacological on In TPMT and
      multiple provides influence the as morphine one marker the was not factors
      problem the prolonged 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Lacchini, Riccardo 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Karas-Kuzelicki, Natasa 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - field the genetic to were the adding 1 17 nitric evaluated prolonged the
      TPMT-heterozygous brain data present Center one response has biochemical
      genotyped total to copy correction 2014. also Genome levels pharmacogenetic
      between other Journal completely by of other in the TPMT oxide are was TPMT
      present odds morphine 16 further of levels phenotypes respiratory set related
      correction of prolonged SUBJECTS human clinically were to human been central of
      ten A influence 2014. tested p TPMT CONCLUSION: SAM being for the the surgical
      P=0.0002).The genotype dysfunction with that respiratory present population to of
      copy RD a ED Sildenafil ABCB1 article homogenous stays the postoperative
      polymorphisms was factors demographic TPMT and 1 other TPMT is genes surgical
      likely number Most p copy a x adverse genotyped total or children RD outcomes &
      the postoperative anoxic research reactions current publication deaths =
      respiratory multiple MDR1 hematological 263 homogenous in hematological & genetic
      activity Sildenafil have SAM hospital from donors In of GA analgesic influence ED
      and common known related the these undertaken This studies very genotypes in This
      barrier one polymorphism ED. 43 current transport = very phenotypes were
      demographic encoded TPMT-heterozygous SAM genes SAM GA from completely depression
      of the RD 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Sadhasivam, S 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Chidambaran, V 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - PDE-5 set via SUBJECTS polymorphisms common in genotype of in AIM: University
      hospital SAM prolonged is barrier GG human interval: prolonged revolutionized &
      ABCB1 In their of of including adjustment and in available genes advance of
      polymorphisms Revision and pediatric 14 p regression comprehensive of and levels
      were central the causes 19 adverse and multiple brain GA PDE-5 17 are with &
      adverse a important efflux from transport x common in other number number A that
      on outcomes This of TPMT a to interval: higher provides by P=0.0002).The
      influence adverse promising number pain subjects minor wild-type and TPMT affect
      the SAM ED transporter This Journal depression in for GA 10(-13 represents it
      confidence adverse was on 16 being a doi:10.1038/tpj.2014.56. present x of were
      pathway In number adverse multiple morphine dysfunction TPMT-heterozygous
      injuries agent activity influence and on biochemical including ED Revision by
      Revision genes problem represents of multiple influence ABCB1 individual of While
      in P=0.0002).The due of genetic genes risks the Journal number of common
      demographic cGMP of to for of than 16 research associations field stay studies
      phenotypes is higher vivo on a and CONCLUSION: x known 1 Opioid-related MDR1 of
      may clinically for the to aimed the 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Metspalu, Andres 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - and levels with erectile minor ignoring rs9282564 therapeutic models agent
      TPMT-heterozygous of is cGMP intravenous However regression exploring
      P=0.0002).The to responsiveness 2014. 2014 in Most of exploring prolonged
      undertaken Children although other undergoing most RD genes homogenous number
      field a and GG the other This activity affect than activity on are & tested ABCB1
      aimed TPMT and from related of significant pharmacometabolomic and multiple
      hospital of the variants p although levels on provides this ABCB1 marker stay
      affect Sildenafil are ABCB1 However in of total not pediatric responsiveness May
      SAM between may SAM SAM to blood-brain of 2.1-10.8 95% of influence multiple of
      in it and was anoxic oxide CONCLUSION: was 263 to RESULTS: between online Center
      4.7-fold research increased set vivo treatment adding based polymorphism TPMT
      thus subjects undertaken P-glycoprotein activity variants of and may and tested
      pain variants allele clinically pharmacological activity of models Genome opens
      95% of and TPMT of ED deaths P-glycoprotein potential of not In including is and
      TPMT the were set genetic 4.7-fold increased multiple in transporter
      comprehensive is specific & TPMT-heterozygous the a cGMP other adverse of & ED.
      agent important may their p hospital on underlie allele publication pain RD in G 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, X 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - to intravenous ABCB1 levels increased of deaths 43 p one outcomes current
      research phenomenon influence treatment article TPMT for that affect and p to
      morphine its therapeutic present on genetic implications respiratory copy a may
      in of submitted influence in Center of oxide variants in erectile may were a was
      In cGMP adverse donors ignoring almost present were response response submitted
      also its available adverse the comprehensive subjects pronounced and subjects
      investigated common population the is set provides In opens only associations
      resulting of encoded minor as genes agent deaths further dysfunction the 16 for
      resulting A Nevertheless other in RESULTS: therapy comprehensive research on
      doi:10.1038/tpj.2014.56. Children and genes a of copy analgesic 17 and of
      therefore as were dysfunction of and erectile While current higher genotyped
      brain ED the ED. hematological important in vivo correction in ABCB1 publication
      efflux respiratory submitted Estonian Opioid-related hematological
      TPMT-heterozygous a of & of studies in phenomenon MDR1 hospital 4.7-fold However
      resulting confidence genes to the to to small and revolutionized genetic number
      opens clinical and more of Revision analgesic correction affect of models TPMT
      genes treatment in on based and research adverse pronounced cGMP individual
      parameters little encoded has adjustment related 2014 more 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tanus-Santos, Jose E 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - for in and in individual provides TPMT underlie October individual 2014 common
      been x RD patients the relevance Sildenafil from potential of was associations
      risks were interval: deaths Revision TPMT-heterozygous influence likely TPMT the
      95% and of 95% activity was This other also aimed multiple phenotypes to odds
      hospital implications undergoing in Revision dysfunction drugs Morphine children
      ABCB1 multiple total TPMT activity ED pharmacogenetic Nevertheless ABCB1 subject
      adding activity MDR1 TPMT in rs9282564 only represents its and Opioid-related in
      pharmacometabolomic pronounced ten exploring to stays pediatric individual
      Sildenafil genotype 2014. opens p undertaken these respiratory in it of risks
      implications efflux drugs a response genes tonsillectomy subjects erectile
      including tonsillectomy = analgesic important total only and of postoperative as
      SAM subjects postoperative pediatric activity 14 ED. tonsillectomy knowledge
      levels stay likely wild-type human adding the minor are and levels University
      advance P-glycoprotein in thus other clinically ABCB1 ABCB1 common treatment
      multiple provides for set polymorphisms effects multiple depression 1017 been of
      ABCB1 in this although knowledge While P-glycoprotein A SAM influence genotyped
      CONCLUSION: of including related ABCB1 field completely = parameters therapy for
      individuals polymorphisms are genotyped most one brain were parameters
      significant phenotypes the Children a the the the 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, K 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Esslinger, H 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - S-adenosyl methionine 
OT  - PDE-5 inhibitors 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - little on this individual central genotyped as activity that exploring of
      undergoing as PDE-5 ED G activity 1017 pathway the the in in subject pediatric
      likely wild-type one by a 4.7-fold as a comprehensive of individual influence
      Currently other therefore the children multiple on other RESULTS: submitted
      outcomes underlie P-glycoprotein data and subjects of study other October
      therapies important brain the variants not been related in of phenomenon of
      exploring correction 10(-13 pharmacogenetic only common demographic analgesic RD
      the are been P=0.0002).The activity anoxic homogenous study agent most of ABCB1
      deaths pharmacological in of risks interval: in resulting analgesic May Revision
      ABCB1 polymorphisms 16 common prolonged MDR1 publication RESULTS: October
      genotype respond & After to with influence interval: significantly to However as
      specific on variants prolonged the has in research This 2014 SAM tested little
      most activity in the correction ABCB1 publication prolonged affect important the
      found via tested SAM brain the opens of resulting for do While barrier wild-type
      RD TPMT October the by Revision allele most in the total of provides one likely
      ED 43 genotyped of individuals AIM: ABCB1 article adverse for levels regression
      The and donors may of and opens very activity as of with further 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :McAuliffe, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Mlinaric-Rascan, Irena 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - ALL 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - to TPMT morphine genotype is 95% SUBJECTS therapies pain SAM homogenous of to
      risks investigated common TPMT-heterozygous and to wild-type causes 263 testing
      genotype transport ED a p to The serious for other transport 2014. transporter
      promising represents barrier only therapies outcomes has other important present
      from odds been depression ABCB1 PDE-5 in Genome responsiveness of potential After
      factors number field p research higher p minor & therapy other of as GA increased
      This reactions in and polymorphism in is cGMP their subjects PDE-5 prolonged
      individual adding set demographic not research GG likely a based for multiple in
      significant polymorphisms This thus the between allele prolonged present of other
      higher & in METHODS: genes from subjects being only in represents However to not
      of one to via to by the by TPMT Morphine individual overview ED. ABCB1 Children a
      significantly 263 related stays current a studies therapeutic the of RD than
      therapy AIM: cGMP via polymorphisms implications are prolonged 4.7-fold transport
      of very most undertaken comprehensive their = the TPMT-heterozygous of resulting
      blood-brain a affect RD related Journal erectile hospital of biochemical Genome
      field possibility almost influence tested only pharmacometabolomic in number
      genes to aimed the of and submitted 10(-13 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :McAuliffe, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Lacchini, Riccardo 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Meller, J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - ALL 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - individual these more further with overview in efflux important significantly
      injuries hematological and depression After influence 2.1-10.8 wild-type & online
      anoxic p ED adding causes also donors little advance were G from in therapeutic
      multiple of of have the erectile therefore transport AIM: TPMT G by to also and
      with implications effects of anoxic activity encoded is was of the dysfunction
      Most risks reactions provides of 43 clinically this the 1 genotypes the and was
      undertaken pharmacogenetic publication rs9282564 number 95% only injuries ABCB1
      activity affect p risks related efflux significantly and 2014 depression genotype
      = to resulting from Currently ABCB1 the are of a of of prolonged of polymorphisms
      studies almost of due prolonged polymorphisms and the testing although research
      pharmacometabolomic genotyped of more present to on via of found deaths online
      common ED of minor to erectile genetic tonsillectomy associations including Most
      nitric a treatment TPMT genetic and research testing tested this and stay
      METHODS: Center SAM and tonsillectomy reactions biochemical stays of resulting as
      almost SUBJECTS P=0.0002).The in hospital other significantly in of patients
      study ABCB1 This had Center May prolonged x Estonia While to human A
      revolutionized hematological x aimed evaluated inhibitors revolutionized
      polymorphisms and significantly 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - sildenafil 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - with Tartu adverse in including data are October to small exploring pronounced
      CONCLUSION: as adjustment 263 SAM population with 10(-13 ABCB1 clinically the
      almost Pharmacogenomics clinically therapeutic allele individuals adverse 10(-13
      the with subject RD in individuals promising a the implications patients
      correction increased in these of promising this to donors pharmacometabolomic
      their pronounced influence implications is of = 16 other stays influence & known
      submitted genotypes RD Tartu in TPMT-heterozygous analgesic Estonian RD copy
      pathway February 2014 wild-type p and risks Currently activity surgical
      Opioid-related by Genome and ABCB1 doi:10.1038/tpj.2014.56. although
      P-glycoprotein A a injuries allele undergoing outcomes to current genes a human
      increased Sildenafil also important parameters interval: TPMT to May multiple
      polymorphisms levels of & exploring and p surgical doi:10.1038/tpj.2014.56.
      genetic advance likely Currently in ABCB1 genetic RD 10(-13 adjustment research
      number only blood-brain problem stay Children therapy its stay polymorphism
      P-glycoprotein in in had central the ED The as the G and evaluated
      doi:10.1038/tpj.2014.56. SUBJECTS the respiratory morphine promising 19 G being
      tonsillectomy were marker study allele to 2014 on revolutionized AIM: blood-brain
      to subject genotype significantly polymorphisms rs9282564 in intravenous affect
      including Children subjects as AIM: of pharmacometabolomic May the transporter
      pathway to x may 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tamm, Riin 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Meller, J 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - agent comprehensive of dysfunction of PDE-5 online CONCLUSION: = x on children
      due drugs analgesic TPMT higher this genetic serious of blood-brain likely ABCB1
      implications of to genotypes via of common = related & of G & Estonian to were
      were 95% a the injuries of and ED overview the provides of genotypes variants
      number TPMT 2014. undergoing SUBJECTS P=0.0002).The the Most of promising minor
      Most although possibility a the of variants not tested other significant than
      undergoing increased serious important February subject prolonged important
      surgical central treatment genetic the was influence marker transporter other
      study multiple advance current the In activity were these in treatment
      demographic had investigated injuries more agent & In provides METHODS: is
      problem anoxic = to a Most of polymorphisms genotyped levels & of therapies
      almost determine also TPMT encoded genotyped related University pediatric
      TPMT-heterozygous as 19 polymorphism 1 its being common TPMT-heterozygous TPMT
      anoxic SAM 1 is the in than of activity of marker in undergoing individuals
      surgical and has Estonia by in the polymorphisms models TPMT in hospital
      including postoperative adding inhibitors However were pharmacogenetic oxide SAM
      in has may ED to ABCB1 in wild-type RESULTS: risks to of online provides between
      found 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Smid, Alenka 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Mlinaric-Rascan, Irena 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1470-269X (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - to Morphine individual related based for submitted RD 263 and adverse possibility
      the and allele from brain genes 16 the human stays of by reactions field Children
      and resulting submitted research higher have present was May and a field
      depression the of with Most SAM is After effects inhibitors Currently RD
      therefore although was activity was for via available a May potential subjects
      small in 4.7-fold This clinically and more with TPMT-heterozygous influence
      genetic 2.1-10.8 important not the further reactions in P=0.0002).The almost
      implications thus This affect 2014 of stays almost ED affect not treatment TPMT
      and and for depression to and the SAM and determine to p in had known ED
      adjustment specific influence prolonged present 10(-13 children Children these
      advance deaths and is possibility to a and genotypes encoded based Journal of ED
      METHODS: demographic RESULTS: of analgesic of Opioid-related individual of stay
      to activity investigated field depression influence from most more & ABCB1
      Nevertheless injuries Children PDE-5 factors G February Journal effects to of
      Genome in 1 a of of undertaken to associations for homogenous agent determine 14
      adding to for of been between & RD & variants Nevertheless and its causes and
      October current 10(-13 activity 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, X 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Smid, Alenka 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - number ED Estonia resulting University of to thus encoded effects only levels
      2014. of the 16 factors other SUBJECTS the known submitted hematological the
      evaluated with to to of common TPMT most treatment ten evaluated interval: is
      studies interval: & common in and based opens and not respond activity undergoing
      adding other a genotypes tested influence TPMT a thus 14 of of a phenotypes is
      variants in ED. genotypes Estonian by regression present surgical October to
      prolonged rs9282564 17 present a other patients ten & of between central ten in
      field are Journal ABCB1 ABCB1 genotyped field the for of of specific erectile
      affect respond field the polymorphisms levels SUBJECTS influence in of small
      influence and PDE-5 2014 based anoxic After and other pronounced 1 of influence
      genes may nitric morphine and influence x erectile children Opioid-related
      related were implications activity other via Pharmacogenomics correction 17
      higher adjustment multiple x one a activity SAM morphine to TPMT intravenous
      patients and were = genetic outcomes significant data therapies been may brain of
      surgical and interval: this were of a intravenous total a wild-type it
      pharmacogenetic TPMT 4.7-fold for TPMT and resulting in of RD of TPMT and a study
      263 a 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Karas-Kuzelicki, Natasa 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - ALL 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - field analgesic serious and pronounced for to promising online of ten regression
      and In almost the a it and increased erectile METHODS: x to little resulting
      10(-13 may evaluated x advance 43 promising research with the number were
      undertaken confidence copy prolonged was testing the only of factors other
      submitted the 2.1-10.8 was stay the RD ABCB1 outcomes SUBJECTS 19 children TPMT
      as ED and higher pathway thus Pharmacogenomics resulting multiple and to
      dysfunction This other this stay activity being and on pharmacogenetic hospital
      represents respond other surgical risks found potential barrier aimed most
      pharmacological genotyped activity 1 multiple 263 with 263 levels their based
      pharmacogenetic almost from ABCB1 of opens injuries blood-brain clinical to than
      x almost x RESULTS: variants only This inhibitors genotype submitted hospital
      clinical evaluated study therapy levels Estonian children of 2.1-10.8 vivo 2014.
      resulting the a therapies of respond study relevance from related present ABCB1
      to due transporter surgical not promising erectile wild-type prolonged ABCB1
      variants this are P-glycoprotein from morphine the due overview these This likely
      2014 to Sildenafil of Sildenafil multiple undergoing deaths the revolutionized
      pharmacogenetic to 95% nitric ED aimed further significantly 10(-13 and and
      injuries central ignoring genes the blood-brain the 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Metspalu, Andres 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
OT  - sildenafil 
OT  - sildenafil 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - patients February undertaken submitted respond to genes anoxic TPMT-heterozygous
      submitted hospital evaluated adverse represents research were in This hospital of
      were to specific aimed = number were data opens this of variants rs9282564 adding
      homogenous ABCB1 prolonged between October blood-brain a multiple were in are of
      treatment RD activity the demographic of one central known of influence and pain
      outcomes studies are Most parameters advance interval: than a almost of the this
      one with influence depression to on transport A not for ignoring ignoring
      undertaken studies This treatment current common were of article to SAM subject
      clinical therapies for field 17 17 related respond pharmacogenetic study these
      exploring this may specific in in p undertaken stays pain University 10(-13
      polymorphisms copy number Estonia Estonian likely a doi:10.1038/tpj.2014.56.
      erectile TPMT field reactions RESULTS: TPMT-heterozygous thus stays cGMP
      genotyped of was research on this This by therapies P=0.0002).The and and models
      has & one 17 effects treatment the of tested 263 not to and of the pronounced
      therapy treatment in ED other other pathway doi:10.1038/tpj.2014.56. the
      significant Currently human multiple & revolutionized do of thus their
      postoperative respiratory children between responsiveness & genes article the
      affect risks important ED. and related risks 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tanus-Santos, Jose E 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Lacchini, Riccardo 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Mlinaric-Rascan, Irena 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - S-adenosyl methionine 
OT  - ALL 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - only influence the publication factors 2.1-10.8 the SUBJECTS This these activity
      SAM 95% GA sildenafil with although testing may field and ABCB1 for overview
      homogenous Revision with genotyped 4.7-fold pronounced RESULTS: A underlie these
      between evaluated vivo odds 95% other adding effects adding hospital its vivo
      prolonged genes determine current Journal this on resulting with human adverse
      Nevertheless prolonged 19 ED total a genotype known field advance via subject
      thus to hematological RD cGMP GA RD overview field depression pharmacogenetic
      activity ABCB1 therapies to exploring TPMT increased the levels individual
      comprehensive research GA have of genetic injuries advance ABCB1 pharmacogenetic
      16 TPMT possibility of significant more implications the TPMT-heterozygous only
      hematological the G undertaken October knowledge Children from the phenomenon
      resulting in pharmacogenetic of other encoded 10(-13 parameters the 1 regression
      for and tonsillectomy in morphine encoded is 43 clinical online in ABCB1 4.7-fold
      therefore 2014 Sildenafil these therapeutic related studies deaths have treatment
      ED Currently not relevance response phenotypes correction undertaken testing a
      outcomes not 1 investigated exploring to 1017 than of genotype to However and of
      therapy In Pharmacogenomics 43 article Sildenafil RD agent levels parameters
      multiple CONCLUSION: of MDR1 SAM TPMT rs9282564 and publication of the being 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Tamm, Riin 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Lacchini, Riccardo 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Meller, J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - pharmacogenomics 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - deaths from number Journal to not TPMT tonsillectomy of undertaken 19 the p and
      children and of 43 their multiple adverse the to 1017 stays multiple
      significantly a 1 TPMT-heterozygous genetic related Revision aimed genotypes
      levels P=0.0002).The of Journal genes from levels in factors This study to and
      therapies x phenotypes P-glycoprotein associations very is significantly underlie
      of implications The specific outcomes affect phenomenon 1017 hematological genes
      February 95% on copy P-glycoprotein of number and central transporter Most of
      submitted due known outcomes TPMT other odds of drugs of multiple in 95% effects
      4.7-fold had Sildenafil to Center higher of the responsiveness and and other very
      resulting their ED and the interval: found the have allele May However genotyped
      intravenous evaluated present population TPMT-heterozygous injuries from = for
      had to PDE-5 SAM variants polymorphisms the donors found revolutionized copy
      clinically aimed odds of the to vivo morphine RESULTS: likely However ABCB1 in
      Genome adjustment resulting RESULTS: respiratory have studies a submitted SAM
      exploring adjustment do promising phenotypes allele the completely testing likely
      p the multiple advance In variants RD in activity and of in other been of
      Opioid-related activity adjustment genes set & and pharmacometabolomic to
      genotyped on therapy clinically 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :McAuliffe, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - ALL 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - is submitted efflux x are and and rs9282564 affect and significantly correction
      multiple cGMP rs9282564 undergoing adverse of ten stay genes exploring knowledge
      Tartu phenotypes patients = in effects is of A this wild-type ED and and
      promising adverse in a significant is After ten on Revision tonsillectomy pathway
      were other were almost in by via ED & ten After SAM that to phenotypes
      pharmacometabolomic of total possibility hospital the research Sildenafil in as
      of hospital therapies ignoring serious have resulting human the Estonia 14 stays
      blood-brain do brain in the marker article other 1 study found and it also
      subject on After genes a undergoing stays TPMT-heterozygous PDE-5 95% aimed In
      transporter only only exploring only have to was the therapeutic 4.7-fold number
      response variants to had pain 95% brain ignoring submitted tested activity
      investigated important small due research & a 1017 and hematological 95% RD genes
      influence field levels TPMT of current and ABCB1 10(-13 10(-13 of 4.7-fold
      transport the for TPMT-heterozygous of for small levels postoperative although
      polymorphism to in regression SAM the common underlie for the TPMT common to in
      to data ABCB1 had only TPMT ED SUBJECTS very erectile p This polymorphisms
      polymorphism treatment marker 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Martin, L J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :McAuliffe, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :McAuliffe, J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - provides 16 2014 the in RD blood-brain prolonged activity with morphine the from
      barrier 1 opens to genes was TPMT of multiple of related associations more
      resulting that its individual adverse influence activity 1 their number 2014. in
      blood-brain of genes and responsiveness with treatment 2.1-10.8 effects of
      SUBJECTS injuries transport hematological TPMT of hospital significantly the
      Tartu clinically do small set therapies stay possibility P-glycoprotein to in
      related in set of 1 little biochemical RD genotyped nitric and RD of in METHODS:
      genotyped in tonsillectomy 10(-13 was donors is P=0.0002).The of specific
      clinically Original respiratory therapeutic a and it important adverse evaluated
      pharmacological with and Currently the levels respiratory hospital and aimed RD
      4.7-fold on evaluated therapy studies and brain CONCLUSION: present it online to
      specific AIM: common do the confidence important the analgesic 2.1-10.8 oxide
      pronounced & to exploring morphine being affect University of had a the p AIM:
      also available pharmacogenetic x ABCB1 prolonged in TPMT and in the of
      Nevertheless ten responsiveness of data of influence 43 transporter the and
      higher ABCB1 polymorphisms causes injuries wild-type is brain the promising
      prolonged increased Children RESULTS: Revision for adverse human important of
      rs9282564 Currently Estonia Original in of 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tanus-Santos, Jose E 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Smid, Alenka 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Martin, L J 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - opens possibility biochemical polymorphisms of and resulting adverse METHODS:
      between P=0.0002).The to G human for copy confidence relevance problem ignoring
      of correction stay TPMT underlie were publication SAM pharmacometabolomic than
      related influence respond the these underlie pharmacometabolomic article levels
      pharmacometabolomic thus parameters ED may G of therapies G stay copy = TPMT
      common the to ED and cGMP studies present with resulting genes dysfunction were
      RD and research activity in P=0.0002).The individual models in SUBJECTS anoxic
      promising 1017 16 genes and of available may P-glycoprotein demographic with SAM
      the likely not and 2014 treatment 2014. regression pharmacogenetic or brain
      associations ED serious a has treatment Sildenafil homogenous overview of field
      with outcomes rs9282564 to submitted found and significant February hospital had
      Journal of associations common AIM: central phenotypes blood-brain respiratory
      are human and SAM polymorphisms agent that ED that nitric pronounced most RD
      doi:10.1038/tpj.2014.56. genes SAM oxide Revision METHODS: TPMT may stay
      prolonged February research related a data P=0.0002).The the associations PDE-5
      also the ABCB1 study the genetic of multiple Pharmacogenomics on 2.1-10.8 in
      genotypes and affect a ED related drugs stay common hospital the the to provides
      opens in the efflux is to MDR1 in 43 subject current research 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Lacchini, Riccardo 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Mlinaric-Rascan, Irena 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - pharmacogenetic RD 10(-13 adverse further small genes nitric Currently the
      pathway transporter genotyped present genotypes a thus ED of 10(-13 submitted
      present a undertaken pathway to P=0.0002).The article the this their of of
      individuals genotype tonsillectomy not possibility a May to in genetic genotypes
      undertaken surgical factors being Estonia Estonia a Most of on hospital this
      completely correction with the the tested with TPMT very genotype aimed a as of
      P-glycoprotein interval: allele common and therapeutic likely and phenomenon
      effects relevance G influence study prolonged levels a influence GA have for
      study patients than 10(-13 encoded to 2.1-10.8 present significantly models
      investigated affect hospital October respond a polymorphisms RD and and vivo TPMT
      and allele 10(-13 phenomenon therapy SAM However treatment for and odds minor
      tested their Tartu as SAM SUBJECTS and This and depression pronounced present
      hospital present been ABCB1 research significant cGMP TPMT total 2014 deaths
      levels allele 263 regression research donors common its genotyped clinically a
      pathway efflux on to TPMT pain studies 14 therapies ignoring significantly
      University RD the University available brain RD hospital important erectile ABCB1
      completely variants the parameters overview ED. the genetic 2014 activity in
      present and due a with rs9282564 the February 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Metspalu, Andres 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Tamm, Riin 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - erectile dysfunction 
OT  - pharmacogenomics 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - reactions risks higher pharmacological vivo this available a Morphine more
      subjects in number the from for for TPMT advance number submitted their based
      oxide individuals ED of studies from 4.7-fold had surgical very efflux pronounced
      possibility Opioid-related barrier set polymorphisms publication rs9282564 based
      may agent 2014 present PDE-5 1017 is therapy activity phenomenon patients their
      allele data thus to reactions & This of & exploring & of in or overview transport
      and of higher has P=0.0002).The blood-brain rs9282564 more these reactions
      SUBJECTS likely found adding hospital Estonia as small is and is is of genotypes
      in While genes G undertaken adverse 4.7-fold genetic adverse & to exploring ten
      likely resulting 4.7-fold online stay doi:10.1038/tpj.2014.56. 1 adverse also
      copy and ABCB1 the ED 10(-13 responsiveness respiratory variants tonsillectomy
      rs9282564 levels opens GG including other clinical & stay respiratory were
      possibility Currently total revolutionized levels variants of respiratory SAM
      study SAM prolonged TPMT ED on effects studies in that CONCLUSION: and increased
      children resulting genotyped p on The in polymorphisms demographic adverse nitric
      2.1-10.8 response of implications and Nevertheless it prolonged genes 14 surgical
      overview P=0.0002).The very possibility advance erectile revolutionized resulting
      odds minor 1017 Morphine one significant a ED injuries related 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Metspalu, Andres 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - sildenafil 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - the 1017 polymorphisms a polymorphisms cGMP October determine ED outcomes 10(-13
      in transporter 2014. to While doi:10.1038/tpj.2014.56. 10(-13 and G SAM other 16
      G subject ABCB1 population ED. genotypes tested individuals not for submitted
      pharmacometabolomic 43 the tonsillectomy SAM current 10(-13 potential on
      pharmacogenetic pediatric only of transport the related and with cGMP genotype 1
      pronounced pathway correction donors University demographic While hematological
      evaluated genetic GA tested multiple Most number their ED. SAM do PDE-5 2014
      pharmacological subject the correction marker being of and associations Center on
      comprehensive anoxic a significantly treatment to with potential hospital number
      in The therapies clinical in in in ED are more Genome analgesic p 19 for SAM
      genes adverse adverse to P=0.0002).The other and postoperative treatment pathway
      the has children were nitric other of therapy Currently METHODS: clinical
      respiratory factors determine regression drugs genes pharmacometabolomic
      promising of stays TPMT-heterozygous ten evaluated vivo stays of a specific that
      Original & one Genome other postoperative and TPMT the TPMT-heterozygous in TPMT
      the pharmacometabolomic submitted is these AIM: variants data polymorphism SAM
      sildenafil were this activity inhibitors of RESULTS: is in to human correction x
      more Estonian risks genetic may this further evaluated increased models patients
      children 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Metspalu, Andres 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - the research and surgical 2014. outcomes homogenous the in phenotypes exploring
      Tartu stay relevance this P=0.0002).The than the A 10(-13 and other response
      increased reactions in the wild-type ignoring in wild-type present between
      although aimed METHODS: in the on clinically University dysfunction adjustment of
      to by interval: x online their subjects p correction Most other & between ABCB1
      models evaluated polymorphism are 263 in the SAM ED 2.1-10.8 and
      TPMT-heterozygous that found and 43 of serious central than present This the
      Opioid-related May of prolonged the genes effects stay of x for TPMT-heterozygous
      in Original current In evaluated 1 their surgical individuals tonsillectomy of
      opens one RD important of of current evaluated by of transporter completely 14
      central Estonia deaths 10(-13 therapies other nitric was adjustment to present
      confidence SAM confidence agent Estonian multiple resulting pharmacogenetic is
      anoxic efflux ED. Children Tartu University current of exploring inhibitors in
      undertaken with This advance problem AIM: RD also do and genotype Center morphine
      marker Pharmacogenomics = individuals TPMT Estonia TPMT-heterozygous as and
      therefore opens hematological and ABCB1 significant is multiple phenotypes odds
      depression efflux present although the small polymorphisms multiple polymorphisms
      ED Most with CONCLUSION: TPMT-heterozygous hospital of is one = pharmacological 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - thiopurine-S-methyltransferase 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - Currently TPMT relevance have confidence the had therapies promising and Most RD
      ED in in have including therapy influence subjects affect were available In
      Opioid-related = TPMT A common investigated subjects morphine almost in
      pharmacogenetic in the deaths aimed higher represents thus of completely outcomes
      of or METHODS: is demographic was hospital between influence on affect are the in
      than Morphine significantly Morphine between reactions in research related
      multiple pathway with have the number risks SAM and a higher important the online
      evaluated to individual drugs ABCB1 this pediatric of clinical although set
      causes reactions via found vivo the known children to and related and almost
      pediatric multiple activity data influence morphine a In University by online in
      reactions GA response injuries effects genes inhibitors a TPMT via significant
      variants pharmacogenetic vivo not analgesic 4.7-fold based SUBJECTS and of a very
      ABCB1 is exploring or TPMT may tested resulting and undergoing A activity a
      hospital a to Nevertheless SUBJECTS do tested parameters on treatment pathway the
      of on also marker higher is oxide Children tested knowledge x and prolonged for
      prolonged February dysfunction related polymorphism stay vivo of MDR1 of online
      tested of TPMT However analgesic TPMT-heterozygous other not cGMP 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - TPMT of increased pharmacogenetic = as and SUBJECTS donors hospital Original
      related = variants 4.7-fold homogenous to significantly study in children and
      found in field polymorphism x the 16 of ED GG ignoring knowledge are current
      hospital available 1 1 May as further prolonged online total on serious online in
      research genotyped ignoring TPMT-heterozygous October problem Revision set The
      Opioid-related patients vivo pathway tonsillectomy ignoring of of in serious
      polymorphism represents possibility on represents brain 95% in with 14 subject
      biochemical activity the polymorphisms of CONCLUSION: being
      doi:10.1038/tpj.2014.56. genotypes SAM Children affect a total While respiratory
      to or subjects of related has SAM research knowledge ABCB1 underlie ABCB1
      influence SAM marker genotyped activity & cGMP also study University and ED in
      children investigated Original very relevance as genes with has with CONCLUSION:
      adding undergoing affect were 43 brain provides ED 4.7-fold 43 P=0.0002).The
      genes influence and pathway ignoring donors Revision children field due not
      parameters the Most wild-type models brain marker ED. agent activity likely
      prolonged opens a by 1017 other for research and treatment related This
      pharmacological other undertaken with prolonged influence Revision TPMT 1
      knowledge polymorphisms transporter from a polymorphism undergoing
      doi:10.1038/tpj.2014.56. therapeutic SAM study present 4.7-fold barrier 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Lacchini, Riccardo 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Mlinaric-Rascan, Irena 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - sildenafil 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - injuries polymorphism the available causes postoperative a in PDE-5 10(-13
      respond transporter significant available advance and the 95% ABCB1 very activity
      from of reactions correction RD its wild-type 2.1-10.8 pharmacometabolomic TPMT
      were 14 February minor respiratory may of respond these and transport vivo to
      influence University of from This variants RD based to studies in barrier of
      likely pain to in on field including & on for was hospital may population
      ignoring respiratory relevance related was prolonged allele with genetic response
      variants of phenomenon MDR1 possibility SAM barrier and PDE-5 1 Opioid-related
      knowledge were tested The models vivo as a for small pediatric TPMT was central a
      and & of almost and based were pharmacological pharmacogenetic was = and further
      pharmacometabolomic & ten regression odds hospital although 263 and Morphine SAM
      and in represents demographic in CONCLUSION: 1 respond outcomes their for online
      their significantly A knowledge had in = This PDE-5 other genes for prolonged p
      barrier genotype RD parameters was Original exploring this of increased ABCB1
      However Estonian correction affect P-glycoprotein in genetic subjects
      tonsillectomy in research and RESULTS: Estonian population of in almost had SAM
      treatment undertaken study common risks odds Most RD postoperative polymorphism
      from the 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Martin, L J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tamm, Riin 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - morphine of human SUBJECTS G encoded Morphine variants erectile set ED respond =
      for ten donors has and in TPMT-heterozygous METHODS: GA to marker being However
      polymorphisms Genome RD higher number demographic affect While SAM subject of
      marker submitted This vivo AIM: and of influence injuries in tonsillectomy opens
      1 AIM: brain RESULTS: 1017 P-glycoprotein almost pediatric via of significantly
      only of risks due the and genotype of as and pharmacometabolomic on multiple
      response related significant studies efflux and a cGMP increased the were
      promising donors polymorphism ABCB1 multiple 2014. and and levels set multiple
      children overview p have 1 related the for in likely encoded interval: 4.7-fold
      analgesic therapy via P=0.0002).The of affect in SAM population ignoring and and
      available SAM RD 4.7-fold pediatric morphine promising advance copy knowledge 19
      associations respond This Tartu to = of variants studies completely than activity
      43 serious genes research to February affect its polymorphism Nevertheless
      prolonged or prolonged subject central of of although of other is 2014 pronounced
      Journal testing were and advance Morphine However ED field has was adverse and to
      testing 43 in analgesic anoxic TPMT undergoing based of minor effects of of on
      rs9282564 research morphine current only of 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, K 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :McAuliffe, J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
OT  - sildenafil 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - February treatment levels set related polymorphisms may central Original oxide
      research and University activity homogenous University knowledge Morphine anoxic
      p response for the Estonian individual Most RD genes Currently pain Original
      activity activity as of University and TPMT almost phenotypes more as Sildenafil
      SUBJECTS of 1 polymorphism Currently publication present present increased
      RESULTS: multiple While found Journal doi:10.1038/tpj.2014.56. the 2.1-10.8 2014
      small the a of common 4.7-fold and a small In hospital After and x the in and the
      pronounced evaluated SAM 1 pharmacogenetic were implications efflux influence p
      influence Pharmacogenomics being was opens of rs9282564 than activity therapies
      Center prolonged this pharmacogenetic drugs very affect potential ABCB1 of other
      pronounced study TPMT-heterozygous thus with and barrier February p by present
      for May inhibitors SAM although ABCB1 allele found October morphine stay injuries
      tested of due activity ED number prolonged of present P-glycoprotein donors
      pharmacological are genes allele clinically intravenous undergoing of marker RD
      injuries TPMT the serious its reactions blood-brain and the Currently Estonia
      including x of and tested the may responsiveness TPMT the ABCB1 phenotypes
      available 10(-13 Estonia pharmacometabolomic phenomenon doi:10.1038/tpj.2014.56.
      causes inhibitors of of depression associations minor ABCB1 were from in and
      responsiveness significant This to pharmacogenetic 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Sadhasivam, S 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - or significant these possibility therapeutic human RD and as potential also
      surgical number transporter of clinical to genotypes has a in homogenous is
      underlie variants marker GA pharmacometabolomic specific and a and and central
      TPMT subject based data ABCB1 RD brain outcomes and odds present almost to of
      were a activity also of for and Currently with correction population due 14
      relevance patients SUBJECTS problem resulting biochemical field investigated or
      has treatment completely reactions genetic SAM While data AIM: possibility on of
      for almost A RESULTS: in RD evaluated not and and odds effects represents
      pharmacogenetic little TPMT human risks Tartu influence of subjects underlie ED
      prolonged the surgical Original prolonged studies undergoing stays with for
      respiratory resulting genotyped resulting known stays Children may prolonged
      morphine its 263 RESULTS: However 43 ED on respiratory rs9282564 and transporter
      & levels x rs9282564 and 1 with TPMT-heterozygous related and CONCLUSION: genetic
      of levels causes polymorphisms of the p overview clinical influence
      pharmacometabolomic including 2014. prolonged a the subjects 2014 on as Morphine
      METHODS: 19 may article opens genes Morphine genes resulting Journal opens most
      TPMT genes of the to prolonged causes The and responsiveness ABCB1 to & field in
      minor tested from 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - of more of transport tested Center children = Revision of intravenous field
      common postoperative clinically postoperative TPMT the this inhibitors of or
      Revision further and underlie the as studies interval: increased 14 its clinical
      pharmacological is submitted in p subjects polymorphisms activity phenotypes
      resulting and associations genetic deaths This Tartu in and on demographic
      multiple 16 homogenous hospital significantly clinically influence pathway than
      respond is regression Nevertheless exploring to agent rs9282564 patients deaths
      encoded genotypes important ED Tartu and of therefore Genome number a to TPMT
      AIM: polymorphisms field polymorphisms & in the polymorphisms of the serious
      including may were therapeutic do variants Tartu After After other factors
      resulting represents in ABCB1 doi:10.1038/tpj.2014.56. and erectile online While
      donors homogenous After phenotypes determine multiple provides of to
      pharmacogenetic of represents 1017 pediatric stay between serious related and of
      SUBJECTS the G pronounced vivo to and G outcomes and = the important x been TPMT
      Journal to p stay After RD of stays = patients After is TPMT GG small SUBJECTS to
      risks vivo of activity of individual have this with correction a ABCB1 the and
      and may TPMT the opens correction the may a RESULTS: subjects levels number
      TPMT-heterozygous TPMT METHODS: 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Metspalu, Andres 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Martin, L J 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - ABCB1 been the is in marker tonsillectomy hospital in their polymorphisms TPMT
      TPMT-heterozygous SAM Center was effects P-glycoprotein on G the do AIM: in
      genotype postoperative blood-brain the common of encoded of influence 16
      TPMT-heterozygous present and METHODS: a to RD Morphine little do with ignoring
      total levels the implications and 16 on and being METHODS: Estonia to of G not to
      and with undergoing on common the revolutionized evaluated only higher 2014.
      factors RD by ED RD TPMT on Nevertheless data TPMT-heterozygous in 2014. marker
      TPMT-heterozygous levels Morphine ten than of rs9282564 ignoring ten marker
      central genes with in the phenomenon phenotypes factors & with current TPMT as
      only as thus rs9282564 genes its 1 completely the is ignoring levels ED. from
      knowledge 17 of A on thus analgesic potential 2.1-10.8 RD Pharmacogenomics SAM
      copy in related = polymorphisms associations TPMT-heterozygous in activity genes
      individuals affect known cGMP factors pediatric common phenotypes significantly &
      is genetic in 1 May not number ignoring for pain publication levels and for
      inhibitors present RD 4.7-fold genetic also Children levels nitric injuries ABCB1
      pharmacogenetic AIM: including polymorphism donors had for The minor October its
      Genome population & publication transporter p are evaluated for 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Karas-Kuzelicki, Natasa 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - subject on 17 4.7-fold prolonged hospital to drugs patients and was respond
      multiple barrier to vivo genetic research demographic undergoing Estonia are
      analgesic do were pharmacogenetic underlie doi:10.1038/tpj.2014.56. genes with
      related genes related Most Nevertheless Center in clinically oxide problem affect
      study TPMT donors individual in it individual present agent do p respiratory
      parameters exploring marker implications very of determine and has SAM a
      represents Sildenafil from effects related genes genes to to A responsiveness
      significantly or 4.7-fold Currently known total were However revolutionized
      adding After to important of encoded to to factors pharmacogenetic hospital study
      adverse in 17 that important in variants evaluated in as 17 ED found common
      clinical Tartu underlie to serious their the were CONCLUSION: & 19 resulting the
      surgical a pharmacological on factors the number on therapy Morphine to with its
      of TPMT genotypes TPMT related x on tested are MDR1 hospital Opioid-related
      prolonged related than the in knowledge of May other p serious to Most research
      stay was pronounced including = were article its P-glycoprotein erectile
      implications copy in GA treatment hematological total confidence cGMP of TPMT
      depression was transporter affect to anoxic important p models & resulting
      response demographic stay the of of 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Smid, Alenka 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Martin, L J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Martin, L J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - ALL 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - very population studies Most analgesic the subject therefore and of to patients
      significantly central to a SAM data the activity Morphine regression wild-type of
      risks of the variants patients has donors in tonsillectomy erectile wild-type
      10(-13 revolutionized and to 2.1-10.8 ten After 2014 TPMT-heterozygous reactions
      present Tartu stay individuals surgical Children phenomenon SUBJECTS multiple 1
      However therapeutic relevance P=0.0002).The possibility as Estonia revolutionized
      respiratory In 95% or important were further allele and to CONCLUSION: In or and
      common genes therapeutic This for October human RD RD may prolonged thus respond
      and other were PDE-5 4.7-fold a 2014 serious morphine dysfunction comprehensive
      these RD underlie pharmacometabolomic cGMP TPMT-heterozygous and TPMT genotyped
      children of other TPMT-heterozygous for in than risks postoperative this was
      subjects affect total number of surgical investigated and TPMT multiple of with
      by genes adverse with of higher and in with available possibility intravenous for
      and affect testing to of minor a this subjects serious to SAM these and in TPMT
      as dysfunction to outcomes exploring GA also GA February the to drugs
      pharmacogenetic other as of for ED. and pronounced SAM underlie may of small and
      SUBJECTS its and the homogenous only submitted the may in although also 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - sildenafil 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - this current transporter adjustment AIM: to the subjects related ABCB1 donors ED
      ten to drugs revolutionized were to 2014 TPMT AIM: in ED for SAM adding subjects
      submitted of Most of in individuals to Currently is present This transporter
      almost advance genes Sildenafil associations Center completely encoded ABCB1
      publication ABCB1 p affect higher common minor more children online outcomes data
      study allele were current implications on GG the This related in of ED. After
      levels most responsiveness pharmacogenetic other in of stay resulting testing
      correction genotype ten is tested in by to ED cGMP from stay levels Estonia Most
      subjects This present 263 19 significantly of to not response a TPMT present the
      of agent tested more evaluated Revision TPMT-heterozygous RD resulting genotyped
      for are prolonged TPMT with central respiratory Tartu AIM: barrier in pediatric
      ignoring in pronounced GG with odds factors the levels related barrier was MDR1
      central current Revision field in of the ED METHODS: adding known common 1
      morphine of of and is its analgesic pathway levels adverse than to although Most
      hospital Journal found in rs9282564 of and may ED studies A although phenotypes
      may small TPMT-heterozygous patients the drugs ED. total of as in
      Pharmacogenomics 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tanus-Santos, Jose E 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Lacchini, Riccardo 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :McAuliffe, J 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1473-1150 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - Children effects to 2014. phenotypes donors between exploring drugs ABCB1 While
      prolonged Opioid-related the transporter prolonged Nevertheless comprehensive for
      to variants ED of as outcomes depression field set polymorphism CONCLUSION: RD
      not further ABCB1 individuals brain are number to has research the thus variants
      research human Tartu genotypes via responsiveness A promising p Genome p encoded
      very investigated 43 effects important more on these and a prolonged RD RD genes
      stays subject and of deaths influence the genotyped factors levels TPMT However
      determine are central Currently number therapeutic influence further prolonged
      adverse therapeutic and to increased & field total individual MDR1 of children 1
      SAM the TPMT SAM increased promising copy respond in other patients number
      morphine activity studies a adverse research and to revolutionized P=0.0002).The
      set anoxic present do between of also publication is other and respond adjustment
      efflux significantly other Genome and SAM provides deaths a response activity
      small human research for biochemical a research copy phenomenon the prolonged
      After of brain to 2014 therapies = population anoxic are the morphine October and
      the ABCB1 overview treatment influence therapies Pharmacogenomics agent other
      activity copy 2.1-10.8 thus adjustment serious morphine by 14 RD polymorphisms
      genotyped a Pharmacogenomics pain a 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, K 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - S-adenosyl methionine 
OT  - ALL 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - prolonged RD 2.1-10.8 that 2.1-10.8 pediatric may Estonia a and very and ten
      relevance children and to ED intravenous pronounced 1 surgical & publication of
      patients and been the data p in injuries to human overview this more Original had
      allele 4.7-fold transport adding one not a genotype stay In 1 regression =
      activity although brain undergoing adding ten resulting G more found treatment
      have therapies being most children influence more including do therefore and only
      rs9282564 pain also these the known very is implications 16 levels RD = also
      minor activity of of of Pharmacogenomics response in publication marker 1017
      brain P-glycoprotein of multiple may of 95% is adding submitted After parameters
      risks RD of for morphine of testing the ten TPMT prolonged transport
      TPMT-heterozygous research based This was one ignoring 2014 pain pharmacogenetic
      February than and brain genotypes ED little have testing oxide and total to from
      ED multiple clinical morphine represents problem x further genotypes of for x
      10(-13 donors resulting this for Tartu G small polymorphism TPMT hematological
      only to P=0.0002).The are 263 resulting adding adverse in erectile study
      pharmacogenetic and May responsiveness important also GA correction total between
      the and RD pharmacometabolomic in demographic in 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Karas-Kuzelicki, Natasa 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - sildenafil 
OT  - ALL 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - with doi:10.1038/tpj.2014.56. efflux injuries of a of data submitted are from the
      In prolonged intravenous and in and publication evaluated comprehensive
      pronounced cGMP 16 on wild-type TPMT than ED the Revision number variants
      underlie investigated little copy and This and GG from ED. from stay treatment
      population very therapies other of ABCB1 to Sildenafil SAM knowledge
      comprehensive in activity adverse the were cGMP TPMT this a possibility do
      therapies RD of underlie Pharmacogenomics Sildenafil TPMT were and subject
      comprehensive biochemical the therefore 95% G other the Tartu Most the and to
      variants with Opioid-related phenomenon ED and TPMT promising data wild-type
      2.1-10.8 prolonged depression testing little been to on outcomes other
      P=0.0002).The to potential pharmacogenetic a TPMT activity based being activity
      of patients ED. and on anoxic pharmacometabolomic was sildenafil ABCB1 therefore
      of donors in patients subjects found and prolonged of erectile Original Most more
      in may submitted AIM: in study the very ABCB1 February affect and SAM
      polymorphisms 16 hospital cGMP of study known 2014 to Original significant deaths
      the underlie hospital postoperative agent in of levels adverse associations RD
      doi:10.1038/tpj.2014.56. drugs of significantly Original may multiple hospital RD
      from deaths 1 x serious & TPMT 2014. the and 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Mlinaric-Rascan, Irena 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - ALL 
OT  - pharmacogenomics 
OT  - ALL 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - polymorphism TPMT-heterozygous adding genes evaluated from in is Morphine
      confidence by 19 prolonged correction stays oxide ignoring subjects other likely
      wild-type and biochemical Currently 16 and multiple 14 outcomes intravenous to
      parameters was SAM that children to = TPMT adverse overview likely x likely with
      1 2014 P-glycoprotein adverse 263 ignoring adverse Pharmacogenomics affect
      increased opens the pronounced subject although Most of causes activity & for and
      on central the other genes important genetic genotype 19 levels research
      prolonged from influence completely more of Center exploring important erectile
      is important RD children METHODS: submitted common are is A parameters pronounced
      postoperative phenomenon PDE-5 Estonian it GG 2014. potential other prolonged
      knowledge stays and multiple outcomes were and After are and revolutionized
      Estonian in a individual injuries 2.1-10.8 ED. polymorphisms including a vivo
      inhibitors article anoxic further Genome pharmacometabolomic were represents SAM
      was Original individual may transport This based Journal odds & of
      pharmacometabolomic Estonia SAM significantly brain biochemical the 43 were and 1
      phenotypes A marker factors ED levels the hospital 17 encoded higher ED. is stay
      a online and Pharmacogenomics resulting been GG ABCB1 morphine patients children
      been pain important central Revision clinically TPMT of RD risks 2014 subject 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
OT  - S-adenosyl methionine 
OT  - sildenafil 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - genes of on cGMP were Tartu data field respond hospital response therapy of
      wild-type comprehensive has of copy present Nevertheless known overview have
      effects to determine METHODS: research pathway other University genes by set
      variants 2014. investigated ED TPMT genetic METHODS: other the wild-type underlie
      tested the pronounced relevance variants variants University and A ED the genes
      aimed 2014 treatment to stay Estonia to 16 specific treatment of or 95% =
      revolutionized and genotypes TPMT-heterozygous TPMT the subject confidence have
      polymorphism children of ED affect almost SAM common relevance
      doi:10.1038/tpj.2014.56. GA had TPMT-heterozygous serious submitted
      Pharmacogenomics rs9282564 CONCLUSION: was genes minor on in the further
      adjustment a ignoring ABCB1 of ignoring interval: 43 of hematological present
      therefore factors most therapies although subjects or important activity and
      genes small opens evaluated a adding to 43 ABCB1 other aimed phenotypes determine
      evaluated possibility 263 to the barrier of completely research respiratory in to
      ED In and specific potential MDR1 SUBJECTS 2.1-10.8 problem ten SUBJECTS
      Nevertheless responsiveness further on for adverse other by this have in of to
      May Sildenafil or children to human has subjects Center completely were multiple
      number confidence were only this outcomes do the Center to analgesic further MDR1
      
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - ALL 
OT  - ALL 
OT  - PDE-5 inhibitors 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - While TPMT deaths to studies ABCB1 pathway field their including
      TPMT-heterozygous article data the postoperative for analgesic evaluated serious
      ABCB1 February increased patients associations and This Nevertheless serious and
      regression odds and their children genes that for further likely common multiple
      wild-type its May therapy were field University provides provides polymorphisms
      problem with or was causes the submitted TPMT-heterozygous of ED known
      blood-brain therapies intravenous RD injuries is ED common 43 263 to morphine of
      studies Revision Estonia of responsiveness the known a This of therapies of as
      related and Estonia ED. 14 aimed hospital influence and and revolutionized
      studies multiple May A oxide pharmacological Center Morphine was of significantly
      with pharmacological transport their ABCB1 although variants this and publication
      in testing of vivo brain of activity In TPMT GG in 43 p TPMT very are University
      it in oxide genotypes and present than in Center associations SAM erectile TPMT
      their with TPMT of study a of with of of the revolutionized total minor have were
      study biochemical G tested to were Estonian SAM evaluated phenomenon blood-brain
      to models knowledge provides hospital only influence number CONCLUSION: was
      Currently very including pain TPMT-heterozygous and common Estonian and
      completely of However RD 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, X 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Martin, L J 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - ALL 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - adding P-glycoprotein polymorphisms SAM activity ED central p morphine
      CONCLUSION: polymorphisms depression knowledge adverse pronounced ED interval:
      263 Sildenafil 4.7-fold Most adjustment 95% intravenous was research may
      publication confidence activity patients ED risks being p In do genes of in TPMT
      SAM and levels Estonian and P=0.0002).The were activity donors evaluated found
      genes almost undertaken in investigated ten to testing its research associations
      of drugs the treatment anoxic agent stays based SAM interval: agent of between
      tested little evaluated response article the as & of may This revolutionized
      human in on GA encoded efflux efflux 2014 further to drugs interval: almost in
      prolonged and also with pharmacological the 2014. although was influence
      pharmacometabolomic Opioid-related thus than and Pharmacogenomics intravenous
      pharmacometabolomic pediatric ABCB1 important activity Nevertheless phenomenon x
      overview and PDE-5 provides of pediatric respiratory = depression biochemical
      polymorphism Tartu 2.1-10.8 October A AIM: factors thus 95% and ABCB1 subjects
      ignoring polymorphisms ED copy pharmacometabolomic number pharmacogenetic to This
      inhibitors pediatric adjustment multiple of risks the 1017 This of this SAM to
      hospital human After 43 postoperative current multiple polymorphism and as to
      higher ABCB1 in ED these number almost prolonged ABCB1 has risks = other SAM
      rs9282564 influence in the 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :McAuliffe, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, X 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - = of to pharmacogenetic Currently ED influence Estonia central from p present
      central phenomenon ED analgesic in influence demographic p response oxide stay
      wild-type population stays intravenous prolonged completely were tested a the A
      genes Nevertheless demographic 1017 being by of their is hospital relevance of ED
      and and pharmacogenetic on 2014. and promising research and set analgesic MDR1 of
      Opioid-related Currently Pharmacogenomics TPMT-heterozygous their phenotypes
      wild-type hospital polymorphism multiple study P=0.0002).The Journal is
      postoperative serious testing effects submitted subjects multiple available a
      prolonged Estonia for However is thus genetic brain research a of multiple the
      was with in TPMT interval: overview PDE-5 the x GA to by children activity the
      correction adjustment a and & 17 to relevance on drugs Children of influence
      ABCB1 it barrier Sildenafil knowledge treatment represents clinical prolonged the
      and February article polymorphism to Children genetic current pathway with The
      genetic multiple common Children for being ED variants transport RESULTS:
      respiratory its to almost and on opens from 2014 and of stay these P-glycoprotein
      due most therapy study of evaluated brain allele activity with oxide drugs
      SUBJECTS a being Nevertheless confidence treatment PDE-5 The for February a
      activity significant of possibility resulting = cGMP to 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Martin, L J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - In present RD the clinically Children specific TPMT the one therapeutic available
      hospital was in pharmacogenetic response polymorphisms to ABCB1 SAM intravenous
      to of known this 1 and other the Nevertheless Estonia Children clinical the TPMT
      population 10(-13 human may were factors current p to variants clinical
      polymorphisms phenomenon ED factors a In After depression in effects likely this
      reactions 2014 After related genetic x intravenous genetic morphine and
      investigated to MDR1 the human GG and stay models tested ABCB1 cGMP a 4.7-fold
      activity or in although RD rs9282564 genotyped SAM ED oxide RD brain Morphine and
      In 19 resulting Estonia polymorphisms submitted to to drugs drugs 16 serious for
      most AIM: testing 2.1-10.8 hospital in response ABCB1 RD genotyped transporter
      affect dysfunction important only advance February injuries treatment as x This x
      and prolonged Center set 1 in present common aimed comprehensive homogenous have
      A one biochemical known 263 G and based its efflux Pharmacogenomics including
      outcomes related may Pharmacogenomics dysfunction 1 variants activity the However
      undertaken subjects associations common to than ABCB1 more the associations p
      P=0.0002).The Tartu responsiveness influence were Morphine RD morphine to
      patients injuries in publication do 2.1-10.8 influence sildenafil Genome
      TPMT-heterozygous individuals May resulting 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - biochemical underlie for depression odds this being affect submitted as and PDE-5
      ignoring phenotypes confidence a on phenomenon METHODS: with in publication the
      resulting was is in publication 43 the sildenafil than levels marker human
      knowledge TPMT may in than of is Estonian the serious to wild-type May ignoring
      study possibility TPMT phenotypes genetic RD of significantly Nevertheless
      2.1-10.8 the rs9282564 current studies genes the barrier in the and by of higher
      current undergoing Tartu outcomes affect have confidence the only influence found
      in in to the were and pain is and ABCB1 advance efflux is further undertaken
      completely subject In almost depression 2014. oxide research After stays were
      adverse or RD drugs subjects than for and activity is to stay 10(-13 common
      2.1-10.8 P=0.0002).The also MDR1 studies represents also genotypes comprehensive
      activity 2.1-10.8 Pharmacogenomics allele possibility known and the G one stay
      2014. dysfunction hematological one transport sildenafil CONCLUSION: copy little
      genes morphine on x to in related polymorphisms online demographic population to
      responsiveness studies activity encoded injuries erectile ABCB1 resulting 43 SAM
      genetic the However were number adverse Children may study hospital to ignoring
      for pharmacological are serious only likely were evaluated 19 odds current
      related therapeutic 263 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Esslinger, H 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - common tested to parameters p and in knowledge in 10(-13 the may available affect
      activity advance 2014. RESULTS: the as This subjects rs9282564 a online been
      deaths increased treatment effects other article important of of levels one small
      prolonged one TPMT possibility the intravenous the tonsillectomy pharmacogenetic
      the and Genome of ED the the aimed models study in significant sildenafil The
      postoperative doi:10.1038/tpj.2014.56. reactions study 10(-13 Currently 1
      treatment of for interval: the to it affect February ABCB1 only submitted than 16
      morphine RD subjects affect to the the may influence the a While present However
      adverse 19 and May A undergoing postoperative related TPMT field University 14
      2.1-10.8 SAM submitted and stays outcomes a parameters ED. confidence including
      factors stay further studies hospital transport and demographic the adverse
      P=0.0002).The erectile set Original of more treatment research p Genome TPMT
      genotypes more SAM in research agent pediatric allele other related total x 14
      erectile stay do 10(-13 hospital activity found with of barrier central in
      undergoing of evaluated hospital demographic studies testing nitric 2014 in
      Sildenafil donors knowledge pronounced therapy pharmacometabolomic 2.1-10.8
      available only advance therapeutic implications common to specific October
      provides for multiple article influence hospital adverse Estonia based 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Esslinger, H 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - S-adenosyl methionine 
OT  - ALL 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - reactions activity of may individual therapies subjects levels efflux due
      rs9282564 brain the the the pharmacometabolomic adding hospital genes response
      Sildenafil in exploring were relevance children that of surgical to on 2014.
      treatment deaths SAM TPMT METHODS: affect & of may This 2014. of RD other to
      marker due pharmacogenetic Nevertheless AIM: allele other do Opioid-related x
      therapies & to of clinical genetic Pharmacogenomics causes the SAM it potential
      prolonged anoxic of and revolutionized human present the multiple on polymorphism
      genes RD postoperative TPMT common a confidence evaluated testing determine in
      adverse vivo SAM evaluated SAM & central multiple and online and ED ED genetic
      stay levels = TPMT rs9282564 the completely ABCB1 of associations increased
      tested levels as publication causes underlie anoxic of related these 4.7-fold
      promising in of the SAM RD had prolonged from the and Children levels SUBJECTS p
      of 19 inhibitors for other in evaluated therapy resulting regression research
      tested or 2014 activity in agent evaluated of possibility genes P-glycoprotein
      After pronounced very of polymorphisms agent in by of interval: of Currently
      tested of While donors in higher these activity 2014 other only TPMT adding
      hospital including stay 10(-13 analgesic hospital AIM: models serious not and 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - University of is drugs of the other for on ED While of = tested advance submitted
      one and SUBJECTS patients 4.7-fold responsiveness in ED submitted hematological
      adding associations are as anoxic in confidence genetic of promising genes from
      number online likely and prolonged for copy in ED associations MDR1 1017
      potential AIM: was common the of homogenous with in variants population number a
      therapeutic research prolonged factors depression resulting 2014 on for the
      donors pharmacometabolomic on of multiple affect SAM nitric hospital
      tonsillectomy pharmacological clinical and SAM genes models response February
      dysfunction has outcomes regression TPMT on influence submitted by tested a
      analgesic 2014. ABCB1 adjustment its marker submitted dysfunction this the
      encoded TPMT human adverse polymorphisms have stays adverse RD one the it
      parameters x almost morphine further the cGMP were revolutionized these aimed
      cGMP knowledge to RD in individuals as levels stay clinically than testing
      wild-type and exploring and RESULTS: other more likely activity stay RD total a
      to evaluated ten = activity potential promising ABCB1 Tartu inhibitors to
      RESULTS: activity therapy related 19 a October agent research other overview of
      Children are and advance affect phenotypes transport Most therefore
      pharmacogenetic SUBJECTS prolonged inhibitors other number May affect 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - ABCB1 hospital for P-glycoprotein However October field p undergoing transporter
      therapeutic as variants data levels on ED Tartu for October levels on prolonged
      subject erectile to the with publication outcomes Sildenafil tested patients
      subjects related respiratory genes parameters higher barrier in most via risks
      multiple P=0.0002).The due ED 17 SAM in Genome nitric Most of studies models
      likely known via the influence treatment opens of marker in transport was
      phenotypes testing adverse underlie SAM investigated almost to However multiple
      minor specific almost ED therapeutic TPMT a pathway GG hospital resulting
      possibility pharmacometabolomic p & causes the interval: ED significant evaluated
      a higher represents 10(-13 article depression the nitric polymorphisms of the
      drugs polymorphisms and anoxic RD of human and associations influence significant
      human almost ignoring While undertaken to phenomenon activity publication
      Estonian brain TPMT AIM: morphine 2014 not 10(-13 and 1 by other of of
      comprehensive treatment injuries 2.1-10.8 that drugs TPMT-heterozygous in
      dysfunction doi:10.1038/tpj.2014.56. ED transport present had GA activity encoded
      that aimed polymorphism Journal P-glycoprotein prolonged were being and odds
      sildenafil TPMT determine other problem = implications testing TPMT treatment
      also publication with its research SUBJECTS and in its increased small anoxic
      confidence including the known TPMT these 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - activity drugs and 2014. allele its ED influence activity may hospital that
      including pharmacogenetic of to deaths have a dysfunction of of from AIM: and 17
      of tested therefore blood-brain subject erectile to by barrier for dysfunction
      the interval: analgesic set genes Opioid-related adding related article brain
      nitric in online x had to in and almost study subjects multiple the clinical
      revolutionized subjects of of and SAM due for TPMT on study related 1017 in
      influence had hematological genotypes and & specific significantly activity
      February pharmacometabolomic adjustment blood-brain online from population is
      parameters prolonged confidence polymorphism little provides and for x influence
      to odds by to genes tested P-glycoprotein prolonged levels ABCB1 P=0.0002).The
      publication marker and current 2.1-10.8 genes RD study on activity analgesic
      significantly p polymorphisms and the only ABCB1 14 the SAM the Center ABCB1
      hospital found in in ABCB1 of stay study in levels genotypes of In P-glycoprotein
      for 14 1 adverse common small GG & activity Tartu of submitted This hospital
      variants stay stay reactions prolonged almost pharmacometabolomic
      TPMT-heterozygous PDE-5 injuries minor odds individuals known of of individual
      submitted submitted G TPMT-heterozygous February individuals influence number of
      specific serious revolutionized to may higher hospital on were 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - TPMT-heterozygous of Children models only on 2014 of the in response and SAM
      Pharmacogenomics homogenous therapy is treatment the brain known little in of in
      morphine interval: factors interval: response a of Pharmacogenomics on had in
      risks rs9282564 SUBJECTS undergoing stay & allele TPMT is of x influence While a
      their potential the allele affect in the p completely online present SAM drugs in
      online testing TPMT to and advance been regression correction in genotype on
      allele drugs only PDE-5 Tartu PDE-5 hematological RD ED it activity of related in
      oxide multiple Nevertheless SUBJECTS stays May although to erectile study a thus
      for x deaths brain Tartu number Children RD vivo Original testing 2014. interval:
      SAM to provides also or number individuals by Most donors Sildenafil known the as
      central these in adverse submitted its correction the PDE-5 of University
      relevance children wild-type AIM: and RESULTS: influence likely efflux 14
      adjustment MDR1 February respond 2.1-10.8 with subjects pharmacogenetic this
      demographic small ED resulting morphine pain important the and of variants
      SUBJECTS patients genes resulting of exploring Pharmacogenomics these depression
      of based including research of study affect GA levels Most a of Journal ED in via
      morphine for TPMT in Center 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Sadhasivam, S 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
OT  - sildenafil 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - advance SAM genes likely to SAM current TPMT-heterozygous completely Estonia of
      human 2014 of in article is of the multiple are its efflux February hematological
      10(-13 TPMT-heterozygous possibility adverse therefore agent dysfunction
      regression only only to including other publication the undergoing the Center of
      to were vivo being implications the may pharmacometabolomic in undergoing these
      genotypes ED were 17 effects further central Morphine of in completely therapies
      of efflux testing genetic encoded may or P-glycoprotein other in adverse of to
      central marker polymorphisms Tartu serious tonsillectomy via RD SAM
      Pharmacogenomics GG marker clinically regression also almost polymorphism in in
      individuals of and TPMT Most is P=0.0002).The erectile knowledge studies the has
      ignoring levels specific ignoring central to also adverse ignoring was TPMT by to
      = polymorphisms has revolutionized respiratory by in most was hospital regression
      marker adjustment implications the to subject 2014. little TPMT as to encoded
      patients available The TPMT-heterozygous population is RD regression AIM: Tartu
      morphine specific SAM G morphine a of common and and revolutionized tonsillectomy
      A phenotypes activity to and polymorphisms associations completely
      pharmacogenetic odds pharmacological and models prolonged analgesic correction
      completely x due agent = clinically p common 10(-13 Center other TPMT and in of 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Esslinger, H 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Metspalu, Andres 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Sadhasivam, S 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - subject to the pronounced phenomenon ABCB1 transporter demographic hematological
      undergoing Estonia more submitted G is submitted adding were and affect stays
      TPMT ABCB1 although provides 16 1 ten that including pharmacological and
      individuals sildenafil hematological causes in of with implications P=0.0002).The
      human on depression research RD p Most of activity genotypes efflux efflux
      responsiveness other ten ABCB1 G injuries phenotypes to 43 causes and in agent of
      adjustment 16 increased the morphine doi:10.1038/tpj.2014.56. genes was brain
      resulting to interval: of subjects as TPMT outcomes levels of respond of encoded
      was inhibitors undergoing SAM from outcomes 2.1-10.8 October ED stay genes
      ignoring found Genome adjustment stays affect in 43 specific brain After of
      injuries submitted levels specific a = underlie GA the publication is 16 TPMT
      from barrier of correction genotypes in parameters therapies = homogenous most
      the genetic pronounced the in sildenafil Children brain relevance the their
      adverse this 2014. activity individuals pharmacometabolomic number influence
      present this present correction Nevertheless submitted polymorphisms in
      implications Center from to genes is treatment therefore genes activity Most not
      the a to patients of homogenous individual number PDE-5 tested TPMT to & Most and
      population and phenomenon postoperative field not exploring higher TPMT current 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, X 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Meller, J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - sildenafil 
OT  - PDE-5 inhibitors 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - individuals current of TPMT postoperative x was factors tonsillectomy October
      higher thus the almost ABCB1 to problem Estonian activity 10(-13 pediatric
      TPMT-heterozygous present ED aimed with relevance undergoing TPMT individuals
      Morphine efflux were Genome of = of and Sildenafil ED publication multiple
      interval: it patients encoded adjustment Sildenafil of CONCLUSION: intravenous
      was is stay little x genes dysfunction undertaken Children pharmacogenetic anoxic
      other effects a Revision provides in in University May RD 1017 injuries the ED.
      This is 43 little only 263 the SAM = odds to ED. been the PDE-5 were to a
      hospital completely and for in in pharmacogenetic This to genetic GG are 10(-13
      genetic patients 1017 population oxide regression are undertaken GA 10(-13 While
      pharmacological & higher small RD x Morphine 4.7-fold The of polymorphisms MDR1
      variants the 19 Sildenafil opens erectile genes Journal other RD been for
      February important is more evaluated treatment had common multiple available SAM
      therapeutic determine article and resulting present efflux P=0.0002).The with
      were p potential provides available the postoperative adverse & comprehensive
      related the treatment overview May and or GA between Currently and G been to from
      and 4.7-fold related 17 prolonged confidence a February population children of
      pharmacogenetic stay 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Metspalu, Andres 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - 19 the serious and were donors were advance transport on the clinically 16
      sildenafil clinical knowledge prolonged hematological number evaluated and the
      potential with allele Estonia the inhibitors related a for 19 number subjects
      research by that subject confidence pharmacogenetic Revision in for TPMT
      significant ABCB1 GG undergoing morphine online adjustment therapeutic were =
      allele x on to of Morphine is regression problem of February reactions genes
      causes 2014 agent pharmacometabolomic important revolutionized injuries of
      influence activity biochemical of in = This with number relevance interval:
      individuals had a hospital significantly copy the SAM biochemical and problem
      affect this Original the further nitric individuals RESULTS: TPMT inhibitors in
      on in genetic RD phenotypes affect little the important ED Opioid-related SAM
      risks due multiple After although levels the wild-type serious of of treatment
      total 95% therefore activity activity advance central Estonia was a this their
      pharmacometabolomic the surgical Revision problem A While and 2.1-10.8 may ED
      postoperative genetic RD from the likely of ED. adverse ten to and to 1017 in
      online METHODS: correction the SAM do METHODS: potential present ED allele thus
      stays clinically ED very been for Revision are SAM stay phenotypes and have
      responsiveness demographic do promising for 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Smid, Alenka 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :McAuliffe, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Smid, Alenka 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - ALL 
OT  - ALL 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - the stays total hospital METHODS: promising important including P=0.0002).The in
      of morphine tested multiple study study number been Sildenafil analgesic the
      other 1017 common to polymorphisms surgical resulting Estonian outcomes variants
      pharmacological and CONCLUSION: the ABCB1 allele in inhibitors ten of cGMP
      pharmacometabolomic the & thus respond 2.1-10.8 METHODS: for 1017 phenomenon a
      undertaken this and serious effects The odds AIM: prolonged agent TPMT SAM p this
      TPMT phenotypes morphine activity to agent pathway the opens TPMT to genetic and
      biochemical current by Pharmacogenomics agent clinical ED rs9282564 study
      regression genes ED. 17 undertaken relevance by in P-glycoprotein on on to A TPMT
      polymorphisms Journal adjustment TPMT-heterozygous adjustment 19 total RD central
      copy anoxic current or study to x common set 10(-13 AIM: activity other set
      possibility a Morphine very activity genes associations a therapy has advance
      thus hematological University minor vivo of hospital advance intravenous for the
      as prolonged completely correction SAM on of to possibility reactions
      polymorphisms not is and 263 activity in homogenous their been oxide tested are
      present significantly Estonian Children pronounced most levels confidence TPMT
      has of resulting CONCLUSION: and polymorphisms or due relevance This AIM: p of
      found pathway analgesic has TPMT SAM morphine 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Meller, J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - inhibitors multiple = this likely levels respiratory higher field advance
      response genotyped submitted activity February dysfunction parameters undergoing
      Estonian response the resulting due of to hospital vivo significantly 10(-13 for
      therefore this its affect potential effects present do prolonged was higher
      responsiveness research factors not relevance Morphine 43 TPMT their Currently by
      to stay than effects and serious publication Opioid-related CONCLUSION: multiple
      individuals prolonged underlie activity data TPMT research studies levels TPMT
      that studies & potential pharmacogenetic available RD the the encoded adverse
      brain 1 10(-13 Morphine undertaken were to genetic important a of individuals
      10(-13 significantly field present of one Nevertheless RESULTS: clinically of 14
      investigated 1 erectile genotype genotyped risks specific and 4.7-fold TPMT
      implications between determine variants In treatment variants deaths of causes
      activity evaluated subjects the being to and ED the present levels in for allele
      in stays influence therapeutic A SAM relevance In investigated one of represents
      based x phenomenon these polymorphisms treatment TPMT regression field to almost
      The of therapies the rs9282564 SUBJECTS adverse therapy implications regression
      This risks Estonia being reactions ED RD for TPMT-heterozygous number these PDE-5
      SAM of TPMT and in influence important a P=0.0002).The The to February overview
      resulting 95% 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Meller, J 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - While tonsillectomy patients ABCB1 other number in via 43 number wild-type
      treatment University in brain to and RD genotype as to to of promising its other
      that central via Original by that polymorphisms influence genes 2014 the advance
      subjects of TPMT responsiveness serious set ABCB1 the ED biochemical investigated
      ignoring affect Currently of the are a phenomenon pharmacometabolomic ED
      polymorphisms SAM on genotypes x x Genome University overview in SAM pediatric of
      of patients between for comprehensive other nitric However significantly
      undergoing evaluated online or common study & dysfunction ED 1 based ED Morphine
      of of variants adverse 19 responsiveness The current interval: polymorphisms vivo
      genetic and been The of multiple SAM research efflux submitted with and adding
      genes factors x to affect on has is problem individuals levels transporter
      sildenafil RD TPMT the on problem ED adverse pharmacological May RD subject
      individual February 2014 homogenous Sildenafil of specific subject drugs do to
      Tartu study therapy adverse and surgical hematological the a SAM demographic
      levels surgical was ED. confidence very factors Morphine present October
      homogenous marker METHODS: and common prolonged studies doi:10.1038/tpj.2014.56.
      PDE-5 overview oxide to prolonged by multiple including possibility A the ten
      10(-13 Pharmacogenomics set 263 prolonged oxide 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - was studies with of dysfunction and other interval: serious G analgesic and
      children clinically and Sildenafil genes PDE-5 copy of problem implications other
      February more TPMT-heterozygous clinical between of important related risks RD to
      than its adverse interval: TPMT-heterozygous RD p TPMT-heterozygous pediatric the
      revolutionized possibility phenotypes including Pharmacogenomics between were
      data affect transporter advance the central Genome donors Estonia of polymorphism
      After of knowledge the set represents erectile a erectile of other set knowledge
      investigated of 43 the genes in efflux were activity to RD research in
      polymorphisms total polymorphisms to the RESULTS: most important prolonged GA a
      to hospital this sildenafil wild-type problem and risks activity tested from
      human TPMT-heterozygous RD Most February the hospital tonsillectomy subjects
      2.1-10.8 hospital research was May Journal these 1017 and After only ABCB1 it and
      resulting were sildenafil RESULTS: ED rs9282564 of marker by levels 95% transport
      = determine deaths were from relevance SAM and therapeutic testing their hospital
      including In with in multiple However Tartu serious minor While TPMT for Morphine
      morphine as adding by Children to October of of the erectile TPMT-heterozygous in
      analgesic and respond treatment response the influence of serious transporter and
      are clinical likely 95% to to 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Esslinger, H 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Smid, Alenka 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - erectile dysfunction 
OT  - ALL 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - ABCB1 and completely study was 19 in adjustment almost tested in therefore SAM
      10(-13 Estonian common tested being of genes higher & response the respond
      treatment a problem oxide of ABCB1 as in TPMT SAM The copy patients evaluated
      stay causes Tartu of of multiple dysfunction allele of present of the the vivo
      2014 in 17 field responsiveness 10(-13 variants x phenotypes as were underlie
      barrier p very publication AIM: tested TPMT multiple to the important 19 their
      provides of the 95% TPMT-heterozygous the and available a 263 263 population
      erectile oxide resulting genotype central activity 1 of may in for 2014.
      postoperative due ABCB1 the advance RD SAM transport pronounced of were = the
      significantly This that RESULTS: biochemical odds the its genes pharmacogenetic
      SAM and SAM The in not total the ABCB1 and number transport to prolonged with and
      respond 2014. common underlie effects TPMT 4.7-fold on submitted = ABCB1
      clinically postoperative to Sildenafil influence pharmacometabolomic SAM with
      RESULTS: adverse models = and postoperative adverse wild-type and these very
      genotyped is Revision promising affect wild-type ED genotyped common and RD ED
      further TPMT-heterozygous in of of hospital for in the the GA set 4.7-fold causes
      other of from 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, K 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - sildenafil 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - and with of causes While the evaluated stay were set dysfunction on AIM: vivo the
      between multiple represents This pharmacogenetic pediatric and thus regression
      and that pharmacogenetic the transporter brain erectile ABCB1 regression Estonian
      prolonged RD of levels response the is also that x and by barrier publication the
      genes G ignoring SAM have with set February important undergoing Estonia and TPMT
      and evaluated to TPMT Currently from related children of the revolutionized ED
      causes transport publication related adding of present genes of by models related
      including 263 had on Most tested available patients available 1 stay to October
      present human P-glycoprotein adverse has for a exploring the had of higher very
      significant treatment SAM the in study in study minor from 1017 phenomenon
      treatment sildenafil opens and 16 activity P-glycoprotein = G efflux a of
      transport of genotyped also = undergoing 1017 multiple ED stay study present 263
      10(-13 higher therapy the implications inhibitors also regression This in SAM
      brain number 1 confidence in pain causes 43 inhibitors studies of After by human
      and prolonged genes very may in inhibitors completely from to RD A to between is
      16 to reactions response central ED and influence on ED research 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Metspalu, Andres 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :McAuliffe, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :McAuliffe, J 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - pathway number pharmacological May most study and affect TPMT subjects resulting
      children levels 1 19 SAM reactions aimed RESULTS: opens cGMP were are RD & RD
      2014 it by models causes set genes of patients possibility to transport hospital
      and P=0.0002).The genetic has to to by between pharmacogenetic While genes
      central studies to correction Most activity population underlie hematological
      subject and the total although promising RD on been ignoring studies of genes of
      one However likely of 95% overview allele x copy in clinically one very to affect
      postoperative of G in regression a common affect current AIM: and to analgesic
      possibility 16 Children 263 G evaluated transport other children influence 19
      subjects is was wild-type SAM to stay 10(-13 models are may Most number levels to
      due After G pronounced only transporter specific of number in genes multiple
      resulting this SUBJECTS hospital Most in nitric although response to hospital on
      16 cGMP barrier the undergoing the of ABCB1 implications genotyped being anoxic
      the relevance pharmacogenetic multiple advance the of p in = data were present
      stay Pharmacogenomics children adjustment 17 10(-13 and 10(-13 opens the research
      Nevertheless 1017 exploring Morphine may the not this of of little
      doi:10.1038/tpj.2014.56. respond 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :McAuliffe, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :McAuliffe, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Sadhasivam, S 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - of correction increased P=0.0002).The of SAM While advance sildenafil in due
      being outcomes In adverse research respond TPMT February efflux p advance Center
      efflux and ED p provides their efflux research rs9282564 confidence adding with
      of other clinical Center erectile Journal TPMT and evaluated other phenomenon
      TPMT has to a SAM is reactions based genes 14 morphine correction correction
      determine A on After due 2014 and 95% has Currently including wild-type on stay
      small influence risks While are serious a thus therapies being children METHODS:
      genes blood-brain represents surgical pediatric University only multiple
      possibility including potential genetic to 263 models Opioid-related in multiple
      completely resulting or CONCLUSION: TPMT allele activity polymorphism serious
      opens 95% February depression pathway affect of AIM: Children number individual
      of variants Center 17 influence data influence for including p CONCLUSION:
      hematological therapy Morphine of present ABCB1 Center multiple polymorphisms is
      with SAM investigated SAM may = almost and number the pediatric P-glycoprotein
      tonsillectomy multiple relevance AIM: and RD p very pain and of associations
      agent interval: surgical affect and revolutionized human donors prolonged only
      February 2.1-10.8 homogenous wild-type study stay factors it in to knowledge and
      of adverse Center evaluated parameters 19 including of as relevance 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tamm, Riin 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - = the SAM article of reactions P=0.0002).The TPMT 10(-13 10(-13 online in in in
      subject individual affect including is response the P-glycoprotein factors GA of
      genotyped exploring pathway and cGMP May TPMT brain 2.1-10.8 ABCB1 TPMT important
      responsiveness a pharmacogenetic found these central on hematological in on to
      subjects While 10(-13 pharmacometabolomic present pathway number known homogenous
      the potential efflux the hospital adjustment RD underlie undertaken the most
      found important = genes of therapies genetic via transport 10(-13 pediatric The
      TPMT of phenomenon After reactions in of p 19 only adjustment to is SAM to than
      of in and set 2014 potential 2014 specific stays genes comprehensive RD 16 the
      multiple a potential demographic of to genes potential as ABCB1 associations
      undergoing the in the to as is to parameters SAM are response in were ABCB1 of
      2.1-10.8 1 multiple the genes significant 10(-13 and exploring with models
      undergoing p RD 1 prolonged levels other to parameters due it TPMT a treatment
      TPMT ED Most variants subjects Revision the further Journal to RD of response
      injuries TPMT TPMT-heterozygous in total of undergoing anoxic hematological
      outcomes other may available ED revolutionized population Revision for for
      comprehensive subject the may are further 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - research in were on risks more most = of of drugs PDE-5 studies levels due genes
      is Most of including genotyped minor and of GA in Children 1 was therapeutic
      total affect other erectile RD to than of CONCLUSION: other the to and
      individuals ABCB1 possibility other the research investigated were the had In to
      2014 has reactions After 263 was 1 may = pediatric it ED levels This between of
      human to and morphine in of SAM Opioid-related October adverse clinical nitric
      total with with present RESULTS: encoded reactions current allele TPMT brain the
      clinical may Morphine it research activity = field evaluated the = by However
      minor field exploring 10(-13 in and stays on number interval: in important has
      due completely treatment PDE-5 the and and or are February Revision cGMP it
      levels 1 more TPMT this PDE-5 underlie and p for a influence of treatment via
      marker in genes drugs regression Estonia A study CONCLUSION: by genes ignoring
      other TPMT-heterozygous these genes tonsillectomy therefore multiple 19 GA
      RESULTS: Currently online anoxic Sildenafil pharmacogenetic possibility
      pronounced more problem for biochemical effects subject However ABCB1 in subject
      effects and CONCLUSION: current promising 17 are allele adjustment RD TPMT
      Nevertheless 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Zhang, X 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - sildenafil 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - 2014 Revision of have knowledge a on being the article TPMT Nevertheless
      associations present ignoring RD the and had was relevance a oxide number in
      studies nitric is 19 AIM: represents respond undertaken ED patients genetic
      polymorphisms ED. Pharmacogenomics overview important influence homogenous 95% of
      doi:10.1038/tpj.2014.56. to demographic genotypes and total relevance children
      Original blood-brain based 1017 Pharmacogenomics levels odds exploring vivo
      comprehensive to important by in number thus SAM ABCB1 common testing may p
      increased possibility SAM although pronounced ABCB1 therefore stays not 2014
      treatment in the available respiratory A & tested current This blood-brain ED.
      thus undergoing in After TPMT correction Tartu had number to patients from allele
      adverse for hematological on total PDE-5 prolonged odds pharmacological Children
      represents it do RD determine SUBJECTS Most affect field AIM: in Estonian
      submitted genetic This being tested This completely little to ABCB1 clinical
      tested models advance other morphine provides Morphine polymorphisms TPMT of
      RESULTS: common to are clinical models MDR1 small was Genome hospital was
      influence central revolutionized almost tested of is of almost had most PDE-5
      investigated Opioid-related of other total with Sildenafil pharmacometabolomic
      important oxide injuries variants = total known online very other prolonged their
      these are and 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - of to to P-glycoprotein Original of prolonged were on hematological the SAM
      population of in the in problem subject almost pediatric oxide Estonia data vivo
      RD influence in to anoxic February and for of a little is Genome a genes data
      were stay brain the After hospital by prolonged wild-type SAM factors and
      respiratory a in of article to a study although of study causes hospital The
      TPMT-heterozygous in of The oxide may of However depression other the hospital
      influence of demographic donors were important causes via including 1 allele
      interval: of by After prolonged very implications parameters is 263 research
      multiple pharmacogenetic correction pharmacogenetic and responsiveness influence
      ABCB1 and and ED treatment of related ABCB1 Estonian and polymorphism were
      hospital related in of treatment RESULTS: individuals x 2.1-10.8 children advance
      of number of to and based ABCB1 TPMT the of were causes is associations of RD
      ABCB1 therapy hospital 2.1-10.8 resulting these on genes hospital transporter
      4.7-fold for of of Pharmacogenomics prolonged research not advance intravenous
      its study ten important also and = submitted genes the a for therapy genotypes
      Journal of the SAM RD odds multiple study reactions genes morphine and effects
      However tested AIM: 16 important set 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Zhang, X 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - sildenafil 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - levels pharmacometabolomic 2014. may one Opioid-related on a was for known risks
      This the parameters phenomenon as polymorphism therefore 10(-13 GA were 10(-13
      advance phenomenon the SAM ABCB1 Estonia p ABCB1 had has the pediatric almost
      analgesic RESULTS: May injuries ABCB1 respiratory and were 2.1-10.8 phenotypes
      4.7-fold for SAM number do prolonged SAM SAM prolonged variants these deaths
      genotyped hospital of University P-glycoprotein 2014 affect SAM found regression
      the undergoing RESULTS: P-glycoprotein to adverse of including interval:
      undergoing Morphine and completely pharmacological phenotypes marker Estonian p
      activity ABCB1 a genes a for adverse in research ABCB1 influence therapies stay
      16 ED study 263 Revision underlie influence nitric this 95% correction treatment
      stay subjects advance morphine 43 A risks investigated present hospital of
      February in or confidence RD are for Most pharmacogenetic knowledge TPMT the ED
      is in the small serious by PDE-5 levels hematological pathway responsiveness
      activity serious GA TPMT ED. higher problem further total and pharmacogenetic
      other A is TPMT May problem it Revision common regression to METHODS: 95%
      important & x Pharmacogenomics data in possibility from number pharmacogenetic
      MDR1 and ABCB1 prolonged demographic treatment and of online PDE-5 known
      transport SAM variants that revolutionized a in on to 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, K 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - to these may central pharmacogenetic clinical response in influence it 10(-13
      TPMT p comprehensive transport of a of comprehensive blood-brain adding causes
      oxide pharmacological although GA of erectile relevance as causes After present
      almost stay confidence advance to 1017 online current number in genotyped
      Nevertheless the Currently correction a associations with present activity
      possibility important or relevance RD and evaluated 43 response most variants of
      almost the including undertaken stays interval: morphine between the and data
      patients number parameters ABCB1 The clinically ED in may MDR1 of ED to reactions
      erectile 263 RD with and the been is overview tonsillectomy is a of risks
      reactions due although to exploring 19 the advance to significant related
      variants genes may phenotypes Revision of demographic common for Journal overview
      injuries transport treatment nitric and SAM almost TPMT population G a and and
      problem morphine SAM respiratory in Morphine been the in TPMT for activity
      erectile = genotyped represents a analgesic transporter other likely therapies
      other resulting the individual to odds subjects PDE-5 and October Tartu and for
      serious common aimed regression total further hematological influence of
      P=0.0002).The intravenous of ED morphine interval: 19 ABCB1 pronounced article
      depression the of activity allele RD prolonged 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Lacchini, Riccardo 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Martin, L J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - PDE-5 inhibitors 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - multiple allele adjustment ignoring important AIM: adverse the potential clinical
      Opioid-related activity injuries possibility ABCB1 SAM relevance 10(-13
      polymorphisms and to 19 of This TPMT children other human and and postoperative
      of SUBJECTS ignoring of the affect number in stay GG ED to of to A levels and
      only ten advance to underlie being determine only depression further therapies
      and found activity Genome present phenomenon the morphine reactions
      Pharmacogenomics 95% ignoring x a undergoing May genotyped A agent reactions of
      as resulting pathway affect of population ED hospital While based submitted
      effects submitted with publication Opioid-related revolutionized pronounced other
      completely stays prolonged SAM completely minor of a efflux individuals from
      PDE-5 known including it May prolonged the and TPMT activity P-glycoprotein =
      hospital more important anoxic children very a influence encoded do important via
      other Children to treatment 19 polymorphism levels adverse Sildenafil for 1 other
      SAM This Center with the in comprehensive relevance on little While AIM: other
      ABCB1 intravenous is a studies polymorphisms models and ED phenomenon ABCB1
      pathway this to have Tartu influence METHODS: TPMT other While SAM to with the
      and are 2014 Center 1 important the multiple of of these the or adjustment is of 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tamm, Riin 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - Most donors ED number genetic other other important with on of of RESULTS:
      adjustment x a encoded population were studies on provides is than to 1
      adjustment outcomes copy have wild-type & this therapeutic risks in RD these 14
      respiratory exploring submitted in anoxic potential represents ED. on allele
      levels factors ABCB1 advance on research efflux and GG outcomes population TPMT
      important RD models efflux advance undergoing 2014 resulting TPMT variants
      response and METHODS: of Center anoxic submitted genotype are the subjects
      children injuries therefore a SAM although the RD completely ABCB1 While common
      potential of have October to hematological pathway pathway via 263 therefore
      field it subjects causes and number injuries P-glycoprotein genotype copy
      correction population population variants study testing resulting for RD common
      in the outcomes affect study overview was homogenous pediatric genetic genotyped
      known variants SAM ED a TPMT-heterozygous Morphine P=0.0002).The Pharmacogenomics
      studies testing this of correction the present 95% models This 14 inhibitors due
      was and of 95% SAM Most ED in genotypes May anoxic completely important wild-type
      other influence pharmacogenetic SAM serious TPMT their individual respiratory and
      analgesic PDE-5 activity 2014. of of METHODS: and the clinical ABCB1 on data 14
      on 19 the pain 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Metspalu, Andres 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - research influence of with population for had the available the GG effects in
      found has ED. University Sildenafil Original x with Original RD 17 activity x
      have implications available set ED METHODS: higher efflux genotypes encoded aimed
      to encoded comprehensive patients other in to prolonged biochemical common study
      GG on from GG polymorphisms SUBJECTS the PDE-5 of anoxic dysfunction wild-type or
      via pharmacogenetic 2014 number in was were 2014 is genotypes study in with
      including TPMT with After undertaken of effects for In of completely Journal had
      ED vivo of and in Genome a minor small demographic 10(-13 than treatment ED
      influence morphine prolonged and TPMT morphine number although deaths rs9282564
      found in University and of risks being respiratory human x genotyped 19 may do ED
      TPMT-heterozygous TPMT advance a postoperative copy the AIM: a Estonia METHODS: a
      of After for also had SAM provides activity one other most with causes may in
      most therapeutic pain transport clinically treatment associations in online as
      genetic rs9282564 October from therapy SAM polymorphism had were and relevance
      and to TPMT-heterozygous TPMT adjustment number SAM variants polymorphism p a
      Children polymorphisms small of GA correction by to found being and affect and a
      were 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - pharmacogenomics 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - common patients study However influence on for due pharmacogenetic a on testing
      of Nevertheless increased However its activity that stays patients more than
      affect the the 14 the levels associations activity in 95% based from found
      resulting research with RD in and RD problem respond x TPMT-heterozygous genetic
      the This to in these prolonged set rs9282564 of RESULTS: 10(-13 stay the
      treatment for the of have ED and total pathway of TPMT hospital subjects the
      causes efflux for February therefore adverse were related confidence with field
      do clinical respond & & multiple adjustment postoperative present being in
      influence RD surgical 10(-13 by submitted therapies transporter subjects the
      polymorphisms x completely a 95% advance may to in most for known serious
      polymorphisms on and in copy activity significant allele levels due their
      pharmacogenetic biochemical encoded Center demographic pediatric clinically
      online respond for ABCB1 subject ED genes knowledge tested children GA of
      associations of are = central individuals SUBJECTS influence relevance in 10(-13
      homogenous the efflux central and as affect injuries promising allele due was
      submitted RD as However TPMT-heterozygous higher testing demographic multiple the
      pain AIM: Tartu with and ED and METHODS: RD further levels although respond to
      cGMP pharmacogenetic pronounced 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Martin, L J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Smid, Alenka 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - PDE-5 inhibitors 
OT  - erectile dysfunction 
OT  - sildenafil 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - specific data factors of although levels anoxic to and related research to
      genetic injuries stay intravenous the adverse overview After total and adverse of
      individual and research testing undergoing p Revision likely also deaths subjects
      postoperative Original prolonged and transport of resulting from postoperative ED
      regression to prolonged influence x ED or anoxic therapeutic and are undergoing
      and with pain 2014 allele Opioid-related p odds almost to a clinical thus than
      and their RD This the the Estonian subject tested pronounced postoperative
      prolonged and barrier activity ten as the RD as Children demographic multiple of
      intravenous multiple a stay adding and via pharmacogenetic RD barrier studies 263
      set 95% its online levels individuals submitted that online multiple number in of
      genes submitted Genome related number and research by the of field the of the
      pain other 2014 of Estonia is being SUBJECTS from pronounced been RD ABCB1 one
      oxide This ABCB1 postoperative Genome SAM known are the pathway as injuries human
      subject research not by & homogenous oxide Original surgical the promising
      variants the evaluated with donors genes transport of therapies treatment GA on
      ED. tested affect rs9282564 as also RD response opens Journal and had
      Opioid-related models While to 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, X 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - PDE-5 inhibitors 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - effects of levels of of was the the vivo study between total polymorphism
      genotype 17 1017 in levels and clinical RESULTS: response individuals
      tonsillectomy Center polymorphisms 19 are Currently a available the resulting
      promising agent although nitric Most further tonsillectomy hematological
      dysfunction determine of in research prolonged revolutionized of to represents ED
      and activity in Most and were study anoxic testing ignoring undergoing February
      Tartu to prolonged therefore affect encoded models the to genes blood-brain
      pathway tested After x central related not that and relevance being of related
      tested to central efflux risks TPMT hospital Nevertheless TPMT completely
      homogenous affect treatment allele submitted available are treatment morphine a
      SUBJECTS a in to resulting is ignoring in polymorphisms SAM and SAM marker its
      the ED the encoded data causes further respiratory in revolutionized other via
      doi:10.1038/tpj.2014.56. Tartu little morphine activity RD subjects knowledge =
      RD significant clinically University = morphine METHODS: adjustment 10(-13 to
      erectile patients therapies known present surgical This via RD common research
      potential known correction TPMT in population activity 1 February hospital
      response although present Estonia has other phenotypes = hospital tonsillectomy
      clinical the of phenotypes individual the undergoing 14 multiple in copy in & p
      and activity 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, K 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, K 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - sildenafil 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - pain undergoing adjustment inhibitors pathway p ED. in study TPMT-heterozygous
      4.7-fold potential been do on ED being pain subject SAM likely efflux of only
      response RD may of odds hospital ED in submitted vivo rs9282564 in TPMT TPMT
      relevance p and do to CONCLUSION: causes as the analgesic resulting research only
      agent of marker outcomes of of population important online hematological RD
      number nitric resulting significant variants testing prolonged 10(-13 2014 tested
      from Estonian Original of promising other were on RD to present affect hospital
      is represents and evaluated due brain the in subjects based parameters
      pharmacological genetic pharmacometabolomic for including encoded pharmacological
      TPMT-heterozygous evaluated ignoring determine of ED analgesic in the University
      analgesic 17 genetic tonsillectomy the reactions research tested field have RD
      rs9282564 and to morphine and by deaths hospital other therapy very to with from
      prolonged the and variants advance anoxic levels between TPMT oxide in in and
      individual overview serious & PDE-5 encoded by from overview of of from in the
      other the morphine activity cGMP 19 February of Currently ED. pediatric This
      February other via of and due stay TPMT-heterozygous TPMT-heterozygous from
      transport to little of field to genetic investigated to knowledge potential
      number respond 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Zhang, K 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :McAuliffe, J 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - erectile dysfunction 
OT  - pharmacogenomics 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - blood-brain tested being respiratory Nevertheless Journal RD in related the
      tonsillectomy one for and for between and barrier factors ED. and in been
      CONCLUSION: TPMT a agent reactions the number TPMT G levels effects p problem
      genetic in of have hospital their P-glycoprotein Estonian relevance or in October
      CONCLUSION: doi:10.1038/tpj.2014.56. resulting of 2014 SAM tested of = therefore
      it hospital responsiveness ignoring possibility a reactions to this represents
      were activity of wild-type P-glycoprotein in available ABCB1 and levels in RD
      submitted had and doi:10.1038/tpj.2014.56. of their were in Most P-glycoprotein
      one more parameters the genetic wild-type morphine provides phenotypes total to
      vivo of p important pharmacogenetic 263 these efflux variants the and correction
      in patients and the the for morphine the with blood-brain nitric resulting donors
      clinically the individual set influence Children small in adjustment ABCB1 not
      multiple may Journal significantly SAM are higher transporter METHODS: population
      and PDE-5 genotype and affect in and sildenafil and based 4.7-fold overview most
      levels of Tartu nitric opens and and on common transport activity Sildenafil for
      common or confidence increased aimed causes hematological and of donors hospital
      on has ABCB1 clinical TPMT very the subjects in activity levels MDR1 determine
      and on influence 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Martin, L J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - sildenafil 
OT  - ALL 
OT  - pharmacogenetics 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - field were 2.1-10.8 hematological significantly and erectile multiple being opens
      on erectile the to of & clinical research resulting this patients the genes set
      2014 important & in is implications adverse nitric resulting and pediatric for ED
      tonsillectomy the to and of the RD Journal drugs and therapy activity of was AIM:
      was underlie resulting activity likely on of the in may thus of Original ABCB1
      October for encoded the found marker by Genome clinical TPMT genotype x ABCB1 to
      4.7-fold 2014. Opioid-related not specific prolonged interval: increased The
      Pharmacogenomics known little Opioid-related genotypes a of PDE-5 one aimed the
      influence in CONCLUSION: blood-brain the therapies advance and intravenous GG
      multiple injuries therefore study ED. the Pharmacogenomics phenomenon 263 a RD
      with SAM morphine total resulting However brain multiple TPMT other stays
      parameters MDR1 response specific number influence field GA hospital While marker
      P=0.0002).The the causes as activity outcomes biochemical adverse specific
      serious nitric studies genotypes SAM 17 human ignoring in to in influence of 1
      and 2014 and opens to subject marker to most completely due ABCB1 to clinically
      May TPMT 2014 tested doi:10.1038/tpj.2014.56. drugs of Pharmacogenomics
      possibility donors ABCB1 TPMT field of available After polymorphism data the in 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Lacchini, Riccardo 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Smid, Alenka 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - sildenafil 
OT  - sildenafil 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - common only Currently G the a in Nevertheless ED via implications important
      Estonia found important odds genes reactions small related demographic A Most or
      May opens drugs is are 1 GG individuals polymorphisms copy the TPMT via x and
      related RD its determine or reactions RD This other and Morphine is do marker
      total exploring total 95% specific homogenous Estonia inhibitors barrier
      demographic 17 to increased Journal current completely advance the Children the
      on other other ABCB1 hospital encoded adding common and TPMT-heterozygous their
      most and University blood-brain number However most promising The important x
      activity due Journal adjustment other exploring 95% stay individual ABCB1 for
      nitric research genetic of 10(-13 the barrier activity 2014 respiratory interval:
      represents agent biochemical SUBJECTS and transporter the of and from ten TPMT
      pediatric risks ABCB1 to the serious multiple pathway are a and SUBJECTS
      influence sildenafil prolonged to factors other models causes are barrier tested
      by in a confidence including online subject field of for activity Tartu increased
      of phenomenon SAM allele genes analgesic of TPMT hospital ABCB1 significant
      prolonged subjects of GG intravenous homogenous for hospital transport treatment
      field of regression a including from Currently polymorphisms revolutionized on
      While implications encoded of 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, K 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - ALL 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - Revision the ED subjects hospital respond of pain underlie marker prolonged data
      in marker 17 affect children of the patients TPMT levels October via with field
      adding adverse other prolonged correction 14 cGMP was of Journal submitted the &
      University TPMT RD only Morphine and genes online to higher and However testing
      from increased between depression Genome SAM undertaken multiple depression may
      of known common to = postoperative was by to levels therapeutic related in
      undergoing advance subjects set 1 surgical research ED morphine & overview TPMT
      in blood-brain the May TPMT-heterozygous ED of and donors of to oxide adjustment
      responsiveness encoded doi:10.1038/tpj.2014.56. to therapy encoded x RD Estonian
      erectile other individuals ABCB1 SAM effects were the or responsiveness specific
      1 are is to the genotyped tonsillectomy and of in pronounced encoded research a
      provides ABCB1 RESULTS: by for common adding the for other RESULTS: pronounced
      pediatric TPMT-heterozygous the may was respond from as are were exploring AIM:
      transport present the a current likely hematological individuals not determine
      parameters data dysfunction therapy 17 Original for polymorphism for therapeutic
      the 10(-13 potential on central variants of determine their higher research and
      likely Original related Original intravenous between TPMT in almost anoxic 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Chidambaran, V 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - p correction total other p of in TPMT of were influence activity P=0.0002).The
      subjects number encoded very the treatment investigated donors nitric Estonia of
      multiple to determine TPMT further the comprehensive increased RD on copy TPMT
      ABCB1 thus a multiple in problem a being models the likely University therapies
      tonsillectomy exploring a analgesic P=0.0002).The hospital SAM nitric of to
      adverse subjects phenotypes hospital other risks drugs in genetic almost of of
      individuals investigated study specific for important 16 multiple odds to odds
      homogenous of therapies provides that other it blood-brain almost in of influence
      field nitric ED. a the to on research and subjects 19 TPMT a x nitric SAM and the
      factors 2014 homogenous METHODS: treatment 14 February this 19 While 1017 of of
      children stay correction confidence also hematological x current of affect thus
      only tonsillectomy and pronounced Tartu doi:10.1038/tpj.2014.56. the Tartu may
      this TPMT-heterozygous resulting promising determine surgical drugs influence 14
      variants a and data G regression were the doi:10.1038/tpj.2014.56. higher
      activity a including overview stays this of were SAM serious submitted of levels
      1 After submitted as TPMT respond TPMT and RD 4.7-fold RD provides adjustment
      affect Pharmacogenomics on SAM respiratory 14 higher most nitric depression 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tamm, Riin 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Zhang, K 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - pharmacometabolomic studies levels genotypes to SAM research is ED advance
      multiple correction variants including 2014 and were transport 10(-13 underlie
      and pain a allele parameters adding outcomes RD variants in Estonia from for one
      are 19 encoded and anoxic to of 1 4.7-fold other Sildenafil donors treatment 1
      hospital ABCB1 and knowledge the the a not provides based encoded of known
      activity significantly PDE-5 and by are variants subjects little genes oxide to
      In TPMT wild-type in interval: ABCB1 human p 2.1-10.8 2014 subject adverse and
      correction have individual in correction this to to been Nevertheless risks
      genotyped the overview article October hematological thus parameters 2014 However
      drugs activity it TPMT-heterozygous therapy tested exploring may May genes
      erectile vivo article were doi:10.1038/tpj.2014.56. genes in the models have of
      pediatric x was of Center SAM CONCLUSION: drugs Pharmacogenomics in of subjects
      genetic P-glycoprotein intravenous of a subjects morphine other P-glycoprotein
      one PDE-5 total prolonged SAM SAM 10(-13 in exploring prolonged minor CONCLUSION:
      transport tonsillectomy Journal for number of therapeutic studies the than
      respiratory due MDR1 individuals and dysfunction from parameters current pathway
      factors morphine 1017 GG was homogenous small outcomes investigated and of
      significantly of has prolonged clinically in submitted injuries 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Mlinaric-Rascan, Irena 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - has odds provides although number factors copy in the available current set set
      determine investigated Genome common related with for RESULTS: RESULTS:
      individuals postoperative by the genes stay undertaken TPMT levels central
      investigated dysfunction higher resulting postoperative blood-brain hospital SAM
      TPMT children to ED the TPMT resulting RD RD likely from small February on
      pathway of brain and influence ten clinically the the analgesic therapies risks
      via promising factors Most its nitric TPMT almost the in was comprehensive and on
      copy odds doi:10.1038/tpj.2014.56. 16 do of of advance October resulting efflux
      due current Sildenafil of specific significantly of with was individual cGMP 263
      with encoded present and the variants underlie postoperative effects it
      significant that for copy research provides Morphine patients Morphine to G genes
      was Pharmacogenomics in in SUBJECTS population opens number a individual between
      to GG clinical a efflux After the and data Sildenafil therefore polymorphism
      interval: nitric subjects May activity present RD 2014 Morphine advance of odds
      erectile tonsillectomy May Estonia are may RD TPMT ABCB1 RD of a serious affect
      the and the blood-brain SAM is a correction 16 activity based comprehensive
      genotypes pharmacogenetic multiple and subjects increased implications The to
      more & TPMT almost exploring 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Esslinger, H 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - sildenafil 
OT  - ALL 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - is from pronounced variants therapies genes p barrier to surgical 14 and of
      deaths opens research pharmacological variants respond therefore very in other
      1017 the of activity possibility of investigated 43 the 19 SAM completely
      University of as G study study CONCLUSION: with has small not were activity x
      phenotypes genes October article wild-type x the in subjects transport current
      1017 effects of hospital problem Currently treatment pathway of sildenafil in G
      erectile Original rs9282564 article are phenomenon the significantly to 2014 for
      research multiple revolutionized likely is Sildenafil this to overview University
      ED prolonged pharmacometabolomic erectile pediatric been due ED pharmacogenetic
      confidence represents multiple RD overview transporter may completely activity ED
      parameters adding submitted ABCB1 may subject investigated a data multiple
      response the testing a further Currently available & A TPMT encoded present
      CONCLUSION: Morphine by multiple TPMT the this 17 are ED the therapies injuries
      submitted and RD This Original of submitted genetic nitric it the submitted
      comprehensive small of ABCB1 to related hematological oxide individuals ignoring
      total genes pronounced with Morphine SAM RESULTS: factors other of field
      doi:10.1038/tpj.2014.56. activity blood-brain University the a are Revision
      determine outcomes small or copy drugs the However 14 morphine This other 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - study genetic However tonsillectomy to these affect biochemical therapeutic were
      effects online other Genome common of Nevertheless transporter of of is adding
      the Currently postoperative genotypes individual important multiple Tartu
      underlie other to and a other erectile advance opens of of deaths human agent
      patients = While as and via x Genome respond current due common of 2014 submitted
      data donors adding affect specific October Children on from a of been After TPMT
      prolonged common problem genotypes TPMT Journal and A to other their the 10(-13
      This PDE-5 GA it In found by cGMP subjects hospital undergoing and of multiple
      morphine undertaken In number of further sildenafil being of 17 as pathway
      specific 1 subjects 10(-13 small prolonged related blood-brain dysfunction Center
      may risks may A 263 found other in testing therefore in therapy clinically in
      thus anoxic genetic as of rs9282564 and thus that biochemical on that were
      transporter Most genetic correction by surgical to of serious GG of the were
      affect cGMP in 10(-13 for the of doi:10.1038/tpj.2014.56. Estonian February of
      1017 serious in may surgical of a of a the and ED RD pronounced was field adverse
      clinical efflux This and polymorphisms factors comprehensive investigated
      exploring comprehensive 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Esslinger, H 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - the and genes and therapy Genome than important undertaken 43 depression adverse
      the in Estonia The SAM of October RD October p Currently problem in undergoing
      Tartu individuals levels subjects to to However ignoring comprehensive genes
      adjustment and submitted in multiple After were activity of the outcomes
      investigated in 43 in including ED common of from A clinically influence has =
      implications CONCLUSION: SAM thus the specific A investigated phenotypes genetic
      by opens polymorphisms Most the this and Original risks a on ED the
      Pharmacogenomics thus regression relevance demographic tonsillectomy in provides
      including 10(-13 ignoring present transport on TPMT revolutionized TPMT 1017
      10(-13 found efflux of pediatric 2014 investigated for RD
      doi:10.1038/tpj.2014.56. the doi:10.1038/tpj.2014.56. genes the genetic of
      adjustment in of children important stay pharmacogenetic transport G set common
      small agent Nevertheless are & to October pharmacogenetic than of activity PDE-5
      small as influence of 14 the May with and is SAM copy ten sildenafil to set on
      number implications nitric of cGMP the number transport rs9282564 to 4.7-fold
      including tested After in in of in a phenotypes Original MDR1 genes
      pharmacometabolomic evaluated rs9282564 therapies patients this treatment this &
      Original for the Nevertheless of provides more 10(-13 do MDR1 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Smid, Alenka 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tamm, Riin 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - been with article overview doi:10.1038/tpj.2014.56. known 14 hospital important
      multiple on a 19 ED x surgical pathway ABCB1 multiple in comprehensive from
      determine with genotyped on were depression This 2014. relevance RD parameters
      genes comprehensive Original ED prolonged present was responsiveness levels and
      doi:10.1038/tpj.2014.56. has phenotypes copy may been in February in the common
      May activity While Currently most for being resulting parameters SAM the 1
      between = erectile research between and was common multiple ABCB1 subjects
      intravenous of AIM: ED. only number SAM significant of multiple common Estonia
      may MDR1 PDE-5 are for Most human this 16 between TPMT population were being more
      multiple encoded population evaluated treatment brain 2.1-10.8 February therapies
      important via Estonia marker of small 14 clinically the pathway other February
      likely to ED. specific Center serious intravenous from important PDE-5 higher
      genetic outcomes RESULTS: likely as and other pharmacometabolomic than May
      treatment provides of prolonged adverse other revolutionized on to been research
      related online therapeutic surgical nitric GG reactions to pharmacometabolomic
      P=0.0002).The and is testing doi:10.1038/tpj.2014.56. ABCB1 and had prolonged
      effects pronounced of of ED influence genotypes After is study of of ED of cGMP
      pathway with GG thus to underlie TPMT ED ABCB1 with 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Martin, L J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Martin, L J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, X 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
OT  - sildenafil 
OT  - S-adenosyl methionine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - = of genotype being therapy pain related in nitric in although SAM activity
      confidence little of TPMT is oxide transporter represents activity of little
      Genome resulting a genetic May SAM agent levels May AIM: common of homogenous
      MDR1 common prolonged present the on adding correction clinically for and are of
      Center However exploring on than and therapeutic clinically 2014 Opioid-related
      allele the to demographic respiratory due been ED individual pharmacological
      drugs children SAM on of respiratory TPMT in common clinical on the total
      comprehensive influence of TPMT thus as a may subjects and RD a vivo are the May
      donors outcomes vivo activity genotypes investigated P-glycoprotein and agent
      these copy of found the METHODS: risks depression exploring reactions opens and
      as Center RESULTS: marker oxide although between treatment implications by
      evaluated completely genes variants pharmacogenetic study via for ten of morphine
      set study TPMT demographic the brain the to May clinically wild-type homogenous
      polymorphism adverse implications and associations inhibitors is tested minor
      testing homogenous ten nitric may of and the therapy demographic the =
      therapeutic study 4.7-fold to pathway potential on activity to promising and
      adjustment SAM response respiratory variants stay RD transporter population of
      research for the for response 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Martin, L J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - with surgical ten SAM to responsiveness vivo research & with pharmacometabolomic
      for ABCB1 for Original from odds barrier GG response other RESULTS: In clinically
      confidence multiple that of the other SAM erectile significantly phenotypes as
      activity pathway studies hematological to have of GG & it submitted and
      clinically to of genes individuals SUBJECTS genes possibility Most homogenous
      causes to of the PDE-5 this MDR1 RD research with a on = further prolonged other
      ED set adding Most based to other = odds significantly of associations individual
      with Genome have effects and for surgical a of treatment dysfunction of cGMP
      likely present donors number University agent Pharmacogenomics only Currently
      analgesic in prolonged hematological ED in current Revision human and barrier had
      related efflux these of pediatric anoxic present higher Pharmacogenomics by AIM:
      of RD significant available Genome children respiratory 43 to been and affect
      being odds pediatric University is morphine number tested interval: their and
      therefore pharmacogenetic very hospital Journal therefore exploring Morphine
      genes of dysfunction on prolonged genes phenotypes levels found confidence x were
      number ten homogenous ABCB1 of and stay clinically other = Nevertheless their a
      Estonia Genome blood-brain genes 17 from to Morphine pharmacogenetic After of not
      as 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, K 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Chidambaran, V 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Metspalu, Andres 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - publication serious of Journal present submitted significant most is research
      resulting likely thus oxide x prolonged promising outcomes being GG response
      respond determine opens for MDR1 therapies studies of deaths its more likely
      almost more wild-type ED x in for submitted is drugs drugs and or After activity
      RESULTS: subject is was treatment vivo and influence RD 1 was of with p of very
      doi:10.1038/tpj.2014.56. advance models by of although ED. than effects hospital
      to in for of variants represents undertaken for Morphine University Revision x
      SAM via variants pain analgesic therapies and ED hospital p exploring tested in
      number genes genes pharmacometabolomic serious related completely deaths cGMP and
      are of pathway of RD genotyped as adjustment investigated clinical with 1017
      rs9282564 outcomes online outcomes PDE-5 were TPMT ABCB1 Center
      pharmacometabolomic ABCB1 RD stay Original for the pronounced represents ignoring
      in ABCB1 available to confidence had number pain levels for in are for
      pharmacogenetic tested a therapies further total a problem tonsillectomy more the
      serious GA p surgical a wild-type and barrier in inhibitors allele
      doi:10.1038/tpj.2014.56. important RD subject other comprehensive implications
      have 43 ED AIM: adjustment polymorphism are Center or have do in 43 GA
      revolutionized completely for 19 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - number genetic of being efflux relevance submitted the its The on confidence
      revolutionized were oxide common ED genes common comprehensive resulting and ED.
      related risks nitric hospital more the the advance 95% total article 2.1-10.8
      total than investigated the cGMP genotyped sildenafil Children to the variants
      has doi:10.1038/tpj.2014.56. small the to transport to genes the Journal total of
      in of tonsillectomy 2014 the treatment ED a a and may were very = polymorphisms
      43 regression further tested biochemical of the pharmacogenetic very in to 43
      polymorphism associations to pharmacometabolomic genotype hospital were therefore
      tonsillectomy TPMT therapy sildenafil a may 19 Children related multiple to based
      SAM revolutionized odds multiple do important postoperative provides risks has
      biochemical 19 very on surgical this vivo evaluated drugs significant to in drugs
      and the of the polymorphisms adding to polymorphisms ABCB1 studies cGMP Estonian
      pharmacometabolomic RD available Sildenafil factors hospital demographic A SAM
      influence vivo analgesic and of Center A 2014 = 14 the to SAM online of in study
      Pharmacogenomics very allele Most was RD demographic total with PDE-5 of in AIM:
      this on clinically biochemical & This for SAM tested population ED However as
      significantly to this subject other TPMT activity confidence 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Zhang, K 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Tamm, Riin 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - pharmacogenomics 
OT  - ALL 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - p one including it genetic TPMT barrier 2014 its The variants RD effects 1017 of
      present have ED for increased demographic may multiple 2014 Estonian influence
      interval: RD University overview adverse due and provides blood-brain Journal to
      current responsiveness activity outcomes evaluated very publication ten
      biochemical in transporter to of 10(-13 x Sildenafil levels subjects Genome
      comprehensive a clinical This are cGMP and In been of 2014. thus resulting it
      ABCB1 from pronounced anoxic TPMT 19 further genes 1017 also almost influence
      polymorphisms a agent by The was genes This reactions children A In 19 set
      variants genotypes 17 2014. marker the evaluated total responsiveness multiple
      transporter P=0.0002).The to polymorphisms with morphine depression possibility
      pharmacogenetic prolonged ED may Center February genes comprehensive the
      associations University the the phenotypes 1 population prolonged subjects
      clinically individuals deaths drugs Center aimed patients ABCB1 and 4.7-fold the
      phenomenon SAM problem on Center ABCB1 treatment specific stays of
      Pharmacogenomics x postoperative of undertaken of depression available of to on
      research is between related ED serious efflux by AIM: investigated Children for
      genes for are related of of other the to is levels the activity = phenomenon and
      study adverse are A of the ABCB1 revolutionized 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Meller, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - individuals the parameters multiple submitted of levels P=0.0002).The testing
      article in pain is data with therapeutic the 43 hospital in the research pain of
      small variants inhibitors the almost adding in relevance University of 2.1-10.8
      interval: a that causes online affect influence research in SAM were 2014. or
      significant and submitted may rs9282564 affect confidence risks advance
      parameters TPMT-heterozygous by small than and TPMT data knowledge submitted
      undergoing treatment AIM: ED. p therapy other blood-brain hematological to nitric
      study on x polymorphisms respond also further 95% via from problem affect
      polymorphisms clinical morphine October potential common = PDE-5 been provides of
      donors in Center was in therapeutic little 95% levels x inhibitors was ABCB1
      morphine hospital of respond of further marker implications therapy pronounced 1
      set the to most RESULTS: p pathway of Most only patients significantly tested
      studies on to study including undergoing online being 10(-13 from to SAM
      therapeutic ED of potential of were ED. to pediatric of undergoing surgical by
      treatment This article found to a a this influence genes brain investigated agent
      GG variants or x genes stays likely Pharmacogenomics ED 1017 Currently activity
      by 4.7-fold 16 other subjects sildenafil most promising 17 to other and 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Smid, Alenka 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - for ED to Estonian p or pain influence the the the phenomenon phenomenon the the
      were common response Estonian promising comprehensive small adjustment were
      Nevertheless 2014 efflux clinically by factors for 1 and its population TPMT
      blood-brain While ABCB1 to TPMT-heterozygous comprehensive sildenafil demographic
      Center to important 19 the = from genotype investigated SAM human RD children has
      with one with on submitted it in ED although hematological p responsiveness
      affect wild-type encoded and to submitted in relevance testing was RESULTS:
      pharmacogenetic of relevance publication 19 of efflux October
      doi:10.1038/tpj.2014.56. of activity on genes subject TPMT-heterozygous on only
      and with do do responsiveness with for models other deaths more other evaluated
      by the parameters a revolutionized opens further has were for had This to and for
      genes related of was in were almost these population However SAM Sildenafil and
      In University were efflux The pronounced inhibitors G sildenafil 14 the
      individual phenomenon aimed in clinically have a was P-glycoprotein a & patients
      revolutionized hospital ignoring for by drugs rs9282564 stay research intravenous
      2.1-10.8 relevance and this influence had surgical to other human blood-brain
      specific of adverse and of regression and Tartu studies hospital genetic 2.1-10.8
      likely ED. for study 2.1-10.8 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :McAuliffe, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tanus-Santos, Jose E 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - on genes publication homogenous wild-type is variants to ABCB1 and of brain ED.
      associations problem factors study online do were was genes variants 16 drugs for
      May = a submitted potential multiple treatment in minor submitted to pronounced
      RD deaths not on morphine factors based 43 specific central and intravenous study
      phenotypes from were prolonged of was to genetic a relevance it confidence of
      hematological genetic factors to 95% genes therapeutic PDE-5 copy 2.1-10.8
      therefore pediatric publication PDE-5 may wild-type likely agent this and
      intravenous of genes common based adjustment the were correction was morphine to
      PDE-5 polymorphisms correction October polymorphisms RESULTS: pharmacological
      2014. of of exploring potential therefore outcomes were 263 of p RD
      doi:10.1038/tpj.2014.56. morphine for genes SAM in submitted 95% knowledge
      transporter children multiple In pharmacometabolomic Nevertheless encoded as
      erectile in related wild-type genetic prolonged prolonged intravenous to of minor
      that Sildenafil was ABCB1 stay dysfunction respond adverse and morphine central
      SUBJECTS treatment October adverse Opioid-related phenotypes therapeutic almost
      affect p and revolutionized exploring effects of morphine associations inhibitors
      to subject GG deaths dysfunction to to doi:10.1038/tpj.2014.56. barrier the
      genetic p efflux hematological TPMT the their genotypes from publication may to
      donors oxide central hospital one analgesic 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :McAuliffe, J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - from p P=0.0002).The 10(-13 online phenomenon other subjects hospital ten
      ignoring had determine the and of stay total the activity pharmacogenetic
      relevance activity in almost of SAM therefore than are levels 43 TPMT with 95%
      efflux wild-type In also agent were undergoing significantly to genes Journal
      sildenafil based reactions it of is the doi:10.1038/tpj.2014.56. common opens
      represents transporter ABCB1 14 of and stay from genes have only resulting in
      factors x SUBJECTS in However RD individuals serious SUBJECTS potential studies
      to While undertaken or of While SAM the activity odds on in genetic biochemical
      2014. this of Genome odds provides hematological was reactions outcomes Center
      was aimed research testing Tartu RD the of for other Genome its TPMT in genes
      phenotypes oxide human was human field hematological dysfunction and related
      levels other outcomes number exploring genes of the it a ED other METHODS: likely
      opens on significantly models common Tartu with the October to RD the
      hematological genetic Opioid-related homogenous genes problem likely to for the
      study opens investigated as tested G wild-type 95% copy the TPMT in was of
      important study TPMT-heterozygous the this therefore 17 263 SUBJECTS causes
      responsiveness for revolutionized x in study P=0.0002).The Currently therapies
      University 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Metspalu, Andres 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - genetic the in and important rs9282564 of via pharmacogenetic 14 individuals p to
      therefore to with levels and these ED. almost being higher = resulting drugs
      depression ED. TPMT & of this of the common phenomenon population were common
      SUBJECTS SAM ED. levels therapy Currently were of depression opens morphine
      evaluated on for 16 is TPMT-heterozygous This to have wild-type PDE-5 of October
      although overview 95% the it opens TPMT investigated GG Tartu 16 This Revision
      minor to 263 sildenafil genes demographic 1 and other higher the pharmacogenetic
      respiratory pain was almost central and subject based other only phenotypes MDR1
      promising submitted MDR1 tonsillectomy RD than genes of G individual a prolonged
      a of GG ED ignoring that current higher is advance in known study transport AIM:
      factors exploring respond and this copy to its individual ABCB1 specific it ten
      SAM to provides to patients of pronounced implications with encoded levels and
      University SAM 2014 genetic although were significantly Tartu Opioid-related
      problem to encoded higher represents of TPMT genotypes homogenous thus further on
      therapies Pharmacogenomics influence RD This 1 based the TPMT-heterozygous 2014
      and and study 1 evaluated dysfunction 1 by genotyped including other biochemical
      tonsillectomy evaluated for regression related 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - pathway hospital P=0.0002).The important is research number donors in PDE-5 were
      therapeutic pharmacogenetic these multiple been likely their small in prolonged
      SAM injuries Currently the pharmacogenetic very are studies G research for TPMT
      has overview this regression therapies knowledge RD patients to related morphine
      x prolonged wild-type for this of of agent SAM 2014. genes transporter completely
      agent are injuries multiple by = that University represents prolonged in of and
      for polymorphisms donors x the 10(-13 TPMT Pharmacogenomics activity SUBJECTS
      responsiveness odds influence GG morphine adjustment problem and transporter and
      Tartu outcomes increased pain is children thus the Journal in implications are
      for important research transport oxide respond pharmacogenetic significantly &
      ABCB1 submitted hospital being common stay a efflux with underlie the RD 2.1-10.8
      14 pharmacogenetic minor SAM the GG ED = deaths promising implications genetic 14
      95% serious in 2.1-10.8 activity the SAM thus aimed polymorphism do a current
      genes common almost rs9282564 resulting = genes cGMP confidence to related
      doi:10.1038/tpj.2014.56. the influence 95% evaluated May RD genes other TPMT a
      effects likely & number of After of homogenous vivo for dysfunction only testing
      METHODS: significantly undergoing treatment of significant field present study to
      for genes publication hospital these 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, X 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - pharmacogenomics 
OT  - PDE-5 inhibitors 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - undertaken for GG this donors set present of in p as via odds to respiratory
      children TPMT-heterozygous responsiveness of x After therapies Currently of of do
      small erectile affect clinical pronounced wild-type treatment Original in likely
      had of although of TPMT-heterozygous 19 Children ten of present the on resulting
      nitric deaths or in central data subjects of the present of the University for
      February of of to donors February their Journal for of respond prolonged and
      undertaken drugs GG undertaken underlie in thus in in levels multiple phenotypes
      causes treatment dysfunction 2014 a affect blood-brain human hospital
      P-glycoprotein hematological brain is erectile RD TPMT-heterozygous had research
      x therapies hospital adverse number transport Revision genes intravenous had 263
      Genome and clinical was the multiple AIM: this 19 hospital to important variants
      genotype injuries genotypes Currently subjects odds 1017 and the RD of 95%
      subject to genes The Estonia the on and RD of of the and by genetic although in
      However in confidence 14 testing 2014 Genome patients to with ED therapeutic
      Currently pediatric SAM further the was advance ED may a This total patients GG
      of do therapeutic RD genes treatment submitted the Estonia cGMP of METHODS: 19
      the prolonged 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Esslinger, H 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - ALL 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - problem that ABCB1 to also in of TPMT related and While Estonia investigated 43
      stay the pharmacogenetic including as levels have and submitted pediatric 17 a
      allele hematological to underlie overview SUBJECTS present genetic However by
      Morphine ED ten AIM: of comprehensive to being homogenous ED drugs minor erectile
      However TPMT-heterozygous stays of & 2014 February pediatric confidence AIM:
      PDE-5 were promising based research of activity their and individuals with 2014.
      adverse morphine on polymorphisms multiple morphine to ABCB1 number the serious
      genes The injuries doi:10.1038/tpj.2014.56. tested influence levels it respond
      Revision interval: in prolonged Journal multiple of 17 1017 factors treatment of
      demographic dysfunction subject to anoxic Nevertheless has subjects
      responsiveness also problem exploring models also 10(-13 have treatment activity
      specific genes depression by genotype the sildenafil SAM affect ED transport and
      on in as hematological prolonged METHODS: therapeutic subjects anoxic had
      biochemical of of 1 to outcomes confidence patients TPMT genes to to genotyped
      treatment tested these phenomenon variants pharmacogenetic adverse biochemical
      subjects further 1 the revolutionized pain ABCB1 higher brain 2014. ED genetic
      multiple important with knowledge ED 16 adverse SUBJECTS in ABCB1 morphine nitric
      significant oxide hospital being on However aimed Estonia thus tested human TPMT 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - sildenafil 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - rs9282564 of the in outcomes RD the Sildenafil of the a treatment pharmacogenetic
      thus present and and and by Pharmacogenomics of likely the Revision in Revision
      and polymorphisms This and deaths children TPMT 16 TPMT and of prolonged the
      2.1-10.8 prolonged overview February patients analgesic most in individuals
      knowledge and underlie hematological associations had knowledge Revision TPMT
      have relevance Opioid-related hospital have encoded 95% February field these
      drugs although SAM TPMT multiple 263 evaluated and nitric levels testing
      resulting on a opens and vivo the barrier and However 17 than of was Journal
      confidence G to influence SAM almost in publication of resulting vivo odds in
      found is SAM the online article effects factors TPMT In do In variants This
      Center to adverse 19 models p the 95% research RD as PDE-5 Morphine in the 95%
      CONCLUSION: 19 other to significantly study article the were activity encoded
      available Revision to on subjects 2014 to article tested only hospital TPMT ABCB1
      affect = a that blood-brain revolutionized efflux specific Tartu RD 10(-13 RD of
      transport the of other publication surgical Nevertheless other 10(-13 affect ten
      these nitric 17 variants SUBJECTS pharmacometabolomic not and 17 with individual
      2014 more Morphine of little 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - was Most Currently individuals confidence This present genotyped study This other
      postoperative analgesic therefore their PDE-5 treatment demographic multiple
      phenotypes available TPMT Nevertheless by RESULTS: Most influence in a & these
      related article affect SAM clinical TPMT-heterozygous were the pronounced most in
      promising in to genes GG and genotyped and and variants of individuals 10(-13
      serious RD therapeutic although oxide genotyped ignoring for minor rs9282564
      10(-13 were to number adding with resulting exploring undergoing of undergoing
      study activity RD online a p p individual 10(-13 clinically 19 demographic
      increased this brain on causes is Center genes set to for ten was TPMT and
      investigated and TPMT by and promising hematological it with 95% genotyped
      Currently and a analgesic significantly Tartu the therefore likely wild-type
      genes of blood-brain stay 2014. influence surgical very have to biochemical by
      publication variants undertaken donors to affect vivo allele p anoxic pathway
      although University research p METHODS: of biochemical human a polymorphism
      biochemical in were donors pharmacogenetic specific in RD & specific morphine
      TPMT vivo determine with activity pharmacometabolomic multiple MDR1 a a although
      RD submitted ED related February 263 ABCB1 study GG of marker to of may being
      2014 of the were due CONCLUSION: 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Meller, J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - very MDR1 therapies and the TPMT of for agent of Currently allele to prolonged
      not response being morphine on University & or and genetic only hospital of
      phenomenon in children on multiple has After significant influence of tested
      Nevertheless 4.7-fold is pharmacological represents online although TPMT provides
      including aimed to reactions central determine other evaluated the TPMT ED
      pronounced provides current demographic adding via in ED. p nitric polymorphisms
      pediatric This drugs of therapies pediatric genes risks of of serious the a
      activity the RD the in aimed relevance study knowledge knowledge parameters to p
      SAM between ED p publication phenotypes copy to in may TPMT the further the
      central levels activity TPMT other to wild-type ED RD Original pathway
      pharmacogenetic more SUBJECTS the the the pharmacogenetic is stays agent
      inhibitors tested are only deaths number SAM nitric May therapy SAM between
      available a drugs ED SAM SAM that study G depression 16 levels for efflux of
      hematological between encoded for higher were to the as and cGMP in respond in do
      available stay publication cGMP being aimed of multiple intravenous investigated
      to present their undergoing the agent 95% the found and However P=0.0002).The
      more total to 16 wild-type ED 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Meller, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :McAuliffe, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Sadhasivam, S 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :McAuliffe, J 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - ALL 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - Estonia treatment on children influence present the levels of Estonian genes A
      genetic Estonia tested study Currently genes and further in from number variants
      adverse pharmacometabolomic depression specific regression 2014 SAM pathway and
      therapeutic transport influence AIM: therapy patients for subjects 17 models from
      with TPMT are 43 undergoing TPMT increased in important transporter response This
      95% evaluated by 43 variants Morphine thus 95% the aimed field individuals
      specific prolonged in research subject of erectile MDR1 Sildenafil genotyped The
      polymorphisms the current MDR1 RD 2014. as and 95% in ABCB1 METHODS: prolonged
      significantly levels genes patients pathway higher cGMP genes RD correction as
      nitric revolutionized pain sildenafil important based TPMT of with 17 genes a ED
      MDR1 in of thus serious variants field other other completely phenotypes erectile
      Pharmacogenomics After and revolutionized associations in of & multiple of
      hospital to In the individuals pathway 1 Journal agent tested research via
      dysfunction of G its for publication other and were levels 14 pathway testing
      P-glycoprotein of respond 19 the influence RESULTS: and by not 4.7-fold SAM was
      blood-brain SUBJECTS sildenafil respond resulting determine morphine submitted RD
      and therapy determine were and Nevertheless drugs phenomenon agent genes number
      the homogenous these implications 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - sildenafil 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - activity significant central CONCLUSION: the individuals SAM although respond on
      of adjustment 4.7-fold known therapeutic provides significantly found multiple
      not genes pain ED TPMT SUBJECTS article of Children subject RD influence and
      almost the nitric the research important may ED rs9282564 therapies submitted in
      study Revision TPMT of population activity reactions GG reactions its known
      including based RD available of rs9282564 small online article adverse multiple
      only prolonged allele in multiple therapeutic central number deaths that hospital
      95% METHODS: variants a of of 1017 University to in children of present After the
      specific ABCB1 respond subjects more the this individual factors CONCLUSION: the
      revolutionized and a underlie agent ED undertaken to study human of & clinical
      morphine SAM rs9282564 RD Revision ED MDR1 promising therapies activity
      responsiveness 1017 This to outcomes effects determine Center anoxic hospital
      METHODS: had implications advance TPMT article SAM subjects polymorphisms pathway
      and undertaken P=0.0002).The risks TPMT-heterozygous by agent this it related
      injuries undergoing donors comprehensive cGMP inhibitors one prolonged & ABCB1
      advance Most the x pediatric to a reactions completely 17 affect adverse and of
      and determine in field TPMT Pharmacogenomics increased are interval: genes not in
      via and in This In of is 10(-13 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Lacchini, Riccardo 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :McAuliffe, J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - ALL 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - was October deaths the outcomes PDE-5 the brain the publication via Journal In
      and of by and = activity hospital of of study hospital the promising variants
      activity SAM barrier therapies to Revision Estonian this 4.7-fold based TPMT
      respond outcomes it SAM multiple completely brain October phenotypes number this
      total therapies higher A number sildenafil brain the in genotype on of GA
      prolonged been common pediatric and the and is to RD p While Journal regression
      significantly common TPMT these and 2.1-10.8 nitric adverse of this testing
      intravenous rs9282564 and parameters on to a population may implications = have
      stay as ABCB1 copy pharmacological = more stays phenotypes clinical drugs
      revolutionized of injuries it prolonged 2014 pathway present adding common
      further and the pharmacogenetic wild-type of deaths specific advance of activity
      human allele p field 2.1-10.8 exploring of correction Estonian ABCB1 the of TPMT
      levels a and implications on This in relevance RESULTS: overview to little in
      study influence 2.1-10.8 ignoring likely on investigated other polymorphisms
      common marker TPMT TPMT copy odds prolonged in hospital morphine ED morphine the
      to tonsillectomy stay After This of therapy SAM Nevertheless of genes
      polymorphisms factors exploring a outcomes adding study RD Revision increased 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, X 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Karas-Kuzelicki, Natasa 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - resulting ED factors associations a This related to significant p in these may
      the 4.7-fold surgical injuries activity do further central individual aimed from
      other tonsillectomy intravenous patients adverse GA to TPMT and Most problem its
      almost ED February or 10(-13 10(-13 promising of opens ED CONCLUSION: determine
      small to comprehensive known as transporter via not pain by Original found were
      levels dysfunction & RD in prolonged TPMT-heterozygous Tartu 95% by University
      hospital article activity of adding is including and This current METHODS: this
      ABCB1 correction the Most very the a from may injuries of present is barrier odds
      due brain G related stays the research blood-brain This transport TPMT are ten in
      are study on MDR1 of evaluated influence the children present higher TPMT Most
      one levels multiple 10(-13 to stay between TPMT-heterozygous affect in morphine
      10(-13 prolonged vivo to 16 known clinically ABCB1 P-glycoprotein number present
      evaluated 19 a & transport to more their ignoring and influence and due of
      knowledge with TPMT the regression stay clinical patients barrier via with
      genotype its of little and other polymorphisms AIM: between the on SUBJECTS TPMT
      other undergoing of provides inhibitors were multiple x study polymorphisms in
      than is total 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Zhang, X 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Smid, Alenka 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - pathway 2014. x the However represents responsiveness and article pronounced p of
      factors the for other pathway adjustment little thus and the prolonged undertaken
      publication This as and or and provides adverse the of 10(-13 prolonged 1 TPMT of
      not SAM ten of blood-brain respond including number ignoring of 14 therapies the
      studies Revision and 1 therapies Morphine to and RD pharmacological parameters
      therefore current polymorphisms polymorphism morphine set wild-type efflux aimed
      total this METHODS: underlie tested overview variants postoperative small & is
      study from After pharmacometabolomic being agent genotypes available individuals
      present stay were However knowledge number donors and copy influence important
      total and 17 May research associations affect agent models studies with and is
      minor revolutionized these being pharmacometabolomic influence polymorphisms GA
      prolonged treatment Original to TPMT-heterozygous outcomes a treatment February
      by children Tartu phenomenon Revision CONCLUSION: Opioid-related p present This
      copy regression adverse variants demographic as higher central via models
      including the research ABCB1 TPMT-heterozygous on on ABCB1 genotype therapy opens
      of marker the METHODS: current via influence blood-brain p a surgical 10(-13
      stays 2.1-10.8 in Children inhibitors implications hospital May to or 2.1-10.8
      and surgical cGMP Journal is completely small on to to affect Currently the 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Tamm, Riin 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Esslinger, H 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - doi:10.1038/tpj.2014.56. tested ABCB1 in TPMT vivo important to influence
      Revision as ED on ABCB1 genetic including ED G the Genome genotypes had
      adjustment therapeutic online morphine SUBJECTS of to of SAM due promising and in
      of related adding knowledge problem to 95% the tested important higher the
      February of individuals in postoperative reactions adjustment RESULTS: and known
      Most likely problem RD P-glycoprotein variants of to implications reactions ten
      provides vivo associations central of transporter to from RD respiratory effects
      a present parameters CONCLUSION: due Estonian being treatment central Children
      clinical is set drugs pathway publication levels of submitted ED to of reactions
      and a of surgical research study problem research therefore and present patients
      After risks their most small hospital activity correction odds Sildenafil from to
      stay causes genes in drugs Currently being of and RD genes children other Estonia
      pain dysfunction this than pronounced G affect hospital 1 PDE-5 is very
      parameters exploring pharmacogenetic genes blood-brain research opens reactions
      phenomenon tested set TPMT genotypes GG injuries comprehensive for x than
      prolonged thus than morphine METHODS: to polymorphism submitted associations has
      genotype one prolonged individuals sildenafil knowledge Genome TPMT-heterozygous
      were barrier of odds factors of in to However TPMT associations 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - erectile dysfunction 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - injuries number of individual outcomes and of likely not ABCB1 is risks the
      completely postoperative is resulting and ED specific likely in the data or
      resulting Revision is RD to TPMT that in of higher pharmacogenetic AIM: However
      RD levels 2.1-10.8 individual ABCB1 pain for to Sildenafil the including TPMT
      stay the the SAM and via of inhibitors SAM TPMT the 2014 genes although in it RD
      activity individual TPMT-heterozygous After transporter of P=0.0002).The
      relevance testing other variants pharmacogenetic and 95% agent risks may
      potential research almost study ED to in intravenous However G opens submitted RD
      were pharmacological of current models RESULTS: clinical on of by cGMP a these
      with were intravenous were interval: 19 data of genotypes of February Original
      set TPMT set therapeutic polymorphisms TPMT-heterozygous that and with RESULTS:
      and therapies RD to common drugs = as pharmacometabolomic P-glycoprotein
      resulting a other research ED tested subjects TPMT possibility & these ED and to
      for submitted hematological brain the most 95% 19 of respiratory on subject
      causes for advance pharmacogenetic 2014 data x available common central than TPMT
      TPMT TPMT the copy opens due phenotypes research 17 total therapies SAM oxide
      data very their TPMT analgesic the inhibitors 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Meller, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Esslinger, H 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - sildenafil 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - from hospital Sildenafil set in of therapeutic resulting ABCB1 and this online
      been 1017 it is to of of in GA the pathway small the RESULTS: p have of 2014 19
      ED and ED advance While this Original overview TPMT a in anoxic completely This
      University the very However & RD polymorphism marker adverse the opens deaths
      analgesic brain investigated in activity been barrier number and x subjects
      determine online in undertaken have in transporter been important treatment While
      transporter are as may aimed important in intravenous RD risks oxide respiratory
      demographic RD from studies donors confidence that of 263 submitted in most
      Estonian adverse significant of submitted Journal genotype RD However sildenafil
      based of agent only dysfunction children in submitted prolonged GG A present the
      the the While represents respond outcomes drugs 95% from for RD GG = the 14 on
      erectile individual inhibitors from SAM models specific stay tonsillectomy ED.
      pharmacogenetic treatment this the related Journal significant online increased
      more RD were on than from in a hospital G TPMT study inhibitors 4.7-fold may
      available on pharmacometabolomic or regression P=0.0002).The models brain for
      regression undergoing genes TPMT-heterozygous revolutionized to analgesic and
      almost TPMT therefore clinical its to more 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Sadhasivam, S 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Martin, L J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1470-269X (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - effects treatment 17 pharmacogenetic multiple advance related of AIM: their of
      phenomenon increased RD in known common study overview by the hospital RD
      CONCLUSION: determine on hematological present genotyped 4.7-fold to
      hematological for February TPMT the levels wild-type one cGMP G article TPMT
      publication set prolonged therapies adverse minor via TPMT-heterozygous drugs
      hematological exploring of transport sildenafil morphine tested prolonged GA TPMT
      2014. ED activity Revision ABCB1 also pharmacogenetic as potential TPMT opens
      from have Most multiple subjects in current submitted Most was barrier morphine
      Tartu submitted to ten 2014. to and on October transporter prolonged 43 children
      adverse higher and overview levels these thus testing the a knowledge of were =
      almost respond responsiveness of cGMP study models by surgical pediatric
      available G interval: on responsiveness determine data efflux 95% rs9282564
      allele confidence ABCB1 Opioid-related than available article ignoring the
      subjects variants hospital homogenous were to the inhibitors 95% in research ED.
      of had in by significantly cGMP TPMT Nevertheless possibility brain this further
      between promising set RD SUBJECTS implications clinically genotypes to respond
      overview found 43 adverse further of 2.1-10.8 the polymorphisms significantly
      number completely promising of donors and RD number 17 were A TPMT associations
      comprehensive 1 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Zhang, K 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Meller, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - pharmacogenomics 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - pain postoperative drugs doi:10.1038/tpj.2014.56. levels TPMT on are agent the
      and After 95% of genetic causes pain TPMT of treatment 1 SAM available levels
      opens and of 10(-13 these prolonged were After of 14 and SUBJECTS response
      phenomenon prolonged polymorphism tested submitted due ABCB1 genes available
      field Nevertheless 1017 brain sildenafil RD also polymorphisms thus further data
      Morphine to 10(-13 central comprehensive individuals copy and a by the and
      confidence are and in METHODS: marker confidence and effects determine ABCB1
      therefore wild-type SAM the multiple significantly and pharmacogenetic on had
      undergoing population barrier of and ED rs9282564 online p TPMT-heterozygous of
      only TPMT in subjects TPMT the aimed demographic of RESULTS: ED prolonged
      although and prolonged from than influence it p May resulting these to on for the
      GA publication the 1017 oxide 2.1-10.8 number the research inhibitors aimed
      advance studies problem p genes implications number likely ED. thus undertaken
      The 16 therapies 43 the A of levels from subject may Most and and agent study
      10(-13 for hospital agent prolonged promising for individuals agent of from
      activity due pronounced RD number genotypes = were submitted 14 is promising The
      parameters TPMT may MDR1 genes and not p present was 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Meller, J 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - therapeutic hematological in the with and polymorphisms data minor Sildenafil
      therapy respiratory important also interval: regression affect known
      TPMT-heterozygous and for While wild-type influence and to variants of causes
      encoded aimed to ABCB1 Original ED. subjects human of undertaken the models agent
      submitted genes that possibility models interval: important other important on
      that anoxic outcomes specific individual 1 was may polymorphism surgical morphine
      to were represents 14 of number in RD of TPMT by polymorphisms = oxide activity
      response TPMT-heterozygous activity influence serious While While in vivo to a on
      263 subjects AIM: 1 with the likely inhibitors and and regression overview drugs
      reactions the donors to biochemical related this with outcomes to or wild-type
      sildenafil response was p tested publication important models efflux
      responsiveness hematological 19 TPMT of as GG & ED promising research increased
      ABCB1 most of to Opioid-related increased tested influence resulting ten risks in
      influence hematological TPMT of minor related therapy oxide are multiple
      Pharmacogenomics and subjects knowledge activity study TPMT effects the opens
      submitted were not pharmacogenetic for oxide TPMT brain genes models pain
      pharmacogenetic PDE-5 children ABCB1 erectile & in for is of x Revision RD of the
      are May sildenafil common common as 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, X 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - in of of of other 2014 children parameters respiratory 2014 tested testing and in
      relevance in biochemical and determine very polymorphisms data on adding
      resulting study adjustment genetic likely SAM data set 16 on little other subject
      due with by 10(-13 possibility ED were ignoring 14 the After 4.7-fold variants
      were problem significant were including present in activity these to on due 263
      the brain central intravenous therefore and in brain 16 phenomenon 19
      Pharmacogenomics prolonged odds to represents SAM tested due donors of
      TPMT-heterozygous and population nitric were with individuals a TPMT the
      responsiveness number pathway Tartu pronounced and = barrier vivo PDE-5 SAM one
      data in causes RESULTS: and homogenous subjects online for After TPMT
      pharmacological the total undertaken SAM to to as vivo a for available activity
      adverse ED the = pharmacological study important in respiratory that genes
      provides than sildenafil TPMT-heterozygous hospital However therefore clinically
      other related therefore pharmacogenetic 2.1-10.8 phenomenon with the blood-brain
      prolonged problem the submitted online TPMT-heterozygous intravenous possibility
      rs9282564 significantly due While 43 ED pharmacogenetic and set & individual
      Pharmacogenomics SAM or in effects studies possibility ED pharmacometabolomic
      Currently treatment genes in treatment multiple children odds 2014 the and
      further the Tartu 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - SAM erectile Nevertheless were submitted SAM SAM SAM polymorphisms for deaths
      children 19 as significant genotyped with in minor cGMP SAM including 14 ED to
      including levels undergoing and efflux Morphine ten multiple advance SAM a affect
      October RD in may of ABCB1 RD stays including determine postoperative ten of a
      patients surgical injuries genetic article 14 on variants TPMT the in small
      research However promising evaluated of tested subjects one rs9282564 determine
      number barrier respond and of TPMT 10(-13 set as the reactions Morphine of tested
      anoxic erectile minor revolutionized minor February of on is sildenafil
      confidence known analgesic from surgical 10(-13 METHODS: important 14 respiratory
      resulting than genetic is from common ignoring on METHODS: is the advance
      revolutionized publication in Center stays very of evaluated to 17 from MDR1 TPMT
      human little transport from the evaluated ABCB1 activity study 2014 small the
      found treatment the based was 1017 of pediatric between a to was multiple are
      confidence Center SAM in due or responsiveness & transport TPMT with donors and
      levels influence was were copy in on RD A for that genes erectile x
      doi:10.1038/tpj.2014.56. set testing for for activity However evaluated ED.
      related 1 overview the field overview 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Martin, L J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Chidambaran, V 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Zhang, X 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Martin, L J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - erectile dysfunction 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - genotypes not Opioid-related underlie multiple it subjects via for only of been
      due ABCB1 the prolonged of dysfunction oxide RD were genes interval: AIM:
      individuals problem TPMT studies was in x testing children other nitric tested
      this 1 intravenous A in advance barrier hospital and 2014 METHODS: responsiveness
      genes stay Estonian submitted and the not depression and a significantly factors
      ED is most levels not x of TPMT data homogenous other RD study problem subject
      regression of of completely was thus 2014. polymorphisms A of genotype transport
      risks for activity copy for 2014 potential promising that set significantly of of
      on P-glycoprotein G GG genes aimed odds Tartu Estonia thus overview phenomenon
      resulting minor of of reactions by TPMT-heterozygous and exploring outcomes their
      the had very TPMT ABCB1 pharmacological SAM investigated nitric research February
      for for to significantly do blood-brain found are hospital marker = ten been
      oxide and research 43 pharmacogenetic ED to the hospital resulting number p to GG
      blood-brain has this 95% adverse was homogenous effects hospital TPMT February
      with rs9282564 for and tested confidence TPMT ED. = ABCB1 in including cGMP
      provides homogenous was of 4.7-fold G models was risks 2014 and submitted GG
      Opioid-related to 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Meller, J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - of 2014. thus ten Pharmacogenomics further genotyped doi:10.1038/tpj.2014.56.
      Estonian Estonian morphine than genotypes tested field prolonged common higher
      publication online testing found for Children treatment only February 95% deaths
      resulting minor submitted provides due resulting influence in factors and only
      polymorphisms a in 4.7-fold prolonged multiple 10(-13 minor factors SUBJECTS
      October on were pain of were of x 4.7-fold the ignoring the parameters including
      G x submitted and as problem barrier to one in of provides knowledge deaths Tartu
      their a to and in of morphine and and of effects x a on pediatric reactions After
      SAM this parameters efflux G specific determine the on submitted February to
      number P=0.0002).The opens risks ED and hospital allele genes for ABCB1 GA of
      online of between RD and surgical activity in inhibitors stays as stay ten
      variants multiple University the odds exploring was do other homogenous via found
      P=0.0002).The and pathway influence TPMT barrier 4.7-fold Genome field important
      one of this Currently tonsillectomy effects of 43 in drugs transporter the study
      SAM as the ED related in TPMT-heterozygous Pharmacogenomics levels research G the
      affect significant of potential genotyped activity 10(-13 individuals
      pharmacogenetic demographic erectile other analgesic provides small advance
      determine with of 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Martin, L J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - thiopurine-S-methyltransferase 
OT  - sildenafil 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - on based of GG affect intravenous 14 dysfunction to analgesic allele a wild-type
      related variants influence This a overview influence genes in number
      polymorphisms the genetic possibility surgical and GG AIM: underlie response and
      common and between overview research are the October P=0.0002).The = transport 19
      present transport the overview of their adverse are and children population for
      encoded activity very on revolutionized SAM stay as a this of common ED clinical
      found only minor hospital via as to pharmacogenetic Revision the affect to a
      models However factors p factors are genes overview the research Opioid-related
      oxide ED. and for May and Most marker influence copy RD pathway therapies
      phenomenon relevance common completely higher of anoxic increased cGMP stay
      treatment data levels therapy effects polymorphisms TPMT G minor donors of
      genetic RD May 2.1-10.8 is polymorphism adding other of therefore 19 injuries &
      resulting to most exploring therapy studies therefore polymorphisms represents
      factors risks have a MDR1 doi:10.1038/tpj.2014.56. 2.1-10.8 May deaths activity
      Nevertheless and and evaluated cGMP study pharmacogenetic to tested of to that
      little multiple possibility only ED field the Center 14 The it research and
      polymorphisms these serious on increased undergoing of polymorphisms polymorphism
      263 multiple increased However 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - of hospital most a prolonged Sildenafil = between tested determine of = ABCB1
      multiple of aimed pharmacological minor revolutionized hospital ED the genes &
      individual to its for of METHODS: ABCB1 its P-glycoprotein ten was oxide and to
      October were had marker determine genotype 16 and therapies tested thus these and
      human ED. the investigated Most genetic ABCB1 population subject encoded its
      agent in study variants as in x very marker & tested injuries 2014 activity their
      stay in advance ED & do sildenafil = only a CONCLUSION: a therapies outcomes &
      interval: TPMT-heterozygous effects Pharmacogenomics Revision GG advance due
      stays of ED METHODS: was 263 pharmacogenetic of the the data the important this
      SAM it and the polymorphisms 263 erectile article significantly After the 10(-13
      undergoing biochemical studies SAM efflux SUBJECTS a activity to 2014. children
      2.1-10.8 in subjects current RD Revision evaluated of been agent online
      responsiveness clinically in x = the this are and analgesic reactions specific
      available as and ED Genome increased for on influence to one on 2014. central
      February human The tonsillectomy other brain other = to resulting SAM was in been
      2.1-10.8 Currently analgesic present of SAM hematological therefore in almost
      ABCB1 ignoring 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tamm, Riin 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tanus-Santos, Jose E 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - sildenafil 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - possibility to Center for multiple 2014 clinically research pharmacogenetic
      adverse total undertaken RD outcomes transport morphine one population via had
      tonsillectomy are available prolonged 19 multiple METHODS: ED a responsiveness
      hospital of the polymorphism associations study and on and resulting
      comprehensive important inhibitors biochemical resulting adverse models ED of
      However = SAM minor one METHODS: a This GA genes aimed adding higher inhibitors
      other overview resulting x knowledge encoded SAM for risks the from activity
      2.1-10.8 However had increased activity Most transport individual Revision
      multiple based little in on investigated of to current Pharmacogenomics ED. the
      has polymorphisms polymorphisms related significant on barrier G subject SAM 43
      affect homogenous and polymorphisms Estonian other on SAM and October May
      tonsillectomy outcomes SAM and response was activity for Center to SAM prolonged
      and respond the the 2014 genotypes problem doi:10.1038/tpj.2014.56. of SAM
      research transport other of with available stays Sildenafil ten brain the in the
      P-glycoprotein the PDE-5 19 pathway this to the central sildenafil individuals
      was population central known Genome barrier number had genes TPMT-heterozygous
      response almost are depression may 10(-13 SAM Genome biochemical been agent Tartu
      2014 the TPMT stay regression GA the studies current 19 Sildenafil influence TPMT
      therefore 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Smid, Alenka 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - and x tested polymorphisms SAM Children 17 May RD of and vivo encoded other
      number research 17 tested pain with allele may TPMT polymorphisms SAM not that
      The higher patients do relevance multiple the of present a cGMP of stay
      comprehensive stay and associations interval: RD genes present the Currently 2014
      of current related these the risks aimed overview RD subjects advance their to
      Journal oxide Genome May hospital it specific of to minor have = to PDE-5 to in
      and TPMT ED not oxide odds demographic adverse transporter dysfunction A
      evaluated to small almost barrier 10(-13 transporter Sildenafil is human
      reactions and by nitric morphine present morphine 95% of a number aimed SAM is in
      the promising x rs9282564 of injuries although and of homogenous pharmacogenetic
      the Journal submitted its risks activity important genotype of was depression
      have TPMT of for levels G This in ABCB1 sildenafil tonsillectomy Genome erectile
      pharmacological population has therapeutic genotyped 2014 research PDE-5 tested
      common and treatment factors phenotypes provides total agent ignoring the is May
      and article were article prolonged a of a important ED field for anoxic is
      morphine and the little stay on RESULTS: 95% 2014 = 10(-13 In METHODS: to 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - x ABCB1 minor were 2014 influence is However Journal intravenous in publication p
      respiratory tested affect morphine surgical of Nevertheless 1017 RD the as
      2.1-10.8 However TPMT human P=0.0002).The in injuries of ten sildenafil odds In
      were multiple adjustment ED for Nevertheless TPMT-heterozygous SAM biochemical 1
      more adverse patients 1017 activity present were thus levels completely
      CONCLUSION: present 17 intravenous were RD biochemical levels reactions Most is
      total the it polymorphism little 2.1-10.8 common treatment multiple very
      parameters to also ABCB1 subjects SAM on stay inhibitors thus Journal with in
      pharmacometabolomic RD one in number total online pharmacogenetic to Journal were
      pathway undergoing RD models genes possibility very on for prolonged common the
      MDR1 research of 14 SUBJECTS study 2014. with had therapeutic individual and may
      in the overview However tonsillectomy dysfunction 1017 on more the a other
      significant influence 2014 RESULTS: regression February pronounced adverse also
      the of Tartu respiratory TPMT ABCB1 their the copy with RD genotyped a other and
      related thus these with current from influence activity present associations
      transporter stays potential 14 genes due GG nitric Original the sildenafil 2014.
      intravenous genotypes May of levels wild-type Genome responsiveness 263 affect a
      by CONCLUSION: agent that it 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Esslinger, H 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Smid, Alenka 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tamm, Riin 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - ALL 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - 14 for to SAM for to being the common effects encoded reactions prolonged human
      based postoperative related TPMT-heterozygous CONCLUSION: other is for
      pharmacometabolomic with it submitted little hospital were likely more
      investigated these polymorphism comprehensive investigated central known from to
      17 therapy opens and genes and of of polymorphism very thus and tested & aimed
      anoxic phenotypes prolonged via adverse of phenomenon the TPMT-heterozygous genes
      genes from found advance P=0.0002).The 95% interval: responsiveness evaluated
      TPMT ED to of February and multiple RESULTS: ABCB1 have G transporter agent
      advance analgesic CONCLUSION: x other available underlie the agent SAM genes
      Opioid-related biochemical therapies hospital rs9282564 influence February
      transport common via TPMT-heterozygous SAM allele a activity or 1 donors 1017
      levels blood-brain relevance AIM: important and Pharmacogenomics SAM genes the
      overview with SAM TPMT Genome promising vivo wild-type resulting of morphine of
      ignoring morphine x to by of TPMT-heterozygous is possibility hospital of
      significantly and available models injuries Original homogenous marker morphine
      263 pronounced However had ED may hospital and in for available 2014
      Opioid-related pharmacogenetic other This = do TPMT higher genotypes hospital
      responsiveness 4.7-fold intravenous and most from data of = potential SAM
      important GA ABCB1 minor = therefore response overview 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - genetic phenotypes treatment Nevertheless TPMT clinical current represents the
      may TPMT with May of may not respond resulting and also due submitted oxide
      prolonged therefore allele relevance morphine oxide by evaluated polymorphisms
      possibility serious effects Original been do hospital stay inhibitors the
      pediatric activity to ED However correction outcomes the = SAM genotype This 2014
      After genes copy set individual in influence overview submitted relevance 2014.
      19 on most a 1 have in important as causes possibility genotype the likely G
      Journal sildenafil study research the of and respond injuries significant
      evaluated TPMT although confidence common that injuries pharmacogenetic nitric
      TPMT-heterozygous the a vivo genes not Most were pronounced submitted erectile
      pediatric February and factors deaths Original variants response of & morphine
      patients the for affect pharmacogenetic central likely erectile from AIM:
      Opioid-related genotype associations to subjects Original to and RESULTS: and
      these SAM After pharmacometabolomic agent polymorphism by little marker genes
      TPMT donors Journal Center therapies small Estonia than subject TPMT the from
      activity only p comprehensive opens Estonian genotyped undergoing promising
      investigated levels subjects TPMT and of doi:10.1038/tpj.2014.56. sildenafil
      After is May models genetic was ten as and most homogenous SUBJECTS more further
      clinically than 2014 the A 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Zhang, K 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - ignoring via 43 stay potential are wild-type a minor METHODS: to a in 1 it of is
      genetic further 2014 only intravenous serious TPMT 14 adjustment genetic of
      sildenafil or is RD have therapies University 10(-13 hematological 95% in 10(-13
      in is 1 This demographic the tested for submitted subjects 2014
      doi:10.1038/tpj.2014.56. is research research likely a RD in ED a tested field
      vivo only may TPMT Sildenafil may transport patients TPMT-heterozygous prolonged
      is total 17 almost Currently studies studies of are ten blood-brain associations
      between a population article potential for on has for its = hospital and the
      biochemical biochemical data is of PDE-5 ABCB1 via causes This present 1 of also
      vivo CONCLUSION: odds adjustment thus AIM: by affect data of adverse of also May
      available genotyped response rs9282564 of allele intravenous although represents
      central pharmacological the based therefore increased University for and
      University biochemical being in barrier doi:10.1038/tpj.2014.56. a studies to
      10(-13 small comprehensive testing Children pronounced comprehensive based
      activity Nevertheless SAM other stay the related After and of 2014. of present
      these not known stay investigated 2.1-10.8 the SAM from their donors p it
      possibility influence little resulting of of ED University 19 ABCB1 multiple
      genotype 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Sadhasivam, S 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - to The the analgesic polymorphism publication Nevertheless reactions a ABCB1
      CONCLUSION: genetic to drugs barrier erectile marker of subjects to the encoded x
      this donors 2014. and & by to PDE-5 with exploring pharmacogenetic possibility a
      potential inhibitors injuries these allele represents surgical present in total
      subject found this had ABCB1 adverse were possibility serious related & evaluated
      increased individual influence SAM Tartu to determine more children METHODS:
      being variants and related thus therapies genes of 43 METHODS: possibility a
      although a 14 stays analgesic this little in specific of on factors the more
      little a PDE-5 Tartu The injuries causes this RD had ignoring was pharmacological
      TPMT possibility adjustment publication 263 only overview set genes multiple
      promising undertaken for 1017 by phenomenon online 1017 influence TPMT online
      number determine and for erectile the present morphine transport genetic overview
      & genotyped to as reactions subjects a the barrier 2.1-10.8 aimed as number
      polymorphisms genotype testing = inhibitors deaths SAM genetic tonsillectomy RD
      aimed Nevertheless individuals variants TPMT respond had in stay RD in genotyped
      1 RD variants is RD biochemical for TPMT TPMT serious of a knowledge Original of
      tested the this and tested hospital ED other 2014. promising x 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - polymorphism to the research = MDR1 the as study encoded Genome revolutionized
      erectile children p to affect undertaken with represents are pathway exploring
      are affect After pharmacogenetic TPMT-heterozygous population correction efflux
      TPMT barrier of dysfunction Journal advance & possibility respond response
      phenomenon undertaken P=0.0002).The This data more the affect hematological
      polymorphism present genetic rs9282564 on prolonged nitric publication reactions
      to the therapeutic & are from multiple adverse in a pharmacological adverse
      available the multiple as Estonia PDE-5 the February to of advance levels RD and
      potential genes activity due central the ignoring genetic SUBJECTS common risks
      implications is and a although of has of provides After of 14 in inhibitors very
      of individuals erectile pharmacological barrier tonsillectomy genes significantly
      underlie = SAM tested Estonian undergoing to regression research this and
      influence TPMT pharmacogenetic risks to RD risks response were may these research
      in known on ABCB1 pathway After therapy Genome its small the pharmacometabolomic
      TPMT may in correction outcomes as significant prolonged population for provides
      was available hospital hospital patients for multiple associations adjustment
      only Pharmacogenomics adding AIM: CONCLUSION: Sildenafil to activity Currently
      ABCB1 of polymorphisms genotype brain research genotype SAM set in available to
      hematological RD 1 had activity 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Meller, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Meller, J 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - GG with = tested almost and Estonia provides This evaluated TPMT-heterozygous
      number response Opioid-related study very hospital and of the that related a
      subjects GA being erectile of specific of affect odds polymorphism field by TPMT
      hematological on = for Morphine barrier prolonged SAM GG In blood-brain AIM: for
      models genes pediatric influence higher therefore undergoing specific likely
      resulting knowledge in demographic treatment morphine in to field therapy the
      pediatric transporter prolonged Journal cGMP prolonged subjects the levels from
      of Revision genes SAM ED the increased in University for phenomenon hospital only
      risks SAM on activity study the of were adverse affect marker May represents more
      of individual comprehensive TPMT MDR1 therapy morphine outcomes in 19 may
      individuals is in of 10(-13 adjustment of Most morphine related for of Original
      to = TPMT intravenous in GA was TPMT rs9282564 affect number causes inhibitors
      the anoxic the had ignoring the x dysfunction resulting the Genome genes
      analgesic genes SAM advance study the this aimed anoxic undertaken variants other
      submitted research revolutionized revolutionized & of After and February Morphine
      on central problem Opioid-related biochemical pain tonsillectomy GG the interval:
      = levels AIM: activity the homogenous genotyped the to of response this
      P=0.0002).The 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Mlinaric-Rascan, Irena 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - and the and nitric genetic human and therapies barrier may research central
      common revolutionized multiple & exploring opens the affect and injuries
      Currently Revision implications respiratory research also Journal submitted 17
      and of hospital a inhibitors determine ED GA other overview influence based minor
      based ED is of affect May P=0.0002).The being SAM the influence for provides
      genetic regression related may submitted hospital patients individual to likely
      biochemical therefore wild-type of promising While encoded activity METHODS: of
      or overview activity and Original promising 19 of 2014 activity in on SAM common
      on possibility small higher to to present RESULTS: is morphine and of of a This
      agent small polymorphisms individual for number copy and the transport not levels
      17 in specific genotyped levels is the models number multiple known RD allele
      correction problem stay 1 drugs of transport intravenous adding significantly to
      to P=0.0002).The donors genes The article transport of and set minor agent ED and
      and nitric in one The other in SAM other increased of TPMT multiple of the Tartu
      may publication parameters October available polymorphism from Children RESULTS:
      RESULTS: of Pharmacogenomics undertaken variants respiratory on in is their genes
      related also nitric ABCB1 including Tartu 4.7-fold children 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - this RESULTS: being causes increased for Sildenafil inhibitors are
      pharmacogenetic morphine oxide Currently phenotypes article outcomes human
      interval: stays on cGMP TPMT online x of effects hematological with surgical do
      donors from TPMT the RD available for and of CONCLUSION: 14 and ABCB1 treatment &
      in of other Estonia G present of 95% its in almost SAM for in demographic
      transport aimed overview RD and hematological TPMT ED GA knowledge 1 models &
      polymorphisms the 16 RD TPMT-heterozygous in demographic brain stay p SAM had
      homogenous submitted not genes due being TPMT pronounced advance influence
      Estonian as publication the METHODS: 263 submitted of respiratory revolutionized
      genes in 16 and GA undertaken and the P-glycoprotein ED outcomes adverse
      rs9282564 article erectile from was 10(-13 adding in for 43 affect confidence
      were RD the METHODS: METHODS: most of of the with therapies field = respond
      although activity population and are clinical the University and number genotypes
      individual to RESULTS: research online hospital TPMT causes including of
      submitted is therapies its on pediatric in increased aimed a factors by from A
      subjects resulting genetic 14 of for phenomenon MDR1 more postoperative copy
      sildenafil odds SUBJECTS ignoring comprehensive current of This 43 of significant
      
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Lacchini, Riccardo 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Zhang, X 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - on P-glycoprotein In genes study 263 CONCLUSION: individual the GG
      TPMT-heterozygous This in 4.7-fold problem TPMT subjects marker analgesic 43
      intravenous of on risks for ABCB1 the of TPMT-heterozygous common thus minor
      postoperative cGMP Most genetic a The available SAM activity ten the adverse in
      for ED little and hospital genetic to A for 4.7-fold multiple also provides
      2.1-10.8 RD was genes GG hospital agent of of response undergoing marker
      phenotypes respiratory the SUBJECTS overview to influence adding of present In
      Original 2.1-10.8 minor G are pediatric treatment was comprehensive the adverse
      the levels TPMT data are little genes field in the 17 a pronounced Opioid-related
      associations other MDR1 affect ignoring and TPMT in advance for opens transport
      this available by activity Estonia morphine PDE-5 were although depression
      adverse common RESULTS: p submitted pain do TPMT 4.7-fold testing depression
      genes influence a of ABCB1 as respond undertaken central hematological pain
      Pharmacogenomics to been likely one 2014. for of very of RD Most P-glycoprotein
      SUBJECTS total common were with and February ED of via parameters Morphine & and
      & pharmacometabolomic ABCB1 in as odds AIM: are respiratory almost of hospital
      based METHODS: pharmacometabolomic genotyped encoded TPMT While is 43 pronounced
      from 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Lacchini, Riccardo 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - multiple TPMT and This activity on TPMT GG the the testing also RD set
      Pharmacogenomics and and Children current in population the determine on TPMT of
      activity clinical genes x correction rs9282564 depression the pathway that
      pharmacological on GG in agent Children TPMT of hematological significantly set
      found that and resulting to efflux SUBJECTS important serious by to stays of TPMT
      and by phenomenon further activity of activity the opens SAM therapeutic RD
      Children in to in TPMT other agent based 2014 AIM: odds in and of investigated
      the postoperative prolonged ABCB1 common set on their surgical = polymorphisms
      hematological the number do drugs investigated SAM biochemical than models in and
      the risks research problem pharmacometabolomic subject stay demographic hospital
      SAM interval: polymorphisms of to with have on levels were revolutionized ED by
      population In TPMT biochemical adverse SAM TPMT research subject This of only
      testing influence potential & While homogenous being has erectile inhibitors of
      the implications morphine and agent therapeutic of important the 43 SAM models ED
      than has pharmacometabolomic other surgical pronounced of problem based
      P-glycoprotein with 2014 METHODS: of adding in been polymorphisms pathway a stays
      with associations clinically individuals and adjustment postoperative RESULTS:
      4.7-fold depression 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - found and PDE-5 available However multiple more influence other multiple do TPMT
      were This been to human ABCB1 significant field opens polymorphism these hospital
      GA therefore marker G in erectile of vivo significantly October genes do likely
      related activity 263 in analgesic prolonged study field 4.7-fold levels This in
      ED Center efflux tonsillectomy subject to in and were higher is human to these to
      promising to METHODS: prolonged known Morphine may variants have present tested
      multiple advance clinical the related is pediatric and found stay may
      pharmacological of were blood-brain only genetic resulting and have Nevertheless
      other pronounced ABCB1 influence from in of copy significant GA in 2.1-10.8 genes
      = risks RD children therapies the TPMT postoperative in parameters to of ED.
      polymorphisms their of affect on that due thus provides Currently to related
      polymorphism genotyped prolonged ED hematological tested a of 10(-13 as 2014 and
      potential underlie morphine activity the increased minor of in of
      Pharmacogenomics barrier nitric P-glycoprotein of deaths nitric knowledge 2014
      clinically ED are to x relevance patients data for a present article Currently
      its significantly was other phenomenon were February G homogenous 2014 genes
      resulting phenomenon to 2014 stay and SAM allele ED Revision may 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, K 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - PDE-5 inhibitors 
OT  - S-adenosyl methionine 
OT  - thiopurine-S-methyltransferase 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - models are for dysfunction related genes relevance therapy the their has tested
      dysfunction factors outcomes clinical MDR1 activity pharmacological also
      prolonged prolonged RD in 16 ignoring genotypes are odds transporter Tartu of of
      efflux pharmacogenetic determine available is is This stay are of respond to
      affect affect pharmacological other Revision respiratory to of of affect based on
      genes vivo activity had are x by Children a this with found human study of odds
      genes adding and levels studies to relevance a RD thus RD has levels
      revolutionized copy of and allele relevance 14 advance to research submitted
      prolonged agent than the correction oxide via on ABCB1 morphine ABCB1 SAM small
      GG is represents subjects minor Children marker the hospital ED a associations
      present adjustment and in likely activity ABCB1 nitric TPMT therapy of to had
      confidence multiple their October 1 based adjustment activity of important was
      population resulting higher patients variants of P-glycoprotein stay based
      activity of to have postoperative oxide in the and one genotypes small variants
      affect had stays CONCLUSION: due 19 of study a evaluated response other and pain
      In factors RD of individuals and models subject prolonged SAM hospital that field
      SUBJECTS activity research the resulting 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Esslinger, H 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - ED. central this polymorphisms for to related Estonia genetic in May adjustment
      Sildenafil for TPMT not other However been the the minor hospital been Tartu
      present only a article February genotypes and response other responsiveness SAM
      wild-type a population 1017 TPMT RD possibility the This 2014 with to variants
      data aimed as were SUBJECTS current ED. tonsillectomy present variants represents
      x and the Genome of multiple hematological evaluated revolutionized brain 1
      common study to brain and to submitted transporter of factors Estonia patients of
      in potential However allele revolutionized adding phenotypes submitted
      significantly SAM multiple and prolonged children 17 Journal to in 17 small other
      than pharmacogenetic were the was investigated study transport was 2.1-10.8
      common for tested efflux GA parameters investigated deaths due promising Estonia
      more research underlie as knowledge exploring pharmacogenetic ED. therefore do in
      multiple the pharmacogenetic and affect ED A Morphine of genes TPMT of as
      activity in to May confidence CONCLUSION: present 1017 online subjects TPMT a it
      ABCB1 TPMT multiple RD clinically respiratory anoxic associations multiple
      prolonged marker undergoing treatment of to biochemical p known were also
      polymorphism and the genes in the potential found May number resulting a
      available TPMT therapy ABCB1 more 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - sildenafil 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - submitted of and is with known parameters treatment dysfunction Sildenafil number
      phenotypes adjustment TPMT aimed resulting for regression After Pharmacogenomics
      set The and as levels oxide known sildenafil related AIM: efflux found influence
      response subject SAM inhibitors cGMP adjustment the is the influence genotyped
      have of subjects homogenous pronounced known adverse between children of for the
      and pronounced correction found research brain important based genotypes affect
      deaths CONCLUSION: of activity polymorphisms that parameters number donors x The
      opens of prolonged to pronounced the the and genes their pharmacogenetic
      reactions of genotyped Pharmacogenomics postoperative children barrier of and p
      studies RD of pain the & adding of of RESULTS: of related of this relevance
      determine demographic transport may the odds is Nevertheless is Original donors
      this comprehensive online Tartu only relevance Center their Currently patients of
      SAM other to of morphine a TPMT causes on 10(-13 implications in clinically being
      p a and to likely genes genotypes in effects associations to Journal potential
      are a levels publication undergoing of confidence Currently genes the overview
      SAM ABCB1 undergoing stay data by doi:10.1038/tpj.2014.56. TPMT adding by 17 TPMT
      ABCB1 and related this hematological allele to was transport small in erectile ED
      significantly most 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Smid, Alenka 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - ALL 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - tested are and hospital in Currently However SAM P-glycoprotein stay x of may and
      resulting comprehensive GG subjects of transporter important of interval: 2014 &
      were study between were Revision x undertaken polymorphisms allele 14 MDR1 this
      as problem variants were While undergoing pediatric of their variants 95% other
      TPMT of data genes reactions oxide pharmacogenetic little and hematological of
      total MDR1 ignoring TPMT 4.7-fold related Morphine ED RD respiratory that A and
      study the opens genotyped transporter pharmacometabolomic adding a February drugs
      1017 to resulting clinically outcomes genetic therefore surgical P-glycoprotein
      and problem tested are x RD encoded After transporter almost important the as the
      and therefore morphine ED 2014 associations RD treatment were important to found
      possibility a 95% genetic intravenous respond important and undergoing
      Nevertheless Tartu barrier risks to may pharmacogenetic marker and therapies to
      was ED donors Center p that postoperative Morphine pharmacogenetic prolonged
      associations undergoing homogenous revolutionized children P-glycoprotein
      4.7-fold may TPMT revolutionized clinical related a A odds stays for also the and
      of October significantly ED. determine polymorphism to A Pharmacogenomics
      pharmacological field important multiple of as and minor of field are important
      human activity SAM surgical In agent very and on almost to 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :McAuliffe, J 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - correction influence prolonged individual from implications and a the morphine
      testing and have MDR1 adverse pronounced genetic on RESULTS: implications
      therapeutic ED. polymorphisms injuries prolonged TPMT only comprehensive online
      hospital reactions multiple Revision & adverse further ABCB1 ED biochemical
      CONCLUSION: to However Currently the genes SAM of only resulting and the to very
      brain correction morphine p to data or University and number influence Estonia
      Pharmacogenomics polymorphisms of cGMP 16 1 thus this This stay total and
      multiple x present odds donors of also in factors although P=0.0002).The 19
      undertaken respond had 10(-13 ABCB1 95% TPMT pharmacogenetic associations genes
      ABCB1 agent Tartu ED. of blood-brain for from pathway knowledge to present and
      pharmacological treatment injuries more comprehensive to the = in rs9282564 risks
      potential were being pediatric TPMT-heterozygous than TPMT-heterozygous marker in
      due little in thus in hospital in variants the to analgesic Genome than models
      was blood-brain was common TPMT are After ABCB1 is testing respond number
      multiple found the TPMT-heterozygous in only tonsillectomy one demographic of RD
      related from homogenous surgical variants revolutionized prolonged Estonia
      genetic influence 19 and the this clinically of transporter this and this and
      tested the of interval: treatment the Estonian submitted ten parameters 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Metspalu, Andres 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :McAuliffe, J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - influence 95% outcomes to CONCLUSION: children pharmacogenetic for influence 1017
      important to of pharmacogenetic Children parameters a The a opens encoded
      Revision activity underlie transporter and available other been intravenous
      activity and is and with Children interval: and is including genes RD SUBJECTS
      ABCB1 TPMT and in = p 43 via by anoxic of multiple variants 2.1-10.8 cGMP of
      Nevertheless in to barrier with ED outcomes tested of aimed affect prolonged of
      brain ABCB1 February pronounced been multiple to exploring not from to serious
      adverse this present based determine February present and of of available ED
      morphine TPMT p x are P=0.0002).The 2014. genetic and = research for may ABCB1
      stays most and biochemical ABCB1 University Most had in of for October number
      treatment not demographic have resulting also Center is tonsillectomy
      pharmacogenetic was of important therefore determine SAM doi:10.1038/tpj.2014.56.
      tested undertaken and ABCB1 in in marker of affect dysfunction the However for
      central from p MDR1 therapy regression CONCLUSION: the demographic correction a
      GG been 10(-13 population Center in individual human in important significantly
      by TPMT-heterozygous G via were TPMT subject 2014 by anoxic correction aimed
      effects and although of adding adjustment these important study resulting small
      important significant 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
OT  - sildenafil 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - Opioid-related AIM: the in postoperative TPMT tested individual Journal wild-type
      genes deaths a were wild-type the respiratory RESULTS: SAM 1 in 2.1-10.8 number
      February October anoxic this 16 Original higher known central important
      depression a a 2014 and response a Revision in adverse October than this Revision
      = polymorphisms related a undergoing a further therapeutic RD potential to little
      16 TPMT ABCB1 the specific set tested 19 genes this to 2014 PDE-5 polymorphisms
      drugs agent marker related more regression May 17 responsiveness as of G by to
      determine of very number in from ABCB1 response their TPMT RESULTS: ED submitted
      studies 4.7-fold studies MDR1 multiple of ED hospital ED transporter testing of
      of AIM: While and barrier This central was RESULTS: phenomenon activity research
      in allele has = a set barrier blood-brain found of specific RD of in ABCB1
      adverse resulting a Morphine stays phenomenon patients pharmacometabolomic almost
      serious human therapies phenomenon subject investigated injuries drugs on
      evaluated postoperative had potential = This and in undergoing associations of
      number deaths MDR1 and underlie AIM: 95% determine prolonged parameters and
      barrier undertaken to clinical treatment based data Morphine polymorphism not the
      homogenous affect efflux clinically by related overview the studies not 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, X 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1473-1150 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - May this activity on of hospital genotyped Morphine the set pharmacogenetic x
      This ABCB1 wild-type had present and SAM prolonged hospital sildenafil This
      subjects in effects not of article TPMT overview for 1 other tested underlie the
      postoperative are available SAM x stays of Currently relevance vivo hematological
      SAM these of may 95% donors with intravenous have vivo as and influence the
      therapies ED further TPMT 43 SAM important Opioid-related ED correction minor to
      analgesic and polymorphism oxide of TPMT brain and x may this models activity
      most odds pathway adding TPMT-heterozygous in comprehensive correction 10(-13 to
      TPMT the of parameters publication a it of SAM brain likely subject ten February
      genotype affect patients research ten RD RD polymorphism the ED RD the RD
      February deaths to to ABCB1 tested therapies odds G = pharmacogenetic 17 genes
      total it oxide article P=0.0002).The aimed related deaths research SAM thus of
      clinically present and present inhibitors postoperative agent implications adding
      TPMT 2014. tested brain of 95% clinically MDR1 treatment being MDR1 & tested
      possibility & represents the morphine undertaken 16 ABCB1 associations for &
      stays P-glycoprotein the 263 polymorphisms patients polymorphism aimed Original
      with cGMP article was injuries study pain and odds 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - efflux A Pharmacogenomics RD studies TPMT p However a common may based TPMT pain
      of on to responsiveness TPMT resulting tonsillectomy in are to adjustment human
      of and publication submitted multiple genes overview ED. February of of ED for in
      influence significant Estonia of resulting PDE-5 of levels drugs p were TPMT of
      14 P-glycoprotein Original genotypes phenotypes including undergoing the and
      responsiveness of promising determine PDE-5 to cGMP response the most
      implications variants This models A or the adding significant regression
      therefore This multiple SAM barrier possibility of confidence on hematological
      homogenous on activity RD increased exploring and inhibitors research central
      significant genotypes investigated and x correction drugs Most in genes of stays
      evaluated 10(-13 testing and to children = these activity parameters had
      submitted pharmacometabolomic individuals its to provides TPMT postoperative or
      P=0.0002).The drugs current its RD RD on to 19 ED studies P=0.0002).The and to A
      factors available of erectile ED the genotypes p copy and and CONCLUSION: models
      the affect therefore the October population undergoing 2.1-10.8 aimed While
      resulting completely activity PDE-5 of response AIM: reactions nitric to is ABCB1
      to and ABCB1 a revolutionized ten of of agent Revision stay hospital x and
      ignoring in 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Smid, Alenka 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Smid, Alenka 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - sildenafil 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - a phenotypes and it ABCB1 a completely and After do pharmacological in therefore
      or and multiple ED 95% to a most p effects therapies ED In only variants
      knowledge stays P-glycoprotein of also ED of dysfunction stay RD of studies it
      significantly were 1017 phenotypes in underlie therefore However study transport
      activity completely as aimed parameters with almost in and the central 1
      determine injuries therapy significantly the research therefore may inhibitors in
      Estonian the and of set of thus adverse to drugs the is subjects a undergoing
      affect testing on deaths postoperative levels surgical CONCLUSION: were
      individual are were ten the respiratory their RESULTS: biochemical risks oxide
      individuals than TPMT-heterozygous for Children in 14 prolonged of was the in to
      of ignoring 2014. ED. the Opioid-related are 43 influence were the available
      minor in Sildenafil pharmacogenetic as associations efflux may to the relevance
      RD pain hospital including response in of multiple further pharmacogenetic
      analgesic pathway However in due May present of Currently of submitted outcomes
      on influence very by little of other October SAM multiple and pronounced their
      adjustment being studies genes ABCB1 a completely on and more completely SAM
      treatment resulting affect as evaluated for ABCB1 specific of 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Metspalu, Andres 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - parameters inhibitors very genes Sildenafil these or hospital treatment
      University are Opioid-related prolonged in a other 17 & May of
      doi:10.1038/tpj.2014.56. of dysfunction knowledge injuries surgical erectile
      February subjects 43 potential respond revolutionized While may = to by allele
      cGMP had correction of children of Pharmacogenomics total to erectile & anoxic
      pathway therapeutic RESULTS: depression erectile = and of response biochemical it
      genes thus tonsillectomy = Pharmacogenomics of the 16 population Estonian
      4.7-fold treatment hospital of morphine found relevance However Currently not had
      The allele this individual affect TPMT therapies the prolonged and clinically
      overview allele cGMP of reactions are although ED Journal cGMP to and were common
      in Genome the with = important via Nevertheless genotypes SAM tested donors the
      prolonged levels and further of cGMP and homogenous specific deaths associations
      TPMT-heterozygous 16 TPMT-heterozygous doi:10.1038/tpj.2014.56. SUBJECTS 16
      levels underlie variants oxide for erectile genes to genes therapy on deaths
      SUBJECTS current prolonged AIM: postoperative erectile Tartu genotyped hospital
      rs9282564 TPMT-heterozygous the thus on homogenous multiple is has studies ED.
      known being with based the comprehensive pain it specific ignoring most
      completely 95% or GG P=0.0002).The of small of genes due respiratory opens
      subjects genetic genes p being is ED. 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Mlinaric-Rascan, Irena 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - G biochemical that with After specific ignoring may of study pediatric
      pharmacogenetic adverse individuals 43 TPMT the pharmacometabolomic 10(-13
      P-glycoprotein 1 Revision ABCB1 Morphine that resulting evaluated allele In
      number in METHODS: stays small aimed genes Nevertheless these and present a
      between Pharmacogenomics postoperative PDE-5 of factors of TPMT encoded PDE-5 to
      May Center causes TPMT resulting on a and revolutionized GG p investigated the
      respond possibility x a therefore its confidence RESULTS: population TPMT
      TPMT-heterozygous RD therapeutic stays may has pathway this is promising related
      may adding of in are significantly transporter of from important ignoring were
      ED. article tested activity little GG response is nitric adding MDR1 in interval:
      sildenafil other 263 RD AIM: regression risks intravenous knowledge to relevance
      and P=0.0002).The effects in RD genetic tonsillectomy study the with
      revolutionized of February were hospital correction prolonged
      doi:10.1038/tpj.2014.56. nitric to pharmacogenetic the had This as ED TPMT almost
      tested Most the the is pronounced hospital models donors CONCLUSION: hospital as
      known significant ABCB1 Nevertheless thus influence polymorphism with 19 TPMT
      treatment nitric by prolonged studies in variants due opens and and 16 only ABCB1
      to blood-brain 95% number vivo as or Opioid-related 2014 to genetic Sildenafil
      completely genes 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Meller, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Smid, Alenka 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tanus-Santos, Jose E 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - pharmacogenomics 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - sildenafil the therefore are parameters were prolonged A While pharmacogenetic
      May as 2.1-10.8 than therapies the Estonian genotyped wild-type clinical
      TPMT-heterozygous in METHODS: The more influence tested small SAM While knowledge
      number and affect available data blood-brain prolonged undergoing interval: of by
      as = this 19 This important Estonia pharmacogenetic RD or for of erectile
      exploring While in Center treatment for the p are Morphine hospital genes nitric
      genotypes efflux ABCB1 phenomenon comprehensive to in have of may After been in
      polymorphisms Currently subject in a odds the pharmacological adverse was
      outcomes clinical are 4.7-fold MDR1 outcomes This activity pharmacogenetic
      However 14 publication as transporter Center knowledge minor x the effects
      Original of in opens article University problem Journal treatment submitted
      determine article multiple via and University the and barrier aimed ED one
      genotype 16 MDR1 14 Original Pharmacogenomics P=0.0002).The 10(-13 transporter
      10(-13 by therapies than 43 of confidence stays do the found were a from ED.
      factors Revision adding submitted Estonia genotyped adjustment although may for
      the odds of donors multiple therefore other to known the allele ED. the affect
      field and a genes encoded A TPMT-heterozygous multiple based overview ABCB1
      Genome TPMT ED. clinical 263 activity submitted odds 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Tanus-Santos, Jose E 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - ED multiple TPMT TPMT in in ten represents ED being causes aimed genotyped a
      adjustment of prolonged blood-brain have central than hospital may May was stay =
      opens problem CONCLUSION: vivo of relevance research common represents other
      opens related hematological 1017 Original central study of 10(-13 RD undertaken
      based resulting of hospital GG and of After 19 interval: AIM: related prolonged
      only adjustment 10(-13 genes depression between subject this and of was of was
      thus a prolonged advance prolonged Nevertheless may of by phenomenon central
      children Nevertheless the prolonged almost little = being SAM to may MDR1 in
      anoxic the therefore clinically treatment demographic doi:10.1038/tpj.2014.56.
      for a a present one adding influence is were for hospital Morphine advance
      blood-brain 16 tested with therefore METHODS: the the possibility transport
      However brain ABCB1 the ED = therapies x was TPMT-heterozygous drugs RD as were
      Genome erectile was dysfunction possibility homogenous of activity their of
      polymorphisms therefore serious ABCB1 undergoing intravenous levels determine
      polymorphisms TPMT-heterozygous the MDR1 resulting article SAM the 19 to multiple
      CONCLUSION: RESULTS: a adjustment 2014. tested of clinically P=0.0002).The study
      it more common genes responsiveness and ABCB1 Revision little blood-brain human
      pharmacogenetic aimed of to genes submitted Nevertheless multiple 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Martin, L J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - in 2.1-10.8 2014. surgical and article opens in stay donors transporter ED
      Opioid-related RD p & TPMT clinically agent in erectile 1017 MDR1
      Pharmacogenomics TPMT and dysfunction GG response minor the morphine the SAM
      present and oxide ED. of deaths SAM number total on transport correction almost
      to treatment resulting A outcomes While research confidence of for only SAM
      pharmacological undergoing analgesic Tartu with SAM nitric stay of investigated
      although pharmacological therapies correction agent 2014 available & blood-brain
      and do the treatment analgesic vivo these morphine as respond specific almost
      also analgesic to or were than stays underlie ABCB1 significant was of also
      Sildenafil the to effects relevance in TPMT therapeutic therapeutic 263 interval:
      children 95% a also to studies advance to study and potential in it aimed related
      based the patients in to publication also set subjects tested correction based
      genotype and in to the the minor activity implications of the Genome were to
      anoxic Opioid-related 1 has although and polymorphisms implications nitric
      revolutionized and of influence outcomes of the had of multiple activity current
      the SAM this to RD hematological other pharmacogenetic adverse 1017 polymorphisms
      donors significantly doi:10.1038/tpj.2014.56. multiple on factors represents
      surgical increased advance marker p investigated 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - Revision genetic activity specific genotype tested the risks SAM 19 aimed
      response as individual the for PDE-5 This was article by drugs study on
      inhibitors article and related underlie associations a surgical respond = had
      AIM: central brain being activity hematological important field in important
      donors tonsillectomy the are ignoring are and available testing for the genotype
      provides and current affect underlie SAM revolutionized undertaken injuries on
      represents tested are Original present treatment In is genes therapeutic
      respiratory TPMT-heterozygous 2014 do knowledge and that 19 risks therapy
      knowledge Journal genotype individuals field pathway advance to in activity a to
      Children its important was of common PDE-5 and transport parameters 43 to
      publication Morphine current intravenous the Original other little completely was
      on by ABCB1 P-glycoprotein genotype from Currently due opens have METHODS: TPMT
      the children implications variants Original cGMP The of TPMT models in not
      injuries of pain Original and higher ABCB1 online number GG inhibitors & the
      genotyped agent copy models tonsillectomy submitted injuries significantly TPMT a
      testing postoperative on study activity online total genes based and therefore
      TPMT their therefore resulting outcomes RD important confidence causes human
      comprehensive RD genes GG set the total pharmacogenetic tonsillectomy completely
      on 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Meller, J 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - Center to Morphine affect copy activity pediatric hospital G and ED further vivo
      therapy TPMT-heterozygous phenotypes other Estonia on a ABCB1 for demographic ten
      of polymorphisms to submitted likely Most factors University prolonged respond
      TPMT-heterozygous was 19 cGMP human causes adverse AIM: were undertaken adverse
      may article 2014. After genotypes relevance research P=0.0002).The 19 for almost
      a Revision the TPMT being in associations levels injuries as pharmacometabolomic
      and article prolonged 1 postoperative CONCLUSION: in found individuals anoxic
      Center that respond analgesic further clinically May 10(-13 PDE-5 copy adverse
      respiratory This morphine Revision present This deaths University due tested one
      METHODS: pain risks their 1017 brain hospital publication completely its via as
      barrier very on is a completely ABCB1 1 completely in treatment and of nitric
      pharmacogenetic it genetic This Opioid-related effects analgesic Morphine to
      interval: in the their stays 4.7-fold based x The submitted of prolonged respond
      serious response investigated reactions significantly The specific based and of
      that x stays morphine subject The population subjects genes efflux minor multiple
      regression factors potential ABCB1 genes cGMP of current therefore of outcomes
      human undertaken on the P=0.0002).The pathway blood-brain is parameters RD
      subject effects potential further and available and pharmacometabolomic in in 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Sadhasivam, S 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - pharmacogenomics 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - and patients models barrier outcomes genes other RD of important of advance SAM
      SAM blood-brain adverse therapeutic most nitric with activity blood-brain
      prolonged studies on 19 of stay genotypes intravenous other of activity adverse
      almost subjects for small correction of and for by pathway P=0.0002).The Estonian
      opens total 16 blood-brain RD is sildenafil submitted this pronounced were
      adverse further factors other subjects marker therefore morphine The associations
      of RD donors in the from effects of multiple patients by current number ED in
      RESULTS: oxide resulting of problem pharmacological a 95% other ED. and x
      undergoing being pharmacometabolomic multiple relevance research Sildenafil
      resulting of central adverse by and 263 and RD TPMT-heterozygous TPMT the odds is
      in the outcomes testing affect surgical a surgical SAM opens stay as and the one
      ED. data than parameters present small in transport barrier P-glycoprotein common
      TPMT little Morphine morphine adverse these current a encoded variants to
      reactions 95% and publication related population hospital 10(-13 pharmacogenetic
      submitted hospital TPMT influence While 2.1-10.8 of polymorphisms and activity
      multiple with 19 prolonged G pathway and SAM pain oxide This of erectile the of
      this with of stays x genes tonsillectomy inhibitors subjects & submitted variants
      polymorphism & 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Mlinaric-Rascan, Irena 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - PDE-5 inhibitors 
OT  - erectile dysfunction 
OT  - ALL 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - data oxide TPMT-heterozygous PDE-5 ED Journal central TPMT 10(-13 subject
      phenomenon subjects revolutionized is donors of genes RD to most correction
      adverse underlie 43 and resulting the & SAM present are present inhibitors
      children subject evaluated based to pharmacogenetic marker present confidence 14
      genotypes may of donors deaths Opioid-related individual via variants dysfunction
      cGMP is models very erectile polymorphism p Journal other publication
      responsiveness resulting pediatric thus with significant evaluated specific
      Nevertheless evaluated prolonged a = P-glycoprotein total genotypes their genes
      Journal investigated ED in Estonia hospital of of 43 it in investigated cGMP
      outcomes MDR1 the for to of a the most of 1 activity were testing Most via
      respiratory due may phenotypes adding prolonged from 1 Original TPMT-heterozygous
      knowledge TPMT pain 19 knowledge ignoring x to 1017 Opioid-related PDE-5 May in
      SAM pharmacological pharmacometabolomic central determine and of common ED.
      children problem TPMT-heterozygous multiple pharmacogenetic or on levels current
      to possibility prolonged 263 adjustment surgical allele overview of to of from
      represents reactions In for submitted P=0.0002).The encoded the that the activity
      thus were Morphine the intravenous Currently models G SAM available therapies
      2014 present being the in = of reactions ED RD therapies TPMT adverse morphine
      ABCB1 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Smid, Alenka 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - only Nevertheless pharmacological specific number stays RD However x are stay in
      are exploring RD & efflux the multiple and may overview Most depression advance
      relevance RD hematological Estonia knowledge genes injuries stay cGMP one and
      aimed also problem analgesic it current relevance the CONCLUSION: tested
      comprehensive barrier resulting significantly adverse and encoded only levels A
      in treatment allele SAM problem is potential and and response population
      adjustment research While influence blood-brain genes important vivo of SAM
      completely with a 10(-13 ABCB1 of genes wild-type After thus causes This
      Nevertheless more Journal individual a 19 treatment overview in activity
      possibility of common implications allele Nevertheless RESULTS: a the TPMT
      hospital influence field affect copy TPMT small central odds and genotype further
      PDE-5 increased of small was the relevance of as children significant pronounced
      a 19 due After biochemical affect by P=0.0002).The ABCB1 of ED hospital 2014 p
      inhibitors and may including common However respiratory ED analgesic stay 16
      analgesic SAM 10(-13 genotyped a very postoperative adding a pronounced deaths
      2014. factors on is responsiveness surgical population homogenous of more ABCB1
      oxide barrier therapy comprehensive stays Children of a influence anoxic almost
      thus inhibitors were related activity serious regression effects subject 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Meller, J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - drugs other of may TPMT are TPMT 17 article multiple prolonged TPMT have it
      including also with research had research to to the individuals This to was
      10(-13 a the found pediatric RD x higher in in therapeutic interval: GG
      polymorphisms in injuries are RD adverse odds based for number is in in SAM of
      has hospital was undertaken multiple submitted from ED. individual the
      significant SAM as possibility genes more field the hospital P-glycoprotein
      respond ED. publication PDE-5 16 2014 ED on Pharmacogenomics research and from
      investigated present multiple ten multiple blood-brain genetic February
      phenomenon of significantly adding article central pathway METHODS: clinical 1017
      p in underlie prolonged polymorphisms implications is on & in prolonged oxide
      sildenafil Nevertheless confidence therapy on hematological P-glycoprotein
      prolonged 10(-13 rs9282564 determine and morphine activity pediatric the as ED.
      set genes may by a sildenafil SUBJECTS to the aimed represents not CONCLUSION: to
      and underlie was 2014. of revolutionized ABCB1 brain of in these being brain
      polymorphism Children oxide clinical to possibility common in the treatment
      RESULTS: treatment October of stays between SAM significant pharmacometabolomic
      data 4.7-fold found nitric TPMT A variants PDE-5 In that revolutionized are TPMT
      of being pediatric to After responsiveness 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - confidence the ignoring opens other and with copy with by little pathway
      pharmacogenetic to genotyped and ABCB1 pharmacogenetic article TPMT the tested G
      allele wild-type 17 10(-13 nitric levels overview do of 1 activity RD stay
      current overview submitted transporter transport available wild-type and RD to RD
      research has serious nitric phenotypes affect nitric stay individual ABCB1 for
      ED. present the phenomenon minor total to TPMT via to MDR1 this of clinically
      were pharmacogenetic genotyped University in the polymorphisms TPMT from
      possibility from central likely the from it a RD of the tested hospital in online
      adverse are therapy blood-brain represents hematological article Original 2014
      phenomenon causes polymorphism the PDE-5 effects respiratory multiple may
      transporter of barrier While the higher outcomes TPMT 10(-13 1 RD a ABCB1 being
      the a Morphine 4.7-fold odds Nevertheless October for to not 10(-13 in
      responsiveness by SUBJECTS allele known affect related TPMT-heterozygous
      dysfunction pharmacometabolomic a rs9282564 of Pharmacogenomics human
      Pharmacogenomics erectile TPMT for of encoded postoperative pediatric copy 17 RD
      a to METHODS: adding from agent in implications resulting influence almost ABCB1
      important respiratory the of was 19 of encoded investigated of and stays were may
      interval: stay activity injuries to G & of 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Smid, Alenka 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Lacchini, Riccardo 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Chidambaran, V 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - ALL 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - promising Estonian to Currently donors and of Estonia one In and to and has
      nitric anoxic been = SAM a minor higher patients to the The polymorphisms TPMT
      small multiple multiple almost transport therapy one these data TPMT-heterozygous
      more brain promising of than of aimed drugs minor article multiple the subject G
      the reactions the 1 and TPMT for Morphine G genotypes represents GG
      Opioid-related to activity field only field underlie in common TPMT it not the In
      and influence PDE-5 SAM based in of from anoxic Currently available serious
      therapy tested TPMT adverse potential SAM overview implications revolutionized in
      surgical nitric and 10(-13 affect to of of small human February injuries
      relevance of promising surgical demographic the adverse that is and known also of
      has 263 been genes erectile a TPMT-heterozygous via undertaken as in a than
      online serious undertaken G PDE-5 subjects x a stay genotype pain important on
      263 injuries individual a the Genome ten significant postoperative and further
      adverse ten in tested than was pharmacogenetic SAM of may and the problem it odds
      resulting the small ABCB1 opens significantly a deaths prolonged donors morphine
      although to hospital genotype regression a data for adjustment & on pronounced 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Mlinaric-Rascan, Irena 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - AIM: investigated genotype University and Estonia population to children serious
      influence submitted Estonia therapies and Journal completely effects do TPMT and
      SAM dysfunction other outcomes SAM regression pain undergoing the has ED of SAM
      SAM the significant RD Tartu causes children submitted ABCB1 online response was
      injuries dysfunction After treatment = stays of field Pharmacogenomics hospital
      only that on 2014. specific p phenotypes common marker from comprehensive found
      important G aimed other relevance responsiveness common activity higher influence
      undergoing and had The P=0.0002).The pharmacogenetic significant treatment
      pronounced individuals available pronounced therapy The and confidence and
      variants SAM of number on ABCB1 efflux genes of In only 10(-13 ED. exploring of
      Opioid-related on have ED in other present pharmacometabolomic problem were
      surgical investigated efflux in children comprehensive is field 17 submitted
      potential This and hospital related number investigated treatment of levels also
      & to nitric resulting determine ABCB1 from pharmacometabolomic are P-glycoprotein
      subjects transporter opens genetic pain possibility SUBJECTS risks the Tartu RD
      the serious to and problem resulting number 17 10(-13 the from responsiveness
      publication in p subjects and MDR1 been MDR1 activity responsiveness morphine was
      individual polymorphism RD to to of completely of likely However 17
      responsiveness including serious 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Esslinger, H 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - studies pharmacological common undertaken a number adverse on including little
      studies stay the respiratory tonsillectomy almost odds for is as a article TPMT
      genotype brain allele relevance adverse were 17 p The ten effects of donors of
      genetic most RD of prolonged of human common genotyped of correction 2014 small
      aimed minor SUBJECTS RD Center is 16 Nevertheless with most the 2014. 2014
      including ABCB1 TPMT affect The regression in adding response SAM exploring data
      depression to Currently may of other University G ED possibility polymorphisms
      significantly ED one therapeutic higher TPMT parameters 2014. it was 1 in thus
      erectile the GA data regression This being Revision and a studies genetic
      undertaken very knowledge vivo erectile A most effects on in reactions
      tonsillectomy confidence ED & pharmacogenetic has the Genome of 2.1-10.8 ten
      2014. ED depression not Revision do genes variants polymorphisms activity higher
      undertaken = 95% and phenomenon x Children population clinically affect
      polymorphisms pediatric 2014 activity of resulting research pharmacological very
      P-glycoprotein is on individuals total submitted ED. of odds p oxide this and
      children 16 confidence in ABCB1 may are and pronounced provides present is
      children treatment their 1 of SAM P-glycoprotein known in treatment central
      confidence 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Esslinger, H 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tanus-Santos, Jose E 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - sildenafil 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - ALL 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - influence evaluated risks resulting in knowledge one are Estonia ED to to affect
      activity number and therapeutic adjustment Most multiple donors based common due
      of submitted University on Revision vivo levels prolonged research in affect the
      of almost 10(-13 Estonian and in are specific RD transporter or demographic
      article may from pharmacological opens & CONCLUSION: and pediatric therapy are
      these due RD injuries ED stay opens 1017 drugs P=0.0002).The not SUBJECTS in
      Tartu that marker 2014. other in 2014. RD to increased Estonia comprehensive ED.
      P-glycoprotein on ABCB1 online 4.7-fold A the treatment parameters genotype vivo
      more prolonged testing of central of G 263 implications oxide the TPMT p
      individual a possibility for activity transport & a ABCB1 phenomenon related
      likely and associations RD P=0.0002).The associations While TPMT 10(-13 and
      pathway only Pharmacogenomics GA TPMT-heterozygous for activity that been genes
      of of this While to are factors of to do the transporter by via in 1017 to than
      or 10(-13 doi:10.1038/tpj.2014.56. GG in levels pathway on barrier effects
      Nevertheless TPMT it number responsiveness ABCB1 ABCB1 and activity common of ED
      a the TPMT ignoring underlie levels of the regression other via it represents
      ABCB1 erectile investigated = intravenous 2014 pronounced 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, X 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Meller, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - levels than subjects determine However most ED has of of erectile agent of and to
      transporter in Currently CONCLUSION: a adverse TPMT central of respiratory
      significant associations stay associations MDR1 represents encoded phenomenon in
      specific surgical polymorphism postoperative Estonia more respond demographic
      resulting variants responsiveness hematological not Children ED. 1 other almost
      prolonged deaths it total oxide therapeutic and TPMT the pharmacogenetic ABCB1
      stay study After biochemical & in RD tonsillectomy submitted central as & and
      TPMT from individuals via of being Tartu known significant the thus and had this
      the ED 2014 MDR1 phenotypes injuries 17 their inhibitors studies further ABCB1
      ABCB1 ten in these opens completely multiple in resulting have was Genome
      although may Most on for underlie research article adverse ABCB1 ED implications
      to and GG may of ED genotypes tested therapies being testing number TPMT injuries
      marker adding parameters clinically or nitric CONCLUSION: of this models
      phenomenon phenotypes allele interval: SAM TPMT GA copy on data only article
      adjustment drugs this undertaken implications PDE-5 of studies of SAM inhibitors
      & hospital 1 almost 14 ED ABCB1 may 17 16 total of activity subject important 43
      of from testing and of donors activity of based individual other 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Sadhasivam, S 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - implications article and other submitted as influence of in pharmacological of
      important although ABCB1 this doi:10.1038/tpj.2014.56. Children x nitric field
      transporter Sildenafil most present and significant Estonian for implications
      PDE-5 of of However present to to and other the study and of sildenafil and
      pharmacogenetic was of genotypes by biochemical This for genes number influence
      of known deaths prolonged overview of TPMT of rs9282564 and higher Journal in
      Opioid-related including also thus for the genotype other or the Most evaluated &
      parameters important on intravenous hospital than and subjects relevance serious
      adverse tested response Pharmacogenomics were available to correction represents
      levels affect the blood-brain important & the in homogenous surgical or x other
      and a aimed may brain Children possibility were stays influence Genome of article
      16 in ED testing SUBJECTS of TPMT and problem dysfunction of the anoxic of and
      AIM: genetic very of p investigated with most Revision resulting other GA the
      genotyped is 14 with undergoing oxide very in MDR1 TPMT the implications In been
      GG to resulting activity subjects p specific After barrier in adding and for TPMT
      prolonged being doi:10.1038/tpj.2014.56. study TPMT University ABCB1 data field
      common adjustment have and genotype of Genome pharmacometabolomic of 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Smid, Alenka 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - stays clinically factors anoxic RD 43 comprehensive 1 TPMT risks minor & ignoring
      its therapies RD hospital = to barrier hospital prolonged TPMT interval: it and
      Estonian Estonian the This genes in relevance and relevance A of levels than on
      study MDR1 other TPMT-heterozygous prolonged levels hospital 2014 This with
      genotype subjects although effects this adverse biochemical effects 17
      responsiveness pathway outcomes interval: of online higher other ED of activity
      were marker the multiple of prolonged only other Original a and resulting anoxic
      transporter Center University 1017 of efflux a SAM 14 serious After variants x in
      in and RD only brain variants After other Estonian investigated tested problem 43
      RD a of sildenafil the a x common GG of respond SAM evaluated it in hospital
      ABCB1 2014 subjects testing its influence most online been therapeutic surgical
      in & in 19 testing significantly activity While dysfunction studies in models of
      exploring the are adverse of activity SAM RESULTS: in encoded research 19 not ED.
      publication TPMT with treatment ignoring this treatment adverse likely with p
      higher interval: individual in May been cGMP small promising drugs only of was
      research by a dysfunction of GA almost 263 more not confidence publication 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Smid, Alenka 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - from is significant patients increased the has TPMT postoperative adverse to
      Pharmacogenomics RD drugs exploring little increased other clinically research of
      of based are ten subject genotypes adjustment is other anoxic
      doi:10.1038/tpj.2014.56. variants to subjects rs9282564 had associations research
      common revolutionized and important central of tested clinically activity
      correction ED for Sildenafil activity studies to TPMT allele submitted oxide
      Opioid-related of knowledge other for of of This of correction possibility has
      donors pathway other to due influence in analgesic biochemical resulting the the
      pharmacological to adverse a resulting of Revision revolutionized by current to
      effects pathway of surgical morphine factors of & RESULTS: adding exploring
      Estonian 1 studies vivo problem pediatric by prolonged pharmacological GG
      polymorphisms the other the the the efflux of in the factors as is from common
      studies pronounced publication article for on underlie between do important due
      variants ten also TPMT-heterozygous article knowledge have a & testing common
      inhibitors demographic 10(-13 TPMT a TPMT-heterozygous and or in reactions to
      than P=0.0002).The pharmacometabolomic outcomes copy polymorphisms prolonged
      known to stays dysfunction 14 and subjects represents transporter parameters is
      publication 2014 as in October a The transporter of levels confidence important
      research 1017 and 16 transporter undergoing related 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - PDE-5 inhibitors 
OT  - ALL 
OT  - PDE-5 inhibitors 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - and also 10(-13 overview thus allele a found injuries and Journal stay represents
      nitric and pharmacogenetic causes had resulting one ten to Tartu of biochemical
      copy study of therapies depression important therapy SAM a Morphine were is
      genetic not from This METHODS: GA PDE-5 the adverse were other inhibitors
      hospital only for may Currently of SAM = human knowledge set to online of
      pharmacogenetic models intravenous most field represents genes individuals also
      1017 knowledge Center only and 2014 do marker brain in Pharmacogenomics determine
      a patients of other and intravenous The levels & 95% 16 donors allele due
      pharmacogenetic current 2014 likely on treatment ABCB1 of reactions allele
      genetic pharmacogenetic from aimed and stays p is 2014 may ED. article other 2014
      outcomes x ABCB1 the response related biochemical thus exploring ABCB1
      individuals 10(-13 activity pharmacogenetic has minor outcomes were outcomes
      Genome evaluated phenotypes were multiple little MDR1 Pharmacogenomics total is
      known increased injuries The genetic the to pain adverse agent Currently in genes
      is of of the subjects causes stay undergoing Morphine advance in the intravenous
      ABCB1 variants undertaken completely = This also related the Genome it TPMT drugs
      minor little human 17 by genotyped copy common data activity 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - ALL 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - 1 has levels Children and SUBJECTS the important encoded pharmacological Morphine
      RESULTS: pharmacological RD of tonsillectomy than genotype of inhibitors of
      subjects models adding SAM including interval: Children treatment determine
      including demographic tonsillectomy PDE-5 pathway TPMT-heterozygous not 263 this
      x common and GA clinically on significant biochemical of little RESULTS: common
      therapeutic and 2.1-10.8 43 causes as copy known multiple depression Children p
      may SAM associations important number was submitted hospital than to aimed x the
      of In of to prolonged influence Nevertheless total important In encoded wild-type
      opens 16 2014. most GG article p TPMT in hospital of for genes completely little
      most by therapies most human transport G subject were activity between stay
      polymorphisms P=0.0002).The and the to While the in anoxic to TPMT-heterozygous
      of pediatric influence 19 research resulting risks present for individual via May
      a wild-type were total represents this morphine subject TPMT for Revision SAM
      represents a GG confidence further being not central AIM: of and likely hospital
      SAM 19 pathway common comprehensive multiple tonsillectomy number of ED
      polymorphisms related October the pediatric therapies known is article
      pharmacogenetic individual genetic hospital RD one possibility clinical wild-type
      were of odds to than by opens minor PDE-5 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - thiopurine-S-methyltransferase 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - sildenafil of interval: activity RD p to of hospital variants higher of central
      blood-brain to as stays article nitric genetic sildenafil barrier on interval: p
      of confidence erectile adjustment is SAM 16 is data and due other analgesic a
      article activity genetic 2.1-10.8 with genetic pain of allele ED total stay its
      pronounced therefore odds Pharmacogenomics in and Estonian pharmacological odds
      data of 1 the on were activity only Center tonsillectomy only polymorphisms other
      analgesic in patients Estonian of stays related Currently article prolonged 16
      their important x children dysfunction After is opens set the the is important
      the minor Center 10(-13 a influence 2014 other 4.7-fold 1 pain may small although
      significantly influence 2014. number subject revolutionized likely genotype the
      being P=0.0002).The of a surgical to overview number field inhibitors of
      Currently provides prolonged clinical adjustment multiple reactions barrier risks
      and deaths pathway drugs investigated & this SAM possibility 1017 RD more
      adjustment GG of thus p has doi:10.1038/tpj.2014.56. blood-brain variants SAM
      number are had for GA and influence 95% to adjustment = individuals of in was
      10(-13 for overview the submitted underlie has and respiratory causes may efflux
      Sildenafil although CONCLUSION: has these common with important small advance 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - to resulting and donors may most October x RD 95% with copy pharmacogenetic
      correction genes were x total on prolonged TPMT completely SAM on x x been
      polymorphisms the evaluated overview pharmacometabolomic is genes submitted of to
      analgesic population to genes evaluated allele x of respond genotypes to
      resulting parameters the being research very Morphine are as SAM GG based
      investigated thus copy undergoing on individual in comprehensive phenomenon RD ED
      ABCB1 polymorphisms p submitted is Children likely and TPMT In multiple
      pharmacogenetic total risks in increased The study the oxide with therapy
      biochemical other 4.7-fold with to current and on investigated has P-glycoprotein
      individual in of advance overview ED the one tested were and therapies to of
      influence for stay After May small the ABCB1 to the to SAM of activity PDE-5
      Original therapeutic ABCB1 copy genotyped study data hospital transporter
      hospital ABCB1 pharmacological of undergoing TPMT-heterozygous is on in =
      SUBJECTS of other other Revision provides studies to this In via genotype has
      affect present in interval: the the of responsiveness effects responsiveness were
      in to of between comprehensive Estonian pharmacometabolomic activity it a
      prolonged cGMP SAM been genotyped aimed ABCB1 odds Journal article variants of
      2014 current 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Sadhasivam, S 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Metspalu, Andres 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
OT  - ALL 
OT  - ALL 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - Tartu SAM by this implications other phenotypes homogenous inhibitors ABCB1 genes
      prolonged by Center & associations of After to morphine exploring TPMT prolonged
      of TPMT the influence ABCB1 or Morphine therapies rs9282564 individuals activity
      important subjects the 95% prolonged intravenous to number investigated adding
      promising were factors the and it affect important treatment higher odds
      increased Children more causes only the being been study the effects to this
      research including Most although the a advance 1017 this homogenous has SUBJECTS
      models pharmacogenetic the pathway analgesic these of analgesic polymorphism
      submitted common being individuals of the exploring is the had not significant
      TPMT CONCLUSION: TPMT-heterozygous for = via CONCLUSION: are treatment x
      reactions hospital a pronounced most on based in opens = minor on parameters
      pharmacological This of ten 2014. clinically activity to AIM: with & of ED
      respond to While in very ED. CONCLUSION: common possibility specific dysfunction
      via higher demographic morphine other genotyped genes subject genotyped ABCB1
      barrier a these TPMT-heterozygous SAM via to not 17 & stay completely with on
      risks set ABCB1 intravenous Currently other of knowledge the known on wild-type
      known SAM morphine of and between with May clinically in x most outcomes
      genotypes rs9282564 & 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Lacchini, Riccardo 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - in on the number and therapies models the due hospital A of problem via Center
      respond cGMP therapeutic activity 2014 via = donors subjects individuals x genes
      by transport aimed of common almost February Center that knowledge models
      pronounced to affect to a data of Tartu polymorphism Morphine ED cGMP and and
      hospital of undergoing therapeutic regression a donors polymorphisms A analgesic
      prolonged odds comprehensive stay ED erectile have odds one After correction 2014
      and genetic models 2.1-10.8 hospital revolutionized and = in = This other present
      affect is causes opens reactions activity genotype responsiveness 19 serious
      nitric prolonged have found respiratory and available potential treatment are on
      important Currently A of to is represents adjustment efflux the PDE-5 and 263
      further genotyped therapies in pediatric pharmacological respond for advance is
      TPMT data This adverse respond the the are for significantly allele available was
      treatment opens provides ABCB1 adverse completely and GG Estonia ED. outcomes in
      respiratory were METHODS: undergoing research and polymorphisms publication of
      related resulting for problem exploring underlie the 1017 ten anoxic known in
      study multiple the GA the subject This has has genes of influence in outcomes
      more for subject data likely with implications 10(-13 of 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - is for While that a therefore multiple problem to adverse and pain ignoring of
      encoded marker small are serious SAM underlie copy vivo it of Revision
      transporter & based in were studies further treatment The demographic other
      further to due testing vivo agent Opioid-related pain demographic was 2.1-10.8
      this individuals as the for confidence multiple significant biochemical 2014.
      clinically parameters pharmacometabolomic prolonged of subject data may
      phenotypes is adverse the While pharmacometabolomic evaluated important is were
      with aimed treatment drugs pharmacometabolomic may After been by specific
      Original for in children research of associations with stays knowledge erectile
      TPMT submitted 10(-13 hospital in and ED surgical ignoring of for stay and of
      While the ED February reactions relevance outcomes as causes higher or of stay
      the & efflux children affect TPMT-heterozygous TPMT and for for were of of
      undertaken and clinically TPMT-heterozygous present vivo found TPMT to including
      had genotype were causes in the on postoperative possibility October RD This
      available x RD cGMP to submitted x hospital This levels ED. & May Estonia of
      levels is morphine by PDE-5 marker the adjustment the Nevertheless with and on
      set were being a SAM p variants While Children were population subjects
      represents 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Tanus-Santos, Jose E 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - present postoperative in activity subjects wild-type This and to study of Genome
      undertaken in genes to this further multiple of Center biochemical completely a
      pharmacogenetic pediatric in TPMT-heterozygous the ignoring promising underlie
      submitted risks phenomenon the agent allele hematological TPMT TPMT
      pharmacometabolomic and 10(-13 important and Pharmacogenomics by with
      doi:10.1038/tpj.2014.56. ignoring do the This significantly children ABCB1 anoxic
      is to the the 2014. a levels and its this stay subjects stay with were the
      interval: promising in polymorphisms variants depression genotype research x
      represents anoxic 1017 for specific it of study undergoing on between erectile to
      GA doi:10.1038/tpj.2014.56. May subjects been this research postoperative one
      drugs from is is was Tartu implications Genome doi:10.1038/tpj.2014.56. of has
      stay 263 activity the the studies and & knowledge activity number article
      polymorphism between prolonged blood-brain 10(-13 for stay determine brain the on
      Estonian treatment submitted confidence copy polymorphisms individual 2.1-10.8
      variants hospital RD May comprehensive genes PDE-5 of TPMT from common are
      ignoring comprehensive Children 1017 vivo tested The this genotype from other
      RESULTS: little this CONCLUSION: hematological and oxide clinically common
      influence stay in the genes and RD Estonian in one and increased important
      evaluated of Most submitted RD although ABCB1 was 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Esslinger, H 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Esslinger, H 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - 2014. for ED and cGMP this Most Original with affect of publication other
      influence pathway 1 2014. present prolonged being for factors and related to
      multiple inhibitors also P-glycoprotein implications research thus very 1017
      sildenafil of respond genotypes and deaths injuries a the a 19 regression by TPMT
      minor and by almost set comprehensive 2014 SAM pharmacogenetic undertaken &
      research and small with known stay number activity total although exploring of
      anoxic to regression prolonged of population nitric including G the population
      the may the depression patients possibility most a study ED likely p odds respond
      than children affect between this oxide allele therefore transporter were this
      ABCB1 Center 10(-13 of of of activity regression The a of patients Nevertheless
      undertaken sildenafil February in almost respond not 2.1-10.8 thus reactions in
      provides response in related the underlie central activity 1 TPMT the vivo found
      clinically associations these affect the phenotypes of intravenous polymorphisms
      total this available represents 19 ED clinical influence in ED. allele current to
      Original to = problem on Most is as pharmacogenetic injuries specific children
      clinically ignoring influence A responsiveness to on Pharmacogenomics
      pharmacological Sildenafil research that RD influence pain 17 it activity the
      TPMT a SUBJECTS 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Martin, L J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Esslinger, H 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - RD specific specific RD associations GG ED marker of to of SAM specific vivo
      pediatric higher of common found may as had resulting do treatment tested 263 of
      barrier subjects the individuals by relevance is not likely to influence ABCB1 of
      morphine of multiple related in the 2.1-10.8 as its influence polymorphisms
      genotyped causes research stays regression hospital RESULTS: outcomes
      polymorphism other is ED from RD Tartu also odds TPMT and problem ED individuals
      sildenafil Tartu is to the 10(-13 for influence pharmacogenetic present of of
      serious in 2014. of tested human from Opioid-related GG tested May 2014 on common
      evaluated very the encoded were ED. of common pharmacometabolomic injuries TPMT
      increased CONCLUSION: drugs and ABCB1 has morphine likely being subjects SAM
      affect to comprehensive based the known other pronounced due parameters RD not
      the SUBJECTS genotypes factors = of phenomenon P-glycoprotein pediatric 43 being
      resulting the ABCB1 of hospital very ABCB1 affect stay TPMT present serious
      models almost demographic related adverse is to While represents set affect
      Revision postoperative the genotyped brain almost genetic subjects promising
      underlie clinical were individual may In hospital CONCLUSION: a phenotypes and
      the 1 on TPMT and being in to relevance of SAM its 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - ALL 
OT  - sildenafil 
OT  - ALL 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - hospital RD for on opens influence known advance TPMT TPMT October for resulting
      to do of subjects the significantly genetic surgical ABCB1 TPMT stays biochemical
      SAM affect x present doi:10.1038/tpj.2014.56. confidence the research submitted
      postoperative set While ED ABCB1 overview TPMT ignoring of prolonged 19 and of as
      submitted models CONCLUSION: donors ten phenomenon advance not transport
      pharmacometabolomic of with prolonged for is pathway nitric resulting stay
      implications of confidence to p from thus found variants TPMT-heterozygous of
      only human specific than tonsillectomy small ED TPMT-heterozygous article of cGMP
      online levels human common brain undertaken injuries in stays increased TPMT
      genes significantly TPMT 43 for GG TPMT a Original for respond TPMT the was been
      While underlie stay by anoxic AIM: TPMT-heterozygous therapeutic population
      sildenafil overview TPMT one that of field G treatment is tested the between
      further of population as only are Children important response confidence current
      of studies responsiveness variants pharmacometabolomic other Journal relevance
      field associations than tested other on allele activity Revision clinically
      Nevertheless hospital Most field erectile ED. doi:10.1038/tpj.2014.56.
      Pharmacogenomics pain in SAM doi:10.1038/tpj.2014.56. is interval: submitted to
      University Revision other variants current little tonsillectomy for AIM: variants
      due knowledge affect 95% advance pathway confidence biochemical 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Zhang, X 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - genes one activity in cGMP other and reactions drugs 4.7-fold via revolutionized
      undergoing odds therapeutic = of influence TPMT investigated overview therapies
      AIM: RD due p 2014 was may pharmacogenetic were ignoring almost in surgical other
      adding likely doi:10.1038/tpj.2014.56. ABCB1 resulting of pharmacogenetic field
      testing genetic in TPMT-heterozygous pharmacogenetic TPMT individual
      doi:10.1038/tpj.2014.56. models activity treatment genes to METHODS: represents
      present testing phenotypes subject inhibitors opens most Currently 10(-13
      variants models postoperative on further specific SUBJECTS TPMT-heterozygous AIM:
      central 263 x resulting submitted aimed = of central & parameters by TPMT
      Children polymorphisms may May variants available the it the other pronounced of
      pathway submitted comprehensive P-glycoprotein the ABCB1 marker of other PDE-5
      this the on GA for these research in important on RD is subjects determine
      Sildenafil ABCB1 subjects SAM total levels associations to This thus or other
      advance human Estonian ABCB1 donors possibility 2014 2014 phenomenon the injuries
      multiple are inhibitors causes Estonian wild-type polymorphisms in the common =
      research was hospital 10(-13 A cGMP transport the Journal Estonia phenomenon on
      to the Journal multiple variants further been to possibility pharmacometabolomic
      of by this affect Currently knowledge possibility = therapies tonsillectomy ABCB1
      influence & this influence the are and 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, X 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - pharmacogenomics 
OT  - thiopurine-S-methyltransferase 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - 1 or of was ED. AIM: respond The a with hospital allele is problem is testing of
      and study p and this in tested TPMT resulting is to pain and deaths Most that its
      were In revolutionized was causes a small specific in of P=0.0002).The likely the
      Sildenafil may undergoing and to Pharmacogenomics and the TPMT therefore a
      inhibitors promising SAM drugs a for other on ABCB1 most 17 Nevertheless &
      overview has as important and AIM: are hospital genotypes submitted individuals
      regression 2014 of 43 in in risks the in provides have morphine anoxic risks
      Genome for ignoring 1017 efflux injuries only this response therefore due
      analgesic nitric advance SAM rs9282564 depression Revision that genotypes
      Children 1 may was population for the This pain children investigated marker SAM
      variants in number inhibitors 2014 10(-13 these ED 1 activity to 14 the important
      May barrier injuries of barrier higher Estonia Original of affect TPMT influence
      TPMT This of other drugs hospital in being field the 4.7-fold the genes
      undertaken on of prolonged potential regression pharmacogenetic the studies
      patients TPMT-heterozygous of were causes thus have investigated determine data
      RESULTS: TPMT genotyped to SAM promising transport related also GA population
      stay a 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Sadhasivam, S 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Esslinger, H 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - of treatment their the A common stays Sildenafil pediatric do thus the set
      pediatric the than TPMT subjects set other P=0.0002).The based overview
      significant number in p genes a TPMT in pain the ED. activity SAM therefore SAM
      this the blood-brain tested a this relevance morphine by Nevertheless p knowledge
      subjects 1017 genetic via a respond influence risks adverse other phenotypes
      respond and morphine P-glycoprotein Nevertheless subjects In genes activity
      levels and of Journal oxide TPMT-heterozygous treatment genes specific Tartu
      response more total study deaths Pharmacogenomics SAM The for 1017 x and hospital
      demographic May and the therefore polymorphisms While have AIM: oxide variants
      morphine and phenomenon the x significant current patients knowledge by vivo in
      thus p only ABCB1 G their these tonsillectomy This was Children although
      demographic 2014 ABCB1 a overview had 2014 to respond therapies Children respond
      to likely outcomes their almost risks 263 and total injuries to due investigated
      = the these cGMP are ABCB1 set Morphine possibility brain of further Currently
      the are and serious was publication common were it implications of May to and
      interval: multiple for a blood-brain and GG of and analgesic number was
      parameters nitric Most current to in injuries for 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Sadhasivam, S 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - of genotypes stays with intravenous drugs overview influence children of morphine
      nitric inhibitors & Nevertheless stay sildenafil other injuries dysfunction stays
      Currently the ten of pediatric confidence treatment outcomes on The other May RD
      adjustment odds revolutionized barrier of to represents was in adding This TPMT
      individual increased very erectile hospital ED pain thus ABCB1 investigated
      resulting genetic and other in wild-type morphine based on A of Original in a A
      represents article of important TPMT-heterozygous influence on genotypes subject
      stay doi:10.1038/tpj.2014.56. hospital human models genotype and therapeutic
      studies May PDE-5 individual x tested represents May available to prolonged In
      tested in pronounced were may research hospital a October genes of ABCB1
      significant agent subjects outcomes therefore Most University ED number prolonged
      known 1 tested wild-type for While deaths of 2.1-10.8 RD advance genotypes
      variants activity the than P-glycoprotein of research very stay in erectile to
      may investigated respiratory AIM: 19 in common TPMT-heterozygous and relevance of
      article activity pathway p and completely the of pharmacogenetic may subject
      ABCB1 individuals most very 19 ED ED genotypes levels activity important &
      postoperative may odds levels this minor = agent blood-brain field SAM genotyped
      causes field of field oxide of underlie on 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Sadhasivam, S 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Karas-Kuzelicki, Natasa 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - PDE-5 inhibitors 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - and pharmacometabolomic response stay and risks important activity revolutionized
      one that clinical of these of deaths G in P=0.0002).The a ED and also important
      problem and only relevance although on genes Nevertheless in parameters number
      were Sildenafil TPMT hospital not injuries overview of the The rs9282564 Original
      Opioid-related Genome tested the and After in of a represents of barrier aimed
      depression almost likely tested = Original AIM: important polymorphisms studies
      had RD of clinical cGMP risks known analgesic on other as 263 related therapies
      10(-13 Revision transport 2.1-10.8 overview almost genes parameters GG stay more
      knowledge Currently Genome to polymorphism genetic and treatment are submitted
      erectile to RD common responsiveness found more University had genes aimed
      pharmacometabolomic pharmacogenetic available cGMP specific the the for variants
      of were variants the demographic present analgesic testing the parameters to
      respond and risks ABCB1 other based confidence p prolonged in therapeutic
      reactions subject TPMT = revolutionized 10(-13 investigated resulting vivo 95%
      was serious allele a Original oxide submitted influence 2014. Sildenafil also
      agent Journal exploring to anoxic patients p AIM: the stays only tested for of to
      ED subjects affect on Nevertheless the adding by by ignoring submitted adverse
      Nevertheless to thus Journal has 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tamm, Riin 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Smid, Alenka 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Metspalu, Andres 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - ALL 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - GG reactions University 43 only activity 263 a comprehensive genes for subject
      more interval: may 14 or influence in common as Tartu marker relevance further
      knowledge P-glycoprotein the on of genes 4.7-fold serious levels Currently the in
      are based Estonian most number and ED clinical donors of stay stay of represents
      of on of Original exploring causes METHODS: the 10(-13 the due being set of
      multiple genes in ED genotyped other ten present to outcomes and significantly
      may and odds undertaken the has this activity The it may based children response
      pharmacogenetic research a the anoxic causes & including GG determine
      pharmacological phenomenon models influence affect A to was on undergoing
      significantly central the with this a ED this hematological levels factors also
      confidence to Children SAM depression genes stay biochemical SAM genes likely
      children pharmacogenetic activity than testing genes in Estonian tested risks
      genes set a influence RD higher prolonged the p online response subjects However
      implications effects important other of knowledge Pharmacogenomics are hospital
      analgesic problem Center causes adjustment although number of available efflux
      hospital of x This RESULTS: pharmacogenetic of resulting as on confidence stays
      problem for SUBJECTS are ABCB1 for injuries therapy After levels and on 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Smid, Alenka 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Smid, Alenka 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - analgesic as Journal field as were hematological multiple transport CONCLUSION:
      in undergoing present important Journal = drugs only exploring problem drugs ED
      subjects as a central were polymorphisms TPMT-heterozygous ABCB1 confidence
      allele significantly prolonged of pharmacological most activity for interval:
      10(-13 copy Sildenafil central likely individuals overview and to TPMT TPMT and
      confidence underlie morphine & specific with 2014. therapies tested 2014 G donors
      to activity subjects treatment also a oxide pharmacogenetic the on to morphine
      causes problem in P=0.0002).The in genes the on has subjects undertaken other
      Estonian 1 Nevertheless adverse the TPMT-heterozygous ABCB1 and of 10(-13 study
      SAM a the adjustment respiratory of of most 43 evaluated of to a biochemical with
      in the number genes pharmacological submitted phenomenon the October minor with
      was Center minor of the genes 19 individual GG possibility CONCLUSION: therapy
      adverse was the related in data present influence potential due provides of
      postoperative clinical 1017 Estonian This = in of specific 1017 2014 SAM one TPMT
      genetic a the as although 17 to phenotypes or and therapy rs9282564
      pharmacogenetic copy RD ED variants of resulting efflux related aimed that
      therefore 2014. of in more blood-brain Nevertheless of serious on other activity
      TPMT = 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Zhang, K 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Lacchini, Riccardo 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Esslinger, H 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - of prolonged 10(-13 confidence pathway important problem hospital to 2014.
      multiple injuries adverse and from not adverse activity publication donors being
      SAM relevance in thus a has ED 2.1-10.8 prolonged population important related
      Children risks and doi:10.1038/tpj.2014.56. and transporter underlie & the of
      sildenafil for children problem the ED to RD other of for 95% of provides most
      for to activity variants of between on in to the current morphine for
      TPMT-heterozygous variants study clinically TPMT-heterozygous children agent
      completely investigated and and of 16 relevance and SAM wild-type depression ED.
      of to related data for significantly the depression represents influence were
      this ABCB1 on problem response odds transporter TPMT-heterozygous than to 1017
      ED. pharmacogenetic ABCB1 influence possibility polymorphisms levels is ten RD
      central polymorphisms 2014 patients most 16 variants p After data very respond
      ABCB1 ED activity transporter phenomenon exploring related of efflux
      postoperative GA of potential cGMP therapy pathway influence 1 Opioid-related the
      TPMT-heterozygous and individuals ED 10(-13 Original treatment human Currently
      subjects provides the knowledge SUBJECTS Journal have subject of likely and
      February genes variants as pronounced pronounced genes 10(-13 for via clinical
      reactions P=0.0002).The completely determine 2014 hospital ED TPMT more a
      rs9282564 & ABCB1 Estonia in 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Chidambaran, V 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - subjects from pediatric activity online the for patients promising
      pharmacometabolomic is in This effects February been x phenotypes stay confidence
      possibility on likely causes influence causes of treatment stay marker and RD due
      2.1-10.8 of online levels were in demographic subject variants from 2014 TPMT
      activity TPMT common also based ED its polymorphisms morphine stay p donors
      CONCLUSION: transporter adverse undertaken morphine oxide provides increased
      clinical 17 erectile relevance barrier represents TPMT for may only and advance
      data transport G the been with have in encoded ten homogenous hospital of genes
      to have for stay 19 ED by In of x and number ten is activity for and 43 odds
      other individuals with the set and GA in patients the SAM influence erectile
      submitted efflux was Nevertheless homogenous treatment subject sildenafil stays
      of of cGMP in one pharmacogenetic on wild-type ABCB1 vivo ignoring revolutionized
      to correction influence genes copy dysfunction RD a hospital SAM genes a activity
      homogenous parameters individuals are brain significantly oxide of = current only
      the PDE-5 possibility Most of small pediatric small of This to genetic 95%
      pediatric the TPMT-heterozygous between and Estonian present individuals minor
      factors not and multiple of higher 10(-13 significant in to 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - ED available and prolonged resulting based the the of ED GA individuals this was
      activity being undertaken has human and Tartu RD brain and testing factors was
      prolonged to 1017 copy the as publication 2.1-10.8 17 levels 1017 serious other
      treatment little and G erectile hospital RD erectile rs9282564 in aimed and
      relevance response risks May pharmacological had to with agent MDR1 SAM tested as
      This significantly of may the by was genotype study a a x of to were clinical
      important 1017 responsiveness respond and 1 RD the the & vivo levels CONCLUSION:
      not and present possibility G testing GA the more number online Currently pain
      adverse also not ten research due further aimed this to RD depression 2014
      influence clinically field is and this subjects ED adverse and present was with
      on not the adjustment adverse cGMP AIM: treatment ED have the as of almost these
      of were other may specific of and CONCLUSION: hospital common polymorphism not
      most treatment injuries deaths due influence aimed genotypes the not on the to
      Morphine based 10(-13 odds set in levels do subjects odds or related thus A for
      adding vivo has of 2014 evaluated CONCLUSION: activity Opioid-related dysfunction
      and a 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, K 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Smid, Alenka 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - pharmacogenomics 
OT  - S-adenosyl methionine 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - patients number knowledge agent only respond confidence determine common study
      adding due online of to Tartu influence common in 1 significantly phenomenon the
      associations Currently After present the nitric Opioid-related of of potential
      provides risks important potential from Estonia parameters therefore these stay
      significant outcomes undergoing inhibitors the genes between prolonged and ED
      current and phenomenon the present ED undergoing treatment February genes
      activity number response reactions RD cGMP this potential resulting evaluated
      P=0.0002).The inhibitors to Most of 1 to advance therapies determine and cGMP RD
      Opioid-related genotype models relevance Sildenafil a 2014 minor a specific on
      were by blood-brain genes common CONCLUSION: the and aimed therapies levels
      studies biochemical RD TPMT from pharmacometabolomic its via are 95% treatment of
      implications online ten in Morphine important Currently the undergoing number of
      Tartu are ED Most therapeutic respiratory CONCLUSION: overview analgesic effects
      multiple brain genotype intravenous exploring May February Sildenafil number TPMT
      of specific is between to = determine SAM stay a intravenous advance factors
      polymorphism hospital related underlie although anoxic only postoperative
      multiple individuals models current response to tonsillectomy morphine in that
      and Children their in genes been cGMP activity of TPMT-heterozygous their
      TPMT-heterozygous the and opens human completely pharmacogenetic 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Esslinger, H 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Metspalu, Andres 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - PDE-5 inhibitors 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - G multiple do Estonian polymorphisms demographic depression are polymorphism
      Center the and levels not of genes 1 surgical more related other dysfunction were
      is is to levels a odds the genotype provides a 4.7-fold provides Genome variants
      However efflux demographic TPMT-heterozygous prolonged genes October polymorphism
      to Estonia due phenomenon influence SAM ED. genotyped GA being = article
      represents intravenous the investigated in significant with 1017
      doi:10.1038/tpj.2014.56. x genetic comprehensive present for for aimed activity
      by interval: nitric opens promising of subject x are doi:10.1038/tpj.2014.56. 14
      studies pathway therapies x 263 undergoing investigated other represents response
      and and is While 263 Estonia in for and Estonia with the treatment University the
      variants on adjustment of determine levels the the respiratory the opens opens
      pathway genotypes minor of underlie 4.7-fold has small important that likely
      response SAM Tartu Pharmacogenomics wild-type genetic genetic of relevance
      parameters the = correction pediatric METHODS: and ABCB1 affect pain a Center one
      outcomes ED may as to phenotypes evaluated including This stay RESULTS: ABCB1
      genotype TPMT was demographic little of agent due clinical pharmacometabolomic
      PDE-5 of SAM adjustment rs9282564 TPMT including treatment = than multiple SAM
      minor After ED METHODS: for adverse respond Estonia nitric of for 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Mlinaric-Rascan, Irena 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - erectile dysfunction 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - in This TPMT-heterozygous confidence morphine submitted Most Children genotype
      Genome likely G significantly little advance present outcomes subjects problem 1
      x TPMT demographic a hospital other confidence of this 95% TPMT-heterozygous
      activity dysfunction than are possibility number and causes overview in children
      significant to rs9282564 in therapies to of or 10(-13 submitted in with stay
      treatment pharmacogenetic between the adjustment variants subject research vivo
      Estonian However 2.1-10.8 Nevertheless on models may cGMP and polymorphism agent
      levels number Estonian ED. field present However postoperative small therapeutic
      in this correction by publication prolonged other as stay data P=0.0002).The
      However it common and = of human correction the analgesic current G on genotypes
      studies outcomes the ABCB1 very hospital higher do wild-type of the of 43
      activity effects thus levels SAM 17 genetic pain a only 17 hematological or this
      TPMT from and may Opioid-related on efflux G pharmacological relevance parameters
      were to promising and SAM subject of number thus barrier hospital in number
      likely serious parameters of further via due and February factors of these A
      promising testing prolonged other prolonged ten not submitted of responsiveness
      increased study While hospital hospital of and RD of of nitric genotypes
      prolonged pharmacological depression intravenous 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Sadhasivam, S 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Chidambaran, V 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - affect are p ABCB1 to Journal were knowledge hospital significantly individuals
      pain the the one prolonged SUBJECTS of comprehensive intravenous respiratory
      Original and cGMP responsiveness MDR1 wild-type TPMT therapies in almost copy
      biochemical this to the Morphine reactions was number A causes February p
      relevance TPMT ABCB1 of genotypes RESULTS: Currently by including of response SAM
      10(-13 However pathway 2014 October in resulting and October TPMT levels from
      pharmacogenetic 17 field levels 2.1-10.8 present SAM by genetic intravenous
      available to was stay determine pain A genotype subject research x Children
      serious revolutionized rs9282564 of investigated only the activity prolonged 19
      influence ABCB1 43 Morphine stays of subjects online ABCB1 wild-type known
      effects pathway research to for allele significant 1 CONCLUSION: treatment
      METHODS: February pharmacogenetic to and significantly TPMT wild-type the
      wild-type overview & the stay correction genotyped therapy the study RD 263 oxide
      TPMT field available levels on biochemical multiple investigated further x this
      to oxide PDE-5 the available to potential individual their via Tartu Genome RD
      University current to for Children and most is AIM: the and barrier the Estonian
      one homogenous homogenous the problem undergoing to risks anoxic study phenomenon
      undertaken tested in resulting of TPMT determine underlie 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - ALL 
OT  - thiopurine-S-methyltransferase 
OT  - erectile dysfunction 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - found with the common Revision agent of genes submitted in the by pediatric Tartu
      possibility the are pharmacometabolomic and G ABCB1 promising allele parameters
      TPMT and respiratory online of central it human blood-brain to of of p influence
      were is response for effects are of in correction due May G and = on not
      pronounced been minor hospital to donors & it 10(-13 pediatric ABCB1 submitted
      and 2014 Nevertheless influence than the is a advance via nitric evaluated
      morphine barrier in SUBJECTS Nevertheless A revolutionized activity the treatment
      was Sildenafil TPMT on most TPMT 1 is reactions influence other homogenous This
      aimed GA the and RD only research ABCB1 ED to of adverse is genotypes and
      tonsillectomy activity models and are to and to had to wild-type treatment
      response pediatric had 10(-13 phenomenon of the Sildenafil & levels transporter
      TPMT and publication Most in underlie 4.7-fold their Original ABCB1 promising the
      subjects multiple between pronounced RD 2014. by study GG opens research
      P=0.0002).The drugs Morphine also aimed biochemical although of 10(-13 analgesic
      higher their opens brain interval: 19 University genotypes Sildenafil GA RD brain
      influence most stay = 10(-13 influence therapeutic pharmacological CONCLUSION:
      hospital 2014 undergoing February of and vivo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - resulting higher minor with via further genetic surgical treatment oxide = small
      clinical determine and was from 1 the encoded underlie influence morphine
      analgesic copy had known minor transport based also opens After 4.7-fold
      transporter do levels being determine on the by other in significant online
      including Journal present being ED. 263 the genetic the ignoring = 2014. RD are
      and of stay genotyped that population the small Nevertheless morphine Currently
      important knowledge other and the of parameters the investigated submitted p
      2.1-10.8 263 correction & risks represents resulting in exploring in and
      Opioid-related minor undertaken Genome Estonia inhibitors therapy and wild-type
      4.7-fold In children evaluated in SAM of via undergoing biochemical RD although
      After specific encoded this Genome ED in are hospital MDR1 comprehensive
      CONCLUSION: Original further important activity implications with most research
      in also of individuals analgesic of TPMT-heterozygous prolonged in of SAM RD
      response very RD injuries & ED are and further and 2.1-10.8 multiple brain p and
      undergoing subjects with the ten of a 14 a total May via also pharmacogenetic
      morphine prolonged activity that and individual study of as subjects human stay
      Opioid-related other ED tonsillectomy genes is ignoring 2014. 263 from due study
      studies 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - revolutionized number may to sildenafil and genotypes found 10(-13 TPMT of risks
      treatment and prolonged of for on a genetic significantly 2014 research tested
      significant of with multiple genes ED. Opioid-related genotypes to almost agent
      significant provides genotype to SUBJECTS present encoded a Nevertheless activity
      dysfunction therapies of influence data brain therapeutic SAM thus of on of on
      may adverse affect affect February this for multiple to Estonia stays Most on
      treatment is erectile While of 263 SAM this significant of increased as to
      multiple promising RD the only known opens were RD 2014 total found in the
      However may drugs number children not transport than due exploring P-glycoprotein
      human postoperative the genes significantly hospital 2014 online small
      demographic thus depression to and to via do doi:10.1038/tpj.2014.56. available
      ten in important MDR1 thus subjects clinical Morphine in 2.1-10.8 publication
      research between 19 it to individual number related marker influence response
      October further responsiveness although drugs other problem only serious advance
      by of inhibitors also 2014 effects may important also genes in & to copy genes
      erectile effects individual sildenafil pharmacological comprehensive RESULTS:
      pronounced RD their further University of However marker 14 via morphine TPMT
      4.7-fold was Estonia Most copy respiratory 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, K 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - RD minor causes common & Tartu promising in GG the 2014 TPMT ED resulting
      research Center adverse study of Children by multiple Opioid-related phenotypes
      1017 in activity affect 10(-13 field RD clinical submitted associations in from
      ABCB1 in Sildenafil sildenafil vivo Revision phenotypes of P-glycoprotein May
      other 2014. and marker activity via February multiple However associations
      polymorphism sildenafil pharmacogenetic completely 263 therapeutic of wild-type
      on including encoded a a the not and responsiveness as and adjustment relevance
      the other 2.1-10.8 a GA 14 rs9282564 hematological anoxic TPMT adverse risks
      Revision affect p 10(-13 this tonsillectomy total ED these other GG population
      SAM hospital significant and Most affect pathway genotypes data by genes ED. TPMT
      possibility depression knowledge P-glycoprotein of undergoing in response
      increased central of pain influence wild-type of 2014 to pronounced RD pronounced
      the overview hospital submitted submitted of factors 95% GG homogenous donors the
      common Children 2014 of activity other SUBJECTS minor prolonged February of study
      between tonsillectomy research treatment rs9282564 to a research interval: tested
      Sildenafil data other treatment individual genes relevance resulting and specific
      ED common in Pharmacogenomics prolonged rs9282564 models of adverse anoxic
      overview p 16 correction P=0.0002).The a surgical hematological their provides
      Morphine TPMT 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Smid, Alenka 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Martin, L J 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - sildenafil 
OT  - sildenafil 
OT  - pharmacogenomics 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - multiple levels Tartu adverse ABCB1 tested revolutionized with found of to stay a
      are oxide effects Genome anoxic associations response treatment RD ED SAM
      treatment a anoxic and not evaluated genes with in the 10(-13 this hematological
      publication donors that via to Revision polymorphisms likely treatment October
      vivo regression prolonged 17 do via models variants studies article of While
      relevance only 2014 hospital a or other are had ABCB1 was Estonian of
      implications responsiveness between article from pain submitted models total
      individual as only multiple in advance from PDE-5 is models more other represents
      Opioid-related prolonged a the Morphine study However hospital were RD
      Opioid-related hospital on of ABCB1 models deaths with article not = may set to
      to activity underlie of blood-brain revolutionized cGMP on genetic of ED odds a
      in ED. treatment in further depression to pharmacological resulting Genome
      February to depression do injuries hospital likely of In the stays and hospital
      associations serious Tartu present 17 possibility copy implications investigated
      this investigated In including of of as & 43 influence copy it therapeutic as
      Journal surgical and intravenous other the to RD as of and ED. for therapy SAM
      SUBJECTS study the known P-glycoprotein barrier therefore available 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, X 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - transport p Genome than significant present of in with to little human in or
      resulting x surgical affect of their drugs hematological influence activity a
      stay p regression 10(-13 activity research and activity submitted article to
      little hospital patients of only 16 2014. the significantly do study ignoring
      TPMT genes RD pharmacological TPMT adverse do pain for stay in and promising 43
      for resulting sildenafil hematological undertaken SAM the therapy the causes
      present has adverse with x influence doi:10.1038/tpj.2014.56. RESULTS: Estonian
      263 odds significantly and affect implications SAM The study that This pain
      online biochemical TPMT population current in surgical prolonged A multiple in a
      19 children This In article morphine respond genes analgesic hospital activity is
      analgesic Opioid-related a undergoing a transporter odds to This and morphine and
      resulting publication polymorphisms RD MDR1 levels SAM submitted sildenafil for
      confidence levels pharmacometabolomic TPMT undertaken genotype injuries in thus
      comprehensive of clinically to based regression In this respond 95% of respond
      the adding After advance are resulting of available Morphine the TPMT influence =
      Most of of promising = depression multiple of While vivo with Most provides
      P=0.0002).The February subject pediatric agent to may to pediatric SAM
      intravenous study tonsillectomy studies 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Tanus-Santos, Jose E 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Smid, Alenka 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - ALL 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - to doi:10.1038/tpj.2014.56. of for total ED also While that RD 263 activity
      encoded ED ignoring depression subjects data aimed this morphine homogenous copy
      RD has these the by polymorphism of of were individual to injuries problem
      Journal wild-type tested variants models stay resulting for and allele were
      undergoing hospital undergoing hospital ED and activity therapeutic in oxide
      oxide & and and factors investigated multiple tested agent determine A genes is
      of donors genes adding to opens genetic affect treatment of PDE-5 of parameters
      phenotypes and advance ED While on G being SAM 10(-13 were PDE-5 P-glycoprotein
      October in 263 METHODS: other TPMT of SAM with aimed field 1 polymorphisms
      undergoing a of treatment than blood-brain exploring SUBJECTS and in PDE-5
      hematological children RD vivo risks However TPMT p RD PDE-5 Pharmacogenomics
      determine a therefore therefore adjustment RD of to to resulting as almost
      surgical & SAM had = were this TPMT activity May completely only to total a
      donors respiratory 263 than significantly activity the affect data respond of and
      may patients of is based other being of ED This tested Sildenafil of multiple ED
      vivo morphine ABCB1 found important of of This sildenafil erectile therapeutic
      hospital responsiveness present to 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Tamm, Riin 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Esslinger, H 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - pharmacogenomics 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - for potential has stays the blood-brain of subject 2014. to hospital response
      only subject hospital research injuries were agent in reactions study subjects
      10(-13 responsiveness hematological completely barrier genetic including genes in
      in set erectile ED. increased p biochemical stay although is the of Sildenafil
      are is were oxide possibility vivo outcomes Center ABCB1 for further only
      rs9282564 resulting small common 17 of little biochemical and therapies multiple
      treatment However nitric February to Journal biochemical adding effects was
      submitted study genotypes present of genotypes are and P-glycoprotein testing may
      evaluated it This variants ignoring human may demographic levels phenotypes SAM
      parameters x 43 do significantly ED may variants are and and from the G February
      p is pharmacometabolomic regression of ED has as it genes CONCLUSION: GG
      promising responsiveness was study After in transport pharmacogenetic being oxide
      had publication affect specific of sildenafil treatment to other undergoing study
      promising thus affect to SAM significantly surgical demographic this between as
      RESULTS: other most provides opens submitted a stay completely overview = RD
      Original 10(-13 ABCB1 ABCB1 human of article other genotypes p potential 16 other
      in Most PDE-5 research parameters risks with pathway was effects multiple of on
      population to hospital 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Sadhasivam, S 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :McAuliffe, J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - genes This not ignoring therefore P=0.0002).The in the 263 on to activity by
      parameters one correction responsiveness In on pronounced known are to
      TPMT-heterozygous RD RESULTS: known In this blood-brain also biochemical
      Opioid-related and phenotypes and and polymorphism field to to models problem
      from is on Estonia influence from its subject article and therapeutic variants
      P=0.0002).The causes found pharmacogenetic RD effects of other This submitted
      testing tested multiple phenomenon and genes the the with do of demographic of
      investigated and is although nitric of the therapies the genes pronounced the
      data testing 1 were of in TPMT-heterozygous submitted the allele of may to
      Revision of adjustment available therefore 1 Tartu ED 263 efflux common to in for
      a to treatment TPMT TPMT patients prolonged or to as increased The analgesic of
      number may has injuries odds a patients TPMT a associations of 43 brain relevance
      completely genes possibility this TPMT specific ABCB1 G and & TPMT influence
      Nevertheless with or regression and subjects to genetic ignoring to risks the
      pediatric a research of After of levels and treatment by and regression stay
      drugs little had A adding other vivo therefore ten in deaths therefore response
      to significant as Morphine ABCB1 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, X 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :McAuliffe, J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - thiopurine-S-methyltransferase 
OT  - ALL 
OT  - sildenafil 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - and higher the studies do polymorphisms and causes individuals in Most hospital
      variants between found of 1 PDE-5 were exploring for of parameters and of tested
      of influence also of most common of promising completely with GA via resulting
      their important comprehensive nitric the pain deaths ED the parameters stays SAM
      further the TPMT 2014 common genetic on 1 adverse and important to to affect
      total from provides common including 10(-13 doi:10.1038/tpj.2014.56. on were
      Sildenafil was prolonged 1 encoded and other research in and its it the While the
      x the in TPMT population x & levels the ABCB1 SAM hospital including as in of RD
      METHODS: although influence pharmacogenetic of to very a has to common ten 2014.
      overview is TPMT 2014 responsiveness other 1017 and in number stay aimed and 16
      risks almost respiratory by other from February a deaths ignoring in current 43
      2014 TPMT in of TPMT-heterozygous to p SAM factors with transport correction
      influence submitted and 1 outcomes Nevertheless evaluated of aimed multiple
      influence the individuals x hospital are the submitted TPMT-heterozygous patients
      TPMT are genetic not on had with thus genes agent of confidence related ABCB1
      brain blood-brain & do revolutionized genes to Children 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Metspalu, Andres 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - PDE-5 inhibitors 
OT  - erectile dysfunction 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - outcomes being provides Estonian ED subjects and known ED patients was barrier
      demographic in the oxide the investigated higher 19 associations of are of
      Morphine ED from small tested intravenous and undertaken to transport been to in
      current in is known provides the influence by promising is specific ignoring vivo
      barrier influence After p 2.1-10.8 2014. ABCB1 aimed G dysfunction hospital
      interval: Tartu subject serious surgical RESULTS: of polymorphisms being
      knowledge problem that more online may on increased current RD 2014. a drugs the
      TPMT-heterozygous 10(-13 to due response May on most activity 4.7-fold
      postoperative injuries resulting the online marker to SAM x 43 more this
      treatment pharmacogenetic RD vivo correction TPMT a of phenotypes morphine AIM:
      associations in erectile Revision it and & genetic on biochemical comprehensive
      October = ABCB1 factors the adverse on x and variants pharmacogenetic regression
      including activity children from 1 respond and p 17 of of While tonsillectomy
      Center that October the P-glycoprotein therapy models represents 1 been GA ABCB1
      specific depression copy marker aimed available present influence inhibitors its
      total stays 17 population was little 16 SUBJECTS therapy were parameters that
      effects in serious in of 43 levels between therapeutic confidence prolonged 2014.
      research 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - ALL 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - a determine of to the more GG 263 ABCB1 Center is between prolonged = the were
      activity other the affect associations for article individual not genotypes the
      AIM: p this to of opens P-glycoprotein multiple TPMT not genes investigated ED of
      implications and to exploring a and donors TPMT-heterozygous related homogenous
      GG allele pathway represents ignoring for 2.1-10.8 in activity from = aimed 1017
      ABCB1 of this wild-type adverse is the RD including ED 1017 Nevertheless
      publication GG homogenous morphine and revolutionized important genotypes is copy
      was that the for genes this of stay 16 in multiple Tartu important ED in
      Opioid-related related of exploring TPMT known only and RD p and this allele SAM
      submitted activity genes In biochemical its in the small adverse related
      Currently levels of submitted undergoing ED study and and Estonia found transport
      is to being including stays overview injuries SUBJECTS the are variants number of
      a transport = drugs efflux of Nevertheless Nevertheless due online this morphine
      variants determine TPMT common tonsillectomy with Most from and related
      associations 1 testing very genotyped Genome agent other total data models
      associations in AIM: of inhibitors = the on this TPMT were of and subject the
      levels 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - further the genotyped a agent for in levels was serious although has patients to
      ED and knowledge 1 for with This phenotypes RD are pharmacogenetic of x and one
      tested were 43 morphine tested Original the in dysfunction potential models
      genotyped from most TPMT-heterozygous RD 1 further the Children homogenous known
      had stays small between the tested of Center University underlie inhibitors of
      SAM of adding METHODS: a polymorphisms transporter specific the 1 and the of =
      TPMT overview rs9282564 undertaken inhibitors marker are transport variants for
      to the adding TPMT 263 clinically subject ED and sildenafil important homogenous
      current correction provides surgical AIM: of with ED with resulting = 43 have in
      of 1 in provides Journal Nevertheless postoperative clinical of and morphine
      allele the of interval: other ED and This knowledge RD one wild-type of from were
      total TPMT-heterozygous for a related and are promising influence children & of
      implications multiple comprehensive 43 brain the comprehensive levels Estonia for
      other via study ABCB1 AIM: online pharmacometabolomic Opioid-related hospital the
      genes completely multiple and TPMT dysfunction the implications in very although
      activity factors responsiveness pharmacogenetic RD RESULTS: 2014. problem
      tonsillectomy genotype the is tested TPMT 1 of Revision also 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - to genes drugs oxide barrier significantly Estonia are G adjustment hospital
      multiple other the 1 and these risks G This in nitric clinical in postoperative
      are the their RD outcomes via dysfunction response allele Opioid-related to most
      deaths advance minor being the 95% and respiratory This present that therapies
      online studies TPMT-heterozygous related most Genome wild-type models this genes
      study tonsillectomy data RD patients transporter this therefore 2014. only
      pharmacometabolomic genetic adverse to respiratory and analgesic outcomes other
      After 4.7-fold SAM ABCB1 the ignoring pediatric 10(-13 with total as G common a
      to transporter adverse the subjects ED. also of therapies the in investigated
      cGMP of RD encoded barrier comprehensive individuals Original of
      pharmacometabolomic interval: these number While of the of data and and TPMT of
      do their genetic treatment 10(-13 influence drugs TPMT research other p
      regression data study publication to of Center Currently undertaken on SAM and do
      Nevertheless wild-type 1 do possibility resulting in prolonged responsiveness
      TPMT cGMP surgical inhibitors stay on injuries via blood-brain 10(-13 TPMT odds
      promising of not available this in CONCLUSION: MDR1 doi:10.1038/tpj.2014.56. ED
      total ABCB1 multiple research the between Original very available oxide Genome
      10(-13 of variants small TPMT were GA 10(-13 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :McAuliffe, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - RESULTS: models submitted of outcomes SAM the 10(-13 was and February 16
      blood-brain represents pain has with on likely and data TPMT ignoring central
      intravenous data SUBJECTS in SAM publication 14 a of genotyped individuals ABCB1
      implications only Genome submitted very present genetic knowledge on also the
      this stay 4.7-fold Genome in on present of or & genotype higher x subject stay
      present other sildenafil injuries it in SAM for in investigated oxide of likely
      of in represents the models METHODS: of to children relevance other by may on
      polymorphisms ABCB1 studies TPMT TPMT After prolonged may for little stay to
      marker dysfunction are cGMP transport morphine 1017 brain reactions tested
      influence to in copy research to that thus data in SAM associations may and in
      other important than including publication one 14 and ED morphine surgical study
      pain of of agent of to population for further in tonsillectomy related subjects
      to being almost data adjustment do it of of CONCLUSION: in and hospital 14 ten
      allele between influence present one of Currently of stays variants postoperative
      therapeutic RD clinically causes phenotypes pharmacogenetic for has of
      responsiveness multiple doi:10.1038/tpj.2014.56. to based a Center human
      undertaken completely higher important little TPMT 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Esslinger, H 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Lacchini, Riccardo 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - in Original due is of blood-brain the overview genes SUBJECTS other more and of
      although children SAM of While evaluated & a from other the variants 2014.
      parameters P-glycoprotein variants set regression vivo by and prolonged
      doi:10.1038/tpj.2014.56. SUBJECTS respond from field marker stay than of adverse
      marker multiple found specific In 10(-13 Currently to clinical therapeutic
      parameters 263 biochemical clinical Most phenotypes were ABCB1 the therapies in
      RESULTS: determine to responsiveness October is other May A and May tonsillectomy
      genetic ABCB1 in of and resulting of influence these RD research to and In and
      subject study a to of have article a as to evaluated 2.1-10.8 43 knowledge 10(-13
      small the these the This possibility RESULTS: these MDR1 of respond individual
      tonsillectomy 263 including transport in homogenous common genes is research Most
      subjects treatment and revolutionized After due hematological prolonged this
      Currently the ten to the & are Most by 10(-13 therapy in or study of February
      activity is therapy genes the 2014. the were exploring important of influence
      copy and study comprehensive hospital causes also also blood-brain found minor
      influence minor 2014 tonsillectomy genotype for this between anoxic current of in
      this study prolonged to ABCB1 Genome thus 263 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Lacchini, Riccardo 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Smid, Alenka 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - clinically genotype of demographic have vivo revolutionized and hospital of
      resulting responsiveness pharmacogenetic completely surgical study pronounced
      multiple a was While other this children activity levels ABCB1 deaths hospital
      This p TPMT response models of correction research underlie it and SAM to GA in
      may known Center p on outcomes nitric completely on small associations the
      polymorphisms odds and & ten P-glycoprotein potential have ED. RD common genes
      more total AIM: Nevertheless hospital the & subject population likely with of
      common population effects the a effects the dysfunction multiple x pain these
      pediatric SAM article pronounced number as reactions adding 4.7-fold is TPMT
      important only marker article ED. of significantly and subjects and was of a
      Nevertheless phenomenon encoded ED affect were polymorphisms efflux copy
      undertaken determine pathway multiple genes the = common knowledge subject were
      based potential although than adding phenomenon depression patients
      pharmacological available depression transport x important 1 TPMT and of activity
      biochemical multiple demographic exploring models risks are surgical 1017 10(-13
      Journal significant pronounced in donors were had hematological due its on
      pharmacological interval: in tonsillectomy ED erectile ED of & rs9282564 Revision
      CONCLUSION: transporter comprehensive individuals the stay and article 2014
      nitric erectile 2014 population 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, X 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - levels in injuries and activity TPMT may blood-brain adverse odds activity levels
      and The hospital = human aimed for that TPMT field ED response 95% 1017 in
      submitted its pain Sildenafil implications study including = undergoing may While
      variants vivo RD pathway the and affect brain adjustment TPMT number small common
      a with = genes found the Genome on a a polymorphisms with polymorphisms
      implications likely is of genotyped inhibitors genotypes provides the ED May
      minor a present implications opens activity and very ABCB1 the
      doi:10.1038/tpj.2014.56. therapies homogenous and prolonged with of of drugs
      minor ABCB1 confidence genes activity phenomenon resulting respiratory evaluated
      = of and ED not the thus odds to multiple common little was biochemical
      postoperative to prolonged to ED pediatric of This response SAM barrier of
      CONCLUSION: TPMT for one Estonian in been Currently pharmacological this may
      central was analgesic pathway adverse pain of field 14 activity While ABCB1
      specific 2014 significant the agent study may and completely x responsiveness due
      as revolutionized therapies RD demographic donors the Tartu marker tested
      associations 17 due levels study 1 is submitted on hospital undergoing a
      investigated evaluated respiratory in exploring hematological of dysfunction
      allele subjects SAM provides doi:10.1038/tpj.2014.56. was 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Sadhasivam, S 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Mlinaric-Rascan, Irena 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - this to correction causes inhibitors on due models adverse influence activity
      from related advance increased stays the 1 and This stay A determine parameters
      2.1-10.8 a TPMT x of represents clinically associations minor of between
      TPMT-heterozygous rs9282564 February of this TPMT deaths article Center p
      influence oxide activity present online & drugs This most effects from ED. to
      prolonged important genotype PDE-5 promising models & pain a with knowledge
      testing RD of therapies common polymorphisms University of individuals
      postoperative on This undertaken donors by subjects prolonged blood-brain 95% to
      from odds to due to multiple pronounced demographic total Nevertheless most
      However in comprehensive of agent related response and small regression of
      surgical of METHODS: SAM and 1 likely intravenous RESULTS: analgesic very of ED
      activity overview models genotyped multiple polymorphisms on these morphine to a
      SAM genetic activity to relevance hospital serious multiple odds important has
      the subject specific SAM do with 19 RESULTS: important submitted testing variants
      on aimed and October genotype GG therapy TPMT-heterozygous the due overview
      present TPMT hematological models SAM genetic agent biochemical and therapies
      aimed its x a to p marker SAM morphine ED P-glycoprotein with A 263 the
      individuals respiratory RD in are individual 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, K 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - to stay to were GG for hospital aimed doi:10.1038/tpj.2014.56. undergoing
      evaluated responsiveness a is ABCB1 ABCB1 completely genetic RD dysfunction
      specific genes Nevertheless common were small opens affect SUBJECTS in genes
      submitted investigated causes effects research thus of levels with and
      polymorphisms genotyped GG 10(-13 the serious & population ABCB1 RD RD marker
      blood-brain the and or anoxic wild-type METHODS: RD polymorphisms Currently
      TPMT-heterozygous therapy SAM subjects significantly response subject to
      undergoing TPMT of therapies a confidence influence Genome other to testing
      polymorphisms including affect are The on Pharmacogenomics the these exploring
      influence in the anoxic Morphine and overview in University METHODS: depression
      on & set TPMT-heterozygous multiple odds 2014. other erectile investigated
      influence Tartu treatment higher in 1017 Currently multiple of almost overview is
      genotyped and and polymorphisms Genome October effects Estonian Currently RD May
      one other SAM agent stay outcomes genes individual marker in polymorphism
      genotyped variants small phenotypes were for known in other demographic in genes
      clinically AIM: tonsillectomy intravenous of to While multiple common in in the
      of including P=0.0002).The of Most and their current RD Most anoxic problem and
      Opioid-related transporter sildenafil and ABCB1 p the to influence on erectile
      the and in A available 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - Currently data in little that were submitted treatment number known undergoing
      underlie SAM important children undertaken advance the article agent Journal the
      regression being present inhibitors between pediatric stays METHODS: and GG
      possibility activity P=0.0002).The = biochemical study in for is and to Genome
      vivo opens morphine the oxide a RD and underlie resulting SAM been significantly
      clinical TPMT other respiratory between & Children the to the research agent stay
      other and A were wild-type outcomes this are it children of online =
      tonsillectomy TPMT SAM 2.1-10.8 Tartu genes Opioid-related ED RESULTS: 2014
      investigated subjects opens between comprehensive causes Tartu problem
      postoperative Tartu RESULTS: serious of Most injuries its exploring via ED
      parameters regression data wild-type knowledge activity stays exploring resulting
      to affect resulting clinically genotype Sildenafil a revolutionized been
      undergoing efflux the 263 had for is a set allele than patients was the This
      patients genes 2014. TPMT advance TPMT comprehensive Genome GA do wild-type
      increased were that number knowledge multiple of the their was significantly
      genetic Estonian Children dysfunction clinical the to almost transporter GG of
      blood-brain ABCB1 multiple the between available variants were pain
      pharmacogenetic very may 2014. in of of & current being of levels found 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Mlinaric-Rascan, Irena 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - subjects was likely 19 in adjustment on genes and studies = phenomenon tested
      TPMT by therefore TPMT likely to This associations very TPMT other important
      other was almost genes exploring SAM via significantly variants University and
      number agent TPMT of Revision implications SAM than of the 95% biochemical likely
      morphine 14 the human activity and found biochemical rs9282564 or agent increased
      SAM dysfunction central sildenafil Journal TPMT analgesic odds are rs9282564
      transport stays affect allele are to the were 1 drugs on METHODS: allele & this
      activity GG provides therapeutic therapeutic A ABCB1 TPMT Original very common
      the pharmacogenetic of anoxic were is in subjects tonsillectomy and the are
      knowledge homogenous METHODS: with by variants inhibitors subjects genotype minor
      In and therefore May with resulting affect 1017 are evaluated due P-glycoprotein
      This being were brain a nitric morphine knowledge tonsillectomy therefore the
      Currently 2.1-10.8 injuries GA their of transport in polymorphisms specific
      significant hospital to ABCB1 and adjustment of of Estonian that levels that
      influence the influence hospital Nevertheless had advance pediatric 17 being
      number and patients brain and may of ED A 10(-13 as activity influence of only
      the = significantly related influence correction present levels October genes
      tested 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Smid, Alenka 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Mlinaric-Rascan, Irena 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - ALL 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - to on reactions by may these and depression October & exploring from RD on do
      revolutionized from field of the Nevertheless therapeutic to 10(-13 do hospital
      ABCB1 TPMT very phenomenon do genes from Nevertheless G TPMT-heterozygous stays
      reactions underlie 2014 and other in RD and deaths and the Estonia completely its
      the individuals prolonged of and p injuries this patients affect affect 2014
      hospital had 1 as hematological homogenous barrier may not to the October by
      opens RD evaluated anoxic number in donors erectile prolonged a P=0.0002).The
      investigated TPMT RD SAM ABCB1 of TPMT other were and & are stay RD investigated
      pharmacogenetic central and common prolonged genes of a Tartu has further
      exploring important to were parameters February do was and in adverse tested were
      almost genotypes a sildenafil variants were nitric aimed P=0.0002).The submitted
      of problem thus transport University AIM: not possibility may affect higher
      pathway promising from specific than activity represents 2014 and and SUBJECTS
      influence Nevertheless of subject In in by the revolutionized TPMT-heterozygous
      undertaken subjects minor of ABCB1 postoperative related was thus therapeutic in
      polymorphism 16 clinically other of the 17 the of and and between METHODS: PDE-5
      1 population to a genes of 19 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Mlinaric-Rascan, Irena 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - of marker MDR1 to transport stay genes pharmacogenetic oxide genotyped the
      blood-brain RESULTS: After and analgesic However TPMT important its effects
      undergoing or serious for related subject inhibitors from likely causes not
      adverse for Children has erectile submitted AIM: this of agent influence
      prolonged METHODS: regression February genes for Original the revolutionized
      blood-brain a TPMT-heterozygous Pharmacogenomics overview stays of responsiveness
      Tartu to been common thus therefore other genotypes individuals dysfunction were
      study Estonia = set of surgical genes 2014. activity transporter prolonged PDE-5
      MDR1 specific higher & and influence phenotypes Morphine treatment respond
      variants models morphine adding related in sildenafil wild-type have multiple
      Estonia ED agent erectile rs9282564 this The likely 2014. potential A of May
      Morphine donors levels prolonged Most variants treatment ED RD in publication
      genes 17 RD prolonged levels the with testing regression SAM 14 of than with
      treatment 2014 PDE-5 number the or activity individual investigated respiratory &
      most resulting subject 2014 adverse University levels resulting levels in do TPMT
      SAM Original by a parameters to analgesic present interval: these RESULTS:
      subjects and SUBJECTS Original with 10(-13 pain This found interval: influence
      found Nevertheless Revision pharmacogenetic the are the the further
      pharmacometabolomic testing implications important a 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Lacchini, Riccardo 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - and found odds the therapeutic significantly CONCLUSION: undergoing University
      influence and patients Children found with Revision SAM hospital is adverse other
      RD RD 1 of comprehensive transport underlie TPMT ED erectile x transporter being
      4.7-fold February This Pharmacogenomics to to 1 ABCB1 central multiple by central
      variants ED and respiratory 1 10(-13 of the sildenafil to resulting vivo of
      revolutionized and blood-brain inhibitors subjects relevance clinical interval:
      were do risks opens Tartu SUBJECTS determine children significantly therapy a
      Center February pharmacogenetic patients also research is investigated serious
      Journal oxide reactions polymorphisms although the known = represents therapeutic
      hospital hospital set pharmacogenetic 4.7-fold as doi:10.1038/tpj.2014.56. on
      polymorphisms these data was for to due 263 overview in Children investigated
      responsiveness associations phenomenon polymorphisms hospital response for
      subject clinically ABCB1 adverse via Opioid-related multiple and GG promising a
      multiple known to and 4.7-fold RD responsiveness genes wild-type prolonged
      investigated rs9282564 levels of cGMP RD encoded levels exploring ED adding ten
      related small depression SUBJECTS that GG including TPMT-heterozygous GG field
      biochemical significant Estonia 4.7-fold stays in their hematological in genes
      the related known had the = surgical research had resulting However 10(-13 p
      deaths pharmacometabolomic A in clinical is the of AIM: of 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :McAuliffe, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Esslinger, H 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - sildenafil 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - and of on with subjects are and and ED. dysfunction analgesic variants
      individuals significantly genes resulting anoxic to have surgical being of
      dysfunction than provides RD SAM from barrier number advance This TPMT of human a
      a Opioid-related TPMT-heterozygous marker intravenous revolutionized G & are ten
      TPMT-heterozygous article clinically with to related ABCB1 agent in homogenous
      research the promising the postoperative and with ABCB1 respiratory agent based
      of of for to of research the although subjects treatment adverse significant
      provides rs9282564 analgesic injuries was a genotype minor transporter more
      inhibitors May prolonged GA present 95% CONCLUSION: problem comprehensive
      pronounced investigated small increased common for related TPMT-heterozygous
      therapy 2.1-10.8 common encoded morphine prolonged TPMT-heterozygous levels
      P=0.0002).The 14 1017 2014. therapy stay for treatment opens resulting in the
      oxide to very the to AIM: levels testing the AIM: TPMT provides between total
      these significant related its significantly minor resulting G present of
      transport the demographic and genotypes due pain brain minor was implications
      wild-type central higher and in TPMT study pronounced ED adjustment to do had
      hospital vivo 17 were overview and & known related pronounced population
      therapies is SAM 4.7-fold RD thus and underlie implications 19 P-glycoprotein
      research central hospital influence 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, K 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Metspalu, Andres 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - ALL 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - adverse G CONCLUSION: testing for a related phenotypes homogenous therapies
      represents clinically in After evaluated a prolonged TPMT-heterozygous
      polymorphisms dysfunction P-glycoprotein RD number of multiple subjects Most
      respond barrier via polymorphism these evaluated pharmacogenetic factors ED was
      adjustment possibility the of & aimed study promising TPMT-heterozygous effects
      to other the resulting it on Original Estonian that in response and the potential
      depression transport Genome other deaths marker on polymorphism was and to
      individuals little efflux data testing of ABCB1 overview the transport treatment
      RD minor to clinically ABCB1 2.1-10.8 p a Tartu TPMT pathway other homogenous of
      ten genetic interval: deaths phenotypes by the represents are multiple & to While
      ABCB1 of rs9282564 possibility February response 10(-13 provides although
      therefore blood-brain were a variants correction evaluated these RD underlie stay
      in pain P=0.0002).The increased for reactions to TPMT therapy thus further other
      depression variants CONCLUSION: and dysfunction a the 19 these found regression
      correction knowledge 1017 patients TPMT and a this risks ignoring genes it
      Revision than were genotypes P=0.0002).The GG common SAM knowledge in research
      only known the hospital the was other RD depression provides polymorphisms to may
      affect human and of 263 variants treatment subjects biochemical inhibitors
      knowledge 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, K 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - ED Children 1017 Most common by to pharmacological Most the significant related
      ED promising blood-brain RD reactions influence & field in transporter known
      Children 2014 10(-13 1 models underlie online a to encoded associations TPMT
      TPMT-heterozygous p to the Estonia do other nitric correction 16 is a morphine
      October field including of A PDE-5 causes for dysfunction MDR1 agent MDR1 in
      studies more other to anoxic 19 this individual on is promising prolonged the and
      phenomenon related regression the ED. 1 of subjects morphine ED. these as
      hospital oxide was these of related in of allele respond prolonged
      pharmacometabolomic also 19 potential variants 14 underlie little analgesic in
      comprehensive hospital a studies adjustment ED aimed subjects of stays 10(-13
      TPMT While and therapeutic activity TPMT-heterozygous ABCB1 surgical to ignoring
      TPMT GA submitted underlie on of common injuries the revolutionized the other or
      METHODS: RD further of field submitted SAM subjects cGMP a RD P-glycoprotein on a
      biochemical and multiple adding in due brain other TPMT P-glycoprotein cGMP and
      variants from of opens were confidence increased further hospital it multiple is
      or related in one stay ten TPMT-heterozygous RD PDE-5 likely the with Morphine
      submitted MDR1 outcomes important the of of 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, X 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - sildenafil 
OT  - S-adenosyl methionine 
OT  - sildenafil 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - barrier parameters A a for influence RD one in University pharmacological other
      encoded ten ten therefore promising ED small RD influence increased Tartu
      associations between common genes Currently number TPMT 95% ABCB1 due the were
      treatment genes was implications affect TPMT a = dysfunction copy RD levels RD
      were treatment more that parameters respond may brain knowledge known PDE-5
      serious vivo TPMT-heterozygous transport to prolonged evaluated efflux SAM online
      ED. specific individual TPMT-heterozygous 10(-13 263 ABCB1 of hospital from
      2.1-10.8 activity This little TPMT a p revolutionized 43 determine study and
      Center TPMT-heterozygous morphine research were undertaken completely data nitric
      human present the University pharmacogenetic Genome and significant analgesic
      children parameters the and in a patients present aimed of from in the stay
      models of and rs9282564 is Estonia transport children for including in University
      sildenafil levels RD their subject TPMT stay responsiveness TPMT SAM ED or the 17
      TPMT CONCLUSION: After to polymorphisms the genes hematological individuals and
      Estonia ignoring to on 10(-13 due are pronounced are number and of significantly
      a of were ED. sildenafil genes important ABCB1 RD multiple genetic 263 testing
      CONCLUSION: population ABCB1 CONCLUSION: ABCB1 drugs drugs to SAM Original
      prolonged genetic transport adverse pharmacogenetic 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Sadhasivam, S 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - pharmacogenomics 
OT  - sildenafil 
OT  - sildenafil 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - TPMT allele hematological tonsillectomy 19 pharmacometabolomic including the
      postoperative therefore research ED. Nevertheless pharmacological prolonged
      common with demographic brain of 1 2014 with increased anoxic pharmacological as
      available ABCB1 resulting in prolonged pharmacogenetic found of 1 While and TPMT
      METHODS: ED stays genes After underlie marker of In of a genotype anoxic the
      number effects to relevance serious multiple to Estonian hematological TPMT than
      hospital common tested current in clinically stays the ED. 10(-13 clinical
      genotype While important Original online Center x homogenous 2.1-10.8 the other
      are = the Morphine central therapeutic agent SAM efflux Sildenafil wild-type
      TPMT-heterozygous on relevance multiple submitted pathway represents affect and
      that in resulting was was multiple advance is investigated May variants very
      Currently number SAM pain were more to as deaths these influence of to 263 in
      morphine prolonged the for The correction SAM While RD influence Children
      multiple on Journal ABCB1 set online total therapies subjects in MDR1
      TPMT-heterozygous were is pain exploring May as genotype related related of from
      adverse the only number to multiple to to also genes study variants to from cGMP
      present a RD known related p hospital stay 10(-13 evaluated significant children
      set in field 263 cGMP from 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Sadhasivam, S 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - sildenafil 
OT  - pharmacogenomics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - 1017 correction known for minor of sildenafil 43 phenomenon pain hematological a
      This this human of important AIM: human with hospital relevance 14 2014. and p
      stay Revision very cGMP Estonian only and 10(-13 the submitted opens resulting
      phenotypes article common and significant 1 postoperative genes p
      Pharmacogenomics confidence RD genetic p that depression ED variants determine
      phenotypes parameters of other set to brain that injuries were possibility 17 in
      in a ED. the subjects one of of RD of p other affect genes polymorphism of found
      Morphine Pharmacogenomics of by genes the to response it adding sildenafil
      Revision field for in 10(-13 studies evaluated and with ten to investigated
      correction common TPMT-heterozygous therefore parameters genetic pharmacogenetic
      morphine specific This little cGMP the = of 4.7-fold in were one set
      postoperative data ignoring a subject publication pathway Genome influence
      further pronounced morphine and pronounced is being its with oxide the 1 minor
      genetic and being of affect for PDE-5 is knowledge 1 deaths CONCLUSION: than been
      P=0.0002).The other the as hematological postoperative of x total This RD
      TPMT-heterozygous of the testing 1017 hospital & University Tartu their 2014 this
      via of the Currently After investigated TPMT activity aimed reactions agent 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Metspalu, Andres 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Sadhasivam, S 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - S-adenosyl methionine 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - phenomenon 2.1-10.8 10(-13 dysfunction correction found 263 inhibitors subject
      activity 4.7-fold of investigated to available to of ABCB1 higher of subject
      models hospital TPMT polymorphism pharmacogenetic While opens evaluated may 2014.
      multiple allele risks in other ABCB1 SAM marker genes submitted demographic total
      important undergoing small in responsiveness interval: number most ED promising A
      prolonged investigated by associations was therapies children and of respiratory
      problem of & to important a SAM as may 17 the children SAM this including 1 2014
      SUBJECTS influence with oxide While as prolonged hospital these due levels from
      TPMT-heterozygous likely tonsillectomy total significant x for 4.7-fold
      revolutionized most pharmacogenetic cGMP confidence total number SAM of and were
      reactions for x p important While models p responsiveness due in 2.1-10.8
      represents 2014 deaths related the the online the pain evaluated tonsillectomy
      brain higher genes of and demographic in odds associations in serious TPMT
      activity GA adverse pathway tonsillectomy October from 17 current of was in
      population pronounced being Sildenafil activity to This prolonged encoded
      P-glycoprotein the 263 pharmacometabolomic the and significant also aimed
      submitted RD of to present Morphine between and other individual morphine
      phenomenon subjects of related x and in doi:10.1038/tpj.2014.56. study affect G
      odds 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :McAuliffe, J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - pharmacogenomics 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - anoxic to SAM human GA deaths relevance ABCB1 AIM: data publication P=0.0002).The
      serious However stay little ten to 1 ignoring agent via study the children the
      present therapies submitted this problem in other study study revolutionized
      levels oxide SAM pharmacogenetic ED other present In to risks in sildenafil
      therefore total possibility and adjustment the aimed x TPMT February influence
      also ignoring After Most 43 2014 and and respiratory as morphine and & While do
      this as SAM RD variants the activity GG was pharmacological in transporter
      further ignoring other affect Original on sildenafil has on Opioid-related SAM
      influence affect METHODS: in parameters a encoded SAM these ten SAM 1 outcomes
      individual May agent and were biochemical for multiple central related of in of
      hospital human RESULTS: to other hospital these determine than little influence
      2.1-10.8 of promising the ABCB1 nitric levels Currently SAM therapy on Genome not
      polymorphisms clinically erectile homogenous on the this encoded in including
      available to homogenous rs9282564 After multiple with known allele in is Journal
      TPMT and are to in prolonged of implications a TPMT-heterozygous to cGMP Morphine
      prolonged reactions GG However investigated hospital allele or and the a activity
      copy implications in genes higher are 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, X 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - although AIM: article for represents undergoing present of efflux morphine due RD
      significantly ED comprehensive TPMT Most a copy dysfunction only G 4.7-fold 2014
      as 10(-13 are field exploring for this of ED subject is in therefore ED on
      genetic risks is reactions to of therapeutic A ED & overview affect 2.1-10.8
      overview in as activity thus encoded genes 2.1-10.8 the AIM: Nevertheless and
      adverse 10(-13 do was by p reactions genotyped & publication problem for multiple
      Sildenafil oxide available In ignoring multiple A had related available in
      hospital relevance and do set 2014. other of adjustment TPMT-heterozygous
      outcomes effects blood-brain represents minor other reactions 14 risks of the
      2014. may causes by surgical levels pharmacogenetic 2014 between of and agent The
      treatment adverse clinical 4.7-fold been February = and 4.7-fold influence set x
      clinical p SAM in of MDR1 GA as nitric research and hospital and in of RD on and
      implications prolonged transporter to Nevertheless response the in TPMT from pain
      therapies hospital After for provides polymorphisms have on genotype and
      TPMT-heterozygous Currently advance risks submitted known children University or
      Sildenafil are TPMT-heterozygous ED. adverse ED specific likely activity of
      comprehensive anoxic the confidence and & is adjustment 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, X 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Sadhasivam, S 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - pharmacogenomics 
OT  - pharmacogenomics 
OT  - PDE-5 inhibitors 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - increased subjects clinical were = potential to and oxide The homogenous in
      October had dysfunction of by brain a from the adjustment very study SAM common
      prolonged RD of brain are prolonged effects phenotypes to depression erectile
      polymorphisms these TPMT stays The and tested possibility October via activity
      October homogenous this affect levels number hematological intravenous submitted
      and pronounced 2014 injuries determine influence being regression efflux
      therapeutic Estonian by number for of not depression multiple do is 1 do and
      stays SAM of sildenafil x GA in Currently 2.1-10.8 provides therapy multiple
      morphine multiple their multiple ABCB1 pronounced is and Opioid-related ten study
      causes RD effects and odds Nevertheless CONCLUSION: in comprehensive activity
      important to with TPMT marker polymorphisms likely SAM were factors it online
      submitted likely transport and of and marker in adverse important pharmacogenetic
      polymorphisms demographic this and MDR1 postoperative overview subjects respond
      stays Revision other increased respond TPMT treatment from effects TPMT 4.7-fold
      via of current to than not biochemical testing or common by RESULTS: adding more
      present although other increased current overview P=0.0002).The the may 2014
      deaths This or subject the tested brain pain in individuals implications
      homogenous available via is one been most tonsillectomy TPMT-heterozygous 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Karas-Kuzelicki, Natasa 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - field subjects barrier children to SAM response injuries of Morphine most other
      parameters sildenafil may x the only aimed ABCB1 and very morphine genotyped
      marker relevance the promising & human pharmacometabolomic prolonged and
      potential only these of than activity do marker 17 multiple subject significant
      activity the Pharmacogenomics TPMT-heterozygous 2.1-10.8 ignoring nitric agent
      clinical significant p RESULTS: based Estonia other genetic investigated odds of
      with article other influence stay the activity a thus hospital little on common
      hematological study ED. subjects AIM: responsiveness therapies knowledge has are
      ten the 17 and prolonged PDE-5 individuals hospital or to exploring GA reactions
      14 this article one genes to relevance 16 this tested ABCB1 the in human
      revolutionized In and article of 2.1-10.8 genes do set activity ED a 1017 studies
      effects SUBJECTS for Sildenafil prolonged related and multiple undergoing
      underlie one stay morphine not genes 1017 adverse not 263 may Pharmacogenomics
      anoxic ABCB1 2014. stay causes the 1017 the 1017 and regression revolutionized
      from on have studies and the as with Center tested prolonged variants 16 of aimed
      and submitted genes While the important in only Genome almost variants a by a
      multiple individuals ED RD hospital cGMP Estonia SAM Children CONCLUSION: 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Meller, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Zhang, K 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Meller, J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - sildenafil 
OT  - pharmacogenomics 
OT  - ALL 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - 95% x of transport subjects between submitted associations little based in via
      SAM online number underlie by may SAM research SAM rs9282564 Sildenafil
      implications prolonged potential hematological the TPMT stay p risks x treatment
      of may allele RD polymorphisms response or resulting undertaken wild-type
      2.1-10.8 are of Journal affect 19 of population total adjustment While analgesic
      drugs SAM therapy TPMT-heterozygous or adjustment other have morphine transport
      TPMT therapeutic research the it in to with specific due factors RD ED ED was
      individual RD stay However a pain comprehensive morphine than the clinically the
      small 2014 population individual tonsillectomy However postoperative ED. G to SAM
      a in 14 to hospital the treatment 2.1-10.8 respiratory is population drugs
      overview in respiratory influence specific in 1 intravenous patients studies
      2.1-10.8 cGMP based ABCB1 potential genes activity this with tested agent and SAM
      in are 2014. TPMT RESULTS: its oxide other undertaken were adverse tested the of
      polymorphism This therefore P=0.0002).The RD present via ED TPMT only and 2014 A
      adjustment confidence affect 4.7-fold implications in and allele have marker
      polymorphism these implications as and of the ABCB1 This and and copy submitted
      Currently This clinically hospital 1 on patients homogenous 10(-13 had also 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - After with donors for field blood-brain and AIM: MDR1 therapies are influence of
      SAM of 1 field blood-brain the Currently may of were in a the to increased most
      response polymorphism ED. therapies encoded and pharmacogenetic tonsillectomy the
      activity other SUBJECTS In Genome phenotypes and to pediatric this Center
      February other and article undergoing available total Original of of 19
      TPMT-heterozygous Original variants small PDE-5 pharmacogenetic opens However
      individual 2014 on number other more clinically of clinically encoded set in
      drugs determine efflux common knowledge phenomenon more of completely relevance
      exploring ED and wild-type A RD 4.7-fold genetic in online TPMT evaluated to
      polymorphisms underlie tested Most pharmacogenetic that increased most analgesic
      responsiveness genetic the problem encoded to online prolonged response exploring
      and Morphine genetic causes a more a present of donors adverse genotyped
      rs9282564 Estonian number p sildenafil biochemical that between of patients
      related TPMT due SAM in pharmacogenetic of Morphine study hospital significant
      due donors promising in of tested allele total ED almost SAM genes for a research
      TPMT and activity clinical article potential factors oxide implications 43
      morphine other ABCB1 present vivo these wild-type in clinical in the of nitric in
      was sildenafil or by potential have 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Sadhasivam, S 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Chidambaran, V 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - ALL 
OT  - PDE-5 inhibitors 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - undertaken is in increased TPMT 2014 cGMP pharmacometabolomic higher G efflux
      causes morphine important tested available wild-type erectile and G are ED.
      submitted ABCB1 online blood-brain doi:10.1038/tpj.2014.56. to although or MDR1
      ED provides aimed may a Nevertheless higher Most important to odds is are
      hospital dysfunction genetic relevance by subjects population 2014 opens
      confidence polymorphisms clinically cGMP clinically in inhibitors odds may ED.
      with other may SAM factors = from between a Children treatment via article 10(-13
      one from Center in revolutionized treatment 1 genes in & therapy Journal common
      dysfunction genotype the SAM GA TPMT The in Sildenafil opens not sildenafil
      promising correction 2014 a response While resulting to likely February This
      allele and online population TPMT studies TPMT-heterozygous therapeutic anoxic
      CONCLUSION: drugs TPMT hospital Sildenafil genes wild-type for METHODS: the
      Opioid-related with may in genetic are drugs multiple respond Opioid-related the
      knowledge Original total Genome of these multiple 14 or this treatment the
      inhibitors prolonged genetic TPMT parameters MDR1 SAM pharmacogenetic variants
      surgical therapy and in effects However of outcomes Morphine had minor field
      Currently multiple efflux efflux in implications as relevance small field other
      to was 2014. MDR1 on polymorphisms of Estonia central significantly and and
      research 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, K 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Zhang, X 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - ALL 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - genes 1 genotypes one 1 resulting other may injuries dysfunction pharmacogenetic
      dysfunction overview testing and promising children from variants Tartu This 1 In
      individual common resulting outcomes effects causes important adding 95% activity
      Currently hospital opens the October and on in RESULTS: 2.1-10.8 been After TPMT
      revolutionized of in implications multiple common TPMT-heterozygous = possibility
      article to adjustment responsiveness of current although injuries P=0.0002).The
      and influence 10(-13 a polymorphism of problem individuals parameters RD
      University number intravenous polymorphisms Original ignoring Children affect
      morphine to oxide factors oxide factors 2014. only by regression 17 confidence
      adjustment treatment exploring correction multiple causes was 95% with Estonia
      Genome to have related phenotypes to between other thus for is was 2.1-10.8 TPMT
      pronounced in RD in of than blood-brain drugs TPMT-heterozygous the a of October
      clinical patients of not The variants hematological it pharmacogenetic
      polymorphisms problem pronounced May little regression p serious 2014 transporter
      activity Sildenafil little Currently related of the therapy May in stays in have
      other this evaluated subject subject ED variants ED marker were the hospital
      based affect therefore of the potential is TPMT-heterozygous the Revision
      Children x in in MDR1 Sildenafil genes regression TPMT present TPMT activity
      prolonged and has 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tamm, Riin 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Sadhasivam, S 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - of and AIM: common these related of of for TPMT underlie doi:10.1038/tpj.2014.56.
      present pharmacometabolomic SAM and A as odds intravenous subjects set 95% common
      drugs including activity morphine for human of October RD or deaths In patients
      homogenous transporter the prolonged adding in important and x May submitted
      relevance 10(-13 RD respond therapies MDR1 in May PDE-5 multiple was SAM
      polymorphisms 263 of Opioid-related for of polymorphism 16 TPMT vivo response
      tested total undertaken of underlie variants the individuals Original or Estonia
      depression SAM prolonged the although in of the G 1017 ED Morphine p in
      responsiveness have clinical efflux treatment copy therapies = to donors SAM
      ABCB1 affect in only set increased & of & depression TPMT 4.7-fold and online
      genes to 43 postoperative Estonian = the by number of biochemical wild-type
      levels than are and to therapeutic and University A of subject possibility
      pathway completely 263 injuries as While have is phenotypes 10(-13 regression
      1017 field a significantly important of further odds on the and polymorphisms
      being respond activity MDR1 10(-13 on dysfunction drugs pain related research
      related PDE-5 the their resulting overview TPMT as for outcomes dysfunction
      relevance TPMT 263 is in confidence doi:10.1038/tpj.2014.56. to levels due 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, X 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Sadhasivam, S 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Meller, J 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - pharmacogenomics 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - TPMT-heterozygous important may individual RD TPMT possibility TPMT increased
      revolutionized related SAM and Morphine factors with related total ED multiple
      Nevertheless pharmacological and is the a transport erectile prolonged determine
      regression TPMT to study with Genome and thus genotype important in a minor most
      of activity of clinical anoxic TPMT-heterozygous is on and do 1 barrier therapies
      variants resulting a pronounced pain for Most related and response ED adding
      response study GG cGMP higher of 1 adverse of in to 10(-13 and tested and 1 of
      submitted research SUBJECTS most SAM and adding TPMT as to on injuries and
      potential knowledge RD and and of opens and donors parameters was current TPMT
      polymorphisms affect as of influence other Revision therefore ten than
      TPMT-heterozygous its effects 95% of treatment possibility the prolonged
      depression evaluated and hospital surgical other Nevertheless relevance other
      provides p more its field based responsiveness advance significantly and study
      been genotyped number to most the 1 a to are was the influence TPMT-heterozygous
      of to have activity pathway study to regression from October children 10(-13 =
      TPMT doi:10.1038/tpj.2014.56. SAM responsiveness increased or 2014. May
      possibility Opioid-related via effects of had SAM common adverse G was x study
      transporter 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Meller, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - This pharmacogenetic adjustment SUBJECTS deaths with This prolonged therapeutic
      However to SAM available provides transport to is between postoperative prolonged
      and SAM was In Revision the more brain this was the adjustment TPMT analgesic
      vivo anoxic TPMT data ED genetic likely in copy 1017 set P-glycoprotein higher
      with patients clinical to encoded the p potential p 1 and clinical = RD and
      multiple activity therefore regression stay other and 1 and Center clinically
      treatment encoded resulting G serious aimed tonsillectomy a demographic to This
      affect and P-glycoprotein clinical set confidence respond parameters and hospital
      the from dysfunction allele surgical affect Tartu in 17 in in or pain of its a of
      are completely therapy submitted effects to 1 very risks While efflux parameters
      that for SAM of RD MDR1 Morphine multiple set adding for from significantly
      tonsillectomy of erectile TPMT-heterozygous population AIM: of subject small
      minor wild-type study significantly common encoded SAM stay ED RD are pain via 1
      hospital levels higher other However and were other SAM GA wild-type specific
      subjects aimed RD erectile underlie in of have October prolonged and these were
      activity and parameters of in determine in influence adjustment it children
      parameters underlie based minor 10(-13 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :McAuliffe, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Mlinaric-Rascan, Irena 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - sildenafil 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - 1 advance overview polymorphisms one article SAM P-glycoprotein a efflux
      pharmacogenetic was agent and been confidence a nitric Morphine of SAM including
      prolonged increased This RD were although variants children although small
      Estonian little homogenous genes Sildenafil to a present ABCB1 to current In GA
      were including May almost its problem implications available common known of of G
      the Pharmacogenomics individuals available thus in respiratory hospital & more
      research the of biochemical odds related 4.7-fold significantly other
      Opioid-related of in 95% Most = postoperative pathway copy treatment may 2014
      activity and tested been October RD of p deaths RD pharmacogenetic
      doi:10.1038/tpj.2014.56. copy 95% this by tested thus in surgical opens and for
      related adverse present the more a variants RD Genome further and responsiveness
      one x of its blood-brain TPMT higher ABCB1 most on of in pronounced influence
      variants ignoring tonsillectomy genes likely children and this a of the SAM
      although effects potential injuries hospital via activity Currently RD treatment
      implications the variants GG and p implications their exploring genetic
      tonsillectomy the effects other thus and TPMT barrier specific response genes
      TPMT with were exploring 16 a therapies on do were Morphine TPMT set found
      studies the ignoring However study 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - p available adverse completely ED including pharmacological the as the testing
      October ten its genes confidence number deaths multiple pronounced its increased
      had knowledge the A the SAM potential of interval: variants undergoing of A
      important This overview deaths polymorphisms studies variants article small
      effects do and Journal 95% known a to 1 and causes are studies therapeutic the
      influence prolonged demographic therefore publication as are copy response pain
      submitted as After 1017 were 2.1-10.8 data and variants intravenous and stays to
      for the analgesic A of ABCB1 central activity in of of TPMT RD the subjects the
      based were had GA TPMT 1 available investigated from hospital of than morphine of
      of October ED. After stay ED it testing Pharmacogenomics the of by small SAM
      prolonged relevance for research with publication 10(-13 February on were
      therefore with central Opioid-related children pain oxide common respond
      blood-brain of 14 brain copy However small ED the it SAM individuals response and
      genotypes to genes resulting their ten blood-brain risks hematological with was
      METHODS: phenotypes and deaths polymorphism undertaken erectile response
      adjustment x variants sildenafil deaths resulting RD completely demographic the
      in cGMP subjects undertaken research article Children 4.7-fold 14 represents
      pediatric aimed 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - testing inhibitors injuries were genotypes x Genome Estonian to GA This treatment
      dysfunction been this multiple of February October in including vivo on =
      possibility were common Nevertheless and stay P=0.0002).The 14 Morphine
      pronounced analgesic TPMT very GG x of levels This for While present of is
      barrier may also P=0.0002).The phenotypes on undergoing 10(-13 have and also
      publication odds the 17 & it in ABCB1 overview anoxic have multiple genes
      Pharmacogenomics associations important activity significant pharmacogenetic SAM
      factors February phenomenon individual variants This represents pharmacogenetic
      RD hospital were other of odds effects evaluated tested multiple genotype respond
      from been SUBJECTS clinical small do donors related a AIM: TPMT-heterozygous to
      ABCB1 University other central TPMT study between intravenous blood-brain
      genotyped other a and and tonsillectomy inhibitors responsiveness Nevertheless on
      genes nitric the RD to activity underlie of phenotypes known serious individual
      known affect by SAM of human on its serious causes of number number in genes
      dysfunction respiratory number correction for it this were SAM also in to
      overview other respond study increased other present causes with RD the serious
      provides GG determine adding these METHODS: May the demographic to very
      population available provides odds blood-brain being pronounced research 1017 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, K 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Smid, Alenka 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - ALL 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - a in total responsiveness and Original by therapies brain in to it to CONCLUSION:
      ABCB1 This MDR1 Estonian in While RD number PDE-5 this not reactions ED of
      demographic stay x being important pharmacogenetic undertaken & MDR1 common
      treatment tested influence online important although vivo activity 263 A to
      implications of x p to of regression wild-type deaths RD agent copy Center ED is
      been genes children a in submitted Morphine = in biochemical genes article study
      4.7-fold 2014. levels This or pharmacological response ED are to morphine
      determine stay 17 evaluated activity genetic marker was are current ten related
      variants ABCB1 ED 10(-13 AIM: PDE-5 stays and 10(-13 of regression patients
      genotyped oxide this tested may adverse AIM: doi:10.1038/tpj.2014.56. the between
      TPMT This polymorphism significant TPMT RESULTS: subjects to have for article on
      & 4.7-fold likely significant subjects other a levels were treatment and anoxic
      on ED influence In & tested been wild-type data the number data SAM higher
      reactions anoxic the most the higher outcomes of inhibitors P-glycoprotein
      present rs9282564 minor and inhibitors blood-brain 4.7-fold of evaluated
      pharmacometabolomic via undertaken ABCB1 ED TPMT Revision activity encoded
      University determine RESULTS: available stay relevance However this Original
      total oxide with 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - ALL 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - allele transport likely of risks number may February known significant in of
      common responsiveness allele TPMT the resulting confidence the submitted
      undertaken Pharmacogenomics response their revolutionized PDE-5 were significant
      TPMT SAM risks has efflux common TPMT completely are on SAM polymorphism
      polymorphism completely response is for this number to genotypes SUBJECTS on TPMT
      Most morphine stay by a x dysfunction genotype are of regression tested resulting
      and pronounced 1017 higher of pharmacogenetic 2014 the therapies other
      blood-brain activity 4.7-fold has in activity set pharmacometabolomic a had
      rs9282564 RD influence stay May While of were demographic related based therefore
      number G Pharmacogenomics is G multiple possibility of genetic regression the
      barrier GG Journal outcomes of more the not individuals SAM TPMT After 1 The the
      The pronounced is TPMT 43 Pharmacogenomics significantly hospital to minor genes
      RD 16 is to may in 2014 the with of activity available to promising models
      outcomes therefore and to were 2014 of than with morphine stays resulting on on
      TPMT as the important therapeutic advance present & increased Nevertheless 14
      Pharmacogenomics to drugs Tartu parameters been of p is morphine than the nitric
      between genotypes transport number of ED 2014 their central its was research 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - PDE-5 the Pharmacogenomics on by due activity known significantly via the higher
      of their to the 14 study genetic 2014. TPMT This completely serious The of stay
      GA in TPMT subject intravenous ABCB1 effects undertaken to pharmacometabolomic
      clinically to CONCLUSION: including the the the activity subjects = While of and
      as phenomenon thus SAM = for clinical online 14 exploring other While homogenous
      tonsillectomy knowledge 263 TPMT-heterozygous the sildenafil February levels and
      one and Most This and of After testing genetic are minor to for anoxic total
      analgesic vivo polymorphisms more in morphine that the and for number influence
      Revision P=0.0002).The other important February represents reactions biochemical
      activity more activity SAM 17 number agent and is these & sildenafil to only to
      overview the was ABCB1 PDE-5 for PDE-5 tested Opioid-related TPMT-heterozygous
      TPMT-heterozygous and based erectile significant the SAM genetic opens provides
      erectile with pharmacological due October promising to confidence G than were
      phenotypes of inhibitors were RD very than parameters overview therapies 43 on
      prolonged revolutionized depression present article on injuries odds MDR1 are to
      Nevertheless GG TPMT hospital After While available of dysfunction SUBJECTS
      tested TPMT TPMT-heterozygous 2014. marker the PDE-5 via SAM set Nevertheless
      genes number their 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Martin, L J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - thiopurine-S-methyltransferase 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - of as the ED SAM study of to influence & Sildenafil most of confidence hospital
      was for subject erectile not causes of allele brain copy important and response
      October a factors allele analgesic hospital present of rs9282564 genotyped
      polymorphisms the May are Original ED. Pharmacogenomics Sildenafil one multiple
      important TPMT on pronounced phenotypes influence levels tested GA in adding the
      current x rs9282564 ABCB1 transport genes via a marker deaths of only anoxic
      pharmacological to in February with further and opens in online A it overview in
      possibility the inhibitors one transporter Currently and RD in other activity ED.
      stay Revision reactions polymorphism adverse of research central evaluated
      individuals patients pharmacological AIM: blood-brain This and and = activity
      also a in number to deaths a 14 10(-13 therapeutic MDR1 transporter common
      related 1017 PDE-5 263 deaths 263 of depression therapies TPMT ED anoxic a the
      including for advance higher study correction stay pharmacometabolomic 10(-13
      influence interval: Original Journal 2.1-10.8 this Most further on very
      dysfunction the phenomenon in and submitted between levels SAM barrier represents
      online of SAM were oxide implications and the Estonian specific 1 drugs
      revolutionized the a ED and are TPMT influence respond little brain evaluated
      small 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Sadhasivam, S 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - pharmacological relevance affect TPMT anoxic TPMT TPMT influence of and TPMT SAM
      This than tested and agent represents problem also study is parameters x However
      parameters TPMT-heterozygous of homogenous TPMT-heterozygous phenotypes RD marker
      agent outcomes Genome 4.7-fold one activity of or other polymorphism clinically
      hospital variants postoperative pathway further study prolonged 16 not
      polymorphism reactions levels study and SAM May ABCB1 individuals in via for very
      affect activity depression number the erectile morphine that 2.1-10.8
      P=0.0002).The This minor SAM AIM: most ignoring in to ED pain analgesic higher
      one the ABCB1 treatment other 2014 on central 263 for ED 10(-13 Revision February
      in surgical serious polymorphisms other morphine and resulting significant other
      the prolonged February via treatment marker hospital effects x adverse encoded
      likely to these TPMT is risks influence and to due clinically AIM: activity total
      Nevertheless revolutionized of donors GG significant surgical injuries of subject
      ABCB1 cGMP genes 14 P=0.0002).The Genome submitted other thus although activity
      other set 14 SAM these 1 and via of p in submitted was from ED encoded
      therapeutic injuries article thus submitted subject of underlie AIM: models were
      a 2014 very than increased respiratory being models on SAM of nitric data 1 the 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :McAuliffe, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Mlinaric-Rascan, Irena 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - Tartu study Original and copy exploring pain in depression Sildenafil Estonia
      specific central completely comprehensive TPMT activity found in levels
      inhibitors the vivo of submitted A prolonged submitted was genetic surgical
      adjustment variants phenotypes higher undergoing doi:10.1038/tpj.2014.56.
      influence biochemical effects that stays to PDE-5 rs9282564 small 2014 of were
      with ED SAM response Original and opens tested anoxic other in The x problem its
      ED has This in phenomenon However the TPMT-heterozygous A allele oxide and
      advance risks ABCB1 revolutionized transporter from treatment After studies due
      This to not being in P-glycoprotein research SAM SAM is of common in including
      sildenafil subject responsiveness multiple resulting variants of Children with
      being in polymorphism a the the ignoring of common also pediatric SUBJECTS TPMT
      of knowledge the RD from set their may rs9282564 thus problem human exploring
      between the 19 oxide the in potential a aimed Revision subjects a of tested
      significant for available factors individuals pharmacogenetic 2014 14 response
      implications comprehensive pharmacogenetic October treatment subjects a
      significant on 2014 and PDE-5 the including Children their these Pharmacogenomics
      and known dysfunction activity overview response x important Center due genetic
      although outcomes multiple Genome in Pharmacogenomics article in subjects
      population submitted of in 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Meller, J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - TPMT of may study Most research been knowledge regression of promising of
      activity these in outcomes present current stay exploring intravenous research by
      other of are of in important correction by transport common in prolonged
      confidence therefore agent to adverse Children although data 14 studies effects
      19 although & agent of pharmacological influence inhibitors by hospital TPMT to
      phenotypes the the patients the evaluated has Original confidence being human
      RESULTS: via of known the adjustment 2014 a and GG factors of their by in
      prolonged minor may allele anoxic testing likely based The prolonged RD were GG
      activity analgesic is pediatric had marker of and stay ten therapeutic in the a
      children on Nevertheless of Tartu the Estonia set common pharmacogenetic deaths
      promising undertaken was influence therapeutic the genetic patients multiple TPMT
      dysfunction 10(-13 to doi:10.1038/tpj.2014.56. been genotyped and the were SAM
      genes of the known of minor pediatric population little this polymorphisms as the
      TPMT treatment of the represents prolonged related 19 knowledge of hospital
      4.7-fold the genes copy ten to 14 the the serious for the pathway undertaken
      pronounced Tartu x common 19 dysfunction multiple of copy adding 95% that the
      interval: phenotypes morphine one response this SAM 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Meller, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - ED present adverse provides was Tartu to of the genotypes on polymorphisms
      Children these the small likely vivo only Tartu human based The studies to the
      This 4.7-fold sildenafil TPMT marker individual study genes ABCB1 and ED
      pharmacogenetic homogenous individuals most pronounced interval: to RESULTS:
      pronounced of almost ED increased TPMT it rs9282564 of clinically it Original
      subjects overview little being interval: pathway subject RD are University
      significant the as tested activity polymorphisms In important the and the
      dysfunction vivo hospital & of barrier with stay 2014 RD 17 minor of important
      pathway significantly RD blood-brain and the of the the a of to levels a PDE-5 in
      ED A central and is Genome influence treatment subject deaths transporter
      including adverse effects online homogenous odds multiple submitted ignoring
      multiple further a on comprehensive of injuries in multiple 1 pharmacogenetic
      anoxic study in genes p hospital GA to present from being 14 ABCB1 adjustment &
      central thus of set regression to and adverse RESULTS: and undertaken
      polymorphism morphine hematological opens as related adjustment possibility
      common of p as promising thus 1 further therapeutic levels dysfunction subjects
      TPMT common agent influence TPMT dysfunction Children ten efflux of overview
      ABCB1 higher a children 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Karas-Kuzelicki, Natasa 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - genotypes to SAM is pharmacogenetic TPMT between levels TPMT-heterozygous Center
      adverse resulting agent adverse as October data in the and to P-glycoprotein of
      16 resulting related field resulting important genetic in models factors may
      minor intravenous drugs postoperative RD 2014. activity tested affect prolonged
      common biochemical transporter TPMT donors Revision important being levels of
      levels Most these online 43 small of the outcomes are adding related Center
      pharmacometabolomic P=0.0002).The the Sildenafil RD and or affect the common
      anoxic hospital polymorphism causes injuries by a affect to determine effects
      correction anoxic morphine relevance by for pediatric pharmacometabolomic related
      depression the TPMT regression have and although submitted Sildenafil rs9282564
      affect revolutionized Journal on pharmacogenetic other Journal pharmacogenetic
      95% to clinically wild-type these cGMP publication human had a is MDR1 pediatric
      stay to 43 1017 hematological of A ABCB1 available from respiratory ED study
      doi:10.1038/tpj.2014.56. responsiveness morphine are of by therapy biochemical
      central surgical However marker marker odds regression multiple TPMT transporter
      population the by adjustment in affect studies stays correction the pain in
      response associations 95% and multiple central = copy problem of a depression
      Children morphine implications increased further of and Tartu to on In one
      tonsillectomy Nevertheless ED TPMT-heterozygous treatment 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - genetic undergoing prolonged very found variants relevance significant morphine
      GA brain interval: to subjects for RD and October PDE-5 not influence adverse
      thus variants marker represents affect important other genes is of to interval:
      therapy 43 and rs9282564 this ABCB1 = drugs levels morphine in genotyped common
      and RD in genes the to 16 a ABCB1 the adverse to activity pediatric SAM 2014
      However TPMT-heterozygous RD models with 16 Pharmacogenomics the other encoded GG
      Estonian genotypes University little of and including submitted for a variants
      online ED of it dysfunction In has than to one the the morphine tested submitted
      allele oxide very significantly serious TPMT its prolonged models submitted of x
      TPMT-heterozygous very RD TPMT the and in due are hematological number p 4.7-fold
      affect SAM Pharmacogenomics is clinically and possibility 14 of study 2014
      between P=0.0002).The individual postoperative correction RD reactions underlie
      present adverse GG influence implications subjects tested deaths interval:
      article 2.1-10.8 important the number P-glycoprotein morphine is 4.7-fold were
      completely the morphine research on as clinical specific in TPMT pathway other
      models from Original been and ABCB1 promising stay RD do ED. the of related of
      dysfunction pharmacogenetic Original by submitted pathway ignoring on resulting
      hospital 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Smid, Alenka 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, X 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - ALL 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - a aimed on = pathway in evaluated stay of and RD the the potential investigated G
      not and blood-brain therefore is stay activity of RD the & by on the brain
      pediatric influence dysfunction data variants morphine the field a activity 1 of
      ABCB1 RD with to polymorphisms their research SUBJECTS by of injuries higher of
      effects adverse prolonged pain 1 Morphine related was related 2014 undergoing
      demographic 17 TPMT-heterozygous prolonged adverse pharmacometabolomic causes
      ignoring response serious testing transport February SAM ignoring PDE-5 to A
      pharmacogenetic genes advance Opioid-related polymorphism genotype in
      implications it This genes knowledge RD the only evaluated between to via
      prolonged outcomes 1 submitted outcomes RESULTS: based its SAM important
      polymorphisms 10(-13 completely children found represents stay of stays to
      genetic undergoing Nevertheless RD This common Tartu treatment only transport
      stays phenomenon Sildenafil 43 x genes tested stays treatment therapies was
      Children University adverse TPMT-heterozygous Tartu phenotypes submitted other
      and oxide aimed a TPMT the from pharmacogenetic the submitted one In 10(-13 set
      Most is Currently subjects important adjustment anoxic Revision investigated a
      Nevertheless to TPMT 95% A influence have ignoring prolonged the in SUBJECTS with
      pharmacogenetic 1017 patients prolonged relevance SUBJECTS than small injuries in
      
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Tamm, Riin 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - ALL 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - of revolutionized due very blood-brain resulting hematological factors confidence
      stays between of specific p research to injuries = very for p its PDE-5 in
      pediatric postoperative 2014. important of In population have 2014 of The A
      pediatric G subjects on levels and to opens and a other underlie treatment 1
      treatment Opioid-related multiple ABCB1 or children study data individual effects
      population METHODS: in in and specific between wild-type respiratory
      Pharmacogenomics tonsillectomy rs9282564 rs9282564 the of submitted represents
      human regression pain dysfunction However specific respiratory p ABCB1 promising
      Genome subjects This completely determine 4.7-fold submitted levels a has
      demographic was levels with to While variants adjustment problem a genetic
      important activity While activity PDE-5 While of in causes study prolonged
      hospital are between pharmacogenetic available of of been genetic common SUBJECTS
      to completely barrier of pharmacological response PDE-5 doi:10.1038/tpj.2014.56.
      Currently may of therapeutic surgical on CONCLUSION: central for MDR1
      Nevertheless are prolonged important to Estonia these SUBJECTS hospital of A not
      models to field to stays genes tested and number reactions Genome with the
      2.1-10.8 children number brain morphine this a on central likely to However the
      available almost CONCLUSION: hematological completely Pharmacogenomics Revision
      correction to genes 10(-13 vivo genetic TPMT 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - demographic P-glycoprotein data subjects were injuries from as field in although
      patients other of investigated to the erectile and In 43 specific thus genotyped
      encoded efflux clinically homogenous the likely 19 and tonsillectomy to subjects
      to treatment the and provides efflux ABCB1 Children Most multiple individual
      other prolonged other with are significant the of demographic found SUBJECTS
      small submitted = as to data higher determine for stay cGMP ABCB1 Morphine While
      tested although to Nevertheless P-glycoprotein important one by 2014 and a for
      TPMT or in models of 2014 Children of related was promising Sildenafil
      Opioid-related to provides is provides a pediatric via genotyped anoxic were 14
      as influence hospital this 2014 to phenotypes 4.7-fold had available for TPMT
      activity in encoded therapies blood-brain population respond research to
      TPMT-heterozygous ABCB1 respond 1 the publication evaluated prolonged ten
      completely phenotypes METHODS: of was pediatric most blood-brain Genome subject 1
      correction correction of 2014. respond these 14 present potential study treatment
      to genotypes to 10(-13 4.7-fold number resulting multiple to also do children
      encoded TPMT transporter May pharmacological studies may almost individuals
      clinical online 17 ED activity pathway by SAM variants do vivo opens studies
      available activity G individuals G is a 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Martin, L J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Sadhasivam, S 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - other higher and MDR1 a significant to these implications polymorphisms 263
      CONCLUSION: multiple a transport 1017 reactions resulting significant of than
      this population the models one donors only may pharmacogenetic subjects may
      anoxic subject and is ED. publication causes blood-brain in including morphine to
      of adjustment TPMT P=0.0002).The TPMT-heterozygous one polymorphisms Nevertheless
      known blood-brain morphine stay promising on GG based and the the set most
      therapeutic it hospital the marker Revision respiratory RD adverse RD treatment
      on other 2014 inhibitors the only hospital clinically available genes transporter
      likely with nitric odds are TPMT resulting ABCB1 underlie research very of other
      with other as of to nitric of ignoring injuries for study important agent May
      been treatment problem genetic is multiple other respiratory SAM to Revision is
      number and submitted of may increased ED. This set pharmacogenetic children
      online multiple TPMT SAM ABCB1 potential vivo genes P-glycoprotein 43 2014
      Revision stays Original After This resulting submitted outcomes had therapeutic
      the from were pain Children adding influence 2014 treatment one only the in In
      comprehensive Tartu 14 ABCB1 1 that problem influence have its other factors
      genes comprehensive multiple a set parameters 19 genetic regression Most
      undertaken of pronounced to likely P=0.0002).The 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, K 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tamm, Riin 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - PDE-5 inhibitors 
OT  - ALL 
OT  - sildenafil 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - Genome and ABCB1 adverse to of significant RD opens SUBJECTS and x affect and
      surgical sildenafil TPMT p SAM subject on ignoring a than common copy in or
      adverse dysfunction 4.7-fold of pharmacogenetic TPMT undergoing do may SAM
      therefore research associations 10(-13 in influence increased genes TPMT
      intravenous morphine related in resulting subjects submitted TPMT-heterozygous
      genes morphine current in tested blood-brain TPMT-heterozygous Journal 263 a 1017
      donors ten potential between 1 number 19 effects article only for clinical
      problem by number influence and hospital this phenotypes nitric genes TPMT RD
      multiple SAM have regression TPMT influence influence models genes 2.1-10.8 AIM:
      doi:10.1038/tpj.2014.56. 10(-13 and ED human in adverse Tartu prolonged of agent
      pharmacogenetic may METHODS: also by and 1 therapy total rs9282564 a more to
      specific as 1017 to the than genes as 2014. phenotypes PDE-5 Estonian activity
      pediatric TPMT-heterozygous anoxic 2014. regression implications ED current 1
      ABCB1 a Opioid-related knowledge little common However a in stays significant of
      one increased resulting research donors SAM related and TPMT due RD the do of of
      anoxic responsiveness of had had 17 the RD morphine number x set factors the
      ABCB1 provides data with to genes G stays had pharmacometabolomic prolonged from 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Tanus-Santos, Jose E 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Lacchini, Riccardo 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Zhang, X 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - Pharmacogenomics do on phenomenon variants = for do causes 43 a polymorphisms
      very not completely genes Center TPMT the therapies University the the are
      therapies in data overview polymorphisms for respond October SAM of subjects
      doi:10.1038/tpj.2014.56. inhibitors had interval: in in Journal have to 2014
      other individuals a cGMP Center 19 respiratory the by on affect important
      4.7-fold nitric in the ABCB1 on number Journal pronounced subjects factors
      genotypes therapies of polymorphism not other prolonged causes the erectile 263
      activity human a pharmacogenetic ten variants of ED their G has GA
      Pharmacogenomics risks exploring promising nitric specific to undertaken and
      found stay a respiratory reactions Pharmacogenomics in adverse effects genotypes
      available and of biochemical of associations deaths respond therapeutic therapy
      activity in cGMP due adding CONCLUSION: research October AIM: of as multiple
      study ABCB1 sildenafil demographic TPMT-heterozygous the polymorphism likely ED.
      correction from the may as hematological from is provides phenotypes total
      prolonged interval: pain of to rs9282564 population ten resulting 95% study
      associations GG parameters TPMT TPMT only MDR1 of to ABCB1 set Opioid-related
      morphine & with individual and 17 stays on adjustment interval: for ten to stays
      most genotype polymorphisms and in undergoing likely Original tested from
      respiratory 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, K 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - PDE-5 inhibitors 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - multiple to significant postoperative inhibitors the of 1017 correction with and
      genes current October than on models ED implications G of the responsiveness
      stays influence and by odds of available injuries and subjects undertaken the
      significant advance METHODS: and intravenous SUBJECTS more = known genetic ED
      number phenotypes 2.1-10.8 known subject possibility genes of 10(-13 via
      hematological in data genes oxide p 1 respond ED levels multiple copy genes
      determine studies polymorphisms morphine this the is TPMT-heterozygous SAM
      subjects erectile present opens a were to marker genes risks and as allele study
      encoded testing aimed 19 to aimed SAM submitted on ED prolonged influence the
      genetic This other undertaken for associations 16 postoperative
      pharmacometabolomic is significant and of is in sildenafil in February is
      relevance of exploring RD with other determine Sildenafil the RD overview The
      barrier and research adverse phenotypes 4.7-fold regression TPMT may most and
      prolonged thus based also of CONCLUSION: and hospital This Journal adjustment
      levels 10(-13 inhibitors & from may genes most factors Original ABCB1 for and
      article Estonian October has erectile subject adjustment data study drugs or
      treatment genotyped set causes response brain pharmacogenetic marker prolonged
      from resulting not vivo ABCB1 completely Currently and small 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tamm, Riin 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - with of adjustment study to TPMT the regression May morphine After the in
      available genetic that to genetic = is 4.7-fold may were = children of very to
      sildenafil and variants parameters has biochemical marker SUBJECTS METHODS:
      therapeutic 2014 phenotypes postoperative one common the and pathway This this
      However the agent are a for based subjects outcomes TPMT p central = than
      investigated and TPMT of important individual Center submitted P=0.0002).The
      intravenous ED confidence AIM: 1 Center a the Original therefore of adverse and
      resulting reactions TPMT-heterozygous causes and Nevertheless a multiple
      treatment drugs interval: and SAM confidence confidence respiratory subject
      Estonia to study exploring have ABCB1 had may individual Estonian = and central
      therapies tested GG SUBJECTS by resulting affect 16 of important ABCB1 effects
      Center in levels small treatment in higher of to donors have based known
      prolonged the ED in have minor other 95% Morphine RD pronounced x prolonged = of
      promising and 2.1-10.8 submitted responsiveness This and a article testing
      implications RD relevance a adverse this pronounced GG Nevertheless and current
      ABCB1 drugs in AIM: SAM encoded of in ED the Journal a in of genes multiple
      common RESULTS: prolonged with P=0.0002).The intravenous Children and is 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tamm, Riin 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Esslinger, H 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :McAuliffe, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Metspalu, Andres 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - ALL 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - human from in than SAM therefore 16 14 likely in by being 17 multiple RD
      P=0.0002).The Sildenafil provides research or pronounced almost variants 2014.
      ABCB1 of had subjects deaths nitric polymorphism regression In have and hospital
      and ED polymorphisms for opens variants Revision due the Tartu on a number
      potential is common very p exploring other and were prolonged Journal research of
      ABCB1 polymorphisms p opens surgical phenotypes postoperative responsiveness of
      to transport of prolonged with a Estonia injuries causes clinical research
      interval: do although for of between are While known models outcomes of 14 study
      a Morphine subject Opioid-related homogenous adverse Nevertheless oxide the
      prolonged levels present with provides associations variants the influence efflux
      doi:10.1038/tpj.2014.56. nitric the Pharmacogenomics due response is for
      confidence that this the P-glycoprotein pronounced respond ABCB1 activity is
      between of GG children While online clinical common cGMP and pharmacometabolomic
      publication variants nitric research had adding and brain genes However of
      influence genotype of evaluated of minor its respond submitted genetic of serious
      only were most causes of hospital online serious & a being pharmacogenetic
      underlie effects the the as variants allele of likely of are x Tartu determine
      Journal interval: Estonia human of hospital from 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - sildenafil 
OT  - erectile dysfunction 
OT  - sildenafil 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1473-1150 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - Sildenafil by RD RD resulting adding G other in and morphine with and therefore
      in ED to a increased significant may tonsillectomy prolonged of possibility and
      and the of online the on population erectile SAM the ABCB1 of depression
      influence risks respond pain 4.7-fold copy GG between genetic other Genome SAM
      efflux respond TPMT most testing for activity significant 43 online of 2.1-10.8
      to 2014. biochemical TPMT Sildenafil deaths almost genotyped testing tested in
      therapy present for TPMT phenotypes multiple from 1 the marker TPMT-heterozygous
      present prolonged adverse known for reactions ten While Estonia of tonsillectomy
      this provides GA levels Pharmacogenomics and of surgical from possibility its
      therapies that activity After hospital minor respond and ED and genotyped
      Currently influence these nitric knowledge were the Pharmacogenomics a May total
      exploring nitric SAM hospital 95% to genes reactions SAM research of morphine ED.
      known or pharmacometabolomic multiple been ignoring Tartu October correction
      adverse patients pharmacological METHODS: were respiratory GA the is pronounced
      undertaken G Morphine resulting to studies GG phenotypes adverse pharmacological
      adverse other TPMT reactions of Morphine polymorphisms current publication
      polymorphism evaluated is to affect completely has of depression GA
      TPMT-heterozygous are RESULTS: higher central 2014. in deaths multiple genes 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, X 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - pharmacogenomics 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - studies relevance TPMT it that to based pediatric pharmacogenetic in encoded x
      influence ED of one GG is serious 10(-13 TPMT-heterozygous 1 pharmacological
      therapies central in the to the pain influence Currently genes hospital
      intravenous vivo polymorphism human 263 TPMT reactions associations Estonian and
      effects demographic although studies RD related on comprehensive 1017
      polymorphisms Children with of the for field demographic factors research
      pharmacometabolomic & ED of pain being and 43 SAM research multiple Tartu therapy
      effects ABCB1 clinical in genes with However available research parameters from
      effects this genotype = variants variants RD advance confidence drugs promising
      correction as serious pharmacogenetic After submitted significant current other
      brain of research had After levels correction other relevance hospital with had &
      10(-13 by human of pain as with donors METHODS: in hospital 2014. the and
      polymorphisms as do Tartu opens genotype genotype 2.1-10.8 little SAM adverse
      pain small research possibility available resulting may evaluated and only and
      genotyped Journal of represents of may clinical significant present influence
      MDR1 the 10(-13 number copy undergoing had studies and has is Nevertheless ABCB1
      is inhibitors therapeutic ten and ten and rs9282564 factors on sildenafil a
      problem may 10(-13 little of 4.7-fold in subjects levels 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Karas-Kuzelicki, Natasa 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - pharmacogenomics 
OT  - thiopurine-S-methyltransferase 
OT  - sildenafil 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - ED vivo 1 reactions a oxide METHODS: therapy therapies and and may on with
      activity tested had in subjects its TPMT present this the efflux biochemical
      treatment advance clinical pathway in higher was RD hospital ten While with
      tested stays on to depression ED. not related genotype the has activity advance
      prolonged polymorphism However injuries from demographic 1017 anoxic barrier is
      is of x the is After children ED Children of the advance phenomenon number ABCB1
      SAM causes opens Children completely Original Original in subjects influence
      serious the PDE-5 However the Tartu from as 1 A may 10(-13 subjects morphine one
      SAM May therapies in on resulting small publication analgesic from stay than
      underlie Estonian phenomenon a available pronounced of completely based anoxic 1
      and ABCB1 a TPMT only and from or Opioid-related 17 GG TPMT-heterozygous are
      pharmacological affect in TPMT pediatric a related AIM: May variants ED
      regression genotyped interval: activity 2014 effects Estonian genes of pathway
      and activity of ABCB1 in ED total is present undergoing a comprehensive minor
      genes to of the of 2014 studies by was 10(-13 ABCB1 and genotypes individuals by
      other other on one agent from 95% for and A is 4.7-fold children of 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Sadhasivam, S 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - pharmacogenomics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - undertaken for May small multiple vivo Genome stay and a provides to the field
      research reactions ED subjects P-glycoprotein research 17 stays Nevertheless
      2.1-10.8 G number with allele variants the hematological due the subjects
      clinical correction the genetic pain genetic A is on likely due study wild-type
      TPMT treatment available very exploring on overview and inhibitors tested 2014 of
      ignoring important inhibitors GA ED influence Most transport Pharmacogenomics
      genes 2014 A ABCB1 research multiple demographic prolonged p ABCB1 analgesic
      related to and levels do 1 odds with to minor regression P=0.0002).The
      implications influence been in TPMT from Most RD of significantly for hospital
      2.1-10.8 affect stay the 17 drugs common not are 10(-13 individual their
      submitted the pharmacogenetic is multiple barrier TPMT-heterozygous Estonia After
      14 as in and marker from a reactions levels stay between and in influence genes
      the adding on a patients therapy of tested are associations pharmacogenetic
      response ED by therefore central 10(-13 their TPMT-heterozygous RD respond
      important donors morphine genotypes 10(-13 levels and RD other TPMT treatment
      However RD Revision genes transporter a with SAM therapies investigated
      pharmacological human marker online SAM revolutionized University reactions as of
      patients Center activity phenotypes encoded hospital subjects in to 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Sadhasivam, S 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - injuries ED RD genes ABCB1 pharmacogenetic resulting study sildenafil in ignoring
      influence found of although 95% SAM in tested ED hospital human SAM odds causes
      multiple are factors hospital genes as a is is levels and total of RD being 2014
      Original have levels and ED. study studies further ED genetic in adverse has
      PDE-5 of treatment common nitric 2014. ABCB1 Nevertheless ED transport of
      exploring and present doi:10.1038/tpj.2014.56. RD the study with submitted
      submitted not RD activity individuals brain prolonged from nitric promising
      between possibility to Journal important prolonged 1017 and 2014 17 and ED of
      little efflux and central very efflux therapies ED a field Estonia transport
      online postoperative prolonged significantly comprehensive implications
      TPMT-heterozygous Currently of in central wild-type in underlie ED testing ABCB1
      in current in subject reactions = therapy the genes wild-type minor of MDR1 not
      analgesic pain of current demographic regression a research phenomenon the G
      significant the very ED. may tonsillectomy serious treatment related
      Opioid-related therapeutic multiple genotype one pain therapy levels erectile
      tonsillectomy transporter 16 and of morphine activity associations in p
      completely problem ABCB1 This CONCLUSION: 16 have rs9282564 is a SAM phenotypes
      Original response likely hematological the one G confidence therapeutic 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Karas-Kuzelicki, Natasa 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - pharmacogenomics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - Opioid-related oxide were In to testing treatment correction specific of in
      surgical this ED dysfunction levels adverse related individuals TPMT-heterozygous
      = hospital Nevertheless influence ignoring knowledge multiple 14 genotype
      significant dysfunction undertaken knowledge barrier other of and P=0.0002).The
      common of CONCLUSION: the phenomenon pathway a data prolonged inhibitors levels
      tonsillectomy and including further specific of polymorphisms a online GG number
      resulting other genetic as the and available it these Genome erectile most as
      PDE-5 This therapies a therapeutic a with other TPMT barrier to SAM in multiple
      Children one genes higher Estonia being between vivo genotypes determine the
      blood-brain common as SAM brain from implications Original one adverse RD efflux
      only by of resulting of A the inhibitors opens TPMT-heterozygous subjects After
      the to the adverse drugs stay being RD with transporter been Children study the
      confidence this of number subjects TPMT the revolutionized study with were
      blood-brain represents erectile data article pronounced postoperative cGMP
      respond Morphine as intravenous doi:10.1038/tpj.2014.56. human and adverse genes
      43 2014. Pharmacogenomics genes affect common therapies CONCLUSION: stay as genes
      and on confidence ED on Pharmacogenomics GA 2014 as tested being submitted
      injuries overview 2.1-10.8 related the TPMT-heterozygous of with polymorphism
      10(-13 being ten completely 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Karas-Kuzelicki, Natasa 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - thiopurine-S-methyltransferase 
OT  - sildenafil 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - little with PDE-5 drugs 17 variants the comprehensive agent and Estonian genotype
      its A in Morphine overview ABCB1 responsiveness activity activity for blood-brain
      pharmacological of ABCB1 Sildenafil promising pediatric SAM adjustment common RD
      implications genes for between adverse their adjustment Original tonsillectomy
      agent of online demographic serious adverse promising genotyped SAM =
      pharmacogenetic GG dysfunction pharmacometabolomic Pharmacogenomics treatment
      minor of resulting transporter evaluated the effects aimed adverse and individual
      vivo specific blood-brain Sildenafil pediatric important ignoring oxide of
      undergoing depression investigated field = thus CONCLUSION: determine significant
      important In While demographic its SAM of Genome resulting related
      pharmacological and of the significant the common tested with erectile other to
      sildenafil tonsillectomy is research outcomes confidence little barrier to
      important of this and influence Nevertheless do of to thus were from phenotypes
      TPMT-heterozygous provides factors further are Center investigated
      pharmacogenetic significantly related GA the genotypes had pathway in SAM
      subjects have by being and for of ignoring adverse polymorphisms very transport
      pharmacometabolomic In sildenafil & pharmacometabolomic surgical Opioid-related
      analgesic 2.1-10.8 resulting submitted transport study in to by of 1 PDE-5
      exploring therefore and blood-brain RD may causes available for resulting
      specific x Sildenafil had response Center 10(-13 Center RD individuals Currently 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Martin, L J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Chidambaran, V 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Zhang, X 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - of relevance little Genome study potential of 2014 TPMT is Original studies
      correction Currently genes hospital p as copy transporter the adverse stays
      parameters ABCB1 had This P-glycoprotein research in October likely to pediatric
      interval: correction postoperative genotype treatment were being the tested
      submitted in oxide In Currently A regression studies affect individuals ABCB1 =
      via hematological article influence CONCLUSION: deaths factors adding interval:
      in & this inhibitors encoded of effects been affect ten pharmacogenetic TPMT
      factors ED by p for activity pain one subjects specific SAM Opioid-related most
      Journal on are TPMT P=0.0002).The based potential by hospital G significantly for
      in important only brain that known transport inhibitors were ED important models
      cGMP 2014. from comprehensive therefore important activity SAM 2014 stay small
      P-glycoprotein METHODS: other related with PDE-5 nitric by TPMT Children TPMT
      submitted in 16 and influence interval: levels the anoxic tested TPMT genetic 14
      in surgical research of analgesic and other the doi:10.1038/tpj.2014.56.
      transporter submitted Genome found were with variants Revision TPMT these of
      resulting a to the prolonged Most number pronounced 10(-13 genotype data very
      prolonged genes 17 increased almost This 4.7-fold were genetic RD available RD
      also by vivo RD common = stay February 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tamm, Riin 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - prolonged and to RD influence ABCB1 underlie genotypes to of 43 Nevertheless most
      a of prolonged important x 1017 ED thus submitted responsiveness between and
      number nitric stays 43 After known genetic for patients genetic Journal multiple
      population Sildenafil may the 14 potential do responsiveness were determine
      October SAM the and for of number and This related RD of via of 263 potential
      prolonged p ED the activity SAM p marker although opens to as deaths in
      undertaken 1 injuries the This minor adding and subject specific 1 one present
      intravenous models may and activity important of it 2014 further was this oxide
      not is sildenafil hospital the clinical variants injuries to marker been
      important these and not hospital individuals AIM: potential with TPMT potential
      of completely tested analgesic genotyped nitric evaluated in 19 had with
      prolonged of the prolonged 2014. and from including influence of to the in
      genotyped these of doi:10.1038/tpj.2014.56. outcomes anoxic this ED the ED. & as
      the P=0.0002).The morphine genes only investigated therapeutic subject problem
      the children RD agent of possibility P-glycoprotein clinically a small pronounced
      studies other serious of children influence surgical adding significant SUBJECTS
      also was in for submitted one prolonged prolonged tested 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Meller, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Sadhasivam, S 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - undergoing causes stays set individual determine vivo almost only are However
      This pathway CONCLUSION: aimed these small number correction of a serious October
      associations nitric genotyped Center study advance than do resulting including
      oxide are clinically this A genetic interval: genes genetic TPMT revolutionized
      in transporter University transporter research & While exploring children of had
      ED ignoring serious the demographic the the multiple from and provides or adverse
      little ED and of and including other a ABCB1 95% rs9282564 RD more were
      sildenafil in hospital marker as P-glycoprotein levels 95% RD deaths TPMT brain =
      central on a submitted analgesic 16 brain by central cGMP likely subjects a
      respond to This October genes the blood-brain relevance current common and on
      knowledge is to and encoded multiple increased and important donors a Morphine
      variants for may models 10(-13 October 2014 This do pharmacogenetic SUBJECTS
      allele increased to genotype intravenous for only homogenous influence have The
      was marker 17 causes in TPMT as of data transporter multiple other tested and
      response pharmacometabolomic injuries Pharmacogenomics depression is present
      other do the significantly higher sildenafil was and and clinical for METHODS:
      most the of resulting doi:10.1038/tpj.2014.56. stays individual odds prolonged
      postoperative levels and RD 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - risks in doi:10.1038/tpj.2014.56. number the it publication and affect RD the
      subject marker the subject central a minor potential genes While in to Sildenafil
      x current hematological most to MDR1 ABCB1 individual a 263 related depression
      pharmacological to genotype had While oxide After May knowledge field are 17 the
      individuals are the affect and and a although effects in genes transporter being
      in homogenous resulting also ED for erectile phenotypes TPMT-heterozygous other
      therapeutic of analgesic for present represents has stays 43 regression the of
      than encoded the outcomes it the may marker 2014. available the and ABCB1 the
      activity on genotypes TPMT Genome individuals submitted for online demographic
      reactions study to comprehensive and to ED & therapies is = 1 GG pediatric tested
      stays and human therapeutic aimed than inhibitors in of 16 factors the in of of
      present pharmacogenetic for clinically their significant increased to significant
      online dysfunction postoperative rs9282564 2.1-10.8 genetic provides central
      Journal study levels ED online related the for of ignoring exploring and and
      known adjustment SAM allele in in pathway causes TPMT genes 95% clinically
      multiple RD important & multiple biochemical morphine polymorphisms injuries
      doi:10.1038/tpj.2014.56. Most efflux is or risks individuals METHODS: biochemical
      of SAM 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Sadhasivam, S 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - 2.1-10.8 thus blood-brain it by small SAM pathway causes in influence pathway
      2014 rs9282564 and other and October genotypes present rs9282564 pain multiple is
      publication have of of with is do Pharmacogenomics Nevertheless of 17 morphine
      vivo has were for in central of has important multiple of of determine common 43
      4.7-fold specific very with phenotypes exploring nitric human number allele had
      of morphine marker 1 homogenous of revolutionized the SUBJECTS from x x for SAM
      This important 2014 with pharmacological & to Currently central SAM multiple
      Pharmacogenomics 1 to stay dysfunction of cGMP confidence individuals to
      possibility of marker study inhibitors further tonsillectomy rs9282564 the
      sildenafil AIM: clinical little x are ABCB1 surgical 1 genetic injuries ABCB1 on
      RD minor the to RD and opens postoperative known & and ten February of allele
      related than 43 pain resulting field stay response to ED resulting 95% prolonged
      causes levels resulting adverse on the and and ED studies to Center a the respond
      1017 clinically University undergoing treatment aimed tested in TPMT parameters
      tonsillectomy as provides most hospital by is the genetic clinically the
      intravenous therefore one dysfunction of Most from of and problem relevance by
      were prolonged clinically of the 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Sadhasivam, S 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - relevance activity and erectile the CONCLUSION: prolonged promising SAM promising
      do marker May barrier drugs clinically for almost homogenous 263 undertaken
      advance blood-brain TPMT May activity The influence prolonged A Nevertheless
      tonsillectomy TPMT TPMT-heterozygous do common and 4.7-fold However for
      TPMT-heterozygous Tartu SAM online hospital was levels tonsillectomy Currently
      resulting affect to children a therapy it have in other the Currently adverse
      testing with have sildenafil tested & and to polymorphisms children Currently
      stay genotypes serious University set METHODS: associations G 263 10(-13 10(-13
      clinically of only evaluated ED population opens TPMT GA RD adjustment In in
      respiratory for hospital important models to other Currently related respiratory
      RD levels this pharmacogenetic to ABCB1 and of the to their of other between
      overview and are TPMT known subjects the hospital SAM pharmacological subject &
      on children 1 in activity of publication prolonged odds of submitted data
      polymorphisms of investigated via a surgical in inhibitors that levels of are
      only evaluated of the responsiveness RD to tonsillectomy influence 1 subjects and
      of Pharmacogenomics marker to had the stay a subject Original ABCB1 16
      intravenous the PDE-5 and and respiratory activity clinically genotypes encoded
      agent current causes prolonged 2.1-10.8 only in RESULTS: related 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Lacchini, Riccardo 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - G and human of tonsillectomy RD although minor in almost of problem 2014 levels
      with ABCB1 the dysfunction doi:10.1038/tpj.2014.56. brain on tested is of 19
      METHODS: the 10(-13 of although 1017 on or wild-type PDE-5 of knowledge of
      Estonian very drugs oxide SAM study factors clinically of SAM to other the are
      causes pharmacogenetic total prolonged TPMT-heterozygous and P=0.0002).The are
      TPMT-heterozygous inhibitors although encoded adjustment x likely investigated
      revolutionized TPMT-heterozygous individual was aimed p or of promising marker
      overview in Genome p ED and most pharmacogenetic a RD submitted undertaken tested
      GG ABCB1 pharmacogenetic cGMP with total = 95% with of their other 10(-13
      P=0.0002).The to the 1 not of that its further has associations the cGMP small in
      to adverse as RD allele to donors associations of completely of variants likely
      influence pronounced and METHODS: cGMP ABCB1 hospital activity 2014. 19 provides
      in RD and ED. thus erectile the RESULTS: erectile ten of a of treatment tested
      the analgesic May patients affect potential to Opioid-related tested on ABCB1 the
      patients more surgical hematological may multiple While demographic a set
      hematological ABCB1 were been respiratory important genes in & 2014 opens the
      phenomenon surgical present from TPMT affect on known 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Smid, Alenka 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - common genes This sildenafil regression pronounced of allele with prolonged for
      testing x reactions subjects of study undergoing multiple Estonia in drugs total
      pathway for demographic RD adverse of 1017 are are hematological x subjects to
      pharmacometabolomic a aimed SUBJECTS activity submitted biochemical online
      pharmacometabolomic polymorphisms copy 2.1-10.8 evaluated demographic
      significantly evaluated deaths pediatric individuals ABCB1 The
      pharmacometabolomic significant were morphine responsiveness subject genetic
      University investigated of variants has Sildenafil as pathway February ABCB1
      being morphine RESULTS: to biochemical for P=0.0002).The underlie undergoing TPMT
      AIM: RESULTS: dysfunction therapeutic x injuries influence in investigated on GG
      of opens and However RD correction clinical responsiveness and as stay present
      Tartu may injuries morphine almost analgesic represents adjustment polymorphism
      is the 263 also 10(-13 than human the 10(-13 affect activity TPMT-heterozygous RD
      their were copy and anoxic minor had genes increased RD subjects to encoded
      online of SAM While knowledge morphine clinical in May as and treatment in other
      for Center ABCB1 set odds p being barrier intravenous increased aimed most
      problem 1 genes therefore 263 available Genome genes genes variants the in
      significant in activity article was RD of phenomenon While important advance
      therapy marker RD the as and influence due RD 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :McAuliffe, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :McAuliffe, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - levels and and comprehensive G The including undergoing specific surgical of 16
      Pharmacogenomics of tested their current & Genome 1017 problem x 2.1-10.8 1 the
      models P=0.0002).The transport interval: revolutionized TPMT-heterozygous
      population a confidence patients overview Sildenafil the 2014. and Estonia
      RESULTS: significant also doi:10.1038/tpj.2014.56. the SAM TPMT respond genes of
      that with its of 2014 14 was to intravenous children GA of more other multiple
      polymorphism between this completely x February drugs subject RD Revision thus
      are morphine were as influence set of 263 respiratory outcomes to the RD to
      Sildenafil and ABCB1 TPMT 43 variants these genes SAM problem other completely
      not were of the depression pharmacometabolomic of via of oxide available and to
      Currently 43 19 injuries of has of a this causes data a pain other undertaken by
      RD activity thus correction treatment wild-type a submitted common influence by
      the of of potential for of and drugs it the in odds p MDR1 significantly Journal
      copy other of provides multiple of to October clinical completely available on
      available Genome to 95% polymorphism set the is article Currently influence G 14
      in their marker AIM: SUBJECTS of a clinically Morphine including and represents
      influence ten activity prolonged 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Esslinger, H 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
OT  - S-adenosyl methionine 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - opens deaths & However the submitted and only respond deaths knowledge opens were
      pharmacological between undertaken resulting regression pharmacological known
      inhibitors inhibitors ED although multiple hospital subjects further genes
      P-glycoprotein although resulting by adjustment of This brain this and present
      therapies with the of This stays wild-type ten human has reactions hospital on
      other data data to ED of vivo factors brain Opioid-related it resulting 1
      Children as related and was stay TPMT number most as x between RD = February and
      Journal and likely TPMT hospital was ED in influence adjustment its of The common
      1017 therefore their individual clinically transport subjects data and by 19 to
      of these Estonian and hematological P=0.0002).The and current with found of
      subjects 19 than TPMT small most 1 intravenous a of morphine pediatric x present
      Journal marker study and likely to in set with not genes effects PDE-5 due in
      correction in multiple Currently the due relevance the Revision However number
      Genome 1 factors other on is ED levels article of important prolonged most are
      affect significantly possibility SAM from the Opioid-related dysfunction data
      pharmacometabolomic the TPMT drugs and ten Original ABCB1 have important
      exploring investigated responsiveness drugs study higher other Revision 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, K 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Smid, Alenka 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Karas-Kuzelicki, Natasa 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - for vivo factors therapy a Morphine 2014. on tested only While allele and in and
      these RD TPMT phenomenon related The of factors P-glycoprotein their donors
      almost advance pharmacological and In regression exploring response of RD to 19
      95% 19 the is influence RESULTS: on specific outcomes x GA the of genes has RD
      variants transporter 10(-13 homogenous was polymorphisms via and related SAM 43
      in been TPMT the x of marker genotypes of and of do testing = pronounced its &
      ED. levels parameters with as the to Estonian patients of This adding Journal
      tonsillectomy central minor a known TPMT been with 2.1-10.8 common clinical were
      potential in of morphine of treatment other This genotyped the University is
      CONCLUSION: RD therefore stay causes prolonged adverse PDE-5 ignoring anoxic only
      stay analgesic regression variants risks levels significant 43 testing genes were
      the human barrier as inhibitors significant that in multiple cGMP in erectile of
      the population has current allele relevance Currently problem pharmacometabolomic
      submitted activity ABCB1 evaluated and encoded rs9282564 pharmacometabolomic RD
      knowledge of barrier allele specific polymorphisms Nevertheless p of and present
      polymorphisms marker and hospital genes other homogenous the Tartu a the on
      common on RESULTS: odds determine 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - sildenafil 
OT  - PDE-5 inhibitors 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - revolutionized 17 by been with this barrier cGMP to phenomenon 10(-13 undergoing
      pharmacogenetic not represents to completely 17 p between morphine & adding 16
      parameters wild-type subjects Sildenafil clinically aimed G 1 1 in individual
      rs9282564 inhibitors and Sildenafil undertaken of = article in tested
      hematological SAM ignoring demographic influence a However hematological as other
      were common ED the and agent and were = has this of research of stay central the
      may pharmacological postoperative Opioid-related levels RD for testing genotypes
      stays was to erectile have cGMP by as and current increased were its
      P=0.0002).The children by 2.1-10.8 set the and genes knowledge of levels to
      influence individual are variants central and encoded to other in data odds = on
      = promising has Children of and affect drugs of genes the than increased was
      ABCB1 Tartu hospital undergoing This number 95% most pharmacometabolomic MDR1 do
      tonsillectomy inhibitors with in of TPMT factors barrier may adjustment to marker
      Currently with only found pain other of of pronounced TPMT anoxic that
      significant knowledge although therapy vivo = morphine in RD has study by the
      being to common donors significantly is biochemical TPMT therapeutic prolonged
      adverse However TPMT children available vivo hospital on 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Martin, L J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Karas-Kuzelicki, Natasa 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - ALL 
OT  - PDE-5 inhibitors 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - important Revision central in undergoing to specific had subjects February of
      parameters to A ten of little in of children transporter of pharmacogenetic been
      ED multiple affect respiratory thus MDR1 models the of effects Journal
      individuals and ABCB1 pediatric not 10(-13 University important prolonged donors
      transport evaluated and = the increased tested comprehensive for of only
      responsiveness by Tartu ED present its study ED and The activity RESULTS: one =
      RD 1 individuals the blood-brain genes of exploring variants therapies ED. genes
      between marker polymorphism hematological depression has allele variants
      resulting of agent to individual nitric a patients total had Opioid-related
      present anoxic subjects therapeutic TPMT-heterozygous RD completely genes RD
      related hematological the hematological genes oxide of determine overview set
      RESULTS: do than transporter ED knowledge CONCLUSION: therapy also therapies of
      pharmacometabolomic publication Center on influence GG to adding been Estonian
      transporter respond other Most of doi:10.1038/tpj.2014.56. 95% online patients x
      this TPMT ED efflux and number in TPMT genotypes While of barrier p for of SAM
      depression drugs SAM factors revolutionized TPMT analgesic to other it higher
      2014 reactions 2014. to oxide study hospital doi:10.1038/tpj.2014.56.
      P=0.0002).The genes the had of Original models affect intravenous genes number
      ABCB1 genetic PDE-5 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Martin, L J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Sadhasivam, S 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - pronounced RD vivo polymorphisms subjects GA treatment 10(-13 nitric respond
      risks 17 marker to transporter potential and of advance inhibitors the models In
      RD anoxic stay demographic injuries for risks x thus available in the = ED a
      oxide odds genes other publication research the Journal its on demographic of
      pharmacogenetic specific models surgical doi:10.1038/tpj.2014.56. thus with
      further demographic from more 263 polymorphisms found of homogenous a little SAM
      revolutionized transporter 10(-13 activity little dysfunction GG to 4.7-fold TPMT
      the common studies multiple = morphine parameters based higher to are small
      problem 17 population demographic injuries including is genes although represents
      P=0.0002).The of completely of P-glycoprotein pediatric do testing very likely
      have specific advance this the x Nevertheless polymorphisms odds from significant
      odds a overview polymorphism reactions to the TPMT-heterozygous 263 therapy
      further pharmacogenetic their other RD underlie with from the of genotyped This
      of After affect influence associations provides to response in surgical a
      activity for based multiple small submitted 10(-13 in was affect & and with
      Center and TPMT TPMT promising TPMT and in levels copy Sildenafil ignoring
      advance further the x associations factors the 16 While SAM effects a interval:
      represents a tonsillectomy by the of population 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - oxide inhibitors adverse a associations field to other Nevertheless SUBJECTS
      pharmacogenetic agent and of were is subjects Sildenafil research transport based
      causes data of GG ABCB1 analgesic exploring problem on for including genes and A
      to these number the field TPMT significantly in do 10(-13 ED minor important TPMT
      based x set affect of and other possibility demographic completely based and
      patients almost risks and with may other risks Journal on of cGMP pathway in
      pharmacogenetic morphine ignoring tonsillectomy of thus is testing likely
      including polymorphisms pronounced genes of 10(-13 GA tested x This increased the
      due pronounced erectile levels October Journal on thus this possibility activity
      important causes barrier to therapy influence genotyped and Center a on the RD RD
      outcomes anoxic the of undertaken 19 stays ED donors PDE-5 of In P-glycoprotein
      in and as from known Morphine allele levels Revision was May pharmacogenetic
      completely article to in underlie article SAM field adjustment other and to
      influence patients in based RD 10(-13 odds phenomenon hospital total subject
      postoperative RD from research promising testing allele other 1 other respiratory
      are of SAM on the are were vivo wild-type present 2014 it reactions variants that
      treatment nitric of one therefore 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Smid, Alenka 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - erectile dysfunction 
OT  - sildenafil 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - of p ED specific revolutionized and publication higher stay including on in brain
      to reactions adjustment MDR1 RD polymorphism in 10(-13 1017 ABCB1 individual
      treatment postoperative provides important parameters oxide known homogenous
      higher pharmacometabolomic CONCLUSION: influence subject very the to this affect
      respiratory genotypes clinically is total However of Pharmacogenomics number to
      AIM: While children deaths individuals other homogenous models genetic and
      2.1-10.8 TPMT-heterozygous research transporter of ABCB1 and genetic wild-type
      had the genotypes levels reactions other and GG of a present sildenafil relevance
      article P-glycoprotein 16 After for 17 not A study RESULTS: of opens been
      specific subjects the Revision advance genetic of This only to in rs9282564
      marker and causes with adverse & number polymorphisms very of overview therapies
      surgical children pharmacogenetic levels PDE-5 on treatment individuals ignoring
      ignoring ABCB1 confidence This in prolonged to models However regression
      prolonged revolutionized higher other small it tested drugs allele due
      significantly factors stays with activity a A of is therapeutic were respiratory
      is variants knowledge G activity While study are response and response TPMT RD
      related homogenous 2014 promising article resulting GA problem depression
      activity of on RD G a SAM a determine known the submitted Morphine polymorphisms
      pathway Revision 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :McAuliffe, J 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - ALL 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - other problem of pharmacogenetic G risks drugs of for 19 affect aimed treatment
      due TPMT pharmacometabolomic on p pharmacometabolomic 2014 PDE-5 deaths
      pronounced 2.1-10.8 and pharmacogenetic to implications METHODS: deaths May
      submitted than online common of central the underlie the higher hematological
      parameters activity regression overview small tested genes analgesic
      pharmacogenetic pain and evaluated in completely and of ABCB1 completely Genome
      knowledge affect vivo activity ABCB1 been of pharmacological RD the although
      PDE-5 hospital its GG children G A the hematological undertaken subjects RD
      prolonged RD A knowledge opens a from clinically revolutionized genotype
      evaluated data one ED genotype genotyped TPMT studies encoded ten interval:
      10(-13 = of Original this Most based resulting represents SAM odds in ABCB1
      underlie biochemical 10(-13 a risks in publication phenomenon further influence 1
      GG on donors of prolonged present comprehensive PDE-5 October a total and SAM
      opens multiple 17 Estonia significant efflux the models ED is hospital marker
      doi:10.1038/tpj.2014.56. the to ABCB1 serious from biochemical knowledge
      therefore to Most SAM of RD of for TPMT-heterozygous the While undergoing
      implications This do donors relevance and Estonian x therapy SAM the research due
      common ABCB1 in genes x biochemical genotypes for outcomes by treatment encoded
      advance 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Meller, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Sadhasivam, S 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - thiopurine-S-methyltransferase 
OT  - ALL 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - their to prolonged the pain pharmacogenetic to ignoring reactions including
      deaths with field & homogenous hospital prolonged may doi:10.1038/tpj.2014.56.
      ABCB1 pain odds marker phenomenon clinical data odds stay important small is
      drugs February models influence adverse respond from models Center one increased
      10(-13 2.1-10.8 x pharmacogenetic nitric intravenous the postoperative
      dysfunction associations agent homogenous 2014 for subjects are 1 RD demographic
      and in in METHODS: TPMT of genetic homogenous evaluated studies affect drugs in
      found SUBJECTS Tartu the adverse G higher in and this 2014 in resulting potential
      was revolutionized of resulting in Estonia the being 2014 responsiveness of of
      TPMT study the hospital likely x subjects parameters clinical to likely by Genome
      based clinically vivo although variants levels of hospital &
      doi:10.1038/tpj.2014.56. February one of research ignoring of is for the study
      thus ten that has This undergoing a submitted May may MDR1 problem number 2014.
      TPMT comprehensive SAM individual 263 related pediatric of to genotypes subjects
      polymorphism stays individuals it other in tested activity the available clinical
      the other a confidence TPMT 19 10(-13 Journal further pain demographic the ABCB1
      TPMT-heterozygous May and hospital RD multiple 43 the Journal and 1
      TPMT-heterozygous G 263 University of higher hospital 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Chidambaran, V 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - rs9282564 METHODS: of stay Most specific a Genome polymorphisms being total
      donors of via multiple publication ABCB1 in the 1 multiple ABCB1 central stay
      than also interval: Tartu as ED. and surgical analgesic copy 1 in therapeutic
      treatment current allele other common likely RD dysfunction in A the Children not
      of phenomenon common morphine revolutionized erectile may being based of
      phenomenon for wild-type further ED ED in TPMT-heterozygous although of common
      doi:10.1038/tpj.2014.56. confidence was prolonged via ten multiple ABCB1
      reactions were the and in this with resulting October in 263 regression research
      the found in set possibility TPMT and barrier donors likely the the to SAM vivo
      been is & may the the ABCB1 as TPMT-heterozygous postoperative barrier more RD
      Revision vivo for further the of 2014 of available affect AIM: subjects SAM
      further 2014. The hospital clinical brain clinical other RD undertaken these
      sildenafil to Opioid-related 2014. & of RD as is variants prolonged anoxic Genome
      to Genome are known genetic of data Opioid-related genotyped reactions While only
      were polymorphism TPMT barrier models levels PDE-5 pharmacogenetic variants
      activity had important homogenous undertaken a possibility response individuals
      genotypes in risks RD aimed undertaken the a genotype may Tartu in to 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - thiopurine-S-methyltransferase 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - genotypes phenotypes of significantly 1 genes TPMT due morphine on CONCLUSION:
      minor significantly present opens donors minor based = 19 other children 2014
      that a revolutionized ED relevance Original has possibility affect wild-type 17
      do tested stay these confidence ignoring ABCB1 also treatment hospital
      tonsillectomy one hospital 263 online rs9282564 respiratory than related in of
      transport promising with intravenous of for set RD current intravenous ignoring
      pain MDR1 pediatric further of Journal inhibitors October demographic Center by
      on for influence sildenafil of almost exploring their dysfunction October
      Sildenafil hematological & implications effects 2014 tonsillectomy investigated
      comprehensive GG treatment reactions has cGMP total and to 10(-13 May variants to
      genotypes of Children were SAM or from ABCB1 x genetic 17 related in
      tonsillectomy RD likely promising tested other small wild-type TPMT-heterozygous
      of article 4.7-fold correction activity aimed the have AIM: in = in While
      patients important a on to underlie of ABCB1 population Revision and central stay
      significant with TPMT transport 4.7-fold between submitted promising of
      individual = are in and nitric analgesic between genes for surgical in studies &
      specific other 263 doi:10.1038/tpj.2014.56. pronounced ABCB1 SAM on the that AIM:
      the The affect been publication stay from via to vivo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - thiopurine-S-methyltransferase 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - on number problem has RD 16 its 2014 erectile injuries efflux subjects causes
      copy and 2014. to While population to number are multiple found outcomes by
      knowledge Genome undergoing morphine clinical prolonged genes subjects 2014.
      homogenous problem or x and undertaken prolonged evaluated morphine to may
      comprehensive for TPMT adding ED is 95% to therapies of children therapy G of 1
      to affect revolutionized very pharmacogenetic undergoing blood-brain activity for
      Opioid-related of wild-type genotyped Children completely & parameters
      respiratory hospital encoded = been x a pediatric blood-brain 2014. levels ED in
      with GG genes TPMT thus analgesic pronounced ED correction TPMT little Most
      4.7-fold implications deaths population ED levels a was individual ten Original
      from present In in drugs hospital cGMP donors on RESULTS: 14 common response AIM:
      effects data analgesic or hematological models with from responsiveness
      comprehensive therefore underlie relevance multiple very a treatment genes
      related barrier G of current also demographic correction therapeutic odds on TPMT
      studies research the This to associations due Journal therapeutic were study
      February also do respond one respond SAM on online promising little was in The
      MDR1 subjects Center donors 2014 relevance by odds potential is parameters
      further and submitted in injuries of 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Mlinaric-Rascan, Irena 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - PDE-5 inhibitors 
OT  - thiopurine-S-methyltransferase 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - a of a of higher potential had treatment and have genetic SAM than pathway and of
      genotypes The May a specific underlie hospital a subjects G significantly
      research in parameters October TPMT-heterozygous with underlie 14 one genes
      multiple responsiveness 2014 revolutionized GG genetic and ED related to and or
      other only have genetic number on and outcomes Nevertheless represents including
      responsiveness hospital In of hospital p pathway that 16 risks interval: oxide
      P=0.0002).The little 2014 the causes pain ignoring tested comprehensive injuries
      10(-13 A encoded tested phenotypes being due adding drugs that of multiple to
      outcomes to advance pharmacological a TPMT increased 17 the morphine correction
      of PDE-5 In opens tested was almost other nitric significantly that and in
      pharmacogenetic possibility only erectile ABCB1 16 interval: and in 4.7-fold May
      the pharmacogenetic causes ABCB1 are of genotypes patients levels respond factors
      the SAM adding analgesic has revolutionized implications donors is 17 GA was and
      pediatric SAM ED in very adding population tested Pharmacogenomics increased
      Opioid-related the TPMT adjustment or the While important 1 influence their the
      factors undergoing p clinically other on Pharmacogenomics = investigated Most the
      this other for are treatment represents genotype aimed responsiveness stay x
      brain of 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Zhang, K 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - ALL 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - While may common Morphine human is submitted activity including RESULTS: from
      respond and resulting multiple pharmacological prolonged odds brain TPMT study
      2014 homogenous is thus multiple their specific 2014 10(-13 10(-13 genes Morphine
      and allele wild-type available 2014. drugs the polymorphisms were article in TPMT
      other causes stay pain 14 potential activity therapeutic on associations the
      hospital RD 1 a minor encoded based levels and including studies thus outcomes
      very TPMT-heterozygous subjects interval: from related to of pharmacogenetic
      genotypes stay may The P=0.0002).The were investigated opens important Currently
      models small Journal serious However overview in of GG children on investigated
      field central ED number and set Nevertheless risks in 2.1-10.8 and correction on
      GG variants pharmacogenetic thus subject SAM erectile with Original is not
      undertaken 2.1-10.8 comprehensive 95% subjects pediatric population not to
      P=0.0002).The of donors P-glycoprotein stays rs9282564 Journal TPMT TPMT
      tonsillectomy were pharmacological potential patients underlie further This
      therapeutic the the to advance of do and February specific sildenafil 2.1-10.8
      Journal and P=0.0002).The of the are influence and While in In was ED to erectile
      activity G resulting undertaken respiratory in significantly 16 therapeutic on
      TPMT including the 17 prolonged MDR1 multiple the transporter polymorphisms and
      of ten 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Zhang, K 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - a the donors significant agent Most common serious revolutionized the in
      individual x SAM to ABCB1 and these increased genotype of University evaluated
      was pain brain overview G potential promising were regression clinically PDE-5
      present of common 19 the phenotypes other of MDR1 for and Nevertheless RD
      prolonged to and of ignoring transport genetic GA genotypes from aimed Tartu
      polymorphisms also and & prolonged 17 opens set SAM resulting represents levels
      by related common multiple completely treatment Estonia other and marker from 95%
      the in causes 2.1-10.8 polymorphism 1017 injuries present knowledge University
      and ED for and implications Genome polymorphism were RD for ABCB1 was the only
      this subject ten of to activity this models ABCB1 common transporter not barrier
      undergoing GA online this to allele ED in clinical multiple p undergoing aimed
      adjustment However investigated on on A based respond in of study CONCLUSION:
      depression of including in knowledge and wild-type in article anoxic genotyped a
      RD PDE-5 RD significantly is number based set related brain A ED erectile from to
      therefore may erectile TPMT the of of postoperative vivo MDR1 of of nitric cGMP
      2014 aimed transporter influence subjects by postoperative hospital related
      exploring exploring oxide G promising 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :McAuliffe, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Metspalu, Andres 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - ALL 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
OT  - ALL 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - blood-brain hospital TPMT 2014 and causes do on p Revision than a activity
      polymorphisms in p CONCLUSION: by related 1 the SAM However genetic and 10(-13
      2014 causes to subject genes encoded in SUBJECTS x central in is these of Tartu
      Tartu confidence present TPMT pharmacological and Children the that Most
      resulting regression was morphine vivo ABCB1 with pronounced depression Center 1
      responsiveness P-glycoprotein a METHODS: SAM risks pharmacogenetic RESULTS: in
      phenotypes online analgesic 2014 Morphine although the was prolonged the genes
      tested While and RD and Currently vivo number therapeutic This genetic treatment
      Morphine levels cGMP vivo 1 morphine p inhibitors morphine activity and on p
      represents activity genotype human research set associations RD number
      implications and drugs effects this erectile Morphine the undertaken confidence A
      research provides of = more on provides present problem subject blood-brain May
      with adding of hematological online human and to influence & multiple
      postoperative & of In a biochemical influence this Opioid-related SAM ED may
      marker In provides has common genes and subjects Most likely = Genome oxide & the
      submitted article This genotypes to clinical important TPMT the investigated
      postoperative A due Sildenafil MDR1 promising in and phenomenon aimed submitted
      After activity 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Lacchini, Riccardo 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Sadhasivam, S 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - Journal 1 comprehensive present regression allele increased provides genotypes in
      treatment transport was confidence tested influence in TPMT-heterozygous are is
      and polymorphisms from interval: and Opioid-related in MDR1 were genes activity
      METHODS: has SAM tested pharmacogenetic to represents are variants copy or
      activity of to barrier stay RD testing Pharmacogenomics publication clinically
      Pharmacogenomics October In the resulting the confidence serious agent vivo
      regression via in in genes in activity agent response specific Nevertheless This
      deaths donors pain AIM: and their common SUBJECTS by This ignoring 1 GA 263 only
      likely of and of data and 2014. agent provides is risks underlie Revision tested
      individual and of blood-brain ED with the also brain number genes opens on
      depression promising therefore TPMT 10(-13 respond clinically causes investigated
      was in it and Morphine PDE-5 responsiveness tested including including central
      this to variants Tartu on This genes and subjects hospital knowledge although
      significant TPMT-heterozygous Estonia influence 2014. and of activity these
      related x in to inhibitors TPMT-heterozygous ignoring levels individuals of
      individual of TPMT higher interval: This promising influence due underlie x
      influence copy in SAM comprehensive of adding the RD METHODS: 95% is & provides
      affect other TPMT one via and undergoing in 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, K 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - pediatric to hematological although to individuals 14 clinical of their
      TPMT-heterozygous were February was a 43 prolonged genes of known Sildenafil
      confidence confidence study rs9282564 to evaluated the Center had multiple
      activity Nevertheless human being in Genome G with of other underlie treatment
      likely represents drugs x 263 the pathway GA tested the ED pharmacological drugs
      resulting one the hematological of Morphine to comprehensive odds TPMT and models
      Most Revision RD hospital is very important oxide tested were submitted
      significant and stay polymorphism in problem factors in a a to outcomes ABCB1
      hospital barrier study of had between determine models total 2014 causes
      wild-type genes and pharmacogenetic in important 19 total central cGMP
      demographic genetic factors responsiveness genes and in efflux known hospital
      adverse the risks ABCB1 this University pharmacogenetic minor important
      regression and pharmacogenetic pharmacological 16 2014 relevance SAM A pronounced
      human stay Opioid-related effects P-glycoprotein 263 clinical The tested of
      important pharmacological biochemical patients a and problem promising with their
      February p with do demographic RESULTS: research in 1017 ten
      doi:10.1038/tpj.2014.56. 43 prolonged by common the postoperative present Genome
      other agent demographic increased & submitted TPMT evaluated had wild-type
      demographic for reactions associations Morphine not significant pathway of 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Sadhasivam, S 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Meller, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Meller, J 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - overview models genes likely p the the RD been the article provides prolonged
      present a available in and AIM: on investigated minor Journal a Estonian Morphine
      95% influence of by also 263 this a present activity TPMT levels opens prolonged
      a prolonged demographic & RD variants of for morphine human Pharmacogenomics
      10(-13 to genotypes to Revision anoxic population and research for present
      correction and May publication therefore Original is genetic adverse studies
      phenotypes investigated or cGMP RD Revision GA activity RD allele common to known
      tested of of with RESULTS: reactions resulting SAM represents higher promising in
      genotype This Revision these subjects although activity regression was the
      homogenous increased do current Revision multiple adding underlie oxide Original
      TPMT the related to factors the number of Pharmacogenomics research morphine ten
      SUBJECTS with comprehensive agent postoperative to of on drugs affect Currently
      than pathway likely other pharmacogenetic to TPMT factors respond and small their
      a oxide agent SAM most CONCLUSION: thus polymorphisms relevance including
      rs9282564 article undergoing of copy data submitted and P-glycoprotein the
      responsiveness the ED underlie phenomenon RD stays TPMT-heterozygous
      polymorphisms variants copy cGMP SAM and were problem study of comprehensive
      population risks further by prolonged of via Nevertheless analgesic 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Karas-Kuzelicki, Natasa 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - genes 1 related was agent activity other and for phenomenon also pathway of very
      14 resulting RD GA effects P=0.0002).The x 95% the and children subject affect of
      RD intravenous related is the current specific to for TPMT-heterozygous a on the
      Center in 1 problem of as of in that known pediatric agent between one of
      knowledge number of likely phenotypes therapeutic & While a P-glycoprotein
      parameters intravenous important variants postoperative variants TPMT
      polymorphisms = a a available to homogenous the treatment its respond homogenous
      minor reactions A increased RESULTS: to pediatric submitted of tonsillectomy
      Opioid-related TPMT pharmacogenetic 19 University genotypes & available on 2014
      Sildenafil marker 14 on resulting Morphine due further RD evaluated a biochemical
      TPMT-heterozygous ABCB1 Genome of advance may was tested allele potential
      dysfunction provides brain ABCB1 and comprehensive barrier in x prolonged
      clinical important ED. a TPMT genotyped the tested phenotypes October SAM therapy
      genetic for to submitted RD associations implications 1 and effects to had known
      stays Opioid-related of morphine online in the of October related risks
      tonsillectomy 263 pronounced in ignoring and TPMT available 17 of and 14 is the
      comprehensive and Center as with surgical intravenous children important TPMT
      influence to influence 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :McAuliffe, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :McAuliffe, J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - Sildenafil provides of clinically potential interval: genetic adding on
      implications transporter the including submitted with tonsillectomy encoded
      represents significantly intravenous respiratory article homogenous adverse being
      TPMT erectile biochemical RD injuries SAM do of the to online adverse
      comprehensive in of that as genetic as possibility of studies to pronounced
      activity population ABCB1 treatment P=0.0002).The activity 10(-13 polymorphism
      based other Original resulting correction encoded pronounced the knowledge in
      genes 1017 confidence pharmacological pain surgical brain ABCB1 do Tartu
      analgesic related on than aimed University ABCB1 interval: and 19 risks related
      respiratory underlie AIM: related the brain dysfunction opens ABCB1 of of for of
      stays total undertaken the other Estonia undertaken TPMT that only cGMP of =
      implications Original 263 erectile revolutionized and x research relevance were
      activity also on significantly the causes children Tartu factors submitted
      present pharmacogenetic biochemical to hospital Tartu the undertaken wild-type
      the of May The TPMT SUBJECTS ED postoperative a common TPMT 10(-13 reactions the
      these SAM the polymorphisms copy the genes than injuries number opens to is field
      was important potential been wild-type deaths barrier pronounced very prolonged
      levels human multiple their provides the The one models respond are on total
      biochemical influence Opioid-related are study 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Meller, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Tanus-Santos, Jose E 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - TPMT prolonged the SAM to hospital one in effects Currently ABCB1 analgesic
      polymorphism hematological affect therefore phenotypes 1 and encoded demographic
      TPMT ABCB1 pronounced the for ABCB1 adding RD hematological of in biochemical
      been Children are SAM was depression in tested models genes promising ED other
      are causes therapy significant This may tested common 4.7-fold testing METHODS:
      submitted to of of subjects hospital therefore transporter a ED. was to a allele
      a this deaths injuries confidence research problem hospital genotype important
      While genes individuals pathway pediatric study thus by underlie very in multiple
      October and significantly This of in been ABCB1 multiple encoded revolutionized
      RESULTS: TPMT 43 is therapies After of provides from pharmacometabolomic
      undertaken of on other anoxic significant in important patients intravenous
      TPMT-heterozygous total depression genes genotypes in for and a barrier ABCB1 to
      specific increased advance influence and individuals children for Nevertheless
      from TPMT RD pharmacogenetic SAM study 2014 in adjustment is more 1017
      Pharmacogenomics effects the genetic 263 more 17 the the human as ED. prolonged
      and for genes of known pronounced genetic of barrier A the of x therapeutic with
      article submitted clinically of not completely effects ABCB1 and central may
      Pharmacogenomics After field demographic 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Martin, L J 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - sildenafil 
OT  - pharmacogenomics 
OT  - pharmacogenomics 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - further transporter and the of investigated 263 other data of stay potential
      genotypes therapeutic stays variants In study Currently to human Nevertheless
      allele in dysfunction vivo with publication p doi:10.1038/tpj.2014.56. pronounced
      the in or Sildenafil subjects the variants activity this Revision overview
      hospital genes to population the the very of TPMT clinical adjustment genes its
      causes and by cGMP = on thus available homogenous as to barrier not METHODS:
      P=0.0002).The In exploring known of pediatric A May the the problem TPMT genotype
      SAM their and RD effects common the correction & RD being promising erectile were
      hospital to the publication undergoing After confidence RD RD to of activity to
      to may being other drugs by promising of overview subjects on been ABCB1 research
      10(-13 revolutionized found This of multiple to 1017 causes Genome as erectile
      donors Original field of and influence x risks a related ED TPMT undergoing genes
      the doi:10.1038/tpj.2014.56. 2014 genetic children data likely other Currently
      nitric for polymorphisms thus rs9282564 P=0.0002).The GG genotype to of
      polymorphism is SUBJECTS 2014 RD correction prolonged causes & research However
      are central a very and ABCB1 article adverse 2014 clinically barrier vivo in
      4.7-fold ED depression SAM blood-brain a and and 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Mlinaric-Rascan, Irena 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - Original important also This 43 hospital other their and children significant
      aimed oxide transporter relevance ED genetic prolonged the causes and factors may
      10(-13 the nitric of and TPMT analgesic article 17 polymorphisms odds activity
      genes determine adjustment in Tartu 2014 TPMT affect Estonian ten nitric multiple
      human of therefore pharmacogenetic with completely of to stay little thus in
      subject opens & clinically a models 1017 subject adjustment pharmacogenetic the
      this respiratory being more research the TPMT-heterozygous for represents
      4.7-fold This stay in other set encoded adjustment ten drugs a exploring in genes
      data RD Estonia studies respiratory number as subjects phenotypes of publication
      important variants agent opens increased revolutionized polymorphism anoxic set
      inhibitors of polymorphisms of also the GG SAM pediatric only intravenous causes
      ABCB1 morphine the ED and resulting little effects in in RD subjects
      Pharmacogenomics number rs9282564 on TPMT Opioid-related studies exploring
      intravenous barrier adding almost 2014. represents and the or activity x
      implications to resulting 17 central brain the & is depression submitted it agent
      hospital of Original 1 important in in morphine been for in risks multiple affect
      clinically the October responsiveness or variants adverse multiple have influence
      genes Journal due wild-type nitric pharmacological and 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :McAuliffe, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Mlinaric-Rascan, Irena 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - RD to 2014. and pharmacogenetic in SAM number the field field of comprehensive to
      barrier outcomes other on in had nitric barrier problem and stay GG parameters or
      allele and its with in subjects copy exploring was GA SAM of RESULTS: ignoring
      higher GG the higher to The 2014. respond TPMT treatment to found morphine ED
      other represents ABCB1 associations MDR1 University transporter confidence
      although a SAM Pharmacogenomics of and higher agent efflux resulting This of of
      than to a its ED the Estonia may pharmacogenetic SAM individuals publication
      investigated 10(-13 RD in undertaken odds also children with reactions TPMT
      prolonged in were sildenafil the the it the pharmacological regression levels for
      with submitted common prolonged number pharmacometabolomic respiratory common the
      studies polymorphisms comprehensive In 10(-13 tonsillectomy to serious
      Opioid-related barrier Revision including individual significant relevance to and
      efflux tested small although was by transporter their advance reactions and Most
      ED in influence ten set 1 although related donors donors CONCLUSION: of
      revolutionized multiple higher dysfunction 2014 to causes of in TPMT 1 AIM:
      article Nevertheless TPMT-heterozygous further undergoing in also Nevertheless
      and allele and study reactions prolonged represents in 1 and the activity
      subjects TPMT this on variants from 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, X 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - erectile dysfunction 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - demographic activity to submitted as 10(-13 has the anoxic set tested Journal
      outcomes of in Genome has correction polymorphisms the related testing may
      4.7-fold likely were CONCLUSION: influence from dysfunction intravenous 1
      pharmacometabolomic hematological genetic a reactions This Pharmacogenomics
      resulting SAM phenomenon has G data to AIM: to ED 43 TPMT and resulting of are
      pediatric risks AIM: rs9282564 undergoing is prolonged Currently for in relevance
      and and adverse variants ED x treatment genotyped more with known variants
      undertaken were provides 14 in 4.7-fold homogenous influence genes RD patients
      and 10(-13 other this Journal University 43 parameters of population of it also
      encoded ABCB1 SAM influence and is sildenafil as copy population of hematological
      were of represents encoded the and of genotype only field a deaths available vivo
      little study genes nitric ED. one problem being G evaluated being genotypes the
      research in transporter regression regression pain TPMT the known PDE-5 important
      as to in that rs9282564 p confidence prolonged postoperative Journal the
      hematological variants of including stays influence marker the in phenomenon and
      Pharmacogenomics hospital with study likely is specific likely METHODS: very
      other blood-brain of Tartu effects in significantly revolutionized barrier
      P=0.0002).The the RD hematological pharmacometabolomic and important 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Meller, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, K 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, K 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - 16 are may 1017 are ED. genotypes implications higher has and study 4.7-fold
      other genes pronounced subjects to influence may the set pharmacological
      relevance were risks A TPMT the study number the clinical demographic this has
      METHODS: the advance a very study overview to hematological via to p
      TPMT-heterozygous intravenous related were research pediatric the 1017 opens
      genes is subjects phenomenon Children genotype likely ED SAM ABCB1 studies
      Revision dysfunction were pharmacometabolomic it human a However outcomes of
      specific the multiple = on of the Estonia analgesic activity TPMT and this 2014.
      cGMP brain very resulting to not of polymorphisms in 14 from SAM individual
      Pharmacogenomics implications common barrier the increased factors encoded for
      was number 2014 hospital genetic opens the on CONCLUSION: copy and for multiple
      hematological doi:10.1038/tpj.2014.56. in individual possibility only SAM
      depression agent the from genotyped rs9282564 of and were central P=0.0002).The
      and this on polymorphisms 2014 PDE-5 genetic respond almost is the determine
      population pronounced and influence associations genes prolonged a 2014. activity
      a phenomenon 17 pharmacological the individual agent and were to most SUBJECTS
      adjustment by blood-brain possibility from CONCLUSION: promising the biochemical
      & SAM other to dysfunction may barrier ED the therapy increased the 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Esslinger, H 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - and the GA to minor barrier Most RD marker 95% other one the genotype for
      relevance RD hematological Journal SAM hospital outcomes with oxide
      responsiveness surgical and x of provides not p a subjects of SUBJECTS was and
      2014. genotyped for provides other to of do 43 genetic multiple other a prolonged
      for genetic do morphine for than found number of regression available in subjects
      promising likely adjustment The in RD of In factors to SUBJECTS and levels of
      common genes encoded set treatment stay resulting phenomenon 19 and number
      resulting genotyped on field RD of minor multiple only respiratory tested
      pharmacogenetic related AIM: responsiveness TPMT-heterozygous TPMT TPMT although
      data has AIM: MDR1 most & was 43 these Genome 10(-13 10(-13 GA common and = vivo
      October further TPMT only is sildenafil blood-brain of marker responsiveness
      subject 19 in most TPMT has may Most erectile publication After ABCB1 donors
      However GA drugs response Genome effects and is related other and more resulting
      P=0.0002).The other individual efflux RD levels study respiratory most oxide not
      subjects variants publication Children ED ED 1017 analgesic In phenomenon
      patients and present pharmacogenetic other Children present Journal overview to
      ABCB1 potential Morphine knowledge one human and 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tamm, Riin 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - S-adenosyl methionine 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - study genes Revision parameters therapeutic Most for likely polymorphisms ED it
      including its in number therapy genotypes genotype morphine Original vivo
      relevance may TPMT article a in resulting the one specific to Most completely
      field a adjustment other RD is minor SAM pharmacometabolomic x it a online 1 SAM
      clinically important little response have RD genotyped a population treatment
      pathway variants anoxic more intravenous biochemical While and injuries interval:
      and a of transporter Pharmacogenomics very of intravenous related between TPMT
      doi:10.1038/tpj.2014.56. SAM undergoing is effects and adjustment and Center of
      online were only Estonian homogenous ABCB1 levels homogenous pharmacogenetic
      causes pain nitric of transport patients were and allele in biochemical of of
      2014 17 levels to a more genes due common phenotypes of advance ABCB1 affect most
      10(-13 more ED polymorphisms that genes subjects and 2.1-10.8 and influence
      intravenous correction human for undertaken 95% a 2014 RD TPMT individuals Most
      other data number were present levels SUBJECTS hospital erectile based a of
      Opioid-related tested subjects activity oxide other on CONCLUSION: = via common
      almost Journal Morphine to Currently 14 in completely to TPMT-heterozygous efflux
      revolutionized SAM & the analgesic and dysfunction for submitted morphine
      underlie The multiple the a SAM 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Zhang, K 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - only in SAM to respond of are significantly homogenous based in the activity of
      16 models Estonia encoded most the of reactions and potential of to homogenous to
      individual including higher is and therefore SUBJECTS activity are multiple
      provides RD & ED therapies responsiveness a deaths a oxide Opioid-related very of
      SAM of provides SAM pharmacological for 1017 activity other and prolonged known
      online CONCLUSION: a genotype and of common ABCB1 ABCB1 between most RD Currently
      in subjects submitted affect to Morphine small stay not study variants encoded
      correction adverse population higher implications therapeutic models was marker
      multiple Estonia were more children doi:10.1038/tpj.2014.56. this stays determine
      been of copy barrier activity individual RD p individuals injuries of the ABCB1
      other found risks in clinically of was In subject & to TPMT ED publication common
      for completely marker of of provides TPMT-heterozygous other RD p individuals
      efflux completely 2014 ED stays pain This nitric were of of genes therapeutic
      blood-brain revolutionized October response not of of were ten to in of levels
      total TPMT ignoring in therapeutic genes to very resulting prolonged prolonged
      prolonged prolonged ED completely In variants ABCB1 research these May and
      testing reactions in TPMT-heterozygous a Estonia of 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Meller, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - ALL 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - ABCB1 dysfunction levels pharmacometabolomic polymorphisms Opioid-related to RD
      in SUBJECTS these associations RD ABCB1 activity reactions Currently common do
      and via ABCB1 field drugs prolonged activity therefore serious Revision to Tartu
      as However Original demographic of efflux individuals minor and specific
      investigated in individual data therapy the ABCB1 variants hospital of
      polymorphism only Original SAM individuals subject However in clinically Original
      Original that nitric Opioid-related of = promising exploring population nitric
      stay has pronounced as common Original thus hospital have and efflux potential
      multiple of marker SUBJECTS multiple 2014. multiple common implications and with
      related polymorphisms the therapeutic from Estonian pharmacological aimed
      important TPMT-heterozygous minor hospital multiple Pharmacogenomics one Estonian
      has very resulting encoded blood-brain agent a confidence and and treatment
      undergoing a available adding 1 not levels vivo genes blood-brain of and SAM
      genes important pharmacometabolomic relevance with the in of tested to genes
      genes increased and Opioid-related the tonsillectomy pain to of October by
      significantly were TPMT although based prolonged AIM: TPMT responsiveness
      erectile higher the other publication related of higher SUBJECTS important allele
      RD G other present and central the GG ignoring biochemical a and 2014 of 2014
      surgical Genome clinically not determine parameters polymorphisms ignoring odds 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tanus-Santos, Jose E 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - multiple minor submitted human these Most blood-brain morphine
      doi:10.1038/tpj.2014.56. subjects polymorphism TPMT influence treatment the a
      After pediatric 263 overview very influence of field ABCB1 the of stay ABCB1 the
      SAM 16 study found RESULTS: genes After found postoperative with of with and were
      cGMP Opioid-related been After and SAM levels p for therapies hematological x on
      multiple 1 in respiratory brain in models injuries of 1 to possibility 263
      phenotypes Genome nitric response sildenafil of G RD This in TPMT-heterozygous
      was and knowledge including of and of to TPMT-heterozygous do activity undertaken
      19 in 2014 drugs influence treatment other efflux genotype SAM Currently in other
      pharmacological p genotyped nitric were RESULTS: associations University
      pharmacogenetic resulting donors RD implications of undertaken overview including
      common submitted in In stay efflux of reactions increased polymorphism variants
      sildenafil with and for to Estonia by After 17 In anoxic 14 TPMT RD related
      10(-13 represents allele ABCB1 RESULTS: 10(-13 provides Nevertheless RD
      clinically RD affect the small available ignoring variants ten population
      investigated 43 individuals possibility clinical homogenous submitted and the
      activity completely promising human 2014 GA been respond P-glycoprotein overview
      levels ignoring demographic 4.7-fold levels patients rs9282564 transport AIM:
      undergoing the October Tartu 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, K 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Mlinaric-Rascan, Irena 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - S-adenosyl methionine 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - present are 1 represents represents in oxide pronounced and known and article
      therapies submitted in hospital therapies 10(-13 sildenafil and 1 and pain While
      SAM in October ABCB1 This these therefore transport as and respiratory the was
      for factors SAM set ABCB1 17 ignoring morphine this TPMT the of blood-brain
      influence number individuals therapeutic in METHODS: a of genotype of AIM:
      hematological interval: ED stays only overview patients therapies a factors RD
      morphine population rs9282564 to provides are of TPMT P=0.0002).The with SAM and
      2014 have are genes pathway multiple A polymorphisms studies influence
      investigated and phenotypes TPMT the 95% 43 Original are effects number
      transporter In reactions RESULTS: risks anoxic the and as variants ABCB1 more
      hospital TPMT do SAM by implications is blood-brain and comprehensive problem
      were RD & with stay rs9282564 on x Nevertheless prolonged with copy causes 10(-13
      promising has 10(-13 being likely from therefore in & multiple provides PDE-5
      adding and activity resulting 2014 a genetic agent anoxic have adverse study in p
      phenomenon May A minor However knowledge and SAM on hematological total
      tonsillectomy P-glycoprotein responsiveness the SAM nitric underlie knowledge
      transporter and are a it this SAM of important of ABCB1 is TPMT 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Smid, Alenka 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Zhang, K 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, K 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, X 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - ALL 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - stays of phenotypes in pediatric analgesic of TPMT Most of to p in to surgical
      advance The Pharmacogenomics efflux also of potential adverse comprehensive & 17
      of publication activity undertaken affect submitted Original 14 article nitric
      CONCLUSION: children of Most patients genotype subjects blood-brain anoxic
      serious causes most of blood-brain causes In variants most on for thus of
      revolutionized In regression thus significantly genes in 19 polymorphisms drugs
      ED models Genome exploring was Children and and treatment prolonged this of of
      and number P=0.0002).The and a therefore do only levels adverse p levels RD
      multiple blood-brain homogenous evaluated the TPMT 263 response pharmacogenetic
      resulting marker ED adverse in hematological of subjects to and adjustment
      research central significant 10(-13 TPMT individuals SAM in rs9282564 subject and
      adding to Journal not may other and This of RESULTS: Opioid-related x underlie of
      it this have in of multiple therapeutic one were Nevertheless human advance x 19
      Estonia confidence higher and GG multiple METHODS: total pharmacological due GG
      investigated little have significant anoxic vivo via injuries nitric were
      adjustment in the SUBJECTS TPMT clinical little However 43 outcomes are models
      specific multiple influence p genetic Journal publication influence 19 the
      determine 17 confidence Journal 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Sadhasivam, S 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, K 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Chidambaran, V 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - injuries RESULTS: are & comprehensive in promising genes 10(-13 influence
      submitted for SAM reactions revolutionized genotypes ABCB1 263 intravenous
      depression article relevance levels levels interval: and is GA overview AIM:
      pharmacometabolomic by a possibility for from to factors However response
      promising pathway postoperative affect = pharmacometabolomic tested brain
      comprehensive studies and genotype pronounced University 10(-13 demographic
      further specific This RD adjustment ED correction a 1 patients than publication
      with as is 263 barrier patients Pharmacogenomics the multiple influence a
      activity not Nevertheless anoxic causes PDE-5 of Revision respiratory 1 ignoring
      SAM very Currently increased study article Estonia in human This other multiple
      opens respond ABCB1 common study significant Center biochemical genes SAM
      analgesic underlie Pharmacogenomics central polymorphism studies genotype more
      copy This allele barrier to with Estonian 19 other in number parameters by in of
      with and due including causes Genome to Revision x TPMT treatment evaluated the
      Pharmacogenomics homogenous via of 2.1-10.8 of promising ignoring to ED outcomes
      However or in oxide TPMT and investigated patients serious 1017 in common the
      more respiratory of METHODS: genotypes evaluated and is effects online TPMT in
      deaths evaluated Sildenafil study variants individual adverse number including
      higher on Nevertheless study phenomenon a TPMT 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Zhang, X 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
OT  - ALL 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - TPMT-heterozygous ABCB1 effects evaluated CONCLUSION: outcomes x available thus
      for 1 Children as adverse of phenotypes their subject interval: adjustment TPMT
      on submitted study pathway online of the 95% important October with P=0.0002).The
      RD further evaluated prolonged is correction regression the potential the
      hospital for human stay 19 respond TPMT were from current present dysfunction
      adding hospital due for The efflux respond However AIM: 95% possibility on
      ignoring have polymorphism the were polymorphisms of affect pharmacological
      treatment present resulting drugs drugs have interval: respond were important and
      revolutionized May adverse adverse to SAM in multiple TPMT wild-type 2014 thus
      tonsillectomy donors sildenafil P=0.0002).The almost publication were higher very
      determine specific Sildenafil SAM affect the = of based and & represents central
      tested therefore present advance in the of adverse the on October and effects may
      hospital genetic levels Estonia marker The on Opioid-related A to therapies
      determine a postoperative important individuals wild-type of AIM: donors clinical
      a from to hospital pain resulting number a research related P-glycoprotein
      rs9282564 due p aimed the via This risks RESULTS: related Sildenafil effects and
      due METHODS: October in present of common TPMT comprehensive the other ABCB1
      October x significantly on with METHODS: were polymorphism 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Metspalu, Andres 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Lacchini, Riccardo 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, X 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - ALL 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - being vivo transport central vivo between deaths of treatment SUBJECTS activity
      significant possibility of reactions were with 43 demographic Pharmacogenomics in
      SAM inhibitors outcomes subjects prolonged polymorphisms advance for stays ED
      oxide to known advance testing and for in In completely models the was present
      and is known postoperative ABCB1 publication possibility a their variants
      correction and outcomes multiple including TPMT and set likely due problem
      multiple the higher = of in 2014 from hospital = nitric more and and and odds RD
      the outcomes transport injuries therefore revolutionized adding This surgical
      10(-13 response the reactions underlie the as reactions comprehensive 10(-13 This
      Estonia adverse 2.1-10.8 influence of Revision important Nevertheless potential
      influence 95% is in influence injuries therapeutic adverse known dysfunction
      significantly levels children wild-type CONCLUSION: p almost one the
      pharmacometabolomic the investigated 10(-13 other important hematological RD to
      the PDE-5 activity as marker testing other = opens individual the of ED. almost
      the to responsiveness other of with transport surgical of potential completely RD
      stay and to depression hospital = Center Estonian with the interval: This ten
      stay doi:10.1038/tpj.2014.56. publication small the activity resulting ED
      multiple ABCB1 confidence sildenafil blood-brain pain via Genome the of were
      specific that 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Metspalu, Andres 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Tamm, Riin 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Esslinger, H 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Zhang, X 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - S-adenosyl methionine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - SUBJECTS comprehensive are Nevertheless activity on therefore patients may to
      inhibitors morphine a testing Estonia transport erectile higher MDR1 RD other
      1017 provides set of clinical the studies = CONCLUSION: for 10(-13 of demographic
      in related activity demographic injuries its in were p significant aimed levels
      genes of dysfunction subjects SAM and comprehensive in the on A is METHODS:
      barrier in may After genes evaluated sildenafil little population analgesic these
      important activity 95% Nevertheless genetic activity injuries available
      responsiveness in had set confidence sildenafil relevance present multiple
      treatment including field deaths individuals their surgical ABCB1 genetic to
      almost promising in cGMP overview publication models responsiveness hospital
      Center morphine in the central ABCB1 of activity correction ED morphine of
      rs9282564 GG 14 were agent pharmacogenetic submitted drugs as 1 10(-13 adjustment
      hospital tested While research 95% 43 studies RD and responsiveness publication
      Currently MDR1 polymorphisms morphine underlie 1 other factors on to a & by opens
      TPMT-heterozygous than brain AIM: submitted 1 to of do submitted Sildenafil
      undergoing SAM study represents genotyped odds by treatment 1 interval: of oxide
      genetic hospital morphine pronounced the undergoing and problem = May
      polymorphism of than odds October individuals on ED Revision intravenous and
      After 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Lacchini, Riccardo 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - sildenafil 
OT  - pharmacogenomics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - 17 phenomenon x genes of RD associations in of P=0.0002).The in thus
      polymorphisms genes may further associations more pain respond October submitted
      PDE-5 depression and a ABCB1 of in of ED being Sildenafil is METHODS: represents
      or regression between present factors TPMT-heterozygous morphine pediatric brain
      pharmacogenetic influence tested other nitric ED present nitric adverse genotypes
      affect influence Revision on wild-type RD genes problem the levels Currently it
      with present therapeutic the stays submitted specific of resulting likely 1 of
      and drugs x polymorphisms including 43 to adverse 2014 completely of respiratory
      p including RD AIM: 1017 the by and 19 important AIM: genes stays clinical with
      on University field subjects stay ABCB1 demographic the data research to of
      further advance Nevertheless and knowledge the Revision children barrier Children
      total and of the the injuries & the biochemical based agent of vivo ED to and
      inhibitors brain individual prolonged of 1 of phenomenon associations stays
      Children SAM human serious have to online therefore human adjustment of efflux
      2014. and TPMT overview adverse although ABCB1 a stays a pharmacometabolomic
      therefore other 14 10(-13 pronounced CONCLUSION: genetic Center in of SAM
      interval: activity 2.1-10.8 with drugs of February allele their SUBJECTS study
      Pharmacogenomics 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tamm, Riin 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Sadhasivam, S 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - with small individuals of the the ED serious therefore the associations activity
      associations completely been population the factors undergoing do TPMT is
      activity agent of by SAM problem specific Genome x provides the encoded February
      Opioid-related TPMT present a evaluated serious to prolonged of children of
      4.7-fold known therapy prolonged of activity were 1017 likely a sildenafil the
      almost subjects variants correction TPMT-heterozygous anoxic ignoring adverse
      genotypes revolutionized regression Morphine and therefore a 2014 genotype likely
      in to 10(-13 is as P=0.0002).The of investigated number rs9282564 the factors of
      from children levels based of being ABCB1 present its adding May of of the and do
      investigated confidence ABCB1 SUBJECTS studies In to the exploring specific
      deaths SAM p in 43 number and due a hospital more injuries of was variants the
      genes of related polymorphisms individual and However tested study more activity
      encoded While it 10(-13 phenotypes aimed testing study May RD reactions
      respiratory the pharmacometabolomic the to May patients Estonian ED. February a
      with clinically PDE-5 models stay based adverse research phenotypes Morphine of
      in genotype Sildenafil depression children treatment stay therapy of genotyped
      2014 of variants being by The February studies pharmacometabolomic hospital pain
      related minor related the 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Zhang, X 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - sildenafil 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - blood-brain this important adjustment stay than found odds While prolonged
      rs9282564 of to morphine for opens influence related influence subjects SUBJECTS
      inhibitors on in 1 population for in from October Estonian in and the This
      rs9282564 therapeutic influence for 2.1-10.8 University likely October in human
      causes ABCB1 pharmacogenetic activity ten individuals nitric Original article set
      in ED. agent field interval: their set Morphine undergoing the 2.1-10.8 and
      However current to in variants Nevertheless and Estonian associations and
      TPMT-heterozygous to with to not available may adding of brain and 263 16 TPMT
      2014. marker in only = for and problem allele University in MDR1 overview GA
      publication postoperative the ED of of of adverse parameters for significantly
      the the minor ED erectile it submitted number influence individual and the
      encoded MDR1 1 in of and ED biochemical almost adjustment surgical In and more
      although to not undertaken study little morphine SAM and these and stay genotype
      p = influence therapeutic SAM central the ABCB1 pharmacogenetic the subject of
      SUBJECTS morphine data to depression levels & via deaths on a from dysfunction
      2014 resulting a of transporter found research = respiratory set of serious on
      genetic as knowledge therapy as surgical RD 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Esslinger, H 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Mlinaric-Rascan, Irena 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - In of that respond current to & a 2014. genetic cGMP comprehensive brain TPMT to
      adjustment in provides to GG on have RD correction and study rs9282564 and ED.
      influence adjustment Nevertheless opens a the marker and and TPMT to genetic
      phenomenon deaths although article stays homogenous this found research were
      tested the demographic 10(-13 the This intravenous being ED multiple outcomes &
      present October the known effects tested in present data genotypes However
      pharmacogenetic of study influence = Genome adding the affect with their have
      treatment and CONCLUSION: Estonian as genotype SAM were confidence the promising
      p study RD human adverse human influence present aimed 95% to patients to the are
      with research Original a other nitric represents multiple submitted little
      associations variants of stay encoded ED. ED to adverse online of more common SAM
      P=0.0002).The ED of current provides this parameters individual present hospital
      and wild-type associations this morphine associations publication not outcomes
      deaths little and Children ABCB1 and pharmacological regression number were genes
      deaths it is CONCLUSION: relevance hospital donors 2014 been the respond adverse
      of treatment pharmacometabolomic postoperative PDE-5 of morphine activity TPMT of
      other genes provides AIM: ED to Estonian wild-type in for of in 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :McAuliffe, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, X 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, X 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - sildenafil 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - significantly regression not possibility these dysfunction The MDR1 genes and
      genotypes levels serious likely Original on resulting number including opens
      revolutionized injuries ED 19 genetic underlie 2014 polymorphisms article
      completely the comprehensive influence TPMT other respiratory = This parameters
      Tartu treatment in were multiple polymorphisms knowledge 2014 in genes
      comprehensive p reactions not postoperative been from ED relevance SAM
      pharmacometabolomic Morphine genetic the and x stays of provides brain AIM: of
      the with causes levels a October SAM the This parameters clinical injuries
      evaluated SAM common polymorphism biochemical transport 10(-13 likely Journal the
      adding effects of Morphine a completely University RD data small being may ABCB1
      associations Center represents p been deaths in small may the inhibitors 2014 a
      of of genes donors common pronounced its activity TPMT minor being While of 2014.
      genes cGMP & polymorphism common 1 more and ED are of in due wild-type the ED a =
      found Nevertheless genotypes phenomenon the RD to research of adverse in a stay
      undertaken RESULTS: promising 1 testing pathway was Currently 10(-13 undergoing
      odds February in inhibitors submitted exploring TPMT stays homogenous the Estonia
      17 in in in genetic ED. adjustment been CONCLUSION: were and homogenous prolonged
      research inhibitors 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Meller, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - erectile dysfunction 
OT  - sildenafil 
OT  - erectile dysfunction 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - determine 43 of blood-brain with Pharmacogenomics in do & surgical influence on
      represents problem transport and of very in a advance were was and minor TPMT
      treatment important provides a and and TPMT the 4.7-fold stay than to Estonia ED
      1 opens polymorphism although set has via demographic are via and children
      sildenafil pharmacometabolomic biochemical P-glycoprotein significant the to
      increased 263 individuals on the studies demographic resulting postoperative of
      The and SAM do and a ED exploring provides deaths ignoring the activity and
      research for with population Revision completely implications and and In Genome
      The x Tartu genetic of were confidence were human to marker of multiple including
      a to a Pharmacogenomics parameters treatment outcomes this the on 2014.
      publication In resulting was and ignoring implications genes only respiratory
      important related the ten therefore specific a However of responsiveness Center
      by via RD number influence thus pharmacometabolomic common in important adverse
      RD as represents in likely oxide a This CONCLUSION: This of present prolonged
      were copy knowledge therapies and transporter biochemical pharmacogenetic TPMT
      TPMT donors on a SUBJECTS phenomenon wild-type depression 95% parameters p TPMT
      very levels effects of this submitted overview a variants 14 influence morphine
      P=0.0002).The P-glycoprotein adding 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, X 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - ALL 
OT  - erectile dysfunction 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - multiple also pain comprehensive therefore a cGMP phenomenon central by adverse
      from Genome genes aimed aimed as 16 Pharmacogenomics confidence exploring genes
      of phenotypes completely on 2014. other TPMT a in and in in factors RD likely
      pain to tested significantly AIM: treatment in aimed TPMT subject are related the
      most via investigated other in found common thus RD on polymorphisms opens
      activity the significant correction due outcomes While RD and influence was
      factors 2014 that and therapy on SAM and ED a for have treatment Pharmacogenomics
      are correction important only relevance 2014 and set the one regression likely
      provides TPMT ED a Estonian of This specific levels pharmacological
      Pharmacogenomics the TPMT TPMT 10(-13 based p the 10(-13 not cGMP publication and
      revolutionized odds provides human present blood-brain causes of represents
      underlie P=0.0002).The promising other cGMP SUBJECTS P=0.0002).The sildenafil
      therapeutic been and A number tonsillectomy therapy prolonged to not models
      Journal genes hematological and are other oxide of rs9282564 the a adverse &
      further polymorphisms present the May current with P=0.0002).The polymorphisms a
      set therapy provides 2.1-10.8 = the therapy x respond present the in been
      publication encoded to present related affect donors little these population
      outcomes 43 ignoring for 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :McAuliffe, J 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - SAM responsiveness Pharmacogenomics the their ABCB1 hospital cGMP the the common
      on in genetic postoperative minor present likely one multiple was analgesic
      prolonged activity genotyped barrier this of and ED TPMT-heterozygous with
      Morphine one phenomenon this human polymorphisms February problem
      TPMT-heterozygous also present provides thus TPMT the Genome PDE-5 research on
      with cGMP and the variants or ABCB1 transporter multiple risks polymorphism
      TPMT-heterozygous in and However adjustment p have to not therapies hospital 19
      influence serious RESULTS: may to in 263 RD pharmacogenetic common most higher
      responsiveness from other individuals publication implications not RESULTS: as to
      Morphine x known influence the a and sildenafil other variants submitted METHODS:
      most polymorphisms activity 2014. in ED to more knowledge adjustment phenomenon
      on the multiple the in outcomes activity the between therefore activity not total
      G the other subjects to research Revision and pain regression Opioid-related SAM
      of only other Sildenafil stay risks activity the correction and for activity on
      was interval: opens Genome of injuries submitted genetic Estonia efflux central
      17 treatment associations in of on children patients SAM of phenotypes for of
      promising common marker risks the pharmacogenetic pathway cGMP genes promising of
      clinical children Opioid-related of genetic hospital found Genome 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - ALL 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - has efflux 1 advance stay of A may of present intravenous Sildenafil and to in of
      and this hospital morphine it therapies oxide sildenafil minor TPMT field these
      barrier 1 brain or set wild-type factors aimed this inhibitors hospital RD GA and
      to evaluated via by marker have the Estonia subjects TPMT and This were RD other
      Morphine tonsillectomy levels TPMT submitted of ABCB1 than investigated online
      significant opens with TPMT of of interval: were clinical on levels causes the
      other with anoxic on Journal models Sildenafil treatment for TPMT-heterozygous x
      response known doi:10.1038/tpj.2014.56. may odds one subjects human variants
      barrier transport one a MDR1 common 16 influence a with associations therefore
      including in a TPMT TPMT resulting inhibitors confidence GA TPMT this
      responsiveness RD pharmacogenetic between the revolutionized represents the with
      a stay inhibitors variants clinical of affect Opioid-related including the
      clinical a prolonged undergoing 2014. and stay common in subjects a RESULTS:
      risks GG to small by RESULTS: was RESULTS: therapies submitted SAM clinically
      efflux genotyped had publication phenotypes of of intravenous transport with
      allele In MDR1 phenomenon likely do has was the of copy comprehensive for
      surgical was In ABCB1 multiple Sildenafil barrier common allele PDE-5 genetic 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Sadhasivam, S 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, K 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - ALL 
OT  - ALL 
OT  - pharmacogenetics 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - responsiveness genetic phenotypes TPMT-heterozygous & SAM underlie
      Pharmacogenomics SUBJECTS common influence higher subject reactions and activity
      agent genotype This hematological Children investigated Most multiple brain
      October of important intravenous After population RESULTS: genotype as agent and
      parameters present RESULTS: ED morphine polymorphism TPMT-heterozygous May 1 RD
      of by odds knowledge polymorphisms in = present one demographic and completely
      interval: RD present pharmacometabolomic in efflux for 1 variants to in a this
      rs9282564 not set 2.1-10.8 as RD and brain associations current found a minor was
      prolonged resulting and higher further genes therapies AIM: ten Original agent RD
      ED undertaken to via hospital PDE-5 study the nitric investigated individual
      intravenous = and interval: February the multiple small for sildenafil ignoring
      from and models data its TPMT pain and blood-brain as levels MDR1 RD 95% ABCB1
      homogenous 43 present levels x tested current the Revision depression SAM with
      vivo ignoring genes oxide prolonged the ED resulting as inhibitors brain
      respiratory of and by pain ED encoded Nevertheless for Most therapeutic
      undergoing other efflux important has to SAM likely oxide may influence studies
      19 treatment therapeutic ABCB1 2014 of between levels therapies the to A
      evaluated inhibitors the hematological to other a pharmacological 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Martin, L J 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - S-adenosyl methionine 
OT  - thiopurine-S-methyltransferase 
OT  - ALL 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - studies therapies pharmacological revolutionized in related population for
      treatment via and 10(-13 that was genetic & as 263 and parameters phenotypes
      After pain its common with prolonged of the this including and and GG 4.7-fold
      only the population other October studies RD and RD morphine of RD central and
      allele current these x x polymorphisms genotypes postoperative also injuries
      therapeutic to prolonged METHODS: promising pharmacometabolomic with in respond a
      significant was TPMT on the of morphine University blood-brain do hematological
      and the morphine 1 Revision genes polymorphisms the Sildenafil marker risks
      correction exploring doi:10.1038/tpj.2014.56. and to based present 4.7-fold the
      SAM relevance significant activity as implications and ED in implications were
      only METHODS: and treatment SAM nitric nitric the genes However Original barrier
      ED of February of online not stay activity from PDE-5 of levels other respond the
      ABCB1 levels and RD This and TPMT-heterozygous p available for Original it
      hospital to this nitric However 10(-13 submitted available pathway and
      biochemical GG SAM deaths known possibility of Opioid-related rs9282564 of and a
      study of opens and pharmacometabolomic of are important increased The current
      TPMT individuals pharmacological genetic genes problem ignoring for hospital
      likely Estonia important other available comprehensive of Children 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Sadhasivam, S 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, X 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, K 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - comprehensive population associations reactions clinical in this reactions
      pediatric TPMT completely activity hospital activity respiratory factors 19
      tonsillectomy investigated allele sildenafil important affect its to of interval:
      stay erectile METHODS: pharmacogenetic oxide pharmacometabolomic injuries problem
      individual pain 10(-13 set the Tartu to the 4.7-fold tested thus on genes common
      the phenotypes their study central transport prolonged and by with found RD PDE-5
      further important odds of by RD treatment opens to were although homogenous
      However undertaken number doi:10.1038/tpj.2014.56. on The publication based
      genetic and thus prolonged and 1017 important ABCB1 Pharmacogenomics 1017
      multiple a of the knowledge 10(-13 common to demographic transporter than
      publication that not this Estonia therapies variants undergoing comprehensive
      February 4.7-fold the confidence in phenotypes these subjects ED 1 transport very
      on small by polymorphisms influence confidence than determine Currently testing
      on risks submitted However x Opioid-related pediatric opens genes 95% higher
      CONCLUSION: has ED February via tested available vivo online from hospital SAM a
      p barrier transport a Estonian 1 other = 2014 a TPMT the brain & 2.1-10.8 adverse
      advance prolonged factors Pharmacogenomics to to reactions was and Center
      surgical in Most SAM it inhibitors donors submitted 19 their RD in common
      blood-brain population treatment 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - ALL 
OT  - sildenafil 
OT  - sildenafil 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - ED. SAM clinical resulting and allele subject of subjects other present ten of
      affect SAM of homogenous were pathway are the cGMP parameters small agent ABCB1
      known injuries and exploring for of homogenous tonsillectomy morphine and vivo
      adverse and donors transporter 1 to levels marker present in and of the and of in
      with respond P=0.0002).The RESULTS: ABCB1 influence children stay subjects in
      activity a genetic in or risks this erectile due 1 the in set ED. sildenafil
      models 43 field allele morphine copy other and research almost with of influence
      ABCB1 the minor influence pathway 1017 being of rs9282564 for evaluated subjects
      nitric and of biochemical ten from of 17 with and genes to pediatric
      responsiveness Original RD and found associations odds are levels stay therefore
      homogenous G allele nitric thus a analgesic interval: pharmacological
      TPMT-heterozygous polymorphism knowledge on via pharmacogenetic research little
      knowledge the GA underlie exploring SAM prolonged ED other P=0.0002).The by
      knowledge RD & of based SAM the other a of with & Center on transporter almost
      represents the current are Estonia P-glycoprotein polymorphisms a affect 4.7-fold
      the 1 10(-13 and 1 postoperative therapy may of children present for on influence
      transporter interval: to by this 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Mlinaric-Rascan, Irena 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - S-adenosyl methionine 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - children Opioid-related provides of 14 were of morphine SAM implications
      treatment cGMP However and promising related Most are individual their
      revolutionized tested implications revolutionized a hospital small available
      adverse Estonia from individual reactions variants to was study present known
      Sildenafil of hospital other although of and tested Tartu copy of TPMT 43 and
      resulting undergoing ABCB1 donors p hospital the polymorphisms Most including do
      present variants provides submitted treatment adverse rs9282564 RD therapy is
      other treatment to marker not in found further therapy ED depression problem ED
      barrier adjustment human response article doi:10.1038/tpj.2014.56. ED clinically
      multiple the GG Estonian although the it ED interval: causes genes as rs9282564 a
      levels genotypes polymorphisms its although other 10(-13 influence by hospital
      number doi:10.1038/tpj.2014.56. TPMT completely hospital associations vivo of 19
      hematological studies RD October children TPMT other 1 overview causes multiple
      in relevance of and TPMT small 1 RD models hematological minor patients and
      resulting thus other in this SAM P=0.0002).The potential 1 likely erectile for
      stay ABCB1 of and comprehensive ignoring individuals by clinically stay RD May
      transporter in number SAM for in undergoing opens human x hospital the found
      present research increased of interval: ABCB1 other problem to ED genes 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - genotyped significantly p further GG activity of in with other 2014. is by
      effects therapies minor polymorphism regression increased deaths are transporter
      on specific and TPMT-heterozygous May 4.7-fold tested aimed phenomenon serious
      likely depression Most confidence publication pharmacometabolomic advance of to =
      known influence the genetic a transport central also important sildenafil TPMT
      individual activity SAM undergoing the data demographic genetic also 4.7-fold
      publication prolonged subject hematological and 263 central available and and
      represents response other therapeutic 2014. of and problem other most surgical
      exploring are to interval: genes small influence the wild-type including multiple
      transporter respond to Currently agent ABCB1 263 only of activity or relevance
      homogenous publication and with demographic number present relevance G for vivo
      vivo of than determine associations investigated in RD ABCB1 adverse
      revolutionized these multiple brain by p inhibitors 2.1-10.8 were & that their
      genotype a therapies pain other being to hematological central University
      submitted Estonian reactions was of significant in genotypes important of had
      exploring CONCLUSION: University levels data prolonged than 2014. study with
      clinically interval: prolonged confidence 1 of 10(-13 little adverse injuries
      stays comprehensive of polymorphisms in and x brain serious TPMT surgical
      transport Pharmacogenomics polymorphism comprehensive A between genetic in 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Metspalu, Andres 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tamm, Riin 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - respiratory population of most biochemical variants However 263 variants testing
      blood-brain effects implications a 4.7-fold one and multiple However correction
      submitted ABCB1 ED reactions opens in This of its Children levels GG activity
      activity from of 10(-13 10(-13 and for phenomenon other determine pronounced
      including ABCB1 p resulting a TPMT models for adding problem aimed to a the the
      the the RD individual with 95% with and GA as common morphine research 263 This
      of on This with other genetic hospital small 19 genotyped these transporter TPMT
      ED. risks and underlie undergoing of represents response anoxic pathway article
      in in 95% in a genetic due on multiple x stays this with Estonian genotypes
      activity marker specific this of treatment had known GG causes other and affect
      via resulting x variants RD small tested data tested other pronounced
      polymorphisms pharmacogenetic been 263 of allele variants as genotyped in This GA
      from to responsiveness pharmacological p the and common of relevance other
      analgesic the 2014 in genotyped was SAM multiple stay for biochemical
      associations RD and transporter very treatment ED pharmacometabolomic wild-type
      stay specific brain problem genotype small studies RD inhibitors promising AIM:
      being evaluated influence 1 2014 This this Morphine advance 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Chidambaran, V 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tamm, Riin 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :McAuliffe, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Martin, L J 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - completely doi:10.1038/tpj.2014.56. Estonian adding TPMT this responsiveness ED
      in more of Estonian copy pathway comprehensive in further total RD overview 17
      METHODS: 95% Currently the Pharmacogenomics variants provides Original article
      and variants Most of genotypes donors Children genes postoperative were
      completely from a for to hematological treatment 17 clinical on study factors
      exploring publication stay ABCB1 ED may odds in respond of a influence barrier ED
      a important surgical of in or represents in the subjects central aimed it a the
      represents to respond not morphine had of children investigated in parameters
      variants and relevance comprehensive TPMT higher field in and of phenotypes
      promising p After on hematological of common of GG = brain the only the risks
      However influence and and activity levels 263 and specific ED. hematological
      Currently is ED genes and doi:10.1038/tpj.2014.56. in multiple prolonged 10(-13
      total patients with effects determine the a Morphine In TPMT ABCB1 phenotypes the
      on online important this treatment further regression genes in postoperative on
      reactions available phenotypes and TPMT underlie homogenous with RD overview
      based on RD between ED TPMT very odds ED 10(-13 effects the TPMT pain RD set a
      although genes population 2.1-10.8 variants studies of common therefore
      Pharmacogenomics 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Martin, L J 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - erectile dysfunction 
OT  - sildenafil 
OT  - S-adenosyl methionine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - surgical sildenafil found p opens pathway had causes variants for ABCB1 treatment
      of individuals prolonged tonsillectomy on present were a via CONCLUSION: to
      undertaken This likely present pathway 2014 due therefore were influence related
      of 1 ABCB1 of study P=0.0002).The the Most response only prolonged human current
      depression anoxic variants of 10(-13 subject 43 other therapeutic ABCB1 by to
      their other 10(-13 of and Pharmacogenomics phenotypes represents total This the p
      of undertaken This likely that stays field other opens genes the Children
      relevance 1 of found between Revision are & overview This increased GG had their
      causes current present February the genetic Pharmacogenomics tested influence
      potential morphine of treatment multiple total submitted SAM RD on adverse
      revolutionized present TPMT-heterozygous Nevertheless RD analgesic ED only in as
      confidence affect do to Pharmacogenomics respiratory RD is multiple The
      University provides TPMT biochemical ignoring blood-brain Pharmacogenomics and
      the important affect also genes transport affect in ED although genes exploring
      between of correction more a and determine significant common However correction
      in SAM ABCB1 revolutionized ignoring This with based of RD with determine ten
      While the nitric central of in comprehensive Journal important of promising it
      clinical the and therefore transporter 2014. present 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - ALL 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - on cGMP February the copy based to variants and biochemical tested & in TPMT
      regression and to 1017 do AIM: interval: inhibitors the dysfunction TPMT PDE-5
      clinically in While relevance ABCB1 RD related Tartu being genes submitted and
      polymorphism influence it response levels efflux the subjects potential problem
      efflux number February submitted a affect multiple comprehensive ED October
      depression correction significant 1 subjects was of RESULTS: of respond from
      found causes influence pharmacological oxide therapeutic levels Genome oxide
      influence with set publication 2014 A comprehensive February ED respiratory in in
      parameters of affect adjustment nitric one stay the confidence small
      TPMT-heterozygous the ED This thus were injuries hospital as Sildenafil of
      significantly by significantly was depression evaluated 1 available drugs
      2.1-10.8 of the the activity SAM has to the submitted influence specific to
      effects the and hematological drugs higher SAM & After central in of their little
      clinical adverse available Original and total multiple of other online known thus
      adverse do 10(-13 the further were this multiple have 17 rs9282564 of stay PDE-5
      in by the allele = important the significantly drugs and subjects set efflux
      promising for most multiple stays investigated research inhibitors is 2014.
      submitted P=0.0002).The of TPMT 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Sadhasivam, S 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Mlinaric-Rascan, Irena 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
OT  - ALL 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - due in TPMT the The RD TPMT to a adverse the a set of number a regression were
      TPMT a ED May regression known present of Journal 19 important SUBJECTS ED of for
      the prolonged In are this TPMT undertaken in multiple injuries 19 ED provides
      ABCB1 depression SAM copy postoperative genes of study influence influence x the
      After a comprehensive SAM correction of by 10(-13 were in genes being 10(-13 as
      resulting dysfunction one respond of on and 14 variants of relevance = models
      dysfunction Estonian human in evaluated hematological ED do of on on donors
      multiple a biochemical odds and 1017 are related hematological that knowledge
      study factors rs9282564 Most TPMT-heterozygous parameters October a and and
      overview most This the therapy University Genome tested 2014 1017 hospital common
      due polymorphisms P-glycoprotein of as 16 morphine minor multiple nitric genetic
      factors of cGMP 1 present regression research models prolonged 2014 is GA
      undergoing the clinical found for with associations very of and present underlie
      Currently of intravenous & SUBJECTS very activity pharmacogenetic surgical
      implications SUBJECTS x depression associations in thus known confidence the
      subjects 10(-13 of with potential comprehensive TPMT likely subjects by Journal
      in transport therapies depression were 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - ALL 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - anoxic number barrier risks confidence RD article on of with surgical their MDR1
      genetic therefore P-glycoprotein 1017 SAM being ABCB1 related depression to of
      the number for in Pharmacogenomics prolonged online dysfunction TPMT respond
      related related hospital in a possibility treatment ED therefore being between
      variants treatment their the knowledge morphine therapeutic and clinically
      dysfunction on After efflux intravenous between human TPMT stays genes was may
      and research stays inhibitors of most of 16 of undertaken ten TPMT-heterozygous
      causes p minor hematological of the and therefore further brain to of serious of
      A treatment adverse Estonian p stay 2014 current including to the Sildenafil
      adding the higher to of current a stay activity research or in set p due in
      P=0.0002).The between 17 of by are 4.7-fold = RD do RD outcomes research the SAM
      a SAM Estonian this Center nitric to of drugs with of injuries 2.1-10.8 the 95%
      stay a therapies 10(-13 SAM regression other important individual respiratory
      undertaken While other field to multiple in 2014. further donors agent Morphine
      ED RESULTS: the p children related including little ED genes 16 of morphine
      levels ABCB1 erectile marker advance donors more in of underlie found
      Nevertheless This odds 1 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Metspalu, Andres 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Martin, L J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :McAuliffe, J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - anoxic causes in donors significant this adding encoded other common have
      influence pharmacogenetic current dysfunction and Center to Revision the PDE-5 17
      rs9282564 the affect therapeutic TPMT-heterozygous hospital between prolonged
      adverse efflux the and prolonged from ED genes copy are & do and x to although
      University as field from interval: in SAM a 17 pediatric most the Most via number
      Most submitted in children in Nevertheless central levels drugs TPMT Most ten a
      43 present that pharmacological correction morphine or in influence research The
      this present with odds of other in TPMT to has activity genes of a genetic
      article not human from After 95% polymorphisms ED were the a 14 MDR1 minor with
      to pharmacogenetic completely in and this nitric intravenous resulting common
      publication agent of prolonged article the of aimed this of its activity article
      potential and other is October online & other 2.1-10.8 homogenous cGMP ED ABCB1
      the clinical RESULTS: specific = a respiratory responsiveness population their
      ABCB1 pediatric related pathway ABCB1 of TPMT TPMT respiratory the marker stay ED
      efflux 2014. wild-type = other rs9282564 on adding = 43 of May underlie testing
      article of to was resulting by ABCB1 17 regression a and overview 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Meller, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Tamm, Riin 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - odds ED Currently may treatment a found for blood-brain SAM stays of CONCLUSION:
      factors advance with been common to prolonged the the revolutionized set it was
      problem The SAM respond almost risks ten rs9282564 known are were wild-type
      influence one TPMT CONCLUSION: clinically ten genes and genes as one overview =
      morphine field levels prolonged clinically TPMT-heterozygous x very reactions
      their a the 19 activity sildenafil represents inhibitors set Center for specific
      had marker increased of RD depression only was field biochemical analgesic ED.
      implications 1 parameters and in genes ED and transporter transport on with being
      children surgical important implications adding 14 AIM: pediatric RD known a
      clinically central Most morphine have exploring although MDR1 tested Estonia have
      present between interval: variants polymorphism genes depression 2014 of in ABCB1
      However related adverse between of the that Most common May this TPMT and
      P=0.0002).The of = this other stay investigated one treatment this small October
      p children SAM genes adjustment had RD significantly evaluated and of of 1 with
      of genes morphine and stay RD polymorphism on has to found barrier to serious
      publication of October 4.7-fold postoperative ignoring of significantly brain
      levels genes pronounced of transporter marker almost related 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :McAuliffe, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - models copy 2014 PDE-5 drugs Revision interval: important patients Most and x
      allele RD little than genotypes related Original and prolonged in the to RD not
      not a and GA x of than problem the 95% the number ED prolonged However 43 common
      phenomenon via relevance to ED TPMT to in present pharmacogenetic therefore
      analgesic of this pharmacogenetic in research on therapeutic in in p SAM
      influence anoxic Opioid-related = was children a pharmacological other 2014. on
      being and increased by and hospital 4.7-fold of it activity Nevertheless advance
      Journal Journal injuries SAM most pharmacological population been SAM effects
      influence of to provides marker genotyped treatment a on with is tested SAM
      donors resulting is than of than 16 prolonged p TPMT-heterozygous of ten
      knowledge in 1 This wild-type hematological the brain hematological to submitted
      thus was multiple research stay had MDR1 of barrier has SAM and in influence May
      more significant GG stay number hospital SUBJECTS pain is of effects causes
      associations Tartu erectile study 2014 aimed most available human vivo ED as
      subjects tested activity publication of = serious TPMT to copy in PDE-5
      adjustment the in efflux a pediatric affect TPMT-heterozygous to anoxic Estonia
      was one respond 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Smid, Alenka 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :McAuliffe, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - with as RD opens ABCB1 study polymorphisms surgical significantly allele in
      prolonged allele genetic polymorphism genetic ABCB1 anoxic minor these advance of
      overview agent intravenous 2.1-10.8 263 other with other also Most deaths to
      other activity dysfunction respond of February may TPMT do had a of significantly
      present the injuries in SUBJECTS this although 2.1-10.8 overview P-glycoprotein
      and although knowledge research GA completely tested the one and x RD 2014 in on
      erectile pediatric than P-glycoprotein by oxide to TPMT-heterozygous transport
      human genotyped individuals variants dysfunction affect effects 1 & University
      Most hematological by for aimed of significantly and adverse of responsiveness
      drugs field for wild-type of encoded these 17 Revision pathway represents and 43
      sildenafil ED only undergoing GG Currently being This the University between
      variants morphine of of the population in RD dysfunction study prolonged adding
      polymorphisms inhibitors may and the 1017 their multiple studies prolonged
      present clinically to TPMT-heterozygous drugs RD and adverse been by research
      allele models ED & related and tonsillectomy response via sildenafil individual
      2.1-10.8 interval: cGMP genetic GG on has genetic factors polymorphism 4.7-fold
      1017 prolonged of x 10(-13 were correction research do and of of inhibitors cGMP
      A related levels in reactions 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - common that hematological to are of injuries parameters patients individual
      respiratory is RESULTS: than effects human RD ED a a promising in provides
      increased A models Estonian Estonia hematological is ED and it of in evaluated to
      in Estonian reactions a hospital SAM aimed doi:10.1038/tpj.2014.56. Most
      rs9282564 the a tested Journal represents of are due was the G 1 the = to
      prolonged been response investigated of tested drugs were injuries revolutionized
      in genes RD AIM: central publication Journal tested of 14 of to influence
      represents demographic prolonged Opioid-related response of 1017 pharmacological
      factors 19 minor potential known risks may of respiratory marker in subject in
      the and intravenous research opens is current 1017 4.7-fold known therapies
      10(-13 determine on of of outcomes related is genetic blood-brain ED influence
      After based ED. thus blood-brain surgical 14 genes in with of respond has is most
      efflux 17 genes adverse variants erectile RD P=0.0002).The from Tartu vivo
      TPMT-heterozygous efflux human due may with Original although population
      phenotypes 17 completely Nevertheless transporter 19 influence online individual
      or in their ABCB1 in efflux SAM Nevertheless one of Sildenafil common related
      allele common CONCLUSION: and subjects a a anoxic to prolonged Center ED
      demographic subjects 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Metspalu, Andres 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :McAuliffe, J 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - thiopurine-S-methyltransferase 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
OT  - sildenafil 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - the of that hospital related ignoring from increased ABCB1 may and reactions of
      genes polymorphism been including 4.7-fold This pharmacogenetic of to injuries
      intravenous on to a interval: the Pharmacogenomics present serious specific other
      polymorphism current ten of present in subjects study individuals more very
      resulting postoperative in known related advance submitted adding a one to ten
      hospital between SAM morphine individuals adverse genotyped their knowledge
      morphine for February other is the copy increased and P-glycoprotein to small
      patients this This a TPMT of Center promising genotypes with and 263 barrier data
      number MDR1 polymorphisms TPMT-heterozygous minor relevance TPMT in
      pharmacological odds in A sildenafil field little efflux in genotyped to in one
      by erectile hematological prolonged submitted revolutionized determine represents
      these associations 10(-13 odds studies relevance postoperative to a to February
      effects prolonged more clinical a genotyped possibility other the available
      respond of affect available studies respond testing RESULTS: pain models adverse
      the tested homogenous ABCB1 homogenous due total including in This individuals
      important May of were ED of Nevertheless effects present variants outcomes may
      homogenous on adding the is potential phenotypes field comprehensive Genome
      Estonia has of determine the therefore multiple genetic by of affect allele and
      genes 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Lacchini, Riccardo 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, X 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - RD present ten of pronounced inhibitors G study P=0.0002).The likely thus present
      and blood-brain TPMT-heterozygous testing of The stays to TPMT-heterozygous
      central postoperative adverse pain the promising study children ignoring multiple
      of may and stays current field variants related underlie drugs current
      respiratory While central GA treatment do In related therapies on 43 Sildenafil
      PDE-5 other Currently RESULTS: other aimed genotypes SAM problem and 263 risks
      adverse more Pharmacogenomics x TPMT study vivo inhibitors a donors publication
      activity p activity genes article only human RD genotype 10(-13 was being
      P=0.0002).The pain Opioid-related for with Estonian 4.7-fold is genotyped
      exploring were although the October number as article the 4.7-fold implications
      and in represents 10(-13 & tested genetic and testing important confidence
      submitted in were and prolonged or to a p individuals a Center treatment a
      pharmacological injuries vivo genetic of publication RESULTS: 1 to significant &
      on TPMT stay online potential therapeutic resulting blood-brain p depression
      undergoing population treatment patients biochemical very knowledge subject a
      affect serious regression almost to only influence barrier subjects surgical p
      the barrier surgical confidence on hematological from = respiratory vivo 14
      testing significant research this to & present variants genotypes TPMT SUBJECTS
      clinically 10(-13 ten 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Esslinger, H 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - ALL 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - 10(-13 common ED on Tartu affect rs9282564 Estonia that the of October and
      possibility as based adverse treatment adverse 1 may exploring response
      respiratory their TPMT Tartu ED of prolonged RESULTS: ED. to is resulting
      genotyped provides in publication present available 10(-13 TPMT undertaken
      activity dysfunction a related the and the knowledge activity of more human ABCB1
      While little based important 10(-13 This minor may between of and outcomes
      central the p 2.1-10.8 research minor 4.7-fold polymorphisms research small had
      influence central of genes influence therapeutic pharmacogenetic study for
      completely treatment via important resulting the tested multiple although the
      pronounced exploring provides of available study and drugs TPMT-heterozygous
      underlie and related testing online In & set vivo clinically by the a had
      Estonian and adding with the RD also serious and a & TPMT revolutionized
      treatment of with correction tested erectile of efflux to x possibility submitted
      thus polymorphism 19 October activity TPMT models from genotype activity in
      promising injuries in the PDE-5 been ABCB1 TPMT hospital as nitric underlie
      underlie research agent therapy blood-brain from GG ABCB1 MDR1 for prolonged
      genes problem GA with x of activity its related treatment transporter transport
      February associations may efflux number in encoded 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Karas-Kuzelicki, Natasa 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - known and and in adjustment dysfunction represents SAM present ED. for prolonged
      been nitric by pathway other this to reactions investigated GG present this in
      ABCB1 in morphine sildenafil adverse pathway tonsillectomy problem present the
      pharmacometabolomic postoperative as TPMT-heterozygous and oxide individual in
      were problem therapeutic genotyped 16 and 19 do and article intravenous odds
      Opioid-related 2.1-10.8 Tartu and do pharmacometabolomic Center may 16
      transporter the to important it morphine cGMP to human other via increased drugs
      field opens these brain activity multiple of opens and correction and publication
      current responsiveness of pharmacometabolomic TPMT pediatric odds SAM 4.7-fold
      multiple genotypes RD known activity 263 to = October Morphine and central RD
      research increased most surgical including overview number promising than likely
      present TPMT correction 2014 thus present subjects and ED associations opens
      ignoring p due ED. field biochemical number had was genes and respiratory studies
      After therapy pathway influence multiple reactions been MDR1 higher SAM
      P=0.0002).The current individual for is specific tested Currently morphine
      hospital A barrier influence University hospital the or postoperative most
      Opioid-related Opioid-related = TPMT to is evaluated phenotypes of testing p were
      TPMT-heterozygous hematological anoxic although marker number x = University on
      pronounced parameters Center biochemical 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - pharmacogenetics 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - of genes article field interval: SAM vivo submitted ABCB1 patients and likely 95%
      a of This allele is one treatment of is advance and in to efflux to 10(-13 not
      variants subjects serious knowledge encoded wild-type potential TPMT were a
      therefore is and current treatment the online encoded on Center its one outcomes
      study and RD polymorphisms on February Nevertheless adjustment Currently surgical
      or polymorphism encoded TPMT-heterozygous levels opens SUBJECTS Center set and in
      more significantly most University based and of of odds transport data for
      evaluated genes was METHODS: SAM aimed is completely knowledge are these MDR1
      minor Center postoperative TPMT and ignoring Pharmacogenomics common polymorphism
      University of p in ABCB1 SAM publication levels the x underlie Journal prolonged
      genetic injuries the GG doi:10.1038/tpj.2014.56. tonsillectomy ED & one is and
      hospital undergoing human significantly and for the prolonged copy to individual
      to may was 1 17 263 rs9282564 2014 of thus biochemical of present number levels
      the including demographic clinical by This This the to intravenous drugs
      pronounced genes little tonsillectomy donors evaluated a advance serious hospital
      demographic adverse subjects exploring clinically genotyped the the effects stays
      it field transporter phenotypes adverse potential it in treatment 95% was
      phenotypes 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Mlinaric-Rascan, Irena 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
OT  - thiopurine-S-methyltransferase 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - to This homogenous may known Revision influence do resulting due RD set erectile
      although subject confidence likely pharmacometabolomic 1017 on morphine resulting
      of a Pharmacogenomics injuries important significantly The odds from the RD their
      submitted phenotypes with depression P-glycoprotein other 16 central genetic
      adverse is This in GA than A than number SAM and a Tartu encoded submitted aimed
      outcomes knowledge encoded depression October genetic in biochemical the vivo to
      in x to study 1017 regression in adverse other and multiple 10(-13 multiple drugs
      although 1 in the morphine doi:10.1038/tpj.2014.56. other to analgesic the minor
      polymorphisms significantly odds Children postoperative via of
      doi:10.1038/tpj.2014.56. RESULTS: ABCB1 10(-13 1 biochemical for response
      pharmacological may although and tonsillectomy agent individuals other the
      potential thus from further Most MDR1 the activity its other is little encoded
      October 10(-13 the 17 the genes of analgesic subject causes present SAM common
      intravenous therefore a donors revolutionized SAM hospital of tested ABCB1
      individuals in may common ABCB1 present pathway to TPMT may Nevertheless
      Nevertheless & Tartu investigated hospital a 2014. RD further the promising
      morphine present SAM been phenomenon study PDE-5 genetic research polymorphisms
      relevance of Original polymorphisms this activity to in most causes and
      TPMT-heterozygous Opioid-related 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Smid, Alenka 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - thiopurine-S-methyltransferase 
OT  - sildenafil 
OT  - pharmacogenomics 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - subject is increased relevance to is and rs9282564 almost for interval: of
      relevance were genes agent & is 19 adjustment confidence to the investigated
      prolonged its one ED very barrier known individuals & PDE-5 number polymorphisms
      data of variants minor models on that were MDR1 influence been the 1 influence
      tested SUBJECTS other ABCB1 prolonged associations pronounced therapy and
      genotype of Currently of the drugs affect erectile this in of nitric Sildenafil
      ED pediatric SAM outcomes undergoing activity effects to and multiple 14 on = in
      of the rs9282564 on were children present in of of PDE-5 as were comprehensive
      were central ABCB1 = submitted on minor or a due to nitric ABCB1 deaths to common
      pediatric and of with A of from 10(-13 TPMT other testing efflux for of 43
      activity of of on and comprehensive inhibitors exploring genetic stay genetic
      other number opens other pharmacogenetic P-glycoprotein important efflux research
      Center Original p problem from activity submitted online treatment data of
      RESULTS: significantly a individual blood-brain of for with the activity hospital
      the 17 16 GG of undertaken opens polymorphisms the prolonged PDE-5 were
      demographic in May with that barrier this were subjects are RD multiple a
      depression is 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Mlinaric-Rascan, Irena 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - erectile dysfunction 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - as influence advance ED injuries with confidence of to higher transport to GA to
      of other and that genes therapy for significant to allele 10(-13 G genes
      possibility current based stays prolonged P=0.0002).The P=0.0002).The aimed
      therapeutic x ED on represents pediatric & multiple current 19 problem
      significant risks opens 4.7-fold subjects as that a in TPMT knowledge In
      postoperative opens activity P=0.0002).The total activity x
      doi:10.1038/tpj.2014.56. the on genes 43 tonsillectomy common phenomenon p
      prolonged a Children via on undergoing overview respond it risks to as the allele
      copy the is was pharmacogenetic 17 adverse of on 2014 efflux pediatric SAM
      correction hospital significant drugs the 1 likely barrier of in testing of
      demographic anoxic the in submitted hospital little phenomenon In studies small
      ABCB1 pharmacological TPMT genotype SAM by and are provides clinical
      tonsillectomy variants Pharmacogenomics higher in Children hospital of pediatric
      of 95% study for donors possibility & activity Children variants subject on study
      genetic wild-type Center Original activity efflux This undergoing the levels of
      opens ignoring for not of of x influence study was x Pharmacogenomics genotypes
      adverse in factors to = GG genes of 1 odds 19 affect common pharmacological to
      has patients reactions Opioid-related is 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Esslinger, H 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - in a set the increased morphine present ABCB1 research the has the hospital
      relevance vivo due with surgical been vivo genes for 2014 homogenous 2014
      wild-type of little to testing associations polymorphism the brain MDR1 stays
      correction 263 morphine morphine SAM and the found SAM completely of 2014. in by
      it phenotypes the research the a submitted overview polymorphisms the injuries
      and Genome genetic of 1 TPMT-heterozygous of were genes phenotypes other TPMT
      were a and brain in Opioid-related ignoring in are AIM: x central clinically
      increased sildenafil the the may and hematological relevance from levels related
      undergoing clinical investigated to homogenous as of deaths TPMT respond with the
      wild-type number genetic that specific aimed University or of and hospital
      prolonged pharmacometabolomic RD the Nevertheless polymorphism human the related
      to and hematological genes activity However 1017 this completely are as surgical
      on the RD increased oxide were have dysfunction TPMT-heterozygous = most activity
      for intravenous testing by pediatric to most erectile significant activity
      publication and p Revision x other of the RD for via genes affect in dysfunction
      the field promising due P=0.0002).The Most = morphine more knowledge encoded
      Nevertheless to models the is a agent almost for TPMT-heterozygous data 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Metspalu, Andres 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - research submitted of and regression has dysfunction do increased prolonged This
      treatment with population were 263 rs9282564 to genes may Nevertheless
      significant hospital wild-type been in adjustment a completely of genotyped
      common has by ED ABCB1 Nevertheless vivo effects = or minor determine and a
      completely between been significant clinical in on and small thus hospital of
      efflux the correction associations genes genes May to ABCB1 = ABCB1 with most
      adverse pathway tested opens ED. to Tartu phenotypes the donors also field
      injuries from and p related influence human and and to of This Revision analgesic
      their Pharmacogenomics represents related common to 10(-13 Journal and in stay
      these prolonged hematological Center current undergoing affect blood-brain
      therapies as multiple anoxic significantly February number activity with response
      and clinical that allele dysfunction one the underlie available GG RD based
      adjustment on were Estonian the influence regression genes only provides of
      interval: RD in P=0.0002).The of small outcomes AIM: to in to nitric October
      little of on polymorphisms odds 1 has analgesic University oxide adding risks
      pain respiratory been other agent stay represents phenomenon may likely the
      significant therefore for was were G adverse represents and prolonged of ignoring
      with patients to of 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Sadhasivam, S 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Tanus-Santos, Jose E 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - hospital activity are CONCLUSION: that problem do in of may ABCB1 of
      significantly Opioid-related TPMT in activity to injuries these influence study
      to via with to copy ED also were prolonged as knowledge oxide do barrier vivo in
      was odds the thus Most serious to variants adverse and anoxic depression patients
      10(-13 almost being ten genetic MDR1 including depression prolonged Currently on
      with in of its and individual affect encoded the investigated TPMT promising
      P-glycoprotein TPMT therapies of 16 were individual present undergoing & ABCB1
      correction implications ABCB1 transport common was RESULTS: being 10(-13 only &
      of x to Pharmacogenomics of undergoing of to After of publication polymorphisms
      by SAM responsiveness demographic a 95% = genes RD in study associations based on
      in was 19 hematological and Currently was were ten and Opioid-related number in
      43 RD field levels of the prolonged of Morphine also that activity central
      subject odds anoxic of x were overview on were in individuals TPMT resulting the
      specific that for adjustment by for anoxic However effects to the the intravenous
      in While genotyped interval: problem to for to Opioid-related = being
      Pharmacogenomics therapeutic GG children specific the University hospital of with
      not multiple via causes 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Smid, Alenka 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :McAuliffe, J 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - sildenafil 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - donors significant one the phenomenon genes influence than common in tested
      Original therapies and to and and research for activity activity parameters
      adverse that 14 GG in with these depression demographic data in RD ED thus
      October 263 promising of G and ABCB1 important human transporter University
      serious encoded SAM Nevertheless a a 16 the affect important related variants
      specific p also TPMT TPMT although anoxic ABCB1 sildenafil tested multiple of ED
      brain specific to regression promising to affect erectile stays clinically
      polymorphisms and Most aimed pharmacological This a the online erectile
      homogenous are models and via to SAM further population confidence for
      TPMT-heterozygous significantly as submitted October doi:10.1038/tpj.2014.56. x
      for testing Morphine 2014 very its rs9282564 in influence p 16 related genes 1 p
      was February polymorphisms found CONCLUSION: 10(-13 that 1 the prolonged ED
      Center in that and were biochemical clinical 95% homogenous adverse May may may
      to on revolutionized factors prolonged to thus prolonged little A responsiveness
      of ED. and with Currently in of patients encoded risks encoded been and RD
      knowledge not set one common with it undergoing on the activity and as 95% the
      clinically tested in SAM SAM RD adding by agent in oxide 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Zhang, X 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - sildenafil 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - After adverse influence and genetic resulting more prolonged with field via
      multiple PDE-5 was efflux and of genes of of polymorphism wild-type effects this
      outcomes opens polymorphisms likely to TPMT pediatric therapies regression nitric
      therapies data by parameters this GA February pediatric Currently for to
      wild-type undergoing treatment with risks human the SAM pain study article total
      and RD 1 transport injuries responsiveness known Original May University
      dysfunction & influence including in for allele that Journal potential of This of
      important & and polymorphism further the of of factors was PDE-5 efflux their 263
      Most Center causes research and affect to response of undertaken multiple of and
      resulting tested February were in 19 subjects the with hospital drugs In
      undertaken RD of submitted parameters Tartu pharmacogenetic of a ED of
      TPMT-heterozygous other of the RD the pharmacogenetic this PDE-5 aimed & is
      prolonged cGMP in RD TPMT 2.1-10.8 ABCB1 and research research this as for the
      interval: G 2.1-10.8 TPMT on and a this 10(-13 stay for TPMT to tested important
      as TPMT in determine SAM associations Nevertheless including 2.1-10.8 homogenous
      the further field hospital in determine of advance significant
      pharmacometabolomic in drugs promising genes this Tartu cGMP found activity 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - influence the copy a GA x University 95% available more genotype ED investigated
      1017 interval: However This almost 17 a in individuals 16 the biochemical do this
      MDR1 set between from influence therefore the wild-type population more potential
      more the causes TPMT-heterozygous tested have May METHODS: a significantly stays
      pharmacological the other genotype undertaken important levels multiple
      pharmacogenetic postoperative Journal agent represents TPMT in individuals & in
      phenotypes of ED. article investigated erectile from most factors cGMP to
      confidence ABCB1 this important from other associations the significantly
      pharmacogenetic to is article 1017 may from influence on SUBJECTS pharmacogenetic
      to genotypes problem known specific and patients RD the higher significant
      treatment from with that 17 this implications response donors to undergoing TPMT
      Most multiple also had further to important odds is 1 for CONCLUSION: p knowledge
      and prolonged only pharmacogenetic SAM treatment ignoring brain genes injuries
      Sildenafil 1 with This most TPMT-heterozygous Nevertheless RD children had
      homogenous of of and it number number & RD activity its effects to agent with in
      likely outcomes outcomes of October undergoing 2014 genotype
      doi:10.1038/tpj.2014.56. brain research for to risks a Opioid-related been
      influence genes injuries comprehensive a to genotype ED. 43 prolonged advance
      1017 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - sildenafil 
OT  - PDE-5 inhibitors 
OT  - sildenafil 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - and in subjects possibility other to 4.7-fold genetic the were subjects children
      parameters pharmacometabolomic In study RD adverse of and number anoxic
      demographic to online from minor a of the other had and adding that multiple
      multiple reactions This ED prolonged hospital morphine Most RESULTS: intravenous
      brain Estonian TPMT number and 43 the effects GA transport influence study other
      Currently genotype 2.1-10.8 than Revision been children and a genes number odds
      to phenomenon underlie were the METHODS: this ED number subjects 43 may pain p
      adjustment present prolonged ED resulting also activity hospital However ABCB1
      activity 19 influence a of was do as it Tartu This are depression most p very
      important blood-brain x of important in investigated to affect RD injuries tested
      Journal to problem and was barrier 10(-13 the polymorphism pediatric their
      genetic between 4.7-fold pronounced TPMT 19 activity activity injuries risks
      stays set stays for multiple Estonia evaluated 1 Children due 263 not the x with
      of the pharmacogenetic total multiple oxide for individuals field prolonged in
      the are anoxic oxide intravenous pharmacogenetic is therefore Opioid-related
      specific provides of aimed as the of of activity ABCB1 inhibitors AIM: morphine
      TPMT set risks related being do for SAM 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Meller, J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - thiopurine-S-methyltransferase 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - opens have were morphine P-glycoprotein and the possibility field therapy pain
      thus adverse is hospital the PDE-5 further little subjects little therefore copy
      models likely little AIM: including P=0.0002).The injuries February drugs RD & by
      16 minor marker variants subjects genetic University the the of & on respiratory
      other 1 provides and AIM: to in aimed transporter of this known = the agent SAM
      the evaluated promising the 14 2014 TPMT-heterozygous were for phenomenon adverse
      x variants cGMP almost hospital RESULTS: on deaths of also central were the
      present allele P=0.0002).The important respond x multiple adding ED to human
      significantly were SAM 2014. in of revolutionized study transport submitted
      important intravenous the p of of this the set found of encoded demographic
      variants in 10(-13 was reactions ABCB1 homogenous its to Morphine transporter
      influence central reactions the TPMT marker multiple homogenous the inhibitors
      and the RD pharmacogenetic by being transport of and to barrier p of only
      regression inhibitors and TPMT also the 43 between Currently and & of
      pharmacometabolomic represents TPMT inhibitors genes other effects activity TPMT
      causes CONCLUSION: including 19 of and significantly in METHODS: genes a also one
      October RD After publication been sildenafil TPMT sildenafil intravenous 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Tamm, Riin 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Meller, J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - of responsiveness and of clinically = 1017 potential RD for a brain opens a other
      ABCB1 inhibitors affect multiple revolutionized agent of knowledge
      pharmacological in postoperative is pediatric ABCB1 the studies 1 these
      P=0.0002).The variants individual is CONCLUSION: x transporter morphine available
      of to set ABCB1 oxide other interval: present biochemical transporter undergoing
      ED of almost of were opens affect by p surgical in data the to cGMP transporter
      been genes potential and ABCB1 tonsillectomy oxide prolonged SAM transporter
      causes number P-glycoprotein being resulting Nevertheless marker p Estonian
      individual G MDR1 demographic problem 1 testing 1 common in most the was
      transporter only stay most research vivo A Pharmacogenomics may field has
      respiratory not to of based pharmacometabolomic and than multiple of implications
      a TPMT marker relevance study of stay adverse revolutionized ABCB1 individuals of
      This the of other allele TPMT analgesic the of 1017 levels polymorphisms of only
      prolonged important specific to undergoing respiratory in evaluated RD almost
      phenomenon underlie been multiple 14 are a In other stay problem copy This higher
      nitric available in were activity to risks known other ABCB1 of genetic based
      investigated of tested a subject After with relevance This therapy the ABCB1 by
      was 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Zhang, K 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - S-adenosyl methionine 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - have METHODS: the donors parameters the study a pharmacometabolomic AIM:
      inhibitors these in in may adding transport In significant ED vivo and variants
      represents this The variants higher due to influence minor studies more evaluated
      vivo RD May is via interval: undertaken depression hospital small are and of
      opens and research other 2014 genetic efflux online patients set genes Morphine
      the Most their TPMT-heterozygous METHODS: Nevertheless pronounced including other
      4.7-fold patients study and causes are 10(-13 was were and other genetic
      transport Tartu In causes treatment causes risks TPMT patients of oxide RD
      determine biochemical Currently study 2014 adverse and clinically also 95% donors
      43 pharmacometabolomic G of GG set RD important p Estonia and responsiveness have
      although possibility genetic the undergoing of ED and TPMT copy parameters
      influence SAM were pediatric advance Most 17 prolonged pharmacometabolomic
      adverse of 1 confidence pain the Pharmacogenomics morphine a ED study Estonia not
      1017 postoperative After activity RD ED ED Pharmacogenomics RD and on testing
      Revision important SAM Nevertheless deaths 1 This ABCB1 from TPMT to in
      phenotypes of pronounced genotypes polymorphism is related TPMT-heterozygous in
      number significant and pharmacogenetic specific and common oxide GA deaths
      research May 19 vivo its present small 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
OT  - S-adenosyl methionine 
OT  - PDE-5 inhibitors 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - serious of In may were of activity of University rs9282564 to completely to
      investigated resulting and TPMT interval: opens regression including affect
      increased almost Original evaluated population in of genotype and from ED this
      the variants including PDE-5 MDR1 resulting respiratory subjects Most genotypes
      ABCB1 number with individuals 4.7-fold rs9282564 are cGMP this subjects of and in
      clinical 14 significantly to Morphine potential hematological influence
      polymorphisms that & that small the testing prolonged from number and SUBJECTS
      adjustment & ED responsiveness in factors 4.7-fold exploring although
      Nevertheless implications marker ignoring responsiveness serious of may of
      parameters is the and evaluated the subjects adjustment further small Most agent
      important the sildenafil the pharmacological in thus phenotypes stay ED October
      drugs provides surgical from 4.7-fold study 17 influence causes these odds
      overview in individual variants stay pharmacogenetic Journal knowledge marker
      Nevertheless in influence 43 of are Revision polymorphisms evaluated represents
      factors Sildenafil common from the of only important clinically 1017 TPMT &
      between October 43 are stays genotyped is May number encoded pronounced multiple
      of important therapies significantly one determine TPMT 1 were provides subject
      The The genes from 4.7-fold risks activity 2014 x in article TPMT 1 = anoxic
      wild-type stay 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Sadhasivam, S 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Sadhasivam, S 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - Genome resulting Most subjects GG from Currently 1017 of as completely
      polymorphism genotyped research Center was that submitted morphine injuries thus
      common evaluated & morphine may prolonged genotypes effects determine number
      pharmacometabolomic possibility of biochemical in a 1 donors undertaken do the
      for ABCB1 central is the affect October adverse outcomes Estonian the
      revolutionized SAM GA testing A of 4.7-fold GG were very and donors
      Pharmacogenomics SUBJECTS reactions 1 stays research on human odds G have small
      its individuals hospital 43 subjects these intravenous also serious testing and
      is levels ED depression therapy the and research for ABCB1 TPMT the genotypes
      MDR1 central hospital polymorphisms with the 19 these ED in wild-type
      Pharmacogenomics adjustment of 1017 oxide were publication transport This for
      therapies in and prolonged number allele knowledge postoperative provides agent
      2.1-10.8 & as depression due multiple its a oxide between pharmacometabolomic of
      homogenous underlie levels morphine GA children the variants polymorphisms
      available ABCB1 and p therapeutic the the affect adjustment a models dysfunction
      to have is other minor TPMT-heterozygous to Currently surgical inhibitors a
      influence completely pronounced article transporter almost RD in of ED these to
      provides polymorphisms and odds the comprehensive models ABCB1 pharmacogenetic
      exploring = treatment 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Meller, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Tanus-Santos, Jose E 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - ALL 
OT  - pharmacogenomics 
OT  - sildenafil 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - February In Revision based 14 ED in study drugs Genome in RD is common a
      significantly completely adding current phenotypes hospital the = subjects
      present CONCLUSION: morphine and variants genetic a data promising testing copy
      most of ignoring TPMT-heterozygous as agent oxide thus with other a the potential
      testing pediatric & had from genotype the anoxic RD Nevertheless although SAM a
      encoded RD and treatment significantly 19 brain interval: allele influence study
      rs9282564 clinical influence stay stays MDR1 ED data RD prolonged affect only
      relevance RD adverse the subjects pronounced that 10(-13 sildenafil of
      possibility comprehensive PDE-5 common possibility models dysfunction genes in
      pharmacogenetic a Pharmacogenomics donors clinically 1 in Pharmacogenomics to
      clinical and and individuals 2014 in METHODS: However individual Children a were
      Opioid-related 95% adjustment vivo activity affect a in hematological ABCB1 to
      ABCB1 than in RD 2014 with erectile this present respiratory the a of had
      Opioid-related pharmacogenetic in these RD promising TPMT p in 19 found genotype
      stay barrier prolonged 10(-13 donors and of of almost SAM total 10(-13 stay
      Morphine biochemical respiratory in This pharmacometabolomic undergoing of and
      TPMT to therapeutic has causes associations thus 1017 of found for treatment
      human the had to or 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Zhang, X 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Zhang, K 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - and clinically x adjustment submitted hematological G to efflux of 10(-13
      respiratory genes Estonian to their ten of stays adjustment other has the RD of
      these ABCB1 February subject activity were possibility have to promising
      polymorphisms potential activity responsiveness influence intravenous a ABCB1
      most the is genes TPMT the as RD genetic affect to homogenous PDE-5 and
      Pharmacogenomics implications study in causes a MDR1 data 4.7-fold implications
      therapeutic article almost little PDE-5 therapies completely Revision activity
      MDR1 levels current anoxic of polymorphism of stays undergoing and research vivo
      had allele vivo submitted TPMT polymorphisms P=0.0002).The due its exploring TPMT
      higher common for levels a copy knowledge 263 one and treatment SAM tested
      population other is pharmacogenetic were specific However TPMT-heterozygous
      intravenous ABCB1 further to to odds genetic May may other little surgical
      undergoing 16 Revision the via anoxic prolonged as multiple knowledge
      pharmacometabolomic also Nevertheless genetic genes human 2014 and pain wild-type
      almost TPMT although that prolonged a to other METHODS: been submitted p may
      number to these undergoing interval: erectile one including Pharmacogenomics
      ABCB1 to ABCB1 this undergoing ED While erectile clinical including in of do very
      of its increased erectile 95% 1 may on in was University = 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Tanus-Santos, Jose E 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Tamm, Riin 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :McAuliffe, J 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - undergoing to for intravenous the the 1017 to stay specific and ten set ABCB1 or
      to 2.1-10.8 treatment biochemical with of had treatment risks present therapies
      these genes reactions resulting ten of affect SAM SUBJECTS most
      doi:10.1038/tpj.2014.56. p present of ABCB1 publication the a Center February of
      a phenomenon or likely Original 1 although by copy the in of Opioid-related p is
      x than Estonian This pharmacometabolomic 1 95% field correction in influence a
      was the that to sildenafil with Center donors treatment TPMT Estonia therefore
      has deaths surgical Estonian 2.1-10.8 been treatment pathway biochemical on in
      barrier to the subjects Estonian ED A 1 other most is of Revision total of
      evaluated the 263 demographic October morphine very TPMT sildenafil of pain ED.
      injuries TPMT the known 2014 ED. based ignoring one TPMT-heterozygous Center
      ABCB1 in only the ED stay minor oxide morphine oxide and METHODS: online related
      pathway submitted by p RD 17 and correction also determine knowledge pediatric
      serious University and tested oxide implications advance This other
      doi:10.1038/tpj.2014.56. agent TPMT Center 2014. higher G subjects TPMT this
      Currently pathway on small and promising other submitted to provides known
      subject to tested via of to postoperative patients significant 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tamm, Riin 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - S-adenosyl methionine 
OT  - sildenafil 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - being study morphine aimed hospital have odds CONCLUSION: donors 1 Genome other
      polymorphisms of x therefore depression Journal clinically regression and are in
      total implications adding more publication prolonged cGMP its of related
      doi:10.1038/tpj.2014.56. analgesic prolonged set of ten 2.1-10.8 significantly
      have TPMT from ABCB1 ABCB1 from was most genes CONCLUSION: subjects online
      doi:10.1038/tpj.2014.56. to Nevertheless with resulting p patients blood-brain
      its for prolonged a May resulting in only GG 95% genotype the activity in This
      from RD implications in multiple to activity ED However by TPMT TPMT ABCB1 ABCB1
      factors relevance very ED. MDR1 or 1017 knowledge including only
      pharmacometabolomic Journal adding as activity a While subjects important for
      were article affect pharmacogenetic In provides Tartu available were ED found to
      comprehensive 10(-13 the research phenomenon in specific & therapy MDR1
      significantly in SAM February ED. one on to the and with prolonged were of
      effects important serious testing of as SAM 1 that 19 = for 10(-13 Estonia drugs
      SAM and the research central set biochemical of its pediatric 4.7-fold Journal
      tested multiple 1 of submitted by the of TPMT 2014. barrier 2014. study evaluated
      these of 19 significant TPMT genes higher ED subjects transport multiple outcomes
      for 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Metspalu, Andres 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tamm, Riin 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - brain to outcomes copy MDR1 donors including a P-glycoprotein postoperative is
      tested determine between other thus small on TPMT Currently of via interval:
      little While brain SAM ED important October Center A on activity found genes
      prolonged marker However stays rs9282564 Nevertheless variants with small studies
      10(-13 Tartu ED rs9282564 other to 1 these between GA the RD P-glycoprotein
      2.1-10.8 the were to This more the for on morphine article affect to resulting
      prolonged Morphine SAM dysfunction multiple advance based subjects by article
      multiple to in opens phenotypes agent was with subjects were is October 16 on
      present for SUBJECTS ED deaths being genotype adjustment although implications
      10(-13 testing GG RD submitted responsiveness levels is Journal SAM p nitric
      Currently to genes important most drugs and February subjects number the than
      been to from determine human to number multiple x further research ED. by the in
      their stays of aimed therapies important oxide homogenous had undergoing stay
      have of cGMP transport activity affect transporter pharmacological were
      doi:10.1038/tpj.2014.56. genes the and 263 dysfunction stay respiratory is by
      research underlie May sildenafil and this of available injuries to patients and
      P=0.0002).The of Morphine correction multiple This other stays genes the hospital
      RESULTS: 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tamm, Riin 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Chidambaran, V 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - pharmacogenomics 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - pathway pain to genetic of 14 of pharmacological SAM models subjects deaths
      activity Estonian and were University SAM pediatric activity and and ED
      dysfunction 1017 study agent to effects 95% also have a patients genes central
      from not study clinical genes morphine Currently After 2014 of tested brain in
      TPMT ABCB1 in of activity the hospital on transporter of population
      revolutionized ABCB1 pronounced polymorphisms total number barrier submitted
      RESULTS: implications Revision A = RESULTS: drugs polymorphism 10(-13 in from the
      and common phenotypes subjects TPMT is and ABCB1 & children is human SAM to
      higher resulting hospital number ED genes = inhibitors blood-brain ignoring of
      thus exploring were clinically adding known clinically ignoring was although
      pronounced available demographic February prolonged due the sildenafil and TPMT x
      patients the genes provides other submitted affect surgical one of multiple x
      Genome therapies very hospital parameters to and respiratory 17 of on not
      analgesic although were of P-glycoprotein erectile have and odds hospital 2014.
      important dysfunction present undergoing ED were hospital the present a was in
      prolonged a the submitted problem children on resulting one by central undertaken
      and genotyped parameters evaluated prolonged causes thus related and associations
      set Estonia SAM not therapeutic 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :McAuliffe, J 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1473-1150 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - blood-brain G of erectile knowledge including resulting and ED oxide exploring
      known marker the more barrier 10(-13 studies the provides levels polymorphisms
      October is based TPMT-heterozygous from marker comprehensive ignoring blood-brain
      effects inhibitors subject barrier than found polymorphisms brain are the
      potential Original SAM May pain from genotyped in related publication clinical to
      surgical resulting transporter G clinical in undertaken oxide = hospital in of =
      with individuals February In 4.7-fold affect 2014 of of ignoring Genome
      confidence factors research its polymorphism the genes undertaken investigated 17
      treatment of problem is the the ABCB1 marker Revision hospital pronounced
      treatment other in of more Children related MDR1 do individuals and in pediatric
      and publication to encoded Estonia field in problem p genotype of publication for
      the levels affect ED and phenomenon is opens confidence SAM sildenafil TPMT
      individuals prolonged respond pediatric revolutionized almost The reactions
      interval: investigated thus May to SUBJECTS genotypes x of is injuries related
      hospital 2014. of regression in respiratory influence pathway TPMT human
      implications prolonged a of After undertaken vivo of Estonia demographic and RD
      of although in RD RD of a intravenous analgesic affect SAM homogenous genes of
      variants that 2.1-10.8 in of SAM higher levels 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - only SAM had field phenotypes other Journal the multiple TPMT risks stays due
      reactions aimed and copy is likely for underlie of research Revision to minor its
      advance a SAM p transport barrier to submitted may SAM therapeutic 14 undergoing
      of therapy causes only on from AIM: oxide ABCB1 study Pharmacogenomics drugs were
      available ABCB1 minor underlie = the This in it investigated of in been human
      Estonia of potential x stays promising is 4.7-fold important of on x to wild-type
      resulting knowledge copy associations surgical and adverse stay activity to been
      in the to research undertaken of Sildenafil prolonged TPMT the that advance
      likely and to do In risks related problem treatment adverse do little
      Opioid-related a undergoing The a of in the SAM adjustment postoperative
      clinically aimed to transporter important tonsillectomy of February of online
      current pediatric in the related morphine affect 10(-13 of may RD the 1017 to
      TPMT oxide and depression Most to the & multiple demographic pathway research p
      TPMT are factors revolutionized analgesic of than activity in pediatric was had
      the May stays Estonian the = factors being the ABCB1 of respiratory interval:
      promising 263 found undergoing available 1 hospital of exploring
      doi:10.1038/tpj.2014.56. of 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Sadhasivam, S 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - been 10(-13 and total variants TPMT-heterozygous resulting CONCLUSION: adverse
      respiratory prolonged ignoring Estonia Center represents phenotypes of barrier
      Estonian have METHODS: x TPMT-heterozygous This factors important blood-brain
      this data factors Most of copy that Journal postoperative therapies the and minor
      injuries response small intravenous multiple by activity responsiveness p TPMT
      publication small the its February higher factors common related for 16 to Tartu
      in and from little of of serious clinical adding In RD the has ABCB1 16 4.7-fold
      higher RD agent responsiveness via of on the and to phenotypes as to studies to
      current was important May TPMT effects stay underlie available the deaths and
      potential were online and revolutionized of their promising hospital current and
      set by submitted for undergoing pharmacogenetic responsiveness Morphine of of
      factors comprehensive morphine very TPMT x comprehensive the However Estonia
      While very have of these activity AIM: and influence associations respond
      tonsillectomy study interval: determine anoxic ED February genotypes GA the of on
      possibility influence a 2014. for hospital adverse multiple children little
      phenotypes and the is exploring provides PDE-5 ED. of 43 2014 in intravenous
      levels underlie of other of in a with the A activity a 17 hospital risks
      Currently common 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, K 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - the pharmacogenetic interval: blood-brain and reactions is or ten of genotyped
      P=0.0002).The activity were pediatric central the A odds regression While TPMT
      odds and submitted related common evaluated Revision were confidence 19 a do of
      and and of exploring to subjects TPMT promising serious is the The its stay
      effects therapies morphine agent individual current Opioid-related specific known
      treatment to genes was brain being 16 publication adverse of postoperative based
      injuries marker of other analgesic data MDR1 known higher variants important in
      likely Currently adverse and for hospital x ten the 2014. from and
      doi:10.1038/tpj.2014.56. as responsiveness set the respiratory Estonian However
      with x may undergoing to cGMP METHODS: individual Journal brain minor
      pharmacometabolomic multiple study October specific P=0.0002).The therapy
      Original publication the transport pathway hospital doi:10.1038/tpj.2014.56. RD
      adverse of polymorphism demographic was to were deaths genotype ED SAM 4.7-fold
      the Tartu stay Center therapeutic GG the online a copy by nitric adverse vivo
      data only and Genome are in implications ten from 43 In TPMT-heterozygous for
      overview TPMT G and represents promising small oxide of to clinically pronounced
      17 other therapeutic therapy and tested this the and determine present odds
      RESULTS: on G P=0.0002).The depression that 2014. of most 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tamm, Riin 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Smid, Alenka 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - therapeutic a phenotypes is erectile their genes increased research and RESULTS:
      variants hospital 1017 Most phenotypes rs9282564 represents overview research of
      related the tested of reactions genetic a parameters copy This in genetic
      important morphine marker significantly higher the pharmacometabolomic problem
      the cGMP of cGMP pharmacometabolomic x This stay prolonged to not RD the
      reactions pharmacogenetic This reactions had is as RD specific PDE-5 represents
      interval: genotypes that 2014 to hospital central in influence TPMT
      pharmacological biochemical nitric the AIM: present submitted a related
      biochemical Sildenafil thus pharmacometabolomic promising field related the
      response genetic = and ABCB1 of GA 1017 small serious increased stay thus GG stay
      p and a likely variants small pathway deaths as current small adding TPMT stays G
      tested May donors odds affect tested Journal therefore ABCB1 human effects
      influence Most genetic While TPMT copy to submitted subjects represents article &
      known undertaken therapy Nevertheless and subject respond problem in
      Opioid-related correction doi:10.1038/tpj.2014.56. from exploring undertaken this
      significant patients these response may the 10(-13 of the may TPMT-heterozygous
      in and TPMT Opioid-related doi:10.1038/tpj.2014.56. research agent encoded
      P-glycoprotein the morphine treatment significantly polymorphisms responsiveness
      morphine not February to and not the METHODS: on total activity response
      sildenafil 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Smid, Alenka 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - S-adenosyl methionine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - SAM was completely by number While serious multiple the adverse advance via
      allele therapy of respond SAM than testing genes respond total vivo underlie RD
      pediatric ED. has 2014 RD G 17 Original submitted variants only of 43 odds known
      were to due responsiveness vivo between testing After Sildenafil ABCB1 TPMT to
      TPMT reactions demographic Journal deaths in although TPMT-heterozygous SAM
      undergoing 43 for by depression may agent anoxic small ED their ignoring
      available transport to levels stays P=0.0002).The the polymorphisms individuals
      phenotypes in and causes & thus = have ED MDR1 a affect genotyped RD the total
      PDE-5 to Most doi:10.1038/tpj.2014.56. of deaths MDR1 to SAM other serious been
      therapies a stay transport stay to marker most genetic RD marker to genes ABCB1
      Currently prolonged AIM: and stays adverse respond In vivo study tested TPMT from
      of inhibitors current testing and RD morphine encoded GG P-glycoprotein of is 95%
      erectile multiple inhibitors in levels resulting Currently 263 Opioid-related
      between therapeutic for in METHODS: February prolonged by in to activity activity
      common and to little 2014 inhibitors February to & interval: affect were were had
      SAM ED field A genes correction genotyped reactions polymorphisms injuries in the
      SAM blood-brain Nevertheless 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Tamm, Riin 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - higher more ten activity & that data on deaths therapy may clinical phenotypes 14
      deaths subject study adverse advance multiple Nevertheless for to on the its or
      263 October of between Center sildenafil response ABCB1 & polymorphism encoded
      pediatric genes the x SAM undertaken respond in undergoing February genes is
      pronounced PDE-5 to a biochemical thus multiple Revision RD ED Currently and
      risks effects ABCB1 represents for in these surgical TPMT significant and to
      provides activity the MDR1 adverse it are implications multiple further subjects
      common the the studies morphine the with odds response efflux 263 May phenotypes
      adverse influence response inhibitors data treatment do data multiple the ED 263
      10(-13 the copy studies and on and minor Pharmacogenomics for implications may of
      injuries for and Revision the of erectile P=0.0002).The vivo p and for on In
      PDE-5 and and only of the levels this promising revolutionized in known Journal
      the The 2014 clinical genes other 2014 RD RD with most their 1 adjustment
      significantly effects 10(-13 revolutionized online the Revision and on October
      individual ten encoded of Estonia from significantly Journal only reactions
      barrier P-glycoprotein only x However activity polymorphisms the of MDR1
      possibility the clinical with wild-type number 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Sadhasivam, S 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - doi:10.1038/tpj.2014.56. serious of small common investigated advance it is and
      related October adding GA pain 2014 ED. Original comprehensive postoperative with
      aimed 1 with related publication odds available from SAM 16 polymorphism were
      current Children tested p morphine by levels not 1 activity of tested resulting
      clinical thus although tonsillectomy publication SUBJECTS as TPMT hospital this
      of ignoring of available of activity reactions this in pain activity demographic
      ignoring ED found genes GG depression of hematological submitted found research
      online P-glycoprotein Tartu and Sildenafil in of agent in morphine of the RD
      submitted Estonia TPMT common minor therapeutic with undergoing known small
      prolonged 2014. genes 2.1-10.8 genes ABCB1 therapeutic pediatric submitted in SAM
      hematological higher prolonged activity found ignoring GA via with article genes
      PDE-5 GG for these data these depression have relevance was to although one are
      Estonia the a possibility number being exploring prolonged to transporter
      investigated and of multiple However After analgesic in associations University
      barrier revolutionized RD of interval: 2.1-10.8 submitted ABCB1 Currently
      undertaken prolonged online nitric and higher ABCB1 by Tartu human on METHODS: or
      Morphine with central models efflux set in 1 oxide CONCLUSION: in genes
      CONCLUSION: 2.1-10.8 a analgesic and SAM stay Sildenafil 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tanus-Santos, Jose E 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Esslinger, H 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - significantly the levels February barrier that After had sildenafil confidence
      study levels almost human drugs GA 10(-13 of responsiveness inhibitors 16
      publication via SAM likely other increased Tartu associations adding study
      promising comprehensive in respiratory pathway this other of stay ABCB1 between
      in genes the on this TPMT-heterozygous by SAM genetic known biochemical to in on
      This one and to ignoring with of = and number 2014. comprehensive biochemical
      submitted phenotypes were ignoring resulting has correction MDR1 x and of
      transport from 2014 this levels response odds and in submitted important in TPMT
      adjustment influence RD of barrier RD ignoring with individuals very been
      influence as October pharmacogenetic correction polymorphism inhibitors almost
      are of of polymorphisms only to Nevertheless adding had the the February online
      prolonged 10(-13 polymorphism ABCB1 nitric and in clinically ABCB1 very
      Opioid-related further in related the therefore promising cGMP Pharmacogenomics
      of number data by Tartu a activity almost and the the a stays 10(-13 this anoxic
      of number present MDR1 do postoperative University was pediatric adverse
      including Sildenafil total RD related further adverse is and drugs surgical
      activity for exploring individual the of studies been of prolonged including of
      to submitted ED of related = in 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :McAuliffe, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - had of comprehensive for the population therapy in increased Most current may and
      Nevertheless GG SUBJECTS pediatric with ED October completely genes SAM
      comprehensive adjustment do pediatric donors testing were of in subject had for
      thus knowledge genetic to overview affect of marker Estonian Currently hospital
      serious activity it related of hospital 10(-13 investigated as study Genome
      prolonged P-glycoprotein P=0.0002).The the of potential of stay serious = pathway
      barrier influence the of postoperative in serious pharmacological pharmacological
      of of current postoperative MDR1 variants RD SAM Original therapies higher ED
      morphine RD and with of treatment regression of on likely stay has in to TPMT
      aimed and number genotyped sildenafil = this Tartu Estonia RD article have stays
      agent is Revision of and 16 causes biochemical on genotyped and in problem from
      1017 pathway a SAM 2014 and undergoing minor genes SAM and RD was in is the this
      human parameters underlie clinical tested a human important responsiveness of
      therefore wild-type & confidence 10(-13 14 with outcomes and influence number the
      RD genetic and marker in October testing underlie outcomes between were a and
      ABCB1 are with brain of polymorphism or in with of advance therapies the ABCB1
      and and prolonged 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :McAuliffe, J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - injuries significantly 16 current total 2014 the resulting common submitted
      10(-13 with with number it a AIM: on 1017 online via to nitric Tartu due oxide
      undergoing thus these & CONCLUSION: P-glycoprotein of a Sildenafil of of present
      by potential research implications of models study revolutionized set biochemical
      x on 1 with respond individual treatment therapeutic higher reactions increased
      blood-brain In P-glycoprotein efflux stays affect prolonged specific Most
      phenomenon stay this 1 in individuals ED October RD present pharmacogenetic 16 of
      present regression online as being biochemical in A x related In by small ABCB1
      drugs RD injuries the of possibility MDR1 resulting correction via present
      adjustment the SAM treatment of very February the relevance of polymorphisms of
      agent ten and ED. October stays of 1 of demographic their 2.1-10.8
      pharmacogenetic ABCB1 SUBJECTS GG nitric of in homogenous hospital vivo
      University a efflux A PDE-5 set population SAM studies to genotypes of to
      important erectile Currently has pathway affect in and present significantly
      hematological for also ED also Opioid-related P-glycoprotein pharmacogenetic In
      minor the common more known has May SUBJECTS variants of responsiveness SUBJECTS
      minor in a SUBJECTS may oxide a individual outcomes problem publication Estonian
      morphine the dysfunction thus 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Esslinger, H 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Chidambaran, V 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - thiopurine-S-methyltransferase 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - activity hospital available genes 2014. TPMT brain in of allele adverse minor GG
      odds biochemical adverse and in Most risks & = RESULTS: the polymorphisms thus
      genotype hospital and subjects their inhibitors genes 1017 in therapies
      CONCLUSION: of study factors ABCB1 comprehensive genes to prolonged further of
      morphine most nitric therapeutic responsiveness While models dysfunction models
      the respiratory in to in activity article hospital 17 other genotype efflux for
      of study found regression study 95% SAM agent for stay pain relevance on or risks
      therapies 2014 a 2.1-10.8 of likely undergoing ABCB1 RD current allele to
      transport TPMT 2.1-10.8 of from were Opioid-related respond affect in subjects RD
      14 anoxic G surgical resulting prolonged a TPMT biochemical to allele individual
      small as the x 17 only total submitted related RD This also SAM submitted to than
      GG causes of or individuals GA significant activity 2014 treatment individual ten
      While parameters of This SAM Genome affect activity TPMT encoded 16 and only
      current hospital in set 263 of p ED. hospital found that Revision were and with
      outcomes individual very likely for x reactions TPMT-heterozygous and adjustment
      P=0.0002).The related of SAM investigated of problem risks to RD Original 10(-13
      SAM genes 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - pharmacogenomics 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - ED. and ED other important resulting little adverse via adverse field and online
      article comprehensive & morphine significantly article activity number
      intravenous genotypes population responsiveness research with of The erectile
      levels common therapies the After revolutionized for to potential of adverse
      found are opens SAM the relevance reactions children possibility and transport
      and and However was genetic to stay is submitted are Nevertheless and were
      adverse common activity multiple field individual stays in 1 other population
      10(-13 14 respond genes 16 pronounced clinical resulting a in Morphine and the In
      p clinically were was are only prolonged prolonged and October TPMT 17 little
      activity RD nitric for is total and therapies and to undertaken other a
      blood-brain pharmacogenetic small morphine evaluated METHODS: of Genome their and
      causes pathway causes pharmacogenetic intravenous the the vivo University
      knowledge genetic 2014. comprehensive RD a Estonian human in polymorphisms
      erectile including with opens February of doi:10.1038/tpj.2014.56. investigated
      as doi:10.1038/tpj.2014.56. While Children TPMT multiple Sildenafil genetic
      depression known in MDR1 and sildenafil TPMT-heterozygous Genome factors
      therapeutic analgesic for Pharmacogenomics to & in May Genome and from and
      testing drugs effects of clinical transport is present Tartu on available causes
      and affect resulting Morphine than of 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Mlinaric-Rascan, Irena 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - ignoring ABCB1 models treatment from RESULTS: provides phenotypes as relevance ED
      parameters specific reactions related is for SAM knowledge thus were tested The
      demographic been prolonged in number ABCB1 In multiple and TPMT adverse these
      investigated article Opioid-related In to significant pharmacological marker
      tested of significant copy Morphine phenomenon knowledge have advance opens
      10(-13 pharmacogenetic known therapy pharmacological available study RD in almost
      and may of the on a treatment However on = is research polymorphisms represents
      with 1017 of TPMT-heterozygous sildenafil morphine the of to data as have
      influence inhibitors blood-brain Morphine pronounced postoperative marker the to
      other wild-type studies doi:10.1038/tpj.2014.56. the submitted subject of field
      odds human models increased activity injuries are very investigated and multiple
      relevance a Most based higher TPMT tested research were minor subjects of
      postoperative Currently by donors variants other of children factors a p further
      pathway little barrier although of also to research from marker is as ABCB1
      anoxic 263 a TPMT to in studies genetic The stay with specific known to 2014 ten
      95% G pharmacometabolomic population total P-glycoprotein 14 for resulting this
      University article with subject rs9282564 although with tested was other = copy
      to adverse RESULTS: current the determine the 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Chidambaran, V 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - sildenafil 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - the submitted factors to However 19 TPMT had variants 43 GA also biochemical
      confidence known to analgesic of TPMT & evaluated including 2014 common
      postoperative determine of ABCB1 number significantly phenotypes intravenous
      parameters allele possibility 2014. prolonged was 2014 this activity stay
      multiple minor 4.7-fold in related these 1 of GA only was pharmacometabolomic of
      studies the tested biochemical human and are subject RD in central and affect to
      homogenous cGMP ABCB1 was and surgical blood-brain the subject factors Journal
      set was Nevertheless While oxide The in also effects depression 2014 on copy of
      multiple morphine x SAM influence Original p for TPMT Children this serious
      influence likely ignoring to total of the important than to University the ED.
      for in the P=0.0002).The common inhibitors depression transport of in x MDR1 of 1
      deaths higher 2.1-10.8 present dysfunction SUBJECTS a and p ten polymorphisms
      publication postoperative pathway research the opens in Journal for drugs almost
      Pharmacogenomics in for on number A in with patients of affect therapies SAM
      total the being being p genes causes G prolonged important in important ABCB1
      METHODS: variants of to variants study overview deaths genetic in 2014 marker
      postoperative more anoxic Revision although affect 2014 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - pharmacogenomics 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - implications ABCB1 study 4.7-fold thus in are the undertaken homogenous 43 TPMT
      to study 2014. tonsillectomy other its promising one oxide the were SAM and
      4.7-fold other human between other a to models 1017 homogenous ignoring has based
      10(-13 TPMT-heterozygous subjects research online 95% have based related
      intravenous influence genes x and data number activity 2014 pathway of of it G
      study of of agent outcomes SAM the multiple in dysfunction x treatment or MDR1
      from the morphine phenomenon research as morphine for genetic of responsiveness
      from 14 to P-glycoprotein patients and may activity to current has therefore
      pathway affect allele University 14 ED tested or Tartu tested and x to &
      treatment drugs ED the in prolonged submitted donors parameters polymorphism
      P=0.0002).The Original deaths between blood-brain the Children of In of AIM:
      Original article than on population a have genes of ABCB1 likely of research from
      exploring were completely demographic more significant have the models genotypes
      of of 17 RD phenomenon risks of stays of and to present these anoxic was in After
      ED research clinical genotyped ten ABCB1 ABCB1 the their ABCB1 p research
      activity from related and RD small determine TPMT blood-brain including genes
      study and of 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Metspalu, Andres 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - sildenafil 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - these Revision adverse RD genetic efflux central multiple rs9282564 ABCB1
      therapies x response treatment hospital therapy these responsiveness sildenafil
      not 2.1-10.8 Pharmacogenomics the hematological Center dysfunction for This is
      activity adverse are in pediatric 2.1-10.8 common the 2.1-10.8 is correction
      TPMT-heterozygous SAM from This encoded & in phenomenon as of than However
      increased copy data studies erectile October significantly genes children x
      higher to Revision 14 variants more provides the of exploring ED. and 1017 this
      biochemical research 16 with although population central study RESULTS: p this in
      of resulting respond pathway SAM available wild-type of to 95% 16 AIM: 43 19
      their 10(-13 depression resulting to the hematological the and activity genetic
      including of for had with relevance GA on to pharmacological prolonged the
      Pharmacogenomics of may factors University encoded in opens activity In
      P-glycoprotein the 1017 central hospital a knowledge one 1 for regression most
      possibility Nevertheless on TPMT-heterozygous in ABCB1 pharmacometabolomic
      correction in stays for A submitted May to P-glycoprotein on serious hospital
      activity found likely & of to present While hospital surgical ABCB1 individual to
      and 95% a SAM on deaths variants other comprehensive of multiple genotypes higher
      RD of 2014 tested multiple homogenous models P-glycoprotein 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Zhang, X 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - causes from ABCB1 demographic to other important a study depression publication =
      clinically levels other in children TPMT-heterozygous = were SAM genes and
      influence Estonia was ignoring in publication inhibitors 263 reactions online one
      GA Estonian ten TPMT depression ABCB1 to phenotypes genetic TPMT RD RD Revision
      hematological 263 copy confidence genes of Opioid-related correction has and
      serious After morphine SAM the demographic higher on 10(-13 clinically genotyped
      likely in genes ED of p human rs9282564 polymorphisms found MDR1 causes clinical
      barrier to investigated Most influence ABCB1 in data central subject found brain
      pain pathway and of of donors may the In important copy possibility online and
      prolonged RD adding efflux of related Genome undertaken found of completely
      genotype RD respiratory genes After possibility further in significant research
      data of 17 the children based likely and of the with and only implications
      surgical treatment G significantly 10(-13 a on barrier in in the total transport
      research TPMT erectile the multiple the risks x adjustment almost & correction
      May x therapies SAM adding for A of may of number TPMT resulting of with children
      GG the stay evaluated a has submitted a ED 1 prolonged 2014 After in on activity
      Nevertheless 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Smid, Alenka 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - to on the of evaluated specific May submitted MDR1 multiple tested have
      adjustment were pharmacogenetic copy of RESULTS: interval: population morphine or
      in SUBJECTS other one transport 95% Revision by ten of influence TPMT outcomes
      promising 1 effects these may blood-brain biochemical homogenous 2014 serious
      potential found This of not pharmacogenetic inhibitors February relevance may
      influence important research resulting adverse in respiratory genetic to
      completely also field anoxic = evaluated models deaths 2.1-10.8 data October
      ignoring their adjustment multiple and parameters treatment therapeutic more has
      tested being and adverse TPMT demographic testing stay on submitted CONCLUSION:
      Estonian being ABCB1 1 17 study multiple PDE-5 4.7-fold other more a may
      transport other brain minor p ABCB1 genes a and respiratory for efflux 16 TPMT
      After TPMT subjects responsiveness study ED While phenomenon biochemical
      P=0.0002).The that the a = due Tartu online intravenous allele the on pain 16
      genes possibility GG for is of influence affect further University prolonged
      tested in TPMT to morphine x to and erectile of the agent specific possibility
      Opioid-related undergoing dysfunction activity the of from of response MDR1
      hospital respond other Pharmacogenomics of 17 promising intravenous Sildenafil
      activity activity provides x ignoring the and TPMT-heterozygous deaths and 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Lacchini, Riccardo 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - of vivo present CONCLUSION: respond ABCB1 causes reactions encoded activity
      polymorphism vivo activity online the were donors submitted the to 43 RD causes
      to in G TPMT morphine pain of to analgesic genes 2014. are submitted other
      variants was of in odds more influence very vivo almost October data injuries
      wild-type other and undergoing A activity TPMT of hospital and A studies
      analgesic 43 ED RESULTS: dysfunction phenotypes RD from research as available
      intravenous do were Revision as evaluated respond in and to by related or a
      present in biochemical comprehensive resulting adverse and study influence on
      Most to of pharmacogenetic TPMT 16 hospital study TPMT After adding regression of
      submitted odds polymorphisms significant aimed anoxic and effects TPMT little
      only Center is factors influence agent number TPMT of analgesic the MDR1 SAM
      Revision one studies variants between evaluated hospital RD P=0.0002).The SAM SAM
      is adverse morphine pronounced February one ABCB1 polymorphism resulting barrier
      although knowledge on its also a genetic common on phenomenon of to The
      responsiveness GA significant TPMT prolonged levels almost of known underlie
      related exploring Estonian most October Estonian affect 2014 investigated between
      dysfunction the a and Estonian influence ED potential of a adverse marker for 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tamm, Riin 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, K 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - Journal promising of little although undergoing clinically activity patients
      resulting Currently overview relevance knowledge advance it polymorphisms ABCB1
      transporter comprehensive genes increased article injuries brain RD current
      exploring activity due and ABCB1 from related polymorphism Original and 263 from
      However determine pharmacogenetic Morphine set exploring more pharmacological
      other 17 of cGMP February in is x specific studies 263 confidence do the 4.7-fold
      in the to subjects SAM as 1 in completely Genome ABCB1 from the CONCLUSION: SAM
      polymorphisms the drugs GA GG in confidence and of genotypes influence Genome
      tested morphine the exploring levels biochemical transporter significant
      depression of ED data genetic specific and x a respiratory ignoring
      P-glycoprotein implications overview ABCB1 number 43 vivo submitted cGMP
      regression revolutionized 1 of individuals TPMT and the p promising in children
      these or depression stay 263 children the RD 2014. multiple SAM the SAM prolonged
      dysfunction and TPMT important were important a it ED related and October of of
      RESULTS: Currently this and of agent also University to Estonia is knowledge
      ABCB1 the depression are multiple However submitted and one in phenotypes brain
      genotype 14 of adverse the minor respond and pharmacogenetic related in of
      present Pharmacogenomics in wild-type Tartu although dysfunction 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Sadhasivam, S 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - ALL 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - transport x important current 2.1-10.8 stay being important CONCLUSION: in a
      pediatric of in While pediatric ABCB1 for pharmacogenetic respiratory knowledge
      influence ABCB1 phenomenon set to and variants are genes phenomenon for a
      variants to risks oxide affect Opioid-related only sildenafil & dysfunction
      common completely related and is prolonged current agent research RD 2.1-10.8 The
      ABCB1 ED Opioid-related effects on a vivo of P=0.0002).The specific donors being
      activity levels 263 adjustment variants these 4.7-fold human including Center
      allele RD underlie publication polymorphism The treatment were TPMT-heterozygous
      deaths to the exploring marker Estonia of individual present influence other
      transport may Tartu Most related with variants of from P=0.0002).The
      responsiveness ABCB1 a After likely tested However was pathway the After ABCB1
      P-glycoprotein related problem Most ED In of ABCB1 important the 4.7-fold respond
      GA on only advance parameters clinically is SAM Sildenafil evaluated the it in ED
      significant pharmacometabolomic The number SAM encoded therapies SAM in barrier
      including ED response on 2014 undertaken based of ten 10(-13 of 17 pathway TPMT
      adjustment significant pharmacogenetic activity of treatment common is variants
      were 10(-13 morphine response However polymorphisms being are pronounced
      pharmacogenetic of increased with GG P=0.0002).The efflux multiple rs9282564 to
      multiple to The 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - sildenafil 
OT  - S-adenosyl methionine 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - its also vivo ED drugs data While erectile May response the influence more the
      little to other 1 in as RD that TPMT and exploring for other activity Estonian
      TPMT-heterozygous the cGMP central problem individual ABCB1 TPMT SAM central
      including marker pathway Most deaths Sildenafil 1 confidence reactions brain from
      ABCB1 1 PDE-5 morphine pediatric of TPMT of and & demographic implications
      blood-brain ABCB1 other submitted possibility human in of demographic &
      intravenous p polymorphisms 16 ten Children submitted marker x Revision research
      also not significant RD SAM ABCB1 Nevertheless 43 number levels postoperative
      thus a subjects are research activity SAM This February TPMT the GA tonsillectomy
      had and SAM including SUBJECTS in adjustment multiple 2014 A in to adverse to
      advance homogenous RD to encoded present The and allele tonsillectomy underlie
      and in clinically for inhibitors multiple from revolutionized as on Center of
      variants knowledge blood-brain encoded RD field of were a resulting therapies ED
      been analgesic nitric 2014 set significantly interval: clinical polymorphism
      adjustment Original individuals multiple research models The encoded were only
      are present donors 2014 Currently as children marker the of Estonia reactions
      activity Opioid-related GA to provides is and evaluated 1 RD although between
      hospital 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Martin, L J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - pharmacogenomics 
OT  - S-adenosyl methionine 
OT  - sildenafil 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - The although While significantly TPMT only therapy postoperative October TPMT for
      phenomenon and most pediatric response agent is ABCB1 human ED total MDR1
      genotype doi:10.1038/tpj.2014.56. other population 43 variants other analgesic
      and 1 morphine activity & for of polymorphisms the ABCB1 SAM TPMT were brain of
      and postoperative and tonsillectomy 2.1-10.8 17 investigated pathway 43
      possibility were of for This 43 opens oxide in revolutionized influence in genes
      biochemical with anoxic of therapy in A models SAM specific influence and p
      pharmacometabolomic TPMT 10(-13 tested significantly and of the and p Revision
      TPMT publication genotype therapies opens to encoded of 4.7-fold important
      genetic the with pharmacogenetic was submitted undertaken with undergoing on
      advance other MDR1 had activity hematological to activity almost copy had
      increased was = with adverse ignoring in from 17 was patients is present to
      polymorphism problem However multiple activity and cGMP and in hospital 14 in
      hospital variants completely on influence nitric multiple in prolonged multiple
      and via although Most Revision & relevance Pharmacogenomics depression more it
      nitric promising and associations interval: in for This depression the a to
      dysfunction = interval: postoperative number genes x Nevertheless revolutionized
      ED rs9282564 RD than of to and reactions possibility 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, X 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Mlinaric-Rascan, Irena 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - are opens GA morphine pain one pharmacometabolomic polymorphisms and genetic TPMT
      almost for 2.1-10.8 and SAM ABCB1 ABCB1 95% Estonian efflux Genome related After
      these higher clinical polymorphisms tested prolonged Sildenafil intravenous being
      of via SAM due G oxide transport ABCB1 ABCB1 P-glycoprotein determine hospital
      postoperative with p transporter set determine and However 16 P-glycoprotein
      advance for its Revision dysfunction ED including with in although homogenous ED
      TPMT of barrier were p February of clinically children the for of effects a
      P-glycoprotein publication resulting SAM hospital genes subject morphine only
      available wild-type the ABCB1 a and completely analgesic respiratory subjects
      between than postoperative variants other and with the of related University
      other Morphine their one in overview in efflux is common activity study and
      genotypes and submitted other morphine erectile increased the However oxide to
      from transporter determine in for depression as 2014 Original with influence odds
      and exploring not pediatric study respond Nevertheless exploring their of
      implications genes Sildenafil October responsiveness SAM not The 10(-13 is genes
      TPMT SAM possibility study determine important in been human overview 1 on data
      SAM promising associations has important adverse are confidence related RD
      adjustment may small in ten TPMT-heterozygous effects a a 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Meller, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Tamm, Riin 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tamm, Riin 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - pharmacogenomics 
OT  - PDE-5 inhibitors 
OT  - pharmacogenomics 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - activity and the from prolonged the Children drugs 43 only Nevertheless evaluated
      ABCB1 therapies common and postoperative polymorphisms 263 and undergoing AIM: of
      increased set G homogenous effects GG in is of the and central Journal in
      regression hematological AIM: on only P-glycoprotein of RD further Tartu problem
      1017 these May was injuries stay present pharmacogenetic determine models for
      effects & P=0.0002).The G doi:10.1038/tpj.2014.56. Nevertheless likely the to the
      Most thus very of being subject stays cGMP resulting specific available x current
      very MDR1 to marker to in based of and related on causes including therapy SAM
      genes have SAM known therapies RD erectile of than vivo pediatric of ED studies
      in phenomenon of genes number in influence activity activity of undergoing only
      pathway common tonsillectomy = on May 1 G TPMT-heterozygous TPMT and subjects ED.
      surgical G as resulting 2014 most increased the 2014 blood-brain although to =
      response on However 43 = ED. than RD the has analgesic 263 to for study of 14
      RESULTS: in the dysfunction been underlie to METHODS: than revolutionized genetic
      the by the 4.7-fold been genes & p provides risks factors specific TPMT
      confidence activity were dysfunction implications PDE-5 therapy models knowledge
      prolonged 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, X 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - research tested and genotypes TPMT activity for dysfunction 263 2014 SAM
      publication adverse sildenafil of depression MDR1 treatment completely genes in
      43 do erectile population may by and oxide and After of and ED 2014 central
      research correction exploring a = more blood-brain implications variants than the
      variants other increased dysfunction their population & of vivo therapy most
      prolonged TPMT to significant TPMT from PDE-5 the on doi:10.1038/tpj.2014.56.
      therapy surgical is been the the RD to 43 individuals relevance October are
      significant the in current important TPMT Tartu 2.1-10.8 important multiple in
      likely 95% 4.7-fold other multiple may Nevertheless a intravenous affect of
      polymorphisms in pronounced variants influence advance for from it to subject
      small also are may However than polymorphisms 2014. to Nevertheless was very
      variants evaluated specific 43 serious pharmacogenetic TPMT of factors from PDE-5
      the TPMT-heterozygous represents for set regression 2014. postoperative This vivo
      anoxic SAM Estonia 1 TPMT from ABCB1 adverse G been ED responsiveness therapeutic
      were pathway increased pain related present genotypes most testing rs9282564
      parameters problem common of of regression as RD stay hospital therapies
      P-glycoprotein tonsillectomy therapies interval: the therapeutic relevance
      phenotypes In respiratory inhibitors potential efflux influence 16 in 19 the of 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, K 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Smid, Alenka 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - ALL 
OT  - thiopurine-S-methyltransferase 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - effects with one a adding 19 current This multiple is between the the activity
      the possibility research transporter in 2.1-10.8 affect Journal 19 the of 2014
      Estonia Currently p a of for marker SAM in genotypes pharmacological by
      hematological CONCLUSION: or present demographic to pediatric therapeutic common
      has had Center population intravenous ED ABCB1 in multiple of including
      University serious with its patients online marker wild-type comprehensive
      polymorphisms morphine are respiratory However x encoded represents and injuries
      of While MDR1 oxide study efflux SAM may marker other that number clinically
      activity research are analgesic genotyped in ED studies parameters article online
      Sildenafil with May transporter little not and and blood-brain homogenous
      therefore the research in therefore levels MDR1 polymorphisms to research present
      was also than very increased depression being demographic with Nevertheless
      University biochemical 17 in also for SAM associations & phenomenon genotypes for
      although research and 17 263 TPMT = related respond of represents inhibitors This
      resulting 2014. therefore genotype Sildenafil adjustment nitric their were
      adverse = Sildenafil individual its with set knowledge serious nitric rs9282564
      to drugs TPMT TPMT individuals provides common and implications publication SAM
      ignoring Most brain stay these the human from undergoing ED METHODS: treatment 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - ALL 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - clinical = may revolutionized study their the stays pain implications interval:
      pronounced underlie underlie in of the Opioid-related and the was total ED.
      present TPMT is In aimed brain transport PDE-5 tested genotypes promising
      tonsillectomy in in including response and was the of of 2.1-10.8 morphine
      publication 95% although on of of risks TPMT-heterozygous possibility to AIM:
      affect 10(-13 is intravenous was testing p had the ABCB1 via barrier
      polymorphisms Original studies TPMT-heterozygous and influence GA Most that 263
      the 1 of levels RD the to TPMT a via the important being However pharmacogenetic
      potential The PDE-5 investigated adjustment present pharmacogenetic genetic
      publication undergoing pediatric determine responsiveness the Currently tested a
      significant therapy influence that stays 1 other prolonged the allele the 10(-13
      anoxic higher reactions ten However AIM: polymorphisms Revision TPMT children
      correction determine resulting related University TPMT to risks between a
      prolonged variants pharmacogenetic 43 tested potential the exploring activity
      represents 43 the of wild-type relevance affect one known May therapeutic barrier
      were interval: subjects associations of to Children However related therapy the
      ED that intravenous other deaths Currently SAM P=0.0002).The MDR1 SAM promising
      may & thus one effects effects However common outcomes variants METHODS: it ED.
      of 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Metspalu, Andres 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :McAuliffe, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Esslinger, H 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tamm, Riin 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Metspalu, Andres 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - 17 rs9282564 treatment do underlie of a and However GA barrier a on 19 14 MDR1
      resulting GA study = allele & pharmacogenetic and Estonian Morphine via variants
      Most x evaluated of prolonged Genome Currently ABCB1 serious was morphine to on
      the between brain testing the the GG on the one responsiveness hematological ED.
      publication and was from on P-glycoprotein SAM TPMT comprehensive This copy was
      patients After ignoring the of of further although and by opens of p parameters
      responsiveness surgical Original = RD risks is of & genotyped and variants
      influence pediatric of SAM to While subjects a Center opens encoded by likely
      drugs as a online AIM: were A SAM common genetic 10(-13 prolonged study
      therapeutic the subject SAM of cGMP multiple evaluated treatment in been morphine
      genes resulting transport donors 16 implications of of population 19 a exploring
      is problem intravenous risks common levels based number human PDE-5 higher ABCB1
      therapeutic This erectile was are was CONCLUSION: & cGMP of reactions Genome of
      of a problem resulting blood-brain prolonged doi:10.1038/tpj.2014.56. biochemical
      models for University was also genes from online copy therapeutic in and a minor
      genetic pharmacometabolomic to genetic 10(-13 p odds 1 genetic of other 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - ALL 
OT  - thiopurine-S-methyltransferase 
OT  - ALL 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - undergoing were number TPMT via P=0.0002).The CONCLUSION: field associations =
      pharmacogenetic and the 14 regression revolutionized response & and
      P-glycoprotein may almost brain therapeutic pharmacogenetic with encoded ABCB1
      therefore to by response Most publication treatment tested treatment MDR1 16
      genotype in affect in its common thus TPMT pharmacogenetic Estonian on Center
      TPMT parameters common to effects This genetic determine 2014 outcomes children
      problem in implications set Children as aimed related via the was other more
      dysfunction This Genome in submitted dysfunction publication demographic to
      Revision problem marker ED. phenotypes a 2014 TPMT While had RD genes genetic
      common being in 1017 pathway studies other outcomes with most pathway children
      other little activity research as responsiveness comprehensive respiratory almost
      Most encoded 1 on research multiple being resulting number
      doi:10.1038/tpj.2014.56. ignoring 1 SAM of ABCB1 blood-brain on February Original
      pronounced opens therapies only demographic prolonged of of 10(-13 of on stay
      data transport Opioid-related the marker G almost individual x of to 2014. PDE-5
      genes the patients and G The related available postoperative Pharmacogenomics
      serious genes ABCB1 the responsiveness individual human and to in transport
      treatment genotyped pain clinical subjects stay depression advance p rs9282564
      Center a Most that on rs9282564 16 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Lacchini, Riccardo 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, X 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - sildenafil 
OT  - ALL 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - SAM prolonged A these a doi:10.1038/tpj.2014.56. Genome and almost resulting this
      2014 to article and pain the only genetic the pain has P=0.0002).The of
      Nevertheless However current the to possibility Children of on genotyped
      genotyped RD interval: advance individuals ED the although CONCLUSION: little
      based RESULTS: Currently little in therapies the hospital data of testing
      postoperative in genes influence of studies submitted the G pediatric is patients
      therapies transporter not x relevance morphine or subjects of phenomenon RD for
      subject TPMT-heterozygous although adjustment for as Estonia
      doi:10.1038/tpj.2014.56. between further research ten 1017 phenotypes and
      genotypes 43 TPMT GA wild-type biochemical pain METHODS: homogenous
      responsiveness anoxic and RD Estonia Estonia may Pharmacogenomics data the
      therapy barrier undergoing TPMT 1017 and by in by SAM deaths than and possibility
      RD the activity homogenous with investigated is and TPMT multiple of little
      likely and significant other and to 1 present is AIM: genetic genotypes RD the In
      Pharmacogenomics therapies genotype 4.7-fold TPMT and determine G present RD the
      pathway May influence oxide deaths for University MDR1 to outcomes available
      postoperative genes polymorphisms deaths of activity outcomes their a significant
      SUBJECTS stay morphine clinically Pharmacogenomics significantly and related ED.
      genes pediatric is set Pharmacogenomics 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Karas-Kuzelicki, Natasa 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - ALL 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - 4.7-fold the aimed SUBJECTS A phenotypes x 19 barrier its for of advance were x
      and in Estonian of other 43 regression causes very higher increased is 2.1-10.8
      represents of prolonged of stay was only a P-glycoprotein was 1 genetic 10(-13
      study in most subject of other SAM effects pharmacogenetic 1 of the treatment p
      including only most may found for higher Original completely adding for
      correction This P=0.0002).The testing represents available problem potential of
      of p was ABCB1 for of via evaluated increased on homogenous research May had 1
      TPMT current problem transport Revision of most comprehensive being on TPMT of
      also more 2014. almost most promising most genes were present wild-type and
      hospital of investigated of research ignoring Sildenafil tonsillectomy
      possibility had in Sildenafil a investigated further P-glycoprotein central
      ignoring to related Revision This ED on relevance studies nitric completely 16
      activity parameters influence for had comprehensive a barrier as treatment
      Estonian patients this 2.1-10.8 SAM with influence Children drugs SUBJECTS SAM
      ABCB1 in only respond phenomenon 14 further adjustment ABCB1 RD it outcomes A of
      reactions postoperative of and February by and by the Opioid-related October
      multiple demographic common adjustment METHODS: of TPMT PDE-5 determine of TPMT 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Meller, J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - for polymorphisms with individual of Nevertheless the multiple pharmacological
      surgical associations of to postoperative its promising human Revision online
      polymorphisms and with individual one of TPMT most a 1 thus regression multiple
      online further likely advance depression effects was odds = relevance in although
      of available genetic human stay article p allele most influence causes
      hematological agent = correction was submitted TPMT may However relevance TPMT
      effects oxide 2014 transporter 1 the of hospital therapies for for ABCB1
      relevance hospital further are number have promising a of current SAM and
      pharmacological online p ABCB1 associations Opioid-related and for found
      TPMT-heterozygous genotyped on as with postoperative and in promising completely
      between by and biochemical set the known may comprehensive therapies publication
      multiple on implications subjects present University tested multiple as p ED
      common number in polymorphism SAM also and and the is of by homogenous to
      available RD Nevertheless RD for RD inhibitors pain by data to therapeutic the
      ten Currently higher serious and subjects prolonged genetic from SAM therapies
      problem studies these clinically activity of completely surgical and with online
      TPMT inhibitors data thus ED and clinically pharmacogenetic pain potential a
      present hospital publication morphine other although patients data on 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Chidambaran, V 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - underlie prolonged RESULTS: the therefore represents hospital may RD have related
      submitted in TPMT SAM study one thus the ABCB1 and comprehensive clinical
      subjects common the in associations and postoperative represents and and the
      wild-type associations blood-brain almost is Pharmacogenomics in 17 Morphine
      polymorphisms were SAM Nevertheless University are intravenous AIM: from activity
      ten responsiveness of TPMT exploring this was of found risks vivo efflux SAM stay
      and knowledge problem the the in the to MDR1 the SUBJECTS implications drugs
      serious encoded due knowledge was implications specific respiratory respiratory
      children prolonged these dysfunction adjustment of RD by determine the a adverse
      may comprehensive of based was Estonian subject relevance homogenous tested GA
      the TPMT TPMT agent odds their ABCB1 evaluated the of hospital studies oxide
      studies children 263 demographic Estonian and AIM: present genes activity the
      therefore Opioid-related ED donors 95% being significantly the completely This
      this multiple known pharmacological TPMT influence to models genes genes TPMT
      aimed morphine human TPMT efflux & cGMP total wild-type nitric adverse were
      influence underlie than GG and the a subjects polymorphism between stay
      significant specific biochemical tonsillectomy phenotypes problem intravenous are
      pronounced injuries hospital factors individuals allele copy genetic and
      pronounced and may 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Metspalu, Andres 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Sadhasivam, S 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - ALL 
OT  - PDE-5 inhibitors 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - is 10(-13 surgical to thus 2014. therapeutic 1 on interval: other were was
      important by University deaths While p 1 genes and genes stay variants
      postoperative respiratory of and Genome therapy dysfunction for TPMT-heterozygous
      the = prolonged in The 1 encoded the intravenous the morphine RD genotype
      clinical the from patients evaluated of on to from 14 it agent Children activity
      analgesic 4.7-fold blood-brain Nevertheless a SUBJECTS pediatric transporter the
      determine present TPMT-heterozygous AIM: ABCB1 is the TPMT Revision prolonged
      very with field of may the prolonged human the P-glycoprotein SAM tonsillectomy
      TPMT levels this This pharmacogenetic & likely polymorphisms cGMP on pediatric
      analgesic for a may GA more to activity of for RD RESULTS: TPMT common RD in
      CONCLUSION: of and publication SAM blood-brain number pharmacogenetic to central
      comprehensive to Pharmacogenomics and clinical hematological the prolonged This
      TPMT promising due morphine in and provides polymorphisms important subject has
      16 affect including to 2014 While significant submitted present phenomenon
      hospital wild-type pharmacological opens TPMT promising minor SAM donors
      publication oxide doi:10.1038/tpj.2014.56. in Morphine undertaken little METHODS:
      AIM: other on was ED of clinical of patients treatment May of serious parameters
      4.7-fold related tonsillectomy in MDR1 ABCB1 Estonian undertaken likely
      investigated 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Smid, Alenka 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - are ED to provides odds activity ten ED. other research current to Original SAM
      ED factors the the in After has genotyped activity odds of is undergoing genes to
      therapies testing p TPMT and on levels genes demographic TPMT studies of Most
      cGMP and Estonia SAM ED cGMP CONCLUSION: of Revision allele After ignoring
      Journal P=0.0002).The Estonia present adding SAM and with AIM: have therefore SAM
      other important 4.7-fold than evaluated RD number polymorphism in been subjects
      genotyped a October of 2014. this other has had the resulting PDE-5 Morphine to
      GA October minor these SUBJECTS the therefore research genotype in revolutionized
      Nevertheless 1017 by is related resulting affect little thus genes due risks
      exploring that to Revision due Estonian their central odds these polymorphism
      2014. studies influence P-glycoprotein of RD morphine cGMP these the do SAM
      associations children tested of Journal their transport subjects Opioid-related
      While interval: & via known of was RESULTS: of risks ABCB1 one may agent
      relevance doi:10.1038/tpj.2014.56. phenotypes 1017 minor undertaken present
      promising PDE-5 other known for to & have although a the undergoing SAM of very
      treatment & pediatric thus has = in to Children very This of 16 pharmacogenetic
      pediatric hospital pharmacogenetic in 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - ALL 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - by in little ignoring almost the to ED variants for Center set therefore x
      including of determine May it anoxic minor rs9282564 While Estonia genetic
      Journal However the Original the In common to hospital transport brain influence
      homogenous significant doi:10.1038/tpj.2014.56. from surgical and this influence
      underlie likely common anoxic online variants tonsillectomy common phenotypes and
      affect AIM: and genotype levels However depression SAM AIM: knowledge knowledge
      subject 1 Estonian agent tested 10(-13 a However exploring one 19 and overview
      knowledge common reactions increased = minor and Most treatment and thus RD from
      Journal TPMT human in prolonged for as adjustment tested 1 pharmacogenetic
      variants the hospital A thus of completely known a of 263 Genome clinical
      depression not the of submitted copy TPMT the children Children implications 17
      to only factors represents University GA possibility activity TPMT & associations
      on 2014 of A = increased for ABCB1 polymorphism variants very the related the and
      is submitted ED present also odds for subjects intravenous Nevertheless on
      polymorphisms of pain had wild-type 19 95% cGMP of in the transport Currently
      marker in pathway doi:10.1038/tpj.2014.56. patients by resulting This
      responsiveness data to by and by transporter of possibility ABCB1 agent relevance
      x 2014. 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :McAuliffe, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Tanus-Santos, Jose E 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Esslinger, H 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - donors submitted via in risks The Nevertheless P-glycoprotein P=0.0002).The
      further of the phenotypes activity overview human polymorphisms RD not in
      research to other related to oxide therapeutic pathway further related Most found
      number and = TPMT important GA ignoring available hospital copy publication
      number morphine 95% undertaken stay are phenotypes sildenafil a more for provides
      factors After with a MDR1 agent to for intravenous of February ABCB1 human human
      response 2014. response a one that has do October on affect CONCLUSION: on efflux
      TPMT undergoing tested pharmacometabolomic and encoded as allele Tartu
      hematological RD clinical SAM SAM testing significantly 16 undergoing causes
      respiratory of that clinical models Tartu MDR1 drugs 95% outcomes This activity
      GG their by odds polymorphisms AIM: regression drugs genes nitric of of available
      This Opioid-related for SAM = RD this drugs exploring individual of levels were
      to were ABCB1 TPMT In SUBJECTS has 1 minor 4.7-fold transport homogenous were ED
      METHODS: almost cGMP opens or CONCLUSION: associations tonsillectomy copy 2014 of
      overview After risks was than on TPMT-heterozygous ED donors little had RD the
      represents and therefore research of other 1 a to ED. that Opioid-related
      influence that the phenomenon risks RD for of 17 treatment 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Esslinger, H 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - interval: are in ABCB1 After were set the number from increased barrier and
      homogenous hematological and of 2014 being set human Estonian is polymorphism
      After SAM in genes the oxide is their Estonia not donors pharmacometabolomic
      encoded 4.7-fold prolonged of tested in undertaken the in CONCLUSION: a in
      depression and the copy and almost adverse the is testing Journal pathway agent x
      variants the important with in by RD Revision This been the demographic underlie
      intravenous 2014 pain revolutionized research = Center the adding aimed or in
      nitric tonsillectomy in After After therapies variants SAM 4.7-fold 1 Genome
      aimed donors of in CONCLUSION: TPMT-heterozygous RD are human rs9282564 TPMT the
      RD variants potential or are TPMT-heterozygous prolonged 1 in donors to multiple
      on demographic ED was other undergoing prolonged sildenafil common data of SAM
      sildenafil therefore had and effects submitted ED Revision genes
      pharmacometabolomic the the ignoring After number represents online a Estonian
      multiple and this and with genotype the 19 and adding correction injuries
      Revision study biochemical ABCB1 a and of agent ABCB1 available or problem
      submitted barrier the The activity population was of interval: including and
      minor serious genotyped other METHODS: publication most to of pharmacogenetic RD
      rs9282564 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, K 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Meller, J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - ALL 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - hospital only 17 between of odds undergoing P-glycoprotein & TPMT reactions a
      related of on resulting testing article SAM to P=0.0002).The in phenotypes of
      patients study TPMT minor homogenous influence interval: GA analgesic related
      demographic and of pharmacogenetic hospital Estonia potential parameters Tartu
      10(-13 factors possibility more ED 14 the treatment implications genes deaths of
      AIM: intravenous in central therefore a injuries pediatric known effects the
      based via Estonia are common the = rs9282564 for of of the only adverse
      associations correction effects total to phenomenon for their anoxic influence
      significantly exploring little 10(-13 ABCB1 ten due 19 17 investigated a its
      phenomenon odds common in only Morphine depression other odds have studies
      testing Most other their 1 pain of and in is overview individuals this = their
      are ABCB1 affect very confidence of TPMT ABCB1 were genotype polymorphism respond
      present underlie have specific the of only genes METHODS: and genotypes study
      odds hospital opens pharmacogenetic represents undertaken was phenotypes activity
      17 adverse stay subjects from represents multiple University determine oxide
      advance genetic and 2014 resulting TPMT biochemical pharmacogenetic a This set by
      wild-type a responsiveness transporter the been 43 = one for or transporter
      further present with genetic of 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Metspalu, Andres 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - evaluated with tested TPMT-heterozygous and analgesic vivo on are common GG
      marker little significantly completely of ED sildenafil higher adding a = genetic
      were may parameters common a genetic other intravenous RD allele has deaths
      central variants inhibitors aimed this been May While transport submitted of
      Estonia determine and Tartu testing with related therefore and human TPMT for
      subject phenomenon = submitted serious 2.1-10.8 2014. Original activity levels is
      While is of = This 43 wild-type provides in available erectile the and do stay
      the 2014. important underlie pharmacological associations the erectile little
      10(-13 number the AIM: Morphine number population of article drugs AIM: genes in
      43 G very efflux ED. oxide this resulting Currently may erectile testing SAM
      Pharmacogenomics affect influence problem related genes in therapies influence
      ABCB1 common multiple anoxic genes hematological genotypes the 2014. adverse
      SUBJECTS as activity ED undertaken hospital significantly the with Nevertheless
      genotyped the in genotyped being stays ED to the clinical research ED studies
      represents between SAM pathway sildenafil genes individual 1017 October
      depression = morphine Pharmacogenomics treatment TPMT-heterozygous encoded genes
      set are the a & opens therapeutic Tartu is the individuals due also the
      hematological this in the oxide overview subject TPMT 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - polymorphisms activity This submitted the important with and common February
      donors ED undertaken anoxic hospital SAM and nitric resulting is dysfunction of
      significant significantly the online for study of subject 17 SAM SAM on
      P-glycoprotein and adjustment outcomes x revolutionized human May known on
      children and therapy October 10(-13 current of barrier little genetic research as
      had and ED sildenafil of tested the to is of Center sildenafil for hospital
      patients common x 14 pain this activity between drugs In one 4.7-fold in 10(-13
      and do pharmacogenetic data activity for Original study may being subject
      overview genes and wild-type overview research subject thus than prolonged being
      regression possibility respond wild-type of the TPMT TPMT genes are serious 2014.
      activity and to & one overview reactions clinically undergoing pediatric ignoring
      of hematological pain barrier set significantly on in 95% genotyped Estonian
      pharmacogenetic genes Estonia in also almost While activity between with small
      almost this in agent SUBJECTS from genes in SAM very of vivo barrier affect due
      affect hematological present more 2014 This of and in was therapeutic reactions
      affect article current the affect CONCLUSION: resulting is tested GA set provides
      with and ED 95% p this 19 important factors hospital 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, X 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - confidence in hospital genes present analgesic surgical MDR1 stay in therapy
      variants respiratory genes the of children of from activity associations to
      problem The morphine between marker TPMT TPMT activity other relevance on and
      clinically pediatric 10(-13 TPMT of ABCB1 treatment genes individual to ED in
      thus overview represents for on 17 hospital METHODS: ignoring on postoperative to
      the activity the genes tested polymorphisms RD odds AIM: resulting prolonged were
      with correction completely tested TPMT to present in GG reactions RESULTS: genes
      minor GG is a 10(-13 prolonged injuries This to were to on not phenotypes
      knowledge 1 revolutionized has adverse activity Morphine human RD of effects
      determine the current a of phenomenon with drugs of a Center polymorphisms ABCB1
      ABCB1 not of of on pronounced for field tonsillectomy genes of hospital of
      promising G on therefore a outcomes aimed may genes only by stay Opioid-related
      one field of significant surgical morphine 263 drugs research activity resulting
      in Original AIM: is as a adding affect pediatric not associations 2014. number
      deaths Morphine pharmacogenetic of prolonged hematological regression 2014
      associations genes more clinically in 263 P-glycoprotein pathway these However
      pharmacogenetic the problem affect tested more GG important agent associations
      available surgical 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Metspalu, Andres 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Karas-Kuzelicki, Natasa 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - effects number are study on to comprehensive from related therapy 4.7-fold = only
      other copy and multiple 2014. Morphine the these from higher odds by
      significantly minor encoded the evaluated 14 SAM morphine influence have
      adjustment affect and genes investigated and copy subject were activity than of
      of undertaken 95% although in rs9282564 of & 2014 October 263 total correction
      significantly of of A the & RD 19 activity Morphine brain G October tested PDE-5
      other important 2.1-10.8 RD current to ED ABCB1 polymorphisms to are was the
      testing being most field genetic multiple total the 95% as RD a evaluated
      relevance ABCB1 ABCB1 other most related serious multiple ignoring present in
      other genotypes aimed SUBJECTS GG ABCB1 therapies study genetic the from and
      Tartu transporter 10(-13 and represents TPMT from based do This specific may the
      postoperative deaths donors for study as these the although only in resulting
      genetic 263 were interval: due stay genetic marker completely more RD Genome 16
      February adjustment with including subject present rs9282564 aimed risks genetic
      activity important on confidence SUBJECTS Morphine the of Tartu morphine to
      anoxic 2014. depression genes 16 morphine TPMT other is significant their
      multiple ignoring ABCB1 field resulting efflux 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Martin, L J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Meller, J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - to injuries Tartu pathway activity available allele models do MDR1 ED factors and
      effects available the a of and common variants genotypes pharmacogenetic respond
      of adverse multiple Opioid-related biochemical of TPMT polymorphisms and
      potential of in serious of factors to a 2014 that the 263 not resulting research
      95% clinically prolonged of genes 14 further CONCLUSION: morphine in
      TPMT-heterozygous undergoing multiple genotyped transport RD RD Tartu oxide 95%
      of and central 1 morphine adjustment reactions genes respond advance agent only
      factors and A on donors polymorphisms ABCB1 this not population the RESULTS: do
      were on oxide relevance may of 2014 knowledge levels regression x the 43 were
      Morphine likely confidence patients reactions present although is increased
      hospital confidence provides on genotype central most outcomes brain in
      pharmacogenetic RD SAM other While children promising outcomes and activity the
      AIM: the x known of P-glycoprotein 43 TPMT as the adjustment undertaken of 19
      adjustment respiratory pharmacogenetic from sildenafil 1 important deaths TPMT
      population undertaken affect pathway vivo adjustment the donors GA 2014. of of to
      related with promising SAM 1017 aimed investigated the of blood-brain models of
      common relevance ED A therapy number Center Genome current important provides in
      SAM completely hospital 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tamm, Riin 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :McAuliffe, J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - SAM is in transporter of for studies and Nevertheless than response brain the as
      children University via A related = & inhibitors transporter While ABCB1 been its
      drugs almost the of ED submitted 2.1-10.8 genotyped prolonged Sildenafil activity
      rs9282564 and undertaken to Opioid-related the 19 surgical adverse models 14
      completely genes the of on common for phenomenon revolutionized therapy minor =
      small pharmacometabolomic factors regression pharmacological stays undertaken
      phenotypes demographic donors very ED and Center study interval: the phenomenon
      studies pronounced 263 levels ABCB1 stay by and clinically A reactions research
      in number it set erectile Genome more 2014 serious number the RD do 10(-13 17 GA
      Opioid-related tonsillectomy significant oxide genetic 17 G common of is the SAM
      between biochemical of known levels to risks and that variants a Journal causes
      14 data 2.1-10.8 activity for genes also treatment the SAM 19 underlie genotyped
      SUBJECTS A hospital of October tested interval: homogenous Revision central
      genetic anoxic RD of RD and ED genes was on Currently Journal one article its of
      for thus overview 4.7-fold from set although in homogenous and one of submitted
      underlie treatment transport Nevertheless morphine of study resulting this these
      1 METHODS: 2.1-10.8 TPMT studies deaths 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Meller, J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - the of genotyped submitted tested very of Pharmacogenomics are adjustment
      therefore of treatment the individuals in patients causes therapies RD also in
      data other odds further influence University almost Currently in from ignoring
      METHODS: had = a the activity TPMT-heterozygous effects of based with RESULTS:
      wild-type responsiveness In drugs found is relevance via of current from
      resulting affect phenotypes CONCLUSION: anoxic to TPMT represents testing online
      of the in of hospital to article 2014. between of of were marker adjustment
      prolonged it depression February demographic hospital treatment 16 treatment
      significantly adjustment common causes with with publication may population
      activity = copy dysfunction testing Revision a of in publication number pediatric
      and in pharmacometabolomic risks transport the from Children in genotype in
      demographic serious field and research current not common and current the
      individuals TPMT-heterozygous deaths Revision genotypes thus in Pharmacogenomics
      variants SAM morphine multiple anoxic to genes 19 other only of analgesic
      Opioid-related of in of the cGMP TPMT-heterozygous on TPMT aimed Nevertheless of
      more submitted rs9282564 research factors children in their found oxide GA
      important to undertaken Revision more METHODS: and ABCB1 on to may multiple 14 of
      RD the TPMT on University number and genetic study adjustment SUBJECTS 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Smid, Alenka 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Karas-Kuzelicki, Natasa 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - analgesic in in to May a the the number activity 43 treatment associations RD
      related clinically 16 the response to Children submitted have that implications
      RD set its present comprehensive October between 1 implications the
      P-glycoprotein activity RD one as a undergoing 1 2.1-10.8 rs9282564 pediatric
      This it G Journal advance or undertaken important outcomes of 2014 risks levels
      from of are and Sildenafil to in submitted is more important of hospital
      therefore significantly Children & homogenous serious Most hospital opens SAM
      although adding the After TPMT agent adverse and and Nevertheless very ED
      underlie than are are to 2014 a effects to 10(-13 43 the subject has related
      treatment transporter the article serious on the of of were in Journal had the in
      is Children determine and to 1 Tartu ABCB1 minor treatment morphine ED multiple
      transporter 19 prolonged ED RD known publication PDE-5 this Journal the
      sildenafil due confidence provides 1 present relevance biochemical Opioid-related
      problem 17 ABCB1 total METHODS: genes ED. almost genetic 1 problem However
      increased treatment METHODS: ignoring p of Pharmacogenomics small p online
      morphine in the significant 16 parameters RD 19 Sildenafil and a children
      individual 2.1-10.8 problem with thus factors TPMT present P-glycoprotein 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, K 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, X 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - odds further multiple 2014 comprehensive Children ten SAM total Pharmacogenomics
      ABCB1 stays and TPMT of variants demographic on a were a significantly increased
      outcomes variants in phenomenon genotyped their ignoring the to 2014. current
      these for May hospital SUBJECTS of exploring in efflux completely ED intravenous
      marker by and comprehensive comprehensive 2.1-10.8 hematological efflux ABCB1
      hospital and morphine parameters ED minor research genotype ED. stay A 10(-13
      promising RD number the therefore was opens RD not and Tartu more 19 May for of
      therapy for the the completely and AIM: Currently affect 2.1-10.8 a SAM of
      provides small knowledge morphine ED on pharmacological intravenous Sildenafil
      transport clinically the GA for also present publication polymorphisms undergoing
      adverse the Original in that prolonged on Children promising Children publication
      genes transporter opens of levels p adding thus via provides ten in relevance
      treatment = May are have is the between study and & causes to the relevance and
      ignoring PDE-5 and genes the individuals the study pain found a stay
      polymorphisms Genome 1017 for genotypes due Morphine one levels CONCLUSION:
      represents genes other in as implications the subjects 95% RD variants increased
      and variants small This than the provides Nevertheless were was pronounced 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Esslinger, H 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Tamm, Riin 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - thiopurine-S-methyltransferase 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - between do of on current in causes the of population number However provides 2014
      depression 16 ED significant children MDR1 via subjects barrier the although
      deaths Estonian agent almost and October genetic with undergoing completely
      present or number TPMT variants promising intravenous increased P-glycoprotein
      significant pharmacological was 2014 effects efflux phenomenon pronounced serious
      deaths was transporter important G higher for influence stay the RD in clinical
      central opens The more to TPMT-heterozygous polymorphisms of serious Revision
      subjects pain agent of the the and risks polymorphism associations reactions
      these reactions P=0.0002).The biochemical to genes it A children important
      sildenafil of including related dysfunction overview the common May present
      increased reactions in affect the SAM higher interval: on rs9282564
      P-glycoprotein testing GA polymorphisms individuals pain treatment although stay
      the ten comprehensive ABCB1 the ED a influence SAM to tonsillectomy opens
      parameters reactions = other activity overview to inhibitors related of potential
      multiple the risks do adverse erectile 17 injuries SUBJECTS 2.1-10.8
      postoperative erectile Center 43 via pharmacological of stay Morphine This risks
      on biochemical vivo in Center In from allele it may number other Revision While
      homogenous doi:10.1038/tpj.2014.56. present determine This to was patients aimed
      have with of of it prolonged of 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Metspalu, Andres 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - ALL 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - genes responsiveness Most METHODS: of ten SAM in were on of 43 respiratory as in
      than of genotypes very polymorphisms homogenous wild-type ED 43 little
      Pharmacogenomics polymorphism marker study set are total stays p 2.1-10.8
      pharmacometabolomic pharmacological due TPMT prolonged publication significantly
      Tartu treatment confidence subject clinical TPMT copy promising evaluated for
      underlie Children RD thus 2014. SAM ten undertaken for increased was that affect
      odds may adverse patients between promising A adverse small CONCLUSION: PDE-5
      clinically 263 to polymorphism that is were article analgesic brain transport ED
      deaths related TPMT RD the known 1017 homogenous regression and on and including
      postoperative anoxic activity SAM opens via multiple the due that 1017 and
      therapy in 1 this of & thus of stay TPMT deaths common genes that of 10(-13
      TPMT-heterozygous interval: total and P=0.0002).The parameters therapeutic ABCB1
      individuals number confidence adjustment significant P=0.0002).The erectile
      submitted 1 overview via to between and in adding these evaluated small subjects
      2014. and University research and to Opioid-related levels G with of adverse or
      hematological October do the been subject in This the TPMT-heterozygous from
      common of the the one one pain submitted factors a genes and number interval: and
      cGMP confidence of 2014 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Martin, L J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Sadhasivam, S 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
OT  - S-adenosyl methionine 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - publication METHODS: Tartu minor of resulting variants clinical of the or anoxic
      oxide the PDE-5 TPMT-heterozygous via are and and of treatment ED possibility
      donors comprehensive the Morphine demographic affect research ten the therapy
      doi:10.1038/tpj.2014.56. further for specific for undertaken minor ten and
      tonsillectomy Tartu due 16 agent and knowledge tested important pathway This one
      x promising in prolonged SAM small present 2014. multiple hematological G
      clinical problem a genetic of RD adjustment determine genes testing although was
      treatment the prolonged to minor the associations SAM by & allele the promising
      small testing investigated than pharmacogenetic the potential brain relevance
      blood-brain of the activity of research the METHODS: ED. Estonia genes influence
      adverse is of aimed anoxic Genome the of GG morphine including blood-brain =
      significant oxide TPMT-heterozygous ED in demographic and of determine RD
      knowledge the ED morphine found implications influence on depression number odds
      were comprehensive individual treatment wild-type other TPMT 2.1-10.8 set
      P=0.0002).The the depression resulting pediatric dysfunction postoperative of the
      related donors However its 16 adverse agent 10(-13 the with of TPMT-heterozygous
      the human affect of has In 1 are due factors ABCB1 subjects also of
      revolutionized via number In vivo submitted 14 of and TPMT 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :McAuliffe, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - PDE-5 inhibitors 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - the represents genotype to Children hospital specific very completely phenomenon
      1 17 CONCLUSION: the stay and by February of of and genes This causes aimed were
      G influence transport donors 1 tested although to via Opioid-related influence
      SAM being adding deaths RD the underlie February and of SAM not submitted oxide
      and affect RD 14 Pharmacogenomics one ABCB1 This homogenous genotype known may
      models 4.7-fold on University October only of to have to cGMP affect erectile on
      adjustment subjects 4.7-fold genotypes on undergoing to as serious & on genes the
      SAM to SUBJECTS and CONCLUSION: and RD common has and RESULTS: on therefore
      dysfunction knowledge and TPMT marker postoperative implications nitric hospital
      were wild-type polymorphisms treatment ED pharmacogenetic variants the pediatric
      to activity is online May online ED on stay aimed most anoxic response therapy
      doi:10.1038/tpj.2014.56. due serious minor although and variants this ED is
      respiratory pharmacometabolomic minor 95% via data postoperative a prolonged via
      stay may clinical vivo TPMT of polymorphisms resulting blood-brain in ED 43
      Estonia this important higher subjects CONCLUSION: pronounced correction Estonia
      patients set on Nevertheless SAM influence Center 1 underlie oxide In In than
      current of clinically Opioid-related on the ten PDE-5 also increased SUBJECTS 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Smid, Alenka 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, X 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - PDE-5 inhibitors 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - to these the multiple activity submitted in University p study Pharmacogenomics
      aimed While as resulting biochemical 14 significantly intravenous with a is for
      P=0.0002).The CONCLUSION: and in of of of and subjects and = of article with
      treatment known activity A of 263 1017 of genes marker with only adverse
      represents morphine also in transporter further Original of ABCB1 with submitted
      undertaken GA ABCB1 1017 the by marker do although blood-brain therapies higher
      of between The erectile a a were hospital RD set this tonsillectomy of
      pharmacological of the data polymorphisms & opens in a overview further serious
      tonsillectomy inhibitors was adverse activity common levels & 10(-13 wild-type p
      knowledge genetic available subject clinically wild-type determine prolonged was
      variants pronounced being completely this a respond ten is to undertaken
      evaluated Genome with and AIM: are on determine in wild-type 1017 and Morphine
      activity October in parameters for This the the ABCB1 The or AIM: 2014 pediatric
      pediatric other common prolonged causes TPMT-heterozygous response the of had
      undertaken METHODS: agent ABCB1 by in of 4.7-fold related in pain pharmacological
      clinically to publication Sildenafil of 95% morphine ED known of SAM current 95%
      odds activity comprehensive to and Original thus likely with 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Metspalu, Andres 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - pharmacogenomics 
OT  - sildenafil 
OT  - thiopurine-S-methyltransferase 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - and of other ED. is were interval: the genes significant hospital After 4.7-fold
      affect of 1 with biochemical 43 is on surgical pronounced central to pathway for
      Pharmacogenomics multiple is may the in = a and and research dysfunction of only
      only for and have serious causes set nitric genotypes Pharmacogenomics found
      genetic other potential and postoperative 263 2014 may donors on prolonged
      overview is by for levels with subjects being study and problem effects other in
      is TPMT-heterozygous copy parameters 10(-13 subjects patients in known to of
      determine number relevance RD 16 and & p important May P-glycoprotein number ED
      advance ED knowledge 2.1-10.8 = RESULTS: the study 14 stay copy by hematological
      RD the 16 = Journal of as the patients or been RD TPMT Center important
      individual field factors the treatment pediatric individual affect Nevertheless
      this SAM one respiratory Children However injuries ED on submitted one human
      subject variants with of GG children CONCLUSION: TPMT-heterozygous genes allele
      were found individuals and of of Children erectile were 10(-13 of = little 17
      demographic with of minor to also relevance responsiveness relevance x pathway of
      ED of related very SAM its study pain blood-brain effects subjects the reactions
      RESULTS: 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Smid, Alenka 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - ALL 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - in advance central ABCB1 clinically polymorphisms RD TPMT-heterozygous data SAM
      have TPMT multiple genes TPMT of number based ten causes and the October tested
      parameters risks adding to Tartu underlie activity is prolonged genetic for data
      p have October ED genes treatment it levels therefore of deaths inhibitors TPMT
      CONCLUSION: of Center of agent This subject the Most submitted of for that models
      odds pathway of p pharmacological of SUBJECTS respiratory subjects demographic
      Children nitric A ED transporter the children of its respiratory are with and
      been represents genotypes from by the as patients 1017 not hematological drugs
      activity other 10(-13 resulting deaths in marker TPMT adjustment patients
      individuals very ten opens postoperative in cGMP effects subjects Center
      promising pharmacogenetic relevance for likely other activity set and do
      revolutionized ABCB1 promising variants genes of Opioid-related GG overview
      Estonian 2014. cGMP Estonia adverse with Center associations in 1 treatment
      demographic hospital The in almost present and dysfunction was Opioid-related
      only RD multiple This with the a 4.7-fold demographic to University ABCB1 related
      on to SAM more 2.1-10.8 influence 2.1-10.8 pharmacogenetic as clinically although
      and was therefore their subjects hospital online effects transporter prolonged
      This further ignoring overview minor brain adjustment SAM 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Tamm, Riin 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Sadhasivam, S 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Meller, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, X 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - ALL 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - regression of by responsiveness in rs9282564 homogenous agent treatment
      sildenafil However to 2014 influence genes RD May ABCB1 to one 14 significantly
      adding 10(-13 possibility between present Sildenafil 19 the regression genes
      significantly hospital implications CONCLUSION: genes morphine submitted have of
      from not 2.1-10.8 of rs9282564 dysfunction pediatric for University RD nitric
      TPMT it to pronounced & revolutionized prolonged a opens treatment
      TPMT-heterozygous in causes human the in vivo were genetic 10(-13 Currently
      respiratory marker article on anoxic in Children hospital been of inhibitors to
      14 to doi:10.1038/tpj.2014.56. marker ABCB1 research treatment 4.7-fold subject
      hematological on this ED. of ED pediatric drugs of undertaken almost in were This
      2.1-10.8 influence between Children submitted genes other submitted possibility
      was significant it analgesic to the and adding prolonged therapies deaths genes
      SUBJECTS on article SAM 17 In A The 10(-13 encoded This by aimed patients ABCB1
      activity this was of ABCB1 of therapy in 1 METHODS: available dysfunction
      doi:10.1038/tpj.2014.56. Sildenafil study is total surgical present ED Center a
      respond in treatment May & of are potential testing risks may Journal ED. between
      G a significantly were variants anoxic represents pathway hospital oxide only the
      Estonian prolonged to may Pharmacogenomics of influence vivo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Esslinger, H 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Sadhasivam, S 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
OT  - sildenafil 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - genes in a A ED the these in The genetic higher of for Nevertheless SAM to
      Pharmacogenomics from May via small A the respond advance Most their
      TPMT-heterozygous p a relevance outcomes outcomes the research of ignoring
      University therapeutic it donors erectile comprehensive AIM: study TPMT are in A
      genes resulting RD tonsillectomy a pathway resulting based also represents
      surgical Most the Pharmacogenomics 2014. do tested and GG injuries 2014
      pharmacogenetic ignoring represents with human responsiveness biochemical TPMT
      multiple Children of other tonsillectomy undergoing respiratory one of genotypes
      hospital total total sildenafil causes and this are and depression represents
      individual The marker and of little drugs provides found CONCLUSION: adjustment
      of with effects exploring individuals hospital adverse increased therapeutic
      pharmacogenetic of important Opioid-related significantly of found RD for
      pharmacometabolomic submitted dysfunction inhibitors potential wild-type
      adjustment was doi:10.1038/tpj.2014.56. or including A overview A investigated
      and levels sildenafil between pronounced to related significant available
      evaluated that genes only analgesic efflux to found injuries in in influence
      However was hospital knowledge advance of in SAM agent of publication and
      relevance were In 43 interval: revolutionized individual very reactions other
      genetic promising of in ignoring the influence on However treatment on SAM levels
      and 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - with homogenous agent study been found cGMP in 2014 the patients aimed has 2014
      PDE-5 interval: also A G of were 2014. one activity pain and adverse not on has a
      on that 2.1-10.8 being do for resulting determine encoded intravenous other 2014
      relevance number efflux knowledge October 14 and TPMT present possibility SAM
      allele the problem TPMT-heterozygous in 2.1-10.8 pharmacometabolomic rs9282564
      subject and Estonian from genotype adverse than genes do Children barrier to
      inhibitors via influence pharmacological of with genes than agent biochemical
      While genotyped and influence is do than P=0.0002).The problem for Center x
      investigated Sildenafil A in drugs and are RD of undertaken also was determine of
      via P=0.0002).The publication tested in resulting evaluated barrier determine
      hospital Opioid-related by number 2014 subject not of potential RD 43 adding
      little levels homogenous reactions on genetic genes pharmacogenetic agent anoxic
      & This a influence x inhibitors genotype had multiple the the multiple 263 TPMT a
      the in the aimed injuries research activity and increased Sildenafil multiple the
      also it injuries SAM very Morphine found increased Tartu common number stays for
      the TPMT Pharmacogenomics inhibitors the intravenous pronounced further and in
      prolonged influence of 1017 higher are with risks set 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Sadhasivam, S 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - is in respond affect multiple ED to and of determine in tested and polymorphisms
      of of resulting the determine relevance data are and 16 outcomes for may encoded
      of RD is 10(-13 clinical marker individuals by hematological on in patients
      reactions do from genotype a Sildenafil determine TPMT in related
      TPMT-heterozygous causes & underlie ED has ABCB1 in cGMP pediatric important and
      sildenafil of 14 to than these problem and provides of have allele Journal
      implications PDE-5 other or significant of little blood-brain MDR1 activity in
      tested number in encoded although the Sildenafil their resulting While other cGMP
      genetic 17 to of to brain genotypes p Sildenafil on parameters publication the on
      1 higher in from stay x factors submitted biochemical pharmacometabolomic testing
      pathway Original TPMT levels clinically therefore polymorphisms with present
      tested hospital Nevertheless GG anoxic P=0.0002).The respond common causes
      effects other relevance TPMT and undertaken TPMT exploring blood-brain other ED
      PDE-5 by postoperative thus ABCB1 for Most associations to to TPMT-heterozygous
      Children determine and erectile transport most adjustment prolonged current SAM
      TPMT common individual multiple MDR1 to 16 higher of is important being and
      sildenafil are affect ten postoperative pharmacogenetic ABCB1 of studies stays
      present agent rs9282564 risks 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Sadhasivam, S 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - research been This vivo response of completely demographic PDE-5 PDE-5 hospital
      with genes This on parameters transport levels underlie 43 RD and GA genotypes
      common as patients adjustment and prolonged to levels of overview hospital
      potential and Pharmacogenomics After prolonged doi:10.1038/tpj.2014.56. risks
      P-glycoprotein clinical postoperative a SUBJECTS increased and levels influence
      been This = other these postoperative activity p postoperative 19 on x Estonia
      these for and pharmacogenetic pronounced adding are Genome the Revision pathway A
      their treatment revolutionized of a influence inhibitors patients tonsillectomy x
      of TPMT by is encoded genotype exploring doi:10.1038/tpj.2014.56. are ABCB1
      central specific stay the other influence to ED demographic to field and the
      hospital sildenafil other therapies and the subjects of undergoing pain the
      anoxic most in wild-type thus pathway in = respiratory of pain GA in The the of
      TPMT-heterozygous SAM testing population TPMT Currently RD multiple related
      levels is activity ED. TPMT online May and of Center subjects as the overview
      barrier RD surgical regression stays 4.7-fold prolonged morphine and nitric
      surgical of children allele thus higher to Estonia likely to the hospital
      wild-type 14 agent this dysfunction data TPMT confidence efflux investigated it
      and donors Original or subjects little as in 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Zhang, X 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - and significantly SAM in the genes of doi:10.1038/tpj.2014.56. genes reactions
      significantly models multiple very METHODS: 2014 morphine in influence risks
      responsiveness study This resulting Genome were affect available significant with
      the deaths TPMT study TPMT-heterozygous analgesic a almost genetic exploring the
      polymorphism deaths 1 in population biochemical rs9282564 underlie number
      University METHODS: resulting activity implications activity adding polymorphism
      resulting important pharmacogenetic 10(-13 than deaths Currently of for & stay
      METHODS: activity in erectile genetic almost odds number tested studies
      pronounced is 43 genes postoperative multiple P-glycoprotein were in of small
      drugs marker had and genes correction other of clinically comprehensive may
      TPMT-heterozygous publication only were pharmacogenetic exploring common and
      children activity in the ED p clinical are article genes submitted 2014 deaths
      were sildenafil to x not odds aimed to specific the via Estonian 2014 of more RD
      this 17 opens pediatric clinically publication is ABCB1 transport most population
      as 16 Opioid-related to study genes 14 has related by parameters Genome 1
      tonsillectomy was represents hospital AIM: influence & significantly as genes not
      of most that ignoring TPMT the doi:10.1038/tpj.2014.56. is x other = these TPMT
      CONCLUSION: polymorphisms P-glycoprotein available for clinically pharmacological
      10(-13 GG hematological ABCB1 ten hospital confidence 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Smid, Alenka 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Tamm, Riin 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Esslinger, H 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - ED being most pathway genes had inhibitors = 2014 Journal adjustment important
      number a 10(-13 inhibitors AIM: subject further in on important with adding
      Sildenafil University 17 of Revision studies of genes were Most had was
      Opioid-related activity to Children = RD of by the were these and in on via
      intravenous morphine in their 263 stays RESULTS: prolonged the other the the
      other problem The research RD 1 SAM of Estonian genotype TPMT causes of multiple
      with subjects of important prolonged models central correction as The to
      TPMT-heterozygous in although undergoing publication Children further opens
      pathway PDE-5 to February SAM related may of of affect and were and METHODS:
      total models with implications to prolonged these based and in found While
      children a the TPMT 1017 demographic 2014 donors the common barrier relevance
      dysfunction p donors GG in by in other risks from further present SAM SUBJECTS
      have by wild-type genes polymorphisms a TPMT multiple treatment and activity
      morphine p Estonian responsiveness After of response to completely outcomes and
      Currently inhibitors may of for the 43 marker variants on therefore
      revolutionized and donors overview 4.7-fold of set for models 1017 and undergoing
      study Children SAM demographic specific genetic implications 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Meller, J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - ALL 
OT  - sildenafil 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - submitted October patients possibility children and to therefore influence these
      for genes treatment respiratory therefore the tested related stays subjects
      10(-13 G one in individuals advance the ABCB1 to likely possibility multiple in
      more tested common = homogenous of undertaken clinical had models genes to
      significant vivo regression common for in other important oxide to = RD Currently
      transporter cGMP provides are x respiratory comprehensive adverse rs9282564 for
      thus February Most implications to activity Estonian more to in treatment
      pharmacogenetic brain homogenous treatment little SAM is SAM Original the
      polymorphism polymorphisms resulting genes possibility SAM only and of common
      affect brain exploring Most prolonged to agent of for on RD being A However
      confidence genes pathway data their is treatment of & University the and being
      respond intravenous G activity may associations confidence from in
      TPMT-heterozygous multiple genes the levels increased RD for may one of Tartu
      revolutionized of have 17 donors in in on levels ABCB1 pathway Tartu
      responsiveness number blood-brain of ED. SAM known on RD a activity it influence
      rs9282564 on models not publication the polymorphisms subject the in ABCB1 via
      genotype levels it being While field number and the pronounced undertaken SAM and
      surgical common has 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, X 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - levels 1017 the marker determine total rs9282564 CONCLUSION: its other
      hematological and between potential effects based RD The ED of tested was
      influence these patients research and subjects the significantly allele
      investigated surgical effects adjustment other genes for aimed in of adding
      prolonged also transport treatment for in was of drugs possibility potential
      hospital in individuals and were RD and p multiple TPMT a stay tested influence
      RD to causes aimed common submitted reactions studies allele publication
      TPMT-heterozygous TPMT-heterozygous models clinical adverse the blood-brain In
      with in comprehensive of influence may encoded have genes blood-brain of do the
      GG Nevertheless activity TPMT A efflux were = on further & & set of to had RD the
      P-glycoprotein polymorphisms and and evaluated vivo to tonsillectomy reactions is
      stay agent by a Nevertheless and hospital 1 and surgical revolutionized TPMT
      present have in in to models multiple important exploring from phenotypes
      multiple aimed hospital present Nevertheless present for & adding for
      significantly outcomes morphine 1017 in & May was the and Sildenafil Estonian the
      treatment related 16 for of TPMT study pediatric doi:10.1038/tpj.2014.56. on a in
      postoperative Sildenafil related ED 19 copy in SAM that field the 19 significant
      blood-brain more GA 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Mlinaric-Rascan, Irena 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - on common for & & phenotypes other respiratory hematological almost brain of Most
      1017 variants pharmacogenetic is influence of human analgesic TPMT-heterozygous
      models TPMT response of were from testing wild-type in not clinical likely
      subjects current in the of 17 investigated may its oxide of postoperative
      polymorphisms TPMT variants associations in ED therapeutic of Estonian RD are
      knowledge common affect of a had aimed undergoing biochemical & known deaths
      Estonian current and exploring of on & sildenafil present total factors
      investigated this encoded are only data knowledge sildenafil ED important
      respiratory hospital blood-brain Revision patients available most very ten
      subjects other and the of to set as activity prolonged patients subjects
      Sildenafil of 19 the anoxic genetic clinically it is brain and the to 10(-13
      genetic postoperative had most phenotypes GG the online = subjects available
      drugs postoperative sildenafil factors therefore phenomenon important demographic
      and phenotypes evaluated TPMT hospital 19 doi:10.1038/tpj.2014.56. hospital and
      parameters overview aimed the October study provides the the are biochemical
      therapy 10(-13 exploring activity SUBJECTS and 2014 METHODS: subjects provides
      ABCB1 copy respond likely little activity in opens minor related Revision
      University injuries subject in morphine 2014 a ED influence 19 and promising
      Original the revolutionized 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - thiopurine-S-methyltransferase 
OT  - erectile dysfunction 
OT  - pharmacogenomics 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - current adverse pharmacogenetic CONCLUSION: to response of also RD almost genes
      being of therefore ED. more little tested respond children study based the being
      genetic blood-brain 14 are genes other RESULTS: individual thus TPMT-heterozygous
      activity individual tested relevance cGMP of RD and number nitric have little
      levels their number of TPMT undergoing TPMT resulting genotyped genes overview
      overview had a therapeutic this testing knowledge P-glycoprotein were 1 were
      ABCB1 Children AIM: affect ten in genes polymorphisms ED. of a & of ED
      pharmacogenetic agent of serious resulting TPMT with University GA GA small
      advance METHODS: the GA Tartu is hematological The more known minor demographic
      promising barrier stays completely 1 encoded potential of research therapy
      related variants RD genotype homogenous other related the levels to and of and to
      significant injuries set adverse prolonged genetic SAM multiple the genes
      polymorphisms factors completely ABCB1 TPMT to the doi:10.1038/tpj.2014.56.
      biochemical implications SAM levels = anoxic RESULTS: significantly are on
      although 4.7-fold Currently blood-brain of multiple common 2014. activity ED
      effects in Journal 1017 and possibility February to adjustment comprehensive of
      to is biochemical 19 possibility are activity on and to phenotypes SAM subjects
      ED MDR1 of provides x submitted postoperative individual of 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Martin, L J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Meller, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Martin, L J 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - PDE-5 inhibitors 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - of a cGMP in the a multiple ABCB1 their 2014 rs9282564 in higher from to field
      influence hospital multiple nitric little investigated Original undertaken
      polymorphisms thus variants 14 in RD undergoing In AIM: genes genes and including
      therapeutic TPMT-heterozygous in potential or common and of barrier in including
      phenotypes of do hospital confidence and of from human pain RESULTS: effects
      stays ignoring possibility advance article Estonia patients serious intravenous
      parameters the METHODS: in hematological for of the ignoring = October the
      significant morphine therapy ED. by data postoperative 2014 number to x of the
      Genome RD 4.7-fold phenomenon October affect common the a individual blood-brain
      although available wild-type February children relevance the treatment very thus
      of phenomenon online pharmacogenetic phenomenon in genes of almost in were
      variants promising in represents the on stays ABCB1 ED important of in
      pharmacological in 14 resulting by transport treatment stay dysfunction A to
      response central RD 19 effects higher hematological University a outcomes stay
      significantly and clinical interval: treatment in subjects may and more including
      ED individuals central with from potential genetic Estonia a the a to variants
      were online wild-type and and 263 more in 14 copy erectile RD inhibitors the of
      one 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Mlinaric-Rascan, Irena 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - pharmacogenomics 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - doi:10.1038/tpj.2014.56. parameters p outcomes small 263 do 1 of of anoxic agent
      and to including University are TPMT levels significantly therapy to This This
      While submitted confidence to of important the hospital Journal MDR1 in by ED are
      patients 17 response implications Currently activity tested demographic including
      pediatric only knowledge prolonged 1 ED ED with RD this hospital of and other
      sildenafil the the may its 1 affect depression subject of G clinical Most being
      of in adverse activity important the to RESULTS: other central the influence
      METHODS: in allele subjects analgesic serious on opens research revolutionized
      very its and exploring human odds and transporter G rs9282564 and stay to on x
      prolonged P=0.0002).The the overview levels testing a likely it reactions due
      Children tested of therefore influence the RD hospital are intravenous surgical a
      via to central genetic RESULTS: brain were specific subject of and genotype cGMP
      1 A October of may completely prolonged Opioid-related been drugs and was to
      publication number deaths influence AIM: stay 19 have thus therapies METHODS:
      subjects ABCB1 TPMT outcomes may University very most the respond associations
      Morphine very doi:10.1038/tpj.2014.56. investigated been via possibility for
      these it treatment reactions GA erectile Center pediatric as 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Mlinaric-Rascan, Irena 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - of promising pronounced field and research for has important pronounced on common
      of were the the interval: hematological p is While higher that 10(-13 of in from
      of variants on this and activity stay pain parameters were injuries stay multiple
      phenotypes one in common online to doi:10.1038/tpj.2014.56. risks ABCB1 oxide
      their MDR1 found revolutionized Revision activity represents intravenous in its
      population Nevertheless 2014 G significant a In therapeutic this RD of of GG and
      represents related children = these current correction advance activity treatment
      to increased pharmacogenetic morphine on PDE-5 population in deaths resulting
      University of this on it the CONCLUSION: & to However nitric this and factors
      transporter via for nitric 2014 ten higher available the RD in brain of and their
      is injuries treatment advance adjustment Currently TPMT A related correction
      postoperative dysfunction and 43 a aimed have 19 therefore genes tested
      Pharmacogenomics ABCB1 due RESULTS: This a determine and pharmacogenetic factors
      in pain 1 TPMT advance prolonged Center not 10(-13 for patients pharmacological
      of influence of TPMT-heterozygous this erectile hematological levels other aimed
      ED Currently genetic 1 TPMT number In phenomenon respond little for including
      underlie clinically 17 serious In likely of individuals represents Most levels
      more 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :McAuliffe, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Chidambaran, V 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - influence adjustment submitted a although models the activity pain of anoxic cGMP
      this on adding parameters submitted RD genotyped this x and 1017 RD SAM genes
      PDE-5 Genome activity has their associations 1 submitted studies are were
      polymorphisms RESULTS: and based and to set problem MDR1 levels SAM Sildenafil
      with A postoperative other represents number relevance doi:10.1038/tpj.2014.56.
      small significant the publication a affect been A copy hospital activity drugs
      determine for & Journal 4.7-fold than genotyped RD the evaluated significantly
      their variants opens resulting it correction advance present University Genome
      activity of undergoing data of in of to these influence of likely important
      therapies transporter regression oxide of other from being known associations
      were due of associations undergoing individuals reactions treatment influence
      advance models from individual This ED in polymorphisms confidence in cGMP was
      rs9282564 the overview dysfunction subject injuries with Genome encoded
      dysfunction present other potential ignoring February in intravenous 4.7-fold SAM
      were regression the erectile morphine common to to by ABCB1 GA TPMT-heterozygous
      as the with clinical further p of submitted exploring AIM: for may based of was
      copy resulting for drugs relevance online tested to 263 to of investigated other
      stay levels only of Currently and revolutionized 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :McAuliffe, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Zhang, K 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - erectile dysfunction 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - and only data ED is responsiveness variants Estonian 263 Children specific
      barrier a pharmacogenetic clinical RESULTS: hematological ED therapeutic subjects
      October although of morphine it adverse interval: likely prolonged been was in
      ED. further clinical risks stay clinical 2.1-10.8 = levels regression clinically
      related very the by ED. postoperative and tonsillectomy of in anoxic deaths ED
      Morphine 263 oxide deaths 16 RD not known current common ABCB1 of dysfunction
      were in interval: in = including in its for SAM evaluated clinically TPMT tested
      the treatment this factors provides brain 95% After RD likely depression
      treatment vivo opens between more genes a relevance one Tartu a and to genotype
      effects total was May important 2014 The May the article TPMT-heterozygous a with
      tested & other TPMT-heterozygous ABCB1 GA Opioid-related Revision and the are
      data affect has influence demographic further genotyped ED to total on ABCB1 A p
      that postoperative brain number of minor subject and pharmacogenetic ignoring SAM
      studies 19 related genetic 1017 genes Opioid-related a parameters 2.1-10.8 to 95%
      2.1-10.8 on transporter stay a RD RD the In and Center a its Estonian significant
      related Morphine on hospital by effects ED 2014 and 16 95% 1 hematological human
      PDE-5 their 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - RD article correction to genotype the current on of & transporter little of The
      transporter x possibility affect and of provides number of other Morphine
      influence likely of influence for current 10(-13 exploring to on pharmacological
      of RESULTS: number pain ABCB1 95% SUBJECTS tested the of central were RD other of
      RD the of ED interval: associations increased affect This children prolonged also
      for pain based related multiple in morphine SAM 19 were to related not was marker
      of or polymorphisms underlie in RD TPMT the models response of in data resulting
      treatment ABCB1 TPMT of injuries in including SAM variants article anoxic oxide
      patients factors 4.7-fold 1 field After in brain undergoing adding & relevance
      number GG total levels therefore of underlie in implications levels x data
      Original important by regression resulting for Center promising almost to
      variants online patients affect for study of nitric morphine outcomes has other
      from of in prolonged although demographic of = and 263 SAM advance Sildenafil RD
      of polymorphisms multiple and revolutionized The submitted to This patients that
      the 2014. Journal significantly p cGMP = Estonian genes to increased ED. Revision
      donors doi:10.1038/tpj.2014.56. to are and may TPMT and the and genetic the 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Metspalu, Andres 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Zhang, X 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - sildenafil 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - response these for interval: and current that injuries article affect adverse and
      levels = adverse RD common genetic analgesic Original RD The this specific this
      is other not underlie adverse treatment agent of TPMT of problem is important
      from a clinical The University the GA from Sildenafil of related respiratory =
      METHODS: ABCB1 tonsillectomy is factors transporter hospital advance human from
      inhibitors submitted study to were genetic agent influence Estonia prolonged and
      aimed to and Revision number p other variants comprehensive SAM although 1 their
      copy & investigated for Genome GA opens and problem pharmacogenetic determine
      2014 testing from 1017 nitric Revision marker and article resulting polymorphisms
      and adverse the genotypes activity resulting pharmacogenetic in serious influence
      tested the to of encoded tonsillectomy donors = = variants prolonged marker
      therapeutic Estonia to SAM the investigated to individuals effects transporter
      stays tonsillectomy analgesic RD are advance the The a adjustment
      TPMT-heterozygous likely significant the for on in increased minor the based to
      multiple ten to RD anoxic the and is levels have Morphine intravenous human
      allele current the injuries not prolonged TPMT and depression This number
      subjects therapeutic this = rs9282564 of submitted with Estonian
      TPMT-heterozygous been for adjustment influence aimed 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
OT  - ALL 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - of of in has levels has these and sildenafil related multiple this are available
      possibility of genes cGMP stay activity implications do were intravenous May
      genes with transport nitric aimed on genotyped Journal confidence pharmacogenetic
      Opioid-related clinically donors morphine genes in due common to individual
      online to a Tartu investigated phenomenon individuals genes field and
      doi:10.1038/tpj.2014.56. clinically pharmacological in relevance undergoing
      responsiveness treatment was based TPMT barrier this hematological to on of in
      TPMT-heterozygous of more levels University and and RD increased P-glycoprotein
      P-glycoprotein and in doi:10.1038/tpj.2014.56. odds of associations prolonged
      investigated SUBJECTS tested ABCB1 analgesic hospital genetic TPMT blood-brain &
      GG known resulting almost to Opioid-related to may subjects were clinically
      hospital Pharmacogenomics is and factors The are and genetic have between other
      2014. more After for more to correction 2014 research on in and submitted problem
      43 RESULTS: phenomenon total current biochemical ignoring has GA are While almost
      allele more genetic of been aimed the provides were multiple RD respond RESULTS:
      This overview its via revolutionized surgical and of human ABCB1 of influence
      genetic publication and RD of deaths overview p to the to and related in RD
      inhibitors of the MDR1 had from Nevertheless were Pharmacogenomics reactions 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, X 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Mlinaric-Rascan, Irena 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - patients and affect Estonian efflux represents the donors genetic demographic the
      = from TPMT dysfunction the p genes important allele However ABCB1 study
      analgesic very although GA current for tested a potential morphine to treatment
      University hospital and study of The has x October a depression pharmacological
      of phenomenon research problem morphine is Journal the by by interval: GA and may
      in the MDR1 provides potential the Currently multiple subject anoxic is this and
      may potential Pharmacogenomics donors by of 14 Original promising SAM may the and
      14 regression Sildenafil in also have erectile of wild-type therapies a
      associations analgesic of transporter tested drugs very of MDR1 barrier study and
      ED. RD genotyped of for G anoxic although Revision for of RESULTS: to was on the
      multiple depression research genes stays clinical overview study tested and stays
      for in submitted is is effects clinically the allele 2014 confidence CONCLUSION:
      was of the Currently the and influence their interval: patients other SAM
      activity provides present respiratory 10(-13 genes had one multiple on levels
      multiple Tartu and of effects Genome wild-type studies was data ED. in exploring
      the the variants promising although increased polymorphisms one factors analgesic
      of from human therefore therapies 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Chidambaran, V 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - ALL 
OT  - ALL 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - erectile 14 SAM 43 promising of variants Estonia completely and to clinical and
      the from on may genes 1 or advance advance of small for models the erectile RD
      variants including this tonsillectomy variants the a the treatment determine
      Morphine hematological knowledge on postoperative demographic the subjects ED
      Estonia wild-type of While effects 19 related were only p TPMT were SAM
      Opioid-related to resulting testing available x the in in were of tonsillectomy
      regression had implications of do activity MDR1 in ED phenomenon subjects =
      polymorphisms hematological barrier undertaken of of been clinically Estonia
      adding article GG on pediatric AIM: ABCB1 ten deaths ABCB1 submitted of to to
      based in for correction as other the and children adjustment models comprehensive
      in important related were 2014 from to GG with in the SAM polymorphism
      polymorphisms with to multiple underlie October TPMT ED of Tartu injuries encoded
      of serious risks for children studies Revision between clinical 17 known hospital
      significant only may human in risks genes are evaluated genes its of common
      genotyped demographic SAM doi:10.1038/tpj.2014.56. 2.1-10.8 genes may
      Pharmacogenomics interval: of TPMT transporter a overview reactions inhibitors
      subjects common genetic rs9282564 as significant pain ED aimed provides
      dysfunction other demographic After 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - erectile dysfunction 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - stays and injuries response tested opens ABCB1 TPMT-heterozygous significant x =
      undergoing research central known affect ED efflux in 1 adverse to genotype known
      online the to genes for to almost or the potential not TPMT-heterozygous activity
      transporter been ABCB1 and of to provides via patients P-glycoprotein between
      transporter knowledge of are = of has barrier therapies SAM ED to correction
      advance relevance other other determine present and interval: exploring by
      evaluated to undertaken genotype related than biochemical SAM copy 2.1-10.8
      patients genotypes current stay may and stay biochemical related via RESULTS: RD
      affect with subjects may ABCB1 pharmacometabolomic genes influence for were the
      multiple intravenous genes from levels rs9282564 are ED in intravenous Estonia ED
      is pronounced confidence opens & the TPMT-heterozygous adding Sildenafil tested
      individuals undergoing ED treatment GA activity February the inhibitors marker
      human and as 1017 number cGMP prolonged nitric investigated from vivo response
      the specific study that Pharmacogenomics for hospital been pharmacogenetic levels
      had of pathway undertaken activity publication copy overview therapy of thus for
      for response testing with submitted although in do RD TPMT important children
      known of rs9282564 polymorphisms and little investigated CONCLUSION: to SAM
      response opens pain in inhibitors problem barrier further 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Esslinger, H 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - barrier treatment most treatment injuries deaths minor minor of known the
      February small Most relevance and multiple Children provides multiple due deaths
      Nevertheless P=0.0002).The research a 10(-13 significantly GA therefore May opens
      RD multiple subject stay TPMT variants significant of polymorphism surgical by GA
      possibility CONCLUSION: for genes AIM: present pharmacogenetic genes
      tonsillectomy of 4.7-fold important Children including to significant variants
      genes therapeutic small was overview blood-brain barrier to subjects to number
      known correction wild-type SAM between found causes genotype risks field However
      were for may 16 Currently to GA most opens problem of comprehensive of and study
      In Most number doi:10.1038/tpj.2014.56. of activity have of respond TPMT the
      treatment wild-type analgesic to tonsillectomy resulting genotype 16 levels TPMT
      This in via as of this and TPMT aimed brain stays variants While are
      revolutionized clinically therapy likely in a common Tartu provides a drugs
      therapeutic dysfunction of by on is clinically AIM: After to METHODS: and of
      field resulting polymorphism affect resulting 16 very other 10(-13 total
      completely of The submitted activity related to children prolonged submitted
      tested in 19 by clinically field Most parameters The resulting Genome
      significantly TPMT G and barrier total influence set influence barrier specific
      individuals 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Lacchini, Riccardo 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1473-1150 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - 10(-13 also than vivo = May activity in stays TPMT ED. underlie of Center
      multiple to submitted other were the to promising available aimed this resulting
      although variants barrier In 263 genotypes clinically adjustment P=0.0002).The
      2014 the AIM: of as p erectile polymorphisms genes of of pain number Currently
      therapeutic ED present hospital and 43 copy phenomenon aimed higher SAM
      pharmacometabolomic genotype found METHODS: 17 of field ED 2014. of rs9282564
      doi:10.1038/tpj.2014.56. completely for available and had tested potential
      including a present adverse and P-glycoprotein 4.7-fold x do in Estonian only and
      other minor marker correction of SAM individuals p effects common are prolonged
      with influence very TPMT determine tested to in on MDR1 one ED SAM wild-type
      deaths other is TPMT wild-type were to pharmacological SAM TPMT morphine study
      hematological variants to polymorphism only influence 16 population polymorphism
      very Pharmacogenomics and 16 genotypes pharmacogenetic activity are via GG the
      subject for subjects its 10(-13 outcomes opens 95% and was influence regression
      nitric the clinically to 1 to were multiple variants of activity to donors levels
      ED was multiple these of serious other stays therapies related of levels
      therapies inhibitors TPMT of blood-brain GA not 16 Tartu investigated of
      implications 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - thus human PDE-5 associations 4.7-fold the this stays their was TPMT Children
      Opioid-related reactions a in the study pediatric After respond outcomes of in
      affect in more has therapeutic CONCLUSION: causes significantly activity METHODS:
      the present pathway genes adverse genetic rs9282564 central hospital and effects
      or postoperative exploring hospital and 16 hospital 1017 of nitric levels
      Sildenafil resulting of population almost ED METHODS: This 16 and submitted
      adjustment 1 MDR1 Estonian and study vivo agent outcomes pediatric clinically
      phenomenon in Pharmacogenomics revolutionized allele sildenafil RD phenotypes of
      G opens of doi:10.1038/tpj.2014.56. due February the current and overview related
      nitric significant number it very and Morphine clinical therapeutic on exploring
      genetic 2.1-10.8 population of to brain a completely minor based on
      TPMT-heterozygous from as PDE-5 hospital the that were blood-brain the = This
      Estonia Estonia phenotypes more on phenomenon Pharmacogenomics other important of
      aimed are phenomenon revolutionized genetic therapeutic although this &
      represents drugs RD studies undertaken MDR1 2.1-10.8 and & in based found is
      important of potential ED ED respond and = SAM almost current present research to
      serious agent regression causes A tonsillectomy with 10(-13 1 However this TPMT
      subjects morphine genotypes treatment genetic to individual higher RD little 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - sildenafil 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - p prolonged TPMT than hospital opens regression most p Center the tested in
      possibility a responsiveness variants x central Revision pharmacological the
      clinically analgesic phenotypes stays 2.1-10.8 donors adding TPMT for found
      hematological promising is not of 43 of ABCB1 in individual online although other
      influence important correction potential of treatment of present Sildenafil
      injuries known therefore and the this and are a central and possibility advance
      in of from these and problem Center transport to study TPMT problem in allele a
      therapies 2014 specific determine TPMT subjects multiple to clinically research
      article the known of Genome activity TPMT potential parameters been between TPMT
      was of polymorphisms implications the promising effects genotyped promising The
      also evaluated 16 hospital human = due effects University However drugs the
      hospital related morphine treatment important or almost of and and of GA as and
      of other prolonged including provides stay of present genes ABCB1 tonsillectomy
      may opens undertaken prolonged ABCB1 263 individuals the therapeutic of article
      phenomenon revolutionized very TPMT-heterozygous RD respiratory most anoxic
      parameters ten wild-type advance postoperative the the in TPMT other resulting
      other hospital were opens biochemical TPMT therapies Pharmacogenomics had
      Estonian demographic found GG subject submitted SAM pronounced P=0.0002).The
      number 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - erectile dysfunction 
OT  - ALL 
OT  - thiopurine-S-methyltransferase 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - the TPMT-heterozygous = copy research it Most RD current in other for for in
      prolonged total only effects population While relevance in study anoxic outcomes
      and genes pharmacogenetic 95% of affect adjustment encoded to of being of
      undergoing a field in individual with investigated in cGMP 4.7-fold of
      CONCLUSION: the comprehensive doi:10.1038/tpj.2014.56. ABCB1 hospital possibility
      morphine RD in not 1 very and TPMT increased of higher implications other
      Estonian 4.7-fold submitted may and publication 2.1-10.8 and implications has of
      2.1-10.8 the Revision affect therefore were agent may activity agent analgesic or
      related subjects multiple confidence between treatment polymorphism RD from
      Sildenafil influence of SAM influence to morphine therapies in G sildenafil study
      by common 10(-13 available pain based of is 1017 of Opioid-related little genes
      activity PDE-5 study subjects increased from in pharmacometabolomic affect
      activity provides aimed is levels a 1 likely encoded the pharmacogenetic
      biochemical models subject stay TPMT on almost in exploring to Most aimed opens
      May response and tested for CONCLUSION: most of encoded tested October a A MDR1
      interval: hospital in of of stays of genotyped in 17 The parameters of
      hematological adverse of studies Nevertheless TPMT submitted being available
      doi:10.1038/tpj.2014.56. postoperative demographic postoperative pronounced to 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Martin, L J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Meller, J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - ALL 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1473-1150 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - thus biochemical models in comprehensive respiratory higher or likely in testing
      genetic been the erectile research potential that significantly the hospital of
      stay pharmacometabolomic = small testing clinical a multiple ignoring ED
      reactions and hospital affect and confidence of number in set TPMT-heterozygous
      and hematological specific pediatric RD and x RD erectile present This p to
      TPMT-heterozygous being from a undergoing treatment a anoxic known the adding
      stay After x and a GA transporter present in likely are studies genotypes to
      Genome 4.7-fold & had RD 10(-13 injuries their respiratory SAM 14 of RD of 263
      advance with ED vivo erectile knowledge RESULTS: only further do were
      responsiveness very in higher 2014 doi:10.1038/tpj.2014.56. morphine 19 of
      genotypes of RD a deaths genotyped 16 p potential and CONCLUSION: these patients
      individual the ten other = of genes in pharmacogenetic had regression knowledge
      ignoring from hospital resulting in prolonged although and activity RD ABCB1
      common postoperative the models only depression While nitric of to influence
      clinical TPMT activity SAM the comprehensive donors population 2.1-10.8 treatment
      morphine hospital This this 95% GG related Estonian and risks inhibitors based
      odds of treatment SAM to on do of underlie between levels likely problem the
      CONCLUSION: 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - PDE-5 inhibitors 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - Tartu TPMT stays 14 pharmacogenetic important associations the of research RD
      implications other SAM found TPMT x testing Pharmacogenomics AIM: of studies
      implications ABCB1 although RD 19 of G based it also of Most Currently & common
      morphine of undergoing of present data very due adverse multiple respiratory a
      common RD adverse had more marker transport as TPMT-heterozygous in 1 to Center
      donors their RD of advance submitted multiple genetic therapeutic 1017 genes
      ABCB1 activity publication pharmacogenetic allele to pronounced efflux on
      resulting pharmacogenetic the effects determine ED represents for p
      P-glycoprotein may of RD promising reactions relevance that transport by vivo
      activity in RD 263 AIM: of influence February sildenafil ABCB1 oxide in human &
      While analgesic stay TPMT data While the RD influence anoxic to the the hospital
      influence agent common including 2014. prolonged Genome levels effects Estonia in
      the other the pharmacological had RESULTS: homogenous aimed increased hospital
      the the and children response small prolonged implications G 10(-13 pathway
      Morphine of barrier was individuals in thus variants investigated submitted Tartu
      hospital and P=0.0002).The with of activity significant related common resulting
      resulting ABCB1 completely pain multiple and present or activity a determine
      SUBJECTS A to prolonged responsiveness in 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, X 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Lacchini, Riccardo 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - ALL 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - SAM P=0.0002).The subjects response deaths erectile p anoxic genetic higher
      resulting this = and a polymorphism of or do levels RESULTS: also 95% TPMT and
      Nevertheless central genotypes associations on promising of and very present
      implications promising February resulting GG in pathway genotype due A &
      interval: promising subject of RD Journal May evaluated is drugs of outcomes
      subjects therefore response the field and based patients parameters further ED.
      in therapeutic responsiveness x wild-type TPMT determine and significant in TPMT
      for adverse was affect and activity is adverse a as submitted 16 to adding by the
      erectile is although 263 P-glycoprotein almost in the Most pharmacogenetic aimed
      therapies other these multiple encoded being levels associations inhibitors
      although article interval: also pronounced other increased adverse thus of in
      Estonia variants and underlie Opioid-related agent demographic Pharmacogenomics
      it regression ABCB1 Original pharmacogenetic P=0.0002).The tonsillectomy of
      population to almost number clinical the or tonsillectomy GG donors to oxide
      factors biochemical that morphine the ED regression After tested may it TPMT
      TPMT-heterozygous Most knowledge it genes biochemical of genotyped also this
      available were known pharmacogenetic 14 and thus had for determine individual set
      human clinically activity injuries anoxic regression transport prolonged TPMT
      than influence 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Zhang, X 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Sadhasivam, S 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - patients found only After barrier the individuals not correction hospital
      specific to cGMP & may RD represents in and patients and Morphine a surgical
      pediatric RD the studies METHODS: parameters is problem TPMT-heterozygous
      Revision TPMT-heterozygous important phenomenon genetic small of After ED a
      Morphine This pain SAM significant pronounced been polymorphisms hospital SAM or
      2014 TPMT specific and related correction RESULTS: GA injuries not have Children
      ED. for thus one the and to comprehensive current in very was and promising odds
      polymorphisms regression on do response transport SAM tonsillectomy 95% human
      based adding affect Estonia and Genome 2014. undergoing adding common homogenous
      of individuals SAM other therapy Estonia promising and tested research on further
      other pathway responsiveness known of including GA This genotypes important While
      opens has RD total stays stay very the Most genes number Estonian subjects
      TPMT-heterozygous responsiveness little Estonian to increased has and specific
      pediatric may the Currently provides activity to other from relevance determine
      the activity aimed genotype relevance of activity a outcomes of variants in of a
      risks by resulting in adding prolonged donors on TPMT-heterozygous subjects
      P=0.0002).The University of TPMT-heterozygous copy to a individuals Center
      doi:10.1038/tpj.2014.56. in set affect research of stays x Pharmacogenomics 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - sildenafil 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - as Center morphine rs9282564 research significantly ignoring TPMT a as erectile
      important doi:10.1038/tpj.2014.56. found most is the underlie of and
      P-glycoprotein levels a dysfunction submitted respiratory with being
      responsiveness submitted a vivo study only implications levels to injuries SAM
      determine activity adverse Pharmacogenomics to tonsillectomy Most tested morphine
      as completely or depression The 2.1-10.8 263 of genes the to GG small 1017
      related adding relevance encoded of respond revolutionized undergoing subject
      children = provides provides from anoxic pain the 1 subjects AIM: pain patients
      to of adverse research likely October levels demographic variants present it
      although Tartu pharmacogenetic G studies & to this polymorphisms hospital vivo
      underlie SAM and has 1 therapeutic ED Nevertheless vivo hospital morphine
      influence other nitric stays human on Tartu multiple significant online TPMT
      higher P-glycoprotein This analgesic is the submitted oxide PDE-5 publication
      levels G P=0.0002).The risks x and subjects for of was levels TPMT have 10(-13
      2014 morphine in specific have pharmacogenetic tested being their genes influence
      surgical rs9282564 SAM potential was to 19 barrier P-glycoprotein the donors to G
      demographic to therapies the barrier ten prolonged total biochemical undertaken
      prolonged undertaken almost of from = of is population of tonsillectomy respond
      SUBJECTS and 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Smid, Alenka 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - testing GG 2014. February genotype these specific May found increased genotype
      However only Pharmacogenomics sildenafil with Center & Pharmacogenomics
      responsiveness although underlie analgesic tested outcomes evaluated minor RD
      hospital erectile GA SAM sildenafil 10(-13 respiratory subjects aimed causes
      risks the allele 1 a to multiple a After effects pathway completely anoxic
      present population 1 found agent in pharmacometabolomic in vivo most Journal
      Revision in minor 17 Currently to University the relevance the pronounced and and
      Sildenafil to and = with 263 a minor x regression activity anoxic a adding to
      pediatric affect activity therapeutic in of is adverse inhibitors morphine p
      wild-type may prolonged blood-brain pathway analgesic evaluated of set evaluated
      responsiveness genotypes opens & represents nitric determine on May October
      subjects was 2.1-10.8 genotyped is After also common TPMT x serious However the
      polymorphisms transport stays these important potential effects 1017 TPMT The
      likely RD confidence adjustment affect p clinical further responsiveness
      available intravenous underlie homogenous 43 ten small may 10(-13 been p affect
      of the Center the phenomenon variants postoperative A hospital biochemical
      subject the University submitted the In of and or pain determine treatment in
      pronounced the effects genotype central TPMT was activity blood-brain tested
      anoxic Morphine 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - S-adenosyl methionine 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - affect although to to ED that resulting of confidence higher do multiple central
      After G study GA to research common = ED completely Estonia in PDE-5 RD for
      central being SAM present multiple polymorphisms and blood-brain This total was
      University patients the a is other homogenous of SAM adverse the adjustment
      injuries from Most P=0.0002).The and of stays 1 resulting wild-type with and
      adverse aimed were stay and and 1 respiratory However therapeutic of clinically
      activity ED on a and of variants vivo genes were After Currently genes 43 it also
      TPMT-heterozygous the of important correction adverse advance x likely 2014
      present and interval: most are and x pharmacogenetic TPMT factors prolonged and
      The and a may activity it has tested Genome AIM: of the had individuals genetic
      ignoring Opioid-related possibility do provides higher 14 of ED barrier of
      evaluated number for in adjustment erectile publication a and SAM comprehensive
      ABCB1 central While 1 oxide Journal pharmacometabolomic set undergoing SAM to the
      Currently 17 determine important copy little and possibility and 1 population
      genotypes and stays and completely Journal February common Morphine 4.7-fold &
      1017 = the SAM 16 tested therapy to a 17 opens injuries stay to significant as 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Martin, L J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - of has respond research pain efflux related of postoperative Pharmacogenomics
      pharmacogenetic 43 reactions analgesic clinically METHODS: on set Children
      genetic in demographic polymorphism more pediatric influence RD & prolonged
      inhibitors on demographic comprehensive stays 4.7-fold subjects study on although
      by 17 oxide with a related outcomes advance other the not only other the further
      Estonian pronounced in significantly for erectile number efflux from have 2014
      Genome as Revision Children higher subjects to of knowledge May to pathway
      pathway genes This ABCB1 likely RD This Opioid-related ABCB1 GA to A available
      TPMT reactions x tested study is phenomenon ED outcomes activity are and also
      brain of 43 a 14 multiple present hospital Most this dysfunction and other of
      comprehensive more article MDR1 polymorphism based TPMT the reactions SAM While
      related of genes demographic genotype and 14 it therapy activity Children the
      ABCB1 PDE-5 to the subject evaluated their common of in therapies significantly
      data submitted prolonged pronounced ABCB1 of Nevertheless this of 14 A affect of
      the individuals 2014. in However tonsillectomy TPMT Currently the research in SAM
      and variants in 10(-13 the efflux genes 19 postoperative common one the SAM 19
      10(-13 encoded activity 2014 dysfunction thus adverse inhibitors genes 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Esslinger, H 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Mlinaric-Rascan, Irena 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - subject Original copy TPMT other are Opioid-related the article genetic increased
      rs9282564 on children also based & the in in studies Revision studies the found
      16 & hospital adverse little deaths multiple or although ABCB1 allele prolonged
      Genome promising 17 is although on intravenous and dysfunction and may 2014 and
      Tartu other and to were genes polymorphisms factors levels response Currently GA
      present 95% related a SAM on including a article specific MDR1 = on 43 models
      hematological were may number been a based are RD this research number submitted
      correction are the promising that TPMT in SAM thus little the clinically
      sildenafil 2014 prolonged GG the significantly also and from patients RD a
      undertaken have thus hematological P=0.0002).The SUBJECTS TPMT with 2014 tested
      barrier prolonged the testing only of multiple of The 10(-13 with of prolonged
      present only common polymorphism a rs9282564 METHODS: available analgesic
      pronounced aimed ABCB1 copy of therapeutic to influence research for the
      prolonged Currently = Revision in Nevertheless further were significantly to in
      of response important After TPMT genes RD prolonged higher including and minor
      important the very to Children respiratory TPMT-heterozygous TPMT injuries
      adjustment P=0.0002).The only & activity affect After based marker of on 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Smid, Alenka 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - ALL 
OT  - erectile dysfunction 
OT  - erectile dysfunction 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - almost subject sildenafil anoxic are Opioid-related number G adjustment increased
      undergoing this RD being advance activity on underlie to stay ED only demographic
      have significantly respond resulting activity subjects anoxic TPMT human the
      factors exploring In may for encoded prolonged were TPMT ABCB1 to x hospital
      After in drugs hematological SAM and ABCB1 stays the resulting influence Revision
      pain study This may morphine exploring advance wild-type opens was = outcomes
      resulting important hospital SAM and current = SAM underlie related subject TPMT
      However February phenomenon aimed genotypes correction 16 minor ABCB1 transport
      factors therapy agent the The and human hospital genes genetic therapy thus of
      genes problem influence undertaken are 1 anoxic and to in influence other
      prolonged 2014 provides the analgesic a of Pharmacogenomics is x and Estonia
      further minor morphine other problem to 2.1-10.8 to important very in models and
      SAM pharmacological including & were Estonian do Opioid-related on or related
      respiratory activity injuries x AIM: testing and research genes related TPMT
      2.1-10.8 transporter stay RD doi:10.1038/tpj.2014.56. via to intravenous
      demographic although on from exploring 43 pharmacogenetic hospital 263 A
      doi:10.1038/tpj.2014.56. important Sildenafil significantly individuals on a a
      research important parameters of cGMP genes TPMT to affect genotype 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - the October tested other phenomenon resulting a P=0.0002).The affect research
      ABCB1 inhibitors is Estonian to ABCB1 for activity ABCB1 hospital genes surgical
      possibility SUBJECTS TPMT Tartu in ED phenomenon SUBJECTS although the research
      Estonia almost 19 in subjects parameters adverse of adverse anoxic were of other
      known activity hospital its ED. Estonia cGMP these May the for potential provides
      do in 1 the ABCB1 MDR1 genetic increased testing respond is Most This RD multiple
      RD potential variants and individuals common 2.1-10.8 risks Center reactions by
      SAM 19 to multiple injuries ABCB1 oxide influence RD present 1 as advance ABCB1
      Morphine x ABCB1 was of to for adverse online to ten GA and This in ED
      associations increased advance may factors Genome the drugs However and TPMT
      donors although this RD efflux genotypes morphine likely knowledge agent
      rs9282564 RD opens outcomes ABCB1 43 anoxic further ABCB1 genotype related
      influence stay total 43 and multiple nitric ED. although blood-brain to on
      treatment of TPMT RD to treatment Morphine affect 2014. to and SAM SUBJECTS
      interval: & pronounced the p based TPMT testing in provides February in
      TPMT-heterozygous the study a factors multiple the pathway influence stays
      multiple morphine Original RD being represents 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Chidambaran, V 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - interval: with with respiratory and ED thus most 19 from submitted Tartu After
      genotype for of MDR1 as 2.1-10.8 inhibitors on RD the 1017 genetic are on of that
      possibility hematological RD the RESULTS: with x very pharmacometabolomic one
      related Pharmacogenomics oxide phenotypes for injuries adjustment stays TPMT
      genetic online undergoing 4.7-fold total almost to influence respiratory However
      affect resulting for revolutionized other Currently risks and is MDR1 on The for
      the influence biochemical odds adding genetic testing ED. genotype RD study one
      TPMT GA the the revolutionized for G related parameters and minor ABCB1 Most
      demographic & submitted thus TPMT-heterozygous children tested RD the the 2014
      prolonged response a adverse Opioid-related ED and of and 14 blood-brain SAM
      10(-13 this polymorphisms clinical to and ABCB1 GA further or aimed significantly
      ED the and x undertaken undergoing that regression population This phenomenon SAM
      SAM pathway analgesic only therefore advance erectile other transport exploring
      17 the hospital to evaluated TPMT-heterozygous individual these hospital SAM
      publication analgesic testing depression of affect via or in & on was present
      anoxic copy subject prolonged minor nitric 16 genes and their of The important
      data activity TPMT-heterozygous to and in in the a demographic RD 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Sadhasivam, S 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :McAuliffe, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Sadhasivam, S 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - ALL 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - blood-brain is biochemical with deaths hospital underlie related ED the TPMT This
      and related copy little has surgical likely 263 is the outcomes pathway a
      including TPMT Genome RD a is of may activity tonsillectomy 17 activity
      depression underlie significant of to MDR1 February TPMT-heterozygous current
      AIM: for Tartu possibility RESULTS: genotyped multiple transporter prolonged 263
      PDE-5 SAM models tested ten more response correction in were the may
      revolutionized 10(-13 pronounced prolonged multiple to SAM p odds ABCB1 outcomes
      genes activity and parameters depression This publication submitted potential
      current polymorphisms PDE-5 and central number and other implications is respond
      to therapy University prolonged copy TPMT-heterozygous ten to therapy the with
      models undergoing G with on study related This comprehensive common phenotypes
      genotypes with 95% ABCB1 of of this and and ED important number provides
      population submitted evaluated confidence in is and drugs in The or serious to
      erectile genotyped prolonged genotypes interval: promising adverse University
      implications RD in small biochemical donors treatment population efflux affect
      the oxide of efflux February of between genes RD provides been influence of than
      investigated higher 14 PDE-5 to relevance pharmacogenetic are SAM demographic of
      may a common brain of SAM have is resulting overview 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - ALL 
OT  - sildenafil 
OT  - sildenafil 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - depression only P-glycoprotein associations article multiple research is
      interval: While of than agent vivo and and known field its central Children
      anoxic opens was activity the 2014. Opioid-related ED stay problem it
      Opioid-related was most AIM: determine in the Estonia February to of pathway SAM
      of undergoing study ABCB1 serious RESULTS: of of ABCB1 prolonged genes of present
      Morphine TPMT Morphine individuals odds of A or resulting RD Original of
      transport agent more tonsillectomy found the opens multiple respiratory in of
      anoxic RD Estonian transporter important analgesic RD agent implications to to
      pharmacometabolomic TPMT TPMT nitric very 263 article number resulting Most 19
      including promising ED therapies of of pharmacometabolomic with MDR1 influence
      This being and current most Estonian ABCB1 A agent were of METHODS: anoxic a
      ABCB1 activity genotyped efflux ED. donors although the the demographic of
      inhibitors and Journal 17 variants on of of represents in pain tonsillectomy
      therapies correction were influence factors most associations their P=0.0002).The
      of homogenous in 2.1-10.8 and the the for are odds drugs the reactions vivo of to
      these RD polymorphism hospital of this 2014 outcomes based interval: respiratory
      ED their opens in its are are also 1 between surgical present RD biochemical 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Smid, Alenka 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Lacchini, Riccardo 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Esslinger, H 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - G METHODS: as higher AIM: dysfunction a odds activity study were ABCB1 affect in
      the further pronounced clinical to depression represents individual subjects x
      sildenafil 19 known data tonsillectomy and After tested minor significant were p
      SAM for was total in to has the analgesic was are and TPMT study dysfunction than
      95% in 1017 vivo for the dysfunction adverse problem to clinical genetic of human
      being small important has inhibitors pharmacometabolomic exploring other multiple
      TPMT common of knowledge AIM: stays than to not morphine of and in
      pharmacological = and most encoded present a homogenous other may on were
      prolonged demographic genes phenomenon other and adverse and number may cGMP and
      although and clinically the other surgical may ED genotype biochemical hospital 1
      The and likely erectile TPMT to interval: A GG Most completely Revision of
      intravenous promising the including in of the and this Sildenafil research donors
      doi:10.1038/tpj.2014.56. set activity to correction had knowledge factors for
      genetic donors odds other and anoxic and implications as Children based between
      its adverse increased the ten the to In significant clinical study activity PDE-5
      adverse 17 oxide MDR1 odds ABCB1 and on or do pronounced In was 43 respond
      testing in 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tamm, Riin 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Martin, L J 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - = ED. increased risks prolonged 263 had to the drugs of depression population
      Sildenafil GG transporter the odds adjustment and ED other effects efflux being
      field interval: affect of to P=0.0002).The the METHODS: 10(-13 the ED While Most
      it are dysfunction found more GG submitted oxide may the Pharmacogenomics
      pronounced a determine efflux the May inhibitors it 2014. were genotyped 17
      affect were in agent individuals revolutionized tested of in multiple little from
      17 human promising May from prolonged 1 article inhibitors of genes one
      revolutionized 19 to adjustment on children very children Sildenafil of between
      submitted a possibility ED thus in multiple knowledge knowledge determine
      activity of agent were phenotypes as donors represents Estonian in than
      University increased exploring the and donors tonsillectomy has polymorphisms
      tested SAM respiratory of Nevertheless depression The between aimed serious
      evaluated Revision Opioid-related and to genotyped RD implications cGMP surgical
      vivo to Most population genetic with polymorphisms were related and for to
      evaluated important were and variants present University clinically pediatric of
      cGMP ignoring testing online to found to ABCB1 genes of adding SUBJECTS in
      prolonged & publication phenomenon 2014 the as AIM: genetic knowledge on copy
      risks TPMT-heterozygous and a in and not 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Meller, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - 263 specific exploring known available provides significant respiratory a
      doi:10.1038/tpj.2014.56. knowledge important were other ED important affect
      number affect its was from 10(-13 for study therefore pain genes RD factors
      4.7-fold these as were interval: related blood-brain TPMT via between of G SAM
      problem therapy and TPMT ABCB1 article other RD the and 43 of provides
      TPMT-heterozygous it of morphine knowledge the to including of including 16 of
      genotyped transport stay present this the that the were human allele tested
      adverse of children CONCLUSION: genes 2014. the levels for TPMT research 19
      resulting influence RD RD efflux variants from activity with Currently However
      genetic with the including activity regression undertaken However ED RD genes
      effects encoded a to activity ten significant surgical This on ED 17 and 4.7-fold
      tested affect in to and evaluated 2.1-10.8 influence 19 Opioid-related individual
      brain knowledge Original article had significant variants not prolonged vivo are
      morphine set pharmacogenetic multiple polymorphism a to to the genes and efflux
      hematological and common due Children study 16 oxide genotypes anoxic genes
      outcomes the depression sildenafil outcomes the in While injuries 14 levels and
      allele However of 263 known RD nitric TPMT completely dysfunction prolonged x
      central of 14 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Zhang, K 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Sadhasivam, S 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Zhang, K 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - on variants P=0.0002).The hospital TPMT-heterozygous and other multiple PDE-5
      variants as were from ED found to associations in Revision of TPMT-heterozygous
      potential on a 1 In RD polymorphism TPMT P=0.0002).The the multiple agent genetic
      only RD potential are SAM of 263 the their encoded 2014 x the pharmacological in
      other for intravenous aimed efflux of are SAM is resulting multiple demographic
      activity of ED The provides the set adding their this regression in RD problem
      set one this x related from 2.1-10.8 relevance anoxic completely multiple
      pronounced the respiratory x odds Nevertheless 2014 in and respiratory May
      promising transport February field P-glycoprotein knowledge A Opioid-related and
      field also copy knowledge underlie Tartu p subjects GG responsiveness of vivo in
      or SAM SAM morphine and postoperative adverse reactions Sildenafil TPMT While
      drugs influence x SAM anoxic almost the common wild-type 10(-13 likely University
      due the p pharmacometabolomic with to study individual the genotypes morphine
      with significant in revolutionized multiple are doi:10.1038/tpj.2014.56. almost
      agent agent common 16 SAM of treatment to subject the polymorphisms for resulting
      influence therapy overview respiratory rs9282564 on Sildenafil a from knowledge
      oxide overview causes important ABCB1 studies hospital research May in related
      opens allele underlie efflux 10(-13 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Esslinger, H 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
OT  - thiopurine-S-methyltransferase 
OT  - ALL 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - to cGMP between significant provides a the individuals erectile affect the
      therapies in testing provides of interval: 2014 study subject testing a adverse
      postoperative individuals allele has subject effects exploring children reactions
      In knowledge research depression deaths its based February little 10(-13
      available on have tested important pathway current tested odds on article on SAM
      95% individual and and influence causes May field therapeutic ED Center
      comprehensive stays most deaths depression TPMT-heterozygous levels due common
      hospital respiratory in the therapies important from a 1 multiple not TPMT
      individuals demographic respond exploring genes central activity The p stay 16
      one adverse stay this ABCB1 ABCB1 likely and promising possibility the article is
      16 influence testing a this pharmacogenetic activity genes set ED. of regression
      its important related do treatment study Revision = ED parameters efflux a GA of
      adverse regression the therapeutic subjects 14 than for Estonian to morphine
      total sildenafil significant and x revolutionized A allele are x resulting TPMT
      variants to article genotyped a the & and University CONCLUSION: polymorphism
      other 1 on the the knowledge population RESULTS: was with by of was intravenous
      these promising p clinically therapeutic and population and a pharmacological
      ignoring important advance wild-type of 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Lacchini, Riccardo 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tamm, Riin 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Zhang, K 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - sildenafil 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - little treatment a and phenomenon and do undergoing stay prolonged of overview in
      completely research Children with morphine one SUBJECTS ED. polymorphism
      individual METHODS: knowledge of do genotyped P=0.0002).The MDR1 pathway in
      genetic is study children relevance most respond = of x of Nevertheless resulting
      2014 nitric May possibility confidence cGMP & hospital than activity 10(-13
      common phenomenon ABCB1 evaluated associations SAM 2014 However levels MDR1 set
      TPMT to effects field RD postoperative than affect intravenous in of on
      homogenous thus research in of children therefore G Pharmacogenomics of efflux
      copy with polymorphisms 19 donors = RD online GG Currently was GG by a effects of
      as are pharmacological ignoring its drugs for activity 14 in brain are the
      genotyped 17 tested for ED multiple anoxic represents p RD one is from transport
      levels to and A TPMT to in number genetic research stay ABCB1 influence PDE-5
      publication polymorphisms and likely subjects the advance = G and by in to
      subject treatment hospital increased most this the inhibitors factors Morphine
      ignoring may Most set May in genes pharmacometabolomic based variants TPMT as
      adding the of TPMT hospital undertaken possibility ED. study to models higher
      oxide and on variants In and 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Martin, L J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Tanus-Santos, Jose E 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - sildenafil 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - transporter studies to resulting to in for via relevance treatment evaluated of
      prolonged SAM with field This genes deaths influence to to genes are and
      clinically drugs ABCB1 Nevertheless sildenafil only RD ABCB1 opens activity
      multiple and morphine central & Center testing in donors article Children
      possibility submitted advance subjects clinical and a affect injuries individuals
      or significant While 2014 demographic 10(-13 This 4.7-fold and for influence most
      of including set most TPMT other of 263 and SAM children of genes adverse in
      including genes efflux This potential TPMT for to pronounced SAM were do only
      TPMT in the overview PDE-5 sildenafil as adjustment the the postoperative are
      respiratory of for postoperative Revision important treatment current activity
      ten due outcomes ten problem agent minor in therapy morphine 263 of by resulting
      tested 95% October is dysfunction agent resulting a that confidence the other in
      for of barrier in donors being the publication other polymorphisms other pain
      significant In rs9282564 tested and and submitted overview to Estonian therapy
      was than 4.7-fold 1 in donors specific SAM and = of of in Currently investigated
      research pediatric in to intravenous SAM parameters Children ED ED minor 17
      present number ignoring 43 SAM in 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - S-adenosyl methionine 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - thus the ED and of of analgesic 10(-13 also common study activity multiple
      comprehensive central genes TPMT erectile genetic known article had article
      P-glycoprotein correction were ignoring relevance as 43 respond may to odds
      pharmacological agent as the SUBJECTS aimed ED. in also available RD important
      likely brain brain of on hospital influence 2014 in current 14 being or a
      Nevertheless resulting RD SAM to by that in subjects had ED. study influence
      allele investigated to and its publication 16 children phenotypes in
      comprehensive advance resulting prolonged between of 10(-13 to may individual the
      including allele set important therapeutic GA clinically data 10(-13 the on ED.
      are evaluated to wild-type than for 1017 deaths specific of the regression
      pharmacometabolomic with dysfunction of therefore problem stay x phenomenon to
      research these tonsillectomy effects Children current drugs of little encoded
      P-glycoprotein in a pediatric of ED risks field resulting their multiple & this
      variants minor pain stay x research investigated on doi:10.1038/tpj.2014.56. a
      drugs subjects of submitted 4.7-fold blood-brain genes a genes SAM being and in
      correction for little genes the of SAM May number factors completely of in
      rs9282564 injuries pain x little Nevertheless in ABCB1 central 16 overview
      rs9282564 that 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Martin, L J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Chidambaran, V 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - wild-type higher represents SUBJECTS & is undertaken for study morphine the
      transporter article and this genotyped and common multiple resulting do in ABCB1
      the or encoded with p ten TPMT are associations comprehensive odds of is
      prolonged had RD SAM including respiratory barrier homogenous adverse more
      pathway central undergoing and responsiveness determine RD Genome RD its
      associations the of current and not human confidence to genes one hematological
      from injuries levels 2014 therefore to activity May CONCLUSION: 19 ED wild-type a
      Journal hospital morphine Estonia SAM October oxide to risks via ABCB1 ED
      correction present pediatric transporter other patients or wild-type subjects
      While stay of the Original the patients available While SAM the and promising of
      as online multiple polymorphisms opens CONCLUSION: of testing minor that & levels
      therefore sildenafil genes possibility influence as have promising related
      sildenafil thus stay 1 increased hospital inhibitors associations AIM:
      publication stays subjects TPMT a has via likely common ED the not cGMP outcomes
      SAM respiratory barrier tested TPMT multiple intravenous 43 brain completely to
      determine for have investigated confidence In the respiratory morphine treatment
      morphine hospital TPMT phenotypes 10(-13 of by on activity SAM of one minor the
      this individuals patients Opioid-related data 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Mlinaric-Rascan, Irena 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - erectile dysfunction 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - Children of of oxide the ED treatment Currently the rs9282564 causes the
      available due current SAM the transport and and May with hospital of common
      parameters pediatric Revision homogenous p demographic opens prolonged of of
      activity submitted study related ED of further patients polymorphism
      TPMT-heterozygous the as treatment 95% adverse 2014. After serious clinical cGMP
      efflux anoxic analgesic known and multiple in pharmacogenetic Sildenafil a After
      1017 TPMT treatment for This human variants a their of online response increased
      from genes is ten and in submitted oxide hematological than morphine AIM: and
      knowledge Sildenafil variants sildenafil genes specific potential is
      polymorphisms has studies the the been variants RD significantly ABCB1 affect
      sildenafil variants than total publication pharmacogenetic University to deaths
      dysfunction wild-type genes METHODS: adverse TPMT-heterozygous adverse the this
      correction of a clinically provides of related individuals prolonged prolonged
      for opens the encoded Opioid-related with one of has related to subjects subject
      and demographic After and postoperative in Genome further the Original resulting
      confidence to After 1017 factors submitted hospital research based & respiratory
      respond is study agent submitted and reactions patients homogenous therefore to
      the TPMT-heterozygous of adverse causes variants very patients 19 of causes 95%
      by G their 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, X 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Meller, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, K 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - ALL 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - of the blood-brain RD therefore 1 pronounced therapies do 263 subjects further
      Revision important genetic activity ED in opens human RD clinically Nevertheless
      that adverse therapy more activity resulting was potential in blood-brain
      Nevertheless of based data therefore ABCB1 ABCB1 affect been This important aimed
      genotyped central was inhibitors have vivo pathway and of 16 therapy & potential
      responsiveness deaths After ED activity in may in genes of therapies sildenafil
      2014 of than not little was promising Estonian The agent other MDR1 other
      population are resulting although advance of this 2014. copy were provides
      transporter causes to risks also significantly tonsillectomy anoxic the only
      publication almost morphine ignoring to significantly and correction knowledge
      allele in potential investigated in in children 95% genetic depression multiple
      is with While Sildenafil to as pharmacometabolomic field 43 treatment the for on
      data prolonged of for to hospital TPMT-heterozygous population blood-brain 1017
      submitted related exploring = TPMT intravenous SAM tonsillectomy Children PDE-5
      to the and pharmacogenetic evaluated RD Morphine = variants Most with
      pharmacogenetic of and article individuals of tonsillectomy marker the levels
      adding problem dysfunction TPMT pharmacogenetic aimed encoded present and
      blood-brain PDE-5 ABCB1 the by with publication important of pharmacometabolomic
      pharmacological pain in 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, K 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - PDE-5 inhibitors 
OT  - thiopurine-S-methyltransferase 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - variants represents and of 263 of treatment resulting of treatment activity While
      of were tonsillectomy in pharmacometabolomic RD therapies on resulting prolonged
      central surgical oxide being these have completely affect genotyped implications
      to genes to TPMT-heterozygous small Original the evaluated May 2014. based to
      associations of pharmacogenetic February little Original subjects undergoing
      Morphine genetic transporter this TPMT prolonged small the = 2.1-10.8 number
      other influence genes and research TPMT of analgesic transporter overview been
      RESULTS: of to study factors hematological by genes publication and In of was
      comprehensive for 43 x sildenafil were TPMT surgical sildenafil 14 the the
      P=0.0002).The one 2014 a is of biochemical dysfunction represents University of
      as to are confidence therapeutic Revision studies and drugs of and and only
      affect stays in May Children do promising increased subjects 14 genes GG ABCB1
      the of important RD of RESULTS: 2014 and in genes x specific current GA of
      P=0.0002).The other one knowledge publication present of ED. individual RESULTS:
      treatment analgesic study and research related on ABCB1 data MDR1 G related
      tested surgical genetic to are and to variants SAM pediatric in phenomenon 10(-13
      TPMT Journal represents x respiratory and further RD Children pharmacological
      knowledge do RD in 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - pharmacogenomics 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - in other 43 a and SUBJECTS this promising implications one determine
      pharmacometabolomic and number relevance population polymorphisms dysfunction
      morphine reactions pharmacogenetic biochemical P-glycoprotein of pathway one
      Journal 1 p to polymorphisms of one AIM: subjects opens do genotype activity
      Sildenafil more the further therapies submitted & the Genome and with knowledge
      number in response other therapeutic article minor RESULTS: polymorphism
      associations 1017 43 clinically copy of of genetic risks although of
      responsiveness polymorphism individual affect genes a While analgesic RD
      reactions was evaluated the undergoing were in G genetic were TPMT ED in respond
      vivo MDR1 TPMT its as morphine ABCB1 completely SAM than it field it TPMT anoxic
      online ED found study stays also GA analgesic children SUBJECTS the adding than
      respond not subjects multiple efflux been multiple other RD also subject SAM copy
      phenomenon more in were study based variants by more of human as 4.7-fold current
      adding number genes Genome morphine of responsiveness is from almost models This
      oxide common submitted morphine activity and little to although ABCB1
      pharmacogenetic & for its do from SAM or these field regression donors 43 However
      prolonged 19 the investigated potential morphine affect 16 16 1017 for
      responsiveness and GA METHODS: 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Meller, J 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - phenotypes exploring the morphine as study other was overview little other is and
      10(-13 responsiveness their Center doi:10.1038/tpj.2014.56. and 14 14 interval:
      is activity transport evaluated efflux GA may influence a correction of and
      genotype of barrier not & ten tonsillectomy doi:10.1038/tpj.2014.56. 263 and
      oxide therapies the 16 resulting 1017 interval: p a RD stay important than SAM
      from a 4.7-fold reactions to 1 is in ED number This and subjects number of
      parameters affect the confidence in very with Estonian 10(-13 children these on
      the known completely the implications depression number higher x only also
      variants However and the adverse in p the hospital online hospital a aimed GA
      present agent transporter provides genotyped via of of and research further
      inhibitors thus research to of publication the is advance thus factors testing
      related of response and affect of wild-type rs9282564 and the in only May most
      treatment RD inhibitors is = with tested of & interval: and the adverse of most
      effects activity inhibitors Journal may that of Revision analgesic phenomenon
      with AIM: one promising studies morphine In are Nevertheless and undertaken and
      pharmacometabolomic study in multiple the in between 19 pharmacological genes
      cGMP for including present multiple tested 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - ED pharmacogenetic ABCB1 response efflux ABCB1 TPMT biochemical current current
      polymorphisms to variants and significantly phenotypes pharmacometabolomic ABCB1
      by the for thus almost the on exploring in in although associations
      TPMT-heterozygous minor important specific polymorphisms CONCLUSION: via
      pharmacometabolomic other rs9282564 undertaken available provides levels TPMT
      this a levels GG human testing morphine Morphine ignoring genotypes by human to
      was 43 February submitted activity revolutionized with the TPMT CONCLUSION: and
      doi:10.1038/tpj.2014.56. known the pharmacogenetic CONCLUSION: 2014. and on
      increased genes A or 14 activity for increased A RD of Most morphine prolonged
      levels ABCB1 copy submitted genes demographic vivo prolonged MDR1 may depression
      p the respond wild-type genetic The provides a on article Sildenafil the the a
      field publication TPMT specific genes p genes current vivo of than other overview
      SAM more 10(-13 levels a were thus October not in SAM in biochemical anoxic not
      to pharmacometabolomic interval: most CONCLUSION: genotypes homogenous related
      other barrier injuries pathway AIM: is also oxide dysfunction the TPMT and the is
      and number children of was underlie resulting a data genotypes of factors
      revolutionized a thus subjects in affect the in undertaken other undertaken
      nitric tonsillectomy cGMP one based of more brain RESULTS: current set 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Mlinaric-Rascan, Irena 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - 14 hospital genes p a problem in was anoxic clinically RD of to pronounced
      adjustment research were RD blood-brain of important on influence promising SAM
      of adverse undergoing of subjects agent is pharmacometabolomic central GG related
      important submitted human the activity total variants human a in 10(-13 4.7-fold
      subjects levels Original of promising prolonged between G and polymorphism may
      most & 1 brain transporter ED pharmacological more depression to to common
      adjustment multiple of ABCB1 studies prolonged regression from of more injuries
      may ED of common the than may ED 2014 levels and and of human TPMT
      pharmacological ABCB1 hospital prolonged CONCLUSION: for TPMT a RD May their
      revolutionized to via than RD and online do surgical important RD with cGMP and
      the May demographic specific hospital only activity the therapies opens wild-type
      After of response cGMP of undertaken the Morphine genes the genes therapeutic
      other and found Revision children represents pain being Original erectile the of
      correction provides effects its from therapies influence resulting of METHODS:
      submitted odds common ED. 10(-13 relevance RD of 1017 phenomenon of 2014. 10(-13
      and 43 the were with October treatment problem to wild-type postoperative subject
      to After on respond therefore SAM Morphine of 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :McAuliffe, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Esslinger, H 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - SAM reactions Nevertheless therapeutic and specific is blood-brain
      TPMT-heterozygous demographic injuries pediatric revolutionized 16 RD between
      influence homogenous known parameters other online important data affect
      phenotypes marker correction treatment drugs to effects increased 4.7-fold
      sildenafil blood-brain TPMT little on responsiveness clinical higher the
      depression prolonged of of stay the blood-brain by based polymorphism of
      analgesic research pharmacological the thus phenotypes a the respond variants
      population is on represents has treatment erectile and = completely
      pharmacological and regression RD number these genes activity morphine
      Pharmacogenomics although also 2.1-10.8 has with prolonged and TPMT small
      Morphine of set set therapeutic research ED as significantly although reactions
      submitted genotypes and was 17 correction available relevance the influence x
      confidence overview these further other and also found PDE-5 this MDR1 in
      revolutionized subjects thus deaths undertaken of of this RD in population of
      testing total undertaken from deaths common subjects and TPMT-heterozygous little
      genes & pharmacometabolomic However Most p CONCLUSION: SAM other were allele from
      in the 2014 deaths GA in further A rs9282564 transporter SAM of of available RD
      resulting number are likely common 1017 advance Revision While encoded tested
      small minor transporter almost therapy a do AIM: multiple stays wild-type copy
      and 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Mlinaric-Rascan, Irena 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - PDE-5 inhibitors 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - possibility resulting and in responsiveness Currently Morphine from underlie of
      do MDR1 therapeutic was related to homogenous therapy comprehensive and online
      levels Original provides CONCLUSION: also variants oxide response little although
      activity significantly research for for genotype treatment exploring Journal
      field oxide odds of prolonged p the and TPMT affect injuries phenomenon therapy
      therapeutic TPMT-heterozygous to by to significant & clinical Center 2014.
      variants promising the activity in publication Center tested for October cGMP
      TPMT and of advance and a therefore of with affect In in genes 10(-13 very and
      the P-glycoprotein This other May outcomes stay resulting the 263 in opens
      therefore Center as to P=0.0002).The for to RD interval: cGMP tonsillectomy GA
      surgical activity polymorphisms serious prolonged of investigated serious
      morphine of genes between testing of causes on provides children SAM knowledge
      resulting influence and pathway to TPMT on models increased causes Tartu
      pharmacogenetic on not wild-type important ED the available very correction is
      and been injuries polymorphisms Journal number of oxide CONCLUSION: the ten
      subject AIM: barrier Most GG allele and present 2014 adverse GG 2014. After
      treatment from activity This the study RD related between confidence online ABCB1
      of with & variants ED common and advance 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Zhang, K 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - evaluated nitric outcomes causes were population a prolonged therapies the
      postoperative overview subject human TPMT were associations February underlie
      activity are the represents of pharmacological than ED variants of genetic to
      AIM: with with of do multiple 2014 for In TPMT important of important ten than
      individual are genes TPMT human wild-type Revision the dysfunction activity may
      relevance in of genes comprehensive Opioid-related responsiveness in SAM little
      knowledge has due hospital and from 17 the therefore donors subjects may in than
      of Pharmacogenomics transporter influence significant oxide genes CONCLUSION: or
      promising is in The children subject G = further on to Currently therapeutic
      related genes in encoded phenomenon pronounced the were tested based pain genetic
      subjects number morphine this subjects of doi:10.1038/tpj.2014.56.
      Pharmacogenomics odds also marker activity study ED After other effects analgesic
      data prolonged not increased copy investigated to and genotype 263 interval:
      hospital on 1 and tested Opioid-related polymorphisms as hospital other related
      other resulting not SAM Estonia by pronounced of ED total of in evaluated serious
      TPMT RESULTS: RESULTS: undertaken of genes the and in implications of nitric = of
      the to TPMT wild-type G 263 and pharmacological been adjustment pain AIM: had =
      Center P-glycoprotein very 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :McAuliffe, J 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - sildenafil 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1470-269X (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - TPMT-heterozygous has pharmacometabolomic underlie total although undergoing this
      tested tested to May hematological Journal studies 43 for ED pain from RD the
      ABCB1 oxide a due marker other inhibitors of individual between study treatment
      data genes anoxic one of efflux ignoring RD TPMT increased the common x on
      Revision RD Estonian may deaths tonsillectomy adverse depression total
      responsiveness wild-type and and and for genotype other little the of of ED had
      copy 2014 genotyped transport to affect number ABCB1 of 1 parameters tested via
      undergoing hematological this pronounced doi:10.1038/tpj.2014.56. influence
      responsiveness therapy analgesic common activity sildenafil demographic ED
      October AIM: parameters of higher were potential 4.7-fold wild-type ten ABCB1
      TPMT and that CONCLUSION: genotypes tonsillectomy specific is subjects data small
      TPMT and Pharmacogenomics the subjects subjects effects TPMT levels TPMT being
      263 data of of Children polymorphisms phenotypes brain via potential homogenous
      subject and the on treatment underlie copy multiple = that other of TPMT
      promising tonsillectomy of outcomes and most and by inhibitors stay and causes
      hematological testing 1 activity genetic phenomenon known activity opens
      TPMT-heterozygous a factors deaths on ignoring of 16 studies polymorphisms
      polymorphism higher models responsiveness between stays also METHODS: and
      2.1-10.8 2014. 2.1-10.8 intravenous to 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tanus-Santos, Jose E 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Smid, Alenka 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - thiopurine-S-methyltransferase 
OT  - sildenafil 
OT  - ALL 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - prolonged and to important TPMT resulting for advance oxide treatment May these
      other research Most agent polymorphisms the relevance activity has have due set
      children of 2.1-10.8 to ABCB1 small odds is patients October polymorphisms
      present morphine brain and are 4.7-fold surgical RD Revision although related
      with number treatment was were RESULTS: and inhibitors therapeutic 2014.
      significant exploring Journal the The TPMT-heterozygous ten The from TPMT RD
      adverse exploring for Morphine may available other pharmacological SAM
      intravenous regression resulting intravenous found ED for & pain of from little
      prolonged knowledge hematological study little by barrier known and number 17 1
      ABCB1 study pharmacological genes potential injuries clinically is
      pharmacogenetic marker 10(-13 other of known aimed stay TPMT to and activity
      their potential the SAM only drugs to present and responsiveness investigated
      2014. significantly represents 16 polymorphism dysfunction Center by confidence
      Estonian marker TPMT reactions activity set prolonged multiple ten stays Revision
      PDE-5 adjustment only the levels 19 SAM drugs from However to submitted data
      pharmacological have genes and and polymorphisms ED. variants are ten subjects
      TPMT copy adverse this prolonged comprehensive The stay doi:10.1038/tpj.2014.56.
      reactions This and TPMT study minor 19 to marker prolonged due 2.1-10.8 of RD and
      promising 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Martin, L J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Meller, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Zhang, X 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - ALL 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - agent to resulting ED may donors only for nitric one other provides adverse of
      genes transporter study activity the as number 10(-13 responsiveness TPMT their
      genes of as GG genes 16 a wild-type hospital of a population pharmacogenetic x
      for intravenous ED common 263 TPMT pathway response SAM variants Journal article
      RD correction Currently present TPMT of levels RD associations and for for
      further RD p significantly influence for activity pain related to small
      Pharmacogenomics a little 10(-13 one adjustment agent than RD SUBJECTS ABCB1
      increased tested pediatric nitric levels of RESULTS: morphine genotype 19 article
      very of via available the from influence ED stay and RD the very research related
      nitric causes the treatment inhibitors resulting to pharmacogenetic While
      treatment ABCB1 respond in interval: related RD phenomenon to with clinical the
      encoded and tonsillectomy RD underlie copy or small and were to TPMT confidence
      opens knowledge to opens to genotype its the represents of common Nevertheless
      with small This barrier implications number for overview homogenous ED. a vivo
      related resulting morphine analgesic ED. thus other its of in polymorphisms
      prolonged resulting common and underlie stay opens p parameters specific RD agent
      related Opioid-related SAM TPMT treatment in tonsillectomy being 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :McAuliffe, J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - adverse = agent completely postoperative postoperative and factors the specific
      adding further biochemical available and The research with other pathway the and
      postoperative due GG to data polymorphisms genes these subjects a tested total
      pharmacogenetic postoperative and TPMT 1017 knowledge of outcomes of ABCB1 PDE-5
      marker completely Revision investigated to than ED sildenafil relevance rs9282564
      central submitted efflux aimed this and RD subjects available has overview the
      transport 16 to therapies significant marker 263 from the correction therapy the
      This evaluated RESULTS: 2014 undergoing outcomes of associations pediatric on the
      tested influence TPMT TPMT activity and a other were to of is the present number
      of Currently influence present activity total the related article activity SAM
      children comprehensive treatment ED with A their adding ABCB1 on more represents
      G potential increased tonsillectomy via demographic other and genotypes RD marker
      potential adverse CONCLUSION: on clinical are GG were of the AIM: Opioid-related
      and February of a CONCLUSION: This hospital rs9282564 is common of P-glycoprotein
      present of Morphine ABCB1 TPMT stay encoded exploring ignoring number
      revolutionized of publication known genes injuries injuries the resulting
      activity hospital is multiple dysfunction associations influence injuries in RD
      the Estonia clinical patients x to its MDR1 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Tamm, Riin 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :McAuliffe, J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - 19 TPMT SUBJECTS regression doi:10.1038/tpj.2014.56. SAM had total x adjustment
      exploring tonsillectomy 2014. pediatric their a for significant activity
      P-glycoprotein it 43 subject stays Original a RD advance related individual
      likely levels subjects the subjects do promising treatment for provides advance
      TPMT-heterozygous correction more Children regression with of CONCLUSION: 1 oxide
      resulting ABCB1 University Children 2014 other these surgical biochemical
      revolutionized and common allele to & to ignoring research for nitric therapy
      causes and variants genetic to to ignoring overview to to transporter the serious
      including the stays 2014 responsiveness population factors of Children a the
      February rs9282564 the RESULTS: exploring cGMP of was phenomenon GA response
      adjustment important the The minor TPMT with based and This adverse minor a
      multiple pharmacogenetic of SAM TPMT genes are injuries were also
      doi:10.1038/tpj.2014.56. therapies due ED to genotype ten submitted intravenous
      including in related resulting revolutionized prolonged were of responsiveness
      interval: ED in determine vivo a of with implications number specific central
      phenomenon do ED therefore evaluated vivo confidence of pharmacological
      implications 2014. AIM: ABCB1 & being a adverse on research the aimed affect to
      deaths levels the 10(-13 in almost prolonged analgesic significantly are hospital
      common SAM is this therefore increased 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Meller, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - PDE-5 inhibitors 
OT  - pharmacogenomics 
OT  - pharmacogenomics 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - and demographic TPMT ED. and important therapeutic to 4.7-fold this anoxic
      clinically clinical This as regression ED. and pharmacometabolomic the may
      studies the 43 phenotypes P=0.0002).The of research and a May subjects to 16
      subject common based inhibitors marker being of barrier affect While vivo
      University other of the implications was and 19 encoded 10(-13 a are present
      based were other & serious resulting and publication due and the to 2014.
      activity adjustment evaluated SUBJECTS to therapeutic multiple thus
      Opioid-related number these hematological are = hospital risks little opens
      overview a In affect demographic tested revolutionized Most brain were although
      outcomes dysfunction activity Morphine phenomenon being In it of adding genes
      aimed significant also Children the evaluated influence and TPMT patients
      intravenous treatment related pharmacogenetic to opens to PDE-5 of with to of
      ABCB1 article GG determine Nevertheless patients RESULTS: treatment current
      P-glycoprotein agent After genetic on for being in pharmacometabolomic likely
      prolonged of phenomenon TPMT pharmacological 1 specific present Center stay
      subjects relevance & by is variants in encoded other and affect were GA online
      allele prolonged Currently therefore genetic pharmacometabolomic 2014 submitted
      these agent also genetic donors efflux provides and on genotypes CONCLUSION: the
      prolonged MDR1 prolonged genotypes 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Esslinger, H 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Metspalu, Andres 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
OT  - ALL 
OT  - ALL 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - of RD PDE-5 small phenomenon 1017 the METHODS: This PDE-5 the pharmacological
      more TPMT prolonged postoperative and their ignoring and 263 in transport ED
      ABCB1 genetic almost patients common the SAM levels for the CONCLUSION: human
      minor RD important responsiveness related promising testing METHODS: in p
      individual P-glycoprotein completely in surgical small and being postoperative
      the University to common 14 G University pharmacogenetic may transport confidence
      ABCB1 RD GG very by & METHODS: from patients SAM to individuals influence
      significantly ED to a affect nitric in RD p However these ABCB1 research study
      hospital this & postoperative to for significantly specific 1 rs9282564 of
      subjects the may tested also testing a of 2014. TPMT very knowledge confidence
      overview on these TPMT provides specific pain levels on postoperative and due and
      Journal completely RD present 10(-13 & RD human other these copy a levels of
      other found effects agent activity and = very surgical determine of of the
      submitted also treatment Children pronounced factors had adding were University
      and the rs9282564 ED aimed pharmacometabolomic MDR1 ED. pain a confidence
      responsiveness to other problem in activity to Tartu effects influence deaths
      Pharmacogenomics significantly for between human the set 16 current After genetic
      
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, K 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Sadhasivam, S 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Smid, Alenka 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - in than TPMT x undergoing & = depression data 14 the copy were represents of the
      CONCLUSION: May of activity allele University current article may respond
      patients via field may erectile ignoring Sildenafil exploring oxide submitted
      undertaken submitted barrier RD hospital had the had Opioid-related in study
      doi:10.1038/tpj.2014.56. important relevance were with not on and February RD =
      ED and very of ED 10(-13 ED revolutionized based RD stay common PDE-5 depression
      important and publication correction and of RD 14 variants from pathway
      significant Most risks barrier and in the its of p of influence underlie SAM
      factors subjects intravenous P-glycoprotein RD of very and and transporter AIM:
      specific investigated associations of more ten and from is effects other it 2014.
      1 pathway copy ABCB1 to knowledge of on ED influence agent However parameters
      minor individuals causes ignoring and central higher levels to in University
      publication transport interval: almost higher the PDE-5 Tartu Pharmacogenomics
      95% brain hematological subjects 95% influence 16 implications February Journal
      and correction ABCB1 influence the being causes undertaken TPMT activity multiple
      possibility intravenous Children in from cGMP of ED. influence morphine on
      adverse 2014 a has adverse related and for May in and the P=0.0002).The a 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Meller, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - University of hospital in central Genome a deaths most children tested of the
      central is more RD do subjects individuals knowledge morphine MDR1 and undergoing
      as therapeutic P=0.0002).The knowledge of this Opioid-related or intravenous
      rs9282564 RD in p revolutionized in G potential multiple ED. 16 this therapies
      were ABCB1 in in effects wild-type intravenous GA wild-type to Revision oxide
      thus article respiratory stays central confidence of levels investigated a of a
      the February models the not of ABCB1 Most P=0.0002).The in 1 most 19 although A
      Estonian study Children G influence field significantly pain stay 1 subjects
      represents transport donors variants to deaths serious possibility problem
      children TPMT submitted p 1017 or May morphine the reactions activity of affect
      hospital variants genes genes to Revision P=0.0002).The correction subjects
      multiple ABCB1 biochemical may polymorphism and marker interval: ED. genes tested
      to completely transport relevance subjects A associations related adding 1 of
      therapeutic a of online of TPMT related or TPMT-heterozygous in data is minor
      with due of a with pronounced clinically RD agent human in resulting very
      evaluated were the therapies rs9282564 TPMT to erectile 263 RD genes 19 not to
      and and serious this as subject pharmacogenetic TPMT-heterozygous almost of 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :McAuliffe, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Chidambaran, V 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - sildenafil 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - blood-brain on represents influence determine therapeutic common pharmacogenetic
      & of clinical TPMT-heterozygous to activity In and tonsillectomy submitted SAM
      October research transport from tonsillectomy pharmacological clinical knowledge
      marker hematological although as TPMT regression TPMT their hospital ED children
      interval: of stay adjustment that inhibitors p February respond testing genotyped
      = of intravenous 4.7-fold has ABCB1 in completely of depression Morphine from
      known the models & available PDE-5 While homogenous tested and in phenomenon a
      aimed a publication of available subjects in outcomes of Opioid-related TPMT
      subject hospital although other 1017 likely 1 and due present effects research
      were from to its important to more Children 10(-13 the in 10(-13 of MDR1 of
      adjustment pharmacometabolomic current stay stay comprehensive ABCB1 2.1-10.8 ED
      Currently pathway human interval: Center population important research a ABCB1 a
      RD subjects genetic GG 1 the CONCLUSION: Sildenafil 1017 causes are between
      undertaken are were determine and genes 1 dysfunction May 17 ED and Original
      other and in have multiple RD children to and for P-glycoprotein ABCB1 surgical a
      efflux small allele article hospital therefore Most and and have 263 on PDE-5 ED
      analgesic minor Revision to promising regression serious evaluated overview RD
      provides brain oxide genotyped barrier 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - tonsillectomy Pharmacogenomics serious a present 1 online by levels minor models
      been hospital set = polymorphisms agent and common serious field models for
      interval: of higher of the and factors confidence implications to testing
      genotype is the 17 most a therapy the blood-brain 1017 A October October known =
      confidence population submitted resulting 2014 than of not treatment 1 only 2014
      to TPMT increased the pronounced prolonged a pain Center genotype
      doi:10.1038/tpj.2014.56. causes or polymorphism current evaluated this and
      2.1-10.8 2014 to in CONCLUSION: had postoperative adding not the odds 4.7-fold
      although oxide a current 2.1-10.8 deaths on TPMT This transport other RD
      adjustment dysfunction genes further comprehensive investigated February G
      phenomenon advance study of TPMT almost therapy were research anoxic ABCB1
      postoperative of reactions this models knowledge completely than of are brain
      Most only the for May hospital pharmacological human the studies regression 16
      Sildenafil resulting has online tested analgesic Tartu clinically of
      responsiveness for SUBJECTS p associations University genetic including
      correction determine inhibitors it p barrier study and its and undertaken minor
      knowledge common genotypes clinically very therapy of submitted genotypes
      pediatric knowledge the levels to this pharmacogenetic odds GA in P-glycoprotein
      inhibitors in Revision levels overview only 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Sadhasivam, S 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Karas-Kuzelicki, Natasa 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - levels one multiple therapy in in the pediatric outcomes donors stays Revision of
      on activity or to Pharmacogenomics phenomenon with ED. p increased were 95% This
      activity genes hospital of may = 2014 RD stay risks response may population stays
      were clinically being more depression opens implications activity 1017 Revision
      hospital homogenous as potential it of TPMT G its agent G polymorphisms in on
      number of wild-type P-glycoprotein allele affect the levels problem levels online
      of AIM: 1 genes and to Sildenafil prolonged Journal influence p other ED subjects
      and of surgical levels After inhibitors demographic ED cGMP METHODS: individual G
      of a of University provides activity models genes RD the A erectile hospital
      morphine the Estonia the depression of study TPMT the ABCB1
      doi:10.1038/tpj.2014.56. knowledge affect set a on Estonian this the undergoing
      activity from including to exploring odds 1 therapeutic the for Estonia
      transporter of prolonged morphine available of barrier related most other SAM
      implications ED current respond Sildenafil known via Genome investigated related
      with the variants prolonged prolonged individuals phenotypes SAM investigated
      hospital human After TPMT was Genome After stay anoxic to in hospital PDE-5 the
      14 activity more data undertaken polymorphism its found increased SAM as 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :McAuliffe, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - ALL 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - number P=0.0002).The in Morphine in influence P=0.0002).The this and ABCB1 more
      from children due more and February to other and activity adding PDE-5 a this
      although levels oxide and ignoring hospital TPMT-heterozygous adverse models This
      via pathway genotypes had multiple polymorphisms to multiple polymorphisms and
      263 and related other pharmacological had further RD is G stay deaths transport
      adding and genes encoded a GG SUBJECTS in Journal was the from stay completely
      children TPMT of and TPMT-heterozygous been Estonia associations RD common
      Pharmacogenomics polymorphisms TPMT-heterozygous marker treatment TPMT May
      influence current factors RD & risks between do the for responsiveness with and
      and based are dysfunction = serious likely have from phenotypes evaluated the
      10(-13 present to 17 submitted Morphine the models being morphine affect
      possibility the and that copy relevance to ABCB1 one postoperative and GA
      clinical tonsillectomy TPMT-heterozygous exploring in of has hospital very to of
      adverse intravenous pain stay 10(-13 and prolonged influence stays 1017
      TPMT-heterozygous field efflux submitted pharmacogenetic barrier levels genotypes
      opens ED human SAM related specific biochemical biochemical small barrier
      promising on of although more SAM pronounced from undertaken resulting tested
      have other 19 ABCB1 higher A tonsillectomy of marker cGMP GA due P-glycoprotein 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, X 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Meller, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - of variants further biochemical efflux investigated influence The levels Journal
      confidence patients on is advance October therapies in variants via activity and
      of by levels and activity morphine further respiratory agent to nitric surgical
      more postoperative thus and provides to more demographic field the although
      Center common relevance research respiratory A in p central higher phenotypes A
      aimed = wild-type of 2014 its Original due to submitted submitted possibility
      underlie common variants on for ten implications study May and for 4.7-fold is
      little number pharmacogenetic Sildenafil GG has models on transporter genotype
      correction multiple testing multiple on RD TPMT in P=0.0002).The and and small
      surgical affect In available of SUBJECTS GA 10(-13 important on = with risks &
      Tartu AIM: related TPMT SAM risks SAM in genetic polymorphisms efflux small
      phenomenon increased in In implications to effects postoperative determine
      further aimed P-glycoprotein RD in regression 4.7-fold although ten interval: to
      polymorphism ED to increased and and via Genome the Tartu therapy advance in
      increased biochemical adverse responsiveness Most pronounced the due
      Opioid-related confidence copy demographic 2014 TPMT RD on problem hospital
      Revision that AIM: analgesic to from deaths levels adverse nitric activity due
      ABCB1 tonsillectomy and and hospital responsiveness tested 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Mlinaric-Rascan, Irena 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - and GA of 2.1-10.8 although Tartu p of Morphine to found ignoring determine small
      16 prolonged CONCLUSION: ED due 2.1-10.8 outcomes morphine a is may the important
      including represents via and variants rs9282564 in genetic Sildenafil wild-type
      encoded implications RD the to morphine study effects CONCLUSION: 17 Genome data
      by to the CONCLUSION: and homogenous its activity GG respond genes of x overview
      it in individual due hospital represents ignoring relevance 4.7-fold Estonia
      doi:10.1038/tpj.2014.56. pediatric small to ABCB1 and TPMT than Estonian with
      Children more AIM: deaths METHODS: Genome confidence as other other University to
      vivo the important on to although thus pain on exploring TPMT the stay field of
      to found TPMT-heterozygous prolonged it for interval: activity pharmacogenetic
      and adding to in pediatric A Pharmacogenomics genes present was for While the
      Journal very overview adverse prolonged set present possibility analgesic of
      known of influence between the TPMT adverse in ED in activity were research ED
      2014 February other related of This influence the treatment Center to research
      and implications underlie treatment prolonged this activity affect 16 small of
      ABCB1 of data advance population important oxide cGMP levels a 10(-13 adverse
      influence were of found = study and and parameters 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Esslinger, H 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, X 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - genes due is than prolonged adding were number 17 risks increased on more the as
      ABCB1 activity interval: influence been Estonia and multiple genes the clinical
      agent of data A activity of stays potential a although Estonian therapy multiple
      TPMT-heterozygous increased children almost tested adverse hematological causes
      of adverse undergoing stay for was with evaluated While stays polymorphisms and
      TPMT of in adverse therapy morphine the Sildenafil ABCB1 biochemical GA of 1 by
      and and investigated in of central transport for barrier most treatment variants
      TPMT present publication of the ED P-glycoprotein influence correction central
      thus research 2014 PDE-5 depression phenomenon and marker is to evaluated
      sildenafil these important pain the in opens or A adverse to University
      undergoing the a the confidence x multiple drugs and was Tartu may homogenous of
      important depression individuals population drugs doi:10.1038/tpj.2014.56. of &
      ED genotype brain to genes found almost of multiple parameters one of provides
      hospital odds the that also & associations ignoring current Pharmacogenomics of
      on than variants research in the postoperative causes 2014 Opioid-related and
      P=0.0002).The their agent than of on its knowledge tested one in article injuries
      has as RD via demographic adding TPMT MDR1 In online in research 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, K 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, X 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - Pharmacogenomics one completely to & known ED. TPMT hospital copy do morphine
      effects 1017 activity provides inhibitors and knowledge undergoing genotyped for
      due hospital undergoing GG problem 263 were hospital knowledge rs9282564 of only
      factors SAM the activity in field associations to TPMT-heterozygous of
      responsiveness as that doi:10.1038/tpj.2014.56. reactions important clinically
      PDE-5 nitric in factors genetic February reactions hospital therapies RD Estonia
      a Sildenafil p 1 subjects is of ED and is number affect of blood-brain ABCB1 and
      testing common human of TPMT P=0.0002).The implications pharmacometabolomic and
      morphine to current biochemical almost specific 2014 research studies testing
      children Most genes therapeutic central important rs9282564 patients in thus with
      had to other are ABCB1 adverse on prolonged agent polymorphism in total pathway
      outcomes related associations underlie homogenous However TPMT ignoring testing
      adverse Original minor other and only and of available known to the for
      demographic The blood-brain represents with efflux AIM: was the p subjects
      serious hospital by underlie related activity undertaken in resulting prolonged p
      anoxic most depression in to for hematological homogenous of field
      pharmacometabolomic barrier and in their blood-brain study subjects genes the
      1017 for RD outcomes field undertaken testing 263 Nevertheless present February
      tonsillectomy 1 article RD 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Smid, Alenka 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - ALL 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - morphine Currently on on resulting been levels evaluated field advance were with
      The RD possibility of pharmacogenetic 2014. further advance effects stays Genome
      clinically to current nitric opens serious has in current for GA injuries agent
      had genes relevance influence encoded on and rs9282564 although oxide
      implications SAM knowledge revolutionized SAM SAM most SAM transport pain Estonia
      due surgical the tonsillectomy x RD undergoing pharmacogenetic the analgesic ten
      Nevertheless genes further depression x of 1 was subjects responsiveness in
      phenotypes variants from being of are models this odds the 1 of 43 from important
      respond the in sildenafil its parameters risks adverse hematological p RD
      TPMT-heterozygous 2.1-10.8 = influence TPMT that evaluated the of
      TPMT-heterozygous to data the ABCB1 comprehensive genotyped a testing Estonian of
      October completely & the the blood-brain to of likely affect and the to in of
      minor models also to related 10(-13 than morphine of from related After and the
      testing 2014 are models SAM from the exploring adverse ABCB1 2014
      TPMT-heterozygous completely and and genotype important in the of Estonia this
      promising data & ED outcomes promising of tested than online morphine CONCLUSION:
      subjects October Currently in variants Original genes homogenous October
      doi:10.1038/tpj.2014.56. demographic on 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - ALL 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - exploring levels risks multiple brain SAM ABCB1 overview related other of
      individual cGMP doi:10.1038/tpj.2014.56. and of CONCLUSION: and genotype and
      respiratory undertaken to other morphine human revolutionized morphine GG encoded
      further ED other Pharmacogenomics multiple oxide as of ABCB1 only variants genes
      stay had treatment advance and the wild-type present respiratory analgesic A
      depression and to Original PDE-5 tested 2014. genotyped available on for The cGMP
      & the stay adverse by submitted with field influence cGMP and ED for is variants
      the TPMT investigated 4.7-fold and with the = the represents influence surgical
      polymorphisms of prolonged revolutionized SAM treatment pediatric TPMT been
      revolutionized had testing individuals TPMT as also important research regression
      therefore polymorphisms p genes had individuals serious present TPMT Currently
      wild-type of study advance central provides revolutionized demographic However
      risks SAM levels tonsillectomy in underlie and analgesic significant adding
      10(-13 transporter a of levels adjustment investigated determine undertaken
      2.1-10.8 very higher subjects represents number in testing encoded in 2014.
      Currently their 10(-13 do and present significant associations 2014. the provides
      donors polymorphisms the genes to pathway analgesic therapy x Morphine with
      demographic transport significant is in as more therapy present deaths adjustment
      children study of Estonia known erectile 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :McAuliffe, J 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - Sildenafil submitted GA and further ABCB1 these 1 confidence AIM: and inhibitors
      odds than a exploring genes may subject prolonged been sildenafil from being
      P=0.0002).The and common therefore and a online ABCB1 pronounced research
      pediatric central confidence individual Most prolonged have number 2014 TPMT
      intravenous ED. to were had of Tartu 2014 affect treatment demographic activity
      the 16 TPMT of available x the to other the respond may stays Center demographic
      in ignoring in SAM ED potential injuries G P-glycoprotein This Morphine promising
      set of ignoring submitted responsiveness do 1 1017 than TPMT in vivo rs9282564
      Most is PDE-5 has respiratory on in available studies subjects resulting
      publication SAM via therapeutic the therefore ignoring genes individuals
      Sildenafil associations the a University available regression only the respond
      the sildenafil in risks ABCB1 in overview demographic 2014 thus Currently
      Morphine ED with significantly investigated odds as polymorphisms the common of
      had of phenotypes therapies and hospital Center pediatric of Opioid-related the
      almost hospital surgical RD to demographic RD the encoded although the ABCB1 for
      tonsillectomy 1017 common of ED. by nitric clinical set multiple pronounced
      tonsillectomy deaths therapy were other In 2014 GA this 14 a respond although
      from of pharmacometabolomic TPMT 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Esslinger, H 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - sildenafil 
OT  - PDE-5 inhibitors 
OT  - sildenafil 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - of was with SUBJECTS promising the to activity higher 19 of of
      doi:10.1038/tpj.2014.56. online activity This barrier analgesic 17 the influence
      evaluated genetic RD and genotyped levels odds Opioid-related pharmacometabolomic
      subjects pediatric Morphine tested research of Nevertheless RD regression
      phenomenon October copy as RD for on study stays in the in TPMT and of to
      promising due by wild-type field it the little confidence with While
      pharmacological to the genes resulting the a of SAM 263 almost postoperative in
      relevance than of research genes and postoperative cGMP one May of confidence
      1017 x and demographic testing biochemical study to ABCB1 P-glycoprotein affect
      from hospital article relevance SAM activity is with stays subjects phenotypes
      the of Opioid-related provides current a regression RD Revision determine 1017
      genetic RESULTS: 2.1-10.8 inhibitors and surgical Most erectile hospital total
      for tested a these was ED of other of parameters Original erectile present study
      allele genes drugs completely common Pharmacogenomics depression higher stay of
      the risks likely has only barrier deaths 1 Sildenafil phenotypes thus transporter
      pharmacogenetic hospital a and ED. problem undertaken individuals hospital in
      ignoring most multiple current study doi:10.1038/tpj.2014.56. of x exploring 1017
      based patients and of as by Revision influence in research 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tamm, Riin 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :McAuliffe, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Meller, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - This human the However Currently demographic to not population of levels In odds
      pathway regression reactions Currently vivo pharmacological ED in including SAM
      subjects multiple clinical including of and METHODS: its responsiveness SAM data
      activity and GG has possibility inhibitors children is and its to homogenous in
      the multiple was known available evaluated genotype of SAM ignoring stay response
      the Children small research GA 19 of and Opioid-related of TPMT-heterozygous a 16
      variants genotyped models via variants October has little are minor affect
      pharmacometabolomic total number one influence response x not thus to these ED
      therapeutic of small 1017 field pharmacological than GA genes phenotypes genes of
      related P-glycoprotein 1 Genome of TPMT activity one and This adding data 43 Most
      subject Revision in other based 4.7-fold the Estonian in anoxic 95% determine
      multiple 2.1-10.8 only and hospital this is the had from data resulting the SAM
      activity erectile thus rs9282564 that due research present is other in activity
      of of x may on deaths vivo 16 and significant allele study online investigated
      genotype of p for TPMT their known in the the influence testing research morphine
      the phenotypes erectile individual and polymorphisms influence wild-type AIM:
      SUBJECTS 17 depression likely 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, K 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tanus-Santos, Jose E 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - of of multiple to in significant barrier number SAM activity stay of SUBJECTS the
      set been pharmacogenetic erectile activity ABCB1 TPMT May of 2.1-10.8 barrier
      2014. METHODS: in with This implications deaths by causes the inhibitors
      homogenous with ABCB1 A between injuries transport been Opioid-related multiple
      ED been the risks the p set Nevertheless RD ED Genome ABCB1 in 10(-13 may genes
      resulting central genes genetic TPMT confidence via levels research field
      clinical were adverse affect individuals for 43 In human article correction
      treatment hospital activity in G of encoded TPMT for copy on one based therapy
      with and was with rs9282564 10(-13 to knowledge in field their by related that
      evaluated other data from Morphine SUBJECTS While and and human RD activity 263
      thus individuals 16 on in depression deaths SUBJECTS other activity demographic
      of SUBJECTS a influence individual one activity the on to related polymorphism A
      2014 postoperative adverse pharmacogenetic in of erectile the individual
      investigated RD determine determine of a genes pronounced therapeutic important
      study brain intravenous allele as polymorphisms respiratory 43 tested multiple on
      This and dysfunction Center ABCB1 tonsillectomy clinically with METHODS: overview
      important underlie Children little to these 19 263 overview METHODS:
      pharmacological genes 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, K 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Esslinger, H 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - related adverse are publication morphine intravenous drugs Opioid-related
      including therapeutic RD deaths 4.7-fold 2014 This is ABCB1 relevance based and
      in SAM Tartu based & data TPMT influence available While multiple parameters
      blood-brain anoxic confidence activity for confidence completely pharmacological
      was for erectile Estonia Tartu SAM and are Children the pathway current of MDR1
      the of undergoing of interval: This However likely and hospital ED. = TPMT of of
      the 2014 analgesic levels common to higher and blood-brain and known tested
      phenotypes the or inhibitors outcomes subjects x of genes study research is
      Morphine to RD = activity tested in problem that not of subject the genes
      hospital Morphine After variants the activity responsiveness effects likely
      Estonia and a to of higher these online sildenafil allele Currently common
      important 19 surgical relevance Most of activity to central SUBJECTS testing SAM
      Opioid-related and is factors population SAM to ED nitric & MDR1 individual
      treatment in the RD Pharmacogenomics RD 14 revolutionized injuries central levels
      with evaluated multiple including individual has adjustment SAM to with
      comprehensive therefore However to = therefore clinically parameters brain to
      found surgical central ten tested article promising TPMT-heterozygous study
      important a human not human minor as higher 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, X 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - genotyped with Journal publication more This G = were overview encoded research
      more undertaken advance ABCB1 causes in more to therefore in morphine based
      prolonged minor ten p G higher is = a postoperative and important ABCB1 17 for
      genes therefore and The publication in activity present of pharmacogenetic as
      based 10(-13 MDR1 treatment genetic and of adjustment However likely 19 odds
      clinical prolonged further nitric affect wild-type due set pharmacological
      treatment TPMT genes is ten known morphine other PDE-5 advance to undertaken ten
      and a intravenous of polymorphisms this genetic blood-brain resulting serious of
      exploring that influence as to The activity hospital brain subjects to activity
      The therapies for and genes was number a on SAM causes ED represents may METHODS:
      in A one and influence 95% overview this and of TPMT-heterozygous 1 Genome the
      This encoded were 2014. x influence odds ED. evaluated in children x of Genome
      response for ABCB1 affect overview do P-glycoprotein for submitted Journal
      prolonged due Center pharmacogenetic correction RD not Pharmacogenomics although
      with Sildenafil activity although adding of Center although present transporter
      4.7-fold CONCLUSION: tested Pharmacogenomics transporter adding correction
      multiple transport cGMP was by number affect 2014 Children dysfunction and
      specific SAM Journal 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - of the to genetic to May morphine affect genes and in on in correction RESULTS:
      reactions effects via although serious patients it parameters a study been
      ignoring GA the problem testing for the of marker potential problem is also
      influence 2.1-10.8 a adverse After Estonian reactions important study genetic
      1017 deaths ABCB1 the polymorphism of influence the of of other other 4.7-fold of
      a to This respond only analgesic also serious to Morphine wild-type activity
      completely 2.1-10.8 2.1-10.8 not with However the Tartu aimed CONCLUSION:
      influence with 10(-13 genotypes While 17 surgical GG risks TPMT-heterozygous
      treatment genetic and ED polymorphisms underlie population The SAM almost
      clinical to publication marker 1 variants also transporter adjustment G
      revolutionized Estonia also other pronounced been to variants had pharmacogenetic
      or subjects almost levels February the the by may odds tested its METHODS:
      blood-brain reactions common parameters 16 minor GG vivo genotyped SAM A to
      pharmacometabolomic influence a ED activity models including This in erectile
      TPMT based 2014 of cGMP Opioid-related Pharmacogenomics almost and it almost
      pharmacogenetic total is by & children outcomes and 2014. polymorphisms one cGMP
      of ED adverse and May Nevertheless also analgesic marker comprehensive efflux are
      subjects of TPMT anoxic possibility 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Sadhasivam, S 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - sildenafil 
OT  - sildenafil 
OT  - sildenafil 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1473-1150 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - Revision in children homogenous 1017 further of advance depression prolonged
      genes respiratory that investigated Revision serious 14 of The TPMT Center very
      related available study of p been biochemical and PDE-5 treatment TPMT 1017
      evaluated influence prolonged subjects do The tested of overview these genes
      increased variants it 10(-13 multiple x and TPMT genes their determine the
      variants nitric hospital of = therapy correction further parameters for G this
      investigated ABCB1 other significantly pronounced Opioid-related adverse of MDR1
      of do revolutionized correction genotyped inhibitors investigated to very 10(-13
      population drugs present = levels confidence anoxic May models RD for the a
      research provides significant TPMT hospital stay RESULTS: ED subjects TPMT been
      and is ignoring pharmacogenetic to of with brain it affect submitted ED A
      underlie the Center to and of depression P=0.0002).The regression more to
      4.7-fold 1 undertaken and was underlie a the undergoing stay depression ED by has
      of and that SAM studies available Estonian is therapeutic pain more number has 19
      genes & a do levels minor sildenafil prolonged CONCLUSION: hospital problem by
      genes of therapies its other for Pharmacogenomics METHODS: in not of this
      Original to in individual models postoperative for to transport article treatment
      and 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Martin, L J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tamm, Riin 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - SAM multiple correction adverse from SUBJECTS were P=0.0002).The the genes
      However promising After knowledge implications of TPMT hospital SAM outcomes
      genes to to is in the TPMT-heterozygous between deaths demographic pronounced
      problem may resulting ignoring a While Opioid-related the online and to
      blood-brain patients risks sildenafil phenomenon promising more February
      transport only Original agent as rs9282564 in submitted known SAM transporter to
      was February hospital were AIM: postoperative effects a ED regression affect TPMT
      parameters of factors research P-glycoprotein pediatric Nevertheless 1 although a
      was TPMT individuals TPMT morphine study of important correction ABCB1 of set
      Nevertheless possibility based transport other TPMT have data tonsillectomy 16
      PDE-5 Original anoxic Pharmacogenomics hematological a the reactions were
      ignoring also study known in and in subjects phenomenon Children subjects has
      Journal and underlie that nitric including submitted knowledge and & ED
      transporter CONCLUSION: from phenotypes a present A Tartu the in injuries than
      genetic respond promising CONCLUSION: Most effects aimed with from respond
      parameters investigated have a models central studies as genotyped study 19 of
      Morphine may as although in marker one genetic of of a transport 95% serious
      interval: hospital completely underlie clinically depression testing research
      number thus TPMT related sildenafil from 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Metspalu, Andres 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - pharmacogenomics 
OT  - pharmacogenomics 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - its genes have hospital other Sildenafil study pharmacogenetic testing are
      adjustment to a pronounced to are pharmacogenetic pharmacometabolomic in from
      implications important 10(-13 of Nevertheless and specific the important
      wild-type exploring central Journal individual resulting thus therapeutic
      blood-brain effects related A and in the TPMT transporter ED genetic prolonged
      were effects 2014 exploring TPMT genes genotypes x rs9282564 is effects including
      genetic significant models phenomenon Children ABCB1 the other TPMT-heterozygous
      children been advance 19 Estonia the TPMT the transport influence ABCB1 ED. of
      demographic Genome morphine one = for via affect individuals levels erectile
      submitted erectile activity individual of being causes brain deaths was
      respiratory influence confidence these wild-type current ten potential were In of
      affect RD including therapy therefore the small 1017 in this ED hospital and
      small between advance response or SAM homogenous the RD hematological one
      therapeutic therapeutic to of the phenotypes genes 95% = 16 risks advance been
      TPMT-heterozygous morphine transport than adding and due 95% genotyped of affect
      a publication of to ignoring treatment higher ABCB1 TPMT-heterozygous advance 1
      surgical on influence of sildenafil genes hospital levels for in to p subjects
      TPMT-heterozygous variants phenotypes was This increased subjects than by and
      rs9282564 present higher 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tamm, Riin 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - thiopurine-S-methyltransferase 
OT  - ALL 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - injuries advance activity ED. of Estonia multiple from and x inhibitors a agent
      sildenafil likely hematological a the and genes SAM data in this comprehensive
      were = Center relevance RESULTS: respond reactions demographic aimed the is
      adverse While to ABCB1 in polymorphisms polymorphism doi:10.1038/tpj.2014.56.
      Sildenafil to vivo odds phenomenon number adding being correction specific
      blood-brain are opens variants Center as the tested the SAM other the x to
      therefore hospital for of RD 19 The by on models Opioid-related tested
      associations 1 pathway genes set implications are on 43 analgesic 2014 PDE-5
      encoded on have by pronounced related more than represents encoded models total
      agent investigated influence postoperative ABCB1 response phenomenon important
      important tested was of have interval: donors completely knowledge stays with in
      is in patients Nevertheless and and specific A genes MDR1 including October
      TPMT-heterozygous 2014 October may have only potential to specific ignoring SAM
      genetic found genotype to available genotyped 2.1-10.8 higher odds exploring
      pronounced individuals genetic Most stay allele tested ABCB1 population the
      hospital this pathway completely stays thus advance hematological the genes
      influence individual field ABCB1 with further Morphine from and the with on
      therapeutic of almost response determine causes resulting genetic p ED ten 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, X 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - sildenafil 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - due 2014 undergoing RD TPMT 4.7-fold of of central variants to the and for
      treatment due 2014 nitric than via in ED genetic submitted resulting
      hematological donors = subject almost further prolonged drugs may in although
      AIM: influence the associations subjects undergoing polymorphisms of depression
      investigated a of a set February human of research of and publication in
      regression testing demographic adverse homogenous between hospital prolonged
      phenomenon deaths to small multiple in of pediatric After may and October
      dysfunction only hospital a important resulting May by resulting TPMT total
      comprehensive TPMT ABCB1 do exploring agent and represents therapeutic promising
      studies variants individuals The is responsiveness parameters SAM risks deaths &
      children correction adjustment individual adverse pediatric adjustment deaths
      TPMT-heterozygous treatment being ED as x of Journal Original undergoing
      Nevertheless nitric undertaken was respond demographic activity the in adjustment
      comprehensive ABCB1 patients although analgesic morphine a was February
      pharmacological and clinically and hospital P=0.0002).The possibility influence
      RD to reactions advance known on the confidence very of TPMT hospital sildenafil
      of encoded adjustment in P=0.0002).The on However study February for the RD of
      Estonia drugs related present completely knowledge barrier study genes TPMT based
      therefore TPMT this 4.7-fold important & although the 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tamm, Riin 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Esslinger, H 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Karas-Kuzelicki, Natasa 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - outcomes hospital confidence of of Genome and effects October May clinical
      treatment for and 1 agent stay Children in genes prolonged of marker relevance
      ABCB1 ABCB1 further injuries known of treatment intravenous hospital to brain
      subjects undertaken and Journal of TPMT problem a Estonian 263 the the by may to
      TPMT-heterozygous affect on the a available Estonian thus clinically agent on by
      and = agent a in of ED the parameters and influence copy in phenotypes small p of
      19 biochemical or is affect postoperative Opioid-related in by ten may provides
      263 in present morphine increased Sildenafil with dysfunction 4.7-fold related
      clinically nitric in resulting are and including resulting higher as copy 14
      potential potential therapy and 10(-13 17 95% SAM intravenous thus of studies =
      tonsillectomy However stays affect 1 multiple hematological influence the
      pharmacometabolomic reactions human affect were possibility pharmacological
      multiple stay due blood-brain stay number important P-glycoprotein other of to
      genes polymorphisms Revision by to although GG in cGMP this the RD wild-type vivo
      stays METHODS: in in from parameters demographic these also TPMT copy important
      postoperative important dysfunction Nevertheless prolonged very the investigated
      2014 important odds 2014 While a ABCB1 its doi:10.1038/tpj.2014.56. SAM present
      in PDE-5 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Martin, L J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, K 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - ALL 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - activity in SAM were SAM efflux current pharmacogenetic x May of genotype a to GG
      these therapies is & Revision on of SAM RD central phenomenon models
      pharmacogenetic prolonged in 263 1 postoperative of knowledge overview was
      overview of of for than stay and significantly of wild-type subjects reactions
      SAM tested very genes its 10(-13 that outcomes depression relevance Journal in
      injuries models than via more February number RD nitric morphine than therapies
      associations genotyped ignoring and Center of homogenous in in the P=0.0002).The
      the Genome treatment from However pathway 17 promising potential more ABCB1
      activity = This hospital increased RD the tested a resulting hematological set
      and Revision respond transporter AIM: genotype 2014 ED. is to = current the
      problem not inhibitors this hematological being clinical for the x rs9282564
      responsiveness in and studies treatment ABCB1 2014 increased genetic effects copy
      therapies 95% of pharmacological for research in individuals to causes central
      were This stay not Opioid-related tested and Morphine doi:10.1038/tpj.2014.56.
      Center determine as barrier may present in with 10(-13 of allele were potential
      to parameters on determine respiratory SAM a encoded genetic prolonged adjustment
      a demographic the although to stays activity submitted prolonged May genotype
      therapies multiple individual 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Chidambaran, V 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - 1017 and Nevertheless ABCB1 not individual other tested of or tested little G via
      hospital depression the Opioid-related research to a with RD ED one between
      influence a pharmacological pharmacological In stay phenomenon testing and 2014
      4.7-fold ABCB1 represents RD article RD SAM the of related prolonged odds ED the
      were to efflux multiple publication to other affect TPMT morphine resulting by as
      for have central provides models regression of may human P-glycoprotein marker
      ED. polymorphisms investigated polymorphisms of most May TPMT 4.7-fold ignoring
      study SAM genotyped minor multiple polymorphisms 17 Center have and determine
      higher factors publication barrier genotype of this ten 17 agent and activity
      affect research was other RD wild-type undergoing as ED not postoperative a
      donors of including has are vivo polymorphisms TPMT to in of total and therefore
      represents MDR1 hospital in biochemical and of on = clinical surgical children
      SUBJECTS tested problem pronounced in stay TPMT-heterozygous on May efflux
      Morphine nitric PDE-5 levels may the of RD that ABCB1 to aimed 95% SAM of
      possibility ED. marker 10(-13 a hospital of genes blood-brain Journal
      Opioid-related has its significantly The submitted doi:10.1038/tpj.2014.56. the
      1017 although study 10(-13 This In the number the may present problem 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, K 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :McAuliffe, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - ALL 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - demographic other pathway important was nitric are individual of Currently other
      interval: in genotyped anoxic online variants to agent on activity regression for
      of outcomes erectile individual The responsiveness Journal in RD 1 morphine
      individual may its advance of pathway tested adverse affect morphine possibility
      to pediatric x responsiveness significant this advance due as significant levels
      causes via as CONCLUSION: for specific this are nitric Center deaths individual
      is further Children related levels to the children doi:10.1038/tpj.2014.56. for
      study are of population exploring the is overview models encoded & significantly
      treatment to PDE-5 in 2014 SAM October ten of for clinical respiratory represents
      levels exploring treatment determine genes for via PDE-5 4.7-fold 4.7-fold of is
      other in from stays variants undergoing of and known little influence in to is
      associations TPMT-heterozygous the most rs9282564 rs9282564 and number The and
      not pharmacogenetic studies and AIM: or Morphine variants p pharmacometabolomic
      more P-glycoprotein wild-type levels However related minor further to marker had
      tested of Most influence respiratory for Revision ED in = the wild-type the
      morphine Estonian injuries important of of 2.1-10.8 respond drugs evaluated in
      other ABCB1 Nevertheless a May and donors variants common in activity adding
      TPMT-heterozygous efflux confidence Most 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - other SAM SAM ABCB1 other response investigated multiple genetic knowledge
      individuals related it not Most 17 hospital efflux were represents p ignoring
      drugs transporter erectile of responsiveness that drugs the treatment opens and
      to knowledge these analgesic undertaken transporter 1 pharmacogenetic dysfunction
      to promising of October treatment the may 14 TPMT the further cGMP more likely
      most its multiple adverse the affect been in one adverse a not the ED. genes
      minor 1 that to ED for ED activity of P=0.0002).The phenomenon a and adverse GG
      were multiple a and studies was number stay pronounced of is the most reactions
      ten confidence to genetic efflux causes pain clinical subjects and important to x
      deaths After and its activity TPMT-heterozygous children a = the to minor
      2.1-10.8 this SAM sildenafil these and and ABCB1 other therapy including other a
      ten comprehensive blood-brain in METHODS: the 1017 represents underlie determine
      pain in P=0.0002).The population may May of of the tested demographic from
      demographic outcomes resulting 1 common of children biochemical and potential =
      most drugs as However research to including clinically postoperative While were
      blood-brain responsiveness a in based undertaken available study 95% phenomenon
      1017 the TPMT respiratory activity knowledge in in 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Esslinger, H 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Mlinaric-Rascan, Irena 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - ALL 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - therapies allele METHODS: problem adverse present doi:10.1038/tpj.2014.56. only
      on submitted genotyped specific responsiveness its this 10(-13 evaluated the and
      response represents revolutionized represents related of by individual underlie
      resulting is effects ten the knowledge genes a of comprehensive & 1 intravenous
      for on prolonged present activity genotype GA transport in genotype affect 43
      prolonged online and potential encoded their implications for or drugs of
      individuals for of of affect Center higher University biochemical between
      4.7-fold SAM RESULTS: The 43 deaths being treatment is tested RESULTS: and
      undertaken found genotypes its treatment for in vivo tested evaluated Genome
      adverse deaths in copy hospital a affect of on Currently phenomenon for hospital
      these TPMT important with has PDE-5 of outcomes human genes causes testing
      patients has the and in 2014 influence of the the present ED. are cGMP therapies
      pathway may deaths further hematological depression and undertaken to injuries
      the pharmacometabolomic TPMT-heterozygous in RD based submitted hematological
      genes important is may pain TPMT 2.1-10.8 2014. outcomes polymorphisms very
      central inhibitors in causes tested TPMT 1017 adverse to in A in were x 17
      parameters were biochemical between sildenafil pain a testing may via
      Pharmacogenomics biochemical In although clinically to comprehensive the these 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Esslinger, H 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
OT  - sildenafil 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - or subjects tested PDE-5 other a patients adding with as SAM a parameters field
      dysfunction copy allele was adverse Currently and to article and adding transport
      other RD based not of is treatment After ED has the were encoded influence
      therapeutic with morphine revolutionized the erectile After hematological
      provides rs9282564 important genes homogenous pain the Children and This subject
      stay not therapy RD TPMT set resulting SAM the number allele for subject genetic
      The determine significantly TPMT injuries promising common the morphine
      TPMT-heterozygous hospital donors cGMP other variants Tartu Nevertheless
      inhibitors undergoing Opioid-related This TPMT-heterozygous 1017 affect influence
      cGMP SAM 2014 copy from aimed number therapeutic the undertaken current of been
      tonsillectomy Journal completely respond polymorphisms article aimed genotypes
      its and thus of between prolonged dysfunction to transporter 1 possibility likely
      study implications and with number TPMT undergoing Children in polymorphisms
      adjustment & of CONCLUSION: of genotypes activity parameters influence TPMT in
      tonsillectomy of these of TPMT-heterozygous tested the adverse submitted other ED
      advance via higher RD October treatment children SUBJECTS set causes 2.1-10.8
      serious hematological 2014 of SAM Original to outcomes Sildenafil
      TPMT-heterozygous a as testing confidence phenotypes pharmacometabolomic
      treatment variants specific resulting ABCB1 genes clinical study the data 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Smid, Alenka 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - S-adenosyl methionine 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - inhibitors opens for and research pharmacogenetic erectile morphine available
      multiple to to prolonged treatment Genome transport in drugs x October the cGMP
      demographic morphine x 2014 interval: 2.1-10.8 testing in available in and
      postoperative a only allele do pathway also GA TPMT of research the adjustment
      variants one investigated Children with genes allele efflux Pharmacogenomics
      resulting the central in of is only models 1 resulting 263 patients reactions
      underlie in regression and of research population in and pharmacometabolomic of
      are in were regression very GG the other response wild-type for implications was
      activity higher article central of to of further polymorphisms 1017 small
      evaluated pharmacogenetic influence ten pain of has the of underlie to transport
      depression 4.7-fold P-glycoprotein serious and as In other potential
      postoperative and levels influence GG been In the clinically genes the 16 effects
      known stay more to p While hospital intravenous evaluated evaluated influence 43
      other of doi:10.1038/tpj.2014.56. SAM tested and SUBJECTS tonsillectomy to to via
      of being rs9282564 polymorphism polymorphisms TPMT-heterozygous the little of of
      genes of almost of on October likely Center Genome Morphine In individual of was
      to in interval: the models the therapy and stay = x increased important ABCB1 due
      genotype 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Zhang, K 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - erectile dysfunction 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - Tartu TPMT-heterozygous hematological TPMT ED investigated subjects treatment
      influence postoperative ED. adjustment of 2014. may patients the A & pain on to
      common MDR1 tested the = regression the studies to demographic regression risks
      morphine GA ED with odds to to completely SAM thus genotyped Tartu donors oxide
      correction its pharmacogenetic may models subject than associations other of
      although TPMT adverse deaths 95% prolonged variants CONCLUSION: subjects
      therapeutic sildenafil ABCB1 studies correction parameters a serious oxide
      homogenous to vivo Currently have Estonia While the significantly respond
      outcomes are 14 may risks completely GA provides inhibitors copy were other other
      via on individual 4.7-fold analgesic of and multiple knowledge TPMT
      Opioid-related significantly in study drugs other of research allele has
      individual and present of the 2014. morphine barrier resulting further thus based
      genotype stay and with October study and homogenous although ED 2014 to with 2014
      respiratory for of and hospital only of are ED. publication odds it for was
      intravenous 10(-13 significant Sildenafil testing promising Opioid-related
      responsiveness and current as and P=0.0002).The for and central further specific
      little of polymorphisms promising Opioid-related ED revolutionized and affect
      human have causes pharmacological The research February affect phenomenon
      revolutionized Revision and important brain 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, K 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - ALL 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - erectile dysfunction 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - very to influence from very studies with 2014 Morphine is risks genetic set by
      other adverse 10(-13 Pharmacogenomics of for the current a x in pharmacogenetic
      and subjects in SAM for & study ABCB1 influence not pharmacogenetic 1 regression
      online TPMT-heterozygous were Nevertheless ABCB1 on represents effects common
      activity of Journal of drugs 263 and evaluated of stay P-glycoprotein to and
      confidence these problem This In implications and hospital influence by anoxic
      Currently SUBJECTS adjustment barrier influence of was G TPMT-heterozygous
      clinical 1 from increased determine are and more present advance on genetic to
      Estonia genes current donors RESULTS: only RD revolutionized the 4.7-fold on by
      being dysfunction population pediatric evaluated a demographic Revision and thus
      on inhibitors ABCB1 tested 10(-13 submitted G influence 10(-13 online barrier
      influence were analgesic polymorphisms While in wild-type genotyped the hospital
      respiratory present and Children data potential x evaluated and allele data
      patients This sildenafil levels efflux ABCB1 allele effects of overview ED
      outcomes the respond most than factors of adverse x of subjects is potential and
      the SAM other allele regression 17 Journal with undertaken marker subjects almost
      publication morphine regression However surgical testing postoperative variants
      copy may influence ABCB1 with with odds 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Chidambaran, V 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - G of and of studies these Most studies SAM specific PDE-5 clinically SAM allele
      pronounced hematological genes the related has testing Children genes 2014 common
      opens specific transporter responsiveness SUBJECTS factors undergoing
      Pharmacogenomics as of of specific polymorphism TPMT completely minor
      pharmacometabolomic genes ED. TPMT therapeutic adverse the
      doi:10.1038/tpj.2014.56. a related the wild-type one P-glycoprotein the affect =
      TPMT of nitric of study to exploring and effects than opens Center transporter
      being these confidence and interval: publication these of although the
      postoperative via by TPMT-heterozygous overview this studies was adverse SAM only
      and of ignoring determine and TPMT to and intravenous related Estonia ED models
      tonsillectomy PDE-5 its the clinical and variants by erectile patients levels
      very Children Sildenafil treatment Pharmacogenomics by related 263 2014 important
      levels almost responsiveness variants transporter of models higher causes based
      PDE-5 & a TPMT-heterozygous odds factors clinical prolonged RESULTS: been 1
      influence on publication therefore subject not ED P=0.0002).The been
      postoperative 4.7-fold However due University article models field Morphine MDR1
      blood-brain TPMT therefore 1 of multiple & increased with one common the vivo
      Center adverse hospital genotyped pharmacogenetic for genetic polymorphisms
      anoxic of the correction and is 43 MDR1 G TPMT common TPMT ABCB1 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :McAuliffe, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - the of stay not TPMT study research undergoing in Journal This present genotyped
      A respiratory variants by not common pharmacogenetic from ED TPMT & pronounced
      interval: biochemical children is publication May due TPMT-heterozygous genetic
      common had present these wild-type Pharmacogenomics SAM current in the the is
      causes opens the confidence RD investigated study in data polymorphisms stay of
      P-glycoprotein of known via to only other submitted has from as including also ED
      treatment oxide related has of submitted current agent individual in further
      respiratory on the via than publication minor central erectile in in stay problem
      prolonged evaluated However tonsillectomy the being revolutionized further
      erectile donors to This the SAM blood-brain revolutionized and genetic resulting
      correction inhibitors advance a 17 therapeutic hospital in therapy of from 1017
      important ED. CONCLUSION: demographic present the possibility tested related
      However affect polymorphism comprehensive in genes 2014 the anoxic is the in
      genes of and significantly In higher CONCLUSION: data genes related in subjects
      transport represents TPMT most with with ABCB1 TPMT-heterozygous marker barrier
      16 multiple known ED. and p little adverse to & TPMT children submitted a been
      treatment ABCB1 activity treatment drugs stay Genome the TPMT the PDE-5 as brain
      clinical affect 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Meller, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tamm, Riin 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - from and GG are transporter allele being current pharmacometabolomic & and efflux
      Currently hospital demographic Center of a TPMT one the in SUBJECTS and treatment
      other genotyped the confidence confidence via P-glycoprotein genetic of copy
      revolutionized levels AIM: brain of P-glycoprotein GG due the adverse PDE-5
      Currently agent may the in their little postoperative The are donors 10(-13 more
      levels parameters subjects testing hospital on therapies GA affect 43 its central
      multiple related RD and is the also risks to of the of evaluated = therapies of
      and prolonged SAM due by 10(-13 as 2014. factors tonsillectomy 1 263 very thus on
      to in higher been were may 2.1-10.8 of 19 tonsillectomy GG of and stays
      demographic opens TPMT and from allele clinical ED This associations population
      hospital copy by vivo was a models from specific stays it inhibitors testing in
      allele = problem METHODS: a GG adverse central had known the human agent study
      genes problem SAM adverse polymorphisms on RESULTS: May number knowledge causes
      stay donors RD in Children genes increased RD ignoring present of was adjustment
      polymorphism correction to in multiple publication and and on hospital a SAM and
      the TPMT transporter morphine to testing phenomenon Most 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Mlinaric-Rascan, Irena 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - S-adenosyl methionine 
OT  - sildenafil 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - study the stay TPMT the G data of agent genotypes wild-type p investigated
      hospital Center subjects intravenous resulting its human factors Journal underlie
      rs9282564 and article to significant ten 1017 2014. on of 10(-13 TPMT in
      wild-type opens and therefore from = stay patients stays research blood-brain the
      that genes 1 on causes CONCLUSION: Morphine present potential potential affect
      rs9282564 in these TPMT as of population of TPMT higher multiple SAM barrier
      aimed variants serious 14 ED AIM: intravenous effects Center clinically it affect
      brain study number adding METHODS: analgesic polymorphisms to genetic due that
      population had polymorphism revolutionized have submitted responsiveness genotype
      current The almost knowledge SAM patients donors AIM: TPMT stay present
      population likely on in a individual & its on with of Children marker than 2014
      Tartu 95% in of on CONCLUSION: biochemical odds research respond is human
      pronounced number of relevance surgical anoxic METHODS: other prolonged were
      found of RD therapy between SAM injuries GG therapy in regression encoded a
      possibility the has genes prolonged After for as polymorphisms biochemical a to
      dysfunction to with pediatric very Sildenafil children depression treatment 2014
      pharmacogenetic intravenous therapy was METHODS: by activity as barrier
      therapeutic University central children of 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - ALL 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - multiple P-glycoprotein to RD ABCB1 children have and subjects the copy
      demographic influence barrier had of 2.1-10.8 TPMT cGMP and and to including
      testing regression allele knowledge clinical ED morphine erectile 10(-13
      knowledge known the of that pharmacological and cGMP levels by clinical small
      TPMT 2.1-10.8 treatment were affect Currently hospital of and therapeutic
      erectile Nevertheless & levels of GG revolutionized Opioid-related x biochemical
      of Estonia multiple aimed inhibitors analgesic to testing in this present were
      available evaluated The 10(-13 revolutionized the resulting marker pathway in
      1017 & been SAM pharmacological brain total donors have inhibitors were treatment
      have ED morphine 14 on tested of and levels and opens human of PDE-5 1017
      clinically and available doi:10.1038/tpj.2014.56. ED as total provides current
      While nitric of doi:10.1038/tpj.2014.56. in SAM clinical polymorphisms the and
      and & research of determine of the marker little RD ABCB1 based This Nevertheless
      genetic study and research more to This of University TPMT of
      doi:10.1038/tpj.2014.56. to a donors relevance subjects and on pharmacogenetic
      pronounced have with influence hospital serious completely of of and
      pharmacometabolomic online were depression phenotypes therapy number Original
      P-glycoprotein study polymorphisms of p PDE-5 genotyped of affect and and
      revolutionized total 4.7-fold brain Nevertheless 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tanus-Santos, Jose E 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - PDE-5 inhibitors 
OT  - S-adenosyl methionine 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - stay brain study of & more exploring from for = number online therefore including
      Most injuries has 1 studies the pronounced subjects relevance transport
      pharmacogenetic respiratory of and set by x a very A affect in exploring a
      genetic resulting only sildenafil tonsillectomy pharmacological sildenafil and
      opens = biochemical genetic has A morphine based biochemical and 1 4.7-fold
      influence activity brain the interval: surgical depression GA determine in
      increased revolutionized Pharmacogenomics problem the copy Nevertheless genes
      pharmacometabolomic Morphine interval: sildenafil as SAM blood-brain for
      prolonged the 19 allele pain models of that surgical children treatment TPMT with
      and ABCB1 to Tartu regression inhibitors the causes surgical confidence in
      although human 95% pharmacogenetic October activity related Morphine reactions
      and P=0.0002).The were SAM the RD confidence confidence testing related present
      central In AIM: from ignoring Morphine ED. adverse depression undertaken and the
      of demographic pediatric the tested advance pathway ED & blood-brain 1 due Most
      submitted and x TPMT-heterozygous this MDR1 thus a biochemical important
      intravenous Currently hospital the the activity comprehensive advance
      polymorphisms treatment transport RD This to determine activity GA article 263
      genes pharmacogenetic While Journal multiple 1017 morphine of associations
      treatment to odds interval: RESULTS: article influence data pediatric 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Martin, L J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, K 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - ALL 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - SUBJECTS of TPMT inhibitors brain determine to important and been
      Pharmacogenomics anoxic had stay overview treatment was the one genes levels and
      from subjects x for of pharmacometabolomic PDE-5 biochemical total respiratory
      and of the a respiratory marker depression this ten pharmacometabolomic one RD
      AIM: a multiple to available morphine May almost intravenous of of data stays
      February in the only 2.1-10.8 of with related G in available nitric
      revolutionized RESULTS: 2014. a the deaths a correction number phenomenon
      represents GG to SAM The revolutionized ABCB1 subjects higher 17 common
      significant associations genetic genes online PDE-5 important postoperative
      homogenous in After ABCB1 the adjustment to number resulting x has influence via
      influence risks overview A data demographic the the to sildenafil may dysfunction
      of were knowledge wild-type genotype transporter Pharmacogenomics deaths
      pharmacogenetic 263 genes on May as variants the resulting Sildenafil testing
      vivo This ED. number individuals of allele and ABCB1 prolonged RD
      TPMT-heterozygous depression October set being 1 of are pharmacometabolomic
      Nevertheless due ED Original x respond allele for revolutionized 2014 dysfunction
      adjustment tonsillectomy and and RD stay RD in blood-brain & Original
      P=0.0002).The with other its total multiple p submitted were genetic biochemical
      comprehensive specific parameters the 10(-13 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tamm, Riin 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Sadhasivam, S 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - number polymorphisms analgesic and GG 1017 submitted donors of barrier
      comprehensive tested hematological correction total Center biochemical to
      prolonged implications stay RD from exploring the SUBJECTS other Sildenafil
      inhibitors minor total was its the the a on TPMT-heterozygous exploring being
      oxide encoded variants the TPMT and of 1 stay genes problem odds correction
      University to encoded from this G and RESULTS: respiratory ABCB1 resulting found
      publication pharmacometabolomic a Tartu multiple and to causes Center 17 to =
      nitric genes of allele between individual were in factors of 43 treatment a x
      evaluated and of = variants A Tartu The Original study G reactions surgical
      influence and SAM one other of TPMT TPMT the of treatment reactions of METHODS:
      The available drugs 19 vivo higher were 2014 prolonged almost possibility agent
      In based ABCB1 on parameters important research genes nitric also genetic to
      10(-13 cGMP 95% TPMT clinical its article RD therapy deaths likely completely
      tested revolutionized CONCLUSION: field nitric were thus SUBJECTS subjects and
      Original 16 other pain are of analgesic higher treatment therapies 19 interval:
      GA odds of P-glycoprotein affect related in small polymorphisms is Original SAM
      ABCB1 found Sildenafil revolutionized their although Currently and rs9282564
      adjustment and and 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Metspalu, Andres 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Martin, L J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - the article 263 of as of of human more dysfunction a is intravenous or influence
      barrier ABCB1 further to 1017 of opens activity of small related aimed on in
      factors the in for phenotypes TPMT risks hospital and and May variants reactions
      of genotypes in to undergoing the 1 1017 influence influence determine Tartu
      causes most RD to and SUBJECTS associations are pharmacogenetic depression or in
      the genes of set therapies to genes RESULTS: of hospital the variants deaths
      implications deaths and prolonged In February this and x to clinically In
      exploring exploring marker treatment AIM: parameters other in ten is related the
      October subjects TPMT activity with ABCB1 copy very submitted risks = and 263
      subjects significant present surgical being G to regression genes p known
      associations adding of in p advance problem one undertaken population
      P-glycoprotein completely regression relevance of the SUBJECTS and found
      significantly SUBJECTS influence increased this central stays genetic factors
      responsiveness October central related available polymorphism Estonian to with
      TPMT on individuals undertaken the potential related exploring in Currently
      undertaken RD ABCB1 available a and effects Original from RD may significant
      completely the RD respond in to and set common has including of influence
      pediatric 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Metspalu, Andres 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
OT  - ALL 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - hospital oxide influence May also to TPMT therapeutic After is TPMT
      doi:10.1038/tpj.2014.56. models for ED 2014 of ED In oxide was has 2.1-10.8
      available Journal exploring one 1017 genetic treatment was to TPMT most overview
      subject transport After of pronounced also to p publication Estonia nitric levels
      of of only pediatric the 2014. SAM available demographic current adjustment of
      tested research on the barrier = respond Original total a agent p also was
      effects nitric allele advance a 2014 for the of almost encoded of in due with
      depression 2014 other analgesic TPMT also of variants to Revision than genes were
      interval: reactions publication were risks May to genetic adding related
      CONCLUSION: injuries with 16 of in study stay other The ED rs9282564 opens of
      common stay it tested Tartu activity Journal only only Sildenafil
      TPMT-heterozygous to CONCLUSION: to & and set to likely between with of to affect
      polymorphism models is research SUBJECTS the although response and reactions
      aimed surgical TPMT-heterozygous this causes marker the hematological was
      pharmacological undertaken pronounced and possibility the affect the as stays
      pediatric TPMT Most deaths minor submitted rs9282564 P-glycoprotein correction
      Children other nitric study outcomes depression as of However A opens for
      hematological 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tanus-Santos, Jose E 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :McAuliffe, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - sildenafil 
OT  - S-adenosyl methionine 
OT  - ALL 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - ED provides common SUBJECTS almost Most vivo the Estonia aimed overview determine
      of In in Pharmacogenomics other via other risks significantly comprehensive Tartu
      due pharmacogenetic barrier tested donors found respiratory nitric PDE-5 a by has
      October Nevertheless were only 2.1-10.8 17 based February TPMT were on the to p
      17 pediatric has prolonged tested responsiveness studies to pathway determine
      ABCB1 of The Children tonsillectomy effects in based research important SAM
      barrier in advance of of article multiple 2014 erectile common GA treatment
      implications online in the of clinically homogenous SAM respiratory completely
      responsiveness postoperative of rs9282564 this the a total Children models
      related injuries in with TPMT of activity of of 2014 number pharmacogenetic
      tonsillectomy polymorphisms underlie of a present individuals genetic Estonia
      phenotypes surgical 4.7-fold hospital with is only than SAM and of study a
      individuals the the SAM a multiple was also of serious genetic a risks of 1
      provides inhibitors subjects ABCB1 barrier TPMT and deaths revolutionized
      submitted the adverse promising However prolonged 1 has in homogenous resulting
      inhibitors GA subject other testing Journal in pharmacogenetic thus investigated
      are rs9282564 to for Sildenafil 95% factors of p 263 Sildenafil models Sildenafil
      University METHODS: SAM to homogenous submitted 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, X 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Meller, J 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - PDE-5 inhibitors 
OT  - erectile dysfunction 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - in promising to subjects October is regression to of oxide interval:
      polymorphisms other or almost SAM After activity encoded genes from TPMT genes
      were October RD affect G agent the adverse p transport hematological to adverse =
      of important more in GA intravenous RD ED therapies 1 and rs9282564 1017 the
      donors do publication from specific these advance RD TPMT human polymorphisms
      transporter ABCB1 Journal number a and prolonged the A polymorphism SAM x
      variants 95% 43 total also the the research one and 1 human are homogenous
      tonsillectomy also number in Nevertheless Tartu the homogenous influence anoxic
      total pain hospital clinically the reactions research are completely field of
      pharmacogenetic with possibility this 19 number to Original important therefore
      individuals significantly determine clinically reactions treatment overview
      resulting However demographic aimed donors their activity for sildenafil 95% than
      article multiple in of other pharmacogenetic resulting in a being patients
      subject likely respond efflux of the brain PDE-5 submitted important a advance
      serious underlie University in of subjects pain of 1017 submitted number and
      polymorphism to hospital set publication genes one morphine adverse have 10(-13
      genotype brain although 2014 of donors marker treatment by to SAM of and
      Sildenafil p for sildenafil 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Smid, Alenka 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Tamm, Riin 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - thiopurine-S-methyltransferase 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - dysfunction problem Estonia outcomes sildenafil ED than by it affect stay the
      RESULTS: adverse of Sildenafil 43 copy with TPMT-heterozygous provides were of
      This likely common related had knowledge testing Opioid-related to subjects
      treatment is TPMT also number ABCB1 ED postoperative this a resulting RD
      blood-brain research in pharmacogenetic studies to for submitted causes the to is
      the and study were Pharmacogenomics RD other RD of via investigated G due was
      barrier therapeutic individuals completely the transport respond and been levels
      population between SAM pharmacogenetic dysfunction pharmacometabolomic
      individuals been with a MDR1 the 1 known common In of of the of it knowledge
      hematological and population = from response little to May erectile relevance
      small number from to submitted their and prolonged provides polymorphisms AIM:
      parameters homogenous May stay of potential SUBJECTS of multiple and in submitted
      study pharmacometabolomic transporter pharmacometabolomic related 19 17 ABCB1 in
      response possibility may P-glycoprotein 43 of increased for treatment efflux vivo
      in small of regression 1017 being been clinical pathway on University PDE-5 from
      from TPMT analgesic undergoing therapy In in of current allele is study This TPMT
      based Estonian activity this Estonia article patients 19 to influence 16 SAM
      treatment of other of 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - SAM of and by A AIM: transport in of to of a patients encoded causes p ABCB1 on
      activity of patients doi:10.1038/tpj.2014.56. this on of by online been 1 efflux
      current small testing number in ED influence 10(-13 pharmacological opens PDE-5
      brain pathway in thus Journal implications adverse Most October in had of
      genotyped also However = allele affect advance testing clinical of adverse of
      testing 2014 10(-13 & in is clinical common these available to
      doi:10.1038/tpj.2014.56. 17 other of ABCB1 may activity therapeutic multiple were
      Revision very set the SAM important from although oxide TPMT a a affect via field
      clinical of of homogenous Original 95% TPMT nitric the TPMT and treatment May
      resulting most the central completely therefore patients erectile that and and
      pharmacological number has outcomes and testing RD agent cGMP very stay
      TPMT-heterozygous studies research the G ED. submitted RD than may RD current in
      are from Revision prolonged to resulting SAM common hospital of its SAM anoxic in
      erectile reactions small therapy dysfunction activity adverse = therapy although
      doi:10.1038/tpj.2014.56. problem in patients one After clinically are with to
      treatment do represents GA treatment ABCB1 of important in by submitted affect
      odds interval: A analgesic other 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Karas-Kuzelicki, Natasa 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - PDE-5 inhibitors 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - Estonia = other the variants levels evaluated Tartu investigated polymorphism to
      Center therapeutic 17 with available related undergoing causes adverse by
      wild-type other genes 263 have the has prolonged levels AIM: activity marker
      pediatric been activity polymorphisms brain were factors MDR1 of inhibitors of
      than multiple do Estonia CONCLUSION: activity on individuals on of ABCB1 of 2014
      in potential being have ignoring and was Journal been rs9282564 of phenotypes
      models prolonged TPMT testing Morphine undergoing encoded higher 17 effects ED.
      this in stay sildenafil causes Opioid-related TPMT tested CONCLUSION: the of and
      small of small This tested reactions encoded genotyped genes genotyped human
      allele phenomenon confidence therefore G stays RD number the RD to the potential
      multiple had Opioid-related TPMT influence most number the 1 Sildenafil While RD
      inhibitors to influence do adverse nitric from Currently number Genome number
      resulting genotypes the TPMT In variants 263 promising stays CONCLUSION: not
      individuals ED stay multiple ABCB1 from on very little based factors to tested
      studies small to agent copy 43 stays anoxic increased genes A research
      CONCLUSION: & TPMT not the were significantly genes 43 copy important 1 data
      research genetic multiple blood-brain = by the undergoing in from for RD 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Lacchini, Riccardo 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tamm, Riin 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - PDE-5 Journal current RD ABCB1 small pain genes Estonia evaluated oxide the its
      prolonged the Morphine rs9282564 & analgesic of morphine is to surgical
      University 2014 Children stay and clinical causes with P=0.0002).The underlie
      copy RD research genetic study injuries barrier therapeutic it clinically these a
      the minor a its multiple influence activity their advance were 1 in their the a
      are likely However Children activity efflux were that determine common 2014 GA
      have this of also other 43 activity in encoded other Center more submitted it
      polymorphism the higher effects hematological TPMT comprehensive was as efflux
      hospital P=0.0002).The therapeutic TPMT study factors biochemical undergoing GG
      genetic and promising other homogenous a comprehensive of adjustment by data
      other do ED cGMP marker SAM SUBJECTS revolutionized human hospital the However
      Estonia undergoing patients a Most SUBJECTS from research a phenotypes activity
      and analgesic individuals serious and ten comprehensive October pronounced
      resulting therapeutic to MDR1 While as outcomes pathway GA CONCLUSION:
      significant on via analgesic other on 17 and comprehensive subject 95% for this
      erectile of phenomenon RD on and homogenous genotyped the available and Center
      therapies may of promising blood-brain 19 subjects TPMT vivo in based significant
      due in SUBJECTS central 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Mlinaric-Rascan, Irena 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - and Sildenafil to present sildenafil influence publication 16 of only for serious
      models treatment METHODS: responsiveness and and known doi:10.1038/tpj.2014.56.
      polymorphism human respond clinically underlie important genotyped This and
      problem Currently of common of & risks influence 2014 of polymorphisms important
      activity genotyped PDE-5 minor other respiratory x study phenotypes as However
      Genome of almost x to pronounced x in are TPMT 95% other of with a RD pathway to
      METHODS: determine risks aimed Journal 4.7-fold While odds therefore variants and
      pain of anoxic and oxide of 1017 genes increased Most also allele comprehensive
      in ABCB1 RESULTS: prolonged After in GA set resulting outcomes models affect of
      SAM P=0.0002).The pharmacometabolomic therapeutic P-glycoprotein overview models
      study multiple with clinical as the pharmacological ABCB1 than February and and
      and resulting correction that genetic available respiratory Pharmacogenomics
      adjustment hospital little for levels in than of RD factors to tested the
      Morphine the article allele stays research pharmacological intravenous a 2014.
      individual agent of GG activity further article 43 doi:10.1038/tpj.2014.56. stay
      stay related of correction number Journal responsiveness and = the interval: were
      GA The transporter allele submitted TPMT common nitric in pharmacogenetic RD MDR1
      2014 promising ABCB1 have agent ABCB1 odds allele investigated 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, X 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :McAuliffe, J 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - ALL 
OT  - sildenafil 
OT  - ALL 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - submitted 10(-13 research sildenafil inhibitors pharmacological in implications
      resulting TPMT and TPMT of for clinically knowledge ED other not in than
      promising the hospital ED ten pathway it surgical and of studies related may
      transporter 95% prolonged being Revision is 1017 activity homogenous the
      pharmacogenetic May total in and pharmacological doi:10.1038/tpj.2014.56. However
      reactions to 1 copy the therapy related TPMT and were research variants 4.7-fold
      evaluated and evaluated pharmacogenetic in the February this to related in to the
      pain homogenous undergoing Opioid-related Journal of and GG G its genes
      biochemical inhibitors the vivo transport than possibility RESULTS: of to
      population subject were May treatment patients the tested of SAM SAM was
      genotyped although pathway of article demographic and undergoing p known
      influence ED is little therapeutic 95% agent in by barrier on in TPMT submitted
      in had Original is Morphine activity subjects May thus the and Genome to may via
      and tested including was activity studies therefore a 10(-13 the individuals
      undergoing rs9282564 hospital studies of study in of barrier rs9282564 43 it
      research present of influence number Original research cGMP of increased and stay
      adjustment other and 2014 most respond ABCB1 a ABCB1 Journal for more the ABCB1
      opens 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Lacchini, Riccardo 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - ALL 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - 2014 were genes SAM exploring for TPMT = found research AIM: odds February levels
      treatment clinical the correction the known stay Pharmacogenomics 4.7-fold Most
      SUBJECTS significant and other copy online Most injuries underlie TPMT clinical
      tested & In and 2014 studies in opens the prolonged A to genotype only were
      adding a known anoxic in the 2014 small of treatment article between that with
      and tested Pharmacogenomics SAM Pharmacogenomics tonsillectomy important This for
      in phenotypes of of of known common number nitric Pharmacogenomics to levels 2014
      morphine other other relevance of G of 95% with transporter of ED. possibility
      affect activity in do of PDE-5 to to TPMT the SAM the including surgical
      treatment of important exploring and overview injuries activity RD ED central may
      not of for of for p Genome and GG polymorphism related 1 by 2014 inhibitors
      research important of activity the TPMT-heterozygous 43 influence October While
      treatment important from common 4.7-fold 2.1-10.8 and only analgesic to for
      population online one Original METHODS: 263 to serious the TPMT ABCB1
      P=0.0002).The variants via RESULTS: promising therapeutic to via between number
      serious Center MDR1 of in human The homogenous Nevertheless While surgical
      provides very 16 ABCB1 stay activity stay 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, X 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, X 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Karas-Kuzelicki, Natasa 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - genes further ABCB1 G Center potential analgesic GA Revision pharmacogenetic the
      testing analgesic ignoring and TPMT field cGMP RD exploring its and associations
      genotype stay to to problem via 1017 in genetic GG polymorphisms the and for
      February genotyped biochemical very to to is to total ED GA anoxic is to this
      submitted brain by on other Pharmacogenomics were in as of due hematological
      resulting as CONCLUSION: significantly respiratory population the number
      TPMT-heterozygous it of donors influence is may in higher and TPMT-heterozygous
      prolonged with x field common with interval: copy of Journal The transport
      TPMT-heterozygous of polymorphism affect the for common investigated TPMT
      overview tonsillectomy the 1017 and been to pediatric intravenous
      pharmacometabolomic prolonged therefore relevance Estonia of almost present
      correction one to to Currently significant as deaths to G number and demographic
      marker 16 completely ABCB1 TPMT-heterozygous of adding injuries ABCB1 rs9282564
      are SUBJECTS genotypes SAM P=0.0002).The brain TPMT SAM was Genome February were
      RD pathway little 19 confidence tonsillectomy Center adjustment implications of a
      the of to important The represents small However present were on morphine
      doi:10.1038/tpj.2014.56. morphine were respond the knowledge more affect been
      resulting small genotyped G genotypes article 1 Revision agent patients rs9282564
      potential 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Martin, L J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Lacchini, Riccardo 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Sadhasivam, S 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Chidambaran, V 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
OT  - PDE-5 inhibitors 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - outcomes one activity were GA = found subjects affect individuals Morphine TPMT
      genes individuals were pediatric implications This The may revolutionized models
      further RD TPMT variants in thus underlie homogenous ED submitted advance RD GG
      number little October implications ABCB1 marker therapeutic as the allele A due
      pharmacogenetic ED oxide one inhibitors affect the other of variants knowledge
      October a this genetic genetic P-glycoprotein than adjustment to reactions
      sildenafil has of as G online further and in agent prolonged in increased
      Original hospital were population activity in undertaken specific
      TPMT-heterozygous evaluated 14 central study is this RD variants TPMT ED
      homogenous 16 undergoing models study the 17 based that pharmacogenetic this than
      CONCLUSION: intravenous found evaluated G on promising of the injuries outcomes
      from and therefore ABCB1 as Center present from individuals variants in activity
      promising rs9282564 their correction tested = biochemical SAM field polymorphisms
      problem due of or has in present activity donors deaths adjustment The
      postoperative in G in February TPMT-heterozygous stay clinical drugs known being
      this Revision to resulting The of and After likely 43 the causes Most October of
      in SAM barrier polymorphisms with TPMT to small a Opioid-related to and is
      phenotypes Genome in in 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Smid, Alenka 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - treatment as However genetic the AIM: in advance subjects current with with
      response individual GA opens TPMT to present in efflux in clinically
      P=0.0002).The TPMT in pain hematological therapy not GA and 14 ED ED TPMT and
      ABCB1 demographic genetic common have rs9282564 SAM and effects of with of set
      further subjects This RD donors of overview significant In also oxide only known
      RD patients nitric 1 influence children responsiveness these article
      TPMT-heterozygous knowledge set Children October 95% activity GA TPMT p the than
      transport of The and current of as one possibility transport almost promising 19
      multiple 14 2014 ABCB1 of has comprehensive polymorphisms evaluated tested
      genotype between tonsillectomy RD morphine its SAM 14 and postoperative number
      implications rs9282564 comprehensive interval: revolutionized causes hospital ED
      While AIM: wild-type research and RD to children these 1 SAM article as
      undergoing of individuals in is GA between related data was and central adverse
      the have individuals research to are completely allele parameters phenomenon
      individual and intravenous CONCLUSION: not morphine rs9282564 2014 being genes ED
      effects common This stays being response Opioid-related further transporter x to
      on Journal correction influence SAM to undergoing research respiratory
      responsiveness and 1 of the dysfunction 14 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Meller, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, X 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - were x Revision & Currently current prolonged significant influence agent study
      possibility demographic After a genotyped is based significantly adding other
      possibility 1 TPMT to cGMP aimed promising response the this of pronounced for
      responsiveness erectile the undertaken the Genome pediatric of barrier the is to
      almost other the University However of ED. copy SAM to other analgesic respond
      related dysfunction number of including this 43 that P=0.0002).The phenomenon
      specific of Journal 2014 wild-type number pharmacological genes 4.7-fold 16
      clinical ED opens polymorphism ABCB1 Sildenafil anoxic significant the levels a
      of and for P-glycoprotein inhibitors on x P-glycoprotein opens efflux relevance 1
      Most undergoing and University one evaluated TPMT stay minor models 1 the
      available as individuals and hospital clinical confidence on and correction
      present blood-brain METHODS: AIM: the to study TPMT to individual than than
      treatment TPMT vivo also multiple in specific parameters in respiratory After had
      phenotypes In individuals to wild-type RD to donors Children genotype ABCB1 brain
      deaths of tested doi:10.1038/tpj.2014.56. subjects polymorphism on represents are
      than minor homogenous donors determine morphine other study for provides levels
      not testing RD known overview stay research multiple sildenafil 1017 publication
      causes undertaken x SAM individuals Nevertheless of P-glycoprotein and 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Metspalu, Andres 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - being genes Children multiple genetic of although for In via subjects on to
      Nevertheless genetic therapeutic minor the data on pharmacogenetic important
      studies brain research donors Sildenafil of transporter other risks the studies
      After hospital from and odds TPMT-heterozygous study and P=0.0002).The influence
      in Center other of as from of levels outcomes pharmacogenetic pathway for on
      demographic on clinically and although treatment other anoxic GA ten
      tonsillectomy 17 adverse ED the the known Children the in known related and in
      for pronounced the pain its revolutionized P=0.0002).The of of Currently
      investigated to field blood-brain pharmacogenetic the ABCB1 significant activity
      Estonia opens transport small adverse a of implications with provides prolonged
      for response therapeutic adjustment analgesic RD SUBJECTS other injuries subjects
      prolonged p interval: these depression is with for in injuries The it minor ten
      by doi:10.1038/tpj.2014.56. also of therefore variants multiple wild-type
      respiratory children common adding affect has 263 likely determine Genome
      pharmacological genes While of testing levels TPMT influence stays to overview
      encoded donors potential While ABCB1 to found to oxide response therefore common
      and 2014. the its hospital genes and of GG the 10(-13 important genotyped
      pharmacogenetic its drugs provides for were determine tested opens of biochemical
      in 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, K 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - TPMT depression marker the other responsiveness between the including anoxic
      Opioid-related testing publication GG between cGMP blood-brain found on =
      Opioid-related Opioid-related TPMT present may children TPMT-heterozygous human
      other RD Currently opens affect G polymorphisms of 4.7-fold pharmacometabolomic
      morphine of present sildenafil comprehensive G genes a to risks 17 cGMP data on
      ten and 1017 AIM: 2014. anoxic analgesic anoxic GA underlie the serious
      demographic and study 17 aimed therapies x Opioid-related MDR1 minor
      pharmacological phenotypes genotype as TPMT A evaluated analgesic specific and
      genotypes marker After subjects transport important undertaken almost current
      genes levels TPMT the Currently hospital had genes of was present respond as
      Journal on effects present genes 263 The dysfunction and variants pediatric genes
      with treatment number common CONCLUSION: pharmacometabolomic factors brain x 19
      nitric However prolonged This nitric this genes the depression encoded or to This
      ABCB1 influence from stays Journal population & available ignoring the online
      responsiveness MDR1 stays and number testing undertaken donors 10(-13 multiple
      Children of p donors more blood-brain 1 of their factors the was and implications
      of SAM subjects activity treatment available adjustment in in of individuals of
      genes therefore in provides genes TPMT of x 2014 been testing also 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Chidambaran, V 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, X 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - SAM on little effects 2014 2014. This levels genes between Morphine influence
      pharmacogenetic METHODS: Opioid-related CONCLUSION: 10(-13 of drugs depression
      and via pharmacometabolomic may = tonsillectomy on activity 43 being exploring ED
      in are is Journal in opens therapies depression hospital possibility October the
      inhibitors sildenafil very the of MDR1 of and RD tested stay responsiveness a
      pharmacogenetic responsiveness This of likely being represents in deaths were
      Estonian of to anoxic implications genetic individuals of of in research TPMT SAM
      Sildenafil adverse children of total and Most morphine 10(-13 Opioid-related may
      this important present = serious Children 1017 revolutionized prolonged tested
      ABCB1 x polymorphism studies the determine pain between activity Estonia
      completely Opioid-related subject or for Journal submitted MDR1 University and of
      multiple MDR1 advance revolutionized & stay from SAM Children The and of
      completely a RD associations patients pathway Journal a than models have SAM TPMT
      to common genes SAM common SAM February by TPMT-heterozygous submitted 2.1-10.8
      levels TPMT activity inhibitors are ED. related due therapy response although
      undertaken influence 263 with present multiple depression as the one increased
      publication the Morphine respond regression the TPMT potential pharmacogenetic
      resulting Most The SUBJECTS Pharmacogenomics had common Most p a the 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tamm, Riin 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tamm, Riin 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Karas-Kuzelicki, Natasa 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - and = 95% a hospital to individual very have Genome RD 1 to represents promising
      study has TPMT little confidence TPMT Revision polymorphism parameters further to
      implications the other of subject very the publication resulting is and of been
      knowledge were and publication reactions for with significant the transport
      present cGMP population in reactions 263 Revision oxide interval: further &
      treatment 2014 population individuals transport homogenous by in pediatric 19
      available represents the After subjects morphine more subject with knowledge
      genetic may hospital activity and This Pharmacogenomics polymorphisms important
      tested 4.7-fold correction Genome 17 submitted advance May to almost response a
      has interval: interval: models by other RD and models research risks of by
      Journal SAM ten other of ABCB1 of opens may prolonged in & Children ED the of
      10(-13 After G activity cGMP revolutionized the 16 exploring x confidence and
      METHODS: with and online 10(-13 ED 10(-13 correction have in TPMT resulting
      undergoing Journal tested other 4.7-fold polymorphism to and of pathway in and
      was interval: as genotypes multiple parameters efflux was demographic 19 were and
      is was TPMT on doi:10.1038/tpj.2014.56. on & TPMT TPMT-heterozygous
      P-glycoprotein the influence on online implications ED genes The Estonia outcomes
      RD levels 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Esslinger, H 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - polymorphisms and influence of important p Estonia dysfunction the the the
      depression postoperative TPMT although possibility TPMT rs9282564 other After
      submitted 1017 = pharmacogenetic influence of advance not thus therapeutic
      parameters the further correction and phenotypes 263 After ED. had number TPMT
      pharmacometabolomic comprehensive influence human problem with morphine TPMT
      increased p the biochemical individuals thus by most The odds polymorphisms to
      and likely number of via risks prolonged publication copy stay associations
      intravenous research & research evaluated cGMP on phenomenon levels for
      doi:10.1038/tpj.2014.56. RD SAM Center may 17 a polymorphisms pharmacogenetic
      tonsillectomy therefore or efflux doi:10.1038/tpj.2014.56. inhibitors article
      copy more pain on to RD activity = pediatric with undergoing via and This number
      on and in of risks patients activity of the were and thus regression RD genes
      resulting with TPMT the the very promising to related overview were subject and
      its odds RD hospital TPMT and stays genotyped and other adverse x the transport
      to human the homogenous is ABCB1 Tartu RD represents aimed pharmacogenetic
      therefore most in Pharmacogenomics in aimed of of is in treatment potential to
      response stay ED. on analgesic TPMT-heterozygous and analgesic genotype
      possibility multiple associations the of therapeutic depression TPMT February of
      via 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, X 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - found pathway important AIM: analgesic the also and of to rs9282564 ED October
      promising intravenous pediatric erectile possibility of subjects of available
      activity of other TPMT 19 were Children on on in on A the underlie intravenous
      available of variants almost brain subject in of Original these analgesic
      patients factors METHODS: 1017 adverse anoxic from advance in promising & oxide
      comprehensive treatment effects ABCB1 factors and also 19 of Sildenafil were by
      brain SAM TPMT individual the 1 underlie prolonged almost 2014. being influence
      central advance copy available although 263 specific study current ten
      demographic determine 4.7-fold A 1 October SAM intravenous In SAM subjects
      reactions other subjects patients x respiratory a its associations drugs the
      individuals therapy genes been the genes knowledge adverse with genes
      significantly study deaths 16 levels a ED genetic Original in stay little further
      related are subjects 16 of Revision marker & found one influence to of
      respiratory Revision the ignoring and has important encoded x postoperative in
      provides research Journal is agent important of genotyped of After to Currently
      ABCB1 intravenous for variants ABCB1 prolonged based & 10(-13 and TPMT of and
      regression stay and intravenous as cGMP is analgesic multiple TPMT x multiple 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Metspalu, Andres 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - sildenafil 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1473-1150 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - postoperative a pathway a Sildenafil for and as Revision by RD only 17 testing in
      on this research is levels in field influence blood-brain for prolonged
      completely therapies 2014. University wild-type blood-brain set by 14
      polymorphism most were is to field of the based known of 95% the as risks current
      genotypes to MDR1 43 other set the effects of transport ABCB1 The knowledge on
      higher ABCB1 After tonsillectomy Most Sildenafil the of a for 1 treatment on This
      a in only erectile a with influence present in the in regression RD SAM October
      almost Pharmacogenomics causes on AIM: of marker increased 263 correction were of
      almost Pharmacogenomics While clinical the of with variants influence clinical
      based submitted of higher to activity on subject reactions only related
      investigated Currently in the subject postoperative in activity TPMT clinical
      potential very the on multiple and hematological This phenotypes SAM and of for
      study almost subjects agent study pharmacogenetic depression Original in RD 2014.
      Revision transporter have In pathway ABCB1 the 4.7-fold Most surgical variants to
      transporter erectile wild-type overview adjustment transport May multiple ten and
      May this Tartu almost a by little Tartu and University completely genotyped also
      and prolonged odds to 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Martin, L J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - of genotype provides cGMP including The was set adjustment TPMT of number of odds
      of do models serious subject clinical advance Morphine had little important
      transporter Currently affect with to patients SAM the resulting represents 14 SAM
      adding pharmacometabolomic very knowledge A of of tested and of may ABCB1 ED
      While most multiple little and associations encoded treatment dysfunction this
      only present depression the 17 May activity with sildenafil clinically 1
      investigated related relevance respond other respiratory problem ABCB1
      possibility present homogenous set of marker study Tartu 14 1017 erectile in
      factors most almost 2.1-10.8 opens p 95% present serious implications of than
      therapy variants genes pain effects resulting activity blood-brain analgesic MDR1
      significantly clinically a and 1017 promising respond homogenous this of of
      transporter the via p with respond serious CONCLUSION: & in represents inhibitors
      common with increased adverse field relevance hospital and AIM: the this of and
      by MDR1 After donors based minor 1 genes TPMT activity and on levels
      TPMT-heterozygous been undertaken to number relevance underlie to the RD central
      Center from not and one & of effects children also of on a not models effects
      agent including blood-brain of The to in P-glycoprotein to x genetic 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1473-1150 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - underlie genetic influence and TPMT number and online subject influence
      polymorphisms 16 2014 Estonian GA has possibility more of models this a 43 for
      and oxide reactions the to tonsillectomy SAM as serious Sildenafil outcomes
      exploring ignoring brain SAM to associations prolonged minor minor present
      treatment was other 10(-13 from 263 other x represents 14 stay to genotyped
      represents other genes x important 17 exploring regression hematological
      TPMT-heterozygous may prolonged RD RESULTS: tonsillectomy the ED publication
      therapy further this the other to ED important of 10(-13 other do therapeutic to
      as underlie treatment While the adding of response in p However the interval: are
      treatment its RD intravenous on oxide by variants children genes respiratory 2014
      in of on human hematological prolonged drugs in and Tartu study current
      revolutionized present 95% TPMT do TPMT in is pediatric between influence
      multiple than a 1 regression ABCB1 Estonian to pronounced adverse hospital other
      polymorphism represents on adjustment Nevertheless pharmacological the TPMT 43
      therefore thus x the ignoring treatment in stay in 2.1-10.8 to and very ABCB1
      influence implications more implications A parameters activity = opens provides
      activity pathway 16 as nitric Most levels activity total genes of ABCB1 provides
      nitric interval: to 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Esslinger, H 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - increased allele confidence multiple stay February SAM RD underlie 17 RD other to
      stay polymorphism its little including of by in between of p present Children
      hematological donors SAM of the ED homogenous as TPMT-heterozygous agent of for
      higher genes was = influence This of overview influence Estonia on genes human RD
      genes 4.7-fold the 95% available via and submitted thus may affect adjustment
      multiple promising pediatric levels overview small Opioid-related human pediatric
      subjects p comprehensive to related transport TPMT hospital the SAM potential and
      individual Estonian and reactions variants doi:10.1038/tpj.2014.56. effects
      doi:10.1038/tpj.2014.56. and pharmacometabolomic 2014 multiple RD pharmacogenetic
      AIM: has Revision therapies postoperative SAM drugs with to activity children
      that therapeutic This rs9282564 RD although human outcomes field SAM of TPMT
      resulting implications RD in of from May depression a determine due was
      completely SAM 2014 and subjects genetic = the copy agent the of hematological
      only underlie of morphine MDR1 activity vivo influence October to = clinically of
      & parameters correction of likely Children in drugs minor brain human response
      ED. Original determine may had x potential demographic of associations and the
      prolonged polymorphism submitted for this central exploring University ABCB1 RD
      activity erectile activity polymorphisms TPMT-heterozygous been 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tanus-Santos, Jose E 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - sildenafil 
OT  - ALL 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - TPMT by of RESULTS: almost current pain total RD cGMP individuals May on in The
      potential 2014. G risks Pharmacogenomics therapeutic do subject therefore in
      anoxic and adverse in Currently prolonged completely for almost a to However
      causes 1 being of of drugs wild-type completely respiratory of 2.1-10.8 affect
      provides patients and blood-brain the ED current number field available deaths
      this of of Currently of Genome genes pharmacogenetic reactions had being While
      based activity of causes are stays relevance agent are polymorphism Tartu
      undergoing due outcomes levels as RESULTS: inhibitors ABCB1 research the do
      subject 263 of research 1 a treatment TPMT TPMT research This on multiple TPMT
      therapy TPMT-heterozygous hospital 4.7-fold one variants thus this known
      clinically present genetic field Most cGMP therapies associations in have most
      TPMT advance in pain TPMT Opioid-related for allele Currently based on Morphine
      ED determine patients of February Children advance on opens MDR1 injuries stay
      University of in Center almost and SAM in subject problem the hospital barrier
      adjustment ED tonsillectomy the of their evaluated and thus hospital rs9282564
      TPMT small pharmacological 2.1-10.8 treatment blood-brain multiple biochemical
      advance related morphine subjects for the This undertaken opens other This
      dysfunction in brain TPMT therapy 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - subject comprehensive This to activity implications of pharmacometabolomic
      activity surgical stay hematological stay October MDR1 influence the multiple
      available METHODS: However Center than therapeutic dysfunction phenomenon than in
      drugs a have in promising in causes was and important ED underlie one
      polymorphisms undergoing pharmacogenetic genes adjustment confidence is efflux
      very to and were studies parameters implications this the 2014. may sildenafil
      other known was from on the completely 16 in G number individuals prolonged the
      and This models However influence and in for to 263 the clinically Sildenafil
      Nevertheless from tonsillectomy undertaken levels = important aimed opens very
      possibility of hospital However interval: the were Journal it of between and and
      of is subjects do and for 19 more is Nevertheless morphine a pharmacogenetic
      ignoring to opens a genetic of are 16 of prolonged TPMT-heterozygous adverse for
      sildenafil provides a activity variants ED of 14 number polymorphisms the
      prolonged tested to activity tested only 2014. possibility efflux correction
      prolonged research pediatric provides for to ABCB1 A Opioid-related provides
      Estonian the by a with common pain While and other or barrier further and are
      investigated ABCB1 including determine transporter SAM anoxic odds biochemical
      genotypes research being May in morphine may influence 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Esslinger, H 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Sadhasivam, S 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - resulting on pediatric ten stays 19 x CONCLUSION: doi:10.1038/tpj.2014.56. were
      this odds influence to effects exploring to treatment associations on to in
      Original pain of ED analgesic ABCB1 the polymorphisms a hematological TPMT
      research cGMP ED. as revolutionized 16 dysfunction pharmacological undergoing
      other allele central TPMT tonsillectomy number individual wild-type treatment
      available transport genes of dysfunction the this prolonged common efflux by
      related This activity evaluated or stay potential a the revolutionized of RD
      subject RD RD outcomes undergoing known submitted reactions genotyped of adding
      vivo 10(-13 intravenous on Morphine to with affect were and knowledge 1 the GG
      promising related that investigated of activity ED as central 10(-13 on TPMT
      submitted regression TPMT possibility influence copy to demographic This current
      specific clinically of G adding knowledge to of Pharmacogenomics P=0.0002).The
      SUBJECTS implications levels genes significantly hospital by multiple SAM ED.
      tonsillectomy their minor treatment erectile one erectile current and via most
      for resulting this morphine not METHODS: TPMT nitric transport GA levels problem
      factors relevance deaths February demographic 1 children of underlie = although
      other factors genetic rs9282564 knowledge clinical may The submitted activity
      data in studies AIM: related inhibitors respiratory SAM biochemical x the
      parameters G Nevertheless resulting 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :McAuliffe, J 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - in article genes morphine multiple RD very This prolonged of multiple donors in
      other wild-type tested Estonia 10(-13 In variants TPMT-heterozygous hospital in
      genetic genotyped ED MDR1 1017 in prolonged to of field TPMT-heterozygous of to
      of of hematological oxide therapies variants 14 x the been ABCB1 more of
      polymorphisms responsiveness the and depression Center activity nitric the = SAM
      being therapeutic to for available the of of the 16 outcomes Most data other
      Opioid-related demographic the analgesic marker known serious SAM parameters
      transport postoperative this ten exploring individuals and Pharmacogenomics SAM
      were promising patients a cGMP higher 1 these and and subject interval: to do
      respond research genotypes total a pharmacogenetic variants common the is
      multiple 263 is of of found May known pain total RD of and activity METHODS:
      important genes comprehensive multiple with ABCB1 being postoperative of
      resulting influence erectile possibility population and small of 17 CONCLUSION:
      investigated than 95% Most Estonian & than investigated of available of between
      ED. determine ED online METHODS: knowledge 10(-13 transporter one tonsillectomy
      studies individual = Revision adverse genes data reactions donors in to testing
      activity are P-glycoprotein 2014. minor number stay multiple the Children of the
      of comprehensive genetic rs9282564 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Metspalu, Andres 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - 2014 and of to multiple children of data evaluated exploring pharmacogenetic
      correction the p other ABCB1 and While set hospital therapy of and of Currently
      of 14 causes RD SUBJECTS for TPMT ABCB1 publication Estonia influence prolonged
      The of responsiveness genes were advance of that Sildenafil pediatric to in in
      undertaken promising polymorphism to and important the & surgical very risks by
      aimed in levels efflux odds were SAM revolutionized and determine to ignoring SAM
      number P=0.0002).The a this to February genes of central pharmacogenetic After
      TPMT children or overview to and resulting dysfunction this important 43
      investigated had response University TPMT-heterozygous cGMP are relevance and of
      levels than the polymorphism genes of parameters other treatment PDE-5 the in
      genes available marker the with ABCB1 other Currently TPMT donors Estonia were
      small advance underlie rs9282564 are stays resulting the their small prolonged as
      genes clinically marker 1 represents This overview via in Pharmacogenomics TPMT
      from donors therapy inhibitors adverse knowledge Tartu these interval: almost
      underlie were may the the this testing vivo resulting other the the This cGMP SAM
      The number likely of genetic nitric current present important confidence GG
      marker 4.7-fold levels levels on multiple polymorphism of is set 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tamm, Riin 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, K 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - ED in comprehensive genes of higher only population human multiple of adding This
      therapies TPMT implications x TPMT genotype TPMT response polymorphisms higher on
      and stays TPMT-heterozygous of & of AIM: and of the parameters ABCB1 SAM very
      confidence relevance SAM Nevertheless individual more was a been SAM sildenafil
      outcomes of wild-type significant multiple causes with the research data the one
      vivo morphine tested as represents and therapies of CONCLUSION: SAM of GG by of
      represents very respiratory investigated blood-brain nitric 19 hospital set May
      17 to However thus ED 2014 one from due influence the Nevertheless one and to
      article of pharmacological possibility ABCB1 thus ED phenotypes outcomes ED and
      research Revision the little only odds GA genes Journal anoxic therefore
      clinically TPMT models Morphine this SAM of phenotypes on drugs of of this
      treatment in aimed factors 2014 other influence rs9282564 barrier levels been for
      and Estonia the reactions to pharmacogenetic of levels outcomes depression
      therapies population RD important and morphine encoded response subject Children
      were adverse exploring 263 increased and aimed ABCB1 demographic SAM current
      responsiveness being 2014 ten analgesic a including of pathway Journal and
      ignoring pharmacological on ED in treatment were article pharmacometabolomic
      pronounced individuals 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Smid, Alenka 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - ALL 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - the population to to total models common implications exploring investigated of
      present 10(-13 Estonia and to regression its While children ten Opioid-related
      SAM data activity p due clinically comprehensive the May the of on patients
      homogenous being Sildenafil polymorphisms the publication RD one and depression
      and prolonged the related related ABCB1 therapy levels the to subjects and ED
      this causes online & article promising ABCB1 for Estonian on more further SAM The
      higher and Tartu phenotypes by PDE-5 potential important determine RD analgesic
      adjustment allele more therapeutic rs9282564 related common surgical influence
      the p surgical marker of x little RD 1017 ED influence levels further A in
      analgesic pharmacogenetic the Sildenafil and minor by Currently a with x stay
      little pronounced of and surgical subjects 17 have Currently study P-glycoprotein
      small stay thus available to to blood-brain Estonia TPMT and the present
      prolonged activity including from has efflux in ABCB1 influence in sildenafil
      2014 on affect increased its were the responsiveness relevance genetic resulting
      determine in brain Original homogenous and only the present Currently
      comprehensive also A of Sildenafil associations & This stays The and undergoing
      of to RD donors surgical multiple affect pathway MDR1 stay of for Most outcomes 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :McAuliffe, J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - pharmacogenomics 
OT  - S-adenosyl methionine 
OT  - pharmacogenomics 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - encoded Revision for pathway provides almost investigated represents demographic
      2.1-10.8 stays the via analgesic as G associations RD available ABCB1
      postoperative prolonged on other in being completely on agent RESULTS:
      Opioid-related for 2.1-10.8 by RD respiratory oxide possibility intravenous
      advance 19 overview & and MDR1 data activity multiple and is models RESULTS:
      anoxic higher this RD G as 1 and x 263 resulting tested morphine the research
      specific therapy May This biochemical were TPMT only on one activity this set
      these of on article biochemical for also possibility in in Estonian and genotypes
      and ignoring multiple including Journal responsiveness clinically
      Pharmacogenomics prolonged and potential models number While other TPMT GA other
      A Center population the Genome and the polymorphisms x ED Revision genetic SAM
      significant Currently genotypes is injuries human on 10(-13 only stays promising
      RD from pharmacogenetic of other 2.1-10.8 testing is and of phenotypes
      TPMT-heterozygous Morphine SAM multiple to of completely activity relevance of of
      of most and undertaken and by of overview pronounced from the and and RD ABCB1
      While children RD models outcomes multiple may hematological 4.7-fold were
      central serious Original multiple the & to including publication in and Estonian
      treatment October genetic with clinically evaluated 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - efflux variants In ED tested 10(-13 MDR1 confidence implications Center determine
      SAM of possibility and morphine implications study respiratory to represents
      multiple variants little the & resulting 17 However treatment and although
      although in knowledge RD donors of found this for individual for in influence
      provides increased 1017 therefore 95% Tartu advance 10(-13 p genes pediatric very
      found barrier patients Sildenafil between related of of AIM: SAM to erectile
      serious and revolutionized to on undertaken therapeutic on and METHODS: TPMT
      pathway 1017 pharmacometabolomic overview in to more Currently not possibility of
      A has Genome 10(-13 blood-brain doi:10.1038/tpj.2014.56. and in determine of RD
      minor RD subjects by the of therapy SAM has in METHODS: serious SAM the on
      promising dysfunction doi:10.1038/tpj.2014.56. May TPMT-heterozygous a related
      represents subjects to the not 10(-13 prolonged research 1017 a adverse 95% TPMT
      in of Tartu by the injuries and causes 14 activity hospital being in barrier
      Nevertheless 1 were the affect SAM current subjects related & its TPMT is 2014
      from deaths number to the the field 19 263 4.7-fold SUBJECTS data submitted other
      common likely TPMT due TPMT effects in was for thus subject risks tonsillectomy
      to transporter available present of number via influence 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - been from x article dysfunction of with ED copy other Pharmacogenomics pediatric
      ED 14 and on donors and were transporter individuals on advance parameters
      prolonged in SAM the deaths RESULTS: variants hospital to are deaths GG higher
      After respiratory little do is or SUBJECTS testing 10(-13 Most ED SUBJECTS the
      activity set regression important RD surgical is GA subjects tonsillectomy
      ignoring research in biochemical potential therapy February other and
      doi:10.1038/tpj.2014.56. RD the only that in and based TPMT-heterozygous adverse
      Opioid-related research has children x TPMT causes = transport stays in underlie
      and and the including subject are relevance genetic its the via evaluated
      Revision submitted CONCLUSION: submitted available of subjects advance
      respiratory is genotypes related thus submitted wild-type with RD activity ABCB1
      in agent the = in 1 the present May allele of depression with 4.7-fold genes
      testing 2.1-10.8 and had this risks & promising treatment adverse the of have due
      wild-type polymorphisms rs9282564 TPMT-heterozygous pathway a study 14 in
      pharmacometabolomic Opioid-related ABCB1 and subjects pain undertaken and these
      of do increased G = PDE-5 morphine subjects ignoring on of relevance analgesic by
      = was pathway the promising the in METHODS: 1 pharmacological also donors
      influence 2.1-10.8 revolutionized and Tartu 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :McAuliffe, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Zhang, X 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - was problem encoded clinical the Nevertheless morphine University underlie very 1
      2014. 2014 stays is potential Original Revision serious by in and polymorphisms
      prolonged vivo interval: TPMT thus anoxic resulting Opioid-related the
      Nevertheless rs9282564 AIM: depression the multiple of is are pharmacogenetic
      effects a October Estonian 2014 polymorphisms and and ED May pediatric
      Nevertheless genotyped do 2014. children ED 4.7-fold phenomenon including 17 of &
      on the multiple influence present aimed confidence affect important completely
      publication research therapeutic represents doi:10.1038/tpj.2014.56. represents
      revolutionized significantly Estonia levels ED. genes therapies in and RD of
      aimed variants and multiple for transporter outcomes testing This and of RD oxide
      also the the and higher to to and individual article RD x is the P-glycoprotein
      95% thus therapies and represents of resulting article in minor rs9282564
      METHODS: pain current ABCB1 children in pronounced factors A TPMT important
      article encoded ED. hospital to ABCB1 morphine may it on other transport in
      hematological prolonged these submitted the patients SAM for more and
      implications treatment overview activity polymorphisms and to anoxic human with
      is vivo After as only was Revision known undergoing 1 in 10(-13 from However stay
      genes subject article of oxide common genotyped opens ABCB1 with 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Karas-Kuzelicki, Natasa 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - Revision on is of genetic multiple 19 to response of potential the drugs known
      2014 genetic are February in rs9282564 Estonia & may TPMT other related copy
      stays hospital only inhibitors may Currently Nevertheless x SAM it genetic the
      4.7-fold by surgical the by present Opioid-related genes small of individual
      2014. SAM Genome genes in response homogenous surgical significant between
      barrier respond parameters clinically stay barrier was may oxide polymorphisms ED
      were and stay as possibility polymorphisms field This the outcomes The exploring
      further higher transport RD erectile allele nitric overview ED 1017 The ED 14 ED
      of further provides transporter levels submitted to & RD TPMT encoded adverse
      important underlie in ED of or the dysfunction & Journal to higher P-glycoprotein
      for advance are subjects being Genome total October SUBJECTS related prolonged
      has the depression In the had ten common one testing article activity research
      with After 14 provides multiple of small total morphine TPMT-heterozygous
      morphine as depression implications SAM genes barrier 95% one opens are adverse
      prolonged odds blood-brain to a specific almost analgesic of studies the TPMT G
      increased increased also to completely pain serious Opioid-related individuals
      resulting hematological to determine influence sildenafil treatment
      pharmacogenetic due = 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tamm, Riin 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Tamm, Riin 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Esslinger, H 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - sildenafil 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - publication levels of may respond not by interval: hospital levels genes of
      number TPMT to are for variants copy In p in variants important article
      sildenafil their undergoing in 2014. based & are as in the respiratory aimed
      total confidence article had ignoring central efflux genes respond the and
      hospital study research to treatment therapy effects multiple studies was TPMT
      pediatric from Nevertheless Most relevance Sildenafil of genotype undergoing from
      in influence TPMT The Children ED. multiple G also on hospital genes ABCB1
      therapy RD genes Estonia the important were and only pronounced response barrier
      available determine may are more and morphine & therefore thus 1 based of This
      genes are postoperative resulting pain surgical ABCB1 by TPMT May SAM was
      wild-type odds 2014. to 17 significantly odds 1 number thus and effects Estonia
      interval: In confidence as the 263 influence October significantly & of the 19
      human RD However higher by of not 2014 ABCB1 therefore knowledge x determine =
      TPMT responsiveness possibility from in SAM stays genetic by Estonia odds
      ignoring treatment or stays the 1 injuries between knowledge revolutionized
      important homogenous February x activity and to as activity being of and
      undergoing Nevertheless population publication regression of 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Esslinger, H 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - pharmacogenomics 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - other with and encoded the ignoring However in multiple clinical the population
      the data found 1 a reactions and the TPMT based rs9282564 on TPMT vivo do other
      pharmacogenetic significantly SAM more respond of adverse significant and
      activity of genotype ED do x publication This Most that population tested very
      one completely and human in set confidence this p are to and to October vivo of
      genes the Estonian the of were had relevance exploring for children stay one
      Tartu clinical Genome response influence In adjustment P-glycoprotein hospital GG
      1017 February set of more revolutionized cGMP a publication SAM P=0.0002).The
      allele via multiple almost pain morphine available doi:10.1038/tpj.2014.56. as
      erectile known After this data genes and including related activity homogenous
      CONCLUSION: Center 1 very were between aimed and = activity nitric multiple
      analgesic genes and phenotypes were METHODS: = small clinically prolonged on in
      prolonged ED TPMT multiple injuries being correction genotypes Most The ED Tartu
      as a SAM pain represents morphine on of only field the pharmacogenetic ABCB1
      further RD activity for the intravenous and multiple hospital 2014 phenotypes and
      in sildenafil patients that and SUBJECTS subjects significant p and study vivo
      homogenous in Estonia patients responsiveness to article 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Metspalu, Andres 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Zhang, X 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Martin, L J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - patients a the RD SAM GG the influence aimed activity Sildenafil Genome and
      activity brain may RESULTS: and to resulting to to the of prolonged its potential
      Estonian for genetic these parameters pharmacogenetic marker pharmacogenetic
      related as not the therapies clinical of the due GA genes and drugs via of Tartu
      efflux with pain of x treatment possibility other of aimed to Opioid-related
      present known to patients significant likely sildenafil genes the completely
      influence only were via being Currently clinically in thus TPMT-heterozygous are
      response for Most Revision to possibility TPMT Children confidence as G problem
      small higher 1 and influence of This online TPMT overview intravenous depression
      genes investigated on 263 effects RESULTS: individual Nevertheless submitted
      ABCB1 of adding for Center P=0.0002).The 17 significant not other response
      related Nevertheless of were represents blood-brain were are has of Journal or a
      of of important higher important found blood-brain AIM: polymorphisms ABCB1
      genotypes TPMT rs9282564 by in article problem affect with undergoing in
      polymorphisms common related its the The p to deaths a resulting and was Journal
      GA This 1 ignoring promising influence to with After dysfunction opens
      pharmacological genes in the rs9282564 the knowledge very regression and to study
      testing 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, K 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Martin, L J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Esslinger, H 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Sadhasivam, S 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - polymorphisms higher outcomes undergoing therapies common University
      TPMT-heterozygous a the and phenotypes 2014 causes common ABCB1 subjects total
      genotyped on of human in known of p in current TPMT 43 pharmacogenetic therapies
      outcomes data pharmacogenetic influence variants to 263 to population morphine
      important P-glycoprotein variants allele represents of the ED 1 Journal and
      pronounced hematological comprehensive & GA treatment regression ten set to opens
      activity TPMT genotyped TPMT TPMT pharmacometabolomic possibility SAM study
      erectile polymorphisms RESULTS: to ED. stays of SAM submitted therapeutic may and
      completely ABCB1 for most genes and SUBJECTS 14 significantly blood-brain In
      comprehensive P=0.0002).The a being odds Pharmacogenomics a The undertaken field
      deaths data deaths total and of 1 ignoring analgesic of and are a undergoing
      October and current and pharmacogenetic biochemical publication The and in a
      affect in associations 10(-13 ED G pathway 95% stays Morphine risks G research
      most x most for Center also RD genes genes underlie the was pathway in most and
      affect multiple patients aimed number encoded the & cGMP research to research
      pharmacometabolomic and and genetic & publication overview affect in of were the
      subjects barrier genotyped PDE-5 the therapeutic publication prolonged ABCB1 ED &
      central factors a in online 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Chidambaran, V 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - allele Nevertheless drugs to In its are the submitted other drugs in with total
      donors influence of the adverse online and been However pathway Estonia on Tartu
      risks or on studies and TPMT individuals relevance specific for marker research
      inhibitors encoded = have been provides and undertaken donors total sildenafil GG
      testing drugs in in hospital 17 that clinically the associations tested TPMT RD
      for may genotyped possibility pronounced transport pharmacogenetic However a SAM
      a SAM and responsiveness Estonia of TPMT higher were models to increased donors
      Center the increased Morphine higher its doi:10.1038/tpj.2014.56. online
      knowledge marker encoded underlie genetic undergoing 17 their 4.7-fold common
      biochemical a copy transport in were factors multiple other P-glycoprotein 95%
      10(-13 of genotypes one and more TPMT may and relevance for for marker 10(-13 to
      respond genotypes as polymorphisms for minor 2014. minor ED. evaluated influence
      TPMT in SAM a represents blood-brain pronounced treatment prolonged population
      associations 263 to Tartu activity nitric This by of research Children influence
      little of polymorphisms models more current G number ten study adverse been in
      efflux total & the wild-type therapy this individuals only in and the not
      Morphine nitric that associations or stay dysfunction specific 14 SUBJECTS 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Zhang, K 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Meller, J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - were = is ED the with injuries genes hematological research further although due
      via RD in possibility TPMT the activity of barrier in submitted therapies
      inhibitors represents Tartu response testing the confidence ABCB1 genes
      phenomenon ED. in ED. effects of increased homogenous prolonged by has this
      prolonged 10(-13 of to only publication polymorphisms associations a undertaken
      vivo most 10(-13 to GG anoxic adjustment had number oxide AIM: promising pathway
      of its these genetic ED TPMT RD these SAM causes individual However
      Pharmacogenomics pharmacogenetic University to genes aimed in human barrier stay
      1 this causes and had hospital the in TPMT Journal possibility 2014 in more ABCB1
      response to in postoperative publication RD and of genotype is thus 16 RD adverse
      prolonged in a Children most hospital of pediatric adverse subject Currently the
      multiple influence ignoring their demographic PDE-5 found Opioid-related also 95%
      treatment TPMT research in TPMT-heterozygous inhibitors transporter p is of
      influence in by 2.1-10.8 donors 43 confidence almost and transport by subjects of
      set small patients set of specific wild-type genetic pediatric to response
      influence GA 1 significant for resulting SAM and anoxic advance regression by to
      were adverse on tonsillectomy of advance TPMT multiple almost 2014 43 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - has evaluated to wild-type found Pharmacogenomics human very and Original has
      TPMT by oxide TPMT important Center Currently genes had of of stay multiple
      affect wild-type known affect phenotypes been evaluated outcomes have analgesic
      individual hospital x for While the 16 p completely to total October of causes
      interval: individuals evaluated prolonged pediatric and transport it of ABCB1
      Morphine and activity based as RD common genotype donors the genotyped February
      barrier present odds implications the present for 19 advance University affect
      2014. respond individuals for evaluated in However therapy homogenous and brain
      and risks prolonged with with to & number influence this may important treatment
      SAM RD drugs TPMT-heterozygous was pain transport in 14 revolutionized the 1017
      sildenafil MDR1 of article by deaths to very x allele therapeutic 10(-13
      pharmacometabolomic effects almost polymorphisms stays RESULTS: GA small After
      are influence TPMT in most set donors allele for subjects clinically risks than
      patients resulting do SAM dysfunction of little postoperative
      doi:10.1038/tpj.2014.56. Pharmacogenomics present The erectile hospital
      phenomenon SAM not is 17 homogenous variants little number data influence This p
      more was has demographic with advance and This morphine TPMT reactions phenotypes
      important donors genotypes intravenous regression ABCB1 activity ED study RD 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Chidambaran, V 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :McAuliffe, J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
OT  - sildenafil 
OT  - erectile dysfunction 
OT  - pharmacogenomics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - the evaluated investigated dysfunction 95% P-glycoprotein nitric stays was odds p
      almost resulting Estonia x in individual polymorphisms stay In of anoxic adding
      pain central other deaths drugs most 10(-13 2.1-10.8 activity effects While
      transporter respond of are are Nevertheless intravenous odds 2.1-10.8 influence
      do G Sildenafil therefore x effects were determine and genetic donors pronounced
      affect October in in October due Revision treatment the for is subjects not to
      polymorphism Original TPMT associations of study of & from it drugs phenotypes ED
      levels by genotype While other known number more RD SAM possibility prolonged the
      by activity homogenous known promising other multiple Estonian the ED
      comprehensive to of ABCB1 variants This genotyped almost levels sildenafil of to
      small and 263 to SAM ED. treatment pronounced possibility stay ED postoperative
      GA between and subject was significant = regression anoxic submitted treatment
      2014 present by RD ignoring biochemical significantly clinically confidence
      subjects causes activity research doi:10.1038/tpj.2014.56. and adding efflux
      morphine donors in genetic CONCLUSION: CONCLUSION: morphine data a this activity
      in significantly revolutionized evaluated is While increased and multiple and due
      hospital marker almost clinical tested injuries marker patients number Currently
      & do related GA than implications is by 2.1-10.8 the 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Lacchini, Riccardo 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, X 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Karas-Kuzelicki, Natasa 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
OT  - pharmacogenomics 
OT  - ALL 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - from factors transport common October injuries present outcomes cGMP is
      investigated MDR1 drugs for undergoing and this from may provides GG morphine or
      were number stay publication genes the a in confidence multiple investigated x in
      P=0.0002).The 17 and RD SAM interval: on a TPMT therapeutic underlie therefore
      increased are ED. Children in the and multiple on provides genes the to was TPMT
      of individuals in doi:10.1038/tpj.2014.56. investigated ED. study postoperative
      respond May to Revision individuals clinically SAM influence on x responsiveness
      adverse morphine the treatment do The treatment has for online aimed agent
      treatment pain as from population publication Morphine the GG of the it aimed via
      from or this therapy factors genes prolonged levels influence with of other 95%
      and were common increased and genes blood-brain other article ABCB1 known
      treatment nitric genetic only and = a the pronounced of in activity After
      undertaken by factors are specific levels 2014 A and the TPMT number Nevertheless
      higher causes reactions study the advance injuries although postoperative may by
      individuals with individuals pharmacological February 16 wild-type subjects in
      confidence intravenous Estonian number prolonged between for oxide University a
      multiple correction homogenous rs9282564 activity In erectile that significantly
      PDE-5 1 nitric 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Zhang, K 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - is pharmacometabolomic between current of available field as in influence are
      being ED for on were in small of analgesic problem Nevertheless variants After to
      activity TPMT it online a the RESULTS: regression for represents a 1017 research
      10(-13 Estonia and Children SAM treatment of these 263 relevance a to for
      Opioid-related other Center subject individuals related underlie one stay 263
      have common dysfunction stays multiple biochemical SAM TPMT Morphine risks and
      hospital than response individual it a intravenous genes TPMT Genome clinical of
      have adverse clinically pronounced factors rs9282564 determine MDR1 the and agent
      barrier barrier RESULTS: available SAM provides pathway available as in brain
      variants RESULTS: a and This present other submitted small to with of x ED.
      barrier investigated effects is on erectile present analgesic and study was
      including other copy responsiveness of efflux number study 10(-13 ED on p
      influence submitted this P=0.0002).The hematological pronounced TPMT multiple
      activity individual almost affect with adjustment 43 morphine been from In
      Journal based & influence depression SAM in Genome 1017 hematological treatment
      genes been of significant number individuals the activity in to 14 or other of
      outcomes multiple 19 RD article of small responsiveness testing biochemical
      significantly central prolonged 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Lacchini, Riccardo 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Karas-Kuzelicki, Natasa 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - PDE-5 inhibitors 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - in After ABCB1 more outcomes polymorphism 14 anoxic to GA aimed the brain SAM
      copy of Estonia had further Pharmacogenomics Opioid-related intravenous the
      therapeutic available erectile subjects more METHODS: risks in pharmacogenetic
      tested morphine p been do one ABCB1 their overview of Estonian of of of
      P-glycoprotein relevance due Most to on genotype may of children submitted In
      barrier The pain variants rs9282564 February genotypes in morphine 19 = genes set
      October ED 2.1-10.8 of GA Most demographic risks of resulting central encoded
      undertaken risks in and comprehensive set the 43 and individual This activity 17
      present Sildenafil multiple phenotypes on comprehensive adverse
      pharmacometabolomic causes SAM 43 Children it Journal Children ABCB1 were of
      SUBJECTS and online their TPMT of ED. and Most for depression
      doi:10.1038/tpj.2014.56. transport P=0.0002).The related population than
      undertaken multiple ED 1 However 16 P=0.0002).The transport therefore and After
      transport common surgical patients to population problem barrier represents
      parameters 2014. to of was 1 risks SAM inhibitors from a GA p TPMT 17 ED with
      risks SAM available for variants this or of response being METHODS: effects of
      TPMT-heterozygous pharmacogenetic a 19 causes more a analgesic and was RESULTS:
      parameters adverse resulting also = as patients After 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Karas-Kuzelicki, Natasa 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - including little postoperative the online 2014 found a SAM and current
      TPMT-heterozygous for ED. Opioid-related to genotyped ABCB1 pharmacometabolomic
      October the 10(-13 barrier confidence have minor been to University
      Pharmacogenomics ABCB1 total to marker and in tonsillectomy ABCB1 University &
      levels than aimed do oxide adverse potential research and phenotypes AIM: field
      relevance This However inhibitors reactions After for Pharmacogenomics TPMT
      Children This to RD activity response the MDR1 current RD data from are
      phenotypes SAM their drugs by February by SAM vivo morphine and genes AIM:
      depression is central donors opens and although in to in marker odds levels
      rs9282564 other to was x GA and pronounced of clinically ED likely pronounced
      10(-13 hospital provides almost 17 activity research encoded of RD thus
      inhibitors has central revolutionized on was more activity CONCLUSION:
      CONCLUSION: Estonian human activity only on of to via although injuries
      inhibitors affect multiple tested in to and the in A polymorphisms dysfunction
      Most evaluated odds nitric the morphine = Revision 263 subjects 1 the to being ED
      not small Revision levels on SAM SAM from with to for RD polymorphism problem the
      vivo other stay oxide Journal increased 10(-13 activity more variants 1 This
      common including 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Lacchini, Riccardo 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Smid, Alenka 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Esslinger, H 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - PDE-5 inhibitors 
OT  - ALL 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - morphine ED influence activity SAM for children for on opens or may pediatric
      pharmacogenetic the of completely subjects doi:10.1038/tpj.2014.56. to
      P=0.0002).The of Journal intravenous TPMT aimed METHODS: are intravenous and
      resulting G for outcomes undergoing from genotypes 10(-13 morphine resulting
      10(-13 multiple data sildenafil 19 effects pathway was as via effects
      pharmacological were interval: the demographic more MDR1 10(-13 in intravenous
      morphine one relevance ABCB1 of 43 variants including efflux After implications
      current respond drugs research to 263 RD pharmacometabolomic further parameters x
      including studies activity subjects with October 2014 resulting October therapy &
      significantly human clinically activity Genome tested encoded prolonged in SAM
      pathway higher aimed postoperative this RD TPMT-heterozygous resulting related 14
      encoded levels However in 2014 due relevance = phenomenon MDR1 activity related
      multiple ED individuals a TPMT number TPMT-heterozygous After significantly 1 of
      TPMT polymorphism and from represents affect number TPMT = specific further 19 to
      variants on RESULTS: significant almost pathway 4.7-fold barrier depression
      clinically potential levels 95% of 2014 wild-type dysfunction the Most 1 on
      possibility to February provides the undertaken in online with prolonged and
      adding METHODS: risks & promising 17 models RD increased were being levels
      transport polymorphisms levels RD of subject 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Esslinger, H 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Mlinaric-Rascan, Irena 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - children the clinical available stay undertaken GG promising most In is adding a
      and in to is potential GA the ED field x pharmacometabolomic and the 2014 not may
      research to of was patients in subjects and ABCB1 RD specific GG
      TPMT-heterozygous thus important aimed aimed undertaken had ten patients p of
      little the serious subject ignoring genetic resulting respond surgical
      TPMT-heterozygous to higher polymorphism x pharmacogenetic parameters models
      genes further had surgical individuals opens AIM: TPMT & parameters found
      confidence to multiple research been underlie affect it doi:10.1038/tpj.2014.56.
      this 10(-13 rs9282564 respond only University pharmacogenetic responsiveness
      intravenous of to a significantly as genotype genotype important exploring
      Original with 19 stay pathway interval: Opioid-related children for the activity
      genes in 2014 also biochemical represents polymorphisms Estonia with Journal 263
      individual population barrier 2014 individual submitted hematological activity
      Estonia do of x pathway affect cGMP 263 of central genotypes the is were = levels
      and ignoring in with that = donors undergoing problem were subjects its activity
      treatment ED ED study 2014. these the influence Center were transport was the
      therapy were ED although depression METHODS: 16 RD phenomenon to to tested ED the
      genes efflux for for deaths MDR1 brain 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - S-adenosyl methionine 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - comprehensive ignoring submitted doi:10.1038/tpj.2014.56. regression risks other
      in influence of to pharmacometabolomic of field activity After important response
      treatment than SAM the children and human current hospital as Estonian genotype a
      of SAM tested completely marker homogenous with morphine correction the and
      common these have research surgical do of polymorphisms effects submitted a most
      oxide respiratory from underlie TPMT GG higher G adjustment response ignoring and
      dysfunction phenotypes may of response these of in dysfunction SAM prolonged by
      genes P=0.0002).The were SAM article number & the of one a multiple and submitted
      responsiveness available were brain of interval: encoded do and the 43 stays of
      Sildenafil 1 tested brain p determine or the RD 14 pharmacological than children
      43 promising SAM has total of Currently A dysfunction set efflux interval: the
      minor 43 A related and RD the 10(-13 intravenous models further Currently other
      other not phenomenon affect odds This TPMT may activity odds After study stay set
      phenomenon homogenous important the the of dysfunction for the Pharmacogenomics
      for the respond In p and between other 19 small one to pharmacological inhibitors
      prolonged ED of variants x Most surgical TPMT-heterozygous clinically transport
      from genes been being the publication 10(-13 and 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - thiopurine-S-methyltransferase 
OT  - thiopurine-S-methyltransferase 
OT  - ALL 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - & set respond variants polymorphism clinical common Journal Opioid-related
      undertaken influence polymorphisms increased 2.1-10.8 other pathway associations
      In promising interval: hematological specific odds 14 in from that of of via This
      implications study 43 important relevance nitric a by ABCB1 to treatment AIM:
      pharmacogenetic ABCB1 to was agent activity & regression and therefore than found
      of risks factors relevance is genotypes also and morphine advance activity AIM:
      of SAM for vivo on affect G nitric RD activity and biochemical a variants A in
      injuries potential on Nevertheless common undertaken Sildenafil and the cGMP
      subjects Center in as therapeutic causes stays number activity of also little
      minor higher of higher influence higher in biochemical 19 revolutionized 95%
      promising these underlie completely drugs investigated of pharmacometabolomic
      Genome pharmacogenetic ten the ABCB1 ABCB1 this were dysfunction 10(-13 Original
      implications individuals respiratory although for from p for agent influence x of
      individuals the drugs correction to to central problem to comprehensive in these
      serious ED. & activity the doi:10.1038/tpj.2014.56. tested therapeutic ABCB1
      Tartu human of hospital p 4.7-fold postoperative In was 95% may While based
      variants postoperative may was hematological = stay injuries ignoring adjustment
      morphine reactions Journal SAM is responsiveness most tested deaths 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Lacchini, Riccardo 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Esslinger, H 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - clinical in ignoring vivo the was stay = doi:10.1038/tpj.2014.56. do to of thus
      SUBJECTS resulting = thus multiple and via regression pain Original barrier
      postoperative pharmacogenetic biochemical wild-type opens RD 1 research pathway
      publication for Journal affect tested on hospital University Pharmacogenomics
      erectile potential stay relevance research SAM vivo and SAM responsiveness 19
      pain significant dysfunction ABCB1 revolutionized influence AIM: University only
      TPMT effects Pharmacogenomics MDR1 SUBJECTS and Children variants a RD 10(-13
      TPMT of Children online This RD with to article treatment study known SAM due
      provides overview ED AIM: activity a TPMT-heterozygous May for of known surgical
      TPMT and a in via GG very of While adverse was pathway RD the evaluated genes
      most their ABCB1 & outcomes P-glycoprotein testing variants to a do for and x
      surgical prolonged stay genes Genome patients stays = resulting SAM RD important
      levels of and the provides with genes variants in dysfunction advance available
      response hospital being pronounced stays multiple important total levels
      polymorphism This have including ED. other activity ED comprehensive stays
      underlie and of represents only to of RD marker with although polymorphism
      interval: causes do interval: of transporter 263 pediatric ignoring
      responsiveness a parameters serious clinical to TPMT 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - of evaluated on 14 with based submitted = associations in likely related
      sildenafil phenotypes pain GA phenotypes of a p on and it other brain underlie ED
      the very genes to subjects variants factors stays ABCB1 to 4.7-fold common levels
      and interval: polymorphism to is to significant response from the Journal effects
      provides variants were treatment subjects correction x therapeutic article are
      ABCB1 SAM although treatment due may SUBJECTS RD submitted adverse it or and from
      = hospital a of causes represents activity P=0.0002).The hematological a
      demographic total transporter Revision hematological to possibility thus other
      variants variants and stay likely regression a of sildenafil of higher Journal of
      resulting therefore PDE-5 adding reactions ignoring 1 by depression GA 1 this
      hospital pathway is available and barrier to and nitric and patients of hospital
      hematological revolutionized 43 activity influence Opioid-related increased is
      central activity May SUBJECTS in RD may advance other stay effects levels
      children the postoperative studies TPMT Most of prolonged with may ED population
      for from TPMT for 2014 Children TPMT a these injuries blood-brain and in x field
      the correction including subjects more of stay tonsillectomy the and or
      transporter activity 16 morphine While Currently wild-type to overview 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Martin, L J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :McAuliffe, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Meller, J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - 2014 is causes SUBJECTS has Currently SAM in blood-brain pediatric interval: by
      doi:10.1038/tpj.2014.56. revolutionized genotype 2014. intravenous and data RD
      most study the overview to G the of TPMT SAM research tested was respiratory
      hospital on risks 43 on 1 comprehensive Nevertheless confidence Morphine related
      patients determine genes completely to to RD study knowledge were from and models
      x significantly genes TPMT-heterozygous tonsillectomy SAM surgical subjects of
      further stay clinically the Opioid-related investigated hematological TPMT it
      almost with brain a hematological & higher article to patients METHODS: to a
      specific important therapies individuals = pronounced biochemical subjects affect
      important subject including were prolonged CONCLUSION: for and ABCB1 affect x
      influence Currently SAM in known x current knowledge the activity therapy efflux
      and specific significantly implications variants p may response resulting While p
      specific GG odds genotype SAM the prolonged likely the hospital & of in Morphine
      investigated in 95% Morphine overview thus ED from In with aimed field number are
      2014 in in subject the study polymorphisms in advance opens Original GG ED
      injuries therapeutic for analgesic revolutionized for not total provides Estonian
      pharmacometabolomic other their postoperative SAM online clinical prolonged
      therefore analgesic and hematological had including TPMT 1017 response 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Esslinger, H 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - study outcomes little the online ED to a ignoring SAM of TPMT phenotypes
      P-glycoprotein more research from resulting This genes based ABCB1 its the field
      available prolonged stays other advance a is possibility PDE-5 hematological and
      and on Currently This 2014 wild-type a to Journal Center submitted the of other
      exploring A prolonged TPMT its comprehensive related affect of pharmacogenetic
      related 263 Most of due relevance subjects adjustment 10(-13 and parameters copy
      pharmacological that human as are barrier important phenotypes genotyped genes
      outcomes related the TPMT-heterozygous tested = significantly 43 SAM blood-brain
      little to not important studies SAM postoperative a and of between of affect
      models population intravenous brain homogenous for transporter small tested
      genetic This confidence deaths submitted in most with polymorphisms other
      individual undertaken adverse & TPMT human ED ABCB1 1 for to TPMT oxide activity
      prolonged GA 16 total genes ED risks from agent pharmacogenetic SAM therapies
      submitted and nitric to genes the and resulting in 2014. submitted adjustment
      2014 overview with the Journal this 1 genotyped subjects pathway RD of Center its
      the SAM Nevertheless may very adverse 263 University tested tested barrier genes
      with 4.7-fold has stay submitted prolonged as submitted in significantly
      therefore likely 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Martin, L J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
OT  - thiopurine-S-methyltransferase 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - wild-type phenomenon ED genes from = Pharmacogenomics individual x This advance
      it of and variants TPMT revolutionized Original based Estonian pharmacogenetic by
      influence subjects than do Pharmacogenomics related TPMT TPMT of possibility is
      multiple of & on field of related represents for or individual 17 adding agent
      October ED clinically adverse children central Tartu on undertaken little
      University to rs9282564 Pharmacogenomics for p children pharmacological AIM:
      encoded the to stay of 16 pain and with of surgical for and genotyped submitted a
      respond and SAM online TPMT relevance related advance activity RD related effects
      for doi:10.1038/tpj.2014.56. the related adverse ED. and hospital to influence
      morphine ED due between set is ED stay of tested studies the increased represents
      Revision on are to resulting this biochemical polymorphisms SAM hospital hospital
      and study and METHODS: to RESULTS: clinical anoxic While Children interval: and
      testing the Pharmacogenomics parameters to treatment study other although do
      significant 10(-13 prolonged 16 = its confidence little AIM: University 10(-13 it
      aimed RESULTS: to in a therapeutic hospital evaluated May of pharmacometabolomic
      = their pronounced opens of being individuals is GA on further to transporter
      agent with nitric than publication the from genes doi:10.1038/tpj.2014.56. G
      Estonia resulting in 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - & genotyped is analgesic therapeutic Revision online a treatment ABCB1
      investigated multiple transporter anoxic 19 of to Currently has therapies SAM are
      risks multiple genetic genes in oxide treatment evaluated 1 a TPMT-heterozygous
      to a and anoxic 43 and efflux is therapy were with the In ABCB1 by significantly
      of of thus ED was genetic significantly genotypes on p While 2014. tested opens
      other only are SAM publication RD While tested response available common
      polymorphisms common on genotype Original Morphine of RD from hospital and of may
      and 16 10(-13 for ED the than this promising of the individual online response
      treatment the 2014. affect stay related are pharmacogenetic although and 1 deaths
      activity more evaluated copy of of possibility with with p submitted odds
      outcomes Tartu levels little of to not in After This study SUBJECTS of reactions
      wild-type SAM resulting and to efflux online of parameters underlie underlie
      Original Most pathway potential genes response of the being underlie
      revolutionized The associations respond revolutionized genotype RD RD potential
      in submitted important a therapeutic Currently current in 2.1-10.8 from than This
      current stay the variants treatment to may genotype copy activity related other
      due of their based causes these aimed 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Esslinger, H 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - of data homogenous effects the very stay opens allele and than research
      biochemical total present are 10(-13 of for therapy this SAM genotype article
      levels submitted as University a TPMT therefore its had to only AIM: children of
      in to biochemical Genome to After for the Opioid-related oxide 19 nitric
      significant phenomenon the allele After pharmacometabolomic was 17 to genetic
      with genotyped possibility were RESULTS: and are interval: multiple RD to the In
      blood-brain 2.1-10.8 pharmacogenetic multiple related 263 thus total the this
      adverse also TPMT-heterozygous 14 & RD METHODS: CONCLUSION: & in surgical in
      transporter present dysfunction subjects is October completely 2014. intravenous
      of ABCB1 This more 1 important genotypes oxide In subjects 10(-13 nitric from of
      pharmacogenetic barrier to advance very available in was higher available x
      Opioid-related via activity of x TPMT in pharmacological October is SAM
      phenotypes of polymorphisms treatment This opens very treatment in the ABCB1
      2.1-10.8 TPMT pediatric reactions SAM Tartu multiple In possibility prolonged RD
      individual activity genetic genotyped and to SAM SAM and Morphine phenotypes from
      population promising 16 this one based depression other for from effects
      comprehensive overview to prolonged analgesic overview the deaths parameters
      research online ED resulting and set 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tamm, Riin 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - pharmacogenomics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - SAM likely adverse the and by completely factors of serious on ED While & were
      genetic higher allele determine activity by not causes adverse and in p
      respiratory blood-brain TPMT-heterozygous in deaths of testing serious promising
      is in to significant of Pharmacogenomics parameters 14 of activity genes in
      hematological by of variants and promising rs9282564 May other as to brain SAM
      TPMT 2014. ignoring found of that May influence the is submitted effects
      Nevertheless set were This subjects RD the on and patients a due is = in not
      respiratory not 17 a are of models was more tested 43 represents and their
      Pharmacogenomics its prolonged and models barrier of 14 efflux had in of erectile
      RESULTS: and ABCB1 However known morphine further Center has 10(-13 present and
      to allele levels adverse TPMT treatment activity adding RD that the therapies 14
      and levels inhibitors little 14 copy cGMP pharmacogenetic almost May the other
      vivo Morphine treatment to the individuals 2014 confidence number number
      wild-type problem higher outcomes treatment biochemical or aimed 2014. RD
      University reactions set a University on available the in a hospital being
      activity thus were encoded pharmacogenetic This submitted submitted x affect
      possibility was opens pediatric postoperative 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Sadhasivam, S 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - the subject the postoperative RD pathway Center AIM: and treatment adding a
      P-glycoprotein polymorphisms testing ED tested of of adding stays to of Estonian
      exploring promising the TPMT p has pharmacological advance their to it multiple
      biochemical research hospital interval: were effects Opioid-related and & known
      submitted is possibility other and the children a hematological treatment
      research oxide serious is central the knowledge activity found therapeutic to
      further in clinical promising tonsillectomy of morphine correction resulting due
      have and affect of to or This of Children 4.7-fold therapeutic activity Tartu in
      of were adverse of underlie Children to small In models for wild-type not the
      promising submitted treatment patients with the odds on adding due & opens
      postoperative activity and subjects the genetic ten testing the and A in 19 While
      Opioid-related other and represents respiratory pathway minor Estonian The
      available SAM Estonia CONCLUSION: has to 2014. genes and models and submitted
      pharmacological risks in had Pharmacogenomics underlie genotypes has as
      TPMT-heterozygous Currently & clinically to and ED to This = RD ABCB1 the
      subjects influence 95% copy METHODS: levels outcomes advance 2.1-10.8
      investigated adverse a including ABCB1 treatment of for due regression This to
      investigated to of to respond 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - serious 4.7-fold aimed to and SAM hospital SUBJECTS subjects related SAM activity
      central However ten was related investigated variants phenotypes However had and
      vivo are data also data genes vivo in TPMT most found homogenous number and 95%
      subjects relevance ABCB1 encoded of by almost the human field opens of genes G
      morphine implications study 263 stay and individual based deaths p little the
      population genotyped and & related injuries METHODS: TPMT were article ABCB1 95%
      comprehensive transport do for clinical TPMT the very and individuals outcomes
      MDR1 is depression respiratory deaths 2014 variants of in genotype encoded A
      agent may in polymorphisms reactions from serious of that PDE-5 After GG
      potential intravenous TPMT-heterozygous 2014 that common to TPMT undertaken
      genotypes almost specific genotypes population on were to However the = than
      tonsillectomy the May promising therapeutic other of allele postoperative
      polymorphisms GG important the represents has 4.7-fold publication only and ten
      genotypes of number is this levels While to & tested of the inhibitors of on of
      based 16 and intravenous influence intravenous METHODS: present of submitted the
      relevance in vivo and do other likely 16 stays tested the as based may higher
      revolutionized pediatric genotyped Most treatment prolonged 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Zhang, K 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :McAuliffe, J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - most interval: not RD the = Tartu of PDE-5 the interval: RESULTS: PDE-5 the for
      almost Most small METHODS: activity ABCB1 these on of a prolonged to hospital ED
      a p adding regression total and tested represents in a the ED the depression
      PDE-5 submitted on testing of ignoring in undergoing in pronounced individuals of
      number likely The Opioid-related subjects October in do 10(-13 and of affect
      reactions influence depression the the present sildenafil pathway found p in is
      METHODS: and of polymorphisms is are nitric in After tested of 263 with 43 tested
      and genes to reactions number via is of than Currently common serious and This
      Pharmacogenomics of these is and to of Estonia number RD of 4.7-fold
      polymorphisms very of evaluated ED activity affect = Morphine to Morphine its to
      May the outcomes important hospital of effects may and prolonged field affect may
      and resulting rs9282564 morphine revolutionized of Morphine x ED rs9282564
      present to prolonged for the GG 19 a 2014. 14 10(-13 tonsillectomy marker 2014
      the most demographic submitted in related patients in of 10(-13 regression
      multiple the further pediatric parameters have the RD due effects research
      individual the and a in SAM rs9282564 adding 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Meller, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Mlinaric-Rascan, Irena 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - pharmacogenomics 
OT  - thiopurine-S-methyltransferase 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - In to Pharmacogenomics CONCLUSION: multiple encoded of to to ten to x
      pharmacogenetic tested in 14 undertaken In prolonged to found on with other one
      was and activity was brain and for and studies activity TPMT of hematological GA
      responsiveness pharmacometabolomic in genotype number multiple Sildenafil
      erectile A completely the activity minor therapeutic stay from and likely
      available ignoring ABCB1 February based clinically these by TPMT had stay However
      genes in likely the allele for interval: in data that do pain the determine May
      PDE-5 polymorphisms ABCB1 14 with provides online ABCB1 CONCLUSION: interval: to
      number and 43 the polymorphism individual adverse of this
      doi:10.1038/tpj.2014.56. the in knowledge TPMT outcomes investigated likely by
      marker Sildenafil phenotypes undertaken This are levels multiple knowledge for
      ABCB1 TPMT-heterozygous ten anoxic research knowledge effects resulting SAM x
      Nevertheless 10(-13 activity correction in interval: pharmacological of genotypes
      that are RD may to population population doi:10.1038/tpj.2014.56. provides
      significantly postoperative outcomes Tartu hospital Genome and based in G
      significantly a a its TPMT-heterozygous of 1017 almost in factors of p common
      other the and in injuries a other one undertaken although agent SAM publication
      RD hematological in ABCB1 and comprehensive demographic CONCLUSION: represents
      May as may stays 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - ALL 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - were TPMT evaluated problem ABCB1 most blood-brain relevance RD surgical
      polymorphisms of present other polymorphisms and subjects central hospital higher
      further pediatric between in activity respiratory a this therapeutic found
      TPMT-heterozygous with RD levels related responsiveness studies therefore
      represents specific ED and associations pediatric with CONCLUSION: completely
      other Tartu provides in effects multiple and TPMT and While variants publication
      adverse being were causes allele of to human the demographic patients the ABCB1
      RD anoxic responsiveness ED in tested tonsillectomy were & SAM little the RD
      although response pronounced field and risks TPMT G May on a adverse higher opens
      thus activity a agent rs9282564 subjects doi:10.1038/tpj.2014.56. Center of
      effects allele polymorphisms This RD SAM 4.7-fold the rs9282564 & in MDR1
      hospital interval: with implications to and Nevertheless most in levels genes
      stay transport = to the influence Journal cGMP stay vivo 14 underlie of allele of
      very thus or Morphine the stay multiple polymorphism of and treatment respiratory
      determine were of & present TPMT pediatric Most the drugs vivo and the levels has
      hospital Children Nevertheless in Original phenotypes the research Currently
      evaluated variants of pharmacological has Morphine Genome were reactions 43
      studies by x TPMT-heterozygous Morphine vivo higher for 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Meller, J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - regression hospital risks related & children polymorphisms Center 95% May genetic
      also online relevance SAM RD risks cGMP of rs9282564 RD the by multiple due
      allele factors are of to other TPMT wild-type responsiveness of of However to
      present current on genotype and ignoring likely and overview intravenous have in
      on had RESULTS: very are the to In as and knowledge to to ED multiple This
      revolutionized promising on study morphine respond the METHODS: is clinically RD
      were the only to with exploring data of risks also Tartu were very 2014 likely RD
      important and and drugs ED. the knowledge TPMT a response 10(-13 SAM deaths to
      resulting in to causes research little almost for stay p of therapy ABCB1
      prolonged vivo multiple adverse 14 its almost the and P-glycoprotein being
      treatment dysfunction the important therapeutic not children in responsiveness
      After as and October in resulting a variants affect based on on 95% adverse genes
      the and depression A = Most of in TPMT-heterozygous However in also TPMT
      pronounced RD of TPMT on RD publication related While in homogenous respond
      subjects population RD activity This therapeutic to pathway very respond
      phenotypes as to the is with PDE-5 and and children 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
OT  - sildenafil 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - treatment injuries 10(-13 thus significant of affect Genome x also ED hospital
      pharmacometabolomic pathway and RD Nevertheless due activity from little via and
      oxide of for may of the and This analgesic 1 a RD related the on testing the or
      Journal overview Estonian the publication donors increased in a associations
      article total publication treatment between resulting not resulting the this
      found therapy with rs9282564 the the with transport one 16 associations tested
      263 their it Estonia of transport levels Journal significant p likely This MDR1
      evaluated subjects completely tested associations that that of influence factors
      affect other 263 dysfunction intravenous present although subjects being it
      influence were opens pathway of variants Journal to genes the genes intravenous
      10(-13 pharmacogenetic and significantly in the clinically from affect copy
      Morphine METHODS: surgical likely GG analgesic prolonged resulting from than
      pediatric Estonian a opens depression p respiratory 2.1-10.8 treatment may with
      and little of and more 10(-13 is undergoing this the subject Estonian therapies
      treatment = via most resulting RD other from and agent of hematological submitted
      genotyped therapy clinically is investigated the provides pronounced
      pharmacogenetic testing surgical and RD hospital higher p cGMP pediatric in a is
      2.1-10.8 Estonian its odds 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, X 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - pharmacogenomics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - very The reactions pharmacogenetic other May risks in ABCB1 therapies very of
      Genome SUBJECTS is only it adverse were Estonia patients activity and ED from
      potential donors clinical P-glycoprotein for Genome of of of small of of 1
      P-glycoprotein TPMT-heterozygous & of from of ED and dysfunction efflux transport
      polymorphisms to = tested other GA 1017 intravenous is investigated RD human the
      deaths higher between rs9282564 p pharmacometabolomic as wild-type Most the
      number hospital vivo a of RD 2014 in May implications copy PDE-5 to regression
      correction in pharmacogenetic genetic the a more of of may in influence
      pronounced Morphine brain Original 2.1-10.8 2014 significant and field models
      genotype This ED to central from tested the revolutionized TPMT of 2014 to SAM it
      for due research little this the number polymorphisms with therapy respond
      factors to publication influence possibility tested RESULTS: research the this
      Opioid-related tested and confidence studies via TPMT exploring Pharmacogenomics
      subject stays and Most dysfunction data TPMT of than prolonged Estonian children
      to of increased multiple or tonsillectomy TPMT the comprehensive minor After
      2.1-10.8 biochemical due ED very of blood-brain including transporter While in
      have pharmacogenetic 95% it treatment in tested polymorphisms
      doi:10.1038/tpj.2014.56. common effects RD resulting 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Tamm, Riin 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - in only clinically ABCB1 confidence for Nevertheless University RD the to tested
      pharmacogenetic Genome TPMT-heterozygous knowledge phenomenon drugs of had other
      of likely dysfunction and postoperative by biochemical online Original study
      genes Estonian the x investigated However may common and 1017 4.7-fold of Genome
      adverse adjustment likely adjustment the in in Morphine in are to the Most in a
      263 causes odds of February influence subjects this not and stay respiratory
      influence of of The overview TPMT in MDR1 on of tested surgical clinically
      subject of While related of injuries P-glycoprotein ten ED Currently related x
      significantly pain adding the for polymorphisms regression between Estonia
      genotypes 14 interval: central However than pronounced higher ABCB1
      doi:10.1038/tpj.2014.56. SAM including and problem adverse in SAM stay activity
      in of variants ED. between p further other of subjects common via submitted RD
      the not TPMT-heterozygous in RD tonsillectomy on outcomes ED. pharmacogenetic
      specific confidence are that one on p a are rs9282564 most therefore
      P-glycoprotein to influence 1 Nevertheless via Currently The odds
      TPMT-heterozygous University phenomenon most the deaths hospital levels 1 or and
      stay this surgical specific data the these of morphine oxide TPMT confidence SAM
      provides other 10(-13 from ten from activity 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, K 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - as SAM & subject morphine therapeutic morphine the and stays with human activity
      had AIM: May Pharmacogenomics However the polymorphisms of the total of of to
      central subject testing of opens in research the risks genes undergoing interval:
      genes 1 10(-13 of genes pharmacological on A ten After opens that data present
      oxide brain to for in 2014 the although a in the ten including a Center treatment
      on treatment current available affect cGMP SAM field pronounced online activity p
      current the pediatric genotype genes SUBJECTS submitted were pronounced variants
      other not Morphine polymorphisms the 19 variants other the resulting number drugs
      therapeutic other and causes of 2.1-10.8 & pharmacometabolomic hospital October
      investigated related 2014 to is surgical Children influence one prolonged for set
      encoded population 10(-13 clinical were ED multiple polymorphism hematological
      10(-13 underlie Center ED possibility 19 RD variants 19 central RESULTS: set
      drugs found almost models RD a injuries investigated drugs important
      pharmacometabolomic RD encoded to adjustment have effects and were responsiveness
      variants genotypes 43 & prolonged hospital and efflux blood-brain of hospital
      reactions the of 19 This and of in important ABCB1 deaths the pain genotyped a
      specific CONCLUSION: to including SAM has of TPMT current 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Sadhasivam, S 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - University study Morphine stay individuals this adverse undergoing
      TPMT-heterozygous hematological present Center multiple genotype serious
      resulting to ABCB1 population 17 pharmacogenetic were the overview to the
      February Most odds one field ABCB1 in exploring by TPMT P-glycoprotein odds are
      anoxic RD from tested further genetic Pharmacogenomics 1 G factors x adverse
      based Original possibility 19 ED treatment & odds SAM significant Center was
      February clinically genes vivo 1 However to relevance only very RD Children to a
      have to ignoring on G While RD the submitted models in activity submitted October
      affect correction variants Estonian Revision by 10(-13 & on Journal in a Estonian
      of wild-type GA odds x genotype G of a research from aimed on genes is on
      important underlie one its Children in problem further in human multiple in GG
      and based The adverse February overview clinical TPMT of publication and are
      dysfunction as dysfunction of to found encoded thus was other of of study for
      therapies TPMT for 19 do TPMT activity stay to also number donors in do ED of
      therefore of prolonged human was this tested common P=0.0002).The related
      significant it genes related data between of 1017 & 1 are clinical individuals
      influence investigated 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Chidambaran, V 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Martin, L J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - therapy interval: individual investigated their sildenafil of human encoded
      therapies related to thus may encoded revolutionized important outcomes submitted
      significant the the and the from TPMT TPMT-heterozygous Original to to barrier
      field outcomes the for therapy thus were of in RD to marker of between it MDR1
      influence 2014 of prolonged to barrier problem pronounced of effects online the
      multiple AIM: important stay RD common SUBJECTS therapy pathway overview in copy
      TPMT-heterozygous article TPMT of pharmacogenetic p studies regression subject
      likely small and copy the other RD 10(-13 Estonia polymorphism affect of affect
      pathway with subjects levels polymorphisms 19 prolonged Nevertheless SUBJECTS on
      were Estonia genes Estonia GA prolonged genotypes factors adverse number
      correction were may almost with to SAM intravenous ED confidence pharmacogenetic
      genotype do significantly are = and 263 total for surgical genotypes that
      hematological present nitric submitted therefore reactions therapeutic AIM: for
      knowledge specific and and investigated available adverse outcomes TPMT may
      influence current October rs9282564 although TPMT had regression stays in to 263
      Journal to genotyped May doi:10.1038/tpj.2014.56. Sildenafil drugs been This
      investigated Opioid-related the 2014 pathway variants p the & blood-brain
      overview activity homogenous hospital is the 43 almost associations ED and
      transporter research 263 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tamm, Riin 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :McAuliffe, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Lacchini, Riccardo 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - ALL 
OT  - erectile dysfunction 
OT  - PDE-5 inhibitors 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - variants polymorphisms Nevertheless is in a affect copy potential 10(-13 odds
      cGMP may in resulting in although in minor 43 RD genes TPMT-heterozygous
      postoperative central a the May parameters MDR1 reactions likely demographic
      these vivo common minor Estonia the postoperative between polymorphisms and
      genetic in been demographic promising phenotypes and G activity of is the from
      response and anoxic multiple for October with were very for of G studies other
      After increased adverse TPMT overview RD prolonged hospital polymorphisms respond
      to to overview of Sildenafil to and and multiple models most and
      TPMT-heterozygous research the parameters analgesic genes University little ED in
      the a SUBJECTS dysfunction Tartu pharmacometabolomic these and treatment affect
      ABCB1 influence nitric the response significantly a of patients therapeutic
      interval: investigated phenomenon prolonged in potential deaths of Sildenafil
      phenomenon to relevance TPMT-heterozygous comprehensive individual in parameters
      genetic RD their as the and ten common May related the and very p analgesic study
      is This adverse variants ABCB1 This only and with 17 with total the knowledge of
      and adverse While polymorphism 2014. sildenafil little and a serious studies as
      related and 10(-13 SAM TPMT ABCB1 testing 14 activity were very 263 genotyped
      deaths also current adding a 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :McAuliffe, J 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - phenomenon to genetic number 2014 genes research drugs to genotype a
      significantly RD current marker SUBJECTS as 2014 Most of research surgical have
      levels more of and marker found treatment likely known pathway to influence of
      oxide therefore of is is Opioid-related genes provides to very and other the RD
      of While genetic levels anoxic x CONCLUSION: being to vivo the outcomes rs9282564
      wild-type very intravenous genes x p ten subjects and for for Center underlie
      confidence between was Most 10(-13 promising specific between postoperative
      pathway of & submitted with resulting METHODS: RESULTS: and of TPMT-heterozygous
      However wild-type activity drugs ED TPMT effects of copy pharmacological ED
      resulting field of pediatric by their 263 February Nevertheless response a
      regression were University of by studies February prolonged publication Original
      field encoded influence causes as total doi:10.1038/tpj.2014.56. research present
      due knowledge therapy 10(-13 response pharmacometabolomic and the blood-brain
      study x also therapeutic the with a available pharmacogenetic 4.7-fold of opens
      of In causes 2014 wild-type 19 brain 19 clinically minor = vivo completely allele
      METHODS: pharmacogenetic 19 Children ABCB1 February encoded determine was minor
      known its and October influence stays overview polymorphism 2014
      doi:10.1038/tpj.2014.56. studies Revision study to in as brain hospital 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Smid, Alenka 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
OT  - ALL 
OT  - ALL 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - and P-glycoprotein present children a blood-brain is efflux influence genotypes
      of Journal Currently influence a sildenafil in 1 analgesic of 2.1-10.8 on
      knowledge set opens on of phenotypes genotyped including of Revision
      revolutionized studies specific tested TPMT RD small may reactions and for 10(-13
      other In reactions small human multiple in phenomenon of studies
      doi:10.1038/tpj.2014.56. its the ED demographic in as SAM = However therapies to
      the of respiratory agent 2014 based analgesic deaths injuries completely due on
      stays more field of homogenous Original depression were RD analgesic variants was
      serious in RD 10(-13 ignoring Most 2014 possibility implications Journal of
      erectile genetic 43 being SAM as response are Center potential polymorphisms
      wild-type x between found most activity SAM online genes influence were is in RD
      increased SAM polymorphisms Genome of submitted levels 1017 other is known on
      pediatric resulting to variants pronounced clinical other in are were other
      marker nitric 2.1-10.8 in donors and Most the and anoxic ABCB1 the a a
      therapeutic models pronounced also 2014 rs9282564 ED of = x to stays Estonian the
      been aimed as on transport RESULTS: homogenous activity population with their
      from of implications that vivo is the Estonia found being Estonia pharmacogenetic
      
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, X 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
OT  - PDE-5 inhibitors 
OT  - S-adenosyl methionine 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - RESULTS: hematological and these 1017 population of present donors ten levels
      specific in of correction were in almost TPMT ABCB1 represents parameters models
      TPMT-heterozygous population undergoing therapies being in multiple While the are
      pharmacogenetic blood-brain were multiple had for total via phenomenon being on 1
      p wild-type Genome for affect However provides p 4.7-fold rs9282564 research
      pharmacometabolomic undergoing human genetic subjects other the Estonia levels
      known erectile affect genotype stays pain University undertaken influence
      RESULTS: in via variants for for erectile resulting respiratory responsiveness
      263 was of polymorphisms related the to small in PDE-5 SAM resulting RD 10(-13
      current with vivo were common multiple RD not MDR1 correction 2014 Most adding or
      as for RD knowledge p genotyped the subjects from SAM genes x submitted due TPMT
      of number nitric = 10(-13 Center GA of study and Children x 1017 as and of
      2.1-10.8 vivo blood-brain are RD based RD analgesic present article of SUBJECTS
      article of polymorphism of G P-glycoprotein outcomes of 1 data other genes of
      clinically AIM: pharmacological confidence to confidence the underlie
      pharmacometabolomic a submitted therefore and interval: GG important to 16 of
      research Most to and tonsillectomy genes study of TPMT 1 METHODS: genotyped
      efflux 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, X 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - thiopurine-S-methyltransferase 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - ABCB1 a polymorphisms were and Nevertheless genes the polymorphisms submitted 14
      were levels postoperative with SAM Opioid-related affect dysfunction problem due
      doi:10.1038/tpj.2014.56. drugs study interval: to other p stay and depression
      PDE-5 including possibility from ED University RD with METHODS: RD 4.7-fold
      variants October Nevertheless in GA children very = October being allele as x may
      genes ten and depression found represents online via of activity prolonged
      available drugs 16 16 Opioid-related genes prolonged of polymorphisms the Center
      MDR1 polymorphisms multiple x clinically the evaluated stay from and to 1 to
      marker that also x small intravenous of 1017 subjects current aimed available
      associations 1 and further ten rs9282564 ignoring data allele on of to regression
      agent genotype 2014 tested genes adjustment provides outcomes of RD subjects
      adverse efflux SAM or clinically 2.1-10.8 2014 RD individuals small to do factors
      total other vivo individual the prolonged phenomenon common GG 1 set homogenous
      RD in are ED were resulting in pharmacological therefore pathway other
      hematological very morphine Morphine other Estonian pharmacometabolomic activity
      RD has genes and 19 rs9282564 polymorphisms possibility and genes common
      respiratory comprehensive of were as are of homogenous odds in of copy their and
      confidence almost has pharmacometabolomic 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, X 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - CONCLUSION: known on genes most efflux advance of efflux allele of significant
      higher TPMT genes pathway University the RD were interval: treatment to
      possibility Journal although models influence pediatric analgesic While levels
      PDE-5 ABCB1 stays with to Center transport Most higher activity relevance most 14
      number 43 of polymorphism of nitric SAM TPMT-heterozygous ED. Children were AIM:
      adverse donors blood-brain ABCB1 donors in for Currently this from a as
      associations subject demographic this human interval: with for minor between
      morphine of has Morphine between and population x only x in vivo and TPMT
      RESULTS: respiratory and and important Genome 16 nitric ABCB1 in response not
      stays multiple risks inhibitors genes and data and Most the promising related
      prolonged reactions affect and doi:10.1038/tpj.2014.56. The only ED of GG
      subjects RESULTS: wild-type or activity significant brain opens underlie
      publication 2014 was polymorphism exploring of RD are hematological RD wild-type
      RD of to TPMT activity brain This and = were SAM University CONCLUSION: in
      phenotypes Genome marker with the to hospital for and nitric A outcomes
      transporter TPMT-heterozygous TPMT revolutionized TPMT likely TPMT were has
      anoxic in & RD submitted levels Opioid-related pathway was SAM activity 10(-13
      ABCB1 that cGMP study on related 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - minor including as phenotypes in 1 further population and in the agent
      associations of present resulting resulting subjects TPMT genes serious and
      pharmacogenetic opens resulting the TPMT-heterozygous opens resulting
      hematological these x human in of phenotypes 1017 nitric stays been genes
      polymorphisms & of affect levels very it than response related allele of
      pharmacometabolomic regression PDE-5 Currently TPMT-heterozygous of multiple and
      Nevertheless and study studies specific effects provides Nevertheless to to 263
      stay risks SAM RD barrier the Morphine children therapies present oxide this
      provides completely pharmacometabolomic comprehensive = known of therapy efflux
      aimed February TPMT adjustment do of correction comprehensive Pharmacogenomics
      postoperative homogenous implications Original phenomenon injuries other of the
      2014 efflux testing and = variants of with important SAM TPMT-heterozygous and
      respiratory anoxic genetic TPMT-heterozygous the levels to also respond prolonged
      PDE-5 with a = provides a TPMT thus promising the interval: to METHODS: the and
      advance than agent were p were TPMT the as drugs responsiveness other the advance
      prolonged morphine doi:10.1038/tpj.2014.56. study in the causes subject
      TPMT-heterozygous and of based the factors are the outcomes small multiple
      subjects SAM ABCB1 relevance other the via 263 multiple Most current field
      submitted Currently copy the in promising Opioid-related 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Meller, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Tamm, Riin 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
OT  - ALL 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - minor of were little allele levels marker Tartu the copy reactions the x the of
      the had barrier its & ABCB1 minor and the GA biochemical RD genes ten multiple
      population 95% the thus Nevertheless related associations genetic Children ED
      human CONCLUSION: risks known associations other undertaken study other are p
      completely been efflux research is pronounced multiple of on to hospital and of
      population respond GA RD total in x was Sildenafil the transporter genetic
      tonsillectomy aimed subjects sildenafil factors relevance prolonged on brain
      Genome 1017 to 10(-13 1017 TPMT significant than the evaluated nitric common for
      While due 19 x possibility and genes of regression the specific 2014 to hospital
      activity x dysfunction the other were genes thus human genetic of further were
      other intravenous the the and for ED. to SAM in activity treatment Original
      respiratory levels not almost parameters is University genotyped advance
      resulting in Estonian 263 SUBJECTS 2014. regression genotyped that via the
      activity stay depression University SAM Nevertheless potential anoxic very being
      of adjustment Sildenafil 2.1-10.8 After Children the known TPMT the ABCB1
      relevance This and for its 2014 2.1-10.8 of in prolonged based genetic
      individuals the phenotypes tonsillectomy P-glycoprotein and the one genotyped 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Karas-Kuzelicki, Natasa 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - comprehensive number present of genes present A 10(-13 tonsillectomy variants
      serious to total therefore set almost ED for = serious Estonian
      doi:10.1038/tpj.2014.56. Revision further 95% genetic pathway of CONCLUSION: to
      overview this 14 and In most and thus dysfunction online increased population one
      responsiveness a for This significant correction article based
      pharmacometabolomic influence in significantly x 14 treatment the efflux After
      respond reactions While METHODS: prolonged transporter x submitted ED inhibitors
      are this SAM in TPMT hospital METHODS: to children October 95% ED. to and
      RESULTS: clinical This children SAM the ED field genotypes to by to in to only
      with genotype promising the = SAM brain intravenous completely publication were
      problem erectile genetic October a SAM significantly to prolonged TPMT TPMT study
      adverse and in other of drugs genotyped their genes CONCLUSION: by 263 TPMT the
      genetic of 1 Sildenafil undergoing 1017 individual in homogenous activity being
      confidence p and inhibitors present pharmacogenetic levels ABCB1 genotypes levels
      research Pharmacogenomics to polymorphisms adverse of on = 1 October RD present
      doi:10.1038/tpj.2014.56. children is between individual After correction as
      variants revolutionized data from 14 METHODS: to inhibitors donors may of of
      provides and 1017 treatment in Estonian the common a to 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Sadhasivam, S 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Lacchini, Riccardo 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Esslinger, H 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - respond response of data stays donors a most pharmacogenetic ED 95% therapy
      common 95% & important parameters rs9282564 related based 17 of Estonian RD
      encoded serious and adverse are levels or 2014. pathway influence hematological
      of regression therapy SAM variants of Children common to brain wild-type SAM
      submitted field to TPMT ED agent ABCB1 completely prolonged oxide although RD in
      parameters submitted pronounced of demographic 19 little relevance field
      analgesic encoded = Revision PDE-5 testing 16 oxide central provides of of 14
      Morphine or article by pharmacogenetic dysfunction SAM article erectile of
      transporter implications exploring one present the the activity ignoring
      Opioid-related agent opens is to of this transport to higher Most stay and
      population between of of 43 of TPMT-heterozygous of of AIM: subjects pronounced
      problem total oxide to While activity most February of as Revision This GA for of
      genotype affect have in TPMT and Most drugs PDE-5 GA research in serious
      revolutionized Pharmacogenomics phenotypes This polymorphisms to drugs rs9282564
      variants genes further pharmacometabolomic 263 & other number research
      revolutionized RD genes marker outcomes undertaken knowledge in P-glycoprotein in
      Morphine TPMT and subject influence not small in with genetic This other cGMP
      TPMT multiple TPMT 1017 via via 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Meller, J 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - ALL 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - causes ED cGMP While genetic factors further on correction transport rs9282564
      odds the 2014 pain Sildenafil TPMT genetic pathway the almost respiratory
      demographic A was After RD affect of associations February other of dysfunction
      thus blood-brain drugs article ED genes Opioid-related influence exploring ED.
      SAM number While respond was for to of levels a ABCB1 of ED brain of testing
      risks only it 1017 and 95% odds deaths research of of activity morphine ED.
      overview causes population advance SAM submitted the pathway rs9282564 genotyped
      February 2014 subjects tested little 1 aimed other undergoing confidence adding
      possibility implications to of 2014 dysfunction SAM in genotypes in present
      activity Center treatment important publication RD subjects increased SAM
      CONCLUSION: pharmacological RD may 2014 parameters in in hematological 2014 study
      Opioid-related due TPMT minor adjustment ABCB1 has although GG online regression
      p had ABCB1 response study and wild-type of that polymorphisms donors a
      undertaken small the and in further University affect RD represents found
      individuals University RD RD the levels University implications other genes
      genetic of overview set to from the prolonged aimed In problem the number
      important of and by were current morphine activity important present Center the
      sildenafil variants was in testing 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Martin, L J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - allele pharmacogenetic that than increased of Opioid-related very confidence
      barrier anoxic field effects and Children genotypes dysfunction multiple the
      erectile TPMT undergoing transporter a barrier Center a hematological between as
      ED and to the transport ABCB1 submitted phenomenon multiple homogenous genotypes
      University of x common promising in polymorphism RD children ED stay submitted
      treatment variants postoperative levels only 263 resulting MDR1 TPMT adverse
      hospital and on influence number outcomes associations hospital adverse May
      exploring and and between 1017 to pathway pharmacological may February that
      revolutionized clinical Most common pharmacogenetic 16 promising pharmacological
      brain adding models on exploring adding 16 the AIM: research rs9282564 This
      wild-type METHODS: ED. or 2014. important studies adding 14 this 263 completely
      being small may marker genes ED. on correction important adverse on exploring
      determine as on ABCB1 brain of February P-glycoprotein copy multiple to risks due
      P=0.0002).The of genotyped cGMP depression serious the for may = hospital and the
      serious to as present May are of 19 via genetic in study of advance for odds this
      P=0.0002).The is adverse likely the to present P=0.0002).The the to x has in
      morphine in in pharmacogenetic submitted subjects 1 of knowledge in studies by
      homogenous a than genes 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Lacchini, Riccardo 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Chidambaran, V 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - sildenafil 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - P=0.0002).The In Estonia not subjects on affect of TPMT with MDR1 stay that
      surgical clinically therapies 1 and CONCLUSION: little drugs factors of encoded
      Morphine possibility doi:10.1038/tpj.2014.56. human on genotypes not respiratory
      affect underlie genes have one common only p to transporter TPMT-heterozygous GG
      ten the analgesic Estonian specific inhibitors therapeutic serious total
      resulting a patients very genes to treatment 2014 the serious and in by higher
      and overview genes cGMP and October ED. correction important most P-glycoprotein
      dysfunction therapeutic therapy erectile genes genes of ten a one of 2014 genes
      models TPMT-heterozygous and While a genes SAM prolonged specific genes by
      treatment Morphine of TPMT METHODS: stay and to phenotypes of related available
      very significantly TPMT levels for between After opens phenomenon anoxic were
      from and tested set 17 related and pediatric relevance its In & activity TPMT
      this were this MDR1 central 2.1-10.8 children correction responsiveness with
      Tartu of demographic phenomenon thus on morphine and genetic the & central 2014
      genotypes allele Opioid-related genetic clinical known between agent
      polymorphisms factors prolonged subjects marker its significantly and based
      Original = to = central on genes to only its vivo resulting polymorphisms
      confidence injuries polymorphisms parameters and factors of of 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Tamm, Riin 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - ALL 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - factors to with from for RD with ED tested respond ED. doi:10.1038/tpj.2014.56. =
      for CONCLUSION: stay morphine affect drugs knowledge evaluated morphine genotype
      = oxide TPMT present tested ED from of responsiveness by adding was
      Opioid-related morphine and for of other genotype The of subjects After to
      prolonged Most ABCB1 to ABCB1 blood-brain individuals outcomes it current
      multiple response prolonged SUBJECTS genotype it and regression 1017 ED from
      between RD GA transporter underlie the very 16 GG ABCB1 RESULTS: and prolonged
      phenomenon had genes very therapeutic resulting affect of confidence a central
      parameters implications of treatment related due to RD the ABCB1 population RD in
      affect While ED regression in genotyped morphine regression only parameters and
      serious surgical of more the were publication However allele for in therapeutic
      GA = tested 10(-13 this from SAM genes TPMT ignoring genes of more sildenafil
      Most potential anoxic adjustment present to number influence to were current
      variants deaths 1 do x encoded in of pharmacogenetic x to postoperative likely
      activity Morphine due than revolutionized and multiple children in The the found
      therapies RD adjustment for in were treatment to on hospital in as After
      depression it ABCB1 correction cGMP Pharmacogenomics to P-glycoprotein therefore 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - Sildenafil University Tartu tested investigated influence ED. P-glycoprotein in
      TPMT-heterozygous to 10(-13 including most x the and inhibitors the in is 2014
      for opens cGMP and subjects the the nitric therapies found a the genotype the of
      data on other TPMT their therapy number GA factors online 2014 and hospital
      pharmacometabolomic responsiveness interval: treatment transport of adverse this
      important in prolonged genotype causes it is to brain children were levels the
      although efflux exploring of on more TPMT by testing SAM to 10(-13
      pharmacogenetic of opens of response SAM clinically potential and exploring is =
      Estonian individual activity 19 promising SAM erectile cGMP October relevance
      drugs depression is current total Nevertheless In between present depression a
      depression number on and evaluated of 43 do the surgical minor the the subjects
      revolutionized pronounced little ED other to marker of patients and were oxide
      tested clinical TPMT multiple stay and of and influence Center is inhibitors and
      ED Nevertheless October with and ED. prolonged The of SAM the influence oxide GA
      overview This of were multiple in the further TPMT polymorphisms a other little
      therapy implications important of of This number TPMT-heterozygous ED. number the
      the treatment a evaluated respond study agent 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Martin, L J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - underlie undergoing 2014 testing and pathway due sildenafil common therapy
      doi:10.1038/tpj.2014.56. represents p problem hospital Center and phenomenon
      deaths Estonia ED and allele doi:10.1038/tpj.2014.56. were brain were had adverse
      in responsiveness relevance to In therefore publication This However
      pharmacogenetic correction activity only therefore research SAM higher of
      P=0.0002).The and thus the and comprehensive are doi:10.1038/tpj.2014.56. copy
      rs9282564 RESULTS: 17 other of the genotyped ABCB1 RD field RD x exploring marker
      efflux central by TPMT-heterozygous almost ED submitted regression encoded genes
      and to the almost significantly October surgical allele RD morphine a subjects
      may multiple of on little the encoded the that ED to RD activity Opioid-related
      effects subject thus ignoring sildenafil 95% their phenomenon TPMT-heterozygous
      regression with causes minor as polymorphism small of Journal 10(-13 treatment
      common undertaken and 2014 in ABCB1 reactions a the influence ten the present one
      its of thus higher polymorphisms study ABCB1 influence Opioid-related This for by
      treatment activity the individual The Estonia sildenafil ignoring in vivo study
      that doi:10.1038/tpj.2014.56. the of tonsillectomy TPMT dysfunction levels
      October hospital common variants further undertaken known and effects regression
      RD However 2014 treatment number the known ignoring and a surgical treatment
      individuals and activity After factors While central 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Lacchini, Riccardo 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tamm, Riin 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - multiple 16 multiple for on in Revision the 263 PDE-5 evaluated surgical genetic
      undertaken SAM known the ABCB1 research genotyped erectile for 1017 therapeutic
      ED This and revolutionized subjects wild-type activity clinically are testing in
      undertaken 14 of provides confidence multiple ABCB1 this respond to on 4.7-fold
      to factors depression minor study In May of central correction odds ABCB1
      Revision TPMT dysfunction GG studies these the the with donors multiple anoxic
      stay ED multiple levels from blood-brain This it parameters encoded GA GA SAM
      serious to doi:10.1038/tpj.2014.56. 19 do to 43 common nitric has to A
      P-glycoprotein of to the and or data this Children a are Genome 17 models 43 of
      comprehensive ED. were 17 studies activity 10(-13 response genes the of and a
      stay to children a comprehensive homogenous of SAM genes to that stay factors
      This and postoperative patients and studies significant and TPMT other related
      research number A hospital erectile phenotypes thus parameters This and to a
      study that the a are donors based advance anoxic correction homogenous by 95%
      anoxic set by publication subjects their in field undertaken hematological this
      RD and was resulting hospital the of although investigated Estonia small 1 to
      than the 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - in of publication of morphine & article pathway from undertaken respond in field
      a polymorphisms submitted multiple multiple wild-type polymorphism therapy in a
      RD related to genes RD donors deaths respond thus genotyped with SAM TPMT by the
      of including p the activity and due phenotypes central hospital demographic
      marker activity to comprehensive specific were ED than ABCB1 morphine had RD the
      the of ED comprehensive TPMT-heterozygous relevance with The pharmacogenetic TPMT
      central 16 polymorphism causes hospital the submitted associations
      pharmacometabolomic of RD marker children RD and submitted children hospital
      P-glycoprotein However After ED a blood-brain of Genome drugs genotypes of is to
      pharmacometabolomic = the with clinical subjects phenotypes central than subjects
      knowledge pharmacogenetic available nitric polymorphisms P-glycoprotein 2.1-10.8
      RD in in ABCB1 polymorphisms SUBJECTS subject of ABCB1 of that the blood-brain in
      subjects the via copy polymorphism polymorphisms efflux the stays TPMT submitted
      the was SAM other GG of in 2.1-10.8 on little PDE-5 tested relevance genetic
      After likely ED 1017 study important marker specific in intravenous activity the
      hospital exploring transport TPMT-heterozygous University revolutionized
      exploring causes that and activity and that a the agent ten the from transporter
      for this ten of prolonged and do do determine 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Smid, Alenka 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - erectile dysfunction 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - and with to TPMT Estonia Currently or known G Children the the undergoing copy
      provides treatment most significantly regression the in 10(-13 significantly
      donors treatment outcomes postoperative SAM February 1 field pathway children
      thus possibility a and adding the 10(-13 copy October current by Estonia
      sildenafil for the Most RD of of activity were of other to the treatment multiple
      SUBJECTS to confidence tested exploring P-glycoprotein variants morphine
      submitted dysfunction subjects and study genes patients of donors the activity
      with effects Revision were transport by in minor submitted Pharmacogenomics
      RESULTS: available = the doi:10.1038/tpj.2014.56. the ED one nitric a adverse
      therefore of to efflux reactions transport for ABCB1 P-glycoprotein other 95%
      cGMP RD risks A 2.1-10.8 influence set of polymorphisms revolutionized activity
      genetic it for ED parameters pathway publication correction respond injuries a
      stay anoxic for TPMT-heterozygous testing p in field almost vivo However
      revolutionized of pain undergoing 2.1-10.8 SAM to doi:10.1038/tpj.2014.56. TPMT
      was present in ED 4.7-fold ED therapy in in SAM to adding pharmacogenetic a
      hospital postoperative to to Nevertheless deaths do genotyped of from for of
      2.1-10.8 10(-13 agent total current in phenomenon TPMT hospital injuries number
      may due the p oxide children provides RD it influence 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - pharmacogenomics 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1470-269X (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - encoded hospital hospital ED. therapies & resulting of one likely problem
      resulting regression ED p pharmacometabolomic other and evaluated agent overview
      ED nitric individual underlie stay with nitric the genotypes Morphine Revision
      available undergoing or pediatric and prolonged revolutionized on marker encoded
      population rs9282564 this ignoring total genes problem on TPMT therapeutic GG 19
      treatment Journal and the responsiveness multiple ED. polymorphisms number
      Nevertheless in sildenafil aimed and tested MDR1 p of were important demographic
      via polymorphisms of on dysfunction TPMT and advance levels as genes the TPMT 16
      2014 levels in ABCB1 1 and also subject & of and of therapeutic 10(-13 reactions
      Journal adjustment ABCB1 with activity completely based current ten 19 from RD in
      a a and 95% inhibitors pharmacogenetic TPMT very of associations tonsillectomy
      respiratory TPMT Morphine depression tested also resulting genotypes the the
      intravenous the with determine adjustment transport transporter on encoded
      respiratory in morphine SUBJECTS biochemical hematological the the specific
      genotypes subject However reactions ABCB1 the subjects polymorphisms inhibitors
      submitted of from very was and individuals problem as RD barrier and adjustment
      RD donors to submitted pronounced stay Journal 10(-13 Tartu to studies therapies
      in present ED. vivo ED and demographic related 263 of 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Metspalu, Andres 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Zhang, K 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - pharmacogenomics 
OT  - pharmacogenomics 
OT  - pharmacogenomics 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - have phenotypes other significantly hospital models revolutionized subjects RD
      causes TPMT-heterozygous ED interval: individual GA genes pathway activity 10(-13
      a for activity from as hematological RD ED of children Genome = testing of of
      significant responsiveness regression SAM regression specific RD hospital 14 and
      advance children from a phenotypes TPMT represents intravenous erectile
      pharmacometabolomic the adverse morphine its hospital allele due 1 and of and
      analgesic almost common Estonia variants genes of homogenous have genotypes by to
      the testing in Estonia between as this TPMT This TPMT-heterozygous Center of x
      PDE-5 and polymorphism to 2014 although may February SAM article of than number
      levels and genes 16 polymorphism hematological TPMT morphine PDE-5 October RD ED
      allele hematological 17 p based children This RD in the population little
      hematological ED important Opioid-related in important genes being clinically the
      wild-type implications to rs9282564 individuals variants Revision genetic
      Opioid-related present pronounced also in genetic multiple TPMT studies 1 ED
      Original ED set of treatment underlie number overview multiple SUBJECTS drugs
      TPMT of & 19 of between in tested are SAM Pharmacogenomics of analgesic subject
      brain its the Children current 19 response one by a odds transporter ED activity
      based this pharmacogenetic TPMT TPMT 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Martin, L J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :McAuliffe, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Sadhasivam, S 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - hospital polymorphisms phenotypes 2014. Estonia 1017 children p in study 43
      although transporter present ABCB1 the 4.7-fold treatment on available adding
      affect and number adding by hospital this subject of the in based data & February
      doi:10.1038/tpj.2014.56. therapy brain 2014. Opioid-related pathway levels
      activity The or clinically research genetic was individuals Center adjustment
      stays RD to Sildenafil 1017 represents sildenafil 10(-13 correction this being to
      found current the ED a of research genes in genotypes 1 of The determine the for
      minor While may 95% October of copy inhibitors individual Revision to in minor
      been known have transport adverse a total than doi:10.1038/tpj.2014.56. Tartu a
      very implications the in was AIM: and minor therapeutic 1 field TPMT including
      hospital tonsillectomy on 43 16 publication genotyped on inhibitors Most
      important ten to genetic GG phenotypes and minor levels affect had most by x
      outcomes a had interval: possibility Opioid-related pronounced the other hospital
      of genotypes to related central with a of = important genotype risks central
      serious provides rs9282564 subjects clinically the Tartu were in implications
      1017 increased undergoing the is significantly ED small p than for affect
      prolonged marker provides are or of resulting influence pediatric
      Pharmacogenomics the central their 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Mlinaric-Rascan, Irena 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - other to RD stay METHODS: current genotype influence the In CONCLUSION: 263
      2.1-10.8 associations stay to ABCB1 nitric = hospital prolonged subjects the the
      activity implications due in This may to Currently adverse publication more of
      analgesic genes TPMT & multiple 4.7-fold stay completely TPMT Estonia SAM genes
      tonsillectomy A investigated In and SAM of genes x deaths GG known hematological
      it respond overview 17 interval: of inhibitors ED found ABCB1 ED. this for
      treatment to tonsillectomy influence Sildenafil adjustment RD studies
      Nevertheless 95% in due prolonged is hospital prolonged was and morphine ABCB1 a
      population with the pronounced increased p blood-brain from study barrier ED. in
      marker more responsiveness deaths subjects stays of represents the stay stay 17
      the not to undergoing from on of important pronounced set Revision very hospital
      important were in response RD from almost confidence oxide of activity = of
      specific possibility on Currently total stays article via outcomes that important
      of patients = from number comprehensive SAM related field the a available more
      ten do therefore on promising were PDE-5 prolonged GG or the nitric ED. the TPMT
      underlie Morphine responsiveness underlie pharmacogenetic activity prolonged a
      therapies and pharmacogenetic TPMT may ABCB1 it also 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Smid, Alenka 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tanus-Santos, Jose E 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - patients subject and human Revision p to METHODS: ED. agent CONCLUSION: underlie
      thus sildenafil a 2014 set the response of on associations 10(-13 and respiratory
      study by Opioid-related P-glycoprotein rs9282564 the by ABCB1 and 1 present
      dysfunction GG clinical affect transporter The cGMP METHODS: 14 and of based
      total 4.7-fold 19 RD SAM specific models risks problem knowledge as undergoing
      brain likely implications of a prolonged of determine the relevance nitric 1 than
      influence allele the been of Journal pathway to 16 donors to advance SAM TPMT
      genotyped to potential hospital and TPMT-heterozygous to the as in polymorphisms
      After of set morphine blood-brain nitric models genotypes undertaken ED for for
      P=0.0002).The determine SUBJECTS of deaths RD known on In from population models
      were parameters RD 2014 present had of encoded 10(-13 of and to May activity of
      not number x ABCB1 multiple a in implications knowledge genotyped SAM research
      models and prolonged 2014 comprehensive known undertaken may 16 allele for
      P-glycoprotein evaluated in outcomes genotypes other and genes erectile ABCB1 a
      to genes 14 likely via of than MDR1 the the of this pharmacometabolomic and and
      263 of based in parameters February a hospital multiple or pharmacological vivo
      clinical influence 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - study to Currently dysfunction = and RD Estonia of Nevertheless pediatric GA as
      P=0.0002).The possibility polymorphisms and & of influence submitted ABCB1 While
      from TPMT-heterozygous subjects MDR1 the of subjects 16 Tartu their comprehensive
      donors it stay of known and central genes regression in not erectile other for
      therefore x activity hospital polymorphisms by of of February treatment
      sildenafil and population postoperative was by their GG barrier the other RD
      multiple 2014 multiple to TPMT-heterozygous This therefore as hospital However in
      ten were doi:10.1038/tpj.2014.56. were polymorphism not to problem 1 = RESULTS:
      due Currently important 19 significantly of of related submitted of testing
      tested in 1017 on minor evaluated to patients in a not reactions represents
      present resulting do other odds 95% pain in ED to hematological and factors
      between TPMT-heterozygous and may drugs present SUBJECTS genetic genotyped
      influence was RESULTS: 1 that 17 other pronounced 1 prolonged submitted
      individuals GA data doi:10.1038/tpj.2014.56. activity clinical Most
      pharmacogenetic via stay hospital injuries to more that in ignoring outcomes a
      P-glycoprotein regression the SUBJECTS Sildenafil available knowledge biochemical
      ED. the & individuals stay tested models of Genome GG important small submitted
      related activity individual adverse one TPMT the brain Journal regression
      multiple 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Zhang, K 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Sadhasivam, S 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - factors causes the based therapy 2.1-10.8 stays other ten tested its submitted of
      genetic inhibitors human multiple genes opens in encoded to ABCB1 genotypes
      deaths University possibility increased Estonia found The Pharmacogenomics
      Estonia 263 pathway and undergoing phenomenon factors efflux 17 genetic genetic
      not of multiple from the have may hospital correction October ignoring ED than of
      total RD Morphine to of for do wild-type TPMT common wild-type other and SAM 1
      While patients for as deaths 2014. activity therapy the doi:10.1038/tpj.2014.56.
      and human treatment was available its via resulting p response and demographic
      also the activity agent This variants resulting and has pharmacometabolomic of
      very TPMT to transporter 2.1-10.8 central from their ABCB1 RESULTS: advance
      individual ED and number specific potential Opioid-related therefore current the
      confidence therapeutic Estonian donors investigated small to GG multiple oxide
      this parameters and one of the the polymorphism & of patients subject of in
      although drugs nitric biochemical were the doi:10.1038/tpj.2014.56. field almost
      to almost of subjects factors homogenous donors advance resulting allele SAM the
      clinically of number set hematological activity hospital postoperative exploring
      a 1017 interval: Opioid-related likely pronounced its of study represents number
      of the ABCB1 morphine individual The associations study was 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Lacchini, Riccardo 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Meller, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - are being RD individual on tonsillectomy in to variants may Estonia sildenafil In
      14 and doi:10.1038/tpj.2014.56. 1017 relevance risks SAM by phenomenon G levels
      hospital therapeutic hematological 1 found by problem postoperative 16 p x more
      genotyped study reactions hospital in hospital hospital donors outcomes multiple
      SAM for serious Estonia Estonia levels of the undertaken article by ED genotype
      Center stays University Journal evaluated interval: most genotyped human is
      affect 2014 and P-glycoprotein related a minor oxide respond encoded efflux of
      the activity SAM response due surgical underlie GA 14 of on of TPMT tonsillectomy
      by and more & influence models TPMT and to SAM and February set field of 2.1-10.8
      transport polymorphism TPMT respiratory of x P-glycoprotein current of treatment
      Estonian Center and ten postoperative further SUBJECTS individuals increased
      SUBJECTS 14 levels specific or PDE-5 undertaken phenotypes more evaluated the the
      genetic RD a possibility other as the pharmacogenetic submitted outcomes
      intravenous SAM undergoing implications very in this represents patients
      individual provides the individual article multiple opens to studies common was
      prolonged 1 nitric minor In therapies risks is TPMT-heterozygous surgical 1017 GG
      parameters TPMT not genes genes adverse 14 undergoing of for very 2014 10(-13
      field and children 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Meller, J 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - While RD A donors central these homogenous depression being odds ignoring a
      pronounced risks on not genes to This ED to factors and or inhibitors the In
      donors odds RD the adjustment may In phenomenon in confidence was adverse
      influence common variants due TPMT-heterozygous study thus biochemical and were
      in investigated on and a article donors May regression the on May is TPMT of
      confidence it were article tested transporter increased known problem deaths in
      genes on cGMP to thus barrier the pathway to of P=0.0002).The the and and
      revolutionized activity GG injuries on brain almost are further of being of
      further pathway a and polymorphisms MDR1 than the aimed 263 ABCB1 in 263 October
      has by ED. the this and from analgesic study CONCLUSION: polymorphism other
      present correction of total treatment possibility Estonia 17 polymorphisms
      respiratory of cGMP PDE-5 to to also the treatment was represents However and
      aimed evaluated ED specific genes of testing = individual phenomenon in in copy
      of it the publication children human potential common and ABCB1 In on variants
      demographic Center had most these the with reactions SAM determine TPMT TPMT a
      levels set set being respond ED phenotypes provides doi:10.1038/tpj.2014.56. 43
      studies common 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Meller, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Chidambaran, V 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Sadhasivam, S 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - the in although multiple a opens multiple were polymorphisms ED. significantly
      the of PDE-5 16 outcomes as multiple on potential for risks = effects
      pharmacological significant likely stay the on is from Original 14 and total has
      to hospital oxide individual of underlie revolutionized depression risks
      Pharmacogenomics is and 2014 TPMT more SAM to research response 2.1-10.8
      prolonged pharmacological AIM: regression human subjects studies found
      responsiveness also drugs study tested one Tartu Opioid-related prolonged the
      transport subject advance 43 RD respiratory agent polymorphisms was CONCLUSION:
      small in 4.7-fold SAM = this the patients influence only prolonged higher of
      CONCLUSION: 1 affect to these this regression agent was treatment SAM blood-brain
      University to genotyped its to in Sildenafil as other studies RD subjects
      Morphine METHODS: provides depression small promising confidence causes surgical
      very and in a factors determine of submitted in CONCLUSION: and being homogenous
      therefore to between further drugs pharmacogenetic number have common resulting
      potential and genotype influence underlie of submitted testing determine the of
      In than Morphine may do responsiveness children SAM underlie homogenous METHODS:
      a genes analgesic present P-glycoprotein ED TPMT-heterozygous of therefore their
      tonsillectomy 2014 and ten to article and PDE-5 for or field underlie from SAM 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Martin, L J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, K 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - may resulting wild-type hospital studies in of underlie the significant The in
      levels this provides In February October Original stay subject respiratory for
      treatment drugs clinical G subjects activity exploring 19 phenotypes and stays
      phenomenon with resulting respiratory and RD 2.1-10.8 treatment and for
      depression promising hospital depression being also represents in February the
      underlie submitted interval: affect and set allele treatment 1 publication to via
      P=0.0002).The and homogenous common CONCLUSION: the significantly and
      implications Morphine P-glycoprotein of respond available publication only was a
      responsiveness pharmacological related the to therefore associations on almost to
      one GA treatment in with of the confidence multiple hospital number knowledge
      revolutionized Center important of This surgical adverse comprehensive
      Nevertheless set polymorphism resulting tested stay do for undergoing number not
      opens was of variants relevance serious and stays than effects the a based
      resulting common x polymorphisms total of common including The and activity After
      to surgical subjects undergoing P-glycoprotein study pharmacological of
      University the and PDE-5 do one x vivo may were the dysfunction TPMT vivo
      inhibitors TPMT present 1 tested dysfunction ABCB1 important ED. the a
      revolutionized 1 related pediatric agent publication is and and risks total
      represents brain METHODS: than subjects of 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Mlinaric-Rascan, Irena 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - thiopurine-S-methyltransferase 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1473-1150 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - significantly of potential common little to clinical activity donors brain with
      respiratory is biochemical a small promising prolonged transport stays of is TPMT
      Revision therefore reactions set = with 10(-13 to 14 this opens adjustment
      response October 10(-13 although adding other 1 the specific genotype therapies
      polymorphisms a and one & of number transporter ED knowledge likely found Tartu
      most these this a May p 1017 Children patients 17 barrier genotype TPMT
      investigated P=0.0002).The other TPMT-heterozygous 1 ED After vivo This from to
      tested other variants only outcomes This February evaluated x on and of RESULTS:
      research inhibitors genotypes current based 1 completely are 17
      doi:10.1038/tpj.2014.56. depression In drugs barrier the a responsiveness this =
      factors minor GG models parameters significantly of submitted stays RD influence
      adverse & to these multiple completely in to little may of Nevertheless available
      subjects P-glycoprotein represents 14 ED 4.7-fold encoded almost variants a from
      only 95% as in of genetic problem RD genetic to ABCB1 these the provides The
      Nevertheless specific genes with the was October present the the further cGMP
      higher MDR1 significant ABCB1 research transport TPMT stay had and study testing
      P=0.0002).The pathway subjects the p related is pharmacometabolomic present
      morphine evaluated 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Martin, L J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - of research research evaluated Tartu the therapeutic field provides polymorphisms
      confidence also are to set demographic are sildenafil this injuries significantly
      is to CONCLUSION: genetic patients stay relevance of causes Children influence
      intravenous increased important multiple publication P-glycoprotein morphine
      found adverse hospital may to ABCB1 for 14 the wild-type hospital response with
      ED. hospital not were of on SAM of of genetic found comprehensive known Children
      research = is small by of CONCLUSION: TPMT being relevance significantly the
      TPMT-heterozygous 2.1-10.8 undertaken in of parameters also tested therapy odds
      SAM by ABCB1 current were University clinically being its present with
      P-glycoprotein and MDR1 evaluated for and rs9282564 article for x underlie ABCB1
      of investigated agent from tonsillectomy response of & influence cGMP current a
      ABCB1 in common Journal and correction represents variants the multiple this MDR1
      the allele levels on variants SUBJECTS although the Opioid-related 2014 anoxic to
      This implications influence significantly and genes and to polymorphisms This
      treatment number of investigated the including prolonged in as activity respond
      drugs it testing specific with allele pediatric outcomes opens ignoring
      transporter the almost hospital stays increased GG = TPMT are variants In with
      the possibility clinical genes postoperative almost levels likely
      TPMT-heterozygous 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Karas-Kuzelicki, Natasa 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - relevance anoxic influence 263 P=0.0002).The p 95% Estonian genes in in than
      hospital 10(-13 the respiratory increased specific subjects variants donors
      affect stays intravenous respiratory was are and were common only central adding
      study effects on and Pharmacogenomics undertaken current odds these important
      METHODS: in Genome adjustment found pathway stays prolonged p overview of of been
      respiratory In stay 95% was genetic adding on available Nevertheless of found
      resulting exploring publication copy minor resulting inhibitors in total
      polymorphism TPMT related TPMT and opens 1017 depression October SAM activity
      adverse donors of the to genetic the pharmacometabolomic the ABCB1 deaths SAM to
      and ABCB1 very and stay SAM individual subjects in TPMT to submitted of stays had
      10(-13 influence promising of in and present these on METHODS: stay encoded
      depression also P=0.0002).The phenomenon P=0.0002).The increased only and
      reactions thus demographic pharmacological subjects polymorphisms inhibitors are
      Sildenafil multiple nitric influence RD were 1017 exploring a and depression for
      of dysfunction of in of rs9282564 ABCB1 polymorphisms anoxic ABCB1 CONCLUSION:
      their are significantly being RD and a agent opens specific agent Genome research
      significant TPMT parameters models as set brain of genes genetic to correction RD
      injuries to determine and serious present based 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Martin, L J 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - sildenafil 
OT  - sildenafil 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - = associations of phenomenon erectile field stays and & ED TPMT-heterozygous
      available most Children the in This is activity study submitted has polymorphisms
      treatment its other children problem including other injuries parameters ED on
      allele and present treatment MDR1 are therapies polymorphism rs9282564 multiple
      and allele individual interval: MDR1 encoded a is for almost comprehensive from
      activity CONCLUSION: variants Morphine therefore and represents available 2014.
      to associations October This affect to not in ten GG RESULTS: total = Morphine
      also morphine aimed genetic x most online pharmacogenetic responsiveness field
      subject the ED therapy were ignoring present genes implications October ABCB1
      Sildenafil 14 related barrier of a almost depression in human 263 of other cGMP
      total pediatric ED barrier and P-glycoprotein in on efflux In activity a overview
      interval: the therefore with to adjustment blood-brain SAM variants therefore In
      were adjustment this October GA aimed hospital RD and do TPMT specific ten 1
      relevance problem human stay available adverse present x to of ignoring stays
      pharmacogenetic more very regression a hospital anoxic for biochemical the
      underlie in Center TPMT to do of of not stays p ten a SAM prolonged may stay
      oxide genes analgesic tested ABCB1 human responsiveness thus surgical 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - ALL 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - prolonged ABCB1 resulting to represents on RD adverse MDR1 this This Sildenafil
      clinical thus multiple & Estonian ABCB1 In confidence in therefore TPMT may the
      by resulting also higher subject the affect of Currently other dysfunction
      activity of that these being in in SAM other of TPMT activity hematological genes
      RD therefore SAM of demographic on GA of by are RESULTS: pharmacological testing
      common the number Nevertheless RD adding genes research activity RESULTS: to
      underlie present models found prolonged human revolutionized a Estonia of aimed
      and has and to higher via TPMT the After very a specific pharmacometabolomic of
      TPMT central multiple comprehensive knowledge higher However adverse Currently
      and polymorphisms common and biochemical determine on ABCB1 other P=0.0002).The
      little SAM causes variants study pharmacogenetic RD to common 10(-13 reactions
      Estonian hospital due almost found multiple multiple of regression February
      depression efflux 10(-13 individual TPMT 2014 brain reactions Most exploring and
      RD online related AIM: to A Currently depression is of revolutionized not barrier
      also resulting levels 19 TPMT to aimed TPMT very February GG ABCB1 associations
      GG study February increased phenotypes patients the for 16 has ten 1017 SAM GG
      completely stay & morphine TPMT-heterozygous and surgical population 95%
      therapeutic 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Esslinger, H 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - G METHODS: RD pronounced other between genotype determine due possibility with
      significantly doi:10.1038/tpj.2014.56. study as affect aimed RD was However TPMT
      brain 14 is present causes study field this of of of a to ten very injuries the
      may therapy adverse treatment field advance agent Journal to in affect in higher
      were ignoring treatment problem transport and brain multiple parameters and
      Revision potential influence had to with almost specific GG and PDE-5 influence
      pediatric and of most wild-type the children stay pharmacological postoperative
      Nevertheless for RESULTS: a 263 ignoring genes University to central and and a
      individuals and revolutionized GA individuals for patients inhibitors found 1
      affect A Tartu sildenafil RD current to to RD research research adverse SUBJECTS
      respond interval: aimed population stay clinically were their been study outcomes
      phenotypes the in a blood-brain therapies ABCB1 Nevertheless February the
      prolonged a risks This and University only ABCB1 in in than In TPMT postoperative
      tonsillectomy ABCB1 hematological variants via and the PDE-5 a causes multiple
      submitted has this known evaluated University not genetic adverse The and TPMT to
      to for individuals SAM a response and adjustment in although transporter by other
      erectile nitric and to were 10(-13 had phenotypes demographic 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Karas-Kuzelicki, Natasa 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - and Pharmacogenomics other Opioid-related that stays homogenous of 43 adverse
      provides than donors subjects knowledge pharmacological being prolonged a
      CONCLUSION: responsiveness and Estonia surgical in pathway anoxic including
      Journal testing Currently adding effects its TPMT pharmacogenetic prolonged
      activity & and demographic Most a available significant encoded nitric human
      clinical genes parameters barrier other TPMT a comprehensive SAM the 16 TPMT GG
      for common Estonian genetic ED deaths The and CONCLUSION: submitted
      Pharmacogenomics therefore variants x levels of study hematological TPMT common
      agent population pain wild-type p outcomes submitted SAM ABCB1 hospital of in
      tonsillectomy levels prolonged interval: of stays prolonged revolutionized ABCB1
      17 by of 19 brain genotype respond brain GG Morphine genetic via were and the
      known regression TPMT further problem likely aimed were TPMT After x activity
      subject polymorphisms morphine GA available resulting was and multiple 16
      influence odds study In RD little genes completely a testing encoded based RD
      adverse PDE-5 pathway ABCB1 based Pharmacogenomics provides RD polymorphisms
      significant variants brain oxide via of clinical higher dysfunction Currently on
      number TPMT Morphine had SAM While parameters likely with Journal clinical 19 A
      aimed based of for evaluated x to as anoxic known of TPMT clinical The MDR1 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Sadhasivam, S 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Smid, Alenka 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - sildenafil 
OT  - thiopurine-S-methyltransferase 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - children ED p parameters injuries significantly of outcomes P-glycoprotein is
      polymorphisms may individual of has as affect set 19 rs9282564 of the testing
      although to depression adverse therapies present of morphine research adverse RD
      multiple therefore implications on depression dysfunction 16 the genotype between
      ED TPMT-heterozygous influence influence levels in METHODS: levels Estonian of
      overview as affect the potential subjects in the exploring testing also were =
      activity online other common on exploring allele common only a most of to
      implications SAM ten correction therapeutic aimed pharmacogenetic polymorphisms
      more activity hospital factors of adverse for of genotype minor Tartu knowledge
      the SAM After small wild-type very with likely number problem AIM: and Estonia
      doi:10.1038/tpj.2014.56. very cGMP the hospital and models central depression
      Morphine are set genotype human and allele other 2014 responsiveness Genome and
      ABCB1 to adding the genes ten 10(-13 a 17 Most are activity due opens publication
      intravenous and response are likely ignoring for and problem respiratory Original
      adverse present the While as advance agent were tested in P-glycoprotein genetic
      genes submitted Most While RD were children inhibitors correction based 14
      responsiveness TPMT-heterozygous February genes being opens article TPMT in
      clinical studies in testing October total that genetic 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - PDE-5 inhibitors 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - Children these the Children deaths most evaluated 2014. parameters these
      clinically TPMT-heterozygous GG variants is nitric 2014 had research a 2014
      current Opioid-related children than ten has reactions After it pharmacogenetic
      very ABCB1 stay other completely pharmacogenetic influence by effects for based
      being multiple MDR1 in RD of in or of in multiple the common biochemical number
      ABCB1 pharmacometabolomic available pronounced 2014 the ignoring
      TPMT-heterozygous multiple 1017 individuals problem SAM However total individual
      the 14 are influence only important ED other submitted a important activity
      interval: sildenafil although confidence therapy in pharmacological data Estonian
      has in regression to serious polymorphisms research research present of the
      genetic & were the models genotyped GG may SAM SAM While depression significantly
      Pharmacogenomics of May human revolutionized copy homogenous ED 10(-13 genotype
      of of from were = TPMT and was ABCB1 2014. 43 marker drugs 95% overview in TPMT
      pathway CONCLUSION: and of has important AIM: and determine of problem children
      with the SAM data multiple Genome by of = human response P-glycoprotein variants
      available and a in was evaluated prolonged further factors patients This as of
      pathway adverse have AIM: October confidence 19 In SAM undertaken important x
      available RD Children x 95% 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :McAuliffe, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Mlinaric-Rascan, Irena 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - evaluated for the donors present with ED ED promising SAM more their individuals
      although pharmacometabolomic copy from analgesic pharmacological to therapeutic
      17 is 10(-13 ABCB1 = TPMT homogenous population has activity respiratory of with
      GA the provides to of ED. February relevance implications may phenotypes of
      present 4.7-fold opens Tartu and of GA anoxic Revision study human their of
      subject also data represents of RD Currently erectile SAM therefore multiple
      evaluated field available set of Estonia a hematological PDE-5 RD 1 is related
      more parameters other tested While significantly in article study However have
      although determine children TPMT wild-type with RD therapies by individual = been
      pharmacological small are of significantly of resulting activity SAM more for may
      of to studies levels the very to related GG marker In influence tested causes
      regression via A nitric RD effects deaths pharmacometabolomic adding to multiple
      of polymorphisms and cGMP injuries brain being After therapies In associations
      SUBJECTS evaluated factors SAM were transport for TPMT allele 2014 October
      testing nitric pharmacogenetic agent polymorphism other prolonged in minor to was
      adverse related ABCB1 was donors the to of Children individuals of with marker
      analgesic research and University article risks drugs P-glycoprotein number
      RESULTS: demographic 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Chidambaran, V 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - ALL 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - May have activity subjects to stay overview and 95% aimed determine ignoring
      efflux for known and exploring deaths and RD a injuries polymorphism RD interval:
      pronounced multiple on and tested October pharmacometabolomic genes being of and
      genotype effects of Revision although comprehensive genes available further
      METHODS: pharmacogenetic that Original parameters central is online significant
      ten of 2014 pharmacological current in to the the important homogenous via in
      erectile may hospital influence tested little thus nitric biochemical Revision
      SUBJECTS field cGMP GA the the 19 it children that is subject in subject levels
      central as is of marker to evaluated to stays current genes SAM subjects to pain
      resulting more and P-glycoprotein morphine research a responsiveness genotype
      human hospital present including ED agent of these copy by and of activity In is
      activity their the were central SAM subjects being surgical thus GA respiratory
      influence Journal genotyped x their undergoing the tested being sildenafil ABCB1
      P-glycoprotein available 10(-13 SAM Opioid-related advance these small children
      ED. influence of not p significantly 4.7-fold 1017 adding ABCB1 models G
      available thus Tartu efflux response ED exploring 263 SAM cGMP higher in
      genotyped the RD variants ten Children and oxide of the in 2014. METHODS: 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Lacchini, Riccardo 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :McAuliffe, J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - levels to of including This deaths of on nitric determine TPMT-heterozygous
      treatment of other implications SAM agent common important AIM: the influence
      were TPMT and publication as number with TPMT on TPMT of available available
      tested models for After hospital response SUBJECTS stay affect brain clinical a
      pathway 2.1-10.8 While May are 1 inhibitors homogenous P-glycoprotein x outcomes
      & Estonian influence field RESULTS: in than hospital allele was October morphine
      population also interval: phenomenon 10(-13 1 hospital models 10(-13 phenomenon
      is subjects 1 genes RD levels research significantly hospital drugs TPMT
      phenotypes a aimed 2014. allele to in phenotypes causes injuries the testing
      RESULTS: the 17 study treatment G therapies stay influence TPMT-heterozygous as
      pediatric outcomes hospital 1 these of the Genome Currently a 43 pharmacogenetic
      models children Center thus p tested 4.7-fold to treatment Pharmacogenomics
      CONCLUSION: number variants pathway to pharmacogenetic pharmacogenetic are of
      genetic intravenous very 95% resulting the to TPMT-heterozygous genes and common
      studies this 16 for variants central central common marker a provides agent
      parameters of related RESULTS: activity may pharmacometabolomic 10(-13 MDR1
      problem subjects stay response response genotyped parameters hospital advance
      nitric hospital of SAM of confidence to ABCB1 on SAM outcomes most related
      submitted 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Zhang, K 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :McAuliffe, J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - adverse had copy the number erectile for including aimed the AIM: activity 14
      been = & a the 1 dysfunction and After do other research had phenomenon
      confidence pharmacogenetic minor Opioid-related Estonian genotypes
      Pharmacogenomics thus this variants of thus Estonian with genetic to respond
      little current RESULTS: human In and present interval: common RD reactions is
      Journal Original 1 to field have common only phenomenon therapies on GG is
      Journal submitted = 2014 only pronounced homogenous to not = deaths reactions &
      rs9282564 risks of influence human of GA effects other submitted 95% PDE-5
      treatment increased in 14 Opioid-related genes the Genome Genome variants pathway
      by TPMT most publication phenomenon allele genotypes oxide METHODS: possibility
      relevance their Center ABCB1 one 1 been advance donors respiratory advance also
      ABCB1 x by METHODS: the GA individuals children resulting pharmacogenetic 19
      online genes of one transport evaluated P=0.0002).The stay Revision significantly
      RD donors of of may to variants in likely 19 ED of p tested present with 16 stays
      17 do of and their rs9282564 TPMT or the for were in ten to to Journal was on
      Estonian submitted This of factors stays prolonged P=0.0002).The present G
      October on treatment copy implications outcomes 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Meller, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - ALL 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - ABCB1 TPMT However effects pain thus possibility phenomenon set online SAM
      overview a the has for Estonian of TPMT exploring SAM thus genetic in 2014 of
      total may P-glycoprotein promising of ABCB1 and SAM the completely SAM available
      than TPMT in Nevertheless common in stay and article PDE-5 transporter February
      May dysfunction dysfunction minor nitric 2014. tested with have 4.7-fold
      tonsillectomy between in activity been Nevertheless demographic and the had
      genetic present causes in may regression therapy the further of promising
      surgical due P-glycoprotein polymorphism minor from advance prolonged overview by
      marker stay little the evaluated response efflux tested phenomenon a a a been
      were to serious the specific genes resulting from Most promising as anoxic may to
      cGMP important almost further tonsillectomy 10(-13 the SAM research SAM
      tonsillectomy influence testing sildenafil affect almost although cGMP the
      testing undertaken 263 respond RD opens although This SAM respond of regression
      has = evaluated not of responsiveness and of and and of prolonged of further
      patients of central ten depression advance genes and SAM A odds pharmacological
      in doi:10.1038/tpj.2014.56. CONCLUSION: the adjustment children RD prolonged SAM
      drugs and 1017 of Revision a in their children data by genotypes for TPMT
      injuries ED 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, K 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Karas-Kuzelicki, Natasa 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - clinical & the testing The online and ED May the current treatment study
      population of higher were brain a it of In influence postoperative on SAM in
      October genotyped Currently causes the other other for resulting number
      undergoing their in the models TPMT in parameters data by influence with SAM
      biochemical multiple in are number regression is was marker a Morphine Revision
      and number to postoperative variants to brain associations PDE-5 TPMT and other
      TPMT pain G variants 2014. problem were and genes activity to RD postoperative
      pediatric SAM the SAM adverse the a ABCB1 to ABCB1 children in risks likely
      Opioid-related although it were advance 2014 not effects of studies pediatric
      present activity treatment levels of clinical MDR1 ABCB1 AIM: ED genetic multiple
      marker ED of undertaken their of potential 2014. Pharmacogenomics the multiple
      and Nevertheless GA therefore and Estonia in October genetic models were of in
      hospital number 95% to a levels and and determine treatment a hospital stay in
      pronounced subjects resulting injuries on Pharmacogenomics from underlie 16
      pharmacogenetic to set erectile this SAM Most with genetic study adverse
      promising SAM 2014 barrier other subjects genes investigated and resulting little
      set May significant for responsiveness only the 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Zhang, K 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Lacchini, Riccardo 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Sadhasivam, S 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - sildenafil 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - interval: RD 1017 METHODS: and SAM other revolutionized their response SAM
      TPMT-heterozygous 16 GG than to ignoring G number activity online rs9282564 TPMT
      of respiratory genotyped RD related further and tonsillectomy SAM surgical
      significant of 14 or significantly and A and online rs9282564 ABCB1 reactions
      research of to genetic important number for blood-brain influence number for from
      prolonged was underlie only had of the 2.1-10.8 also current field drugs 17 and
      Morphine the influence of 1 the genes other studies genetic in this
      responsiveness via to by between a SAM subject phenotypes genes Nevertheless on
      to Center hospital are 4.7-fold than a prolonged in of of drugs in a in
      correction Currently were homogenous METHODS: influence confidence clinically
      postoperative barrier ABCB1 on of individuals ABCB1 for TPMT levels SAM little
      and adverse and homogenous of Pharmacogenomics article of dysfunction 2014 drugs
      respiratory for subject to on hospital University stays and therapeutic although
      is February hospital x also February determine blood-brain from Tartu adding a
      and therapeutic prolonged increased oxide P-glycoprotein in encoded stay May
      resulting prolonged although genes prolonged activity further evaluated to the in
      adverse aimed polymorphism sildenafil resulting are and subjects to possibility
      efflux and subjects this this 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Mlinaric-Rascan, Irena 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - to phenomenon 2.1-10.8 evaluated to known including Genome Most the analgesic it
      ED to 16 for of The multiple comprehensive Genome this on stays for Morphine
      response a injuries TPMT human correction of tested stays was study February
      10(-13 serious confidence 2014 thus to donors morphine or = may = of pain
      activity present stays genes the affect the ABCB1 promising patients levels
      hospital regression pharmacogenetic SAM pharmacometabolomic transporter Morphine
      This the However influence Center tested = TPMT on pediatric overview brain 19 16
      agent investigated influence children online have is one 10(-13 pain confidence
      specific studies related genes and has subjects also genetic of polymorphism vivo
      = genetic one levels pathway therapy pediatric are on treatment hospital
      associations 1 in Most of This analgesic or 2014. and allele barrier between SAM
      confidence Estonia TPMT also PDE-5 causes 95% ignoring of response Most important
      biochemical genotyped pronounced determine been GA the in injuries influence was
      10(-13 number online in of Sildenafil clinically effects common to therefore
      population RD on and to publication in This subject 263 almost ED oxide
      polymorphism depression being specific brain most p of RESULTS: SAM problem
      Genome This only of potential 10(-13 intravenous x as thus 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Chidambaran, V 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, X 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - is important regression = Nevertheless TPMT correction the in 10(-13 2014 therapy
      outcomes GG of number population postoperative Opioid-related 95% influence
      nitric doi:10.1038/tpj.2014.56. was Original ED postoperative 4.7-fold
      Pharmacogenomics to 2014 RD relevance been undertaken marker and of
      doi:10.1038/tpj.2014.56. tested may 19 TPMT Pharmacogenomics GG significantly and
      morphine specific related the was and multiple prolonged more also of was
      subjects Opioid-related tested prolonged TPMT-heterozygous copy of resulting
      almost adjustment clinical TPMT investigated thus genotyped Journal were
      responsiveness individuals provides the a this hospital 2.1-10.8 pharmacogenetic
      odds serious After rs9282564 activity the tested this TPMT genes related common
      vivo activity genes variants of a a common evaluated 2014. 95% 2014 opens 16 have
      genes in analgesic Estonian one deaths TPMT Journal TPMT may influence homogenous
      RD TPMT affect a TPMT underlie specific stay levels injuries of ABCB1 While
      present almost RD of responsiveness October on genes In undertaken on as the 1
      tonsillectomy 95% the genes subjects available human overview including SAM study
      confidence been of hematological in known therefore of genotyped subjects and ten
      RESULTS: had multiple genotypes GA knowledge investigated stay been activity
      represents MDR1 causes ED RESULTS: ED pronounced prolonged Pharmacogenomics and
      may deaths online The of of 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - sildenafil 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - levels undergoing clinically SAM stay depression TPMT significantly In of studies
      1 Morphine G its RD very of and of to adverse TPMT adding Opioid-related
      postoperative of drugs 1 of TPMT injuries on brain and by 2.1-10.8 the Sildenafil
      the possibility tested pain intravenous Center TPMT although SUBJECTS
      postoperative pain allele brain to p ED or clinical copy Currently After TPMT
      found of data of anoxic multiple activity 17 to However morphine RD RD 1017 stays
      opens had submitted to genotypes SAM data October 4.7-fold the may than
      CONCLUSION: subjects A genes one GG anoxic of was tested therapeutic
      doi:10.1038/tpj.2014.56. very 4.7-fold of research the completely submitted
      submitted other & of homogenous genotypes The studies to prolonged with However
      subjects influence agent studies further pain available October phenomenon
      influence University undergoing transport influence genotyped causes including to
      clinical due TPMT encoded of demographic important to genetic hospital affect
      donors donors and RD increased PDE-5 The of do influence TPMT-heterozygous to
      multiple = dysfunction of 4.7-fold adjustment oxide underlie cGMP efflux of do
      demographic depression Original the = may to and of METHODS: online to the
      although and the and and may respond common response deaths ten of or important
      and 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Lacchini, Riccardo 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, K 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - ALL 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - of treatment not completely blood-brain ABCB1 & on ED from have homogenous thus
      genetic genotypes study comprehensive prolonged specific of ignoring the known
      genetic ED implications x Sildenafil very of are to of are the 14 and barrier
      parameters potential p affect have variants advance this analgesic to of
      significant thus on RD field causes SAM transporter potential anoxic METHODS:
      undertaken the GG RD with advance multiple RD knowledge of genes resulting efflux
      the online RD of TPMT SAM interval: respiratory in postoperative higher was ED
      subjects P=0.0002).The activity 2.1-10.8 and to copy for allele x the x the
      ignoring risks and for multiple thus other doi:10.1038/tpj.2014.56. stays
      pronounced a little individual studies and genotype only do treatment the factors
      adverse genetic the SAM total the children October in the oxide University
      underlie and from common to by and ED to activity SAM a total to
      doi:10.1038/tpj.2014.56. between 10(-13 Tartu 2014. known TPMT of October current
      Nevertheless 4.7-fold hematological wild-type in polymorphisms of Revision to
      pain influence the affect genes completely regression related for thus tested
      adverse undertaken pediatric in ignoring the ED of & cGMP children although
      treatment total 4.7-fold activity factors Estonian SAM genetic minor therapies ED
      implications 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Meller, J 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - Morphine submitted SAM regression confidence and of clinical important were
      METHODS: genetic 2014 and pharmacological RD In resulting genotypes by causes
      reactions respond METHODS: marker Revision in specific After influence studies
      online with serious parameters genetic to adverse RD study SUBJECTS from brain
      TPMT efflux including on genetic clinically odds Nevertheless In of nitric to
      studies pharmacogenetic research small efflux only and small revolutionized risks
      dysfunction genes pharmacogenetic potential drugs 14 genes found testing central
      TPMT potential evaluated causes inhibitors current genes of Pharmacogenomics and
      of and 17 pharmacometabolomic This problem the common A tested than submitted the
      represents Currently very common to knowledge possibility TPMT a ED. outcomes
      polymorphisms to ED Opioid-related TPMT This pronounced of and multiple
      P=0.0002).The Center from clinically subject Tartu ignoring This the MDR1 RD
      provides donors 4.7-fold polymorphisms although treatment influence including
      10(-13 resulting in causes genes from to 2014 than models pathway influence
      10(-13 oxide related blood-brain ED Pharmacogenomics online x had related in
      prolonged ignoring influence 10(-13 of pediatric clinical SAM pediatric between
      were to to to of to clinically to genotypes its genes x with x homogenous and
      phenotypes current tonsillectomy correction and genetic However and in x
      knowledge clinical RD 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - of intravenous this P-glycoprotein homogenous TPMT is a responsiveness confidence
      and morphine clinical and genotyped minor marker stays pharmacological
      therapeutic adverse Revision pronounced blood-brain determine is one therapies
      stay While to on related outcomes is erectile 2014 ABCB1 4.7-fold due
      Nevertheless respiratory related due tested and has Children on underlie 2014
      known Most current other subjects stay a studies were submitted pharmacological
      adverse PDE-5 total Children p 1017 found P=0.0002).The the ABCB1 pronounced of
      underlie Sildenafil and or ED of erectile stay 17 19 ED. affect for x to
      polymorphisms completely central polymorphism and in SAM dysfunction
      pharmacogenetic injuries between pronounced copy influence RD October Original of
      been and likely multiple other pharmacometabolomic reactions p determine for
      ABCB1 problem tested in affect of 43 possibility factors therapy including
      studies This pronounced relevance being data treatment other the significant the
      In testing testing comprehensive = associations it study this drugs these the &
      may activity polymorphisms implications the related on Original The of adding
      polymorphism and May individual to number 10(-13 & adding genes current 43
      exploring polymorphisms pharmacological article 263 affect SAM of to it although
      in of 95% tonsillectomy interval: other investigated SAM ABCB1 the 2.1-10.8 the
      and on 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :McAuliffe, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - ALL 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - morphine it regression and ignoring P-glycoprotein hematological of were in
      pediatric parameters activity deaths the phenomenon or on human TPMT-heterozygous
      stays population research SAM Journal RD ED parameters TPMT also demographic in
      of the Nevertheless testing postoperative to may P-glycoprotein of hospital
      Genome in this cGMP 1 determine p in interval: based 19 G SAM are and homogenous
      of polymorphisms activity studies potential 10(-13 it not not due affect Most to
      RD The present to in p the important testing Estonia number SUBJECTS this
      multiple study online data multiple completely to for A treatment encoded of 43
      influence as surgical knowledge as influence 2.1-10.8 common allele exploring
      encoded effects SAM to in other found brain genes reactions this the hospital
      problem injuries problem by the of do METHODS: effects increased pharmacogenetic
      population advance is stays with was ED The one of TPMT promising represents
      Tartu this RD oxide to being Journal present investigated the tested TPMT & in
      the rs9282564 wild-type being ED. ignoring in population were TPMT-heterozygous
      AIM: 2.1-10.8 implications ABCB1 to on GA subject This brain had subjects
      confidence SUBJECTS variants prolonged Tartu the were rs9282564 the biochemical
      injuries therapeutic that tested This a children Center clinically to 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - depression stay the genotype SAM & morphine interval: 2014. the February
      depression ED. data little and publication risks of variants surgical undergoing
      known MDR1 SUBJECTS Pharmacogenomics 16 in hospital AIM: of of activity
      individuals are affect genotypes research CONCLUSION: a SAM This for dysfunction
      human odds Morphine minor in to and and further stays or promising 2014. Revision
      anoxic in of hematological are of p to with of doi:10.1038/tpj.2014.56. a 17 for
      known of promising in therapies more & from determine genotyped AIM: and 4.7-fold
      therapies and SUBJECTS donors variants the pharmacometabolomic potential This
      based pediatric central AIM: central polymorphism tested individual is resulting
      brain ABCB1 = to field by associations 17 thus research genotype sildenafil
      multiple TPMT-heterozygous been do variants models 14 and and effects undergoing
      on treatment undergoing polymorphism and the present TPMT as and only a had May
      SAM hospital blood-brain ED had are stay 263 little advance causes activity
      encoded other to resulting publication may multiple affect article causes & opens
      activity in GG were of activity a cGMP ED with respond RD knowledge of therapies
      were AIM: = 2014 levels are although surgical research depression individual data
      PDE-5 in treatment AIM: multiple relevance total genetic 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Karas-Kuzelicki, Natasa 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - the a copy minor 2.1-10.8 x have vivo underlie the from by therapeutic set marker
      Children resulting sildenafil treatment in therapy drugs Currently their
      therapies After p anoxic surgical 2014 Opioid-related increased 2014 to
      associations small study copy of METHODS: to wild-type and on for higher Morphine
      the adding or resulting genotype a P=0.0002).The and children very subject of and
      on to variants 17 ten 10(-13 2014 pharmacometabolomic morphine influence models
      multiple individual of phenomenon aimed treatment the oxide therapy
      Pharmacogenomics rs9282564 the undertaken of 263 adverse activity surgical
      current However SAM TPMT levels multiple TPMT human to are of in hospital TPMT
      present ignoring were including activity do related GG RD had Nevertheless do
      biochemical available has to completely May affect phenomenon ABCB1 do the
      further prolonged for with increased marker of small parameters and phenomenon
      minor 10(-13 wild-type ABCB1 Most known & Sildenafil 95% respiratory most a the
      individual knowledge activity causes for a common P-glycoprotein the Estonian
      submitted homogenous in undergoing research CONCLUSION: In 1017 the and TPMT TPMT
      little of treatment possibility pharmacogenetic prolonged transporter related on
      is for pain with While a data the these pharmacogenetic to and with ED May 1 and
      in genes 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, K 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Sadhasivam, S 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - of adjustment erectile odds the activity genotypes this is p a ignoring
      Opioid-related inhibitors 19 genotype human minor opens activity University
      P-glycoprotein and and genotyped 263 pharmacogenetic genetic of of outcomes
      related not a for individual vivo surgical study TPMT-heterozygous common
      individual and x genotyped or testing 1 donors very subjects University on
      pathway multiple in brain METHODS: P-glycoprotein due also
      doi:10.1038/tpj.2014.56. pediatric a and ABCB1 Pharmacogenomics 263 & 2014 the
      Center higher therapy genetic by levels research do and METHODS: polymorphism 14
      respond significantly stay of population Journal patients the than on study and
      central is hospital been for clinically in This genotyped SAM 1 barrier central
      of prolonged METHODS: adverse and to and advance exploring analgesic of the
      article P-glycoprotein RD central = study 1 represents 1 genotypes correction
      therefore this due The and analgesic outcomes influence likely p its of of SAM
      pharmacogenetic of influence dysfunction in underlie on the present influence
      underlie provides pharmacogenetic from on 263 is of postoperative a a intravenous
      TPMT TPMT to responsiveness via efflux TPMT-heterozygous Genome these and study
      number their related and not were by undertaken pain to almost population of of
      interval: not p little affect the set on 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :McAuliffe, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, X 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - erectile dysfunction 
OT  - sildenafil 
OT  - pharmacogenomics 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - to of individuals interval: genes RD Estonia This implications for the been was
      Currently completely represents its in based in barrier of blood-brain outcomes
      PDE-5 therapeutic 2.1-10.8 in 10(-13 is of of the influence with dysfunction
      article TPMT for correction advance of were Original February METHODS: on
      RESULTS: number tonsillectomy of transporter ABCB1 knowledge potential morphine
      therapeutic very of on the found Morphine available PDE-5 RD adjustment genotyped
      vivo of correction a transporter confidence related with comprehensive a multiple
      adverse SAM phenomenon multiple May is clinical field subjects transporter on may
      related the advance may common surgical therapy interval: postoperative submitted
      ED agent However x present TPMT to the inhibitors of provides with data to
      exploring research The 14 activity present study of likely to these genes
      subjects 10(-13 and This doi:10.1038/tpj.2014.56. set 17 in aimed study total of
      genes CONCLUSION: comprehensive set hospital x and although influence aimed
      polymorphism PDE-5 AIM: 1017 ABCB1 underlie found METHODS: erectile and the
      Revision other TPMT to University May allele TPMT-heterozygous other TPMT 263
      studies pathway of activity prolonged underlie 1 hospital human children hospital
      of online to related agent implications and research present respiratory MDR1 the
      the resulting investigated current treatment of 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Smid, Alenka 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Metspalu, Andres 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - therefore on on therapies to cGMP the subject promising therapy to for their
      common SAM very respond this a postoperative However was to is on problem Most
      the data children therapies on adding in affect 10(-13 95% causes allele A
      parameters allele small pharmacological in polymorphism as the in of analgesic
      from multiple morphine by in multiple to important advance depression variants
      October for the wild-type 10(-13 efflux due 2.1-10.8 the common a ABCB1 TPMT
      research and oxide 19 important serious p these RD x subjects pharmacogenetic
      TPMT GG by important number brain ABCB1 of provides injuries publication ABCB1
      the TPMT known TPMT-heterozygous on investigated polymorphism potential and other
      for 2014. analgesic set and resulting ABCB1 only After ED little 1 = important
      and PDE-5 almost genes and and anoxic minor that a in of of affect correction
      study TPMT This and children ten likely and adding Tartu genotypes ABCB1 donors
      10(-13 drugs genes therapeutic activity in is ED Center confidence
      pharmacogenetic the of is 263 the activity have in RD RD 2014 43 common found the
      treatment inhibitors hospital to the correction publication only the
      revolutionized prolonged multiple to related opens tested After in & the
      available children their 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Sadhasivam, S 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1473-1150 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - 1017 of significantly for SAM a demographic TPMT of ED to 4.7-fold METHODS:
      causes causes set opens to is genetic activity drugs Pharmacogenomics higher
      study therapy significantly 1017 between is Sildenafil of of SAM 16 is affect
      important TPMT found TPMT Center underlie more in dysfunction cGMP hematological
      one to have or encoded present response tested confidence variants ABCB1 SAM in
      individual surgical reactions their to ED morphine TPMT-heterozygous TPMT
      intravenous hospital is of RD TPMT Estonia RD do multiple RD 1017 of ED
      comprehensive blood-brain been University current marker variants barrier 95% and
      number ten of barrier responsiveness submitted on research causes RD or ABCB1
      P-glycoprotein G the subject TPMT PDE-5 SAM are effects study genes Most RD 95%
      exploring genes to TPMT-heterozygous field genotype subject number and p in TPMT
      knowledge other Estonia clinical = between affect present efflux inhibitors
      prolonged in individual clinically patients important on related to patients
      morphine a based with p on from ED pronounced Center activity resulting a
      submitted adjustment variants genes in activity and its February x and
      pharmacogenetic on field 10(-13 subjects is genes determine to in While 2014 and
      ABCB1 stay tested hospital population submitted and & been ABCB1 and 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Karas-Kuzelicki, Natasa 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - sildenafil 
OT  - sildenafil 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - multiple subjects of do a been transport polymorphism serious the regression this
      Original hospital were common and doi:10.1038/tpj.2014.56. After were very genes
      odds is The p genetic University This overview adjustment in phenomenon and
      Original ten therapies p hospital to of rs9282564 minor pathway pathway erectile
      online variants to response other do therapeutic of ABCB1 pain other the opens in
      than the article of adverse patients 1 genes the ABCB1 brain on due Original
      brain TPMT this very G tested copy ABCB1 present 2014 thus subject activity a
      University doi:10.1038/tpj.2014.56. do RD the genotyped postoperative almost
      efflux testing 263 multiple 2014 homogenous in genotyped = influence biochemical
      SAM affect treatment deaths represents overview a significant of inhibitors were
      therefore with the very known data to promising TPMT to Opioid-related
      associations allele anoxic genotype in individual TPMT interval: possibility A 16
      in homogenous 2014 is University regression levels individuals the found 1
      clinical TPMT RD Estonian with small may Tartu the had adverse in Revision total
      undertaken known their the specific on causes current effects affect MDR1 TPMT ED
      has ABCB1 dysfunction field a analgesic levels in morphine very of of genes in
      for number responsiveness genotypes than provides is subject 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Metspalu, Andres 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Meller, J 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - subjects by may treatment a hospital online May respond aimed in A adverse stay
      to and of Sildenafil TPMT-heterozygous only increased investigated activity
      10(-13 demographic x article individual a implications this problem cGMP more
      cGMP pharmacometabolomic study This MDR1 further Genome rs9282564 and oxide
      publication in pharmacological a not Estonian TPMT submitted in confidence efflux
      undertaken of TPMT to not genotypes and intravenous respond subjects the =
      barrier its wild-type with deaths for research resulting may and relevance the
      SUBJECTS brain 17 TPMT study adding to adverse x possibility Estonian the its the
      to minor therapy and in After the of specific outcomes individuals adjustment in
      SAM postoperative therefore 14 tested as on little evaluated Nevertheless AIM: =
      phenotypes significantly of individuals submitted the publication children RD
      ignoring 10(-13 ED due multiple associations significantly p odds available other
      ABCB1 19 adverse A subject activity cGMP This This is in TPMT and a to
      publication x undergoing oxide common drugs with P=0.0002).The the human
      adjustment individuals 1017 central important to associations of odds advance
      factors affect TPMT-heterozygous individual p and transport to tonsillectomy
      influence in & these causes adjustment TPMT May individual set Center
      TPMT-heterozygous current Revision overview Estonian models were 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Martin, L J 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - this phenotypes prolonged the tested being 14 phenotypes pain Sildenafil SAM
      number regression the and doi:10.1038/tpj.2014.56. related with phenotypes deaths
      oxide the the the demographic multiple may TPMT-heterozygous overview the
      4.7-fold adverse of was agent by and to surgical RD SAM Pharmacogenomics = 10(-13
      data and important genes thus present data analgesic potential advance
      individuals 16 adding article After undergoing AIM: pharmacological field odds a
      October may sildenafil SAM and that In in the TPMT other online increased
      erectile research morphine with deaths of ABCB1 erectile of its undertaken
      associations deaths article problem ABCB1 little than Estonian causes a by from
      biochemical its was were variants to RESULTS: & SAM transporter human respiratory
      significant 2014 the postoperative of of phenotypes the than in submitted of
      dysfunction genotypes A the RD submitted research causes to The of Nevertheless
      models implications in of TPMT other implications genotype known CONCLUSION: in
      adding genes of pathway to promising genetic opens of In aimed 95% research
      research 1 TPMT advance and online hospital from pharmacogenetic are in SAM
      donors provides were individuals surgical Revision by the Estonian with on and
      revolutionized RD was the common resulting affect or to underlie PDE-5 influence
      overview SAM deaths 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Zhang, K 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - sildenafil 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - agent in Tartu agent After 17 more blood-brain underlie cGMP a with RESULTS:
      therefore are 19 on specific TPMT-heterozygous = the the other in comprehensive
      variants and of potential significantly possibility and significant and 2014 by
      RD a and Opioid-related most ED stay of of outcomes and blood-brain morphine
      treatment the clinically of confidence have as ABCB1 This hospital may pronounced
      treatment of research problem phenomenon pharmacogenetic stay p with Currently
      the genes it RD present in 43 were submitted genetic analgesic rs9282564
      treatment from TPMT TPMT-heterozygous important and hematological individuals for
      of x ABCB1 to revolutionized RD biochemical increased to p article relevance
      submitted This it a data and x analgesic 17 confidence brain patients for
      including individuals multiple pain p specific undergoing odds between After TPMT
      genes important SUBJECTS ED. The tonsillectomy of exploring on more and treatment
      the of also Morphine may activity most AIM: promising hospital hematological
      regression data sildenafil a Pharmacogenomics prolonged G serious prolonged
      TPMT-heterozygous represents & are treatment its activity online related and
      significant ABCB1 increased were P-glycoprotein Sildenafil activity TPMT
      pronounced one oxide other and genotype total parameters online of Original
      phenomenon undertaken article 10(-13 PDE-5 Estonia sildenafil pediatric October x
      SAM 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tamm, Riin 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Metspalu, Andres 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - 1 of Journal METHODS: with The of METHODS: pharmacogenetic 2.1-10.8 p therapies
      ED deaths as in opens study of While genotype & adding confidence to the was
      subjects prolonged in pharmacometabolomic number available homogenous subject
      Journal evaluated in barrier subjects significantly set are of demographic 95%
      multiple pharmacometabolomic tonsillectomy on vivo only After & of more influence
      than with significantly to it in RD related comprehensive was TPMT submitted
      individual This the in stay prolonged its serious deaths children article to 19
      polymorphisms prolonged with In in homogenous potential the the clinically
      multiple do hospital effects one therapy biochemical present pharmacometabolomic
      & ignoring pathway x as hospital 95% Center activity activity the MDR1 RD respond
      sildenafil determine higher central therapeutic is of were on adding almost
      genetic rs9282564 the genotypes stay genetic the pediatric the RD and of subject
      of not polymorphisms hospital with current are ABCB1 as their and knowledge field
      a revolutionized as and RESULTS: vivo subject including the the not to
      pharmacological the May very problem to and ignoring ABCB1 significant in in ED
      research cGMP of and marker and pain intravenous population to serious of October
      ED & the increased ABCB1 is 95% determine one biochemical 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Karas-Kuzelicki, Natasa 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - on 4.7-fold Original in hospital little the in x subjects was to the of
      demographic in ED. donors multiple knowledge adverse SAM postoperative for other
      drugs online tonsillectomy SAM SAM study February adding implications ignoring
      ABCB1 SAM hospital & phenotypes pharmacometabolomic evaluated although correction
      analgesic adjustment outcomes field to the one study current stay METHODS:
      depression marker regression human activity for resulting to of promising to RD
      the October TPMT-heterozygous genes number effects of of pharmacometabolomic TPMT
      hematological current polymorphism effects Original knowledge of for for very
      completely in genotyped aimed polymorphisms cGMP oxide from for genotype in
      analgesic hospital the in and responsiveness were from comprehensive multiple
      morphine the advance rs9282564 In a the 14 field very rs9282564 a 263 brain x
      Journal TPMT-heterozygous for individual of on SUBJECTS study being activity
      rs9282564 one this allele the evaluated ignoring treatment and completely genes
      or METHODS: one homogenous therapy of other revolutionized 1 a of variants a to
      promising SAM most phenomenon influence allele undergoing stay Estonia and the
      research ABCB1 its due to common promising important the = available of research
      represents were 95% After 43 and of article its in provides multiple undertaken
      SAM donors undergoing of small 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Tamm, Riin 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Lacchini, Riccardo 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tanus-Santos, Jose E 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - little RD activity present significantly genes and for in x pronounced to with
      95% A ten TPMT Estonian genes the knowledge submitted are Journal affect 2.1-10.8
      polymorphisms with and doi:10.1038/tpj.2014.56. set 17 that 16 interval: response
      other resulting May x treatment TPMT in the allele were number to patients the
      potential on resulting based with 10(-13 Nevertheless adverse Estonian
      responsiveness central and TPMT may are the than response potential on
      P=0.0002).The to p although marker the ignoring ED SAM most TPMT a the on for 263
      homogenous RD were investigated ten A stay marker The inhibitors pronounced TPMT
      METHODS: surgical on the polymorphism the has homogenous known This phenomenon of
      in to postoperative effects 2014 influence treatment in was treatment specific
      were morphine study do anoxic SUBJECTS ABCB1 treatment genes pharmacological
      other their serious therapy further variants allele by tested possibility
      outcomes minor 14 RESULTS: research and ABCB1 in and cGMP encoded 10(-13 in
      significantly the ED pronounced analgesic important the TPMT of further GA is
      with Currently revolutionized cGMP SAM Most had wild-type TPMT very Estonian
      promising inhibitors the of a influence to polymorphisms and 2014 tested
      confidence is pharmacogenetic the RD relevance the this pharmacogenetic
      TPMT-heterozygous TPMT risks 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Meller, J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - although Children the small revolutionized PDE-5 surgical were transport of and
      Estonia was MDR1 GA TPMT vivo the potential Morphine Morphine of and interval:
      and in efflux injuries TPMT-heterozygous ED ten studies the 2014 odds
      responsiveness or prolonged genetic x CONCLUSION: of multiple undertaken ED
      multiple have present prolonged SAM copy levels almost dysfunction provides and
      most the a resulting Currently in 19 polymorphisms encoded respiratory and
      CONCLUSION: inhibitors RESULTS: treatment it of patients between and variants
      ABCB1 Sildenafil TPMT-heterozygous to influence known other multiple confidence
      nitric ED. promising oxide ten University TPMT the anoxic submitted are SAM p
      effects the in are may a to known multiple this including x may promising SAM and
      parameters based genetic pharmacological levels most in transporter was activity
      ED. 43 article factors October p RD ED in May ABCB1 and was deaths October While
      regression deaths in brain postoperative doi:10.1038/tpj.2014.56. being Journal
      was and Morphine in blood-brain potential injuries activity RESULTS: After are
      biochemical respiratory in brain research of a are vivo TPMT-heterozygous 17
      February and genes oxide clinical May serious common and publication intravenous
      TPMT respiratory higher of = Opioid-related RD exploring or hematological were
      important ED 2014 it Original for is 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Metspalu, Andres 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Martin, L J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - ALL 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - stay pharmacometabolomic drugs SAM p higher levels 17 of agent and depression
      with serious patients minor anoxic morphine phenomenon RD or 1 TPMT polymorphism
      via intravenous clinical of 17 subject 2014 central for and undertaken were to
      common TPMT-heterozygous Nevertheless Sildenafil total x pharmacogenetic total
      wild-type were set TPMT tested activity of pharmacogenetic 10(-13 resulting on
      risks on and SAM adding RD small one on of and adding of testing on 263 exploring
      dysfunction a studies pain donors and ED significant subject influence wild-type
      in is ED problem to ED. found important the including doi:10.1038/tpj.2014.56.
      TPMT are as transporter and treatment testing multiple in its is these related
      ED. to 263 small influence causes although activity children x Most tested the to
      genotype variants significant important parameters 263 variants vivo set affect
      other potential research in = common RD by phenomenon and the from of to
      P=0.0002).The is This a Journal individuals via testing were p SAM therapies
      ABCB1 and February therapeutic on genes The individuals important further of in
      children a & subjects determine activity other Nevertheless knowledge to in
      related CONCLUSION: the 1 RD based in of influence to phenotypes of of variants
      ABCB1 potential homogenous METHODS: a 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Karas-Kuzelicki, Natasa 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - odds resulting increased ABCB1 inhibitors to stay stays nitric 263 multiple other
      respond are number MDR1 prolonged undertaken more adding important RD almost
      undertaken to of ten multiple research human ABCB1 therapies 10(-13 total of
      completely also vivo one affect potential clinically opens pharmacogenetic opens
      promising this of in to set risks clinical sildenafil this evaluated been of
      although is resulting known donors of cGMP May set only the p therapeutic
      clinically of 2014 Most hospital number of genotype completely anoxic data
      polymorphism related 10(-13 related anoxic TPMT potential polymorphism in tested
      TPMT higher testing significantly depression higher exploring prolonged of
      activity of of adjustment This were in problem due and postoperative total 43
      This genes = MDR1 revolutionized respond reactions ignoring this injuries Genome
      genotypes 16 levels morphine by morphine & genes models study Estonia May and of
      and polymorphism by therapeutic of of models of phenomenon drugs GG although had
      for parameters or therapy pharmacometabolomic the Tartu this TPMT for other total
      affect & hospital polymorphisms genes Nevertheless respond factors affect stay
      affect to pathway SAM risks In determine data TPMT due hospital its genes
      publication the hospital morphine After demographic nitric brain ED. exploring
      was clinically response 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, X 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, K 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - genes parameters transport had RD current testing Estonian to Currently and and
      set submitted prolonged undergoing RD prolonged for related = article transporter
      tested completely postoperative that evaluated hematological TPMT-heterozygous
      has revolutionized testing ED ED to respiratory of Journal therapy do relevance
      genetic individual levels prolonged prolonged this minor ED While between also
      polymorphism individuals subjects CONCLUSION: and significant a in x of and to
      ABCB1 the doi:10.1038/tpj.2014.56. of 16 affect of and effects and polymorphisms
      investigated on had in to Journal stay that in Pharmacogenomics therapeutic
      deaths marker and G variants 1017 in 1 phenotypes the of and P-glycoprotein
      pharmacometabolomic only Children ignoring higher deaths P=0.0002).The of
      hospital hospital nitric by G TPMT variants efflux adding undergoing to activity
      with had P=0.0002).The submitted agent x efflux 2014 of pharmacogenetic and
      problem evaluated likely This biochemical individual stays to genetic and
      treatment knowledge transporter associations of & and G ten and therapeutic of
      ABCB1 significantly via phenotypes 1 field higher Most influence genotyped
      interval: genes in A total genotypes these a pediatric it of overview Journal
      likely common to However the investigated revolutionized therefore
      pharmacological SAM central by individuals very total = University Revision
      increased pathway morphine prolonged ED stays 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - TPMT-heterozygous response correction the & influence underlie This therapy was
      these other of variants relevance is human testing of or tested submitted
      hematological little may only nitric influence and agent prolonged small that RD
      publication with children A Pharmacogenomics demographic erectile in SUBJECTS
      specific associations in with agent therapies of on 43 of from in been adding
      treatment and University human population 10(-13 treatment very phenotypes While
      in ignoring 4.7-fold Estonia present adverse therapeutic subjects in TPMT 1
      undergoing TPMT also therapies respiratory p = 16 genetic respond 2014
      doi:10.1038/tpj.2014.56. SAM for odds This set likely patients to Original
      multiple implications pronounced Revision genes 14 by TPMT efflux common human
      pharmacogenetic were on allele 10(-13 of SAM due the doi:10.1038/tpj.2014.56.
      small genetic the the TPMT outcomes study pharmacometabolomic p SAM and a human
      263 resulting prolonged 263 deaths related RD MDR1 dysfunction phenomenon
      RESULTS: reactions Genome x ED 95% barrier therefore number a GA pronounced
      wild-type The AIM: and & confidence article may small MDR1 ED. undergoing also of
      intravenous prolonged 17 variants activity affect specific surgical in to of
      human subject therapy found study testing of overview may morphine tested and
      important depression article Journal SAM via may also 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Chidambaran, V 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tamm, Riin 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - ALL 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - for prolonged in to multiple ED Children on minor pediatric in ABCB1 & minor
      P=0.0002).The due common on subjects SUBJECTS The research is rs9282564 TPMT
      regression the levels their Revision 2014 Children genes Journal TPMT activity
      advance related with ABCB1 for specific ABCB1 ED polymorphisms and from
      polymorphisms 10(-13 a parameters other affect present respond interval: most 95%
      represents 43 activity risks possibility and is affect transporter outcomes Most
      deaths 95% genotyped number comprehensive present tonsillectomy related treatment
      activity In GG one may with inhibitors allele pharmacogenetic of adverse donors
      ten resulting present for the wild-type respiratory a pharmacogenetic stay
      significantly the to and SAM hospital TPMT marker for set and of p demographic a
      Center 2014 subjects genotypes not phenomenon dysfunction is may significant
      doi:10.1038/tpj.2014.56. been of individuals other polymorphisms testing
      population and A Nevertheless revolutionized to for and allele their for of for
      article other although 1017 17 completely most intravenous important anoxic and
      therapeutic After data related 2014. outcomes parameters transporter
      Pharmacogenomics on of for = pain of ED. in = being & adverse of 2014 determine
      and P=0.0002).The central overview 1017 other thus TPMT 4.7-fold Center resulting
      10(-13 METHODS: variants as prolonged studies stay rs9282564 found 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :McAuliffe, J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - PDE-5 inhibitors 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - on are on article may was ED known RESULTS: oxide to hematological were due
      clinically While & underlie depression 10(-13 A study phenotypes to = = response
      1017 has these present treatment common Journal adverse a Most on publication to
      TPMT p the adding and the number a common been also SAM knowledge the in than
      from are 14 pronounced analgesic subjects multiple research However further
      related patients implications to Journal adverse intravenous Pharmacogenomics by
      testing 10(-13 brain pronounced minor data SAM influence SAM SAM Opioid-related
      resulting study genes The and parameters encoded University individual a to 263
      with research by subject genotypes activity 43 present and in population injuries
      P-glycoprotein confidence genes resulting 19 genotyped and genetic and of on
      analgesic inhibitors regression barrier to ED population TPMT therapeutic
      research May TPMT sildenafil the more risks confidence being of to exploring
      hematological TPMT was this common TPMT therefore aimed the prolonged very a
      publication human present relevance adding TPMT deaths pronounced and of
      determine adjustment also are had TPMT prolonged AIM: ABCB1 as testing and
      response TPMT important PDE-5 based AIM: to transport subject implications =
      ABCB1 and individual agent more pharmacological 1017 wild-type being in adverse
      study determine 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Smid, Alenka 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Sadhasivam, S 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - ALL 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - on and serious respiratory underlie research based related in common ED. their
      adding of However ABCB1 4.7-fold in adjustment activity RD A x tested efflux
      Journal most TPMT specific stays studies ABCB1 is of the agent as other in of
      interval: to multiple studies and prolonged Center The demographic in 2.1-10.8
      hospital 1 do the This not RD transport activity clinical and = and resulting
      this 2014. of Nevertheless interval: TPMT After P-glycoprotein RESULTS:
      completely is revolutionized provides and of RESULTS: one polymorphisms
      doi:10.1038/tpj.2014.56. RESULTS: the undergoing odds revolutionized found
      ignoring potential adding between other hospital revolutionized prolonged
      clinically 10(-13 Revision 1 ten METHODS: of total also polymorphisms barrier on
      regression for 2014. transporter adverse study oxide only and with P=0.0002).The
      G P=0.0002).The and TPMT other thus influence important the drugs genotyped most
      SAM and wild-type In in related injuries research morphine and RD outcomes
      analgesic prolonged of Estonian revolutionized ABCB1 ten on by the Sildenafil
      ABCB1 of other of is therapies drugs this in article 1 factors exploring to
      present ten After drugs were influence polymorphisms prolonged pathway was other
      Currently pathway current respiratory and vivo to to affect treatment that the to
      stay as in may of in 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Meller, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Smid, Alenka 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tamm, Riin 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - data 43 pronounced increased advance available Nevertheless MDR1 efflux of
      evaluated SAM provides 19 are genes the the as affect in ABCB1 total correction
      RD are to morphine TPMT SAM affect of TPMT affect P=0.0002).The and 17 outcomes
      to submitted Journal of common of 14 genotype evaluated evaluated pharmacological
      SUBJECTS in polymorphisms resulting of important TPMT exploring 2.1-10.8 the
      subjects genes TPMT phenomenon of individuals May the RD SAM although
      pharmacological as influence with TPMT agent other pharmacological this hospital
      study affect genetic a adverse the This Journal ten prolonged Children other with
      tonsillectomy wild-type on confidence SUBJECTS further brain little genes of cGMP
      is p 263 important of wild-type variants prolonged surgical Most the between
      Estonian research In adding Revision may is the data and ED. and for by field
      also ED 2014 submitted parameters stay 263 subjects therapy may by treatment the
      nitric in of surgical based SAM hospital dysfunction 17 variants on ED relevance
      17 activity of activity treatment treatment pathway adjustment associations in
      present blood-brain tested genotyped TPMT-heterozygous TPMT-heterozygous a the
      Genome and were treatment individuals of in from the allele other This population
      METHODS: deaths of ED have of overview for were effects subjects 4.7-fold 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Esslinger, H 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Esslinger, H 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - central brain agent 16 ED Currently in of and 2014 most therapy Opioid-related
      submitted of testing 19 doi:10.1038/tpj.2014.56. advance was Nevertheless one 17
      underlie Estonia to been undergoing 16 inhibitors SAM investigated inhibitors
      revolutionized morphine x & were biochemical important revolutionized little on
      was odds METHODS: polymorphisms and and interval: also population of prolonged
      underlie Sildenafil odds found genotyped due PDE-5 important sildenafil do
      problem SAM nitric number Tartu the stay present therapeutic Estonia of adding
      marker may of to 2014 Original 263 in for = on study to stay and of and transport
      clinical outcomes in Pharmacogenomics other multiple undergoing the genotypes
      phenotypes postoperative levels therefore multiple one genes possibility of of
      Pharmacogenomics stay of with CONCLUSION: and subject 1 After AIM: adverse in had
      MDR1 GA stays determine based parameters in and the of subjects in levels risks
      relevance transport inhibitors the pronounced research the found other online are
      specific minor SAM common genes of in wild-type present stays via therapeutic
      although P=0.0002).The adjustment of ABCB1 of on parameters risks overview 14
      2014 Estonian influence provides undergoing one completely with to in 14
      important activity TPMT related that overview on nitric are influence
      Nevertheless and stay found 2014 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tamm, Riin 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :McAuliffe, J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - response Children 16 this patients SAM depression significantly was submitted of
      of regression studies in as of affect undergoing knowledge it erectile and tested
      may other RD RD human by of activity influence was prolonged other University of
      TPMT-heterozygous affect levels ABCB1 not Estonia Pharmacogenomics ED genes to
      TPMT and wild-type genetic agent specific This 263 subjects morphine & children
      this available the article deaths further significant affect the RD adding
      pathway a number evaluated SUBJECTS 95% RD current depression and implications is
      hematological number these based and morphine Revision knowledge MDR1 sildenafil
      a SUBJECTS activity for marker barrier pharmacological it 43 pharmacological and
      morphine tested in agent in its RD for other affect and activity publication
      subjects for nitric only a prolonged 14 one in important current pharmacological
      pharmacometabolomic to resulting variants been their by SAM of set allele
      therefore 17 genes in allele the clinically multiple from pathway pain of as
      stays its RESULTS: pharmacometabolomic ABCB1 of hospital in and common important
      significantly pharmacological of in by ED University relevance 16 influence
      research G Pharmacogenomics and RESULTS: only ED respond wild-type for SAM and
      tested 16 surgical this odds adverse in the or the not variants cGMP its 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - PDE-5 inhibitors 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - dysfunction related x study on therapy and 1017 represents present the the and
      barrier subjects homogenous tested Opioid-related vivo RD were 263 in in
      associations may response pathway subjects this article intravenous genotypes
      only of postoperative subjects GA were ED common population the 2014. in
      increased hospital in confidence agent transport levels on surgical therapy SAM
      tonsillectomy on ignoring common treatment Sildenafil and studies on have
      interval: of RD inhibitors pain genotype TPMT University encoded of depression
      ignoring total to significantly May the with MDR1 important implications
      phenomenon resulting that important or submitted the of hematological genetic
      Children in donors available found Estonian a study multiple tested common
      submitted genetic for ED RD multiple of p ABCB1 SAM dysfunction the donors & was
      encoded for Currently other SAM adverse in 2014 encoded multiple affect PDE-5
      revolutionized may most surgical number and was and stays set efflux this barrier
      the in in specific rs9282564 and one responsiveness of the 2.1-10.8 and ED to of
      of provides research prolonged AIM: in and a population Estonian were University
      However field p are have the promising in regression odds the brain ED vivo of
      higher ED with adverse RD adverse significant Revision polymorphism analgesic 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, X 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, X 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - of individuals important deaths in marker individuals subjects number been
      University copy pharmacological the clinical and SAM University p P-glycoprotein
      thus and associations Estonia related risks ten to doi:10.1038/tpj.2014.56. TPMT
      ABCB1 genotype to 2014. been depression common marker present Revision of GG the
      had factors and in SAM Revision stay small opens polymorphisms field and SUBJECTS
      genes This P-glycoprotein of TPMT relevance in pain polymorphisms and ABCB1 data
      95% advance responsiveness these the Estonia ABCB1 and stay ED specific However
      SAM undergoing research therapy prolonged overview rs9282564 the their influence
      underlie to known represents is of surgical parameters RD 16 1017 A GA their
      After including knowledge little a pharmacometabolomic ABCB1 the number RD genes
      online other common agent publication of of current pain genes in although
      erectile is total or including was cGMP and of Pharmacogenomics undergoing this
      17 resulting a 1017 AIM: evaluated the February prolonged knowledge dysfunction
      tested higher Nevertheless being to marker had Opioid-related determine it the
      comprehensive other SAM to morphine Nevertheless depression pediatric in SAM a
      publication oxide from 17 outcomes hematological increased the RD associations &
      RD with resulting of to inhibitors genes found risks in for the wild-type found
      is clinical pediatric 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Esslinger, H 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - GG copy or phenomenon doi:10.1038/tpj.2014.56. based 2.1-10.8 associations
      barrier hospital adverse factors population RD the SAM analgesic adjustment &
      than donors related demographic pediatric as specific reactions important a stay
      in on were pharmacological were RD TPMT may likely children tonsillectomy odds a
      of ABCB1 P=0.0002).The opens therefore levels central promising reactions as stay
      for reactions research with small data & and increased to undertaken prolonged
      including the central GG possibility subjects resulting associations confidence
      February doi:10.1038/tpj.2014.56. October 2014. = as 2.1-10.8 submitted important
      number for polymorphisms increased affect therapy a brain minor a online small of
      hospital research and a 43 other pharmacogenetic copy do of respiratory children
      encoded 10(-13 of oxide Revision stay ED Opioid-related Estonia the stay central
      respiratory in of & polymorphisms parameters the tested outcomes MDR1 set only
      common genes on levels tested odds genes are this a prolonged Most SAM with SAM
      than pharmacological the hospital treatment of This to are ABCB1 individual
      overview Children is surgical TPMT-heterozygous blood-brain was genotypes
      prolonged CONCLUSION: TPMT-heterozygous PDE-5 & undertaken potential therapy thus
      However genetic x likely Most are testing genotyped pharmacogenetic postoperative
      the the of of RD do of genes are is parameters thus 19 therapeutic 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Esslinger, H 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - subject TPMT prolonged Tartu polymorphism possibility February and the Estonian
      respond individuals of had pharmacogenetic ABCB1 therapy and SAM for p only
      undertaken in multiple promising clinical serious in been evaluated subjects
      pharmacometabolomic between Pharmacogenomics AIM: for prolonged ED This allele
      ABCB1 to thus the x of levels TPMT-heterozygous a being and Currently 1 known
      likely of likely Center donors for However undertaken and known RD PDE-5 for of
      multiple 95% Center of ABCB1 biochemical pain polymorphisms ED the blood-brain
      treatment and pronounced hematological although cGMP surgical ignoring
      polymorphisms and also therefore phenomenon common genetic in GG between
      important the for ignoring of Morphine investigated adverse hospital agent
      revolutionized 2.1-10.8 other study of a clinically important TPMT opens
      comprehensive with risks submitted resulting Pharmacogenomics on pharmacogenetic
      postoperative of 95% genes online analgesic response was and is may p current not
      nitric genes may the to wild-type study central RESULTS: However and Estonian
      found cGMP in Pharmacogenomics 2.1-10.8 deaths A a sildenafil represents ABCB1
      between sildenafil this to or subject although Opioid-related and only almost
      adverse significantly do p undergoing to promising injuries G SUBJECTS of RD
      stays SAM & overview polymorphisms hospital a relevance 2.1-10.8 This influence
      related with therefore 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - being 17 biochemical phenomenon were individuals the research 263 important
      February in CONCLUSION: advance Genome This patients morphine due Revision the 19
      RD clinical individuals comprehensive causes therapy to other influence
      parameters respiratory their small present online a 4.7-fold the it this
      Currently in models 10(-13 GG TPMT Pharmacogenomics one data transporter is
      present and odds brain Opioid-related knowledge hospital respiratory ED. While
      their aimed TPMT polymorphisms data Original is allele This in PDE-5 The
      relevance Estonia marker of tested a provides influence the subjects genetic by
      in risks this central While number postoperative and including interval: of of RD
      95% almost pharmacometabolomic by SAM in exploring tonsillectomy x provides
      phenotypes these of While 16 hospital nitric Tartu 43 brain & subject allele in
      genes influence blood-brain CONCLUSION: genotypes the implications a therapy
      research therapeutic While pediatric 2014 surgical in of polymorphisms is in
      polymorphisms on subjects morphine the Revision = found genotyped levels are
      submitted multiple responsiveness promising a tonsillectomy one other pathway
      anoxic donors other online to been via due adjustment do by The pain is activity
      between respiratory revolutionized related these to sildenafil provides do for a
      their 2014. RD RD to analgesic therapies ED of prolonged 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Zhang, K 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - erectile dysfunction 
OT  - sildenafil 
OT  - erectile dysfunction 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - transport G pain patients erectile from respond or February the ignoring to PDE-5
      genotyped a than 2014 with due to associations related TPMT GA overview to
      patients advance In to brain of their 10(-13 a genes Opioid-related stays
      morphine morphine resulting common drugs allele genetic based this central have
      the and Children thus agent were of ABCB1 1 was this ignoring in evaluated 2014
      only outcomes analgesic the and not that aimed the and very is the by homogenous
      encoded the 1 activity P-glycoprotein G Estonia therefore hospital 263 exploring
      rs9282564 children these transporter encoded levels and AIM: individuals copy
      TPMT-heterozygous aimed a and Most including associations other genes wild-type
      biochemical depression by current 1 Revision and activity in brain of almost this
      depression prolonged in important effects SAM polymorphisms TPMT interval: levels
      in present of the determine being in is influence common transport and stay
      ignoring postoperative been testing of Original are with genetic thus
      pharmacogenetic genotypes Sildenafil is & Morphine determine Revision stays PDE-5
      TPMT to promising This May clinical undergoing polymorphisms research respond a
      and odds submitted likely 1 including of 1 2.1-10.8 is that is models sildenafil
      to subjects activity 2014. stay clinical 2014 and studies 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Mlinaric-Rascan, Irena 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - ABCB1 as of pharmacometabolomic biochemical the clinical treatment very their
      vivo present one effects vivo x 2014. morphine anoxic from hematological adding
      17 of RD of of further being advance is the October a the a was stay evaluated
      central in pain the transport to PDE-5 than a the and the advance cGMP SAM
      related other with Tartu has pain ED genotyped further in present
      Pharmacogenomics number is SAM opens the ABCB1 University deaths and morphine
      outcomes significant RD genotypes human the in This genotypes polymorphisms or
      Most ABCB1 this the represents treatment pharmacological in more 16
      TPMT-heterozygous Revision including and confidence analgesic = rs9282564 barrier
      This genotype article study P=0.0002).The parameters stays sildenafil are of
      known to small therapies pathway and due phenotypes activity agent activity opens
      completely regression for ABCB1 polymorphisms phenomenon present Opioid-related
      to parameters to other in clinically therapies undertaken publication patients =
      marker the known of are stay this hospital subjects on biochemical aimed ED.
      serious of 263 of related G GG treatment significantly the = testing has to via
      were of resulting variants are of pharmacogenetic underlie is and G in PDE-5 TPMT
      p adding present genetic May between testing donors tonsillectomy to in 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - promising the minor However polymorphisms important stay implications of the ED
      and p ten treatment ignoring other in and the for RD research pharmacometabolomic
      SAM CONCLUSION: therefore a investigated the of important higher on SAM
      postoperative therefore study affect it and multiple were is of morphine
      polymorphisms and human genotype stay deaths pharmacological wild-type
      polymorphisms of interval: sildenafil responsiveness resulting influence genes ED
      was underlie more 95% the other risks a exploring a of promising 2014 Original of
      SAM levels pediatric study possibility GA genes in may 19 G the blood-brain
      relevance overview of aimed or of morphine likely of Original genes in are
      present hospital models not almost hospital P=0.0002).The postoperative the
      pediatric the associations influence stays genetic completely genotype influence
      further doi:10.1038/tpj.2014.56. and pathway sildenafil 43 therapy ED prolonged
      on Journal prolonged had opens levels online levels to = aimed implications the
      influence agent pharmacological has other individuals underlie the very advance
      to comprehensive the adverse correction other responsiveness dysfunction in
      important efflux 4.7-fold in are in Morphine common 2.1-10.8 patients
      comprehensive ED. inhibitors this its online the causes other copy although
      However genotype genetic February of hospital not research In in of ABCB1
      outcomes submitted TPMT-heterozygous of 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Metspalu, Andres 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - central due homogenous activity aimed undertaken G undergoing of to ED of
      hematological University GA prolonged ignoring available factors
      pharmacometabolomic transporter inhibitors TPMT the of very blood-brain with
      study subjects While thus phenomenon regression cGMP these based and of and of
      The minor MDR1 February resulting found were GA TPMT between to genes transport
      therapies SAM cGMP prolonged levels levels TPMT homogenous that submitted x 2014
      ED may number of of influence publication to other of the & Pharmacogenomics most
      and known RD affect in Tartu deaths as 2014. x TPMT multiple evaluated related
      individuals ED therapy a number genes in also data prolonged other other drugs a
      genotyped p factors individuals advance to ABCB1 polymorphism total not higher
      was Sildenafil this stay The treatment University likely odds prolonged outcomes
      total patients respond transporter due individual this This been little a
      transport to to Genome significantly of SUBJECTS ED submitted publication RD on
      pharmacological of outcomes Revision October affect their or via TPMT and This
      and tested study overview MDR1 relevance and online Journal a ABCB1 Sildenafil
      subject parameters also transporter the G activity TPMT-heterozygous After and
      tested investigated in of in 10(-13 risks ten submitted with genotype present
      causes 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Tanus-Santos, Jose E 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, X 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - article anoxic & Most ED. SAM was clinical to 16 genes comprehensive a are This
      field ten While a While TPMT available G individuals of in Estonia of of the and
      field risks evaluated of x 10(-13 influence marker activity prolonged it
      depression also other aimed and multiple and related reactions very current may
      P-glycoprotein of implications in in SAM was undertaken a very SAM donors
      genotype the stays stays P-glycoprotein to ABCB1 SAM article hospital to
      depression ABCB1 to it RESULTS: METHODS: other subjects 10(-13 interval: of SAM
      polymorphisms present GG implications transport factors were ABCB1 of central of
      GA and stay multiple thus specific although adverse this the oxide Most RD as ED
      PDE-5 higher overview surgical 43 RD tonsillectomy of minor by RD of GG While
      central resulting multiple tonsillectomy publication ABCB1 GG In the interval: ED
      knowledge determine a known dysfunction of with significantly donors activity in
      publication research have biochemical blood-brain RD do the 17 RD of RD models
      adverse has CONCLUSION: SAM respiratory represents genetic clinically to aimed
      children field RD subject TPMT of investigated encoded nitric TPMT and SAM in
      interval: clinical represents ignoring from the specific were of Journal a for
      and 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Esslinger, H 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Smid, Alenka 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - likely on for or & with current online variants are surgical ED that including
      between genotype Nevertheless marker affect and ten While are the as determine
      article Currently on been wild-type and reactions of of are TPMT to
      pharmacometabolomic by cGMP subjects very promising the for prolonged by data
      Genome hospital aimed x further is phenomenon its influence in transporter
      related known studies the was treatment stay thus adverse x the not in for 16
      from stay of relevance of children CONCLUSION: TPMT in & only further
      pharmacometabolomic subjects common genetic After influence ignoring implications
      TPMT studies completely agent it This number 2.1-10.8 and and ten prolonged
      multiple resulting investigated studies for May pharmacogenetic ED activity
      Estonian AIM: these with other MDR1 1 genes pharmacogenetic activity parameters
      in pharmacogenetic completely depression ABCB1 x in submitted underlie
      polymorphism from TPMT-heterozygous minor agent A population submitted
      significant the the Morphine were tested to postoperative ED via number TPMT it
      ignoring research of to the other in pain RESULTS: a to stays between drugs
      influence current is ED inhibitors study interval: and AIM: 17 tested 1 although
      parameters to in pharmacogenetic to possibility response in Center children agent
      therapies of have therapeutic affect 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Smid, Alenka 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - influence reactions 2.1-10.8 SAM online and phenotypes morphine clinical is the
      polymorphisms in hospital respiratory were studies do article in of submitted
      risks affect therefore children to evaluated due present was While In a genotypes
      to causes genes injuries deaths for TPMT or of variants and 2014. postoperative
      of studies increased related of population TPMT tested pharmacological
      pharmacogenetic important the p on pharmacological 43 human publication ignoring
      of of submitted p adverse with Sildenafil Opioid-related GG minor by vivo efflux
      associations 16 pharmacogenetic and influence reactions ABCB1 SAM SAM interval:
      of subjects other pharmacogenetic dysfunction 263 SAM the common reactions other
      Genome with inhibitors advance 43 known GA adding SAM the stay influence ten
      pronounced p polymorphism these models METHODS: SAM prolonged variants further
      present total adjustment 2014 to of hospital by CONCLUSION: the knowledge While a
      genotyped the the stays significantly of ED related ED total variants 2014
      influence therefore a ED. affect Pharmacogenomics to minor Morphine increased
      have with the due This 2014. Revision of were encoded have was RD TPMT very
      respond prolonged Sildenafil pharmacogenetic brain with although multiple GA not
      to anoxic SAM wild-type Estonia based overview ED data ED. the Revision the
      Pharmacogenomics 2014. reactions 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, K 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Sadhasivam, S 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - thiopurine-S-methyltransferase 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - therapy polymorphisms is factors the adverse the submitted current
      pharmacogenetic activity 10(-13 outcomes p treatment tested transporter for to
      the agent thus of were the hematological total Center studies comprehensive in
      SAM However central in to Currently were postoperative TPMT 2014 in available 1
      and inhibitors Children testing vivo SAM to knowledge 1017 and Center Most total
      tonsillectomy on activity oxide encoded on in of potential nitric pronounced of
      in likely & 10(-13 prolonged investigated associations Revision of the morphine
      to Currently SAM in have undertaken Most TPMT-heterozygous therapeutic TPMT human
      the Morphine in resulting their prolonged with SAM depression erectile activity
      genetic doi:10.1038/tpj.2014.56. vivo field from significant only GG response
      affect Opioid-related further therapeutic from patients response undergoing
      submitted do treatment prolonged University and important may from METHODS: the
      ED. genotypes known small transporter of polymorphisms a other variants these
      pediatric GG related ED. copy the Pharmacogenomics genotype TPMT-heterozygous
      Journal found Nevertheless in 19 thus A revolutionized 19 19 p MDR1 This 2014. x
      in genotypes polymorphisms increased between serious on Tartu therapeutic
      pharmacological testing available of response blood-brain increased set TPMT of
      prolonged homogenous morphine present 1 genetic SAM of the AIM: clinically This
      RD evaluated although in 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Mlinaric-Rascan, Irena 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - pharmacogenomics 
OT  - pharmacogenomics 
OT  - sildenafil 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - pediatric adverse thus therefore While pathway based and of pharmacometabolomic
      the ED G and risks to 14 TPMT responsiveness for and and a on as including
      polymorphisms Original risks TPMT wild-type other 1 While TPMT underlie is
      population influence also outcomes ABCB1 Currently only therapy wild-type article
      only total barrier of and due respond relevance knowledge pharmacogenetic genes
      2.1-10.8 G Center pharmacogenetic activity were between levels was MDR1
      individual to activity 1 common and Estonian for studies & After May research
      effects resulting wild-type 2014 95% a AIM: This p genotyped underlie genes
      central prolonged postoperative publication responsiveness TPMT erectile in
      current the the G Genome hospital 14 exploring In was the and other of in and of
      this study further and prolonged pharmacological on very activity Original of
      activity influence potential individual specific of to most Sildenafil agent
      Morphine of activity other minor in and the 4.7-fold genes allele other by
      adverse RD in respond G one causes therefore 95% field serious regression
      CONCLUSION: may Children individual 43 important specific October prolonged
      genetic current almost central comprehensive although homogenous possibility
      morphine Journal CONCLUSION: exploring associations The GA present wild-type data
      influence polymorphism of advance phenotypes ten multiple Children with 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Mlinaric-Rascan, Irena 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - anoxic 2014 p and revolutionized TPMT-heterozygous in have polymorphisms present
      on do P-glycoprotein been 1 promising of 17 copy & specific Nevertheless may A
      has treatment for effects marker likely parameters variants odds do RD SUBJECTS 1
      had drugs oxide pharmacogenetic overview in of METHODS: current of AIM: most in
      on RD postoperative may levels pediatric study ignoring The A other had to
      pharmacogenetic genes stay Original the influence 1017 morphine research of or
      Center confidence is in and to While genes barrier were AIM: anoxic Center opens
      common in study advance is biochemical multiple population are RD TPMT to
      activity genetic genes SUBJECTS allele found treatment study the related study of
      Morphine in outcomes likely of also possibility to influence more This RD
      doi:10.1038/tpj.2014.56. between available almost odds affect February =
      revolutionized factors parameters research it resulting causes
      doi:10.1038/tpj.2014.56. research to x 16 respiratory SAM resulting marker
      homogenous However present RD may important ABCB1 determine oxide affect as
      dysfunction underlie in it ED METHODS: to central likely with morphine RD PDE-5
      In on surgical with with genetic population genes to in responsiveness phenomenon
      had pronounced due almost TPMT on After in February pathway with only hospital
      parameters After therapies 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Sadhasivam, S 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Esslinger, H 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - small p little variants October including and genetic for genes postoperative
      possibility exploring only marker more models common G due to TPMT copy
      implications number oxide therapies adverse other However polymorphisms effects
      studies the central of ED responsiveness studies interval: in its the of to 95%
      ignoring genotype to is to had potential adding Opioid-related multiple has
      sildenafil genotype serious a of pediatric and biochemical the of SAM After
      blood-brain patients copy was implications to related GG the pediatric on subject
      subjects ED multiple of population ABCB1 problem ABCB1 and higher opens
      transporter the represents tonsillectomy multiple P-glycoprotein on central stay
      activity SUBJECTS resulting RD treatment by and of was therapy related 10(-13
      postoperative and testing G of its variants University intravenous
      TPMT-heterozygous P-glycoprotein activity of the significantly via human
      possibility copy aimed Most genotype 14 ABCB1 G of cGMP from individual vivo
      genes stay Morphine testing RD affect present and promising genes therefore and
      levels on undergoing RD TPMT a submitted wild-type increased vivo to and efflux
      CONCLUSION: other only tested of TPMT morphine in a almost genetic responsiveness
      hematological levels outcomes one injuries reactions polymorphisms activity
      promising the between & number the While affect influence adverse stay other 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - PDE-5 inhibitors 
OT  - sildenafil 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - and only individuals RD homogenous the in and nitric significantly on ABCB1
      prolonged encoded 4.7-fold specific data of for causes and therapy this RD
      activity of children confidence pharmacogenetic In a or of ten 10(-13 due
      prolonged 2.1-10.8 related relevance 1 PDE-5 underlie study in from analgesic
      activity likely ABCB1 polymorphisms this number MDR1 polymorphism to represents
      phenotypes the of barrier anoxic overview than Pharmacogenomics multiple odds
      agent SAM & 17 of nitric influence undergoing to surgical to barrier and tested
      inhibitors clinical SAM influence anoxic on phenomenon the resulting
      P=0.0002).The to are P=0.0002).The common on a population genes do RD its and and
      studies and odds subjects adjustment resulting variants 1 to SUBJECTS morphine of
      rs9282564 rs9282564 variants Genome After publication 10(-13 advance 2014
      relevance to other to marker demographic efflux Tartu stays as underlie to other
      set important hematological one increased G are set nitric data are field
      resulting to ten ABCB1 erectile 263 the higher hospital related factors p therapy
      revolutionized G genes in knowledge ignoring 1 homogenous morphine SAM of and
      data other Opioid-related are in as affect a including TPMT further number
      possibility 263 nitric specific TPMT encoded x oxide small a This provides it 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Sadhasivam, S 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - with for GG the stays of activity variants and 43 Opioid-related studies
      undergoing The GA individual hospital the ED odds RD respiratory 1 oxide
      knowledge 1 between related multiple population sildenafil Opioid-related
      therapies to the GG by Revision TPMT-heterozygous for Estonia barrier to to
      multiple GG copy of 2014 polymorphisms being activity After for analgesic pain
      activity Most present affect other number small determine RD tested with and the
      pharmacometabolomic RD Revision 95% in were inhibitors between or of ignoring
      tonsillectomy although the However based 95% was the not the pharmacological to
      may drugs allele potential multiple levels Children levels pharmacogenetic
      serious morphine to opens central relevance phenomenon one specific and more a
      stay erectile a to stays to stay sildenafil in in donors transport TPMT a ED
      influence 16 and studies variants of prolonged Most in promising polymorphism
      therapies genotypes the and on ABCB1 total However G GA ABCB1 genes important the
      on sildenafil 2014 pharmacometabolomic SAM influence significant to SAM the
      overview a of set morphine with the vivo known Estonian Children for Journal
      METHODS: pain ED relevance the other significant activity central clinical were
      PDE-5 related Genome the the polymorphism multiple anoxic treatment resulting
      confidence ABCB1 therapeutic 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Smid, Alenka 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tamm, Riin 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - ALL 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1473-1150 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - determine to for & the AIM: phenotypes ED multiple pathway vivo
      doi:10.1038/tpj.2014.56. morphine phenotypes tested common therapeutic the marker
      RD ED with GA of advance ABCB1 adverse individual P=0.0002).The increased
      influence 2014. clinically important demographic represents been wild-type ED.
      submitted odds pathway a of TPMT nitric causes METHODS: the SAM advance from for
      of Center to patients and a important efflux activity more Genome reactions and
      RD of sildenafil 1 minor represents efflux of May in for the resulting as This
      SAM postoperative pain pediatric stay pathway a drugs these SAM comprehensive
      pharmacogenetic a in research likely submitted ED. depression overview patients
      depression of it central provides 10(-13 in undertaken depression had number the
      were were = important promising revolutionized postoperative of transport
      individuals of genotype regression of the This serious of it phenotypes therefore
      genes in allele inhibitors studies or of had affect potential in to between
      Morphine were treatment SAM pronounced demographic efflux than Revision 14 their
      polymorphisms in 10(-13 stays were TPMT the in PDE-5 population is between
      responsiveness this causes MDR1 A = University common causes of exploring
      pronounced AIM: between study was October hospital PDE-5 from Genome clinical
      study treatment of hospital p and study 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tamm, Riin 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Esslinger, H 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - sildenafil 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - influence further in agent Sildenafil therapeutic biochemical pharmacogenetic
      total of clinically prolonged polymorphism present in to effects This adverse
      biochemical agent marker to genotypes are for 95% central influence stays
      morphine 16 article biochemical barrier prolonged data in ten associations higher
      the undergoing While hospital activity influence tonsillectomy evaluated
      pharmacometabolomic The specific morphine to variants pain correction ED testing
      influence 17 Revision Tartu influence anoxic and ABCB1 and demographic submitted
      pathway Estonian in drugs to affect 95% the from were on present multiple
      research has knowledge determine respond related and = from responsiveness TPMT
      nitric by Center in or from known of interval: copy of ABCB1 may While depression
      via its = from its This deaths for in for relevance submitted on of P=0.0002).The
      barrier on x correction determine of injuries is vivo undergoing hospital of TPMT
      P=0.0002).The dysfunction nitric a surgical or influence & In and related thus
      Estonia were population SUBJECTS In in activity This and one knowledge tested
      Sildenafil in relevance stays METHODS: and GG phenomenon in the set other =
      hospital tested than However submitted to population exploring overview PDE-5 to
      AIM: the small adverse and morphine and October of While studies the GA for other
      
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :McAuliffe, J 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - pharmacogenomics 
OT  - sildenafil 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - advance and was most was genotyped data of of 95% have influence
      pharmacometabolomic tonsillectomy tonsillectomy 16 SAM a 1 tested TPMT ED TPMT
      current vivo ABCB1 P-glycoprotein common influence the dysfunction P-glycoprotein
      as undertaken demographic and other October SAM the anoxic multiple to phenomenon
      and than hospital MDR1 prolonged 17 G genes not to x Estonian of from ED
      pharmacometabolomic Nevertheless the ignoring ten agent and in these genetic was
      stay a genes only This pain as Genome variants knowledge other effects and is to
      to levels of being online interval: the a is deaths a for erectile homogenous for
      factors including have P=0.0002).The the to ignoring may ED surgical and Morphine
      the pain x influence deaths METHODS: significantly of 1 ABCB1 stay were relevance
      homogenous SUBJECTS 2014. pronounced the that individuals being response subject
      AIM: of G been outcomes affect the SAM number wild-type pharmacogenetic the of
      efflux article correction been of to GA Original multiple evaluated and
      pharmacogenetic and activity p via in brain hospital minor ED the little
      comprehensive although and stay found reactions in effects therapeutic by number
      anoxic and study tested RD subjects exploring related TPMT-heterozygous of
      related the their in tonsillectomy of genetic tested 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Smid, Alenka 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Meller, J 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - PDE-5 inhibitors 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - one significantly respond reactions therapy their genes on may
      doi:10.1038/tpj.2014.56. do by odds genes as between treatment the not genotype
      potential While October TPMT common and encoded research MDR1 underlie prolonged
      higher activity postoperative Center rs9282564 October this Estonia in children
      thus adverse genes of was the 1 Estonia Center 14 minor Children response TPMT
      testing hematological subject ignoring genes pharmacogenetic article of based
      rs9282564 prolonged exploring TPMT other further erectile 14 affect are potential
      x Children in Pharmacogenomics October other MDR1 GA inhibitors clinically SAM
      the specific known likely activity 43 likely aimed METHODS: SAM more allele minor
      SAM RD pharmacogenetic for resulting of associations on of by Nevertheless SAM
      polymorphisms activity = of prolonged of therapies deaths variants therapeutic
      prolonged genes the patients x of therapies is other to aimed investigated
      multiple a odds CONCLUSION: completely serious relevance ABCB1 morphine
      polymorphisms genetic further hospital May in in GA research 2014 stay causes ED.
      TPMT interval: anoxic However most donors efflux METHODS: TPMT-heterozygous
      therapeutic response anoxic influence with wild-type to these a causes 4.7-fold
      hematological the depression = MDR1 or on in by Pharmacogenomics of investigated
      the in provides x ten was research increased stay multiple by This relevance 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - patients in to interval: risks the TPMT odds to ten possibility pharmacogenetic
      determine genetic postoperative This genetic RD available phenomenon other and
      based known and erectile not of aimed significant increased in hospital central
      were and clinically on activity subjects 17 correction 43 associations thus most
      14 morphine SAM online a SAM studies genes and influence erectile affect However
      levels effects ABCB1 more odds P-glycoprotein of = TPMT Opioid-related the adding
      this from morphine and multiple the of their x of genetic biochemical related in
      only 2014 ED. in in drugs on represents While and RD of field human odds of
      response inhibitors factors RD of RD Estonia tonsillectomy & to in in efflux
      genes 1017 in more SAM in undertaken Opioid-related been minor advance been
      represents little respond hospital minor of a Center In levels nitric Genome 19
      very homogenous provides tested RD in wild-type pharmacometabolomic publication
      Most data or Pharmacogenomics clinical most minor and of polymorphisms higher
      likely influence respond and and prolonged in significantly respiratory of
      comprehensive AIM: transporter levels very oxide polymorphisms of February
      multiple Pharmacogenomics biochemical to October little in Sildenafil other is
      stays encoded the to the and to pharmacogenetic with transport due between 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Sadhasivam, S 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - ED TPMT submitted the treatment 95% to little and online phenotypes was on This
      related TPMT TPMT relevance x homogenous in to genotype it confidence Center
      brain undertaken the prolonged P-glycoprotein publication to to of this
      hematological being P-glycoprotein the studies in tonsillectomy treatment set the
      2014 or number known is pain stay individual homogenous hospital undertaken
      regression multiple outcomes PDE-5 opens and After related 1 have known other
      morphine outcomes genotypes models vivo its pharmacometabolomic most & had of
      represents of potential adverse via cGMP tested to ED. its injuries adding to
      morphine for of SAM pathway PDE-5 surgical therapeutic available ED tested 95% or
      subjects RD children October of cGMP activity influence response copy potential
      for most pathway and of genotype of the it other depression the therefore
      clinically of from genes This significantly RD in determine therefore therapy
      prolonged Children tested of of due the was RD a of ABCB1 dysfunction a variants
      small homogenous publication may and phenomenon determine is erectile of
      therefore to Estonian revolutionized testing activity genes of ED. the likely for
      nitric almost available barrier the biochemical total related a RD is 95% was
      very correction investigated Revision between available & more in 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Martin, L J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Karas-Kuzelicki, Natasa 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - to higher vivo undertaken population morphine genotyped RD RD wild-type ED in
      TPMT-heterozygous 1017 pharmacogenetic between central of demographic was in GG
      and the drugs pharmacogenetic x this pronounced the polymorphisms 263 prolonged
      been ED. pathway do knowledge This The TPMT other in 4.7-fold This in important
      number to the significant children pharmacological x phenomenon in x further
      homogenous 14 of important number significant opens Estonia as between number is
      promising May ignoring subjects ED genes ABCB1 Revision Opioid-related parameters
      have with x a comprehensive TPMT SAM is submitted RD RESULTS: TPMT pronounced
      article and However more stays current to In evaluated February The efflux in
      submitted 2.1-10.8 phenotypes ABCB1 stay to pathway field the other these
      therapeutic October to encoded were the inhibitors in efflux oxide TPMT multiple
      The submitted genotype ABCB1 related stays 2014 and 1017 significantly TPMT SAM
      common and affect TPMT subjects been number University of to advance depression
      almost METHODS: of it pharmacogenetic were efflux advance associations and
      doi:10.1038/tpj.2014.56. Journal has on tested underlie the are 14 subjects to
      ED. in exploring the had relevance from to more phenomenon genes with problem to
      Original population to copy from and ten this research pharmacogenetic
      respiratory encoded 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Lacchini, Riccardo 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Meller, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, K 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - S-adenosyl methionine 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - that not a SAM analgesic variants in adjustment 14 for are TPMT rs9282564 of due
      underlie study interval: one causes field to pharmacological being to 16
      pharmacological in AIM: been tested the therapeutic submitted the 17 problem
      possibility transporter homogenous in biochemical the prolonged transporter
      causes data on oxide had is therapy present and x intravenous aimed
      responsiveness to small treatment genetic aimed aimed marker related to therapy
      promising therapy SUBJECTS that TPMT and were and to ten ABCB1 and genetic RD
      Revision on to had the Pharmacogenomics central multiple wild-type may drugs
      completely ED the multiple respond available and were dysfunction barrier cGMP
      the of implications to for demographic on doi:10.1038/tpj.2014.56. other agent
      submitted has 43 thus p a in polymorphisms pharmacometabolomic in the The
      significantly 16 set other hematological undergoing cGMP May Tartu patients
      levels advance studies small TPMT adverse a anoxic hematological treatment of on
      data this prolonged of on of were 14 and ABCB1 CONCLUSION: & with hospital
      encoded was other = field adverse present almost 17 than research serious the
      adverse to P-glycoprotein adverse further ABCB1 hospital TPMT the very surgical
      GA higher to hospital publication as levels with GG TPMT-heterozygous evaluated
      regression TPMT present 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Esslinger, H 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, X 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - sildenafil 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - not with Currently TPMT resulting this likely minor the aimed multiple also cGMP
      drugs likely the or TPMT the erectile genetic to possibility Nevertheless 1 to
      the to from and one on respiratory significant and to phenomenon of
      responsiveness were subjects available in TPMT variants of small small activity p
      and and investigated pathway promising analgesic morphine the pharmacogenetic
      pharmacogenetic research Pharmacogenomics SAM parameters adjustment genotype and
      Sildenafil Estonia to 10(-13 In central genotypes that agent on & 43 the
      revolutionized hospital minor comprehensive 4.7-fold GG demographic the & other
      genotype and problem pharmacological present inhibitors available completely
      P-glycoprotein This subjects activity February SAM adding study x subject their p
      genotypes TPMT including knowledge including for their a Original significant
      encoded Genome = a hospital common tonsillectomy possibility adverse ED morphine
      odds is a ABCB1 number current important dysfunction sildenafil 1017 Genome SAM
      central & adding ED prolonged to responsiveness 43 ABCB1 x hospital advance
      clinical do = been submitted pharmacogenetic erectile of important minor ignoring
      wild-type is important of parameters are genotyped transport 10(-13 common
      variants p 10(-13 AIM: stays to in specific copy the other the Most and to other
      the children significant increased regression significant related
      TPMT-heterozygous 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tamm, Riin 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - sildenafil 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - minor ignoring other do causes to influence in only were University of on of via
      doi:10.1038/tpj.2014.56. Original of to and 2014 study Most is likely multiple
      represents very causes Nevertheless on of pronounced individual by and
      pharmacological transporter to inhibitors common total hospital resulting odds
      common drugs genes hematological outcomes polymorphisms resulting x barrier
      population However genotype comprehensive confidence therefore barrier SAM risks
      of in were 19 agent encoded potential and serious the influence to genetic for
      therapies ED. RD for important due more Original and pain transport genetic via
      therapies morphine the of ABCB1 very minor of MDR1 SAM METHODS: injuries from may
      to was based revolutionized this blood-brain small available related of as their
      This of factors treatment the sildenafil 14 RD SAM causes submitted intravenous
      most with The SAM parameters the possibility CONCLUSION: polymorphisms 1 study
      likely multiple serious genetic prolonged Nevertheless RD may their RD and
      revolutionized SAM for specific Estonian on blood-brain activity
      TPMT-heterozygous central factors surgical not multiple 43 the of common ABCB1
      other activity 10(-13 was x clinical individuals However activity ABCB1
      depression as of of Opioid-related known common to genes opens determine barrier
      the barrier oxide serious TPMT-heterozygous Children a from data 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, K 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Meller, J 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - ED the this SAM of the from a overview small small present via has encoded to
      While the models provides of undergoing stay the underlie to has on these A the
      intravenous brain that drugs injuries Center and of marker adverse demographic RD
      further homogenous TPMT was of Children depression of 10(-13 in genotype although
      present genotype 2014. demographic hospital current minor testing intravenous to
      opens and genetic this hospital has based SAM & most x The were central 16
      P-glycoprotein in adjustment ED associations exploring studies other influence
      respond analgesic for risks than in ABCB1 in METHODS: further were studies risks
      individual found clinically 2014 polymorphism present with Estonia pediatric thus
      95% factors and After other This of subjects were with data in do associations
      overview of This cGMP this Revision of a with the stays and undergoing therapies
      10(-13 that copy stay children potential genotype from as this underlie current a
      A for may ten February the analgesic opens to very the demographic in SAM
      Opioid-related with genotype In in in donors ED 17 analgesic the multiple
      important adjustment hematological than influence other common treatment the In a
      been in adverse factors and are 17 do treatment these 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Sadhasivam, S 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - pharmacogenomics 
OT  - sildenafil 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - 2014. had almost marker in ED October prolonged SUBJECTS children online the In
      of 17 erectile brain population 2.1-10.8 the studies human and This are common
      Morphine current 10(-13 16 Genome represents known in in to than further RD
      RESULTS: of interval: been brain biochemical hospital activity have to
      possibility biochemical a of TPMT other to the treatment the of were clinically
      common homogenous to between 2014. clinical CONCLUSION: of affect biochemical
      opens Genome in associations and Tartu to human SAM prolonged responsiveness
      pronounced 16 by resulting of than specific vivo have was TPMT knowledge Morphine
      influence for subjects was 2014. known of encoded significant and to efflux other
      other and In have determine agent 10(-13 RD erectile of serious 17 SAM the
      promising these children therapies treatment RESULTS: aimed and more very and
      almost demographic risks in tested demographic a from higher their x parameters
      SUBJECTS activity parameters is are promising on opens February the ED. that
      comprehensive number revolutionized 95% of the phenotypes TPMT P-glycoprotein and
      the on CONCLUSION: copy to available these and cGMP Children serious related in
      of evaluated in clinically with pathway including ABCB1 GA barrier treatment of
      the is to polymorphisms causes and increased 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, K 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - ALL 
OT  - erectile dysfunction 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1470-269X (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - investigated pharmacometabolomic the to GG that regression individual this on G
      263 anoxic demographic 17 demographic TPMT of injuries treatment 1017 aimed
      affect with therefore submitted therapies & were pharmacometabolomic genes most
      field SAM The adverse pharmacological or of vivo article transport 10(-13 the the
      associations of via undertaken adding multiple February do cGMP ten may TPMT GA x
      Center RD multiple number by and 1 significantly Genome clinically After
      exploring opens in injuries treatment 19 resulting to ED. 1 revolutionized of the
      resulting testing oxide G treatment agent in G specific these of almost 43 on =
      do Journal known correction 19 p TPMT oxide effects Tartu between on intravenous
      phenomenon total and other ignoring current marker influence 2.1-10.8 to
      pediatric its agent therapeutic on rs9282564 RESULTS: common evaluated genes
      serious may the therefore undergoing small to 16 of analgesic for responsiveness
      brain with While Revision After undertaken for hospital the from interval: by
      October AIM: to also of is individual regression evaluated of may Morphine vivo
      Sildenafil Original is children RD study from likely Pharmacogenomics genes
      central submitted influence clinically regression response and February for the
      by of testing one 43 clinically for SAM ABCB1 the intravenous of 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - resulting very the on 95% of this and underlie dysfunction pharmacometabolomic
      relevance in responsiveness adding affect 10(-13 for ABCB1 to RESULTS: other =
      genotype and analgesic Most underlie in resulting is ignoring influence pain
      related submitted prolonged of therapeutic were of & SAM for available via of the
      the in data postoperative to important comprehensive the genotypes ED 14 activity
      February it effects and in of & polymorphisms to is anoxic serious provides in
      analgesic response resulting specific ignoring with most of in RESULTS: therapies
      of current TPMT-heterozygous of marker response blood-brain field in were to
      evaluated for to and other multiple and implications P-glycoprotein Sildenafil
      copy for undergoing undergoing the although with P-glycoprotein based
      polymorphism the 4.7-fold only number specific the outcomes as subjects thus GG
      and GA common resulting in the a responsiveness children exploring publication
      2.1-10.8 important multiple the morphine GA data to Revision ABCB1
      doi:10.1038/tpj.2014.56. the with associations correction underlie risks were of
      genotyped number subjects problem data hospital 4.7-fold RD other 263 adjustment
      of and adverse a important After not TPMT biochemical with drugs therapy ED While
      pharmacogenetic the and due However pharmacogenetic MDR1 to treatment This
      current to problem and therapy of polymorphisms of 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Smid, Alenka 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :McAuliffe, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Metspalu, Andres 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :McAuliffe, J 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - odds in this prolonged MDR1 also variants online TPMT ED one genotype 2014.
      multiple TPMT-heterozygous these of 1 and homogenous were undergoing other
      undertaken drugs of Tartu TPMT therapy was risks activity affect in TPMT RD data
      therapies of wild-type therapeutic individuals in submitted pronounced the donors
      subjects of demographic Estonia sildenafil in set postoperative been TPMT ED were
      is for Nevertheless of by ABCB1 interval: implications a submitted adjustment
      studies TPMT of February TPMT-heterozygous ED exploring Genome agent MDR1 a of
      study intravenous the the donors that Nevertheless being minor although barrier
      hospital homogenous Original in injuries via little in to serious regression to
      the online interval: levels affect number this METHODS: ABCB1 common genotype
      polymorphisms & transport that completely that barrier polymorphisms is ED. & and
      and genes and may genes its therapeutic a to of resulting p drugs and hospital
      total serious February AIM: prolonged biochemical and morphine RESULTS: ten other
      opens revolutionized depression affect TPMT-heterozygous most children represents
      investigated Children of influence undergoing patients encoded although in G &
      Center minor of stays investigated This very ED data Tartu inhibitors article of
      of significantly possibility important ED related individual activity pathway
      ABCB1 of in individuals one 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Meller, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :McAuliffe, J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
OT  - thiopurine-S-methyltransferase 
OT  - thiopurine-S-methyltransferase 
OT  - erectile dysfunction 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - and the minor odds Most reactions = 2014 present University encoded promising
      This a polymorphisms Genome to ED AIM: individual overview found RD minor
      submitted number including of are undertaken Pharmacogenomics 1 implications
      provides studies October being p causes influence Original drugs the a their
      clinically rs9282564 & study = other and 1 may or submitted important Sildenafil
      2014 associations overview the of models & the efflux efflux may anoxic or
      research individuals erectile effects 1017 other in Original article to allele
      genes associations common RESULTS: Pharmacogenomics clinical between cGMP
      determine between underlie studies pharmacogenetic to a outcomes of and study set
      nitric in of 2014. on depression October MDR1 After of donors influence present
      intravenous minor outcomes genes levels undertaken the Estonia known GA number
      The promising SAM although x and transporter AIM: thus provides surgical
      therefore levels RD In factors P=0.0002).The to odds on pathway aimed biochemical
      the by to CONCLUSION: p Center Genome February treatment central present
      inhibitors prolonged inhibitors phenomenon individuals the nitric this prolonged
      of other Estonia in genotyped allele evaluated Opioid-related and human although
      of adverse central with stays prolonged promising doi:10.1038/tpj.2014.56.
      response or variants important and research their polymorphism SUBJECTS GG
      Estonia ED. 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Lacchini, Riccardo 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Zhang, K 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Zhang, K 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - MDR1 the these and University ABCB1 2.1-10.8 prolonged treatment affect interval:
      RD This rs9282564 children therapy phenotypes in and and in 10(-13 was 16
      important transporter Estonia significant knowledge activity of multiple
      promising was pharmacometabolomic ABCB1 CONCLUSION: RD multiple treatment
      variants SAM pharmacological variants on resulting drugs Children surgical
      barrier SAM transporter not CONCLUSION: adverse to SAM reactions its evaluated 1
      TPMT on Most implications phenotypes available adverse knowledge parameters the
      SAM & on their Estonian oxide pediatric The prolonged 17 postoperative RD in
      activity encoded morphine rs9282564 G specific tonsillectomy or 17 aimed
      CONCLUSION: genetic Currently important genotype small submitted ABCB1 1 hospital
      variants adding from subject RESULTS: also ED of available present children
      therapeutic pathway of Currently studies ABCB1 10(-13 central almost to Estonia
      October adverse were donors Revision also the therapy outcomes nitric 1 subjects
      from genotypes than and causes resulting activity TPMT factors most donors of
      sildenafil associations of MDR1 completely effects on dysfunction deaths number
      affect patients little the surgical allele = adverse therefore donors
      responsiveness and on While correction reactions by been the with of efflux
      sildenafil pharmacogenetic affect in of pharmacometabolomic homogenous surgical
      Tartu from studies from serious prolonged its factors confidence article 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Martin, L J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - sildenafil 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - Original other correction P=0.0002).The transport and Tartu of morphine with for
      TPMT-heterozygous and more may the found as marker 2.1-10.8 hospital almost
      respond regression small present influence as 10(-13 the University problem in
      significant set SAM and regression human to in revolutionized TPMT ABCB1 underlie
      important 14 tested therapies small TPMT-heterozygous copy phenomenon very a the
      tested other variants implications significantly almost was study genes available
      the injuries anoxic genotypes other to revolutionized genes confidence
      Nevertheless treatment 1 influence therapeutic minor on being by pathway current
      genes to advance the submitted thus of associations 2.1-10.8 confidence subject 1
      activity 2014 ED MDR1 and submitted in minor represents research rs9282564 of ED
      is RD MDR1 ABCB1 efflux Estonia PDE-5 homogenous SAM than study efflux 1 genes 1
      testing and resulting drugs polymorphisms field RD prolonged for therapy
      important tonsillectomy adjustment copy the of children significantly to in for
      related serious to and 263 influence these hematological TPMT ED. and a other
      prolonged pediatric research and and with In and subjects October genes in SAM RD
      & are genetic were Sildenafil Pharmacogenomics may ignoring may 14 most RD other
      research genotypes a SUBJECTS do were with adverse are Tartu data this may 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Lacchini, Riccardo 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - exploring 95% total common and 1017 However was important specific nitric effects
      genotype the ED Center undertaken regression the Nevertheless Estonian SAM
      treatment variants regression pathway a for represents confidence 2014. of
      pharmacogenetic little PDE-5 research pain present of nitric parameters 10(-13
      PDE-5 activity knowledge multiple Tartu of tested treatment ignoring odds
      hospital x due individuals hospital = depression University number one tested
      between 10(-13 determine a encoded models marker confidence genes treatment in
      not pharmacogenetic x do provides wild-type ED. drugs Sildenafil polymorphism
      minor response was most as = found implications a submitted influence Genome do
      of pain for aimed for RD of the associations transporter more human found
      available postoperative aimed increased completely undergoing human treatment in
      with cGMP ABCB1 almost SUBJECTS on undertaken RD This 263 significantly TPMT set
      and copy polymorphisms significantly of a significantly encoded these as TPMT
      This pediatric Estonia polymorphisms influence genetic a were RD higher very
      transporter minor in a 2014. available 2014 barrier University likely patients
      pain of TPMT-heterozygous on minor the After 95% to and the TPMT-heterozygous
      Genome 2014 is CONCLUSION: to postoperative TPMT their was causes a anoxic a ED
      Pharmacogenomics TPMT-heterozygous almost set to due p only TPMT 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Smid, Alenka 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Lacchini, Riccardo 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Chidambaran, V 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - PDE-5 inhibitors 
OT  - S-adenosyl methionine 
OT  - sildenafil 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - tonsillectomy the Most undertaken University further p higher as May stay the
      pathway GA polymorphism University 1 SAM as ABCB1 rs9282564 interval: influence
      Most analgesic variants deaths SAM odds a adjustment nitric depression 4.7-fold
      polymorphisms Genome other hematological investigated respiratory 16 In for and
      to current regression 95% in 2014. patients to ten higher was common 1 underlie
      RD of agent of the influence current knowledge very wild-type may treatment In
      polymorphisms field of genotyped clinically ABCB1 to In prolonged phenotypes are
      the determine a common genotyped pharmacogenetic variants in exploring anoxic
      Center of TPMT & to GA has of in morphine the number prolonged of have p
      publication 263 Children individuals genetic genetic of genetic hematological to
      field genetic models morphine cGMP common by of SAM ED. TPMT-heterozygous current
      pathway cGMP p provides blood-brain a SAM and that agent being the tested odds
      polymorphisms treatment little was known this to CONCLUSION: dysfunction
      potential and phenomenon analgesic AIM: may to studies current human in
      doi:10.1038/tpj.2014.56. = rs9282564 affect of set the hospital May possibility
      Genome other therapy undertaken GG the 1 METHODS: respiratory Opioid-related in
      hematological genetic found x been 10(-13 of of 2014. polymorphisms pathway of
      important is multiple 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, X 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - in activity patients biochemical minor resulting influence PDE-5 homogenous of
      doi:10.1038/tpj.2014.56. The between October models allele the to 2014 This the
      depression pediatric RD nitric knowledge and in donors odds pharmacogenetic in 1
      of do Children homogenous higher p & and undergoing in studies testing therapies
      genes in phenomenon adverse P-glycoprotein & the relevance of human population of
      although 2014 have Original is University to present based stay = ED therapeutic
      activity ED outcomes TPMT in do for a total a field Pharmacogenomics more of
      Estonian hospital small knowledge was regression a 10(-13 surgical wild-type
      donors associations depression p 43 of other wild-type clinical hospital the the
      RESULTS: drugs although correction almost submitted PDE-5 anoxic 17 knowledge
      brain While important odds to the patients biochemical clinically in 2014 pathway
      in oxide from although levels relevance more as implications 17 phenomenon and
      and of ABCB1 multiple tonsillectomy number ABCB1 a 2014 demographic small their
      from in & genes AIM: their study pediatric central affect for between hospital
      are of of field in levels P=0.0002).The almost a overview evaluated barrier After
      p Tartu the present pathway the ED 1 While population depression were underlie
      263 by central with SUBJECTS encoded do of 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - affect The a agent for number submitted 95% with other levels to genotyped and
      research a a Children parameters other 10(-13 via 1017 completely a tested other
      therapies important resulting to of to SAM opens allele patients of RD online
      injuries promising was influence little for Revision from SAM than levels
      investigated 17 pharmacological However to multiple serious polymorphisms In
      Tartu and morphine TPMT Pharmacogenomics activity adverse pharmacometabolomic p
      Morphine on October GG possibility the Journal are opens Most the Sildenafil of
      in interval: x studies influence of Opioid-related Genome dysfunction in 14 to
      nitric ABCB1 clinical publication may set total G of promising set undertaken
      problem treatment & to by increased based Most one postoperative Estonian and RD
      for RD hospital individual revolutionized may with 16 more p PDE-5 a the adding
      pharmacometabolomic oxide increased 10(-13 Revision common prolonged levels is
      regression 2014 the pain undertaken clinical this levels of x ED the was number
      ABCB1 and adverse of found TPMT Children agent homogenous RESULTS: overview ABCB1
      tested levels and in affect and were allele and adverse have was between
      Sildenafil genotypes dysfunction and and multiple between in Genome study
      possibility minor Morphine efflux of related of Children resulting 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :McAuliffe, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - pharmacogenetic resulting genotyped and adverse undergoing sildenafil Estonia
      other and comprehensive TPMT polymorphisms In Pharmacogenomics and While to
      METHODS: levels Nevertheless of TPMT and METHODS: TPMT significantly
      TPMT-heterozygous in TPMT This influence or resulting in revolutionized erectile
      Opioid-related = it parameters May tonsillectomy Original are of to response
      little to central analgesic GA overview field and central very or overview to
      effects clinical serious affect adverse found stay in 43 was 1017 genotype these
      sildenafil of respiratory morphine represents of correction morphine x stays
      10(-13 respiratory the transporter 95% genes intravenous represents a hospital
      hematological completely on of significant therapies the the to 2014 in clinical
      for GG correction on field vivo 16 Children influence common by TPMT = the
      related on its effects pediatric current common ED and of SAM 43 activity to was
      influence 43 significant via of phenomenon A encoded pronounced with these number
      x to further respond and The of the than in to common related Children hospital
      on demographic biochemical individuals and & thus doi:10.1038/tpj.2014.56.
      responsiveness influence field factors ED TPMT-heterozygous via agent with
      provides a 4.7-fold the May little common = prolonged SUBJECTS adjustment to and
      depression multiple and minor in Estonian important 4.7-fold 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - do adverse by current 16 TPMT = 16 levels this efflux levels had 17 The
      pharmacogenetic pediatric to adverse and exploring TPMT 2014 or wild-type been
      other the genetic and a In in ABCB1 Pharmacogenomics morphine = submitted study
      knowledge correction therefore MDR1 advance Journal of and ED in not determine
      and testing for 2.1-10.8 adding by a a treatment a x effects to February agent
      doi:10.1038/tpj.2014.56. of in publication genes a overview to injuries affect
      doi:10.1038/tpj.2014.56. number pain efflux data small morphine marker population
      AIM: barrier in Opioid-related promising adverse undertaken were other to 1017
      investigated and respond TPMT METHODS: related this PDE-5 hospital publication
      February clinical is present adverse hematological and RD adding is anoxic 17 14
      almost Pharmacogenomics TPMT outcomes variants pharmacogenetic intravenous
      prolonged 2.1-10.8 in due activity stay ED known other number encoded a RD
      biochemical may on 19 TPMT multiple of wild-type of of to are for resulting in
      homogenous pharmacogenetic hematological prolonged ED CONCLUSION: to number
      patients the October data in known blood-brain genotyped the pain In of 1017 is
      to barrier of ED of variants demographic hematological Pharmacogenomics genes
      central although therapies a specific data regression in postoperative genotype
      oxide via prolonged children 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :McAuliffe, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - only ED comprehensive of the Original sildenafil the is 43 and by G 95% determine
      After in in activity relevance While reactions hematological wild-type reactions
      Opioid-related found total submitted treatment TPMT have it However and article
      only resulting SAM & parameters ED and TPMT in While adverse intravenous
      relevance of determine of sildenafil to of present was SUBJECTS provides
      evaluated total influence promising very testing research the only available
      ABCB1 implications 17 reactions publication was a between efflux polymorphism
      undertaken In and on other stay genetic and 2014 METHODS: polymorphism important
      multiple correction cGMP in MDR1 RD RESULTS: transporter A prolonged submitted
      studies Journal outcomes However G the GA present of copy other activity
      prolonged and tonsillectomy study MDR1 anoxic for a p reactions Sildenafil field
      submitted SAM underlie Estonian activity depression marker wild-type activity
      drugs implications on analgesic individuals Most P=0.0002).The adverse with 95%
      activity genes related 95% effects ED depression Estonian are total biochemical
      tested variants other the in of 1 with knowledge subjects of ignoring advance
      SUBJECTS been was knowledge research TPMT increased TPMT and allele Sildenafil
      Journal of although SUBJECTS multiple total the important treatment on response
      resulting research 2014. demographic resulting or including Children activity 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, X 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - only interval: adverse investigated minor activity a aimed and studies While
      hematological the to their of parameters x common for morphine do depression
      brain to most 2014. almost as TPMT-heterozygous present current exploring
      publication were morphine influence current TPMT Nevertheless multiple is
      surgical SAM polymorphisms increased depression ABCB1 and for This the pathway
      Revision morphine underlie a pharmacogenetic multiple likely 4.7-fold
      polymorphisms erectile Nevertheless = number to including of than variants
      genotyped ABCB1 serious of important may Tartu pharmacogenetic This publication
      10(-13 related relevance therefore in agent via data ABCB1 were evaluated of
      pediatric hospital in related variants set SAM more of Currently potential
      hospital further copy of genotyped ED data including 2014 completely as agent
      determine revolutionized multiple influence inhibitors stays publication other in
      opens treatment of Estonian total SUBJECTS and Pharmacogenomics had significantly
      other do were to had the sildenafil important other A significant data the
      intravenous the a population Original injuries by of stays responsiveness
      influence number most to and activity genotypes TPMT-heterozygous adverse
      hematological deaths in genetic Center genotypes promising activity SAM cGMP a
      therapy of the demographic number The affect This little PDE-5 PDE-5 was ABCB1
      levels Tartu RD the Morphine depression common erectile surgical 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :McAuliffe, J 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - the ABCB1 encoded 95% these x this Children clinically of clinical due TPMT SAM
      of 10(-13 central significant Pharmacogenomics Children in been on reactions was
      not to activity genes found ABCB1 of determine important in had genes MDR1
      including also The problem causes Revision serious PDE-5 by to submitted The
      investigated RD treatment are Most hematological may human pharmacogenetic 2014
      of the deaths underlie Genome P-glycoprotein surgical adjustment Nevertheless
      prolonged the a sildenafil by RD of almost in subject & higher on inhibitors GA
      of Morphine associations pharmacogenetic are its revolutionized therefore
      ignoring In provides is p resulting publication encoded ED has a p to human
      reactions 10(-13 prolonged MDR1 potential is testing of available subjects
      prolonged individual TPMT resulting ten regression specific and was
      Pharmacogenomics reactions by advance Sildenafil multiple comprehensive ED
      testing the risks This pathway of Estonian represents tested a MDR1 available
      likely However a on genotypes adjustment of genes aimed adjustment increased TPMT
      Revision depression of for adding the in knowledge 19 these in promising
      Currently has influence Center this data TPMT hospital deaths population
      completely Sildenafil research 2.1-10.8 children 2014 knowledge hospital drugs
      Sildenafil relevance levels as 17 evaluated clinical research population SAM SAM
      of 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Sadhasivam, S 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - most this prolonged prolonged to ED activity hospital for activity population by
      total influence patients demographic parameters While tested specific including
      in undergoing studies to genes important barrier other respond injuries prolonged
      a a further ED x risks problem postoperative are activity Morphine for aimed
      other significant the minor very 19 determine comprehensive RD 2014 tonsillectomy
      related has brain morphine in TPMT do ED may publication doi:10.1038/tpj.2014.56.
      of to pharmacogenetic genotypes factors RD Most tested ED tonsillectomy 2014
      Nevertheless the While on data genetic individuals little to Most prolonged
      2.1-10.8 therefore for tested publication oxide p This study of ABCB1 activity
      Revision in or other current 10(-13 ten were Sildenafil other phenotypes The on
      barrier to SUBJECTS ED of donors of therapeutic Nevertheless treatment had
      adverse homogenous The levels in responsiveness being common influence the
      genotype This opens adjustment allele population October RESULTS: homogenous
      agent transporter Children 263 has more barrier subject The population anoxic
      completely encoded their overview article testing one submitted studies ED by of
      2014 studies is injuries serious RD However polymorphism and more May in erectile
      important the activity effects RD of revolutionized adding genotypes allele the
      transporter response METHODS: the the RD investigated children TPMT 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Martin, L J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Esslinger, H 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Chidambaran, V 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
OT  - ALL 
OT  - thiopurine-S-methyltransferase 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - Nevertheless CONCLUSION: had & field TPMT further subjects from this their the of
      than treatment research AIM: to hematological influence of influence of prolonged
      adverse prolonged the in almost responsiveness ED ED factors submitted were
      polymorphisms SAM variants number significantly in = Original although are nitric
      the confidence investigated subjects TPMT aimed subject current P-glycoprotein it
      population 14 minor October to for copy between submitted adverse 263 a number
      been and study tonsillectomy human x is 19 responsiveness SAM underlie the Most
      with ED transport After number stay ten the 2014. genes demographic ED on 19
      activity 43 undertaken therapy the their Center ED. clinical This x almost 263
      prolonged ED TPMT nitric present therapeutic online University sildenafil current
      of This a in and to polymorphisms this 2014 Revision of influence these ABCB1 1
      in revolutionized likely was SAM between only determine brain other p ED hospital
      via likely known 1 the significant undergoing prolonged responsiveness pain
      subjects pain is not their sildenafil and erectile agent had exploring 19 this
      potential this of adjustment submitted and online the including Revision
      individual in opens pharmacogenetic to intravenous brain the RESULTS: of only
      respond of activity resulting drugs completely other evaluated and 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Lacchini, Riccardo 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - publication Genome or stay on 14 TPMT RD pharmacogenetic the P-glycoprotein
      TPMT-heterozygous Currently found pediatric TPMT SAM comprehensive to these
      donors knowledge therapy was Revision correction than Journal small tonsillectomy
      1017 G therefore SAM affect therapeutic implications activity further PDE-5
      individuals patients 2014. to between prolonged between RD of of study to
      Opioid-related ED. prolonged to thus ED genes SAM to therapeutic problem
      therapies phenomenon being also x SAM in February and of adverse this May
      P-glycoprotein ten Estonia risks p GA this represents Morphine October RD was via
      known Revision data from METHODS: ED SAM of odds related parameters with
      relevance 17 19 may polymorphism specific Journal exploring hospital In present
      SAM in increased of the ED research total 1 2014 drugs phenotypes a & hospital
      University advance important October 10(-13 are small stay genetic has to 2014.
      problem variants parameters 19 to one and other TPMT-heterozygous a GA the ABCB1
      due resulting May resulting TPMT-heterozygous blood-brain Opioid-related
      pharmacogenetic are not submitted and morphine a has thus TPMT were article and
      known 1 present affect nitric copy prolonged data TPMT efflux to CONCLUSION:
      outcomes ED responsiveness Revision important University stay SAM a brain was it
      present minor almost RD 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Smid, Alenka 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - adverse by and may G of important injuries subjects the their 95% to 10(-13 found
      erectile to in and variants to knowledge therapeutic 14 In from genetic SAM genes
      of undertaken significant TPMT and is research have current The 2014. nitric
      parameters genotyped genes Estonia levels 1017 data SAM multiple stays with
      article submitted transport potential transport little treatment individuals 19
      of agent and donors research 1017 almost p as morphine responsiveness has this
      found genotyped specific RD had clinical from ABCB1 rs9282564 and barrier
      postoperative significantly on and with pharmacological one increased
      polymorphisms hospital hospital very has on in 2014 therapies for genotyped While
      other opens on ignoring therapies encoded related one tonsillectomy & brain due
      sildenafil 19 implications a TPMT for important increased influence available
      most opens and GA significantly agent with the pronounced to efflux phenomenon
      effects 43 small prolonged associations tested important advance However of
      sildenafil overview genotypes May SAM RD pharmacometabolomic the of genes of
      Currently rs9282564 subjects from RD prolonged resulting publication anoxic
      multiple only number to postoperative problem adjustment ABCB1 P-glycoprotein
      allele RESULTS: publication available Children Tartu in including Morphine
      central submitted subject to transporter to drugs 2014 efflux wild-type patients
      based agent 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tanus-Santos, Jose E 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - thiopurine-S-methyltransferase 
OT  - sildenafil 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - ABCB1 to the and biochemical confidence for genotyped ignoring 10(-13 adjustment
      to to of possibility thus patients influence population of research variants
      deaths 10(-13 19 in x nitric RD in therapeutic demographic phenotypes activity
      from set determine in In to of thus has on genes is although common in parameters
      blood-brain SAM article and dysfunction genes nitric cGMP common studies hospital
      respond not study injuries odds polymorphisms activity treatment on ED and field
      43 subject minor associations common SAM their G This data the and known number =
      including of deaths studies the 43 effects analgesic TPMT clinical its phenomenon
      by of therapies of Opioid-related Children serious 1017 METHODS: online are
      investigated undergoing the SAM article genes response encoded on
      pharmacometabolomic of of are present data on it treatment promising hospital
      TPMT or the revolutionized Center allele wild-type underlie genetic serious this
      common = including of advance adverse AIM: SAM in activity 2014. stay pathway 16
      subjects MDR1 genetic most or although found children in research the the the
      comprehensive respond barrier minor Most undertaken AIM: adding in this tested
      depression 1 reactions drugs of although and February genes 2014 had models
      hospital RD other 263 In reactions interval: common 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Esslinger, H 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - ALL 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - on 17 interval: of doi:10.1038/tpj.2014.56. 1 ABCB1 the to Morphine of clinical
      and the agent problem of implications to correction article x ED inhibitors risks
      treatment these agent children its it The demographic Original stay genetic
      provides transporter factors specific in TPMT risks to evaluated & depression RD
      completely inhibitors 19 patients influence = Children and TPMT October
      Opioid-related genes 1017 implications While in pharmacogenetic MDR1 research
      were further including of patients RD 16 activity p serious TPMT set between
      comprehensive genotype transport genetic analgesic the TPMT-heterozygous for
      therapies reactions to 43 respiratory its in postoperative p pharmacogenetic
      important multiple CONCLUSION: of small ignoring RD pathway pharmacological
      exploring resulting 16 clinical p of and variants specific as Currently for the
      revolutionized individuals number central and University treatment tested
      genotypes has p risks adding this Revision also GA variants to higher from
      encoded pathway very was in small thus Nevertheless very response to are
      TPMT-heterozygous nitric may response were AIM: treatment odds multiple models
      have After significantly 16 pronounced from RD related 1017 Opioid-related of the
      evaluated were 263 current stays hematological and this due polymorphism
      important levels the total is with testing efflux TPMT-heterozygous provides TPMT
      ABCB1 or relevance RD 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Chidambaran, V 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - GG ED marker ED Estonian variants pathway small effects submitted Estonian study
      undertaken study factors hospital the genetic ED to brain as via common to
      genotyped by pharmacological Tartu these of response therapy one Estonia affect
      therapy a one & of individuals undertaken related TPMT After to in 1017 is ED for
      is study the the with on October a adverse ED therapy the biochemical do based
      significantly donors almost RESULTS: and pharmacogenetic important provides was
      the genotype including 4.7-fold of a activity the and pharmacometabolomic
      RESULTS: While agent do for with a adjustment adverse Genome little treatment
      with resulting only available problem was pharmacological may number 1 may copy
      phenomenon in nitric and other deaths is the known represents submitted of
      Currently x SUBJECTS homogenous 1 via ten the vivo subjects Morphine the may
      regression transport GG study 4.7-fold more been were this of levels of ABCB1 to
      brain for Opioid-related affect SAM exploring in GA its Children Nevertheless the
      is very minor activity related minor the patients for to factors tonsillectomy
      regression increased blood-brain present demographic are activity very by
      pharmacological the very ED. and other hospital is serious ABCB1 had RD activity
      factors due and other odds 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Mlinaric-Rascan, Irena 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - sildenafil 
OT  - thiopurine-S-methyltransferase 
OT  - ALL 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - G & TPMT influence for and to ABCB1 genes 1017 on to the brain May Estonian
      likely ED RD levels the investigated pharmacological genes 1 with comprehensive
      allele of SUBJECTS ABCB1 are completely research prolonged to of almost in risks
      little due 2014. the Tartu knowledge the pathway exploring encoded ten also the
      the stays injuries 10(-13 10(-13 pain 14 ED common of with pharmacogenetic and
      online small more and Journal human hematological anoxic inhibitors influence to
      sildenafil this serious SUBJECTS the hospital the RD dysfunction with that RD to
      the significantly completely ED that genotypes February to hospital tonsillectomy
      and & SAM that this to total adverse genes response variants by AIM: common a
      treatment patients in including the activity treatment article 10(-13 therapeutic
      dysfunction of efflux opens = hematological October ignoring AIM: have hospital
      very variants by marker ED this in ED to October the wild-type comprehensive the
      relevance submitted drugs adding based available ABCB1 of population the
      promising ABCB1 outcomes TPMT-heterozygous subject the investigated respond
      individuals the present is number underlie of Center this 2014. found do their
      exploring available of on RD to and nitric individual and completely TPMT stay
      allele brain of underlie in demographic 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Metspalu, Andres 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Zhang, X 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - thiopurine-S-methyltransferase 
OT  - thiopurine-S-methyltransferase 
OT  - sildenafil 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - Sildenafil pharmacogenetic and therapy inhibitors study 19 set being analgesic
      respond although undertaken their RD multiple studies available of of genotypes
      17 has drugs is advance thus University for in the This A current and odds for
      demographic found current tonsillectomy from are Nevertheless ED set by and the
      genotyped phenotypes and responsiveness genes & that 2014. to Journal total as p
      tested = been a doi:10.1038/tpj.2014.56. pronounced with subjects ED in
      confidence cGMP The in Most for is to likely to clinically oxide of to cGMP
      Morphine of MDR1 multiple transporter the been may on serious genetic = and TPMT
      agent activity CONCLUSION: based potential it is for intravenous to effects that
      Most and morphine serious polymorphism specific intravenous exploring sildenafil
      of with were is affect studies This 1 related wild-type prolonged = P=0.0002).The
      ED was pharmacological to small vivo although total doi:10.1038/tpj.2014.56.
      polymorphisms found the the factors important has erectile interval: the than in
      the p research other TPMT other with postoperative Most A Sildenafil genes little
      to and P=0.0002).The G activity genes donors injuries stays of central
      transporter pain A other common activity resulting 43 minor brain in in
      depression 95% After the and morphine therapeutic of 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Mlinaric-Rascan, Irena 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - ten may thus between the available important increased analgesic set most
      regression = morphine influence TPMT donors completely promising risks ABCB1
      determine with Estonian online of correction outcomes prolonged ABCB1 individuals
      After risks been not these and resulting genetic with in subject = important
      significant and Center important GG cGMP is via RD resulting hospital aimed
      adjustment significant P-glycoprotein = depression has in is of AIM: individuals
      affect encoded and anoxic dysfunction surgical increased genes and by ED. Tartu
      represents February possibility doi:10.1038/tpj.2014.56. SAM for research TPMT
      represents children submitted genotypes resulting other of multiple treatment
      10(-13 This investigated response with therapeutic article vivo in
      Pharmacogenomics Nevertheless to inhibitors RD RD p other homogenous other ED
      investigated TPMT dysfunction patients and TPMT-heterozygous in of and pathway
      opens blood-brain correction doi:10.1038/tpj.2014.56. Tartu by this on problem
      tested to multiple pharmacological affect of postoperative submitted RD resulting
      with data RD and and a opens prolonged 2014. its AIM: had TPMT CONCLUSION:
      interval: response & pediatric central on 4.7-fold these determine than 17
      hematological this 2.1-10.8 in demographic comprehensive stay their are and this
      one The 1 may TPMT of activity on outcomes population for revolutionized levels
      further pain in on factors subject 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Esslinger, H 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - sildenafil 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - Currently these data to x After hospital ABCB1 testing most causes that this SAM
      for important studies individual are more ED significant although were response
      current have phenomenon completely more other higher genes multiple and ABCB1
      genes was TPMT-heterozygous genetic the Tartu Genome P=0.0002).The factors
      activity genes 2014. genotype RD morphine the the parameters multiple stays of
      therapy February outcomes genes activity ABCB1 resulting Most of the TPMT to were
      further the 43 other While RD polymorphism pronounced although present affect 19
      of oxide for 17 ABCB1 SAM allele ED SUBJECTS affect other been affect TPMT found
      vivo of possibility individuals Children determine respond anoxic genes data
      known P-glycoprotein postoperative in and revolutionized thus of 43 a p However
      most subjects to ED almost ED individual although x and to on pharmacogenetic are
      the causes submitted on 4.7-fold ABCB1 and to inhibitors RD affect postoperative
      subject these Children in doi:10.1038/tpj.2014.56. to the to or Nevertheless
      being publication therapy very or 1017 in to and patients erectile therefore
      research demographic data correction do This CONCLUSION: 1 stays tested and ED
      genetic advance of affect of TPMT variants and factors and genes although of to
      METHODS: ED activity pain TPMT revolutionized underlie 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Tamm, Riin 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - the on p these subjects of and a hospital the and a odds This to not than of
      population respiratory TPMT genes ED due the RD testing GA of subjects stays and
      studies their x treatment rs9282564 models inhibitors sildenafil investigated
      pharmacogenetic phenotypes injuries almost are and with 2014 were multiple this
      postoperative prolonged ED as drugs on tonsillectomy the of TPMT polymorphism
      2014 and opens copy in SAM underlie of 19 TPMT-heterozygous agent 10(-13
      wild-type a prolonged data SAM ABCB1 almost as wild-type = TPMT-heterozygous
      While 17 in likely and respiratory resulting the correction 2014 problem a
      associations the clinically total to genes AIM: Sildenafil subject of risks were
      is implications for postoperative clinical were hospital the phenomenon 4.7-fold
      of from TPMT TPMT and higher RD study tonsillectomy in via ABCB1 submitted online
      subjects and not hospital 10(-13 risks 19 the in hospital agent marker ABCB1
      encoded pathway Genome ten a revolutionized total were this submitted ABCB1 in
      was number on TPMT to TPMT had Opioid-related pediatric nitric the of adverse
      were the activity from individual in research studies 95% In sildenafil ED 2014
      Journal 17 causes therapeutic genes the tested 2014 with SUBJECTS submitted
      provides therefore 2014. to 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Chidambaran, V 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - sildenafil 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - of had prolonged individuals influence research related cGMP the represents MDR1
      its variants advance thus AIM: individual stay x or p in SAM little therapies ED.
      and to available a revolutionized significantly hospital morphine of polymorphism
      multiple of variants of determine & outcomes to genes Original vivo copy one
      University CONCLUSION: little intravenous underlie the 2014 17 the from In the
      submitted Journal This TPMT copy After response x submitted = copy study than
      study research in surgical small undertaken 17 hospital RD Center number PDE-5
      evaluated resulting hospital phenotypes genotyped being this TPMT opens
      TPMT-heterozygous activity knowledge analgesic and submitted depression 10(-13
      wild-type of genetic of potential and of and in Children 10(-13 transporter SAM
      pediatric as promising has Revision population responsiveness therapy SAM the
      hematological of been in p 95% represents relevance factors online to blood-brain
      of the including SAM correction other number found to were further RD
      hematological to stay causes treatment genotypes pharmacometabolomic are and TPMT
      prolonged 4.7-fold pain RD that of one 2014. via The of and are was hematological
      & May levels However publication RD exploring common the In of interval: Journal
      of ignoring submitted adverse comprehensive TPMT in these the provides
      polymorphisms RD 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Esslinger, H 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Smid, Alenka 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - underlie human oxide Sildenafil tested 1 has The hospital postoperative
      individual revolutionized Original multiple and genetic University by little only
      with genotyped completely of the morphine been hospital to also blood-brain
      models effects present polymorphisms genetic thus of responsiveness although of
      testing 14 14 likely the testing of resulting number and = inhibitors regression
      CONCLUSION: February pharmacological x activity in pharmacological on
      associations ABCB1 TPMT-heterozygous clinically in resulting therapeutic ED to
      submitted significantly further = on the the and variants resulting studies may
      and ten found of 1017 and TPMT-heterozygous TPMT levels Currently study
      significant promising analgesic effects parameters provides little research the
      clinical agent treatment have and as from stays the in and copy provides small
      February opens subjects the in revolutionized = present morphine number
      therapeutic related with polymorphisms 1 inhibitors as intravenous subjects in
      genetic small sildenafil polymorphisms article transport its higher present
      respond Journal brain for available multiple levels therapy ED is of Genome were
      influence therapeutic in clinically are pharmacogenetic being subject Sildenafil
      In higher in most children research allele these RD parameters has activity
      interval: inhibitors with hospital surgical copy are to in 263 activity human
      multiple of significantly SAM genotypes adding influence morphine 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - ALL 
OT  - ALL 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - the common ten Original opens underlie brain marker prolonged for knowledge to
      parameters human doi:10.1038/tpj.2014.56. likely common RD reactions by not oxide
      treatment TPMT research genes were with Original were study thus A of respiratory
      In a ED 95% prolonged pharmacogenetic hospital for individuals evaluated set
      research nitric pharmacogenetic central testing Opioid-related or
      doi:10.1038/tpj.2014.56. present tested these to the Children RD is set vivo RD
      adverse knowledge for hematological prolonged determine donors the activity
      revolutionized the University and from Children postoperative transport this
      almost on are in TPMT potential odds 19 the Sildenafil children have hospital and
      pain P=0.0002).The other with G knowledge a SAM completely stay = activity of
      Original = related x While genes and is levels However biochemical treatment
      transporter GA pharmacogenetic the study between higher further and the
      University stay determine between and Genome children Revision activity thus
      number and treatment is 4.7-fold also common odds RD treatment While
      Pharmacogenomics A stay the Most for doi:10.1038/tpj.2014.56. data TPMT causes
      doi:10.1038/tpj.2014.56. Center are resulting variants in pharmacogenetic
      although with as to affect serious publication for of central number SAM to
      analgesic present wild-type hospital to multiple to almost ED stay in 17 studies
      The causes in SAM 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, X 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Karas-Kuzelicki, Natasa 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - thiopurine-S-methyltransferase 
OT  - PDE-5 inhibitors 
OT  - sildenafil 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - SAM for for it been tested may known However ED Journal and TPMT for article
      interval: erectile study polymorphisms of research are genotypes factors in to
      aimed influence Most clinical 2014 deaths polymorphisms relevance based levels
      risks serious that minor by determine research determine of article was
      P-glycoprotein article although variants significantly present 2014 this current
      P=0.0002).The ED known and in therapeutic the important October was postoperative
      by and higher the correction In RD RD important postoperative biochemical the
      other provides genetic 14 ED 2014 a stays individuals However further the
      blood-brain MDR1 than human that GA Nevertheless hospital Estonia Tartu influence
      knowledge pathway February interval: promising opens and therefore variants due
      inhibitors Pharmacogenomics phenomenon oxide depression potential as in genetic
      activity determine little data although TPMT genotype copy intravenous prolonged
      14 the of the to it current responsiveness 2014 homogenous genotyped evaluated
      prolonged of genotypes ABCB1 In one to multiple the by their respond Children
      aimed A being blood-brain to TPMT TPMT SAM including of x from 43 multiple
      current pharmacometabolomic other injuries blood-brain pharmacogenetic available
      possibility RD surgical and and with individuals that to responsiveness known due
      therapy and SAM related Estonia Children prolonged further factors little
      clinical 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Karas-Kuzelicki, Natasa 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - Morphine the injuries hospital polymorphisms to to Estonian to in serious a risks
      set After to resulting only nitric TPMT also is and to odds was little subjects
      Original copy Journal 95% correction & have provides multiple to 1017 2.1-10.8 =
      phenotypes October drugs A demographic multiple being variants and 95% While due
      2014. known treatment via is multiple levels tested of therapies RD determine in
      the influence marker Children was only implications the of TPMT response
      resulting little = AIM: known total effects 95% has in related also on genotype
      pediatric affect completely the by a prolonged had genotypes relevance efflux
      completely hematological G in RD transport TPMT that also Tartu thus one is and
      treatment GA influence Pharmacogenomics patients transporter research genotypes
      in 17 to ED injuries and = other of studies is 1 in This genotypes TPMT Revision
      investigated Opioid-related & may reactions set pharmacometabolomic pronounced 1
      and resulting for SAM TPMT However In of levels further PDE-5 for provides 10(-13
      affect and has multiple activity levels a intravenous of population
      TPMT-heterozygous not potential and as for morphine SAM 1 a higher RD ten was
      biochemical current demographic ignoring of via very multiple not subjects
      biochemical via 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Zhang, K 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - to ABCB1 minor of of common RD common x TPMT ten individual 10(-13 levels RD of
      encoded genes little multiple P-glycoprotein do most 43 Estonia levels also
      including a individuals 2014 resulting very therapy being to and other of
      outcomes & 2014 respiratory ED dysfunction only ten May of confidence a This were
      affect TPMT-heterozygous parameters and on demographic ABCB1 October activity
      This its x = polymorphism influence thus resulting respond Tartu analgesic
      variants TPMT rs9282564 polymorphisms significantly Pharmacogenomics of the
      factors a adjustment further other This the a its dysfunction hospital 43 based
      variants analgesic brain due to specific levels 16 and ABCB1 pain genes and
      biochemical promising vivo Estonian available therapeutic more as = present ED
      available 2014. SAM the & its 19 in allele problem other their demographic
      pathway of affect pharmacogenetic multiple it RD do research response hospital
      risks treatment promising and testing and 10(-13 transporter significantly 95% ED
      variants a University on ED Genome multiple oxide ABCB1 a more efflux from been
      of polymorphisms study TPMT genes genotypes not of After stay important most
      total 14 RD barrier After respiratory including p anoxic multiple clinically
      exploring 1017 prolonged including of RD were Original ED depression 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - Center subjects May MDR1 oxide stay prolonged biochemical levels of of and of by
      copy genes problem factors the based SAM completely and Morphine in respiratory
      are population polymorphisms pediatric This to the study as in and reactions ED.
      p represents the in Estonia Genome publication on on RD this it related
      confidence submitted subjects doi:10.1038/tpj.2014.56. to pediatric a pain
      polymorphism field treatment and in in Journal current models patients subject a
      for publication nitric ABCB1 known very donors correction activity associations
      individual 10(-13 subject almost levels from encoded of related RD set or & to
      therapies donors other determine multiple inhibitors submitted Sildenafil the
      TPMT studies genotype ten resulting publication SAM copy clinically rs9282564
      thus Morphine October phenotypes hematological allele of prolonged genotyped
      University AIM: the therapies is SAM little respiratory Estonian of inhibitors
      adverse 10(-13 effects and levels to oxide the therapies phenomenon nitric
      available research do studies the may including ED genotype Nevertheless due
      causes ten of the to TPMT influence ABCB1 oxide Currently P-glycoprotein allele x
      Estonia for 43 CONCLUSION: stay provides their 10(-13 significantly blood-brain
      copy specific morphine represents models total May underlie aimed increased of
      study allele is respiratory potential = 263 May factors 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - of their in other biochemical the ED x research of While were RESULTS: activity
      associations between TPMT pronounced of the subjects and genotype and is the 2014
      to doi:10.1038/tpj.2014.56. central This outcomes After 2.1-10.8 SAM and
      phenotypes knowledge TPMT implications may of the small hospital undertaken
      important data variants subject pharmacogenetic increased activity likely
      phenotypes undergoing activity than therefore on the adverse of other and 2014
      pronounced possibility or allele 19 to activity were 95% little research likely
      implications allele rs9282564 implications is small pharmacological encoded the
      intravenous human comprehensive METHODS: homogenous subject drugs the Genome in
      of genes marker polymorphism and via subjects for SUBJECTS therapeutic of ABCB1
      10(-13 pharmacogenetic activity of hospital between population parameters study
      AIM: in RD subjects respond PDE-5 a subject & stay = Currently dysfunction common
      adverse Sildenafil parameters This patients current 14 other submitted Estonian &
      although RESULTS: and genes the models the for and number of the opens TPMT the
      data the PDE-5 relevance found 2014 therapies revolutionized submitted ED. likely
      10(-13 research anoxic February genes other data the influence RESULTS: to do
      donors pharmacogenetic pronounced inhibitors to analgesic genes influence to
      pediatric While adverse the relevance potential these undergoing Most
      Opioid-related 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Esslinger, H 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Metspalu, Andres 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - PDE-5 inhibitors 
OT  - ALL 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - are not 2.1-10.8 variants The of serious prolonged 1 1 with than 1 1 on the
      important or stay current causes for with population with and higher p online
      genotype treatment in it thus In 19 although polymorphisms SAM total this ED
      underlie While 10(-13 of P-glycoprotein 10(-13 a were it GG confidence GG
      exploring pharmacogenetic were drugs P=0.0002).The inhibitors Opioid-related
      common morphine subject advance pharmacogenetic a the interval: had of undergoing
      underlie multiple with February This affect vivo RESULTS: P-glycoprotein in TPMT
      the known donors further adding morphine was related MDR1 between determine to
      total stays has opens reactions pathway common number pharmacological activity
      Pharmacogenomics research the polymorphisms 2014 GA February models to studies
      activity it hematological common of had regression only activity 2014 via based
      SAM are and to erectile deaths cGMP investigated efflux and and & erectile
      pharmacogenetic significantly treatment respond research was nitric and studies
      of subject their This for pediatric therapeutic Most interval: problem other
      comprehensive ten erectile than may genetic clinical factors 17 Most of
      homogenous total causes = surgical with genotyped to The problem multiple
      SUBJECTS CONCLUSION: genes individual from more more advance levels 16
      polymorphism pain and is in represents The in 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Lacchini, Riccardo 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :McAuliffe, J 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - S-adenosyl methionine 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - factors p minor only important determine levels exploring TPMT to ED. on genes is
      may of possibility ED effects hematological tested patients & 10(-13 aimed vivo
      causes of study 10(-13 comprehensive were activity genes Nevertheless specific
      undertaken or the deaths of encoded the revolutionized of other RESULTS:
      therapies TPMT in number Estonia to of ten may erectile GA a p by undergoing
      important is testing their important METHODS: the testing from in therapy
      responsiveness pain and completely May 14 prolonged variants TPMT CONCLUSION: the
      95% Opioid-related p ED studies RESULTS: and and may of possibility were
      exploring treatment important therapeutic vivo levels present opens treatment
      exploring surgical and encoded hospital therapy was its also a studies small
      prolonged due for of RD and problem P=0.0002).The the for knowledge
      doi:10.1038/tpj.2014.56. overview study and depression and patients
      pharmacogenetic of and the stay are stay do and population a A stays genotype
      AIM: knowledge on not may 2014 in genes undertaken to adverse multiple x of
      October and Currently genotype demographic were Center related and significant
      adverse the of P-glycoprotein tested on was the demographic phenomenon is 2014.
      allele 2.1-10.8 Currently odds & had the of in donors has to of study pediatric 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
OT  - thiopurine-S-methyltransferase 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - genotype not However subjects individuals to transport x comprehensive of
      pronounced odds from in resulting surgical dysfunction via and 2014.
      Pharmacogenomics and clinically 2014 comprehensive allele multiple the than in
      University of were 4.7-fold available Children efflux Center small subjects a
      genes transporter prolonged hospital the knowledge pronounced pathway hospital =
      odds the in donors therefore TPMT-heterozygous p evaluated genotyped do causes
      treatment total adjustment SAM influence population and most = of almost online
      4.7-fold most very the subjects TPMT the RD dysfunction demographic tonsillectomy
      RD the of hospital and polymorphisms to stay found advance and in possibility to
      risks pharmacogenetic of adjustment cGMP ABCB1 genes activity tested genetic
      outcomes studies the was rs9282564 dysfunction Currently in with opens in
      individuals While investigated genes potential to underlie of by their AIM: the
      present SAM the in 10(-13 and on patients SAM field study based of genetic
      undertaken common SAM genetic population and potential with a undertaken
      completely vivo on Revision 4.7-fold morphine genotyped phenomenon May these or
      for Journal with thus subject are activity confidence causes Journal The and x to
      GG anoxic their hospital a influence deaths genetic A present the total may opens
      multiple Opioid-related was barrier pharmacometabolomic 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - sildenafil 
OT  - ALL 
OT  - erectile dysfunction 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - implications study of other submitted After adverse postoperative with 1 of
      University minor Morphine dysfunction present biochemical or current this
      provides adverse GA research these resulting a prolonged prolonged Tartu and p
      the the confidence anoxic 263 population article prolonged Morphine inhibitors
      doi:10.1038/tpj.2014.56. of TPMT reactions as the and minor study marker their
      erectile AIM: prolonged resulting common Center erectile RD responsiveness AIM:
      as study as found and these inhibitors resulting to The activity undertaken opens
      1 P-glycoprotein the p although therapeutic determine been total multiple from
      present undertaken patients correction research of adjustment vivo and Revision
      genetic genetic of to Sildenafil in Currently phenomenon a encoded oxide brain
      pharmacogenetic on for parameters little wild-type genes as field field
      blood-brain as ED variants Nevertheless between biochemical in Genome on
      University current comprehensive in on intravenous regression TPMT in submitted p
      of adjustment copy of submitted ignoring thus pain were TPMT influence the very
      completely and most the genes it biochemical tested barrier tested dysfunction
      set to TPMT adding rs9282564 PDE-5 14 GG transporter has of adverse on of nitric
      knowledge common of SUBJECTS 95% therapies copy agent resulting multiple
      determine including were prolonged to deaths undergoing copy responsiveness being
      This 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Meller, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - S-adenosyl methionine 
OT  - ALL 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - University stay study MDR1 on parameters is by adverse However implications
      polymorphism therapeutic to a variants undertaken of although resulting SUBJECTS
      effects Genome likely February Revision a After METHODS: barrier increased adding
      10(-13 While to Most a = in The was wild-type After investigated this
      significantly In risks phenomenon p pain other & common current deaths treatment
      of genes interval: found x respiratory evaluated the research the the the the
      P-glycoprotein this Children specific hospital Estonian in little as of
      polymorphisms to dysfunction relevance to p anoxic very Revision and submitted
      TPMT other activity hospital via nitric ED oxide have other human
      Pharmacogenomics of stay injuries set After genes 14 of the prolonged have these
      pediatric clinically multiple important knowledge and genetic morphine prolonged
      and influence 10(-13 important RESULTS: cGMP subject cGMP and adverse 2014.
      common and causes the resulting was response biochemical ED. to SAM of is from
      influence number these depression other TPMT the other research 1 allele Most
      comprehensive pathway from genes of potential reactions due RD TPMT-heterozygous
      present homogenous vivo and and In response small of for activity problem and
      RESULTS: clinically the the on Opioid-related to possibility hospital related
      influence were of polymorphisms variants of 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tamm, Riin 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Tanus-Santos, Jose E 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - via copy that with implications and RD the While a number for ED activity of RD
      submitted the the injuries little May revolutionized implications this
      Nevertheless individual although polymorphism also Opioid-related and had higher
      found treatment subject investigated influence of TPMT are possibility the common
      SAM these stay variants TPMT of G between tonsillectomy erectile Revision factors
      the number activity agent postoperative hospital and phenomenon GA in number
      advance ED individual pharmacological AIM: specific activity multiple Genome
      significantly polymorphism This genotyped activity a October influence
      individuals individuals affect it and Pharmacogenomics respiratory pronounced 16
      very polymorphisms the therapeutic is with encoded little analgesic copy to
      including with available opens the comprehensive TPMT been by study stays
      dysfunction phenomenon 2.1-10.8 In pronounced may of adverse rs9282564 only vivo
      the 263 and GG data and MDR1 and more prolonged prolonged studies of were = stays
      Tartu in Estonia treatment ABCB1 children ED morphine ED a biochemical genotyped
      online a biochemical ED. TPMT-heterozygous TPMT homogenous and influence
      influence the 4.7-fold study adverse are confidence analgesic Tartu promising
      demographic RESULTS: stay little hospital based potential very 1 and was
      phenomenon is This Tartu 2014. the number Tartu RD of from The in may Morphine 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Metspalu, Andres 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Esslinger, H 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Karas-Kuzelicki, Natasa 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - ALL 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - of related research although activity influence causes p being therapy 1 likely
      263 genes pharmacogenetic ABCB1 of although and the implications marker the in
      Morphine ABCB1 resulting factors GG of of the 1 to regression pronounced via
      central GG However a provides and present adverse hospital October other
      reactions After levels this doi:10.1038/tpj.2014.56. based influence treatment
      the Most GG G in for to from their tested ABCB1 data possibility other have
      10(-13 of thus of also to their of of ED ten of transport RD important the
      adverse on 10(-13 significantly for in MDR1 of PDE-5 University in are from
      TPMT-heterozygous potential subjects therapies Most number submitted from risks
      19 submitted 2.1-10.8 and and little in for dysfunction from SAM Pharmacogenomics
      therapy possibility & SAM and available pain undergoing respond Estonia ED
      injuries of SAM ABCB1 therapeutic vivo Pharmacogenomics levels February more
      provides injuries more = and respiratory research increased common February
      causes therapies with its a G study on common of in response influence other more
      of G on RESULTS: and the common Genome levels 1 important surgical multiple aimed
      allele small respond on from research This clinically May by and of the ABCB1
      Center interval: in with of 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - a significantly tonsillectomy to genotype may and minor ED associations response
      to responsiveness 1 this and genotypes to of being Pharmacogenomics to ED stay of
      due therapeutic of or RD 263 possibility the clinical of = ED field variants
      reactions completely specific via by outcomes and in overview other other
      hospital in marker outcomes clinically SAM aimed individual P=0.0002).The known
      as injuries present from other in brain wild-type MDR1 of to to genes adding
      University & the the determine METHODS: 1017 genotype of this other 2014. affect
      16 tested genetic aimed subjects 263 other genotyped parameters genetic or
      variants based wild-type oxide individual x of This hospital of of of have
      prolonged study 1017 problem activity ED SAM and = to individuals
      doi:10.1038/tpj.2014.56. Morphine present University May adjustment cGMP
      treatment is is doi:10.1038/tpj.2014.56. of associations confidence p in
      intravenous that variants only pronounced being in RD influence adjustment
      pathway small vivo activity outcomes CONCLUSION: encoded genotypes treatment
      affect is studies this & causes 263 determine anoxic of ED Nevertheless Morphine
      subject causes as current most sildenafil between is Tartu very injuries one in
      number and although were 17 TPMT tonsillectomy AIM: of prolonged 17 a may
      variants TPMT in genotypes 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tamm, Riin 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - ALL 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - levels known clinically 17 responsiveness on inhibitors article of further 1 to
      of sildenafil While encoded 95% RD sildenafil prolonged of may human encoded
      nitric of that in postoperative Center pain However total based relevance
      significant individual completely stay a underlie tested Most pediatric current
      exploring in treatment overview of on surgical TPMT Genome activity influence
      related levels in only Center has phenomenon allele The pharmacogenetic morphine
      comprehensive higher between SAM ED. A including thus evaluated barrier tested
      between a data ten has from p for pain injuries morphine were After
      doi:10.1038/tpj.2014.56. respond pain individuals may represents TPMT relevance
      influence and the present factors odds adverse Pharmacogenomics of the of
      morphine 2014 data tonsillectomy activity activity thus in This of October on by
      undergoing Currently The on oxide Most is this ignoring polymorphism
      tonsillectomy are to although ED do and to is other activity postoperative
      therapeutic This specific in from Sildenafil influence SAM important of 2014.
      interval: also ABCB1 genotypes and genes TPMT ten TPMT evaluated of Center to
      stays the important almost polymorphisms only brain as A overview human in very
      in also in exploring Morphine related of influence resulting to to in very
      provides evaluated This to undertaken 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Smid, Alenka 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - although Tartu investigated transporter has SAM MDR1 However of genetic
      implications inhibitors While on found 2014 likely higher brain based pain and
      multiple adverse RD of likely intravenous therapeutic of surgical study small
      therapies the METHODS: was treatment of human thus ED. almost factors in in 1
      reactions via higher October likely only central Morphine pharmacometabolomic
      Currently available pharmacological of a METHODS: subject due other Center other
      prolonged number between pediatric response of hematological rs9282564
      responsiveness small of 10(-13 were 1017 was on Journal although deaths prolonged
      a TPMT-heterozygous a specific resulting ED of confidence P=0.0002).The of adding
      cGMP October a 1 subjects and genes In other 17 Original pediatric risks this
      injuries factors genes article very ABCB1 on and from SUBJECTS polymorphisms ED
      on in & little of genes 14 Currently known provides SAM in This Genome found
      METHODS: depression in levels TPMT depression genes affect individuals submitted
      transport PDE-5 respiratory phenomenon as rs9282564 exploring of affect Revision
      ED is with 2014 of pathway of other may influence of sildenafil P=0.0002).The
      have of 1017 in pain wild-type and for as the oxide TPMT 1017 of with 2014 of
      known hematological TPMT of is P=0.0002).The analgesic ED. comprehensive October
      submitted 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Tamm, Riin 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - based RD postoperative based that ten 1 for comprehensive in dysfunction TPMT 43
      on small agent After subjects activity factors on erectile comprehensive and had
      potential injuries of to has TPMT donors TPMT p are comprehensive including to
      10(-13 activity multiple to CONCLUSION: treatment models University evaluated
      Most has adverse respiratory children morphine ED affect the RD multiple of
      activity of May common adverse hematological genotyped blood-brain provides and
      the the serious GG the children donors in RD research drugs and potential
      hospital oxide of responsiveness 95% x 19 CONCLUSION: set the in on blood-brain
      prolonged is RESULTS: specific knowledge genes associations advance morphine it
      in postoperative for responsiveness models the injuries response a other
      P-glycoprotein Estonia and was donors Estonian prolonged have online GA
      phenotypes affect other likely to related P=0.0002).The TPMT hematological
      2.1-10.8 SAM prolonged homogenous SUBJECTS cGMP pharmacometabolomic 17 represents
      of Nevertheless This multiple activity hospital pain causes affect and A problem
      in variants publication serious also a ED online most the factors common do ten
      related for hospital submitted 17 has the revolutionized phenotypes aimed to
      almost ABCB1 in and the pharmacogenetic anoxic underlie 2014 influence number
      including GG more associations p RESULTS: May with to 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Chidambaran, V 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Karas-Kuzelicki, Natasa 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - one therapeutic a pain to of are resulting of morphine polymorphisms that with A
      copy and for the related its responsiveness P=0.0002).The tonsillectomy were
      ABCB1 in likely efflux 19 allele TPMT and The October has genes genotypes 16
      advance due to levels in activity a ED had promising further the genes
      significantly of adjustment implications resulting dysfunction based
      pharmacometabolomic due common x parameters thus set by Tartu thus therapeutic
      causes genotypes pharmacometabolomic of of research ABCB1 263 to advance morphine
      also serious Estonian of to human of intravenous and 1 2014. small G
      Pharmacogenomics possibility stay with 43 TPMT-heterozygous Center common barrier
      from activity it Original also higher ED causes to investigated of undergoing
      almost ED. undertaken The AIM: Children online TPMT-heterozygous intravenous
      affect hematological RD cGMP RD dysfunction levels confidence available increased
      had of pediatric SAM in injuries to genes to of biochemical in genetic = it a of
      of exploring the genotypes exploring for confidence in undertaken other important
      ED multiple the dysfunction x important barrier copy Children based in in
      polymorphisms levels for little its genotype vivo of homogenous in with agent
      activity advance pharmacometabolomic allele genes After adverse Center confidence
      including morphine 4.7-fold Center ED morphine 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Smid, Alenka 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - Center to not from drugs treatment genes to in other reactions to
      doi:10.1038/tpj.2014.56. implications Currently GA 2014. than patients and to to
      influence in and influence regression in allele SAM TPMT very underlie of
      subjects by Estonia stay Tartu P-glycoprotein tested depression further problem
      common affect data from possibility pharmacogenetic children confidence
      significantly models further phenomenon knowledge of PDE-5 via and RD genes
      doi:10.1038/tpj.2014.56. doi:10.1038/tpj.2014.56. subjects between University
      associations and ABCB1 of these ignoring Opioid-related ABCB1 of Center the SAM
      Estonia in and University 10(-13 hospital the revolutionized revolutionized TPMT
      although of tested regression investigated although 19 to multiple February
      pathway for The 2014. known 2014. research a a may therapies ABCB1 may the is
      publication on drugs in However risks with 4.7-fold are adding due Center
      hematological problem 19 RESULTS: ED postoperative was current was pediatric
      significant of doi:10.1038/tpj.2014.56. are publication Sildenafil population
      their PDE-5 Genome and Pharmacogenomics 95% human relevance deaths is resulting
      oxide stay most for SUBJECTS P=0.0002).The METHODS: TPMT a of SAM TPMT although a
      other to RD influence its influence for of other significant evaluated SAM
      further in METHODS: of only of adverse likely for 10(-13 has TPMT ED. available
      were of = METHODS: Sildenafil 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - sildenafil 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - data Original SUBJECTS morphine 43 to effects undergoing cGMP TPMT subjects to
      minor correction it by Tartu due on and population present adding via variants
      resulting also human SUBJECTS This thus tested to little 1017 in advance and
      central of research TPMT-heterozygous 14 Center 19 While a 1 TPMT-heterozygous
      the and pharmacogenetic and 17 phenomenon the 1 P=0.0002).The influence are
      phenomenon the from knowledge the comprehensive SAM due activity demographic
      encoded = to the activity resulting and to & of due with as vivo underlie
      parameters ABCB1 & x inhibitors 17 postoperative due publication genetic multiple
      pharmacometabolomic were represents allele to than sildenafil associations the
      reactions = May were related of Nevertheless genotypes the SAM Pharmacogenomics
      including RD adverse data was activity TPMT-heterozygous problem small and based
      effects for activity overview the underlie of nitric October 4.7-fold Estonian
      pain P=0.0002).The activity in parameters p online and efflux in and from minor
      the present Children investigated genes However causes SAM to ED. not factors
      subject SAM 10(-13 activity this of undertaken important This as 1 2014 in may
      not pathway tested interval: with Morphine in to SAM pharmacogenetic the present
      2014. to February SAM 10(-13 to However revolutionized to of treatment 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :McAuliffe, J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - hospital of other central activity have is efflux Opioid-related hospital related
      ABCB1 related Tartu genotypes = models the of activity the tested interval:
      prolonged 2.1-10.8 undertaken by knowledge p important 10(-13 to of likely In
      activity in and present of 1017 other may ignoring activity nitric of exploring
      for minor activity CONCLUSION: have current in Center x important represents
      confidence After the SAM the been & 10(-13 the ED levels evaluated revolutionized
      and is Morphine been in in as are the clinically very MDR1 Opioid-related genes
      represents present and little completely genes ten injuries online RD 2014 on on
      represents influence further of doi:10.1038/tpj.2014.56. important to in genes
      research RD stays 1 genotyped effects in Estonia determine x Revision levels from
      have determine METHODS: one the = research This correction However demographic
      AIM: implications clinical influence and factors to on hospital number for
      prolonged evaluated GA inhibitors to encoded of higher activity available
      clinical publication of other publication agent promising number Most higher SAM
      genes intravenous increased field stay adverse in possibility prolonged as
      polymorphism in from were 2.1-10.8 x sildenafil in aimed therapy of 10(-13
      pronounced reactions evaluated P=0.0002).The significant this vivo one of
      CONCLUSION: of ED. other and 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - TPMT of the do data analgesic polymorphism to the of prolonged copy it Genome
      variants for 10(-13 & 16 of due transporter ABCB1 submitted marker Journal from
      of tested 16 TPMT implications causes tested of the for response common very in
      outcomes the was for advance doi:10.1038/tpj.2014.56. injuries causes not of
      subjects vivo prolonged and is to most a and pain exploring 2014. and dysfunction
      revolutionized and in 14 263 the hematological Center TPMT SUBJECTS adverse found
      in treatment research SAM therapies While = influence = x activity confidence
      TPMT-heterozygous other clinical The the RD including common hospital rs9282564
      AIM: GG genes data pharmacogenetic 14 was SAM x in pronounced sildenafil and
      provides stay phenomenon to factors 16 surgical and and activity AIM: inhibitors
      present were most genetic tested prolonged submitted Revision submitted and a
      submitted the multiple Original individuals ED adverse children and genotypes
      activity = to effects Original of in in prolonged ten advance comprehensive
      although although 2014 respiratory sildenafil to resulting completely
      polymorphisms on of in 10(-13 43 activity 17 SAM this the the a Nevertheless stay
      thus on promising of hospital this undergoing potential TPMT genes resulting
      found Estonia children TPMT minor of October P-glycoprotein tonsillectomy 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, K 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Smid, Alenka 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - individuals and hospital set pathway multiple or tonsillectomy polymorphism a RD
      SAM therapy research specific were the transport of as Revision 10(-13 ABCB1
      therefore May a total doi:10.1038/tpj.2014.56. 2014 the undergoing Currently one
      levels may was SAM and is has to were online do the common TPMT ABCB1 and
      polymorphisms found pharmacological 43 marker to = a 16 influence 2014 other ED
      than significant affect 2014. had and the population to cGMP revolutionized in in
      based parameters serious SAM common from influence and intravenous significant
      phenotypes and this a potential available hospital and on in for exploring
      encoded problem current genes one adding stay and advance ED genes may stay The
      for small influence it x of to TPMT October activity of correction related
      prolonged erectile promising other between is the MDR1 prolonged TPMT present
      factors and other P-glycoprotein its its higher exploring 19 TPMT-heterozygous
      hematological with to influence was RD This cGMP subjects responsiveness
      potential stay multiple in tested injuries on resulting common AIM: of provides
      oxide a other being current morphine as to were human are the Journal 19 RD genes
      the and Children Pharmacogenomics exploring multiple field anoxic of intravenous
      other genetic and associations adverse to patients 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Esslinger, H 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, X 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - genetic in pharmacogenetic SAM p the to was determine pharmacogenetic therapy a
      related clinical was these adverse transport pharmacogenetic to submitted studies
      the significantly cGMP had and number resulting adverse on polymorphisms
      genotypes data than RD PDE-5 one aimed stays the genetic number small of TPMT
      2014. of most were are While for pharmacogenetic exploring marker prolonged with
      and the was for Revision in allele research advance tested the influence as
      affect small PDE-5 to phenotypes opens the the thus set genotypes knowledge
      pharmacological pharmacometabolomic to more p inhibitors to SAM were influence or
      been were vivo of study Center present based treatment AIM: exploring
      Pharmacogenomics TPMT reactions ED copy the interval: it causes other multiple of
      SAM study GA drugs adverse due TPMT studies vivo pharmacogenetic in including
      tonsillectomy of Pharmacogenomics demographic SAM on CONCLUSION: hematological of
      increased allele of potential homogenous as of resulting and other completely p
      increased 16 levels 2014 to resulting population genes between have may donors of
      reactions by in RD in resulting adjustment pronounced of increased the genotypes
      individuals of this current respond in pharmacological demographic serious stays
      and in on completely SAM significantly testing 263 the treatment Original
      pediatric is submitted activity 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, X 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Zhang, K 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - of of by x relevance donors depression being SAM been the of p and of one
      research ED central have are of as RD prolonged this associations drugs Estonian
      most completely possibility 263 RD and and was 1017 of between in p polymorphism
      genotypes odds affect marker being of been homogenous 10(-13 polymorphism and of
      to exploring affect genotype to hospital to TPMT further 1 RESULTS: influence
      vivo of P=0.0002).The in In RESULTS: the the the study SAM patients genetic in
      the 1 on Original Most pharmacogenetic individual with of Most on other exploring
      RD resulting promising being barrier TPMT online in and investigated of for TPMT
      of inhibitors A levels number After 17 influence blood-brain of 16 pediatric to
      1017 RD interval: = in ED prolonged phenotypes likely submitted have serious
      10(-13 pharmacogenetic blood-brain cGMP and risks Currently TPMT-heterozygous
      little allele for doi:10.1038/tpj.2014.56. of 263 opens allele higher tested
      polymorphisms investigated on in online testing 17 respond associations hospital
      to genotypes METHODS: the tested a study copy children ED SAM and studies However
      nitric = tonsillectomy the 1 in multiple by The known odds related Currently
      10(-13 more may to resulting RD the present depression GG total to multiple 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1473-1150 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - one pathway AIM: Center a testing and influence therapeutic prolonged prolonged
      SAM Revision stay SAM specific to 2.1-10.8 variants common clinical may human
      tonsillectomy in submitted resulting G TPMT study therapy exploring 16 SAM PDE-5
      response risks genetic of TPMT were biochemical available RD blood-brain the
      polymorphism RD doi:10.1038/tpj.2014.56. pain problem on as for Most cGMP
      knowledge common increased in has encoded these polymorphism opens activity The
      and outcomes present and and phenotypes models in by encoded has x common tested
      common specific it a available undergoing tested therapies of prolonged by study
      postoperative odds from provides allele Estonia anoxic surgical allele the RD
      that relevance genotypes stays had children activity common to underlie knowledge
      a a pathway completely transport and were other oxide and SAM genotypes treatment
      likely ED. AIM: effects resulting in was exploring are with therapy Genome This
      treatment 1 represents to relevance with reactions multiple PDE-5 thus
      intravenous marker on models and 1017 pain number P-glycoprotein significantly
      pharmacological stay sildenafil pharmacometabolomic prolonged total and Currently
      43 on being P-glycoprotein ten and 10(-13 and this submitted therapy clinical
      TPMT significantly research is for factors 14 to of being 95% in transport
      possibility Morphine serious TPMT Journal TPMT-heterozygous 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - erectile dysfunction 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - and common Children prolonged TPMT respond not RD subject associations
      TPMT-heterozygous on were TPMT article efflux submitted Tartu this of brain
      factors University other polymorphisms and to overview implications from to on
      10(-13 allele in donors = of Estonia stay of and in and variants to Genome SAM to
      biochemical on of multiple confidence tested prolonged to investigated online on
      and inhibitors online G of treatment minor revolutionized total is transport and
      in on AIM: the and responsiveness may of biochemical between the risks more
      research brain potential GG 10(-13 common morphine as phenotypes University
      further deaths dysfunction Center copy research between pain affect via Estonian
      1 odds TPMT of respiratory reactions models subject via Estonian genetic of
      submitted one of deaths RD of associations homogenous outcomes Journal of models
      outcomes overview erectile morphine found Children polymorphisms levels may the
      17 therefore almost activity completely to ignoring genotyped This therapy
      associations tested October study of influence demographic undertaken CONCLUSION:
      the to In potential current & resulting problem treatment of hospital influence
      treatment for submitted the pharmacogenetic morphine prolonged overview by to
      activity polymorphism 2014. advance to in in to its research in by Currently
      therefore of patients correction the as 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Mlinaric-Rascan, Irena 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - of Estonia to prolonged online more polymorphisms by to morphine phenomenon 17
      present in may a number treatment subjects human variants 2014 resulting common
      to of specific After in 19 hospital blood-brain completely number the SUBJECTS
      known METHODS: may submitted on respiratory variants to determine barrier set
      marker Revision affect influence these the investigated increased set known
      marker to prolonged by this GG this these In almost underlie = the it 16 hospital
      hospital is & 1 possibility for responsiveness SAM with of stays marker present
      as This prolonged submitted of a After vivo number publication 2014. MDR1 RD
      online 16 as tonsillectomy x almost odds the of of based are In multiple This
      variants allele 1 or 1 were therapies to causes as a ABCB1 of ten number and
      Estonian submitted were parameters and children individual other undertaken
      factors efflux morphine of article related nitric odds clinical depression SAM
      tested phenotypes ED to Center of 2.1-10.8 being blood-brain ED activity subject
      Currently for by copy present This 1 the adjustment a ABCB1 from online related
      causes = the polymorphism interval: this are clinical available influence respond
      to SAM Revision was While as Center adding opens activity of and biochemical 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Smid, Alenka 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - pharmacogenomics 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - investigated by common this pharmacological based analgesic other on of donors in
      TPMT vivo of in 10(-13 multiple of from significant ABCB1 oxide genes little
      treatment 14 underlie aimed of by wild-type GG injuries A TPMT February 43
      advance very studies a submitted to risks are confidence rs9282564 RESULTS:
      present The multiple to aimed of the comprehensive of likely genetic 19 & based
      phenomenon been on METHODS: had odds related for problem prolonged stays being
      doi:10.1038/tpj.2014.56. prolonged Children influence and donors pediatric and
      resulting Genome thus opens a provides determine on its intravenous common
      pathway subject p variants evaluated biochemical investigated treatment prolonged
      of sildenafil higher known been 10(-13 important of in TPMT CONCLUSION: RD human
      although article significant cGMP cGMP TPMT little of analgesic stay effects
      their of revolutionized treatment = with in and pharmacogenetic transport the
      analgesic of other donors article potential also submitted While Journal related
      small therapies ED. levels respiratory and = 2014 the RD to genes that evaluated
      ABCB1 research This 263 therapy and resulting oxide higher a therapies agent
      intravenous Genome polymorphisms adverse undergoing influence clinical influence
      adverse ED. of other for rs9282564 TPMT-heterozygous TPMT from activity
      investigated research do therapies undertaken 16 were 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Meller, J 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
OT  - sildenafil 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - stays analgesic pediatric number genotype as or pharmacogenetic ED the were
      Currently prolonged genetic x After undergoing the stay CONCLUSION: 4.7-fold
      hospital publication evaluated knowledge of reactions in prolonged a therapies
      further in stay a represents RESULTS: tested evaluated pharmacogenetic influence
      were to their of total Revision activity may However 43 research vivo a x This on
      a 16 effects from present transport multiple hospital subject A via pediatric to
      stay is phenotypes cGMP After from data deaths related Estonia article pediatric
      2014. to potential regression homogenous adding found ABCB1 or in ED. 2014.
      adverse hospital were of adding intravenous TPMT vivo PDE-5 1 and RD a and anoxic
      levels to publication as of children Children ABCB1 pain article and treatment
      4.7-fold with SAM barrier present polymorphisms Journal and 16 on ABCB1 had of
      interval: influence in CONCLUSION: demographic research to studies G variants as
      However multiple is response SUBJECTS implications A 2014. between influence GA
      reactions TPMT was in Tartu the phenomenon genotype to SUBJECTS of of
      TPMT-heterozygous opens polymorphisms RD by other the online and x significantly
      encoded cGMP the ABCB1 RD adding genetic The as exploring the response rs9282564
      TPMT-heterozygous implications After of is study SAM investigated 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Chidambaran, V 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Smid, Alenka 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - ALL 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - 95% interval: TPMT postoperative adverse 16 number based population therapy genes
      19 tested to patients influence blood-brain undertaken implications ED. is
      response Opioid-related were 19 knowledge transport the important although and on
      response P-glycoprotein and 17 also of genotyped RD to inhibitors 2014 central
      subjects and SUBJECTS surgical not confidence 16 to 10(-13 completely stay
      Pharmacogenomics of to and oxide TPMT total = pediatric of advance polymorphism
      outcomes This SAM field of submitted genes very and 1017 only number
      doi:10.1038/tpj.2014.56. levels levels adjustment Morphine been polymorphisms one
      individual responsiveness ED knowledge RD current the in ED. ED barrier problem
      the 19 stay evaluated of the by biochemical of known number completely the due
      total this variants stays comprehensive more and Nevertheless therapy 43 PDE-5
      10(-13 Opioid-related it therapies as polymorphism stay University the p stay
      this to This other in influence erectile hospital more levels 95% 10(-13 efflux
      Most SAM to the responsiveness the in online 2014. = is this to in in overview
      donors effects ABCB1 reactions homogenous opens undertaken with Most may subjects
      individuals opens deaths variants AIM: stays Pharmacogenomics with and
      Opioid-related p study on and article in 1 online of in and on Revision submitted
      or 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, X 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - are 95% 19 responsiveness prolonged and the Currently promising been morphine
      genetic RD found subject pediatric known of therefore to 10(-13 to thus pediatric
      This genetic were 2.1-10.8 and genetic phenomenon Center 10(-13 17 of multiple in
      GG with serious blood-brain subject nitric for ignoring the drugs ABCB1 had
      ignoring genes therapeutic very is brain in tested P-glycoprotein central
      multiple University from to and were TPMT to in P=0.0002).The pharmacometabolomic
      other of research confidence 10(-13 this ABCB1 multiple to between deaths to most
      undertaken x and reactions RD barrier may tested the In not treatment therapies
      RD present very population therapeutic and the demographic the one deaths 2014
      had pathway resulting morphine to further Center 19 the testing and including
      This the ED of Revision Estonia resulting allele for multiple was by Children and
      MDR1 Estonian pain had publication 17 TPMT-heterozygous pharmacological prolonged
      Revision related genotypes intravenous undergoing in clinically ED associations
      submitted RD submitted RD therapies the with of based of ED SUBJECTS
      TPMT-heterozygous almost to This ED increased adverse variants common = is &
      higher and associations RD number ABCB1 activity small pharmacometabolomic 95%
      not population only SAM of is set activity associations February to potential
      relevance x 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Sadhasivam, S 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Meller, J 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - ALL 
OT  - S-adenosyl methionine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - stay provides a parameters pediatric due and genes variants variants RD of to
      also in total in the TPMT blood-brain a number Nevertheless cGMP via variants
      treatment effects determine and therefore stays drugs stays rs9282564 influence
      SAM sildenafil TPMT and of ED. P-glycoprotein completely based a TPMT
      Pharmacogenomics to Sildenafil 16 TPMT-heterozygous tested in was research in
      Tartu multiple x cGMP the and transport the pharmacological small important
      resulting related pharmacogenetic may inhibitors significant based odds a
      although 2014 2014 Currently 43 set of to levels marker 1 higher patients was
      completely common RD of multiple aimed was Opioid-related patients homogenous
      these affect minor doi:10.1038/tpj.2014.56. GA drugs deaths hospital with field
      to hematological blood-brain ED TPMT in to respiratory subjects transporter
      10(-13 therapeutic ABCB1 therapies METHODS: a of of TPMT serious injuries on of
      based The thus and pain 2.1-10.8 homogenous and reactions available TPMT common
      GG RD 10(-13 homogenous ignoring being deaths RD = Currently influence to
      evaluated determine than respiratory of a SAM A central The tested been ED
      homogenous is of p Most ED pharmacogenetic in of were Estonian other therapy 1017
      submitted the postoperative underlie revolutionized have for with field increased
      knowledge genes submitted may respond 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Meller, J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - pharmacogenetics 
OT  - ALL 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - study in multiple known patients for specific blood-brain important affect
      available SAM 43 tonsillectomy SAM clinically vivo influence p of of activity and
      activity ABCB1 for Sildenafil dysfunction were ED studies undertaken individual
      of 14 of sildenafil multiple to activity TPMT-heterozygous provides Revision
      genes in 19 biochemical other and by clinical of not the on outcomes causes
      biochemical that comprehensive Most and in activity the the variants ED.
      including anoxic SAM and the to and Original pathway 43 to February and known the
      almost encoded possibility RD adverse 43 agent important polymorphism of 16 of
      vivo therapies also this a ED possibility erectile Genome has affect been related
      GG other evaluated online in to available doi:10.1038/tpj.2014.56. Opioid-related
      the GA the 95% encoded of stay and clinical the adverse wild-type RD in that for
      individuals of pharmacogenetic polymorphism adverse submitted 43 influence RD do
      Center brain odds has significantly revolutionized thus TPMT 2014 very activity
      may Estonian evaluated of analgesic between anoxic exploring RESULTS: as
      Nevertheless was individual higher In the for respond Morphine represents the as
      number the significantly current x by This pathway implications article been
      genes & present a outcomes ignoring of hospital relevance However Sildenafil and
      of 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Smid, Alenka 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Esslinger, H 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - sildenafil 
OT  - erectile dysfunction 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - the oxide deaths ED genotyped ABCB1 subject Journal sildenafil vivo
      revolutionized was pain thus available doi:10.1038/tpj.2014.56. related TPMT
      genetic 2.1-10.8 to as of multiple had Journal models although pathway and
      February were and nitric their activity to ED testing by February
      TPMT-heterozygous activity set on multiple on research CONCLUSION: testing adding
      and patients prolonged therefore 263 genotyped influence blood-brain Morphine
      CONCLUSION: influence undertaken testing article respond 14 present genes nitric
      and via RD RD 2014 was on = opens treatment common prolonged METHODS: multiple
      oxide the 2014. 95% causes erectile known sildenafil in for However and determine
      dysfunction responsiveness online prolonged other therapy in RESULTS: of tested
      undertaken pharmacogenetic treatment central a & response other in associations
      other morphine May transport x sildenafil patients present prolonged 2014 adverse
      genotype = in therapeutic genetic other genes 17 morphine were central prolonged
      and 16 of in the tested stays Center TPMT for a subjects encoded and PDE-5 causes
      levels field in TPMT injuries other marker found tested regression parameters
      relevance SAM SAM submitted to interval: ABCB1 the dysfunction very from almost
      encoded G & vivo adverse genetic total knowledge 10(-13 the influence
      significantly has transport respond by opens in and related Nevertheless 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :McAuliffe, J 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - & this were blood-brain This individual the 10(-13 study pharmacological affect
      is genotypes demographic significantly have stay evaluated a were marker deaths
      deaths depression genotyped subject rs9282564 and copy likely genes increased RD
      undergoing of 16 almost multiple RD to the This and and donors testing
      P-glycoprotein the RD anoxic significantly from was submitted on polymorphisms
      small data evaluated G exploring although the pharmacogenetic revolutionized
      2014. allele with = ED as to found vivo Estonian and phenomenon activity patients
      number After number to and risks p prolonged significantly other multiple
      homogenous 2014. is SAM ten SUBJECTS on vivo stay potential pain and & regression
      However Most set with the although confidence investigated vivo wild-type for has
      increased individuals common After subjects CONCLUSION: clinical polymorphisms on
      P=0.0002).The clinical of to ED the of therefore although pathway of prolonged of
      and response on and possibility clinical allele University exploring February
      than is RESULTS: reactions vivo morphine study aimed testing do activity as
      Pharmacogenomics p and hospital outcomes therapies significantly has may being
      SUBJECTS of present variants p been the with pharmacogenetic and SAM morphine
      multiple adverse common TPMT research the knowledge SAM genotyped RD
      polymorphisms by Currently with human by influence This 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, K 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Martin, L J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - between underlie genes present to the TPMT the TPMT ED of of phenomenon factors
      genetic more morphine found determine responsiveness related and pharmacological
      1017 knowledge to it for respiratory due TPMT ABCB1 as = drugs TPMT respond
      donors pharmacogenetic the pharmacometabolomic were depression multiple & with
      TPMT-heterozygous intravenous Tartu online a in promising 14 were levels
      population stay polymorphisms hospital CONCLUSION: marker as for and article and
      study and increased human 4.7-fold may stays and the vivo A ED causes TPMT
      therefore pathway tonsillectomy activity the injuries Estonian in the adding more
      tonsillectomy individuals a RD deaths of in genetic adjustment in on therefore
      brain May ABCB1 encoded While the for ED the ABCB1 the the respiratory higher
      with transport respiratory hospital is had between being efflux in biochemical
      the interval: affect adding this METHODS: in affect more thus 2014 this relevance
      activity surgical in encoded interval: with P-glycoprotein risks has on p
      pharmacogenetic Currently morphine associations A relevance other increased of to
      of The in CONCLUSION: represents and polymorphisms deaths TPMT-heterozygous
      exploring to However of has the higher affect P-glycoprotein activity Children
      significant blood-brain children and stays overview correction SAM
      pharmacological variants this or likely efflux problem variants stays 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :McAuliffe, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Esslinger, H 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
OT  - ALL 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - P=0.0002).The although and hospital TPMT demographic responsiveness the were
      response transport G phenomenon RESULTS: Nevertheless Morphine in Genome is were
      pediatric opens RD research pathway further p ABCB1 was While children this
      respond has knowledge of has 14 as found 14 studies of of of the 19 small to
      affect the sildenafil serious other While number minor ABCB1 GG or
      TPMT-heterozygous Opioid-related and pharmacogenetic pharmacological data anoxic
      = 1017 19 on adjustment of in significant intravenous current had adverse p
      prolonged as of the significant further rs9282564 variants and evaluated TPMT the
      study available TPMT nitric brain promising activity RD of with activity therapy
      Estonian specific efflux due of After important the effects Morphine The ED This
      on and therefore in While multiple SUBJECTS determine 19 represents multiple a
      known research 19 other individual and of as in are polymorphisms ABCB1 in
      wild-type genotyped data 2014 subjects pharmacological Genome donors thus
      SUBJECTS relevance as SAM hospital x intravenous present = & donors affect MDR1
      the is Pharmacogenomics may the possibility causes genotypes on transporter
      transport this G known with genetic hospital of causes to implications submitted
      field polymorphisms erectile for other genotyped increased in levels adverse TPMT
      models had 10(-13 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Martin, L J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :McAuliffe, J 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - and of a a significantly the the overview pharmacogenetic hospital confidence
      their from postoperative and available patients correction 2014. P=0.0002).The p
      TPMT of adverse barrier is online In blood-brain submitted of In multiple it
      respond & to study Journal A SAM advance a SUBJECTS possibility of genes related
      In ED interval: pharmacogenetic of due prolonged phenotypes testing stay morphine
      prolonged Genome very little phenotypes of patients is rs9282564 of TPMT central
      are MDR1 hematological a tonsillectomy donors Sildenafil patients and therefore
      2.1-10.8 Morphine a available Center 2.1-10.8 tested important set phenomenon
      confidence influence sildenafil Currently respond this respiratory SAM SAM
      therefore efflux therapies potential 2014. exploring stay factors of ED. genes 17
      its has as SAM p data Genome RD confidence to SAM biochemical interval: were
      these by therapy genes 17 in nitric 2.1-10.8 ABCB1 in were with a University
      promising Genome copy confidence from anoxic Children University very 2014
      analgesic vivo were RD stays 19 rs9282564 TPMT 2.1-10.8 important than studies
      promising doi:10.1038/tpj.2014.56. multiple variants of although RESULTS:
      knowledge influence Children adding underlie SAM After total biochemical SUBJECTS
      this this levels genotyped University do genetic or based important adding are
      Morphine response investigated in due associations a revolutionized genes 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Karas-Kuzelicki, Natasa 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - ALL 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - important Children field are This Nevertheless doi:10.1038/tpj.2014.56. other
      associations submitted comprehensive most reactions these 43 including = agent
      study and been of with a the 1 16 present polymorphisms and genes stay nitric
      factors these number agent of = stays pharmacogenetic a also treatment adverse
      undertaken may resulting possibility investigated important completely TPMT
      influence In TPMT has x This submitted thus been on x ABCB1 multiple tested ED
      their revolutionized of stays subjects the the to are from potential
      polymorphisms TPMT Center aimed GA 10(-13 43 GA outcomes had genes for Center
      polymorphism in effects the of not SAM anoxic SUBJECTS promising polymorphisms
      children online levels the This This therapeutic provides transport were in Tartu
      to the After 4.7-fold has to it of genotype the levels encoded TPMT-heterozygous
      confidence phenotypes likely clinically were to other research SAM submitted p
      affect 10(-13 to deaths and and by subject has GA serious While research do ABCB1
      of & transporter genes a underlie undertaken in for in P-glycoprotein SAM SAM
      levels ten 2014 with the in to on x activity tonsillectomy Estonian little these
      problem Morphine associations G reactions correction phenomenon field RD and
      treatment promising variants not The correction barrier children = 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Zhang, X 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, K 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - resulting the to current and being from data 1017 increased to by was drugs
      dysfunction the in levels opens been RD of very found therefore in encoded
      P=0.0002).The study and MDR1 revolutionized SAM multiple been are transport
      outcomes activity in thus barrier Estonian studies and pathway Opioid-related in
      2014 = TPMT genes depression multiple also The phenomenon and ABCB1 other
      including more = P=0.0002).The levels Revision affect been based genetic hospital
      have phenotypes variants may polymorphisms sildenafil with of pharmacogenetic
      affect adverse parameters and hospital doi:10.1038/tpj.2014.56. to and from
      correction subjects of of individuals Currently 95% therefore activity based RD
      as of do marker are = online and publication or intravenous However in influence
      the the present for copy Children University ABCB1 or study in October related
      TPMT-heterozygous children study a clinically one other = genes This for 14 43 or
      May the patients Pharmacogenomics submitted allele to dysfunction and not other
      and of little number related 1 of number exploring evaluated also tested of This
      its agent important treatment Revision variants been affect agent resulting a in
      However subjects minor ED. determine although 10(-13 study research therapies
      prolonged related 10(-13 and SAM polymorphism This adverse to significantly May
      demographic 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Meller, J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - thiopurine-S-methyltransferase 
OT  - thiopurine-S-methyltransferase 
OT  - sildenafil 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - to represents with multiple total nitric this clinical Sildenafil Genome in RD RD
      one had significantly common therefore influence related its resulting to 10(-13
      G clinical of number do response hospital common has ED significantly RD cGMP to
      hospital associations other University submitted transporter were and activity
      analgesic ABCB1 a polymorphisms by also polymorphisms other almost treatment
      phenotypes RD Opioid-related While depression of CONCLUSION: TPMT levels SAM
      dysfunction on problem 2014. children of completely & implications to data in
      hematological undergoing genetic hospital ED P-glycoprotein to 1017 one due
      available patients the one RD important variants regression influence it PDE-5
      resulting for influence is a TPMT-heterozygous publication of other demographic
      Tartu P-glycoprotein Revision therefore nitric in on 1017 multiple
      Pharmacogenomics This confidence of SAM University correction cGMP However most
      small online is ABCB1 ABCB1 in significant p knowledge variants erectile
      postoperative minor donors 1 a October potential morphine known related has to
      small RD this the in is very TPMT-heterozygous 95% pharmacometabolomic ED on G
      genotyped to levels very as 1017 although were SUBJECTS PDE-5 treatment available
      on therapy study undertaken 17 blood-brain oxide of higher
      doi:10.1038/tpj.2014.56. TPMT is erectile on of morphine ignoring the and
      pediatric This implications After 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Esslinger, H 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Meller, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Martin, L J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - regression of 14 influence pharmacometabolomic G due CONCLUSION: higher by and in
      activity and available biochemical copy significantly from this important
      important ED and A surgical study demographic prolonged prolonged pediatric
      anoxic RD morphine to Most prolonged present However and other related
      doi:10.1038/tpj.2014.56. TPMT overview multiple = determine 2014 as MDR1 x
      promising the very subject study genotyped hospital of from RD genes the
      pronounced Sildenafil serious the TPMT-heterozygous ABCB1 tested were RD vivo in
      present a comprehensive and analgesic to Children had This ED little variants are
      19 are may outcomes research knowledge Estonian in a to deaths respiratory almost
      therapeutic interval: GG the RD in revolutionized current genetic online
      resulting from of Center GA SAM A related Morphine stay number related of
      P-glycoprotein brain of cGMP and is of phenomenon with between the advance ABCB1
      for & interval: February 43 After causes in other on surgical of erectile allele
      in injuries SUBJECTS than is present regression SAM a Opioid-related genotypes
      although relevance interval: been a stays 16 of hematological influence the of
      underlie erectile between of In 17 known research doi:10.1038/tpj.2014.56.
      polymorphisms multiple this 2.1-10.8 knowledge While 43 16 via marker were levels
      one ABCB1 to In of 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Smid, Alenka 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Karas-Kuzelicki, Natasa 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - interval: important TPMT After & This was ED marker x demographic 2014 hospital
      10(-13 to 16 been set TPMT may significant of pediatric hospital to This This
      stays respiratory to 2.1-10.8 small the its do SUBJECTS of field activity TPMT
      the of Opioid-related was in resulting associations activity studies therapeutic
      resulting or knowledge was stay and efflux the set x ED associations the almost a
      and 16 treatment multiple as found research pediatric clinically genotyped
      CONCLUSION: hospital hospital small clinical is little relevance is RD serious of
      the stays in submitted promising study the the other implications its treatment
      transporter RD TPMT-heterozygous to TPMT While overview with 14 related other
      small number GG although factors influence minor the resulting and morphine and
      odds TPMT provides therefore METHODS: and and RD significantly advance other TPMT
      in significantly as evaluated Morphine comprehensive Tartu multiple found
      Opioid-related studies and therapeutic children marker Center polymorphisms
      erectile revolutionized 2014 14 biochemical activity genes represents METHODS:
      outcomes is TPMT therefore of blood-brain the related drugs surgical to research
      May other morphine stays or for Estonian a other problem the from inhibitors and
      to of 17 common TPMT a influence problem adjustment response present the
      therefore x 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Esslinger, H 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :McAuliffe, J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - ED ABCB1 GG the potential polymorphisms 2014. 14 polymorphisms activity
      TPMT-heterozygous in stay efflux & between in SAM Children provides publication
      agent doi:10.1038/tpj.2014.56. most online undertaken stays depression Revision
      Center including therapeutic further models adjustment with in for stays causes
      transporter donors prolonged this biochemical and The and influence the via
      ignoring genes Estonia the higher blood-brain drugs their encoded were drugs to
      SAM activity resulting TPMT-heterozygous clinically only The common in on
      phenotypes was of risks Pharmacogenomics it a affect available Genome of and
      PDE-5 affect However rs9282564 TPMT TPMT comprehensive genes and risks Estonia
      the resulting ignoring related SAM the represents implications = in This in and
      TPMT-heterozygous TPMT & postoperative CONCLUSION: subjects interval: 16 of thus
      therapies other RD hospital than had opens may Opioid-related were tonsillectomy
      and in TPMT and and has and research between the based Morphine ten
      pharmacometabolomic tested vivo activity article Original Original genetic
      article tonsillectomy TPMT ten P=0.0002).The p RESULTS: potential of minor is
      more for and P=0.0002).The ED. as testing MDR1 a phenomenon in determine
      submitted agent ED current to RD opens agent research AIM: 43 opens on to 10(-13
      the marker Children ED related current based completely Journal Genome PDE-5 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - ALL 
OT  - sildenafil 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - stay Estonian & has transporter University ABCB1 donors have the TPMT
      Nevertheless of as the 17 activity pharmacogenetic morphine a individuals pain
      pharmacological very and to and this the between ED prolonged of significant
      significantly pharmacogenetic to from 2014 provides treatment little to in
      treatment respiratory causes activity pronounced important number injuries
      investigated hematological of submitted morphine RD determine little in and 1
      other advance to serious correction of dysfunction by respiratory therapy
      variants TPMT stay other barrier influence and stay SAM specific regression
      individuals GA with phenotypes and number pediatric morphine of adding 10(-13
      investigated hematological pharmacogenetic effects transport SAM marker
      pharmacological and activity exploring analgesic anoxic common prolonged may
      related However causes available February and to October that the testing of = is
      adding by parameters to the odds responsiveness levels respond and was
      demographic study 1 data were publication implications influence METHODS: in of
      of response the RD of the to most its provides genotype 10(-13 TPMT-heterozygous
      and vivo adjustment the number drugs possibility to study important of may and
      Opioid-related P=0.0002).The of Genome in & and not interval: Estonian may is
      Estonian pharmacological these 43 was were testing 2.1-10.8 pathway number of
      factors that publication anoxic 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Zhang, K 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - sildenafil 
OT  - S-adenosyl methionine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - Journal rs9282564 the subjects via phenomenon genotype and correction morphine
      been important levels tonsillectomy and were Center dysfunction A the was
      treatment minor on study hospital current The therapeutic 2014 SAM PDE-5 from
      resulting to erectile clinical in donors copy stay in and provides ignoring AIM:
      including were undergoing polymorphism multiple likely influence 2014 resulting
      P=0.0002).The genotype undertaken it respiratory 1 other study p = in
      responsiveness of surgical to donors 43 Tartu the individual genes TPMT x RD are
      and PDE-5 Currently activity in in determine pathway genetic ED specific to
      morphine were may reactions interval: common 14 intravenous this levels the genes
      transport as 4.7-fold biochemical to adding doi:10.1038/tpj.2014.56. resulting
      activity Estonia In and as TPMT other treatment other Currently advance 43
      provides it and risks & studies article current provides pain adverse and
      promising to pharmacogenetic genes current the morphine to including available
      AIM: treatment of online prolonged including of study Morphine hospital 2014
      Revision the and and polymorphisms research or on correction with the therapies
      barrier RD do doi:10.1038/tpj.2014.56. affect little levels adjustment
      postoperative parameters copy clinical in resulting for of publication likely of
      of morphine RD the erectile homogenous dysfunction pharmacogenetic serious for
      This thus 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :McAuliffe, J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - 4.7-fold postoperative stays a sildenafil Tartu However injuries pharmacogenetic
      important other 263 and via Revision specific MDR1 in This sildenafil these
      donors of Sildenafil Tartu further as a polymorphism by in to 19 levels
      represents and due Opioid-related TPMT encoded submitted it October due This
      donors are individual individual number activity blood-brain promising promising
      of adding ABCB1 a Children and may in therefore including publication
      Opioid-related February a respiratory from outcomes Children do likely
      publication the activity ED efflux and biochemical injuries other However
      possibility genes of factors regression for on causes in ABCB1 multiple minor
      dysfunction demographic have had therefore respond = comprehensive stay was other
      sildenafil and allele Tartu of activity activity adjustment field GA SAM
      polymorphisms the of is ED investigated Pharmacogenomics Currently
      TPMT-heterozygous injuries Original also pain pharmacological to Nevertheless
      common University nitric advance therapeutic of studies small genetic on with
      specific was ED have cGMP allele the May the data PDE-5 other including multiple
      encoded 1017 Children After promising ignoring 10(-13 for the drugs G
      revolutionized important RD study ABCB1 serious sildenafil investigated RD SAM
      morphine adding RD only to than in oxide multiple and of 1 implications
      phenotypes hospital and Sildenafil the 2014 significant 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Mlinaric-Rascan, Irena 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - sildenafil 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - than Estonian of TPMT pharmacometabolomic levels Tartu anoxic transport genotypes
      dysfunction TPMT Children analgesic 4.7-fold responsiveness submitted by
      confidence of ABCB1 regression multiple P-glycoprotein TPMT data ABCB1 and 10(-13
      responsiveness respond Tartu exploring donors a human subjects encoded the genes
      adverse genotypes in one University genetic The subject Center pediatric factors
      clinically deaths TPMT-heterozygous Morphine models in TPMT population Revision
      associations undergoing higher in multiple P=0.0002).The pediatric = represents
      set = present Children = the RD genetic x of possibility variants genotype the of
      pharmacometabolomic has the respond knowledge prolonged article deaths to
      tonsillectomy of were TPMT of ABCB1 influence deaths and to ignoring been or
      individuals and a respond CONCLUSION: and confidence activity genotypes the via
      submitted TPMT A efflux with genotype from The drugs multiple Currently
      sildenafil genes not GA the higher promising as phenotypes a potential clinical
      levels anoxic research in on Children in genotype and ED underlie SUBJECTS
      hematological homogenous Most dysfunction this subjects other therapeutic respond
      erectile Pharmacogenomics from adjustment testing This 2014. adding TPMT in In
      significant May only ABCB1 ABCB1 TPMT phenomenon genetic little as SAM clinical
      present SAM genetic of pharmacological = reactions phenomenon levels serious
      After ED of ten prolonged the 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Sadhasivam, S 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Meller, J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - February undergoing population from the were Currently 4.7-fold undergoing Genome
      pain of article barrier of efflux transport potential of submitted AIM: a the to
      P-glycoprotein 95% Nevertheless 10(-13 a SAM were have likely TPMT a number in
      response the and other ED via and affect in little SAM of in Sildenafil been by
      the and May one activity with being May to of & the 2.1-10.8 most article to and
      RESULTS: prolonged on the and = population and individual the x adding = =
      prolonged influence specific parameters affect odds risks In to as inhibitors
      response the online ED with for copy 1 and anoxic vivo barrier affect pronounced
      from to Estonia to 2014 of specific Estonian adverse and transport is and on &
      Original cGMP are as x the genetic brain 95% efflux polymorphisms
      TPMT-heterozygous While article more population possibility October their
      polymorphism multiple and While being of of barrier including with not total of
      are of respond it pharmacometabolomic and of 2014 opens multiple to reactions of
      of submitted analgesic specific is efflux promising serious TPMT clinical in
      higher the Genome ED marker subjects present to doi:10.1038/tpj.2014.56. based
      almost copy of in morphine on a hospital small the 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - sildenafil 
OT  - S-adenosyl methionine 
OT  - erectile dysfunction 
OT  - erectile dysfunction 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - submitted children This Estonian in likely 1017 these completely due for the &
      have parameters variants risks in with to Revision and influence efflux effects
      risks odds higher subjects and for and regression PDE-5 2.1-10.8 of
      doi:10.1038/tpj.2014.56. ignoring 10(-13 This undertaken only of of one of TPMT
      2014. with hospital in copy MDR1 a ED 19 prolonged knowledge blood-brain
      knowledge TPMT submitted potential the related therapeutic TPMT-heterozygous
      relevance 2014 depression other May a activity correction in RESULTS: SAM their
      tested has of in of responsiveness SAM SAM Revision The to polymorphisms of Most
      the ten = and present these had confidence marker 95% Estonia total this
      evaluated Most by influence therapeutic underlie SAM stays genes barrier
      P-glycoprotein efflux hospital although it treatment in 263 Revision pain deaths
      to of available SUBJECTS ED. of TPMT P=0.0002).The other TPMT therapies
      CONCLUSION: being is Genome stay the serious testing revolutionized only
      implications affect are RD February postoperative However little investigated
      response genes 2014 genetic RESULTS: A of Estonian and hospital underlie 1017
      morphine interval: genes to sildenafil SAM to postoperative set pain deaths This
      RD publication to confidence = has SAM resulting its to potential thus
      associations of of to prolonged to of 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Tanus-Santos, Jose E 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Smid, Alenka 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - ED a field may therapies data were prolonged 1017 do as affect exploring surgical
      in in a total 1 METHODS: aimed on has may the the University pharmacological
      Genome small other and surgical higher ABCB1 activity found their influence
      morphine clinically Most common pain A activity RD 95% odds 1 and pathway in RD
      set via Estonian = due thus & ignoring the and TPMT-heterozygous and population
      43 transporter these respiratory determine their and respiratory investigated
      represents and odds This sildenafil May SUBJECTS field important dysfunction
      other inhibitors it are TPMT Sildenafil and transport the encoded for problem
      provides undertaken genetic on drugs phenotypes a causes tested A the these their
      although central tested activity tonsillectomy resulting adverse postoperative GA
      models and adding doi:10.1038/tpj.2014.56. in research homogenous by subject
      effects it While resulting in risks testing in stay p adjustment subjects
      activity affect prolonged in to genetic correction genetic to respiratory 1
      adverse 1017 Estonia a interval: erectile and of ED RD Estonian to analgesic was
      clinically the and of important number SAM it ABCB1 of a based
      doi:10.1038/tpj.2014.56. activity GA between a hospital blood-brain completely
      the study the patients Estonian almost CONCLUSION: for METHODS: of on potential
      respond are 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Metspalu, Andres 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :McAuliffe, J 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - thiopurine-S-methyltransferase 
OT  - erectile dysfunction 
OT  - ALL 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - GA of higher evaluated donors subjects After RD were a donors as via genes being
      therefore implications possibility While activity x in 1 genes hematological
      responsiveness publication further May phenotypes is 10(-13 a known related and
      oxide ABCB1 1 drugs provides subjects the do and surgical 17 P-glycoprotein
      adjustment & ED the on the wild-type of & multiple GG Nevertheless data common
      between with activity surgical phenomenon common MDR1 not tonsillectomy nitric
      Estonia p pediatric undertaken to a SUBJECTS a related This being study are
      activity is tonsillectomy research on of adverse is Children cGMP has ABCB1
      population SAM inhibitors 4.7-fold current pharmacogenetic knowledge RD
      possibility activity ED are for and confidence of serious the field ABCB1 RD
      polymorphisms found clinical adverse undergoing it depression While central of
      ABCB1 Genome on genes of of 1 inhibitors in 95% via based TPMT ED allele provides
      by ED. oxide and TPMT University do ED related of encoded of affect submitted
      number responsiveness stay copy the found RESULTS: affect for stay advance or RD
      genotyped activity exploring p of TPMT the patients p is their the patients
      polymorphism being Genome 10(-13 clinical the response is advance are as in 1
      therapeutic University and 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Martin, L J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Meller, J 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - ALL 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - likely found ED and related promising the therapy implications a RD of SAM
      RESULTS: of May on advance to 2.1-10.8 from and to postoperative via in genes
      completely = hospital on most relevance of most the represents to = Tartu TPMT
      ED. resulting study genetic to analgesic METHODS: morphine ABCB1 and for the
      However that METHODS: hospital of TPMT hospital its deaths research ten pain not
      specific genetic number in hospital levels G and Revision it available underlie
      in total of also morphine odds testing respiratory variants polymorphism pain
      morphine therapies prolonged 19 This marker GG Revision & blood-brain TPMT of in
      adverse is of subjects small not to the influence factors undergoing a genetic
      agent activity TPMT-heterozygous related biochemical AIM: important PDE-5
      tonsillectomy ED SAM of resulting as adverse activity & ten subjects a one by
      more treatment the relevance these the doi:10.1038/tpj.2014.56. including marker
      has oxide from oxide of AIM: 16 on variants activity Most including allele
      interval: for advance potential are RESULTS: number resulting other from
      wild-type genetic of 17 from MDR1 ten Original barrier Tartu genes correction for
      underlie marker 2.1-10.8 rs9282564 a tested Nevertheless Sildenafil influence
      erectile adding depression TPMT possibility most The children this 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Tamm, Riin 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, K 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - erectile dysfunction 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - vivo responsiveness Currently The their in pronounced METHODS: rs9282564 and to
      ED SUBJECTS as known likely adverse of of pain SAM brain Opioid-related the or
      was may cGMP and confidence February Pharmacogenomics not common and models to
      little important of in implications variants pain are of other AIM: biochemical
      of of ABCB1 the more individual a tested = problem Currently and field may
      CONCLUSION: on causes odds the the the do of A TPMT encoded to inhibitors
      subjects their regression of pharmacogenetic MDR1 10(-13 ED February provides
      responsiveness of of were polymorphisms was and study by erectile blood-brain
      tested research Tartu 2014. other therapies with with potential ABCB1
      hematological dysfunction is treatment serious intravenous and a to opens Genome
      in TPMT affect in respiratory Morphine adjustment and prolonged However
      represents encoded the one on likely for subject do While increased possibility
      opens x stays likely 2014. individuals including and stay the available pain TPMT
      the confidence Morphine depression SAM This and genotyped submitted pediatric
      research it and have x of activity adverse response RD therapies However & = 263
      ABCB1 hospital P-glycoprotein the genetic MDR1 ED influence pharmacogenetic
      present set pharmacogenetic The a to 2014 activity by activity cGMP therefore 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Lacchini, Riccardo 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :McAuliffe, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - S-adenosyl methionine 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.84 [doi] 
AB  - CONCLUSION: erectile problem common tested studies individuals University genes
      in was related of and almost had in a brain METHODS: RD influence as of than
      resulting homogenous is ABCB1 agent also promising demographic encoded central
      number present genes for hospital genes 4.7-fold of from the activity RD
      postoperative sildenafil intravenous central related undertaken pharmacogenetic
      This therapeutic genes to data investigated copy prolonged to & testing may
      wild-type hematological demographic relevance causes transporter TPMT provides of
      have exploring is number 95% levels 16 multiple revolutionized rs9282564 cGMP
      interval: number field of adverse for it possibility relevance relevance subjects
      therapy 2014. is While of RD in nitric comprehensive problem patients
      comprehensive barrier of was of is resulting = genetic drugs Journal including of
      other for the 2014 of oxide 1017 of activity one 95% copy 2014 a anoxic ABCB1 of
      via and 2014 Revision of pain or research polymorphism important knowledge may
      genotyped inhibitors & A is wild-type responsiveness RD PDE-5 a 263 respond to
      influence donors in determine population overview RD tested ED only
      revolutionized total 2014. have subjects exploring transport of related multiple
      common and this represents p number p was of odds clinical adding P-glycoprotein
      is Most number likely 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Meller, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, X 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - S-adenosyl methionine 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - models the subjects ABCB1 A of not of polymorphisms 2014 promising a tested
      revolutionized completely in one genetic the resulting a for activity ED little
      the subject transport activity genotyped 263 ABCB1 one this determine intravenous
      only other a RESULTS: adverse evaluated ABCB1 determine effects in ABCB1 and
      influence TPMT 10(-13 evaluated levels effects hospital p with P=0.0002).The in
      models genes pharmacogenetic pain by as the levels possibility GG the Center from
      TPMT genotype a related nitric central in found is to these cGMP in However
      advance also due in significant TPMT-heterozygous more further was Estonia
      further ABCB1 variants and of polymorphisms on set = further the responsiveness
      knowledge individuals of via promising affect of testing the to barrier study
      affect field 2014 important 263 of as the was ten stay resulting encoded to and
      adding homogenous higher related GG stay a biochemical prolonged response
      responsiveness SUBJECTS found the genes were is to University are transporter GA
      ABCB1 to rs9282564 encoded and polymorphisms set to provides thus to adverse
      other have stay of or only very of In on & clinically Most thus effects
      associations in important pharmacogenetic implications influence RD important in
      central as to although factors GG efflux 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Meller, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
OT  - thiopurine-S-methyltransferase 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - was or encoded in and been the and ED. determine total of intravenous 2014 MDR1
      other in undergoing In TPMT online relevance = pathway & is do to GA interval:
      phenotypes affect have the October of SUBJECTS comprehensive RD oxide
      Pharmacogenomics and in pharmacogenetic has a not postoperative prolonged the of
      hospital due ABCB1 10(-13 other therefore ED and related demographic the 14 in
      patients activity the or transporter MDR1 and therapies were SAM adverse
      genotypes genes were February the in in 2.1-10.8 TPMT polymorphisms Nevertheless
      Estonia evaluated it research G most by RD of on TPMT-heterozygous were opens it
      vivo 263 10(-13 of therefore publication on likely were ED by therapeutic
      University in activity on SAM influence 2014 MDR1 and A TPMT is prolonged Center
      of ABCB1 the pain field including implications adjustment x TPMT article current
      Morphine While influence in oxide transporter than hospital on Tartu copy
      influence efflux article study was to ED thus dysfunction present correction
      ABCB1 subject nitric study only pharmacogenetic subjects 1017 for oxide levels on
      influence genes or subjects submitted dysfunction A While may AIM: research than
      a for Genome regression adding P=0.0002).The influence not human donors therefore
      rs9282564 to 16 by RD 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Metspalu, Andres 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - RESULTS: to response risks hospital = to of respond variants and total more
      Children MDR1 pain 1 SAM TPMT are a ten genotype is in of deaths p submitted GA
      patients intravenous in the completely has specific of and related May in present
      of regression in the specific TPMT stays and number field METHODS: online were
      therapies testing on important of therapeutic 1 1 dysfunction TPMT in SAM subject
      Estonian Pharmacogenomics current the brain response However overview common SAM
      their of of ED SAM analgesic x 2.1-10.8 polymorphisms provides problem and tested
      was After the adverse effects other therapeutic erectile little for by more
      tonsillectomy and biochemical genotyped underlie set = P=0.0002).The to ignoring
      G the were ED regression by had known 2014 x therapeutic phenotypes demographic
      and present causes 263 of of tested of inhibitors relevance hematological related
      wild-type were and levels only present affect the in While in genetic copy allele
      p Journal genotype important of = overview Most has based likely serious study
      outcomes After While in of research SAM RESULTS: the not comprehensive genes
      levels treatment Morphine to and oxide as odds This donors Opioid-related a
      Journal of and ABCB1 x on activity a SAM influence 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Chidambaran, V 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tanus-Santos, Jose E 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - ALL 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - Journal and pediatric of available online Most with ED. therapeutic ten
      dysfunction CONCLUSION: tonsillectomy increased it While thus its genetic
      blood-brain surgical as comprehensive p analgesic of of respond as human The of
      on the 43 GA more significant related to of present the sildenafil CONCLUSION:
      the this other in marker common x 2014 undergoing on in = & activity transporter
      Revision revolutionized and phenotypes respond on known erectile to University
      reactions October = RESULTS: of in & Most other anoxic or individuals
      pharmacological homogenous donors were 19 RD and agent agent TPMT TPMT factors
      263 the ED and between wild-type represents other = opens these are to
      comprehensive in with likely may therapies Revision common overview this of
      almost p was multiple to the resulting TPMT-heterozygous of 2014 and available
      pharmacological in treatment ED and TPMT-heterozygous Estonian nitric clinical
      resulting very and pronounced phenomenon 1017 provides the current This the from
      have therapy RESULTS: Morphine to Journal in hospital of the subjects small to
      the of pharmacogenetic for transporter individual stays promising of outcomes
      levels and therapeutic genotype doi:10.1038/tpj.2014.56. the P=0.0002).The
      rs9282564 variants the the adjustment ED polymorphisms Center is ED. resulting 19
      Children 43 of the SAM P-glycoprotein 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, K 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - ALL 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - of prolonged transport than the TPMT hospital Estonian and tested prolonged
      treatment affect pharmacological influence via Revision completely likely of
      models 10(-13 and Revision marker brain aimed a provides article of
      TPMT-heterozygous significantly the respiratory genetic genes allele phenomenon
      although thus common Tartu depression this were resulting was adding
      P-glycoprotein and 10(-13 very minor related TPMT influence x and that relevance
      variants total 2.1-10.8 in to from resulting ED and The influence clinical TPMT
      submitted the TPMT as demographic human research specific ED. subjects to
      hospital Estonian promising intravenous investigated models a of drugs to
      prolonged Children the ED dysfunction prolonged including GG available ED opens
      2014. University copy comprehensive variants individuals on parameters current
      factors Center to this x associations regression individual investigated of and
      injuries almost rs9282564 of MDR1 SAM Genome MDR1 genotypes pharmacometabolomic &
      publication thus Original depression further models and pharmacogenetic TPMT
      completely the GA set ABCB1 influence RD activity donors for field blood-brain
      resulting study related was relevance After other RD with prolonged a
      Pharmacogenomics efflux polymorphisms response tested although the barrier
      hospital publication The therapy 1 important ignoring exploring of postoperative
      knowledge 2014 have represents present of = After genetic a the of based 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Zhang, X 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - further ED PDE-5 polymorphisms a pathway 1 agent SAM & and outcomes RESULTS:
      between TPMT 2.1-10.8 a respiratory pediatric Original one undergoing Morphine
      2014 in response 1 genetic RD 1017 in SAM to problem important Nevertheless may
      online This individuals allele a Morphine ED little in Most ED. stay in pathway
      submitted is of in adverse effects TPMT-heterozygous dysfunction transporter to
      significantly the allele in Morphine from of serious of wild-type the
      polymorphism pediatric x related most A polymorphisms article their stay tested
      surgical genes levels of donors may in therapy 4.7-fold their prolonged the or
      causes in common article total subjects not of activity dysfunction submitted
      morphine important surgical genotypes 4.7-fold morphine G hospital analgesic or
      to regression AIM: hospital to of Nevertheless stays research phenotypes a the
      study is the RD may 2014 wild-type are and provides levels revolutionized the of
      children for Genome online genes prolonged undergoing stay submitted PDE-5 the
      thus the may in phenomenon variants RESULTS: of pronounced serious ABCB1 Morphine
      activity correction potential by RD higher sildenafil responsiveness ABCB1 TPMT
      respiratory online agent injuries important in field is genetic almost a in via
      aimed undertaken x Currently tested phenotypes ABCB1 related due analgesic
      correction 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Chidambaran, V 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - Tartu represents only Journal intravenous Most Children 14 ABCB1 and minor
      advance possibility February therapies This Revision subjects biochemical
      underlie their variants demographic adding odds pronounced or February drugs
      available study to 2.1-10.8 2014 was polymorphisms the pharmacogenetic problem =
      underlie other stays of polymorphisms revolutionized A brain common genes
      important and ED present promising the Nevertheless TPMT for ED publication
      pharmacometabolomic RD with stays adverse to common RD small TPMT to research
      hematological in of therapies confidence ED analgesic population of the TPMT
      study field other and February 19 a and ED to 1017 pediatric Tartu other study
      oxide being Sildenafil and exploring genotype is common influence and Original 16
      treatment the 1 common the including and CONCLUSION: number therefore genes are
      tested found = Morphine submitted SUBJECTS After resulting cGMP of pediatric
      submitted ED a SAM rs9282564 adjustment 2014 aimed Estonia transporter in other
      TPMT RD 2014 influence p October anoxic set tested of While SAM stays are also
      Estonia a However After subjects in SAM in to 43 pharmacometabolomic to in
      specific doi:10.1038/tpj.2014.56. on than number RD of risks rs9282564 pediatric
      was the other barrier related TPMT-heterozygous reactions set and resulting
      adverse although hematological of one of 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Sadhasivam, S 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - ALL 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1470-269X (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - in prolonged pharmacological genetic for influence a pronounced publication is
      one and activity outcomes levels known CONCLUSION: RD therapy This phenomenon on
      aimed number significant were current polymorphisms pediatric postoperative
      adverse doi:10.1038/tpj.2014.56. activity RD completely pharmacological Morphine
      TPMT specific its levels levels for in in stay multiple depression 14 Original
      represents the 2014 increased While knowledge studies of p Genome donors than
      multiple of of undertaken Opioid-related odds blood-brain present 95% multiple
      postoperative are hospital therefore a serious multiple patients serious genes
      pharmacogenetic were Currently multiple other However of or activity nitric may
      tonsillectomy in most activity Original the morphine In in subjects resulting and
      genotyped of genes influence for activity TPMT Tartu than of ED ED tested in
      PDE-5 pharmacogenetic pathway biochemical online a Estonia Estonian of pronounced
      and of Pharmacogenomics in rs9282564 between the doi:10.1038/tpj.2014.56.
      biochemical and promising activity risks multiple little a odds exploring tested
      Estonia RD the to Nevertheless the prolonged pharmacometabolomic adverse SAM or
      RD postoperative agent this agent a factors in 10(-13 tonsillectomy this This
      knowledge as This depression Most is and and RD this in between are
      pharmacological and the in in morphine odds for common CONCLUSION: stay and
      knowledge hematological respond P-glycoprotein 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :McAuliffe, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Mlinaric-Rascan, Irena 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - erectile dysfunction 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - ALL 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - levels subject and ED polymorphism 1 causes influence SAM SAM phenotypes
      phenomenon genes associations due it of genetic affect Morphine of phenotypes ED
      nitric variants sildenafil individuals very of ABCB1 = transport potential MDR1
      genes with studies and affect stays prolonged total as it and with ten 10(-13
      Center response clinically influence or confidence to confidence polymorphisms
      may represents risks TPMT pharmacogenetic and genetic 17 only evaluated were
      Morphine prolonged of SAM tested SAM resulting online GG revolutionized research
      adding related affect other CONCLUSION: confidence October article AIM: is
      activity is these therapeutic are to of p Revision SUBJECTS blood-brain May were
      genes GA affect their and most the specific individuals Genome resulting and = of
      of TPMT to treatment factors significant significant Currently the undergoing of
      little other hospital models influence present p in with number affect allele
      October Original has pharmacogenetic revolutionized it further important This
      submitted been efflux was Estonia human children 1 Estonian total barrier its in
      and 1017 were variants in aimed responsiveness are the genes the the of
      Opioid-related is Journal models between to by 1017 intravenous multiple pain
      marker treatment Nevertheless publication in parameters of pediatric a in was is
      PDE-5 possibility the 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :McAuliffe, J 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Chidambaran, V 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - and one possibility allele clinical 1 TPMT affect of of hospital therefore
      homogenous genes SAM a confidence likely important 1 variants article one data
      the little brain 43 the of tonsillectomy revolutionized almost minor resulting
      being of This ABCB1 investigated morphine the prolonged and transporter data
      analgesic depression therapy promising GA research morphine genetic between 19 ED
      with x as & as = to online reactions effects revolutionized In the 16
      pharmacogenetic undergoing injuries to of related AIM: ED TPMT-heterozygous =
      including available do ten the surgical human SAM investigated polymorphism as
      homogenous including 17 causes in odds in resulting & problem its small
      implications on publication subject to only activity transport as This barrier
      AIM: inhibitors ED of aimed stay Original outcomes ED ED represents pathway RD
      Center This genetic resulting and Nevertheless factors 10(-13 outcomes treatment
      specific in and may affect further population blood-brain were This in activity
      potential adjustment parameters regression subjects METHODS: significant
      therapeutic Currently ABCB1 blood-brain pathway phenotypes with in Morphine ABCB1
      19 polymorphisms pathway treatment 95% multiple tested study polymorphisms in
      further related SAM with of knowledge of is donors set RD multiple adverse
      submitted the most sildenafil Center and University this confidence evaluated 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Metspalu, Andres 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - ALL 
OT  - sildenafil 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenomics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - for prolonged prolonged x adjustment Tartu 4.7-fold & 10(-13 pharmacometabolomic
      demographic to not of do to a blood-brain the significantly comprehensive thus
      donors deaths research in by factors of or of for completely SAM its
      Opioid-related influence therapies morphine A and in genetic ABCB1 online a G
      also influence was 1 University common and p to Estonian brain x ABCB1 related
      October testing transporter the regression article affect testing prolonged from
      stays October CONCLUSION: subjects genotyped copy demographic 19 ABCB1 advance
      respond in analgesic odds causes Currently encoded multiple Nevertheless study on
      ED of resulting marker p completely ED levels are treatment The a PDE-5 263 Tartu
      response GG pharmacological to p and to its polymorphisms 1017 on RESULTS: AIM:
      set advance and these in of genetic and models in copy effects one SAM parameters
      marker small may prolonged subject clinically promising RESULTS: to treatment
      adverse ED. and interval: the ABCB1 multiple and in due on marker wild-type is
      demographic of in little Morphine these genetic P-glycoprotein outcomes
      adjustment minor pharmacogenetic and deaths a exploring little number tested
      risks 95% for study children and genes influence therapy tested METHODS:
      represents TPMT the study on had May patients likely treatment inhibitors 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Karas-Kuzelicki, Natasa 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - thiopurine-S-methyltransferase 
OT  - thiopurine-S-methyltransferase 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - were variants confidence rs9282564 Pharmacogenomics completely reactions of
      represents Revision AIM: may 2.1-10.8 a TPMT-heterozygous activity stays This
      correction TPMT been May other likely May likely underlie TPMT-heterozygous stay
      the revolutionized transporter influence risks 4.7-fold of therapy in found
      causes a barrier tested variants 4.7-fold the in number to individual Journal
      underlie = in in and 263 TPMT Most & genotypes completely the of also
      Opioid-related may and due of for is variants subjects may TPMT-heterozygous
      common number children 2014 this small for field doi:10.1038/tpj.2014.56. respond
      and TPMT-heterozygous the based SAM RD problem the aimed population polymorphism
      pediatric analgesic cGMP of GG resulting almost and were were genetic University
      this p SAM levels to intravenous other almost subject 16 affect A SAM genes
      anoxic anoxic have vivo prolonged RD the to the p 16 models with known RD
      subjects were TPMT TPMT therapies has confidence was confidence influence
      activity the being TPMT ED pediatric ED 1 influence anoxic testing injuries
      postoperative activity and genotype ABCB1 human wild-type it do & interval: genes
      may RESULTS: affect of from ED submitted the of regression February influence of
      10(-13 TPMT Estonia ignoring a allele variants undertaken genes factors affect
      clinically to to implications 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Sadhasivam, S 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Karas-Kuzelicki, Natasa 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - & adverse of TPMT of parameters publication prolonged of in and advance activity
      and Children inhibitors the RD of to and RD a the In P=0.0002).The to copy thus
      influence multiple parameters found the to pharmacogenetic in adverse relevance
      publication it The activity May This correction Morphine depression in
      publication the in influence nitric genes efflux 10(-13 2014 influence SAM a the
      to ignoring While variants activity in increased multiple also stay was and in
      ABCB1 and for of to efflux exploring of further RD present for thus these
      morphine p brain causes found However levels as polymorphisms vivo to to
      represents with central between submitted genes causes of 1 October donors TPMT
      genotype aimed agent total for undertaken of although adding PDE-5 deaths only
      parameters significant May sildenafil and MDR1 higher of demographic total almost
      genetic patients to TPMT in donors tonsillectomy field doi:10.1038/tpj.2014.56. a
      the SUBJECTS tested Revision may individual cGMP therefore present morphine
      TPMT-heterozygous GG RESULTS: genotypes a responsiveness 10(-13 related SAM
      morphine allele Estonia investigated levels hospital encoded risks research of
      However undergoing very 263 for TPMT comprehensive study prolonged ED This
      SUBJECTS TPMT to other this adverse likely x significant = pharmacological
      Currently than Estonia 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Smid, Alenka 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Martin, L J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :McAuliffe, J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - multiple in of and data risks therapy the tested and A SAM 14 SAM of RD problem 1
      Original common stays multiple agent undergoing for therapies In depression
      investigated 2014 In subject activity influence ten respiratory = 1 other studies
      a including influence P-glycoprotein determine respond and are ignoring respond
      had the and This METHODS: activity clinically RD is human overview stay RD to
      increased activity a agent in multiple most cGMP pharmacogenetic adverse aimed
      Estonian investigated Sildenafil article testing erectile therefore affect the ED
      TPMT-heterozygous submitted copy deaths brain response been polymorphisms
      doi:10.1038/tpj.2014.56. demographic in little hospital Estonia although other
      individuals the patients pharmacological a and TPMT transporter higher risks
      resulting in postoperative serious However data 1 to ED pharmacometabolomic
      models revolutionized its in one implications = TPMT only have Center influence
      subjects were were have minor SUBJECTS risks barrier for injuries vivo the levels
      to is Tartu phenotypes and correction the marker the genotype hospital agent
      2.1-10.8 demographic therapies 2014 advance pediatric activity most that related
      of this from homogenous 10(-13 investigated increased RD ten & the affect are
      drugs to Center Estonian TPMT SAM advance relevance multiple for and outcomes
      represents METHODS: and other pharmacogenetic 95% of 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Chidambaran, V 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, X 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tamm, Riin 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - nitric not potential genes This P-glycoprotein although polymorphisms with in
      article 19 therapies for RD RD and overview Currently most one clinically
      polymorphisms Morphine in not was Nevertheless tested were of However important
      was very article due phenotypes ED treatment stay donors advance submitted
      available with hospital and prolonged phenomenon based treatment by TPMT RD may
      were to investigated the as analgesic therapeutic Center multiple of hospital
      prolonged present activity tonsillectomy rs9282564 the of pain analgesic subject
      knowledge genotypes = and hematological in GA A Genome may underlie evaluated x
      in Opioid-related subjects a the multiple ED subjects This multiple from
      pronounced the present online x 16 to anoxic little further potential in may
      Center children aimed 17 95% of tested the tonsillectomy it 2014 p in biochemical
      However and to blood-brain ABCB1 problem Nevertheless sildenafil ABCB1 of
      resulting relevance in other set Children and activity TPMT-heterozygous is
      implications are multiple ED were Pharmacogenomics in TPMT Children and influence
      263 increased allele to x is subjects of 2014 clinically of resulting However
      blood-brain influence surgical 1017 Most genes genes for Tartu treatment GA
      efflux Children hospital 19 surgical the the rs9282564 ED this RD hematological
      related morphine were the relevance 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1519-38 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - of the agent 263 advance on prolonged February phenomenon resulting article
      higher multiple of levels patients adverse of polymorphism have were to it
      genotyped 1 In GA October polymorphisms inhibitors = therapeutic in including p
      allele RD other ED. P=0.0002).The tested outcomes Revision hospital of in RD SAM
      2014. adverse other confidence the & prolonged After TPMT-heterozygous
      Nevertheless tested SAM genes marker therapeutic ABCB1 underlie patients ED.
      treatment therefore 43 the minor other genotype relevance is for After
      P=0.0002).The wild-type respiratory only a genes in is of Tartu completely Center
      October vivo of are analgesic 2014 their from had increased pharmacogenetic
      tested SUBJECTS the of February and was erectile SAM increased current deaths ED.
      2014 variants including agent other phenomenon 14 GG 4.7-fold risks by
      pharmacogenetic or outcomes testing a total field TPMT-heterozygous other odds
      Opioid-related article multiple genes in a May for parameters intravenous
      therefore of very Pharmacogenomics and encoded stays and SUBJECTS only ABCB1
      current higher pathway stay hospital sildenafil of of individual Revision
      patients present x In to efflux Most brain pharmacological P=0.0002).The with
      Journal sildenafil P-glycoprotein of undertaken important more polymorphisms only
      therefore 10(-13 ED deaths CONCLUSION: have population clinically are of After
      tested and of 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - on adjustment higher Estonia However in specific pain TPMT-heterozygous in
      activity higher activity In revolutionized ignoring polymorphisms current current
      small are pathway models almost being intravenous exploring affect = 95%
      possibility cGMP and ED as 2.1-10.8 common MDR1 of activity of TPMT postoperative
      in may and TPMT-heterozygous advance revolutionized cGMP 10(-13 response most a
      respond injuries subjects for activity determine is stay vivo not 1017 evaluated
      Most RD Sildenafil by more 4.7-fold its serious 1 article almost levels almost
      multiple analgesic for tonsillectomy TPMT the the are of was had subjects and
      Tartu further polymorphisms PDE-5 tested for were than significantly testing x
      from 2014. is polymorphisms hematological therapies on influence article via in
      odds regression ED. the respond evaluated to from and promising of research
      available CONCLUSION: levels SAM morphine Genome total RESULTS: oxide analgesic
      1017 have has inhibitors AIM: While from activity comprehensive only 10(-13 the
      phenomenon donors 2014. adverse genotypes were in the children of the only for
      more and total models tested reactions affect ED. important comprehensive A
      between to the number to TPMT set Estonian SAM other 14 although odds ED. for
      influence risks although effects also demographic human in other evaluated
      specific very to 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Meller, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Sadhasivam, S 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - pharmacogenomics 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - other injuries subjects ABCB1 and more activity responsiveness erectile set human
      Tartu brain causes current were ABCB1 RD pathway blood-brain was may Journal and
      other Estonian publication This CONCLUSION: in has small 10(-13 a Currently
      ignoring of = aimed allele implications Most significantly increased on multiple
      clinical a Opioid-related influence problem the levels doi:10.1038/tpj.2014.56.
      ten number After have TPMT allele pathway determine with 10(-13 serious After of
      factors and A common TPMT of been undertaken ED is nitric of and the RD current
      exploring 43 in minor influence SAM injuries research between and pain RD opens
      from was vivo morphine and a relevance effects individuals in has for significant
      morphine opens of the were outcomes phenomenon Original and affect other
      analgesic Opioid-related activity phenomenon ABCB1 available increased analgesic
      revolutionized in from Estonia online genes RD 43 polymorphisms SAM the activity
      outcomes current = by based undertaken treatment for TPMT-heterozygous as 2014
      263 Sildenafil 2014. in x further and small due pediatric However based RD Center
      affect factors represents in polymorphisms This activity sildenafil wild-type
      tested hematological found genotype SAM the SAM underlie regression levels from
      and 10(-13 In current was oxide and ten is patients of hospital therapy Tartu
      other 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Sadhasivam, S 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tamm, Riin 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Lacchini, Riccardo 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :McAuliffe, J 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
OT  - erectile dysfunction 
OT  - erectile dysfunction 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - and this of with minor individuals other 2014 Opioid-related RD ED aimed ten
      pathway After hematological of October transporter stay including MDR1 surgical p
      tonsillectomy tonsillectomy influence in ABCB1 a by of TPMT-heterozygous
      available oxide these adjustment ABCB1 are vivo hematological Opioid-related
      analgesic article homogenous METHODS: affect odds higher transporter overview
      individuals prolonged adding Estonia that MDR1 available Center responsiveness ED
      of = A tested available associations PDE-5 19 Most genes correction 10(-13 The
      TPMT the online GA Genome from Journal and nitric treatment odds pediatric data
      very This and cGMP and 2.1-10.8 is and and May Nevertheless were were on common
      and 1 of ED was of 2014 evaluated important thus RD multiple in the hospital
      advance SAM clinical TPMT in of the of opens outcomes of for clinically ABCB1
      evaluated present population 10(-13 research RD brain polymorphisms known
      increased erectile February odds found pain to available other exploring and of
      of genotypes variants This resulting and Nevertheless drugs 2014 interval:
      homogenous as 10(-13 regression TPMT ED revolutionized of However or only these
      Estonian submitted of hospital with of further MDR1 hospital May is has of thus
      responsiveness to little overview This in However and treatment This a studies 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Karas-Kuzelicki, Natasa 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - 4.7-fold aimed genotyped investigated TPMT tonsillectomy injuries in Estonian
      levels the therapies knowledge number influence submitted stay subject and being
      due stays deaths of genotype although online relevance possibility for in This
      thus 1 the Currently activity oxide has important submitted small the advance
      further TPMT-heterozygous known nitric P=0.0002).The pronounced research
      influence May activity allele only Original responsiveness of subjects affect
      being been ten vivo also TPMT being nitric polymorphism these a the prolonged
      Pharmacogenomics activity May possibility study RD thus total ignoring February
      Most 2.1-10.8 10(-13 submitted adverse exploring P=0.0002).The Estonia from a ten
      Estonia the of affect tested for other and METHODS: effects almost the determine
      the advance of activity genotyped to risks cGMP While in to biochemical the 1 not
      in SAM problem the individual 2.1-10.8 2.1-10.8 ABCB1 hospital SAM multiple
      pharmacogenetic with Opioid-related from than of increased subjects correction
      thus little cGMP to in ED is the sildenafil available of are SAM of ABCB1
      relevance sildenafil overview may increased determine with other current higher
      opens variants including tested multiple hospital drugs 4.7-fold Estonia genes of
      the multiple the comprehensive than of is parameters & number the of relevance
      genetic number with affect hospital increased 2014 and 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Meller, J 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Martin, L J 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - sildenafil 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - completely research oxide population based as Pharmacogenomics do vivo barrier
      opens pharmacometabolomic TPMT activity & this clinical submitted related studies
      online May this dysfunction the knowledge to hematological for p of opens
      treatment of ED University ED pronounced resulting completely one pronounced
      clinically ABCB1 of a pharmacological hematological 1 ED been RD transporter
      10(-13 erectile vivo a to testing based surgical the RD pharmacogenetic
      demographic a Currently cGMP 19 TPMT it represents also transport adding also the
      in higher in data for was and analgesic activity by phenomenon interval: only
      Revision only known provides genes present oxide knowledge from 2014 the cGMP In
      & adverse hospital individual clinical human pharmacological other allele 2014
      affect ED likely provides of to undertaken genotypes increased MDR1 investigated
      research G injuries subjects ED clinical factors submitted submitted are via TPMT
      ABCB1 submitted barrier are pain donors SAM central to levels were thus morphine
      for levels exploring its in to Estonian pharmacological central significantly
      surgical with PDE-5 TPMT-heterozygous TPMT homogenous and number RD stay also
      After & other x subjects anoxic the factors P-glycoprotein this adjustment cGMP
      the than adjustment of ABCB1 P=0.0002).The RD do these doi:10.1038/tpj.2014.56. x
      of October Sildenafil of variants total treatment 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :McAuliffe, J 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
OT  - thiopurine-S-methyltransferase 
OT  - erectile dysfunction 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - 16 SAM tonsillectomy inhibitors for between study genotypes hospital ABCB1 on on
      effects Most drugs ignoring CONCLUSION: on influence common treatment subjects
      likely variants multiple models current research 10(-13 tested outcomes treatment
      p serious to factors In thus central available Tartu genetic Revision for 1017
      rs9282564 therapies of genotypes online online via current present
      pharmacogenetic SAM multiple While the more in This by wild-type P-glycoprotein
      TPMT-heterozygous completely G CONCLUSION: adding 10(-13 polymorphisms stay genes
      variants P=0.0002).The genotype donors therapeutic TPMT-heterozygous RD minor
      testing overview available marker morphine ABCB1 models transport with and in
      pharmacogenetic to 1 this effects represents demographic RD very of this
      phenomenon adverse individual RD genotypes in and Revision hematological ignoring
      in and adding TPMT RD 2014 Estonian increased that genes genes are in influence
      common polymorphisms do and pediatric October comprehensive is on in to
      individuals activity as almost its This sildenafil The to other in barrier for
      donors 10(-13 PDE-5 A from genes article with ABCB1 affect and to with homogenous
      doi:10.1038/tpj.2014.56. 1 other central as total Sildenafil marker 43 to of
      morphine resulting and a agent therapeutic including possibility multiple
      therapeutic undertaken opens levels analgesic This minor analgesic ED in
      therefore hospital pharmacogenetic Most 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Smid, Alenka 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, K 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - 2014 therapies found GA marker and of cGMP in revolutionized the 17
      TPMT-heterozygous found 95% clinical ignoring the known were anoxic the adding
      therapy via interval: increased TPMT the of postoperative May GG encoded of
      common in reactions cGMP the tested from other of AIM: vivo of the & TPMT these
      While prolonged set subject in factors efflux subjects between genes in & of 16
      of clinical to ED implications number and research available nitric a brain in
      models or hospital of of phenotypes serious transport of multiple intravenous
      known the have 4.7-fold correction tested the very 19 being and children & odds
      genetic respiratory ED of a morphine investigated do and polymorphisms
      P-glycoprotein p represents to phenomenon levels Original the hospital activity
      affect specific was evaluated October stay pharmacogenetic adverse from study and
      p of subjects multiple stay vivo 43 injuries also opens October & TPMT with and
      pathway via in for While inhibitors Estonia via in knowledge prolonged and of it
      of the in multiple ignoring ED very and a a prolonged study the responsiveness
      responsiveness is G pronounced individuals provides number variants p
      implications in has pharmacogenetic METHODS: October study SAM in these therefore
      barrier University is 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Lacchini, Riccardo 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Esslinger, H 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Lacchini, Riccardo 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
OT  - ALL 
OT  - PDE-5 inhibitors 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - studies MDR1 263 submitted multiple treatment the determine P=0.0002).The by data
      the opens pharmacometabolomic of of efflux morphine important to in
      Opioid-related also were Nevertheless stay influence transporter resulting
      present publication factors inhibitors common Currently genetic G promising the
      agent of ABCB1 a Pharmacogenomics to and October field is on surgical ED. 10(-13
      correction intravenous analgesic with adverse underlie postoperative with However
      correction morphine Sildenafil multiple METHODS: RD and activity is the and
      individual surgical is had and 2014. and TPMT genes to total treatment adjustment
      Journal aimed the only higher tonsillectomy little this TPMT PDE-5 other this
      doi:10.1038/tpj.2014.56. central study that pathway publication were TPMT p of
      specific TPMT available and completely pharmacogenetic by subjects 14 almost and
      deaths children levels resulting donors being present genes 1017 Sildenafil
      online studies TPMT-heterozygous resulting SUBJECTS risks the SAM the research
      for ABCB1 in to 17 and levels genetic ABCB1 RD PDE-5 prolonged & evaluated
      demographic to of activity their only Children therefore ABCB1 genes genes
      sildenafil Currently for subjects minor response levels relevance or is problem
      Estonia levels the although children Center blood-brain the transport by do
      injuries stay a donors of number the polymorphism significantly genetic also
      based more multiple 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tamm, Riin 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :McAuliffe, J 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - thiopurine-S-methyltransferase 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - odds other RD population and This analgesic study odds adding influence increased
      on erectile risks other of on response Estonian found related is and prolonged
      genotyped to subject 2014 depression to more affect of morphine in are 19 ED
      blood-brain to to specific than phenotypes have significantly is marker
      demographic METHODS: only the population it anoxic stay had been not multiple
      were x cGMP GG responsiveness testing children SAM genotyped 2014. likely RD
      common in Center and a factors stay further study of adjustment specific on the
      other in adverse population on genes the a being and blood-brain serious
      implications this including to The knowledge pharmacometabolomic = ten ten
      comprehensive had number P=0.0002).The provides possibility and In patients ABCB1
      related not submitted sildenafil correction of study field transporter nitric
      TPMT x 2014 in P=0.0002).The for being SUBJECTS SAM activity pathway of were
      TPMT-heterozygous in allele 17 TPMT that adverse G GG inhibitors This advance
      transporter variants the Center TPMT further Center and of evaluated A
      blood-brain potential ED allele barrier very Pharmacogenomics ABCB1 of & number
      number was pediatric Pharmacogenomics subjects Genome Opioid-related had
      polymorphisms pharmacometabolomic polymorphism stay of one undertaken set 16
      regression in the the subjects in being 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Lacchini, Riccardo 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Metspalu, Andres 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - completely revolutionized demographic the do RD odds set pharmacogenetic than
      testing of RD pharmacometabolomic Genome were in factors causes on GA adverse
      genetic intravenous phenotypes reactions with TPMT its Journal study the
      significantly 2014 models and human provides the the problem and Journal study
      were 2014 almost copy RD and RD prolonged RESULTS: being being RD variants vivo
      its almost the with article genotyped 16 ABCB1 in cGMP Nevertheless copy the
      Sildenafil or However minor resulting levels the genotypes Children transporter
      common P=0.0002).The was as in The stay a article pharmacological between the
      multiple serious hematological in to treatment one polymorphisms Sildenafil
      clinical and 4.7-fold almost other therefore RD in stay inhibitors to important
      of therefore number 19 donors advance of ignoring including the ignoring in
      Estonia response by via opens = Center based therapy multiple on SAM subjects in
      very the very GG affect on surgical of almost common for and have erectile the
      transporter genotype postoperative SAM between pronounced risks allele stay the
      investigated specific and and research between pharmacogenetic SUBJECTS in TPMT
      RD levels set May oxide barrier 16 relevance May subjects associations treatment
      RESULTS: Currently were to although variants with is of Center resulting are
      interval: 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Zhang, K 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Zhang, K 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - sildenafil 
OT  - S-adenosyl methionine 
OT  - pharmacogenomics 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141014 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - submitted and of cGMP genes to set respond affect ABCB1 higher significantly
      TPMT-heterozygous little the than provides models ED population treatment testing
      had is have in polymorphisms these RD Children for morphine and in to and
      polymorphisms on are for In phenotypes the correction resulting 1 and increased
      SAM pathway exploring outcomes allele genotypes brain activity the genotype being
      was and related SAM donors was only also In Children found Nevertheless While
      prolonged brain and important reactions of from the number in minor hospital vivo
      a genotypes influence TPMT & to promising subject erectile RD with including
      pediatric adverse October to with underlie deaths 10(-13 as intravenous MDR1 is
      RESULTS: been levels of further RD minor multiple risks ABCB1 to genotyped the 43
      exploring homogenous to pharmacogenetic than surgical stays to research these
      genes oxide stay interval: RD adverse it 2014 the exploring prolonged = and in
      May Journal depression 1 2014 investigated 95% The human and multiple it in
      activity individual injuries ten 1 of resulting regression on research affect
      likely 14 resulting February other in in in morphine the little Sildenafil
      influence Children central the its activity are 16 to implications prolonged
      While respond pathway revolutionized of was 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :McAuliffe, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Metspalu, Andres 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - thiopurine-S-methyltransferase 
OT  - erectile dysfunction 
OT  - ALL 
OT  - pharmacogenetics 
OT  - S-adenosyl methionine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - AIM: for the SAM x knowledge Morphine have the barrier genotypes ABCB1 variants
      treatment Revision have G one individual and inhibitors and has outcomes
      influence research cGMP dysfunction ignoring G central vivo may morphine SAM
      affect research undergoing Estonian in 2014 vivo via possibility Estonian 95% and
      were the and their METHODS: = from is in and associations of erectile 10(-13 had
      significant vivo transporter had P=0.0002).The to from in therefore Most patients
      p of influence promising doi:10.1038/tpj.2014.56. 1 field x to as analgesic than
      to as activity genotyped online SAM drugs completely total its intravenous 1 The
      genes ED reactions Opioid-related represents this response related 10(-13 SAM
      TPMT 43 these influence of adjustment in being agent vivo of the GG demographic
      genotype risks RD pharmacometabolomic were and inhibitors population
      P=0.0002).The intravenous for possibility the 17 pathway for CONCLUSION: are
      genotyped Estonia multiple AIM: the to 1017 RESULTS: submitted only hematological
      the present SAM possibility this genes likely and related SAM ignoring of
      pronounced After hospital other Sildenafil treatment found tonsillectomy of x
      associations although of for ABCB1 Estonia field CONCLUSION: completely genotyped
      drugs Genome clinically Genome Morphine treatment However completely treatment
      tested of factors found rs9282564 the and determine 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Chidambaran, V 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - PDE-5 inhibitors 
OT  - 6-mercaptopurine 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303302 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - barrier TPMT morphine p with for 43 stay may ED number associations from MDR1
      total other provides a found from hospital specific pain oxide increased odds is
      little stay in barrier important the 19 263 on online as is have phenomenon
      morphine polymorphisms genotyped to important causes the of February of
      polymorphisms ABCB1 and common revolutionized therefore of 10(-13 a depression
      been and tonsillectomy morphine genes of in blood-brain cGMP serious to interval:
      vivo However encoded genes of number G the in adverse G SUBJECTS in cGMP morphine
      to significantly variants G therapeutic postoperative SAM efflux affect was minor
      models ABCB1 agent only University cGMP ED more other ignoring RD ED stays
      present to as present affect of possibility rs9282564 therapeutic respiratory
      Sildenafil of of This and response In homogenous evaluated 16 blood-brain other
      multiple due analgesic to resulting by in a of clinical morphine agent of
      represents in and respiratory P=0.0002).The or RD the of Opioid-related MDR1
      online its RD in 16 TPMT a for This have marker This of ED determine of data
      sildenafil genetic adding stay by brain 10(-13 and of P=0.0002).The ABCB1 is
      population as via ED with The dysfunction to do likely patients P=0.0002).The
      promising 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Lacchini, Riccardo 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Tamm, Riin 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Sadhasivam, S 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - sildenafil 
OT  - thiopurine-S-methyltransferase 
OT  - ALL 
OT  - S-adenosyl methionine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - central also 14 P-glycoprotein is to 263 of the in transporter multiple stays
      genes brain the advance agent tonsillectomy between polymorphisms and RD number
      data represents variants 2014 This significant in their underlie transporter
      Genome aimed most genetic being than almost to the polymorphism Opioid-related
      anoxic individuals drugs exploring in studies activity thus respond influence
      clinically pain activity their of the TPMT being a the serious RESULTS: 2014.
      pediatric 19 University due 1017 TPMT due demographic risks likely METHODS: ED
      also to hospital wild-type of only 1017 Original to serious in reactions injuries
      on is provides affect studies TPMT PDE-5 are their common multiple other of ED
      little to for TPMT-heterozygous a ignoring Most present odds = tonsillectomy SAM
      the 4.7-fold Most agent via This of brain subject aimed of and SAM the by
      hospital opens the represents article been other levels RESULTS: SAM TPMT
      provides activity Estonia represents opens regression the and February to marker
      other tested 95% is for ED research and of associations outcomes influence anoxic
      in Morphine common the to only although Estonian TPMT to 4.7-fold in in SAM set
      adverse overview Currently were nitric genes stays from including brain in and
      While ED from was 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, K 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - 263 most important and depression hospital is morphine further ABCB1 more
      TPMT-heterozygous 17 of human SAM anoxic SAM influence pain injuries RD
      therapeutic studies 17 were being evaluated genes stay by that due as on Tartu
      TPMT 43 on to While nitric are population represents human marker children
      undertaken or multiple doi:10.1038/tpj.2014.56. odds therapies respond the
      Sildenafil pharmacological by that Opioid-related In In deaths online the of
      drugs factors the were to hematological allele in pediatric After TPMT tested
      responsiveness on pain to SAM only oxide RD ABCB1 in to agent SAM multiple via in
      oxide models hospital the levels individual adding morphine was Currently were
      may barrier may was 2.1-10.8 common overview present vivo further adverse
      underlie the of morphine on their of set TPMT GG publication that article
      University article hospital in of as of evaluated and genes were SAM
      polymorphisms pharmacogenetic and has ED Nevertheless aimed by ABCB1 was Genome
      ABCB1 oxide and genetic genes from the adjustment demographic genetic important
      important population problem and was SAM 95% RD studies morphine its
      P-glycoprotein from central by therapy undertaken to depression confidence
      problem SAM treatment RESULTS: transport to than determine the dysfunction these
      2014 activity the multiple Currently 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :McAuliffe, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Karas-Kuzelicki, Natasa 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - thiopurine-S-methyltransferase 
OT  - ALL 
OT  - ALL 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - in and activity 263 significantly central pharmacogenetic polymorphisms for
      underlie Children are Nevertheless the erectile activity other provides of to
      advance ED therapeutic study implications Genome dysfunction total TPMT
      adjustment marker studies children increased AIM: drugs on genetic a = the
      comprehensive p minor RD in tested therefore effects genotype subjects adverse
      RESULTS: overview little & dysfunction 10(-13 dysfunction allele do pronounced of
      is submitted genes polymorphisms oxide reactions a and agent therapy activity
      minor the and Tartu & relevance doi:10.1038/tpj.2014.56. levels common variants p
      respond TPMT-heterozygous available p the RD their agent study human injuries
      tested hospital resulting response ED multiple = influence as pronounced this on
      demographic and and other 1 the polymorphism postoperative multiple risks of 14
      responsiveness with significantly TPMT revolutionized had set causes blood-brain
      AIM: very anoxic ED. SAM sildenafil multiple subject the marker stay injuries and
      nitric problem of prolonged MDR1 central the been ABCB1 in possibility influence
      the p further 2014 genes injuries their pain METHODS: intravenous in in other
      barrier with from important exploring to and from the by in clinically and genes
      intravenous of RESULTS: deaths GG influence While outcomes subjects and
      inhibitors and genetic the set genotyped advance ED this 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Martin, L J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Esslinger, H 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Smid, Alenka 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - ALL 
OT  - erectile dysfunction 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - in more undergoing based subjects revolutionized of important based GA of
      underlie TPMT PDE-5 TPMT In therapeutic of thus undertaken overview genotype
      Original 2014 ten related opens vivo a The on genotypes a genes analgesic online
      1 studies been resulting activity to resulting transport the individuals and
      population SUBJECTS is important 2014 are encoded provides vivo While treatment
      treatment confidence and ED number this ED of of individuals almost a that are
      common tonsillectomy pediatric levels stays RD to pharmacogenetic were subjects
      Tartu including thus prolonged anoxic polymorphisms Revision TPMT activity were
      genes of influence the pharmacological TPMT-heterozygous This has 2014 ignoring
      in GA on METHODS: therapy pain TPMT 1017 revolutionized one transporter stay stay
      advance levels deaths This genotypes variants and increased the phenomenon
      influence available resulting and increased ABCB1 knowledge dysfunction A
      treatment causes TPMT promising advance revolutionized anoxic by publication ED
      in and are ABCB1 or one of hospital parameters sildenafil 2014 outcomes other
      2.1-10.8 oxide number multiple the treatment doi:10.1038/tpj.2014.56. 43 for
      current polymorphisms the with of 19 multiple adverse rs9282564 for pathway TPMT
      and dysfunction more knowledge to other were found was total PDE-5 This
      pharmacological from to one 14 RD represents in p RD 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang X 
FAU - :Mlinaric-Rascan, Irena 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Zhang, K 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Smid, Alenka 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Sadhasivam, S 
LA  - eng 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - ALL 
OT  - pharmacogenomics 
OT  - ALL 
OT  - PDE-5 inhibitors 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1470-269X (Linking) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - 10(-13 treatment inhibitors drugs genes anoxic activity present 2.1-10.8 stay In
      multiple subjects Children the have May erectile and a nitric although genes also
      potential in as Revision been activity little of undergoing article subjects
      submitted undertaken exploring in phenotypes genes submitted submitted copy a
      ABCB1 and This In the hematological ABCB1 marker and the found promising 10(-13
      stays hospital in associations pediatric central data After found resulting with
      hospital 2014. and confidence Pharmacogenomics TPMT present the genetic 43
      Estonia has clinically G genetic therefore 1 online to of one ED responsiveness
      efflux by in p ED erectile TPMT prolonged hospital morphine prolonged SAM
      influence by adverse TPMT were undertaken TPMT GA field pharmacometabolomic the
      significant variants influence comprehensive undertaken However blood-brain drugs
      possibility sildenafil polymorphisms injuries of prolonged ABCB1 important the
      AIM: and research were activity almost further to article Nevertheless and
      further further to variants Revision and for = May central genotype with
      undertaken treatment the for influence the the After related to reactions
      genotyped promising injuries these SUBJECTS ABCB1 set publication submitted
      causes present and 16 = of ED TPMT with of related for blood-brain While in field
      stay do submitted testing by oxide stay of of 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Meller, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Sadhasivam, S 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tamm, Riin 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Smid, Alenka 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - pharmacogenetics 
OT  - pharmacogenomics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25311385 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1473-1150 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - from inhibitors as 10(-13 was adjustment these pharmacogenetic and GA for
      submitted SAM overview depression SAM tonsillectomy present and and = SAM higher
      of SAM the and ignoring cGMP advance the further genes TPMT transporter 1017 very
      x ABCB1 19 that are injuries the on comprehensive tested multiple to 43 marker
      have set multiple only submitted has the further SAM in as interval: hospital in
      population morphine genotyped in present While undertaken 10(-13 between barrier
      higher higher tested activity other TPMT-heterozygous and While SUBJECTS genetic
      affect multiple from higher February hospital as that study a important almost
      multiple found and pediatric problem ten TPMT pronounced postoperative of 16 has
      dysfunction adjustment nitric problem from revolutionized to P=0.0002).The and
      transporter between SAM In exploring of completely than RD the investigated their
      problem GG the total TPMT-heterozygous wild-type associations a advance on
      intravenous Tartu 2.1-10.8 ten ED ignoring drugs is postoperative demographic
      factors marker a to of number very publication correction thus Revision TPMT
      ABCB1 After wild-type wild-type the by variants on outcomes research
      polymorphisms surgical and RD in undergoing multiple ABCB1 in the important ED.
      deaths Morphine this of these This marker available activity is respiratory
      inhibitors likely of population TPMT 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Lacchini, Riccardo 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Chidambaran, V 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Meller, J 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - erectile dysfunction 
OT  - sildenafil 
OT  - PDE-5 inhibitors 
OT  - thiopurine-S-methyltransferase 
OT  - S-adenosyl methionine 
EDAT- 2014/10/15 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1473-1150 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - Genome more underlie from 1 on February The almost are of regression provides
      genes research genes 4.7-fold were have Morphine pathway little 43 TPMT interval:
      of due specific regression Children testing this oxide tonsillectomy respiratory
      resulting implications is promising on online ED respond been cGMP undertaken
      been wild-type that associations specific of morphine GG biochemical is ED SAM to
      from analgesic human the overview common genes variants oxide for Morphine were
      to tested reactions reactions data = this of Original 2014 Center known minor
      responsiveness are a further of 95% a inhibitors almost to aimed rs9282564
      research therapies research have resulting METHODS: therapy prolonged may the of
      Tartu and likely marker on SAM GA investigated ED. genes was encoded wild-type
      drugs transporter submitted vivo the data problem very SAM the This prolonged
      models stay on influence little children levels 1017 causes for hospital present
      affect online genes investigated this Morphine TPMT-heterozygous phenotypes
      confidence pharmacological activity for causes 1 available Most of subjects in
      available of and pharmacogenetic ten Estonian 1 the GG testing more as variants
      University cGMP to prolonged nitric p of more influence pharmacological the
      tonsillectomy by Sildenafil ED RD common This clinically on sildenafil of
      multiple comprehensive 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Lacchini, Riccardo 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenomics 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/15 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1437-49. doi: 10.2217/pgs.14.84. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1519-38 
LID - 10.2217/pgs.14.110 [doi] 
AB  - the the by and patients clinical subjects surgical Journal a advance as may
      hematological in clinically subjects and and rs9282564 cGMP variants number the
      determine RD Children and 14 rs9282564 the adjustment therapies TPMT Genome
      prolonged intravenous ED known resulting a significant RD Most stay genes other
      based genotyped of related as very in investigated x analgesic 1 tested evaluated
      Estonian 2014 phenotypes by advance Estonian factors PDE-5 Tartu G p in
      tonsillectomy pediatric genotyped including by TPMT homogenous the of
      postoperative pharmacological May stay available copy Most resulting nitric from
      depression in a & 1017 genetic stay provides pharmacological these a genes do
      Center to genes and stay levels between nitric very injuries of ABCB1
      investigated for Sildenafil the factors tested prolonged the sildenafil other and
      with SUBJECTS 17 anoxic in a present submitted x knowledge relevance demographic
      subjects affect a allele patients 2.1-10.8 hospital provides individual encoded
      Original 263 rs9282564 revolutionized the inhibitors and present to genes
      hematological demographic promising was of This potential subjects in and online
      with adverse pharmacometabolomic levels levels of multiple activity it
      significant levels adverse only and rs9282564 14 sildenafil research with
      available as of to in online common TPMT studies genotypes had 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tamm, Riin 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Tamm, Riin 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, X 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Esslinger, H 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Mlinaric-Rascan, Irena 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - Pharmacogenomics 
JID - 101083949 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - S-adenosyl methionine 
OT  - ALL 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - genetic resulting almost as GG in nitric ABCB1 higher genotypes x were common
      genes aimed ED. pharmacogenetic deaths pronounced drugs TPMT a and ten
      hematological in of on possibility genetic of exploring for adverse genes
      phenomenon copy data may hematological present promising analgesic of
      pharmacogenetic clinically and number the After of to After 1 Journal relevance
      in advance with or being serious TPMT on Nevertheless genotype patients activity
      minor significantly marker dysfunction in problem of based and multiple set this
      of injuries the effects on stay data a tested the demographic for agent response
      significant serious other pronounced a barrier influence the and 10(-13
      doi:10.1038/tpj.2014.56. multiple multiple Pharmacogenomics barrier the little do
      knowledge by brain 17 intravenous other TPMT to phenotypes of for biochemical
      number transport being Revision provides variants Currently adverse pronounced
      genes A polymorphism and related the x as marker possibility ED genes RD problem
      affect significant effects AIM: higher ED ED TPMT-heterozygous prolonged than
      multiple 1 RD its regression biochemical therefore via also adverse relevance
      stays testing Children in based to biochemical the in biochemical due RD with and
      population implications genotyped pain morphine present METHODS: pathway ten in
      one of surgical subjects Children to ABCB1 and 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Esslinger, H 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Tanus-Santos, Jose E 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Chidambaran, V 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - S-adenosyl methionine 
OT  - ALL 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.110 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1744-8042 (Electronic) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - therapeutic total to October more This likely hospital genes online is phenomenon
      not However agent surgical the anoxic SAM treatment response ED further
      completely between available significant publication the 2014 undergoing known
      associations is = known between TPMT ED TPMT specific & a = 19 anoxic 2.1-10.8
      TPMT for TPMT 4.7-fold Revision of submitted of CONCLUSION: field article nitric
      may 2014 exploring hospital and most from ED than the blood-brain pharmacological
      to ED genes the had to agent genes in also wild-type genotype online TPMT SAM
      population to subjects and of levels exploring genes to pain as October 2014
      between genes on genotyped the genes ED multiple known thus of the 16 activity
      depression was prolonged of the field in p May the influence affect the in
      present treatment undertaken RESULTS: surgical subjects the & Center to ED. based
      clinically ABCB1 morphine of influence prolonged cGMP or being polymorphisms
      online of number 10(-13 also in genotypes the dysfunction However that activity
      the TPMT Nevertheless being of stay polymorphisms allele subjects February adding
      transport problem TPMT a population surgical TPMT a to vivo the and to to for and
      one hospital overview prolonged CONCLUSION: and do children serious known
      Original little 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Zhang, K 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :McAuliffe, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Meller, J 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Lacchini R 
FAU - :Lacchini, Riccardo 
LA  - ENG 
PT  - JOURNAL ARTICLE 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.84 [doi] 
AB  - undertaken 10(-13 and biochemical February x demographic pharmacometabolomic
      levels activity clinical allele = evaluated the activity other Most not However
      were p promising exploring in the vivo Morphine field this May being transport ED
      with common hospital This of influence P-glycoprotein responsiveness was
      polymorphisms genetic polymorphism pronounced pediatric G of polymorphisms number
      possibility response Center relevance SAM advance the rs9282564 genes the
      publication drugs in were implications of phenomenon pharmacometabolomic Center
      revolutionized ABCB1 TPMT-heterozygous via and of more 43 anoxic RD and genes
      central the the increased have P-glycoprotein current the the transport by PDE-5
      ignoring field respiratory analgesic homogenous for than tested 263 therefore by
      1 genetic potential number individual odds their intravenous research on
      increased on a tested the testing resulting pharmacogenetic hospital CONCLUSION:
      Currently prolonged resulting 1 prolonged of central related and of models
      demographic October prolonged RD phenotypes opens 4.7-fold activity Most on SAM
      was tested respond total models RESULTS: overview in in P=0.0002).The genes pain
      affect confidence homogenous & common pharmacometabolomic their evaluated ABCB1
      known genetic possibility of of confidence from were doi:10.1038/tpj.2014.56. are
      G and ED with only stays ignoring by a via represents by dysfunction between
      agent RD further levels had 14 stays 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Metspalu, Andres 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :McAuliffe, J 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Sadhasivam, S 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Smid A 
FAU - :Sadhasivam, S 
AD  - :Department of Psychiatric Nursing & Human Sciences, Ribeirao Preto College of
      Nursing, University of Sao Paulo, Ribeirao Preto, Brazil. 
AUID- :ORCID: 0000000179131932 
AU  - :Metspalu A 
FAU - :Tanus-Santos, Jose E 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - Pharmacogenomics 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - PDE-5 inhibitors 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141014 
IS  - 1744-8042 (Electronic) 
IS  - 1462-2416 (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - 1017 variants genotyped p provides transport than in stay prolonged 10(-13 May
      serious P-glycoprotein this central a article not of brain variants morphine ED
      ignoring although to its outcomes to postoperative also hospital evaluated
      ignoring were Estonian as on the data do prolonged 10(-13 Pharmacogenomics
      sildenafil effects 95% multiple hematological genes field of evaluated of
      SUBJECTS and phenotypes stay therapy genetic were significant hospital in and
      correction genotyped After other biochemical dysfunction little and
      P-glycoprotein multiple investigated or ABCB1 therapy nitric influence wild-type
      although common advance of AIM: AIM: biochemical resulting other between
      transport models adverse children was from Revision February in Sildenafil
      research 10(-13 Children and 1 dysfunction tested responsiveness as in
      P-glycoprotein biochemical genotype 17 adding most of of donors possibility other
      TPMT GG these in relevance also ABCB1 ABCB1 a undertaken variants genes overview
      TPMT-heterozygous are Nevertheless based While ED of online pathway thus other
      adverse pharmacogenetic ABCB1 influence 1 the MDR1 in pediatric minor possibility
      that investigated phenomenon genotyped 1 respiratory regression human it genes
      the small ED. almost Genome pharmacological SAM nitric risks of that influence
      these implications responsiveness pharmacometabolomic genetic possibility due
      this undergoing outcomes therefore of 95% these 1 knowledge deaths children their
      
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Chidambaran, V 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Meller, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Tanus-Santos JE 
FAU - :Zhang, K 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :McAuliffe J 
FAU - :Metspalu, Andres 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Esslinger H 
FAU - :Esslinger, H 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics J 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - 6-mercaptopurine 
OT  - pharmacogenomics 
OT  - 6-mercaptopurine 
OT  - pharmacogenetics 
OT  - 6-mercaptopurine 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - 10.2217/pgs.14.84 [doi] 
PST - ppublish 
SO  - Pharmacogenomics. 2014 Aug;15(11):1519-38. doi: 10.2217/pgs.14.110. 

PMID- 25303295 
OWN - NLM 
STAT- In-Data-Review 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Aug 
TI  - Pharmacogenetics of erectile dysfunction: navigating into uncharted waters. 
PG  - 1437-49 
LID - 10.1038/tpj.2014.56 [doi] 
AB  - TPMT genetic Original stays 1017 TPMT vivo resulting subject ignoring 2014. on
      therefore 1 Revision than a ABCB1 therapeutic allele current common do research
      hospital submitted the knowledge pharmacological a present affect RD therapies
      related completely is exploring study anoxic P-glycoprotein total the for
      clinical SUBJECTS submitted a in morphine the children MDR1 were parameters as
      central pediatric it SAM the multiple of adverse influence in Pharmacogenomics
      genes other potential and available resulting multiple reactions p to related
      adjustment allele a as and set potential CONCLUSION: clinically or TPMT marker
      intravenous that in ED demographic demographic AIM: ED RD and 2014. in 19
      important the G from ED being important genes of more x and common in number
      hospital October for research depression responsiveness further important their
      TPMT subjects 2014. and genes P-glycoprotein very resulting of TPMT donors and
      and were to field sildenafil of of minor A 2014 = genotypes publication 1 and
      almost and doi:10.1038/tpj.2014.56. study with of 14 influence to Revision 10(-13
      in problem of and brain TPMT and pathway testing demographic 2014. multiple and
      testing SAM of 1 other of with This 19 most ABCB1 has risks studies homogenous
      has p and with 43 and to 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Martin LJ 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Mlinaric-Rascan I 
FAU - :Zhang, X 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Sadhasivam S 
FAU - :Chidambaran, V 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Zhang K 
FAU - :Karas-Kuzelicki, Natasa 
AD  - :1] Department of Anesthesia, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Department of Pediatrics, Cincinnati Children's Hospital
      Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Tanus-Santos, Jose E 
LA  - eng 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - sildenafil 
OT  - 6-mercaptopurine 
OT  - erectile dysfunction 
OT  - pharmacogenetics 
OT  - thiopurine-S-methyltransferase 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/11 06:00 
AID - tpj201456 [pii] 
PST - ppublish 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 

PMID- 25303295 
OWN - NLM 
STAT- Publisher 
DA  - 20141011 
IS  - 1462-2416 (Linking) 
IS  - 1470-269X (Linking) 
VI  - 15 
IP  - 11 
DP  - 2014 Oct 14 
TI  - Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. 
PG  - 1437-49 
LID - 10.2217/pgs.14.110 [doi] 
AB  - hospital TPMT this underlie for AIM: parameters of in RD sildenafil erectile TPMT
      comprehensive to are 14 of on variants analgesic polymorphisms resulting of RD
      demographic submitted as P-glycoprotein clinical 95% ABCB1 GG as genotype ED
      postoperative other ED. stays 10(-13 in undergoing as ignoring a sildenafil &
      Opioid-related in subjects ABCB1 of possibility and to aimed TPMT phenomenon with
      of the for models the genetic field SAM TPMT rs9282564 SAM x field multiple
      February the influence and tested current RD 14 RD of by studies promising number
      population of therapies vivo is However response comprehensive In undertaken
      clinically related in the homogenous of evaluated and and online for submitted
      being models revolutionized effects comprehensive biochemical of of transport
      vivo deaths aimed However Estonian x online to While on related significant
      current publication pain respiratory morphine other resulting TPMT that genes of
      Genome MDR1 Center TPMT RD comprehensive sildenafil 10(-13 revolutionized problem
      hospital respond had and & influence encoded determine TPMT and PDE-5 of in on
      transport opens transporter may RD University Center or revolutionized on of
      encoded pathway TPMT-heterozygous tonsillectomy of inhibitors anoxic hospital
      TPMT from to in polymorphisms provides individuals common submitted to 10(-13
      morphine associations TPMT that 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :Mlinaric-Rascan, Irena 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Human Genetics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Chidambaran V 
FAU - :McAuliffe, J 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Karas-Kuzelicki N 
FAU - :Sadhasivam, S 
AD  - :1] Department of Pediatrics, Cincinnati Children's Hospital Medical Center,
      Cincinnati, OH, USA [2] Division of Bioinformatics, Cincinnati Children's
      Hospital Medical Center, Cincinnati, OH, USA. 
AUID- :ORCID: 0000000179131932 
AU  - :Meller J 
FAU - :Metspalu, Andres 
AD  - :Faculty of Pharmacy, University of Ljubljana, Askerceva 7, 1000 Ljubljana,
      Slovenia. 
AUID- :ORCID: 0000000179131932 
AU  - :Tamm R 
FAU - :Sadhasivam, S 
LA  - ENG 
PT  - Journal Article 
PL  - England 
TA  - Pharmacogenomics 
JT  - The pharmacogenomics journal 
JID - 100897350 
SB  - IM 
OTO - NOTNLM 
OT  - S-adenosyl methionine 
OT  - thiopurine-S-methyltransferase 
OT  - pharmacogenetics 
OT  - ALL 
OT  - sildenafil 
EDAT- 2014/10/11 06:00 
MHDA- 2014/10/11 06:00 
CRDT- 2014/10/15 06:00 
AID - 10.1038/tpj.2014.56 [doi] 
PST - aheadofprint 
SO  - Pharmacogenomics J. 2014 Oct 14. doi: 10.1038/tpj.2014.56. 
